NEJM-PatientID			1	5	3	7	2	4	10	9	8	10	16	17	15	18	19	21	20	6	13	14	11	12
Mutation			BRCA1	BRCA1	BRCA1	BRCA1	BRCA1	BRCA1	BRCA2	BRCA2	BRCA2	BRCA2	Sporadic	Sporadic	Sporadic	Sporadic	Sporadic	Sporadic	Sporadic/Meth.BRCA1	BRCA1	BRCA2	BRCA2	BRCA2	BRCA2
PlatePosition	ImageCloneID	Title	s1996	s1822	s1714	s1224	s1252	s1510	s1900	s1787	s1721	s1486	s1572	s1324	s1649	s1320	s1542	s1281	s1321	s1905	s1816	s1616	s1063	s1936
HK1A1	21652	"catenin (cadherin-associated protein), alpha 1 (102kD)"	0.15	0.22	0.3	0.26	1.22	0.44	0.35	1.1	1.07	1.46	0.36	0.57	0.31	0.48	0.4	0.25	0.44	0.38	0.73	0.63	0.77	0.66
HK1A2	22012	ADP-ribosylation factor 3	1.54	1.27	0.76	0.85	1.27	0.64	0.9	0.64	0.78	0.55	1.02	0.39	1.39	0.83	1.02	0.61	1.53	0.61	0.71	0.3	0.62	1
HK1A4	22293	uroporphyrinogen III synthase (congenital erythropoietic porphyria)	1.72	1.57	2.13	1.09	1.98	0.74	1.71	1.16	1.33	1.46	0.83	1.13	1.46	2.24	1.18	1.34	1.14	2.43	1.71	1.26	1.41	3
HK1A5	22493	ribosomal protein L26	0.71	1.24	1.69	2.23	1.16	0.82	1.44	2.03	3.6	1.2	1.72	1.75	0.93	1.09	0.67	1.23	1.06	2.08	3.24	2.41	1.56	2.56
HK1A6	23019	"guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1"	0.94	1.53	1.87	1.19	1.16	1.54	1.05	0.91	0.85	1.22	1.29	0.74	0.87	1.05	0.62	1.34	1.08	1.01	3.25	2.2	1.09	1.29
HK1A7	23132	"pre-mRNA splicing factor SF3a (120 kDa subunit), similar to S. cerevisiae PRP21"	0.8	0.95	1.53	1.37	1.02	1.22	0.78	0.96	0.65	1.02	1.22	0.74	0.84	0.56	0.93	0.94	0.84	1.09	0.66	1.4	1.32	1.13
HK1A8	24145	adenylyl cyclase-associated protein	0.78	0.81	1.42	0.97	1.04	1.12	1.04	0.97	0.88	1.11	1.32	0.64	0.67	0.77	1.24	1.36	0.91	0.56	1.57	0.47	0.97	1.36
HK1A9	25584	ubiquinol-cytochrome c reductase core protein II	0.27	0.35	0.87	0.88	0.51	0.45	0.35	0.42	0.28	0.34	0.47	0.38	0.43	0.44	0.36	0.68	0.38	0.39	0.21	0.34	0.49	0.32
HK1A10	25725	farnesyl-diphosphate farnesyltransferase 1	1.84	1.56	0.85	0.94	0.98	1.1	0.68	0.91	0.44	0.49	0.81	1.97	2.68	1.92	1.38	0.99	0.87	1.41	1.5	0.86	1.16	1.57
HK1A11	26184	"phosphofructokinase, platelet"	0.82	1.2	0.74	1.08	0.73	1.27	0.64	0.41	0.47	0.68	0.57	0.12	0.37	0.31	0.51	0.87	0.61	1.13	0.33	0.33	0.74	0.17
HK1B1	26922	deoxyhypusine synthase	1.78	0.71	0.77	0.69	0.54	0.7	0.55	0.96	0.95	1.07	0.67	0.76	0.77	1.02	0.62	0.47	0.31	0.53	1.47	1.76	2.12	0.8
HK1B2	27549	heterogeneous nuclear ribonucleoprotein A1	0.59	1.08	1.16	0.7	0.76	0.52	0.62	0.41	0.43	0.57	0.52	0.41	1.02	1	0.64	0.69	0.82	1.12	0.68	0.29	0.35	0.69
HK1B3	27624	"coatomer protein complex, subunit alpha"	2.17	1.22	1.64	1.79	0.92	1.65	1.32	1.44	1.29	1.25	1.62	1.38	0.93	1.37	1.71	1.07	1.85	3.35	1.27	1.15	2.24	1.42
HK1B4	27848	acetyl-Coenzyme A acyltransferase 1 (peroxisomal 3-oxoacyl-Coenzyme A thiolase)	0.62	0.73	1.05	0.71	0.62	0.54	0.6	0.38	0.43	0.65	0.55	0.76	0.79	0.82	0.52	0.78	0.77	0.69	1.37	0.92	0.67	1.05
HK1B5	28309	"phosphatidylinositol 4-kinase, catalytic, alpha polypeptide"	1.05	0.92	1.58	0.97	0.8	0.73	0.97	1.1	1.55	0.8	0.9	1.2	1.43	1.39	1.46	0.74	0.65	2.6	2.21	1.75	2.03	1.84
HK1B6	28410	"Human AMP deaminase isoform L (AMPD2) mRNA,  exons 6-18, partial cds"	1.69	1.48	1.93	1.88	1.4	1.58	1.89	1.7	1.15	2.22	1.14	0.97	1.45	1.23	0.92	1.5	1.48	1.82	1.65	1.31	1.31	3.62
HK1B7	28985	"N-acetylgalactosaminidase, alpha-"	1.12	1.06	1.57	1.32	1.52	1.31	1.13	1.51	1.15	1.38	1.44	1.57	1.13	1.33	1.53	0.61	1.03	0.83	2.22	2.09	3.01	1.95
HK1B8	29054	"ARP1 (actin-related protein 1, yeast) homolog A (centractin alpha)"	0.87	1.08	0.81	1.54	1.45	0.97	1.63	1.48	1.45	1.57	1.42	0.86	0.82	1.1	1	1.71	1.01	1.09	1.79	1.81	1.31	1.68
HK1B9	30272	"solute carrier family 9 (sodium/hydrogen exchanger), isoform 1 (antiporter, Na+/H+, amiloride sensitive)"	0.7	0.72	1.17	0.78	0.9	0.68	0.85	0.59	0.63	1.52	0.91	1.14	0.82	0.83	0.99	0.6	0.71	0.56	1.72	0.8	1.54	1.69
HK1B10	30664	aspartylglucosaminidase	1.31	3.23	1.56	2.06	2.28	1.91	1.33	1.47	1.41	1.96	1.24	1.39	1.4	1.66	1.19	2.07	1.89	1.15	1.23	1.21	0.78	2.27
HK1B11	31143	"ribosomal protein, large, P0"	0.29	0.71	0.6	1.11	0.42	0.41	0.44	0.33	0.24	1.28	0.37	0.5	0.54	0.45	0.39	0.36	0.55	0.96	1.27	1.57	0.35	0.69
HK1B12	31169	"capping protein (actin filament) muscle Z-line, alpha 2"	0.66	1.11	1.35	1.05	1.38	1.11	1.07	0.96	0.86	1.26	1.95	0.57	0.97	0.59	0.86	2.21	0.97	0.63	0.65	0.99	0.6	0.77
HK1C2	32875	Death associated protein 3	1.43	2.47	0.84	2.1	1.68	2.12	1.52	1.18	1.54	1.58	1.32	1.57	1.44	2.09	1.28	1.68	2.44	4.02	1.47	1.25	1.4	1.83
HK1C3	32898	"enoyl Coenzyme A hydratase, short chain, 1, mitochondrial"	0.67	1.08	2.77	1.26	2.29	1.16	1.4	1.45	1.34	1.7	2.13	0.69	0.59	0.97	0.84	1.09	0.68	1.58	1.93	1.18	1.24	1.13
HK1C4	33525	eukaryotic translation elongation factor 1 gamma	0.51	1.14	0.88	0.77	1.11	0.69	0.65	0.47	0.47	0.81	0.74	0.63	1.05	0.52	0.91	0.84	0.98	1.03	1.46	1.17	1.11	1.07
HK1C5	33632	"glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)"	1.05	1.33	2.3	2.8	1.41	2.77	1.42	2.7	2.81	2.4	2.14	1.12	1.28	1.59	1.04	0.95	1.99	2.63	1.6	0.95	0.86	1.76
HK1C6	34255	catechol-O-methyltransferase	1.53	0.71	0.84	0.71	0.79	0.7	0.8	0.65	0.46	0.89	0.73	1.21	1.62	1.63	1.57	1.05	0.82	1.54	1	0.65	1.09	0.9
HK1C7	34357	"actin, beta"	0.99	1.43	1.65	0.84	1.05	0.83	0.73	0.81	0.89	0.86	1.21	1.14	0.89	0.89	0.88	0.78	0.93	0.95	3.47	2.15	1.1	1.11
HK1C8	34355	"calmodulin 2 (phosphorylase kinase, delta)"	2.87	1.43	1.56	2.16	1.32	1.66	1.13	1.25	0.93	1.19	1.34	1.75	1.57	2.05	1.96	1.43	1.33	1.88	1.44	1.15	0.9	1.47
HK1C9	34396	"Human 90-kDa heat-shock protein gene, cDNA, complete cds"	0.72	1.73	1.29	0.99	1.03	0.95	0.85	1.05	1.23	1.71	1.44	1.01	0.89	1.13	1.29	1.02	1.31	1.17	1.28	1.58	0.84	1
HK1C10	34945	"Tu translation elongation factor, mitochondrial"	0.52	0.97	0.87	0.8	0.75	0.5	0.74	0.6	0.67	0.68	0.72	0.59	0.85	0.77	0.68	0.77	0.74	0.72	0.37	0.78	0.99	0.74
HK1D2	37196	accessory proteins BAP31/BAP29	1.23	1.08	0.65	0.46	0.73	0.98	1.09	0.85	0.8	1.23	1.26	0.94	0.67	0.84	1.26	0.91	0.85	0.91	1.06	1.23	1.06	1.05
HK1D3	37366	"Homo sapiens clone 24703 beta-tubulin mRNA, complete cds"	1.34	0.69	1.81	1.01	1.16	2.58	0.49	2.07	3.13	1.16	1.38	2.24	1.94	2.17	1.33	1	1.9	2.77	3.15	0.71	0.85	1.53
HK1D5	37904	glycogen synthase kinase 3 beta	1.73	0.61	1.54	0.91	0.64	0.93	0.67	1.11	1.16	0.93	1.12	1.52	1.22	1.17	1.74	0.88	0.8	1.12	1.56	0.75	1.15	1.19
HK1D6	38471	"Human cyclin G1 interacting protein (1500GX1) mRNA, complete cds"	1.34	1.17	0.76	0.86	1.09	0.81	1.66	1.49	1.74	0.94	1.45	1.11	1.08	1.29	1.15	1.46	0.73	0.57	1.79	3.23	2.07	1.7
HK1D10	39285	glutamate dehydrogenase 1	0.54	0.6	0.37	0.74	0.69	0.38	0.74	0.75	0.51	0.53	0.65	0.85	1.42	0.99	0.9	0.66	0.87	0.41	0.38	0.82	0.35	0.61
HK1D11	39796	3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase (hydroxymethylglutaricaciduria)	0.81	0.53	0.8	0.62	0.61	0.89	0.56	1.06	1.29	0.64	0.58	1.08	1.07	0.98	0.85	0.62	0.62	0.93	1.11	1.08	0.88	1.44
HK1E1	39993	"superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))"	0.93	0.61	0.84	0.71	0.56	0.52	0.63	0.76	1.32	0.98	0.68	1.05	0.62	0.99	0.43	0.86	0.9	0.96	2.16	0.75	0.99	1.35
HK1E3	40304	"succinate dehydrogenase complex, subunit A, flavoprotein (Fp)"	1.68	0.73	2.33	1.32	1.06	0.86	0.95	1.52	0.87	1	1.08	0.92	1.15	0.98	1.46	0.78	0.9	0.69	0.64	0.7	0.75	1.08
HK1E4	40360	"eukaryotic translation initiation factor 2B, subunit 5 (epsilon, 82kD)"	2.37	2.05	1.22	1.21	1.88	1.21	1.88	1.35	2.1	1.48	1.06	1.86	1.53	2.29	1.4	1.4	1.45	1.6	2.41	1.5	1.33	2.64
HK1E5	41199	"chromatin assembly factor 1, subunit B (p60)"	2.05	0.72	2.05	1.57	0.99	0.66	1.36	1.85	2.38	1.54	0.69	1.1	1.14	1.65	1.06	0.93	1.67	1.88	1.4	1.16	1.01	1.33
HK1E6	41452	spermidine/spermine N1-acetyltransferase	0.36	0.97	1.38	0.58	1.02	0.47	0.81	0.69	0.83	0.9	0.64	0.33	0.49	0.53	1.17	1.85	0.6	0.34	1.02	0.29	0.5	0.76
HK1E7	41511	"eukaryotic translation initiation factor 2, subunit 2 (beta, 38kD )"	0.91	0.69	0.85	0.76	0.79	0.62	0.58	0.54	0.72	0.79	0.51	0.48	0.38	0.53	0.69	1.53	0.78	0.84	0.43	0.31	0.42	0.63
HK1E8	42059	"dihydrolipoamide dehydrogenase (E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex, branched chain keto acid dehydrogenase complex)"	0.67	0.89	0.74	0.93	0.91	0.9	0.62	0.46	0.29	0.7	0.53	0.37	0.75	0.55	0.71	1.23	0.85	0.47	0.55	0.49	0.54	0.85
HK1E9	42096	"chaperonin containing TCP1, subunit 3 (gamma)"	1.09	2.03	0.75	1.47	1.03	1.04	1.15	0.61	0.78	1.17	1.1	0.68	0.72	1.25	1.04	1.01	1.2	2.89	0.73	0.54	0.72	1.41
HK1E10	42214	spleen tyrosine kinase	4.57	2.2	1.77	2.73	3.4	4.33	2.03	2.65	2.91	0.73	1.01	1.66	2.6	2.59	2.22	1.76	2.84	1.52	2.57	1.85	2.11	2.04
HK1E11	42352	adenine nucleotide translocator 3 (liver)	0.39	0.61	1.17	0.25	0.54	0.63	0.81	0.33	0.52	0.8	0.57	0.45	0.56	0.44	0.34	0.65	0.54	0.78	1.58	0.99	0.73	0.72
HK1F2	43021	histidyl-tRNA synthetase	0.56	0.82	0.53	0.92	0.97	0.52	0.92	0.75	1.18	0.75	0.81	0.8	0.75	1.02	0.66	0.92	0.93	0.76	0.88	0.7	1.19	1.08
HK1F3	43129	"phospholipase C, gamma 1 (formerly subtype 148)"	0.6	0.72	0.74	1.02	0.74	0.47	0.77	0.7	0.89	0.84	0.64	0.73	0.69	0.78	0.88	0.91	0.48	0.88	0.78	0.59	0.81	0.65
HK1F4	43231	"proteasome (prosome, macropain) 26S subunit, non-ATPase, 2"	1.89	1.36	1.08	1.19	1.28	1.03	1.05	1.43	1.36	0.99	1.16	1.19	0.84	0.91	0.99	1.07	1.82	1.54	1.02	1.36	0.85	1.24
HK1F5	43338	heterogeneous nuclear ribonucleoprotein C (C1/C2)	0.87	1.46	1.06	1.22	0.66	0.93	0.76	0.77	0.83	0.91	0.93	0.77	0.85	1.09	1.01	0.68	0.73	1.05	0.74	0.95	0.9	1.18
HK1F6	43241	"eukaryotic translation initiation factor 4A, isoform 2"	2.45	1.89	1.14	1.39	1.68	1.03	1.56	1.03	1.18	1.57	1.23	1.5	1.42	1.47	0.98	1.26	1.8	1.02	1	1.29	0.66	1.49
HK1F7	43550	lactate dehydrogenase A	0.29	0.57	0.94	0.34	0.36	0.18	0.59	0.29	0.29	0.68	0.25	0.25	0.45	0.47	0.93	0.56	0.64	0.55	0.43	0.73	0.73	0.58
HK1F8	43563	"cytochrome P450, subfamily XXVIIA (steroid 27-hydroxylase, cerebrotendinous xanthomatosis), polypeptide 1"	3.76	7.81	1.66	2.46	5.38	5.84	3.58	3.73	5.09	2.89	2.95	5.79	4.1	4.67	0.96	1.99	3.45	10.42	10.22	4.09	4.41	8.57
HK1F9	43622	"glutamate receptor, ionotropic, AMPA 2"	3.62	1.03	0.82	1.27	1.06	0.68	1.23	1.3	2.36	4.53	0.83	1.33	3.89	9.58	1.2	0.51	1.17	2.43	1.89	0.54	1.56	1.68
HK1F10	44180	alpha-2-macroglobulin	4.8	12.92	10.07	7.12	10.28	8.27	8.02	11.16	10.24	8.84	5.75	9.13	5.9	13.97	3.64	4.47	5.65	19.54	10.68	5.41	2.03	7.53
HK1F11	44255	"ribosomal protein, mitochondrial, L3"	1.42	0.79	0.87	1.08	0.93	0.89	0.92	1.05	0.86	0.6	0.84	0.9	1.01	1.25	1.27	0.63	1.1	1.49	1.44	0.78	0.76	0.55
HK1F12	44307	"H2B histone family, member Q"	0.56	1.2	1.24	0.58	0.87	0.62	0.62	0.63	0.57	0.61	1.19	0.58	0.92	0.5	0.67	0.87	0.83	0.56	0.45	0.36	0.51	0.65
HK1G1	44537	small nuclear ribonucleoprotein polypeptides B and B1	0.69	1.03	0.87	0.84	0.69	0.85	0.86	0.66	0.83	0.98	2.02	0.76	0.53	1	0.92	1.53	0.66	1.29	1.38	1.28	1.11	0.84
HK1G2	45233	"chaperonin containing TCP1, subunit 6A (zeta 1)"	1.46	1.34	1.16	1.78	1.4	1.63	1.11	0.9	0.97	1.71	0.77	0.85	1.01	1.2	1.69	2.42	1.7	1.21	0.69	0.76	0.75	0.91
HK1G3	45941	DNA (cytosine-5-)-methyltransferase 1	1.71	1.91	2.14	2.71	1.4	1.86	0.89	2.1	2.53	1.29	1.43	0.97	1.52	2.97	1.36	0.73	1.48	3.51	2.36	1.82	1.39	1.56
HK1G4	46171	"eukaryotic translation initiation factor 4A, isoform 1"	0.75	0.86	1.69	0.89	1.33	0.76	1.01	0.68	0.6	0.96	1	0.6	0.88	0.82	0.82	0.97	0.99	0.96	1.2	1.06	0.97	0.76
HK1G6	47202	ADP-ribosylation factor 1	2.03	1.74	1.62	1.46	1.5	1.52	1.44	1.46	0.78	1.58	2.04	0.88	0.99	1.46	1.57	1.74	1.42	1.56	3.46	2.62	1.31	1.61
HK1G7	47833	"Tubulin, alpha, brain-specific"	1.25	1.12	1.86	1.72	0.78	1.18	0.84	1.09	1.03	1.79	1.27	1.34	0.99	1.11	1.48	0.81	1	1.33	1.34	2.55	1.38	1.24
HK1G8	49888	ADP-ribosylation factor 4-like	0.58	0.61	0.43	0.36	0.57	0.36	0.45	0.61	0.46	0.52	0.28	0.82	0.45	0.58	0.8	1.12	0.36	0.48	0.53	0.33	0.36	0.44
HK1G9	50117	glyceraldehyde-3-phosphate dehydrogenase	0.26	0.69	1.23	0.6	0.47	0.43	0.4	0.34	0.59	0.46	0.35	0.4	0.28	0.52	0.29	0.55	0.91	0.97	1.02	1.83	1.12	0.81
HK1G10	50359	mannose phosphate isomerase	1.04	1.45	1.25	1.2	1.49	1.21	1.62	1.42	2.1	1.26	0.64	1.58	1.88	1.91	1.27	1.71	1.18	1.43	1.73	0.95	1.05	1.28
HK1G11	50666	dolichyl-diphosphooligosaccharide-protein glycosyltransferase	0.72	0.68	0.92	0.83	0.52	0.85	0.51	0.62	0.4	0.74	0.91	0.65	0.55	0.53	1.29	0.58	0.68	0.63	0.72	0.79	1.19	0.95
HK1G12	50941	"cadherin 13, H-cadherin (heart)"	0.56	0.86	0.56	0.51	0.89	1.23	0.66	0.64	1.16	0.49	0.33	0.46	0.6	0.59	0.5	0.99	0.59	0.26	3.52	0.48	0.71	0.75
HK1H1	51293	aminoacylase 1	1.09	2.11	1.42	1.21	1.76	0.6	0.94	1.25	2.02	0.73	1.12	0.74	0.96	1.19	0.82	1.59	0.93	1.12	2.11	1.11	0.67	0.64
HK1H2	51666	"excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing)"	1.01	1.8	0.93	1.18	1.39	1.23	0.99	1.15	1.59	1.08	1.01	1.45	1.65	1.18	1.05	1.16	1.75	1.9	1.6	1.75	1.14	1.27
HK1H3	51740	"hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit"	0.62	1.11	0.6	0.7	0.58	0.78	0.34	0.8	0.76	0.33	0.64	0.81	0.74	0.45	0.79	0.46	0.52	0.6	0.87	0.49	0.88	0.82
HK1H4	53316	"malate dehydrogenase 1, NAD (soluble)"	1.24	0.53	0.92	1.34	0.62	0.87	0.48	0.83	0.49	0.52	0.56	0.67	0.6	0.6	0.63	1.5	0.77	0.65	0.35	0.36	0.73	0.56
HV1A3	50794	zinc finger protein 133 (clone pHZ-13)	0.55	0.78	0.78	0.82	0.77	0.45	0.59	0.37	0.55	1.02	0.49	0.58	0.59	0.62	0.53	0.77	0.4	0.34	0.77	0.75	0.91	1.03
HV1A4	768644	zona pellucida glycoprotein 3A (sperm receptor)	2.32	1.49	1.04	0.9	1.68	1.91	1.29	0.87	1.84	1.27	1.92	1.77	2.67	3.35	0.89	1.1	1.09	1.8	1.42	2.74	1.97	2.11
HV1A8	753430	alpha thalassemia/mental retardation syndrome X-linked	1.29	1.77	1.28	1.32	2.31	0.73	1.97	1.21	1.28	0.62	0.42	1.31	1.37	2.11	0.95	1.18	1.12	1.54	0.89	0.82	0.73	1.3
HV1A9	324901	"wingless-type MMTV integration site family, member 5A"	0.63	0.72	1.11	1.17	1.4	0.26	0.71	1.36	0.39	1.66	0.57	0.5	0.51	0.51	0.48	0.8	0.73	0.33	0.5	1.4	1.52	3.21
HV1A11	234856	von Hippel-Lindau syndrome	1.88	0.93	2.16	2.23	1.51	0.88	1.74	2.16	2.71	1.68	0.91	2.03	1.77	2.02	0.86	0.84	1.36	1.67	1.32	0.8	1.46	1.69
HV1B1	755145	villin 2 (ezrin)	0.66	0.87	0.41	0.68	0.83	0.69	0.69	1.03	1.41	0.73	0.8	0.84	0.53	0.57	1.14	0.68	0.62	1.1	2.42	0.73	0.99	1.68
HV1B2	753418	vasodilator-stimulated phosphoprotein	0.61	0.57	0.56	0.46	0.65	0.46	0.53	0.51	0.44	0.52	0.72	0.82	0.59	0.66	0.7	0.79	1.05	0.53	0.89	0.63	0.78	0.93
HV1B3	34778	vascular endothelial growth factor	0.27	0.48	0.69	0.73	0.66	0.32	0.41	0.32	0.21	0.59	0.3	0.38	0.48	0.56	0.95	0.51	0.35	0.75	3.17	6.48	5.5	2.66
HV1B7	812965	v-myc avian myelocytomatosis viral oncogene homolog	0.54	0.85	0.44	1.68	0.55	0.63	0.24	0.33	0.34	0.34	0.27	0.27	1.8	0.38	0.75	0.17	1.59	1.22	0.13	0.77	0.35	0.6
HV1B11	345839	v-akt murine thymoma viral oncogene homolog 1	0.78	0.61	1.19	1.77	0.77	2.16	1.05	0.89	0.65	1.61	1.69	1.15	1.04	0.99	1.25	0.96	0.88	0.68	3.44	6.89	3.83	4.12
HV1C2	180520	"ubiquitin protein ligase E3A (human papilloma virus E6-associated protein, Angelman syndrome)"	1.67	1.08	0.81	0.88	1.08	1.19	0.88	0.98	1	1.11	0.42	1.49	1.53	1.27	0.94	1.05	1.94	0.81	2.8	1.78	1.23	1.51
HV1C8	66686	ribosomal protein L10	0.94	1.32	0.88	0.55	1.02	0.75	0.81	0.82	0.44	0.84	0.78	0.79	1.28	0.86	1.21	0.8	0.67	1.07	1.01	0.73	0.56	1.04
HV1C10	124261	small nuclear ribonucleoprotein 70kD polypeptide (RNP antigen)	1.76	1.96	1.1	1.16	1.95	1.5	1.45	1.32	1.21	1.34	0.72	2.24	2.82	1.8	1.38	1.59	1.49	1.49	2.36	2.35	1.78	2.27
HV1C12	292996	"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide"	1.94	3.25	1.83	1.94	2.04	1.95	1.94	2.76	2.85	3.12	1.19	1.57	1.81	2.36	2.32	1.74	1.93	2.82	1.3	0.72	1.11	1.74
HV1D1	190491	tuberous sclerosis 2	1.98	0.59	1.36	1.17	1.17	1.75	1.21	1.78	2.13	1.23	1.22	2.37	1.67	0.76	1.07	0.94	0.85	0.74	3.99	3.29	1.81	3.2
HV1D3	723986	tropomodulin	1.3	0.72	1.72	1.99	0.97	1.06	1.21	2.31	3.36	0.99	0.91	1.21	0.77	2.31	1.34	0.96	1.38	1.61	3.63	2.12	2.17	3.72
HV1D5	306813	ESTs	0.33	0.97	0.45	0.24	0.61	0.17	0.18	0.22	0.92	0.27	0.2	0.3	0.35	0.3	0.93	0.39	0.33	0.36	0.6	0.24	0.33	0.39
HV1E2	755821	nuclear factor (erythroid-derived 2)-like 1	0.56	0.49	0.56	0.41	0.47	0.33	0.51	0.6	0.71	0.37	0.39	0.61	0.49	0.96	0.37	0.73	0.46	0.73	0.73	0.26	0.85	0.76
HV1E8	810512	thrombospondin 1	1.91	0.73	0.62	1.62	3.4	1.37	2.2	3.86	1.08	1.63	1.71	1.99	1.15	0.59	0.64	1.61	1.02	0.3	5.75	8.17	3.38	8.62
HV1E11	241530	EphA2	0.35	0.26	0.11	0.1	0.26	0.29	0.16	0.25	2.81	0.19	0.25	0.1	0.32	0.24	0.26	0.17	0.13	0.24	0.11	0.06	0.17	0.18
HV1F5	191603	"Homo sapiens clone 24703 beta-tubulin mRNA, complete cds"	1.24	1.56	2.17	1.78	1.13	1.59	0.96	1.35	0.93	1.14	1.13	0.85	0.82	1.49	1.53	1.47	1.71	2.26	1.02	1.05	1.36	1.26
HV1F7	768370	"tissue inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy, pseudoinflammatory)"	1.04	1.08	1.99	2.08	2.07	0.76	1.93	4.73	3.27	2.79	2.76	4.73	3.34	3.63	2.52	0.99	0.83	3.89	11.5	5.91	4.88	9.55
HV1F12	813459	"general transcription factor IIE, polypeptide 1 (alpha subunit, 56kD)"	1.93	2.38	1.09	1.61	2.68	1.18	2.36	1.99	2.26	1.54	0.99	1.85	1.85	2.4	1.85	1.57	1.24	1.47	2.59	2.22	2.1	2.89
HV1G1	771220	v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (p65))	1.16	1.74	1.27	1.56	1.32	1.38	1.54	1.64	1.85	1.56	1.05	1.25	1.18	1.41	1.6	1.04	1.08	2.45	1.39	1	1.54	1.63
HV1G2	163174	"transcription elongation factor A (SII), 1"	1.34	1.07	0.93	1.37	1.34	0.94	1.01	1	0.93	1.18	0.52	1.23	1.83	1.04	1.59	1.4	1.14	1.08	1.37	0.81	0.72	0.66
HV1G4	246300	TIA1 cytotoxic granule-associated RNA-binding protein-like 1	1.59	1.69	0.83	1.12	1.29	0.87	1.67	0.91	1.34	1.26	0.32	0.93	1.12	2.13	0.6	0.98	1.36	1.9	1.36	0.48	0.62	0.82
HV1G7	36393	acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl Coenzyme A thiolase)	1.12	0.79	1.3	1.08	0.7	2.02	1.34	0.99	1.31	1.37	0.39	1.24	1.04	1.14	0.97	1.06	0.7	1.4	1	0.53	1.2	0.78
HV1G9	770014	"T-cell receptor, alpha (V,D,J,C)"	3.59	2.81	4.85	5.39	1.43	5.6	4.8	5.72	5.24	3.67	1.28	7.1	3.91	5.43	1.97	1.84	1.8	2.72	7.82	1.64	4.1	4.49
HV1G10	812276	"synuclein, alpha (non A4 component of amyloid precursor)"	2.1	3.55	1.45	1.51	1.46	1.63	2.45	1.7	2.57	1.49	0.35	2.81	1.71	2.94	1.04	1.34	1.43	3.1	2.63	0.94	1.26	1.69
HV1G11	126858	ESTs	2.02	1.18	1.72	1.68	0.83	1.96	1.55	2.15	1.19	2.38	0.45	1.21	1.42	1.05	1.1	0.88	2.76	1.51	2.62	1.31	2.61	3.15
HV1H1	809535	"splicing factor, arginine/serine-rich 2"	1.56	1.15	1.01	1.8	0.85	1.15	0.97	1.14	1.41	0.98	1.16	1.08	1.41	1.77	1.32	0.84	1.3	1.73	1.27	1.33	0.96	1.53
HV1H2	128875	"spinocerebellar ataxia 2 (olivopontocerebellar ataxia 2, autosomal dominant, ataxin 2)"	1.06	1.88	0.94	1.42	1.1	1.08	1.15	1.93	1.27	1.02	0.76	1.13	1.32	1.15	1.2	1.34	1.13	1.03	0.7	1.08	0.81	0.56
HV1H3	359835	spermidine/spermine N1-acetyltransferase	0.39	1.17	1.14	0.87	1.16	0.7	0.7	1.16	0.71	1	1.11	0.62	0.53	0.52	1.82	0.96	0.99	0.45	1.83	0.39	0.8	0.95
HV1H4	320763	Sp3 transcription factor	1.45	1.63	1.02	2.75	1.05	1.77	0.8	1.69	0.94	1.17	0.69	1.27	1.73	0.93	1.34	1.44	1.64	0.52	2.23	3.26	1.35	1.73
HV1H5	205303	sorcin	0.54	0.71	0.49	0.86	0.53	0.82	0.76	0.84	1.1	0.76	0.63	0.83	0.93	0.84	0.9	0.46	1.02	0.98	0.63	0.49	0.46	0.96
HV1H6	810873	"sodium channel, nonvoltage-gated 1 alpha"	0.38	0.24	0.12	0.07	0.22	0.2	0.26	0.23	0.21	0.15	0.6	0.31	0.48	0.39	0.44	0.3	0.09	0.15	0.24	0.03	0.21	0.27
HV1H7	812227	"solute carrier family 9 (sodium/hydrogen exchanger), isoform 1 (antiporter, Na+/H+, amiloride sensitive)"	0.85	1.03	0.71	0.63	0.92	0.83	1.3	1.27	1.88	1.04	1.18	1.41	1.1	1.08	1.09	0.85	0.62	0.66	1.9	0.88	1.26	1.57
HV1H9	190732	"solute carrier family 2 (facilitated glucose transporter), member 5"	0.83	0.85	1.07	0.97	0.72	1	1.37	1.15	1.54	1.05	0.72	0.49	1.09	1.22	0.65	0.47	1.26	1.28	1.76	0.94	1.11	1.29
HV1H12	823886	"Smooth muscle myosin heavy chain isoform SMemb [human, umbilical cord, fetal aorta, mRNA Partial, 971 nt]"	0.89	2.23	6.62	1.79	1.35	1.27	2.28	2.92	2.07	1.39	0.6	1.52	2.22	2.57	1.19	1.43	1.97	1.92	2.44	1.24	1.71	3.13
HV2A2	486544	"small nuclear RNA activating complex, polypeptide 3, 50kD"	2.33	1.91	1.75	2.28	2.05	0.84	2.24	2.35	1.59	0.81	0.34	1.67	1.59	1.73	0.98	1.58	1.44	1.32	1.01	1.93	0.92	1.77
HV2A4	768561	"small inducible cytokine A2 (monocyte chemotactic protein 1, homologous to mouse Sig-je)"	3.86	18.78	2.58	14.53	4.19	3.32	13.69	4045.48	5362.24	9.07	1.11	4.9	5.96	3.29	1.22	3.04	2.11	2.07	14.76	4.77	2.78	12.17
HV2A5	49970	Sjogren syndrome antigen B (autoantigen La)	0.93	1.63	1.3	1.84	1.29	1.01	1.05	0.95	1.03	1.47	0.5	0.95	1.04	1.05	0.69	2.71	1.79	1.37	0.64	0.74	0.41	0.76
HV2A6	754998	signal recognition particle 19kD	1.6	2.05	1.34	1.77	3.45	1.01	2.24	2.32	2.08	1.71	0.57	0.93	1.37	2.38	1.43	1.16	1.48	1.06	1.09	0.87	0.98	1.3
HV2A11	49591	"steroid sulfatase (microsomal), arylsulfatase C, isozyme S"	0.52	0.6	0.7	1.15	0.65	0.82	0.65	0.74	0.37	0.71	1.12	0.64	0.8	0.65	0.69	0.9	0.6	0.67	0.46	1.38	1.09	1.23
HV2B1	47542	small nuclear ribonucleoprotein D1 polypeptide (16kD)	1.43	1.88	1.1	0.94	1	1.12	0.89	0.71	0.85	0.97	0.57	0.6	0.64	1.14	0.83	0.9	1.16	1.3	0.69	0.68	0.54	0.83
HV2B4	161456	serum amyloid A1	0.73	4.92	0.24	0.84	4.16	0.8	1.52	0.76	0.85	2.24	0.61	0.38	1.76	1.25	1.08	1.67	1.12	3.06	1.12	0.4	0.75	0.99
HV2B7	39798	serine hydroxymethyltransferase 1 (soluble)	0.57	1.07	0.81	1.56	1.34	0.71	0.83	0.76	0.66	0.74	0.84	0.55	0.6	0.57	0.68	0.93	1.01	0.47	1.13	0.62	1.28	0.7
HV2B8	40704	SEC14 (S. cerevisiae)-like 1	1.12	2.23	1.16	1.29	1.79	1.26	1.6	1.14	1.69	1.74	1	1.05	1.41	0.75	0.99	1.58	1.23	0.97	1.92	2.06	1.74	0.44
HV2B9	149013	S-adenosylmethionine decarboxylase 1	0.9	0.6	1.63	2.44	0.95	1.32	0.57	1.06	0.89	1.08	0.69	0.83	0.89	0.61	1.05	0.69	0.97	0.91	1.26	0.47	1.02	0.91
HV2B10	135221	S100 calcium-binding protein P	0.19	0.16	0.08	0.12	0.48	0.15	0.31	0.07	0.15	0.37	0.17	0.16	0.19	0.32	0.57	0.4	0.2	0.19	0.05	0.03	0.19	0.16
HV2C1	809578	ribosomal protein S5	0.33	0.48	0.74	0.45	0.57	0.24	0.32	0.42	0.34	0.26	0.4	0.54	0.63	0.46	0.45	0.32	0.49	0.72	0.66	0.64	0.41	0.51
HV2C2	51981	ribosomal protein L7a	1.52	0.87	0.43	0.66	0.67	0.51	0.87	0.5	0.73	1.08	0.65	0.5	1.24	1.03	0.77	2.06	0.48	0.57	0.44	0.47	0.35	0.65
HV2C3	322561	ribosomal protein L31	1.19	1.48	0.51	0.63	0.9	0.69	0.76	0.65	0.6	0.84	0.48	0.69	1.27	1.06	0.83	0.75	1.12	1.63	0.59	0.36	0.53	0.79
HV2C5	810617	ribosomal protein L21	0.79	1.25	0.74	1.15	1.07	0.68	0.76	0.46	0.38	0.84	0.61	0.49	1.13	1.08	0.82	0.78	0.47	1.39	0.86	0.25	0.36	1.03
HV2C6	549101	ribosomal protein L19	0.77	1.04	0.56	0.95	1.02	0.77	1.61	0.67	0.8	1.63	1.09	0.89	1.38	1.41	1.76	1.71	0.93	1.71	0.46	0.45	0.37	1.13
HV2C10	810802	restin (Reed-Steinberg cell-expressed intermediate filament-associated protein)	1.66	1.64	0.81	1.66	1.6	1.46	1.21	2.43	1.57	1.35	0.69	1.57	1.63	1.43	1.56	1.77	1.43	1.81	1.5	1.18	0.97	0.99
HV2C11	26616	replication protein A2 (32kD)	2	1.26	1.62	1.61	1.08	1.53	0.87	1.32	1.56	0.89	1.79	1.51	1.2	1.3	1.14	0.65	0.94	0.88	2.31	1.46	1.33	1.47
HV2C12	204299	replication protein A3 (14kD)	2.23	1.96	1.24	1.6	2.03	1.58	1.41	1.27	1.66	1.16	0.74	0.6	1.21	2.24	1	2.21	0.88	1.48	0.92	0.77	0.85	0.97
HV2D1	203275	replication factor C (activator 1) 4 (37kD)	3.58	3.01	1.98	3.27	1.75	1.97	2.09	1.31	2.13	1.93	1.05	1.6	1.53	2.59	0.96	1.15	2.88	2.87	1.97	2.16	1.12	1.83
HV2D2	214537	replication factor C (activator 1) 1 (145kD)	1.52	2.62	1.59	1.28	1.35	1.5	1.77	1.73	1.77	1.8	0.69	0.99	1.79	1.59	0.88	1.64	1.65	2.02	1.99	1.45	1.06	1.91
HV2D3	159118	"ras homolog gene family, member G (rho G)"	1.1	2.1	1.32	1.46	1.62	1.25	1.68	2.22	1.48	1.61	1.79	0.85	1.02	1.3	1.14	1	1.19	1.37	2.11	1.23	1.9	1.36
HV2D5	214133	female sterile homeotic-related gene 1 (mouse homolog)	1.27	3.24	2.1	2.1	1.38	1.37	2.32	2.32	2.51	2.21	2.01	1.68	0.95	2.11	1.23	1.7	3.41	1.38	2.17	1.34	1.54	1.84
HV2D9	280752	retinoblastoma-like 2 (p130)	1.16	0.7	0.99	0.61	0.79	0.62	0.66	1.02	4.03	0.54	0.67	1.16	1.14	1.39	0.92	0.77	0.59	0.67	1.73	0.99	1.39	1.36
HV2D12	47559	"RAB5A, member RAS oncogene family"	1.22	1.19	1.54	1.33	1.67	0.97	1.19	1	1.1	1.01	1.37	1.61	1.14	1.1	1.09	1.1	1.59	0.99	0.99	0.85	1.53	0.77
HV2E1	230205	"RAB4, member RAS oncogene family"	0.98	0.67	0.95	1.33	1.13	0.95	0.96	0.56	0.41	1.13	0.64	0.6	0.91	0.71	0.8	1.13	0.59	0.53	0.81	0.68	0.81	1.3
HV2E2	150221	ESTs	1.53	0.85	0.86	1.46	1.28	0.89	1.03	1.27	0.73	0.79	0.6	1.28	1.19	0.86	0.52	1.3	0.96	0.56	2.76	1.21	1	1.17
HV2E3	30093	RAN binding protein 1	1.51	1.85	2.74	1.99	2	1.33	1.67	1.35	1.57	1.49	0.95	0.96	1.37	1.62	1.21	1.57	1.59	2.61	0.86	0.6	0.79	1.03
HV2E6	340630	mitogen-activated protein kinase kinase kinase 8	1.19	0.91	1.3	0.91	1.03	0.75	0.89	1.12	0.53	0.91	0.75	0.6	0.52	0.67	0.85	1.16	1.23	0.6	0.73	0.66	0.84	0.92
HV2E7	756452	tyrosine kinase 2	1.26	2.42	1.79	1.91	2.1	1.76	2.07	1.56	2.65	1.1	1.11	1.4	1.12	1.81	0.97	1.37	1.2	1.78	2.55	1.31	1.71	2.07
HV2E8	813742	PTK7 protein tyrosine kinase 7	1.2	2.59	2.37	1.49	2.76	0.73	2.77	3.87	1.36	1.57	0.67	0.71	0.89	1.36	0.83	2.37	1.61	3.17	1.86	0.8	2.35	1.61
HV2E12	770901	"protein tyrosine phosphatase, non-receptor type 9"	1.24	1.37	1.77	1.31	1.6	1.18	1.27	1.26	1.01	1.4	1.2	0.88	1.32	1.13	0.84	1.9	1.35	1.31	1.37	0.83	1.33	1.28
HV2F2	321661	"protein phosphatase 2, regulatory subunit B (B56), gamma isoform"	0.94	0.85	0.86	1.33	1.39	1.12	1.21	0.78	0.74	1.4	0.79	0.89	1.1	0.86	0.98	1.68	0.74	0.63	0.9	0.84	0.75	1.26
HV2F4	132911	"protein phosphatase 1, catalytic subunit, beta isoform"	1.98	3.31	1.66	1.17	2.48	1.33	1.18	0.95	1.3	1	0.85	1.64	1	1.76	1.27	2.9	1.25	1.99	0.66	0.31	0.76	1.02
HV2F5	359184	"protein kinase, interferon-inducible double stranded RNA dependent"	3.3	3.29	2.31	2.38	1.98	2.67	4.63	4.04	3.13	1.11	1.06	3.06	1.94	2.23	1.81	1.71	2.49	0.34	7.53	2.06	3.31	3.67
HV2F6	811012	"protein kinase, cAMP-dependent, regulatory, type I, beta"	0.97	2.13	1.07	1.42	1.75	1.37	1.57	1.22	1.38	1.59	0.72	1.29	1.33	1.58	0.86	1.71	1.49	2.13	3.39	4.2	3.56	3.61
HV2F8	167280	ESTs	1.13	2.06	1.72	1.09	1.76	1.18	1.3	1.28	1.56	1.81	0.87	1.02	1.15	1.28	1.62	1.23	1.1	1.16	2.13	0.48	2.12	2
HV2G1	134544	"proteasome (prosome, macropain) subunit, alpha type, 1"	0.78	0.97	0.49	0.75	1.75	1.55	0.69	0.75	0.53	1.95	0.94	0.7	0.87	1.2	0.79	0.74	0.82	0.95	0.6	0.54	0.81	0.83
HV2G2	529861	"proteasome (prosome, macropain) subunit, beta type, 6"	1.09	0.92	0.87	1.37	1.43	1.06	1.14	0.83	1	1.17	0.72	0.93	1.22	0.95	0.98	1.72	0.76	0.69	0.96	0.76	0.78	1.18
HV2G8	812048	"prion protein (p27-30) (Creutzfeld-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia)"	0.94	0.91	0.65	0.92	1.42	0.63	0.5	0.81	0.56	0.59	0.73	0.94	0.92	0.53	0.51	0.73	0.63	0.92	0.34	0.17	0.48	0.33
HV2G11	130541	platelet/endothelial cell adhesion molecule (CD31 antigen)	2.57	3.18	5.63	6.22	3.48	3.81	3.26	8.44	5.32	4.12	3.96	4.65	4.35	5.91	2.66	1.65	1.43	3.4	6.62	2.07	3.21	5.11
HV2G12	40643	"platelet-derived growth factor receptor, beta polypeptide"	2.27	2.46	6.26	3.06	3.79	2.72	3.49	6.17	5.14	3.86	2.67	2.73	2.6	4.7	2.72	2.95	1.88	2.77	4.78	2.11	2.2	3.51
HV2H3	810017	"plasminogen activator, urokinase receptor"	1.47	2.08	1.13	0.79	1.89	0.91	1.62	3.04	1.3	1.39	1.56	0.96	1.21	1.63	1.11	0.92	2.12	1.32	1.37	0.61	1.34	0.6
HV2H5	244307	"plasminogen activator inhibitor, type I"	0.71	0.78	0.52	0.71	1.34	0.61	0.9	2.98	1.45	0.9	0.79	0.57	1.14	0.73	0.69	0.57	0.45	0.46	2.61	0.92	1.91	1.4
HV2H7	809981	glutathione peroxidase 4 (phospholipid hydroperoxidase)	0.67	0.95	0.47	0.75	0.63	0.71	1.29	0.92	1.5	1.03	1.28	0.8	0.48	1.04	0.81	0.89	0.68	0.39	1.52	1.59	1.14	1.25
HV2H8	204897	"phospholipase C, gamma 2 (phosphatidylinositol-specific)"	3.74	3.37	1.34	2.4	3.31	3.03	1.89	1.93	2.27	1.65	0.55	1.12	1.85	1.04	0.64	1.39	1.8	3.01	3.43	0.76	1.24	1.35
HV2H9	51916	EST	0.96	0.79	1.57	1.05	0.69	1.04	1.16	1.26	2.67	1.04	0.86	1.36	1.7	0.89	2.37	1.58	1.3	1.61	1.51	1.34	1.56	1.85
HV3A2	162211	"peroxisomal membrane protein 1 (70kD, Zellweger syndrome)"	1.17	1.6	0.82	1.5	1.26	0.99	0.86	1.05	0.84	1.1	0.71	1.04	1.41	0.85	0.93	1.81	1	0.56	0.86	1.17	0.36	1.62
HV3A5	140806	peptidylglycine alpha-amidating monooxygenase	0.69	0.78	0.92	0.67	1.1	0.17	0.87	1.47	0.35	0.77	0.66	0.22	0.52	0.55	0.39	0.6	0.77	1.02	0.44	0.13	0.44	0.69
HV3A8	45556	MAP/microtubule affinity-regulating kinase 3	1.3	1.6	1.34	1.4	1.75	1.02	1.57	0.79	1	1.46	0.72	0.99	1.64	2.16	1.26	1.79	0.99	0.97	1.9	0.8	0.56	1.32
HV3A10	207082	glucosamine-6-phosphate deaminase	1.75	1.39	1.08	1.3	1.16	1.4	1.18	0.87	1.14	1.01	1.18	0.88	0.93	1.03	0.72	1.35	2.02	1.06	1.15	1.49	1.19	1.53
HV3A11	770670	"tumor necrosis factor, alpha-induced protein 3"	0.74	3.33	2.03	2.62	2.07	2.76	2.17	2.54	1	2.46	2.68	2.08	2.66	1.98	2.15	1.04	2.51	1.31	4.12	1.15	1.56	2.03
HV3B1	34773	Human clone 23721 mRNA sequence	0.59	0.7	0.89	2.12	0.58	0.81	0.45	1.02	0.51	0.69	0.72	0.7	0.8	0.37	1	0.45	0.79	0.43	1.37	2.94	1.08	1.47
HV3B3	770027	"Human protein phosphatase 2A regulatory subunit alpha-isotype (alpha-PR65) mRNA, complete cds"	0.4	0.56	0.84	0.43	0.53	0.32	0.69	0.75	0.62	0.66	0.7	0.76	0.48	0.73	0.57	0.63	0.59	0.77	0.57	0.68	0.45	0.63
HV3B4	769657	"protein phosphatase 1, regulatory (inhibitor) subunit 2"	2.97	2.88	1.29	2.12	2.71	2.21	2.07	2.54	2.01	2.89	1.3	1.28	1.66	2.09	1.44	1.34	2.16	0.99	1.5	2.76	1.16	1.95
HV3B5	509495	"proteasome (prosome, macropain) subunit, alpha type, 6"	0.93	1.09	0.98	0.86	0.47	0.77	0.77	1.06	0.91	1.38	0.85	1.33	0.53	0.89	1.5	0.61	0.63	0.83	0.89	1.16	1.3	1.13
HV3B6	68977	"proteasome (prosome, macropain) subunit, beta type, 10"	1.35	2.92	0.86	1.53	3.42	2.71	2	2.37	1.65	3.05	2.28	2.47	0.81	1.54	0.5	1.57	1.75	0.78	3.31	1.13	2.44	3.99
HV3B11	49920	KIAA0024 gene product	1.11	1.26	1.24	1.56	0.7	0.98	0.78	0.74	0.93	0.87	0.86	0.77	1.04	0.77	1.31	0.6	1.14	1.14	0.52	0.93	0.8	0.97
HV3B12	345430	"phosphoinositide-3-kinase, catalytic, alpha polypeptide"	2.27	3.41	1.18	1.29	3.17	1.68	1.75	1.58	1.83	1.81	0.43	1.39	1.49	1.67	1.09	1.27	1.72	1.73	1.81	1.18	1.29	1.83
HV3C1	194804	phosphotidylinositol transfer protein	0.64	0.91	1.14	1	1.25	1.15	0.91	0.76	0.86	0.82	1.07	0.7	0.99	0.6	1.12	0.65	0.76	0.74	0.86	0.84	1.17	0.76
HV3C3	43884	peptidylprolyl isomerase F (cyclophilin F)	0.99	1.77	1.02	1.89	1.29	1.05	1.24	0.83	0.88	1.52	1.44	0.77	1.6	1.41	1.54	1.06	1.35	2.04	1.38	5.74	1.45	1.18
HV3C4	162775	"DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 5 (RNA helicase, 68kD)"	1.29	0.74	0.78	1.3	0.78	1.23	0.81	0.95	0.39	0.99	1.08	0.89	1.17	0.75	1.61	0.94	1.19	0.36	0.7	2.87	1.7	1.06
HV3C8	128159	translocated promoter region (to activated MET oncogene)	3.38	2.66	1.88	2.77	1.8	2.33	1.94	2.04	2	1.29	0.55	2.1	1.58	2.11	0.92	2.46	0.91	1.82	3.12	1.89	1.17	2.46
HV3C10	770452	TIA1 cytotoxic granule-associated RNA-binding protein	1.93	2.05	1.47	2.43	1.7	1.63	0.95	0.97	0.99	1.04	0.52	1.68	2	1.45	0.84	1.29	1.05	1.23	2.87	1.27	1.63	1.71
HV3C11	308281	Human mRNA for upstream binding factor (hUBF)	1.77	2.21	1.47	1.28	2.08	2.27	1.6	2.03	1.8	3.22	1.63	1.68	1.47	2.38	1.29	0.85	1	2.1	2.1	1.22	1.61	1.98
HV3C12	299388	nuclear transport factor 2 (placental protein 15)	2.34	1.76	1.31	1.25	1.78	1.3	1.27	1.74	1.81	1.24	0.98	1.5	0.85	1.58	0.66	1.88	1.22	2.32	1.23	0.52	0.86	0.9
HV3D1	809627	nuclear receptor interacting protein 1	0.33	0.71	0.69	0.55	1.37	0.6	0.82	1.63	2.8	0.54	0.51	1.28	0.97	2.71	0.63	0.65	1.94	0.41	1.09	1.43	1.1	1.76
HV3D2	725473	type II integral membrane protein	1.12	1.47	0.96	0.82	1.38	1.09	1.21	1.2	1.9	0.86	1.07	0.83	0.98	1.41	0.63	1.36	0.88	1.46	0.71	0.44	1.18	0.95
HV3D4	741497	lipocalin 2 (oncogene 24p3)	0.94	2.07	0.22	0.26	2.64	1.14	0.59	0.16	0.22	0.59	0.35	0.18	0.44	0.44	1.38	0.87	0.31	0.51	0.51	0.16	0.45	0.48
HV3D5	753457	NADH dehydrogenase (ubiquinone) Fe-S protein 1 (75kD) (NADH-coenzyme Q reductase)	0.56	0.96	0.67	0.94	0.72	0.62	0.9	0.61	1.51	0.55	0.57	0.96	0.72	0.92	0.91	0.6	0.6	0.78	1.06	0.76	1.09	1.1
HV3D6	813387	diaphorase (NADH/NADPH) (cytochrome b-5 reductase)	0.66	0.67	0.27	0.26	1	0.63	1.06	0.56	0.71	0.66	0.85	1.11	0.48	0.95	0.9	1.24	0.36	0.61	0.28	0.4	0.51	0.51
HV3D7	813279	N-acylaminoacyl-peptide hydrolase	0.58	0.68	0.37	0.46	0.67	0.68	0.65	0.44	0.69	0.99	0.66	0.73	0.75	0.98	0.78	0.66	0.26	0.72	0.56	1.34	0.48	0.58
HV3D9	36493	"N-acetylgalactosaminidase, alpha-"	1.06	0.76	2.18	1.3	1.5	1.58	1.47	1.96	2.02	1.45	1.45	1.5	1.43	1.4	1.16	0.91	0.88	0.9	2.08	1.98	2.21	1.86
HV3E5	154707	"MpV17 transgene, murine homolog, glomerulosclerosis"	1.46	1.75	1.49	1.58	1.27	1.07	1.63	1.83	1.98	1.37	1.38	1.55	1.61	1.75	1.01	1.23	0.69	2.05	1.55	0.81	1.28	1.74
HV3E6	131362	moesin	2.15	1.79	1.66	0.97	1.47	1.29	0.97	1.2	0.69	0.9	0.86	0.58	0.98	0.94	0.73	0.98	1.39	2.42	1.33	0.24	0.83	0.72
HV3E7	809557	minichromosome maintenance deficient (S. cerevisiae) 3	1.43	3.11	3.71	2.98	2.04	1.73	2.07	1.16	2.01	1.99	1.29	1.03	1.42	3.4	1.45	2.1	2.25	4.7	1.06	0.96	0.39	1.6
HV3E10	296880	"membrane protein, palmitoylated 1 (55kD)"	1.39	2.83	2.32	1.87	2.6	2.09	2.43	3.99	3.1	2.28	2.41	2.27	1.8	1.82	1.1	1.84	1.25	1.03	1.92	1.16	1.82	1.48
HV3E11	200814	"membrane metallo-endopeptidase (neutral endopeptidase, enkephalinase, CALLA, CD10)"	0.24	0.23	0.49	0.27	0.35	0.04	0.19	0.18	0.05	0.45	0.14	0.08	0.36	0.21	0.14	0.2	0.09	0.14	0.1	0.04	0.14	0.15
HV3F1	470393	"matrix metalloproteinase 7 (matrilysin, uterine)"	1.75	1.09	2.52	3.33	1.98	0.12	1.68	5.32	1.49	0.59	0.45	0.73	0.78	0.69	0.3	0.47	3.22	9.03	1.79	0.17	0.52	0.44
HV3F6	212496	"mannosidase, alpha, class 2A, member 1"	1.4	2.91	0.91	1.77	4.52	1.35	1.63	2.33	1.52	2.05	1.16	1.49	2.35	1.81	1.74	1.51	1.82	0.97	2	1.14	1.1	1.12
HV3F7	82879	"mannose-binding lectin (protein C) 2, soluble (opsonic defect)"	1.65	0.82	2.19	1.72	0.36	0.32	0.84	2.02	1.69	4.82	0.72	2.05	1.59	2.19	0.77	0.27	1.2	2.36	2.29	0.92	1.19	0.51
HV3F12	768316	anthracycline resistance-associated	0.57	1.01	1.59	0.9	1.79	0.5	0.78	0.78	0.38	0.78	0.74	0.64	1.29	1.04	0.72	1.57	0.72	0.8	1.04	0.36	0.75	1.47
HV3G2	44255	"ribosomal protein, mitochondrial, L3"	1.69	1.19	1.13	1.44	1.54	1.25	1.31	1.63	1.54	1.35	0.7	1.47	1.46	1.97	1.55	1.55	1.89	1.38	1.53	0.77	0.82	0.98
HV3G5	544664	matrin 3	0.95	1.59	1.13	1.27	0.94	1.06	1.12	1.11	1	1.29	0.78	1.28	1	1.49	0.97	0.67	0.87	0.96	0.75	0.64	0.58	0.86
HV3G7	340734	"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha"	1.02	3.51	0.77	1.21	1.38	1.23	1.57	1.42	1.19	2.39	1.49	1.08	1.38	2.26	1.5	0.7	1.35	1.51	2.7	2.25	1.27	1.77
HV3G9	771323	"procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase, Ehlers-Danlos syndrome type VI)"	1.5	1.12	2.25	0.55	1.11	0.82	0.77	0.79	0.54	1.31	0.7	0.4	0.61	0.82	0.91	0.48	1.1	1.41	1.05	0.35	0.98	0.48
HV3G10	289615	lysosomal-associated membrane protein 2	2.65	2.64	1.5	1.52	2.22	1.22	2.04	1.89	1.89	1.64	0.77	1.91	1.97	2.88	0.91	1.62	1.51	1.37	1.47	0.67	0.89	1.3
HV3G11	813823	lumican	4.04	1.89	3.31	10.15	5.45	8.06	9.76	8.79	12.43	13.93	6.2	7.94	7.27	16.54	3.7	4.53	5.34	20.72	17.74	3.79	5.23	16.15
HV3G12	770012	"Homo sapiens HERG-USO (HERG) mRNA, alternatively spliced, partial cds"	1.93	5.26	6.19	1.48	2.95	3.99	2.56	2.87	7.59	3.08	0.66	2.1	2.32	2.45	2.81	2.62	1.43	3.91	2.99	0.9	0.98	1.39
HV3H2	153025	leukemia inhibitory factor (cholinergic differentiation factor)	0.55	1.3	0.38	0.39	3.26	0.83	0.68	0.76	0.53	0.61	0.36	0.34	1.19	0.66	0.97	0.87	0.44	1.39	0.83	0.33	0.45	1.08
HV3H7	32609	"laminin, alpha 4"	0.84	0.9	7.73	2.76	1.66	1.62	1.78	3.37	2.76	1.94	2	1.46	1.38	1.26	1.59	1.57	0.86	0.95	1.96	0.79	1.67	1.9
HV3H8	811900	"lymphotoxin beta receptor (TNFR superfamily, member 3"	1.16	2.77	1.34	1.62	1.68	1.26	1.45	1.81	2.24	0.93	1.48	1.24	1.39	1.6	1.35	1.92	1.74	4.84	1.52	0.57	1.79	0.93
HV3H9	51447	"Fc fragment of IgG, low affinity IIIa, receptor for (CD16)"	3.06	2.27	11.49	11.43	2.7	8.49	8.72	12.48	13.44	13.73	5.76	7.19	4.55	11.18	2.18	2.16	4.29	4.85	17.23	5.81	6	7.6
HV3H11	770355	ESTs	1.29	1.09	0.72	1.85	1.17	1.28	0.93	1.18	1.31	0.72	0.82	1.41	0.87	1.1	0.87	0.76	0.79	1.05	1.67	1.06	0.98	0.9
HV3H12	42558	glycine amidinotransferase (L-arginine:glycine amidinotransferase)	3.55	4.18	5.34	4.87	2.32	6.52	2.26	5.09	2.26	2.1	0.71	3.09	4.41	3.6	3.06	2.39	1.57	1.6	4.49	3.98	3.3	12.9
HV4A2	469345	kinase insert domain receptor (a type III receptor tyrosine kinase)	1.18	1.8	3.51	2.42	3.62	0.81	2.63	4.13	2.33	1.31	1.57	2.07	2.62	2.6	2.54	1.54	1.37	1.12	1.85	1.42	1.27	2.15
HV4A3	327676	keratin 13	0.63	0.26	0.14	0.14	0.35	0.22	0.3	0.12	0.15	0.2	0.15	0.23	0.41	0.46	0.36	0.27	0.11	0.32	0.56	1.19	0.42	1.02
HV4A5	122428	jun B proto-oncogene	1.4	0.93	0.51	0.64	0.86	0.44	0.4	1.07	0.36	0.64	0.58	0.5	1.24	0.69	0.55	0.42	0.34	0.45	1.05	0.21	0.58	0.76
HV4A6	810325	isovaleryl Coenzyme A dehydrogenase	2.05	2.22	1.43	1.49	2.56	1.68	2.26	1.79	1.76	1.42	0.77	2.55	2.4	1.62	0.66	1.53	1.05	1.29	1.96	3.44	1.92	2.76
HV4A8	823696	interferon-induced protein 56	5.1	12.97	17.67	9.54	5.78	1.51	11.21	30.3	49.58	6.56	3.01	8.58	3.04	7.13	1.32	4.3	3.63	3.54	4.07	5.16	2.28	8.6
HV4A9	727551	interferon regulatory factor 2	1.65	1.6	1.99	1.76	1.8	2.13	1.92	2.18	2.19	1.94	1.95	1.68	1.55	1.45	1.15	1.39	1.46	0.84	1.74	1.23	1.82	2.69
HV4A10	811044	"interferon (alpha, beta and omega) receptor 2"	2.65	5.27	4.09	3.32	3.43	1.42	3.2	0.63	1.55	1.37	0.7	2.31	1.89	2.73	1.07	1.87	2.06	1.88	3.13	0.98	2.2	3.22
HV4A11	754080	intercellular adhesion molecule 3	1.12	1.8	1.98	2.13	2.34	3.02	2.71	4.47	4.58	2.3	2.49	1.91	1.32	2.09	1.37	2.47	1.26	1.29	1.86	1.66	1.4	1.52
HV4B2	343072	"integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)"	0.49	0.33	1.07	0.63	0.78	0.64	0.42	1.15	0.37	0.56	0.66	0.84	0.85	0.58	0.8	0.63	0.7	0.61	0.61	0.7	0.49	0.86
HV4B5	770859	"integrin, beta 5"	1.08	0.78	0.77	1.52	1.03	0.6	1.11	2.36	1.02	0.97	1.31	0.83	1.19	1.61	1.2	0.65	0.57	1.1	0.92	0.52	2.09	1.11
HV4B6	811096	"integrin, beta 4"	1.35	0.76	0.26	0.44	0.67	0.44	0.47	1.09	0.35	0.41	0.45	0.21	1.22	0.67	1.06	0.7	0.59	1.14	0.36	0.6	1.49	0.55
HV4B7	233721	insulin-like growth factor binding protein 2 (36kD)	3.35	3.9	1.72	4.04	14.44	2.12	8.67	9.08	15.53	12.44	4.32	4.98	2.37	7.14	1.97	3.97	5.83	7.73	8.98	21	5.04	13.45
HV4B8	148379	insulin-like growth factor 1 receptor	1.68	2.78	1.3	2.62	3.94	1.33	2.6	2.87	2.66	3.07	1.68	4.42	3.16	5.12	0.61	1.78	1.66	3.15	1.33	2.62	1.03	2.95
HV4B11	180803	inositol polyphosphate-1-phosphatase	0.89	1.84	1	2.6	1.26	0.64	0.79	0.94	1.03	0.64	0.79	0.54	0.55	0.44	0.44	0.79	0.78	0.45	1.18	0.55	2.32	0.77
HV4B12	276091	"inositol 1,4,5-trisphosphate 3-kinase B"	3.62	9.47	2.24	9.23	4.92	2.04	3.49	3.98	3.59	2.86	1.33	2.85	1.58	4.57	1.57	2.4	2.46	5.93	4.98	2.43	2.79	3.63
HV4C1	240151	"inhibitor of DNA binding 2, dominant negative helix-loop-helix protein"	0.78	2.42	1.42	1.42	2.31	1.01	1.08	1.59	1.32	1.34	1.08	1.67	0.94	0.77	1.32	1.17	1.08	0.81	1.58	0.38	1.18	0.97
HV4C3	740925	"indoleamine-pyrrole 2,3 dioxygenase"	1.91	2.21	1.42	1.4	1.05	1.59	1.45	1.13	1.56	1.62	0.31	0.99	1.09	1.59	1.2	0.57	0.95	2.06	1.23	0.95	1.36	0.92
HV4C4	810504	proteolipid protein 2 (colonic epithelium-enriched)	1.93	1.18	0.92	0.91	1.01	1.97	1.84	0.78	1.49	1.21	0.67	0.68	1.09	1.61	0.94	1.53	1.36	1.85	1.03	0.6	0.72	0.83
HV4C6	810213	"interleukin 1 receptor, type I"	1.28	1.33	0.99	1.17	2.71	1.26	2.02	2.14	1.41	3.27	0.79	0.97	1.98	1.78	1.07	1.65	0.92	1.16	1.99	0.64	1	1.65
HV4C7	120106	"caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase)"	2.46	4.18	2.21	2.52	1.8	2.04	2.54	2.44	2.47	2.42	0.94	1.87	1.32	1.7	1.05	1.11	1.69	1	2.26	0.69	1.25	1.31
HV4C9	346117	"guanylate binding protein 2, interferon-inducible"	1.3	3.78	1.33	1.99	2.55	3.58	2.02	1.96	2.49	2.17	1.3	2.63	1.58	1.5	1.07	1.24	1.46	0.71	2.62	0.57	1.3	1.4
HV4C10	47900	interferon gamma receptor 1	0.75	1.43	0.98	0.95	1.33	1.32	1.01	1.12	1.25	1.04	0.51	1.01	1.73	1.38	1.36	1.46	1.01	1.1	0.84	0.43	0.75	0.88
HV4D1	50754	mitochondrial translational initiation factor 2	1.11	1.73	0.96	2.24	1.51	1.25	0.72	1.35	1.21	0.95	0.65	1.1	1.17	1.2	1.05	0.96	0.63	1.4	1.1	0.58	0.76	1.03
HV4D2	39884	IMP (inosine monophosphate) dehydrogenase 1	0.55	1.11	0.6	0.95	1.22	1.24	0.9	0.97	0.92	1.54	1.15	0.91	0.81	1.19	0.47	1.27	1.26	0.62	1.58	1.78	1.18	0.67
HV4D3	23282	RD element	0.69	0.88	0.59	0.83	0.67	0.75	0.69	0.83	0.89	1.1	0.87	0.82	0.7	0.88	0.57	0.55	0.92	0.59	0.65	0.74	0.63	0.87
HV4D5	183194	Homo sapiens mRNA; cDNA DKFZp586A181 (from clone DKFZp586A181)	1.48	3.09	1.55	1.7	0.61	1.17	1.68	1.54	3.1	1.06	0.65	1.01	1.42	1.6	0.68	0.79	1.03	0.82	2.97	0.89	1.42	2.4
HV4D7	126243	hydroxymethylbilane synthase	1.78	4.09	2.04	1.66	1.63	1.62	1.62	1.56	2.39	1.49	1.17	0.89	1.19	1.78	0.54	1.42	0.55	1.92	3.13	1.36	1.37	1.27
HV4D10	811108	thyroid hormone receptor interactor 6	0.53	1.62	0.65	0.89	0.71	0.6	0.62	0.63	0.24	0.55	0.54	0.38	0.99	0.64	0.46	0.62	0.62	1.08	0.66	0.46	0.37	0.59
HV4D12	377320	"TAT-INTERACTIVE PROTEIN, 72-KD"	1.52	5.9	0.97	1.24	2.03	0.93	1.29	1.99	2.02	1.13	0.55	0.69	1.29	1.69	0.61	1.4	1.14	1.26	0.72	0.43	0.51	0.59
HV4E1	188232	Kruppel-like factor 4 (gut)	0.73	0.72	0.64	1.56	1.33	0.34	1.12	0.6	0.35	1.69	0.64	0.64	1.45	0.73	1.55	0.7	0.69	1.18	0.42	0.29	0.66	1.08
HV4E3	45138	vascular endothelial growth factor C	0.5	0.64	0.54	0.71	0.69	0.28	0.58	0.66	0.46	0.99	0.55	0.25	0.57	0.43	0.41	0.45	0.41	0.43	0.29	0.1	0.19	0.26
HV4E4	810600	"Human ubiquitin carrier protein (E2-EPF) mRNA, complete cds"	2.12	1.56	1.12	1.22	1.2	1.14	1.66	1.01	2.04	5.01	0.74	1.5	0.92	1.73	1.22	1.82	1.53	2.28	0.72	0.8	0.71	0.84
HV4E5	288896	"potassium channel, subfamily K, member 1 (TWIK-1)"	0.53	0.88	0.41	0.94	1.34	0.82	1.3	1.48	0.7	1.28	0.68	0.38	0.64	0.41	1.02	0.8	1.14	1.9	0.37	0.97	0.68	0.79
HV4E8	341942	"Human translation initiation factor eIF-2alpha mRNA, 3'UTR"	1.08	1	1.44	1.49	1.56	0.87	1.51	0.88	0.88	1.22	0.63	0.91	1	1.16	0.46	1.7	0.76	0.7	0.65	0.87	0.65	1.14
HV4E9	199945	"transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)"	0.86	1.1	1.15	1.8	2.14	2.88	1.55	2.39	1.31	1.75	1.41	1.76	0.57	0.54	1.23	1.38	1.4	0.43	2.1	1.42	2.96	4.53
HV4E10	127677	"Human transformer-2 alpha (htra-2 alpha) mRNA, complete cds"	1.98	1.58	1.92	2.53	2.43	0.86	2.23	0.63	1.76	1	0.53	1.46	1.61	2.23	1.32	1.78	0.98	1.39	1.28	1.29	1.04	2.14
HV4E11	240367	transcriptional repressor	1.47	1.32	1.51	1.54	1.58	1.04	1.4	1.93	1.7	1.24	1.12	1.16	0.91	1.48	0.85	1.04	0.99	1.24	0.89	0.55	0.83	1.15
HV4F1	234736	GATA-binding protein 6	1.16	1.33	1.67	2.66	1.02	0.74	0.91	1.26	1.7	0.81	0.63	0.85	1.04	0.97	0.87	0.51	1.01	1.34	1.34	0.6	1.12	0.98
HV4F2	727192	"nuclear factor of activated T-cells, cytoplasmic 3"	2.06	1.5	1.45	1.44	2.17	1.52	1.4	1.83	1.61	1.78	1.25	2.08	1.41	1.99	1	1.8	1.25	2.34	2.95	1.98	2.33	3.28
HV4F3	725680	transcription factor AP-2 gamma (activating enhancer-binding protein 2 gamma)	1.92	0.98	1.07	2.2	1.68	1.67	0.96	0.95	1.26	0.99	0.37	1.02	0.99	0.94	0.85	0.56	0.78	1.7	1.47	1.45	0.74	1.4
HV4F6	46786	tetratricopeptide repeat domain 2	1.37	2.34	0.85	0.99	1.72	1.26	1.62	1.15	1.8	1.48	0.82	1.58	1.32	1.99	0.63	1.64	1.54	2.1	1.06	0.76	0.99	1.76
HV4F9	361171	Tat interactive protein (60kD)	1.11	1.37	0.87	2.2	1.3	1.51	1.46	1.44	1.44	1.1	1.44	1.45	1.2	1.45	1.48	1.07	1.2	1.68	1.91	1.82	2.01	2.18
HV4F10	110281	syntaxin 7	1.16	3.04	1.16	2.06	2.83	3.62	2.05	2.06	2.37	2.01	1.07	2.55	1.24	1.18	1.75	2.02	1.45	1.35	2.05	1.17	1.76	1.91
HV4F11	346552	Symplekin; Huntingtin interacting protein I	0.6	1.7	0.75	1.51	1.16	0.84	0.89	0.99	0.85	0.81	0.9	0.97	0.55	0.93	0.82	0.89	1.24	1.25	2.13	1.58	2.44	1.63
HV4F12	811843	sulfite oxidase	1.44	2.69	1.08	2.14	1.65	2.01	1.42	1.83	1.36	2.15	1.25	1.43	0.97	1.28	1.25	1.86	1.88	1.06	1.19	0.85	1	1.17
HV4G1	28469	3-oxoacid CoA transferase	1.85	1.46	1.9	1.47	0.67	1.71	0.61	0.59	0.66	1.14	0.38	0.69	1.19	0.75	1	0.48	0.82	0.89	1.12	0.47	0.6	0.91
HV4G3	547247	stanniocalcin	0.67	1.65	1.51	1.44	0.82	0.89	1.34	2.86	1.06	1.72	0.38	2.04	1.4	3.92	0.99	0.47	0.7	0.93	4.7	2.55	1.34	1.42
HV4G4	31866	"pre-mRNA splicing factor SF3a (60kD), similar to S. cerevisiae PRP9 (spliceosome-associated protein 61)"	1.97	1.57	2.38	1.62	1.79	1.73	1.15	1.55	1.83	1.18	0.74	1.44	1.52	1.6	1.4	2.08	2.03	1.37	1.03	0.67	0.96	1.21
HV4G7	250667	"RAB9, member RAS oncogene family"	1.66	1.6	1.02	1.08	2.74	1.12	0.87	0.8	0.86	1.25	0.86	0.72	0.87	0.99	1.35	1.03	1.07	0.98	0.94	0.51	0.64	0.79
HV4G8	292213	postmeiotic segregation increased 2-like 12	1.45	2.13	1.81	1.41	1.52	0.98	1.55	1.58	1.55	1.95	1.65	1.07	1.9	1.98	1.48	1.78	0.85	2.02	1.16	1.49	0.98	1.08
HV4G9	324210	sigma receptor (SR31747 binding protein 1)	2.34	2.26	0.79	2.07	1.25	1.15	1.12	0.74	0.83	1.11	0.7	0.53	1.12	1.44	1.33	0.92	1.02	2.2	0.71	0.75	0.69	0.83
HV4G10	823590	sialyltransferase	4.49	2.49	1.13	2.47	3.15	3.87	2.76	5.16	5.55	2.67	0.77	4.18	1.95	4.97	2.03	3.74	2.76	6.05	6.96	4.88	2.46	7.16
HV4G11	813419	"hydroxyacyl-Coenzyme A dehydrogenase, type II"	1.64	3.69	2.13	1.29	1.75	1.7	1.09	1.56	2.5	1.36	1.54	1.22	0.9	2.07	1.17	2.03	2.27	2.28	1.87	1.02	0.97	1.37
HV4G12	813462	seven in absentia (Drosophila) homolog 1	1.71	1.88	1.06	1.25	1.53	1.56	1.81	1.99	2.64	1.5	0.46	1.7	2.45	2.54	0.75	1.9	1.38	1.02	2.97	0.85	2	1.48
HV4H2	280666	"sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D"	2.27	10.28	2.28	4.97	3.83	3.8	4.01	4.23	4.83	4.71	0.59	2.93	2.9	3.07	1.74	2.22	3.66	3.61	9.4	3.89	4.47	8.05
HV4H3	813533	syndecan binding protein (syntenin)	0.31	0.79	0.48	0.73	0.77	0.54	0.38	0.82	0.66	0.55	0.83	0.35	0.91	0.63	0.96	0.54	0.85	0.46	0.7	0.34	0.52	0.44
HV4H4	303048	ESTs	0.93	2.08	0.83	0.99	1.16	0.38	0.76	0.38	0.35	0.59	0.42	0.36	1.23	0.73	0.41	0.68	0.86	1.1	0.95	0.44	0.29	1.02
HV4H7	187147	"Human ras inhibitor mRNA, 3' end"	1.64	2.21	1.35	2.27	1.4	0.57	1.37	2.46	1.47	1.13	2.01	1.12	3.04	1.5	1.01	1.33	1.76	0.81	1.81	0.59	0.94	1.04
HV4H8	321529	Human rap2 mRNA for ras-related protein	2.06	3.48	2.42	3.7	2.29	2.05	1.2	1.66	1.5	1.19	0.8	1.39	1.61	0.8	2.14	1.33	2.02	0.97	3.94	2.51	2.31	0.74
HV4H9	142122	"Homo sapiens mRNA, clone:RES4-4"	1.49	3.37	1.62	1.07	2.46	1.31	1.79	2.42	2.62	1.11	1.83	1.04	1.42	1.97	1.01	1.85	1.14	1.23	1.26	0.77	0.95	1.16
HV4H10	197176	GDP dissociation inhibitor 2	1.07	1.87	1.14	2.23	1.37	2.69	1.11	1.13	0.75	0.83	1.23	1.5	1.34	0.99	1.39	1.27	1.38	1.97	0.68	0.73	0.51	0.96
HV4H11	810331	quiescin Q6	0.39	1.19	0.71	0.69	1.64	0.48	1.51	1.09	0.75	1.06	1.88	0.7	0.59	0.48	0.51	1.78	1.07	0.45	2.23	1.6	0.83	1.39
HV4H12	210887	suppression of tumorigenicity 13 (colon carcinoma) (Hsp70-interacting protein)	0.74	0.99	0.87	0.97	1.34	1.03	0.86	1.17	0.9	0.74	0.8	0.87	1.09	0.92	0.95	0.99	1.18	0.84	0.49	0.27	0.46	0.53
HV5A2	755054	interleukin 18 receptor 1	1.55	2.56	1.33	3.08	2.13	0.38	10.08	0.63	2235.2	1.53	0.14	2.93	1.99	1.78	1.22	1.24	1.24	2	2.01	0.91	0.97	4.72
HV5A3	47681	"splicing factor, arginine/serine-rich (transformer 2 Drosophila homolog) 10"	2.05	1.88	1.52	1.64	1.67	1.19	1.51	1.3	1.03	1.39	1	0.99	1	0.98	1.02	1.09	1.39	1.59	0.66	0.67	0.69	1.24
HV5A4	810452	outer mitochondrial membrane translocase (34kD)	1.16	1.76	1.4	1.27	2.19	1.33	1.76	1.26	1.32	1.77	0.82	1.11	0.8	1.05	0.71	2.03	1.95	1.38	0.77	1.13	0.66	1.04
HV5A6	41658	G protein-coupled receptor 37 (endothelin receptor type B-like)	2.76	1.66	0.93	1.77	2.35	1.24	1.94	2.22	1.98	1.41	1.16	1.11	1.74	1.6	2.27	2.06	1.14	1.1	1.25	1.73	1.45	3.2
HV5A7	242037	"Human putative cyclin G1 interacting protein mRNA, partial sequence"	1.05	0.65	1.42	1.93	1.08	0.32	0.55	0.7	0.65	0.86	0.64	0.37	0.73	0.77	0.62	0.72	0.3	2.03	0.58	0.82	0.74	0.47
HV5A8	144816	"solute carrier family 31 (copper transporters), member 2"	3.29	2.03	1.08	2.13	2.15	3.18	2.16	2.97	3.43	2.56	2.43	1.16	1.54	2.21	1.23	2.28	1.35	1.32	2.79	1.04	1.88	2.49
HV5A9	380797	RNA binding motif protein 3	1.12	0.84	1.44	0.98	0.89	1.16	1.09	1.04	0.4	1.06	1.06	0.85	0.97	0.61	1.17	0.78	0.98	1.67	0.89	1.3	1.44	1.76
HV5A10	809776	interleukin 16 (lymphocyte chemoattractant factor)	1.83	5.25	3.84	3.95	5.45	5.47	4.04	14.99	3.85	3.58	3.29	5.32	5.14	3.66	3.03	4.68	1.49	3.24	6.31	1.23	1.88	2.65
HV5B1	166934	protocadherin 2 (cadherin-like 2)	2.09	3.02	2.94	2.17	3.38	1.51	2.11	1.03	1.44	1.76	2.12	1.31	1.63	0.98	1.17	2.02	1.65	0.94	3.48	3.18	2.69	2.89
HV5B2	771236	protocadherin 1 (cadherin-like 1)	1.83	1.61	1.02	1.07	2.06	1.46	1.68	1.09	1.54	1.99	0.91	1.84	1.11	1.67	0.92	1.58	1.26	1.49	0.94	1.24	0.89	1.13
HV5B3	342378	dual specificity phosphatase 5	0.41	0.46	0.35	1.37	0.7	0.52	0.55	0.73	0.99	0.56	0.49	0.82	0.98	0.92	0.79	0.47	0.36	0.51	1.5	0.63	1	1.85
HV5B4	146123	"protein tyrosine phosphatase, receptor type, K"	0.42	0.97	0.49	0.84	1.46	1.65	0.73	0.7	0.91	0.59	0.46	0.87	0.56	0.31	0.28	1.3	1.46	0.55	0.9	0.3	0.76	0.44
HV5B5	42739	"Homo sapiens tyrosine phosphatase (PRL-1) gene, complete cds"	0.48	0.62	0.8	0.61	0.56	0.42	0.44	0.64	0.46	0.6	0.72	0.7	0.74	0.52	0.89	0.64	0.48	0.85	0.56	0.48	0.49	0.48
HV5B6	362853	protein tyrosine kinase 9	0.46	0.64	0.61	1.47	1.06	0.85	0.46	0.88	0.51	0.76	0.54	0.83	0.65	0.58	0.47	0.89	1.27	0.43	0.87	1.16	0.49	0.78
HV5B11	809784	"protease, serine, 9 (neurosin)"	0.44	0.69	0.13	0.13	0.77	0.12	0.1	0.08	0.06	0.06	0.07	0.08	0.18	0.22	0.15	0.1	0.05	0.19	0.33	0.11	0.2	0.22
HV5B12	199403	"lectin, galactoside-binding, soluble, 8 (galectin 8)"	1.37	2.92	1.45	1.93	2.61	2.18	2.03	1.59	1.31	2.67	1.76	1.96	1.95	2.7	2.45	2.43	1.9	1.36	2.08	1.49	1.2	1.42
HV5C1	484641	"solute carrier family 21 (prostaglandin transporter), member 2"	0.61	1.53	0.92	1.44	2.07	1.44	1.97	2.85	1.53	2.66	1.83	0.82	1.36	1.32	1.44	1.68	0.91	1.17	1.56	0.62	1.26	1.18
HV5C3	682522	proprotein convertase subtilisin/kexin type 5	0.36	2	0.46	0.88	1.39	0.59	0.76	0.66	0.76	0.98	0.76	0.36	0.47	0.57	0.54	0.86	0.8	0.39	0.99	0.29	0.37	0.72
HV5C4	52431	placental transmembrane protein	0.79	0.4	0.75	0.66	1.18	1.84	0.93	1.23	1.2	0.87	1.03	1.02	0.8	0.67	0.96	1.42	0.74	0.37	0.54	1.43	0.57	0.78
HV5C6	230385	"phosphatidylinositol-4-phosphate 5-kinase, type II, beta"	1.47	2.25	1.48	1.67	2.02	1.53	2.34	2.32	2.54	1.09	0.62	1.85	1.64	1.87	2.44	1.66	1.58	1.04	2.58	2.79	1.83	2.26
HV5C7	198372	"Human phosphatidylinositol (4,5) bisphosphate 5-phosphatase homolog mRNA, partial cds"	2.17	1.89	1.3	1.47	1.38	1.8	1.08	0.88	2.61	1.14	1.22	1.08	1.14	1.43	1.04	0.65	0.68	1.11	3.09	2.48	1.57	1.98
HV5C8	511832	"peroxisome proliferative activated receptor, gamma"	1.03	1.1	1.34	1.01	1.08	1.9	1.45	1.18	0.6	1.14	1.16	1.19	1.6	0.86	1.59	1.3	2.49	1.68	1.05	1.32	1.16	1.45
HV5C9	770080	paxillin	0.17	0.39	0.26	0.23	0.37	0.34	0.48	0.73	0.35	0.47	0.45	0.3	0.39	0.45	0.56	0.3	0.19	0.43	0.56	0.38	0.65	0.47
HV5C11	753917	76 kDa membrane protein	1.96	1.68	0.67	0.85	1.24	0.97	0.79	1.27	1.09	0.84	0.95	1.65	0.87	1.03	1.31	0.9	0.68	0.9	0.81	0.54	0.63	1.39
HV5C12	296476	"ESTs, Highly similar to P300/CBP-associated factor [H.sapiens]"	1.44	2.22	1.26	1.43	1.06	2.62	1.59	1.57	2.83	1.55	0.49	1.87	1.66	1.5	0.92	1.34	1.69	0.77	3.62	1.13	1.35	2.51
HV5D1	754093	nidogen 2 (osteonidogen)	1.7	8.37	13.98	13.07	3.92	3.03	7.05	11.11	304.04	3.09	1.58	3.97	2.22	4.65	2.58	0.65	1.76	2.43	2.94	1.32	2.61	2.65
HV5D2	246786	"Human orphan G protein-coupled receptor (RDC1) mRNA, partial cds"	1.18	4.43	4.84	1.88	3.98	1.12	4.42	5.07	3.36	3.86	1.14	1.59	243.7	2.56	1.79	2.19	1.51	2.02	4.32	1.25	1.79	3.09
HV5D3	221808	nucleosome assembly protein 1-like 4	0.99	2.4	1.46	1.78	1.9	1.3	1.47	1.19	1.16	1.28	1.51	1.37	0.77	0.87	1.03	1	1.86	0.83	1.16	1.01	0.97	1.15
HV5D4	22918	nucleolar protein p40	1.49	1.33	1.1	1.26	1.54	1.32	1.28	1.14	2.16	1.1	0.79	1	1.04	1.04	0.94	1.6	1.48	1.25	0.53	0.71	0.93	0.98
HV5D5	50614	SKI-INTERACTING PROTEIN	0.73	0.81	1.05	1.29	0.87	0.7	0.67	0.77	1.66	0.67	0.69	0.76	0.76	1.1	0.88	0.68	0.5	0.96	0.84	0.62	0.56	0.92
HV5D6	206217	"nuclear receptor subfamily 1, group H, member 3"	0.96	4.09	1.22	1.85	2.42	2.5	2.68	1.48	2.2	2.91	1.96	1.78	2.02	2.23	1.34	1.6	2.06	1.39	3.82	1.82	2.17	2.1
HV5D7	241826	high-mobility group (nonhistone chromosomal) protein 17	2.17	1.06	2.72	1.31	0.81	1.88	1.4	1.23	0.97	1.43	1.15	1.77	1.21	1.92	1.73	0.96	0.71	1.37	1.33	1.57	1.44	1.88
HV5D8	31873	non-histone chromosomal protein	0.87	2.2	1.37	1.53	1.47	1.4	0.99	1.28	0.87	0.99	1.38	0.99	1.3	1.01	0.77	0.72	2.22	1.02	0.61	0.73	1.05	0.8
HV5D11	190887	myeloid differentiation primary response gene (88)	1.11	1.67	1.25	1.86	2.25	1.83	1.68	1.65	1.32	1.37	1.96	1.08	0.81	0.94	1.13	1.17	0.72	0.94	1.75	1.75	1.66	1.63
HV5D12	48614	E74-like factor 4 (ets domain transcription factor)	1.87	1.86	0.79	1.18	1.52	1.49	1.63	1.56	1.16	1.78	0.38	1.24	1.1	1.42	1.05	1.79	1.31	0.92	1.49	0.89	0.81	0.98
HV5E1	810743	myeloid leukemia factor 2	1.19	2.48	1.13	1.85	1.65	1.25	1.43	1.62	2.03	1.29	1.07	1.33	0.86	1.03	0.57	1.31	1.7	2.87	1.76	1.33	2.01	1.79
HV5E2	172765	exostoses (multiple)-like 1	1.77	3	1.08	1.83	1.96	1.3	1.89	1.9	1.9	1.4	0.69	1.51	0.87	1.16	0.65	2.35	1.63	1.84	1.05	0.85	1.16	1.35
HV5E3	292212	"ATP-binding cassette, sub-family C (CFTR/MRP), member 5"	2.03	2.6	3.11	2.24	2.98	1.09	4.8	5.51	10.83	3.01	1.75	4.13	1.64	2.47	1.77	1.74	2.56	2.71	5.35	3.07	1.33	5.41
HV5E7	134269	polymerase (RNA) mitochondrial (DNA directed)	1.73	1.57	1.1	1.66	1.03	1.04	1.02	1.38	1.98	1.1	1.13	1.03	1.15	1.63	0.84	1.1	0.99	1.14	1.32	1.41	1.31	2
HV5E8	193106	"ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9) isoform 3"	1.05	0.65	0.46	0.82	0.84	0.56	0.63	0.56	0.53	0.56	0.57	0.58	0.87	0.89	1.03	1.6	0.64	0.97	0.45	0.65	0.67	0.58
HV5E9	213890	"2,4-dienoyl CoA reductase 1, mitochondrial"	0.65	0.69	0.73	0.66	0.38	0.25	0.42	0.25	0.21	0.47	0.39	0.23	0.54	0.46	0.54	0.68	0.28	0.33	0.22	0.32	0.34	0.49
HV5E11	232772	"ESTs, Highly similar to METALLOTHIONEIN-IB [H.sapiens]"	2	0.92	1.33	1.13	0.83	0.85	1.57	1.46	2.98	1.44	1.06	1.46	1.02	1.47	1.79	1.18	0.64	1.72	1.26	1.16	1.35	1.49
HV5E12	122915	meningioma expressed antigen 6 (coiled-coil proline-rich)	1.75	1.19	0.75	0.65	1.24	0.54	0.71	0.74	0.71	1.08	0.5	0.98	1.39	1.69	0.86	1.7	0.62	0.7	2.54	0.43	0.65	0.78
HV5F3	50188	ring finger protein 4	0.83	1.28	0.78	1.64	1.3	0.87	1.27	1.37	1.35	1.07	1.22	0.78	0.96	0.88	1.25	1.16	0.88	0.66	0.98	1.92	1.5	1.11
HV5F4	26314	syntaxin binding protein 3	1.31	1.91	1.72	1.29	1.45	0.9	2.01	1.15	2.09	2.16	0.33	0.62	1.15	1.06	0.79	1.16	2.02	0.86	1.07	0.81	0.79	0.94
HV5F5	753914	"inositol 1,4,5-triphosphate receptor, type 2"	2.61	0.67	3.97	2.44	0.62	0.82	1.01	14.26	0.95	1.22	0.88	2.2	4.16	1.92	0.79	0.64	2.03	5.1	2.07	1.97	1.27	3.03
HV5F7	730149	"Homo sapiens mRNA for transcription elongation factor S-II, hS-II-T1, complete cds"	0.45	0.96	1.69	0.59	0.76	0.49	0.74	0.97	1.09	0.52	0.72	1.5	0.74	1.32	0.61	0.45	0.36	0.75	0.76	1.2	0.56	0.64
HV5F8	246304	Homo sapiens mRNA; cDNA DKFZp564L176 (from clone DKFZp564L176)	2.31	1.51	1.81	1.4	1.55	1.29	1.22	0.97	0.99	1.73	0.71	0.59	0.79	0.71	0.73	1.46	1.93	1.36	0.88	0.54	0.73	0.65
HV5F9	246120	"HMT1 (hnRNP methyltransferase, S. cerevisiae)-like 2"	0.45	0.94	0.88	0.84	0.71	0.44	0.58	0.54	0.62	0.46	0.72	0.74	0.44	0.74	0.64	0.86	0.84	1.45	0.61	0.55	0.77	0.75
HV5F11	810725	"ATPase, H+ transporting, lysosomal (vacuolar proton pump) 21kD"	1.81	1.72	1.68	1.83	1	1.3	1.84	1.73	3.76	1.91	1.56	1.68	1.06	1.52	1.72	1.64	0.85	2.37	1.88	2.48	2.12	2.24
HV5G1	823598	"proteasome (prosome, macropain) 26S subunit, non-ATPase, 12"	1.87	2.79	1.72	1.59	1.39	1.63	2.21	1.1	2.47	2.88	0.98	1.04	0.8	0.99	1.45	1.84	1.81	1.64	1.16	0.94	1.02	1.04
HV5G2	767049	"proteasome (prosome, macropain) 26S subunit, ATPase, 6"	1.46	1.45	1.41	0.98	0.88	1.2	1.24	1.1	1.75	1.15	0.37	2.08	1.15	2.08	1.57	1.67	1.05	1.17	1.14	0.58	0.65	1.22
HV5G4	210405	"proteasome (prosome, macropain) activator subunit 2 (PA28 beta)"	2.2	5.17	1.76	1.45	1.74	2.28	3.01	2.25	3.48	4.29	1.69	3.22	1.16	1.77	1.32	2.48	1.45	0.95	4.09	1.57	1.92	2.53
HV5G5	810124	"platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit (29kD)"	2.39	2.45	1.59	1.67	1.59	0.77	1.65	1.69	5.12	1.27	1.2	1.9	0.91	4.62	1.49	1.32	1.09	2.96	2.89	1.5	2.33	2.7
HV5G6	33949	phosphoribosyl pyrophosphate synthetase-associated protein 1	2.46	2.97	1.84	3.85	2.6	2.26	1.61	2.68	2.8	1.59	1.97	1.95	1.61	1.81	1.05	2.36	2.96	3.67	2.23	2.44	2.04	1.94
HV5G7	754601	"phospholipase C, epsilon"	2.25	1.05	2.14	1.09	0.45	1.42	0.63	0.74	9.44	1.58	0.59	2.95	1.82	5.23	1.25	0.31	0.89	4.18	3.72	1.17	1.45	2.48
HV5G8	130884	"phosphate cytidylyltransferase 2, ethanolamine"	2.23	3.68	0.95	1.54	2.07	2.14	1.56	1.76	2.7	1.53	1.59	1.75	1.68	2.77	1.41	2.88	1.83	3.32	2.82	2.73	2.06	1.85
HV5G11	176606	nel (chicken)-like 2	1.87	2.15	2	2.83	1.46	1.55	1.48	2.63	2.22	2.81	1.76	2.03	1.65	3.41	1.17	0.53	0.4	4.08	2.92	2.08	2.19	2.86
HV5H1	202577	histamine N-methyltransferase	1.54	13.19	8.74	15.76	4.98	4.49	6.53	17.45	3.28	4.58	4.04	4.77	2.46	5.15	1.62	2.48	2.19	1.75	5.29	3.17	3.13	5.76
HV5H3	813673	"Human mRNA for hepatoma-derived growth factor, complete cds"	1.12	3.84	0.61	1.71	1.73	1.08	1.29	0.83	0.97	0.85	1.08	0.93	0.57	1.14	1.15	0.86	1.83	2.08	0.66	0.55	0.72	0.88
HV5H4	47647	dihydropyrimidinase-like 3	1.59	2.46	0.77	1.7	1.39	2.07	1.81	1.43	1.74	1.71	0.8	1.56	1.27	1.7	1.39	2.26	2.92	2.01	1.12	1.66	1.01	1.36
HV5H6	812196	UDP-glucose ceramide glucosyltransferase	2.85	2.42	0.72	1.82	1.39	1.62	1.49	1.69	1.04	0.73	1.5	1.42	1.72	1.89	1.38	2.08	1.55	1.29	1.49	0.72	1.09	1
HV5H7	726779	"calponin 1, basic, smooth muscle"	2.21	1.02	7.1	1.25	2.36	1.77	2.32	13.46	30	1.22	1.06	2.95	4.12	6.02	1.17	1.26	1.09	3.17	3.2	1.18	2.63	3.53
HV5H8	810612	S100 calcium-binding protein A11 (calgizzarin)	1.42	1.09	0.85	0.47	1.2	0.87	1.05	0.83	0.79	0.62	0.76	0.52	0.6	0.72	0.97	0.91	1.01	1.64	1.22	0.33	0.79	0.56
HV5H9	31842	UDP-galactose transporter related	0.93	1.57	1.42	1.85	1.24	1.19	3.93	1.8	1.98	3.14	1.84	2	0.84	1.27	1.17	1.89	1.09	1.68	2.81	1.98	2.76	2.6
HV5H10	823940	"transducer of ERBB2, 1"	0.72	0.92	0.24	1.12	0.64	0.89	1.59	2.03	1.02	1.75	1.78	1.36	1.26	1.07	1.75	2.63	0.93	0.3	3.78	2.37	2.21	1.03
HV5H11	230100	RAN binding protein 2	1.55	0.84	1.84	1.09	0.75	1.18	1.71	2.28	3.38	0.65	0.59	1.96	2.38	1.71	1.19	0.65	1.73	1.6	1.91	1.17	1.59	1.79
HV5H12	343443	RNA-binding protein gene with multiple splicing	0.77	2.14	1.18	0.81	1.54	0.54	1.06	1.76	1.2	0.75	0.77	1.03	1.65	1.17	0.97	1.35	0.83	0.73	0.83	0.43	0.48	0.73
HV6A1	281465	"phosphatidylinositol glycan, class B"	0.94	1.17	1.18	1.04	1.42	0.83	1.23	2.84	1.74	1.27	0.79	0.73	1.23	1.62	0.59	0.94	0.67	0.87	1.14	0.67	0.9	1.48
HV6A2	810010	platelet-derived growth factor receptor-like	2.04	7.49	8.38	7.35	8.48	1.74	5.29	26.32	11.59	4.81	3.75	5.72	5.18	5.61	3.11	3.23	1.69	3.91	2.55	0.92	2.87	1.03
HV6A5	665658	msh (Drosophila) homeo box homolog 2	0.67	0.87	1.73	1.58	1.19	0.3	1.68	1.92	1.78	1.8	1.04	1.02	0.87	1.39	0.6	0.59	0.48	0.46	2.88	1.42	0.7	2.16
HV6A7	23772	"leucine-zipper-like transcriptional regulator, 1"	1.31	2.67	2.46	1.91	2.2	1.39	2.24	2.36	3.21	1.65	1.99	1.76	1.47	2.33	1.55	1.33	1.17	2.5	3.73	2.27	2.28	3.19
HV6A8	810551	low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor)	1.58	1.64	4.16	2.66	5.06	2.34	4.11	4.86	3.57	4.54	0.62	2.22	2.82	2.27	1.49	2.28	1.52	1.62	5.37	3.01	6.94	6.62
HV6A12	364921	"catenin (cadherin-associated protein), delta 1"	1.35	1.23	1.72	0.85	1.5	1.15	1.05	1.19	1.1	0.99	1.05	1.59	1.79	1.36	1.42	1.43	1.02	1.7	0.82	0.98	0.95	1.34
HV6B1	381166	histone acetyltransferase	0.87	1.53	2.24	1.77	1.58	0.86	1.54	2.52	1.45	2.58	1.58	0.81	1.9	2.02	1.04	1.33	0.86	0.95	2.13	4.87	1.4	3.81
HV6B3	244801	KIAA0380 gene product; RhoA-specific guanine nucleotide exchange factor	1.47	1.57	1.92	1.86	1.95	1.17	1.73	2.06	2.11	5.17	1.56	1.42	1.46	2.74	1.27	0.87	1.47	2.35	2.12	1.17	1.88	1.59
HV6B4	233199	KIAA0379 protein	1.36	2.51	0.84	1.27	3.23	0.85	1.57	1.18	1.67	2.65	0.86	1.68	1.27	1.74	0.84	1.59	1.83	1.51	1.53	0.72	0.62	1.3
HV6B6	32472	KIAA0376 protein	1.9	4.43	4.47	1.86	3.54	1.98	2.73	3.03	3.15	3.61	1.57	2	2.51	2.04	1.81	2.39	1.63	2.84	3.65	3.39	2.28	2.77
HV6B7	666639	KIAA0372 gene product	1.11	0.8	2.21	2.19	0.64	0.53	1.02	1.52	1.32	0.98	0.65	0.64	0.85	0.89	0.99	0.47	0.91	0.5	2.31	1.13	1.94	6.01
HV6B10	811029	KIAA0365 gene product	2.31	3.1	1.41	2.16	2.6	1.59	1.98	1.56	3.02	1.87	1.39	1.81	2.15	3.82	1.07	2.06	1.71	3.17	2.71	1.76	1.45	2.15
HV6C2	281904	KIAA0349 protein	1.02	2.18	1.29	1.17	1.35	1.56	1.39	1.23	1.9	1.44	0.77	1.18	1.75	1.93	0.83	2.01	1.46	1.85	1.42	0.85	0.86	0.99
HV6C4	35271	neuronal cell adhesion molecule	1.73	2.31	1.25	1.65	1.69	1.69	1.74	3.57	3.59	0.74	0.51	3.41	2.46	3.2	2.84	1.92	1.71	7.35	2.75	1.67	0.82	1.54
HV6C5	123061	RAN binding protein 2-like 1	1.14	1.05	1.28	0.99	0.78	1.28	1.02	1.47	1.61	1.47	0.46	1.16	1.69	0.94	1.04	0.6	1.02	0.91	1.43	0.95	1	1.2
HV6C6	753770	KIAA0335 gene product	1.4	2.15	0.67	0.97	0.92	0.89	1.34	1.1	1.57	1	0.23	1.15	2.11	2.27	0.7	1.12	1.05	1.27	1.52	0.64	0.79	1.19
HV6C9	296190	KIAA0321 protein	1.36	1.75	2.3	1.51	1.19	1.27	2.41	2.05	2.3	1.92	0.65	1.63	1.6	2.38	0.99	0.86	1.04	2.11	2.11	0.99	1.4	1.56
HV6C10	40844	A kinase (PRKA) anchor protein 6	1.95	2.3	1.12	1.17	2	2.28	1.84	1.33	2.05	1.56	0.34	1.45	1.85	1.8	1.13	1.67	1.4	1.04	2.01	1.13	0.71	1.69
HV6C11	809944	KIAA0310 gene product	2.43	1.53	0.65	1.19	1.4	1.43	1.76	1.93	2.79	2.11	1.79	1.82	1.59	2.87	1.75	2.07	0.7	0.9	2.01	1.45	1.99	1.45
HV6C12	147630	KIAA0308 protein	1.06	1.08	0.72	0.6	1.15	1.2	0.73	0.84	1	0.74	0.27	0.84	1.51	1.05	0.57	0.95	0.7	0.62	0.71	0.21	0.32	0.55
HV6D3	768031	KIAA0303 protein	1.05	1.15	0.43	0.64	1.37	0.85	0.94	1.31	1.56	0.96	1.25	1.17	0.96	3.19	0.87	0.8	0.38	0.57	3.83	1.25	1.27	2.67
HV6D4	184038	"Homo sapiens beta III spectrin (SPTBN2) mRNA, partial cds"	2.49	2.09	0.46	1.03	1.9	1.89	1.43	0.65	2.06	2.18	0.62	0.37	0.8	0.71	1.77	1.77	1.19	1.85	1.13	0.48	0.92	0.87
HV6D5	233078	KIAA0329 gene product	0.91	1.49	1.86	1.78	1.39	0.95	1.43	1.79	2.08	1.26	0.88	0.98	1.66	1.35	0.95	1.15	0.71	1.73	2	1.33	1.16	1.83
HV6D6	141763	KIAA0295 protein	1.05	2.45	1.17	1.18	1.53	1.15	1.31	1.67	1.68	1.26	1.1	1.5	1.61	1.63	1.2	1.46	1.06	0.99	2.65	1.52	3.02	0.88
HV6D7	756898	KIAA0280 protein	1.7	2.06	1.91	3.63	2.26	1.92	1.41	3.22	4.83	1.46	1.54	1.48	1.8	0.98	0.76	1.08	1.23	1.21	3.61	1.98	1.69	3.36
HV6D8	175103	"EGF-like-domain, multiple 2"	3.68	2.2	1.24	1.67	1.97	1.41	4.16	1.7	6.06	2.44	0.9	1.36	1.11	3.82	0.85	1.72	1.52	1.57	2.55	1	0.98	2.3
HV6D9	753420	KIAA0276 protein	1.28	2.62	2.03	2.54	1.73	1.11	0.92	1.88	1.92	1.04	0.73	1.07	1.14	1.07	0.8	0.98	1.08	0.96	1.69	1.13	0.53	1.06
HV6D10	726678	KIAA0275 gene product	1.68	2.54	0.97	3.45	1.93	1.47	1.48	1.52	1.85	1.42	1.19	1.93	1.99	1.57	1.42	1.57	1.47	1.64	4.2	2.8	2.54	1.05
HV6D11	46154	BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)	0.87	1.54	1.24	1.34	1.51	1.42	1.48	1.34	1.58	1.57	1.61	0.97	0.93	0.96	1	1.09	0.97	0.58	1.4	2.37	0.9	1.15
HV6D12	809541	BCL2-like 2	1.55	1.86	0.79	0.74	1.45	0.95	0.9	1.27	1.69	0.9	0.53	1.14	1.64	1.35	1.02	1.08	0.85	0.81	2.29	2.02	1.72	2.62
HV6E2	20115	"solute carrier family 9 (sodium/hydrogen exchanger), isoform 6"	1.83	2.06	1.09	1.42	1.8	0.77	1.11	0.93	1.45	1.05	0.72	0.46	0.98	0.92	1.32	2.37	1.14	0.6	1.32	0.83	0.85	1.13
HV6E3	140716	KIAA0265 protein	1.24	1.07	1.84	2.11	1.42	1.09	1.05	1.86	1.39	1.58	1.28	0.72	1.38	0.86	0.94	0.88	0.84	0.67	2.48	3.33	1.69	2.6
HV6E4	214448	KIAA0262 gene product	0.89	1.15	0.73	1.49	0.98	1.14	1.4	1.09	1.07	1.26	1.27	1.07	1.18	1.2	1.09	1.56	1.01	1.02	1.01	1.26	0.96	1.17
HV6E5	301380	KIAA0260 protein	1.8	1.4	1.56	1.64	1.16	1	0.92	1.52	1.28	1.52	1.09	1.22	1.31	1.72	0.76	0.55	1.15	1.45	1.07	0.59	0.65	1.31
HV6E6	200136	topoisomerase (DNA) II binding protein	2.29	2	2.07	1.83	2.13	1.5	1.89	1.32	1.51	1.11	0.89	1.08	1.16	1.57	1.07	1.14	1.53	0.52	1.08	1.11	0.66	1.29
HV6E7	295255	KIAA0254 gene product	1.81	1.21	1.19	1.32	1.3	0.97	0.98	1.18	0.81	1.29	1.13	0.7	1.1	0.97	0.95	1.01	0.57	1	0.67	0.81	0.85	1.24
HV6E8	199645	KIAA0253 protein	0.86	1.5	0.6	0.98	2.09	0.85	1.33	0.95	0.77	0.89	1.16	0.87	0.8	1.65	0.88	1.52	1.28	1.11	0.69	1.14	1.21	0.99
HV6E9	110653	KIAA0250 gene product	3.02	2.14	2.56	2.49	2.08	1.49	1.73	2.13	1.49	2.1	1.65	2.9	1.31	1.85	1.33	1.32	1.76	1.78	3.96	1.97	1.53	2.78
HV6E11	767769	"solute carrier family 7 (cationic amino acid transporter, y+ system), member 6"	1.98	1.63	1.39	1.98	2.11	0.88	1.25	1.54	1.47	1.86	0.93	1.18	0.81	1.21	0.73	1.36	0.87	1.03	0.92	0.48	0.96	1.94
HV6E12	358344	KIAA0244 protein	1.36	1.39	0.86	0.75	1.31	0.89	1.13	0.96	1.39	0.92	0.65	1.11	1.55	1.28	1.6	1.2	0.85	0.83	0.69	1.3	0.85	1.42
HV6F1	812042	tuberous sclerosis 1	1.91	1.57	1.84	1.9	1.89	0.82	1.19	1.4	2.6	3.11	1.01	0.81	1.35	1.49	1.01	0.82	0.68	0.86	1.21	0.69	0.84	1.02
HV6F2	346995	KIAA0242 protein	3.06	3.94	0.74	1.13	3.91	1.91	1.91	1.15	1.42	2.13	0.96	4.59	2.36	3.3	1.88	1.89	1.92	4.68	3.61	0.96	1.37	2.27
HV6F3	809779	KIAA0239 protein	0.27	0.78	0.55	0.76	0.55	0.32	0.38	0.44	0.51	5.29	0.46	0.3	0.71	0.91	0.47	0.29	0.38	0.29	0.39	0.46	0.32	0.54
HV6F4	756657	zinc finger protein 142 (clone pHZ-49)	1.28	2.81	0.99	1.61	3.02	1.91	1.66	1.39	1.78	2.46	1.46	2.01	1.68	1.7	1.31	1.7	1.8	2.4	3.09	2.85	2.28	2.42
HV6F5	755752	KIAA0235 protein	1.5	0.73	1.46	1.37	0.45	1.13	0.69	1.41	1.76	0.63	0.95	1.39	1.57	1.67	1.37	0.71	1.26	1.33	1.22	0.84	1.23	1.5
HV6F7	254625	KIAA0229 protein	1.26	0.73	1.21	2.32	0.75	0.63	0.66	1.06	1.36	0.57	0.57	0.78	1.73	1.21	1.19	0.33	1.16	1.45	2.71	0.91	1.35	1.64
HV6F8	809696	KIAA0224 gene product	1.77	1.73	0.99	1.11	2.05	0.94	1.36	1.39	1.64	1.75	1.12	1.54	1.21	1.59	1.2	1.52	1.27	1.94	1.08	0.69	1.06	1.19
HV6F9	341317	ESTs	1.3	1.29	1.29	2.2	1.22	0.82	1.16	1.33	1.42	1.03	1	1.5	1.05	1.35	1.34	0.56	1.12	1.29	1.1	1.48	1.49	1.57
HV6F10	119914	"ESTs, Moderately similar to !!!! ALU SUBFAMILY SX WARNING ENTRY !!!! [H.sapiens]"	1.57	1.82	1.03	1.46	1.69	1.08	1.49	1.58	1.97	1.92	1.2	1.35	1.29	1.35	3.79	2.3	1.57	1.52	1.33	2.16	1.44	2.03
HV6F11	40567	"GCN1 (general control of amino-acid synthesis 1, yeast)-like 1"	0.94	1.48	0.78	2.25	0.88	0.95	0.9	1.1	0.89	0.95	1.02	0.86	0.81	0.94	1.06	0.91	1.25	1.27	1.14	1.94	1.16	1.1
HV6F12	298118	dedicator of cyto-kinesis 2	1.17	1.82	0.83	1.61	1.37	1.86	1.57	1.64	1.48	2.16	1.57	1.16	1.23	1.1	1.29	1.71	1.58	1.69	1.28	2.12	1.14	1.47
HV6G1	195138	KIAA0205 gene product	3.75	3.46	3.89	2.91	3	2.31	2.69	5.71	4.85	2.39	1.77	5.82	3.2	2.75	1.23	1.3	1.55	3.41	4.65	2.59	2.21	4.27
HV6G2	302031	KIAA0204 gene product	0.97	1.08	0.51	0.91	0.85	0.85	0.64	0.72	0.57	0.89	0.41	0.46	0.97	0.54	0.62	1.15	0.89	0.34	0.76	0.72	0.35	0.64
HV6G3	23431	KIAA0203 gene product	1.51	1	1.44	1.32	1.57	0.94	0.83	1.16	1.13	1.75	0.43	0.93	1.21	0.93	1.27	0.99	1.29	1.19	0.97	0.82	0.49	0.82
HV6G4	27104	KIAA0200 gene product	1.1	1.45	1.08	1.56	1.72	1.2	1.24	1.2	1.12	1.16	1.19	1.05	1.49	1.51	1.28	1.25	1.34	0.95	1.29	1.29	1.23	1.37
HV6G5	40365	SREBP CLEAVAGE-ACTIVATING PROTEIN	0.94	1.44	0.81	1.31	1.16	1.18	0.94	0.97	1.01	1.75	0.93	0.84	0.98	0.76	1.09	0.72	0.96	1.26	1.28	1.58	0.99	1.11
HV6G6	33299	KIAA0197 protein	1.75	2.17	1.82	2.43	2.56	2.03	1.23	1.44	1.14	2	0.93	1.14	1.73	1.37	1.25	2.28	2.5	1.18	1.8	1.07	1.27	1.61
HV6G7	362729	KIAA0193 gene product	1.06	1.64	1.07	0.85	1.38	2	1.02	1.54	0.93	2.04	1.13	1.86	0.52	0.34	1.54	1.12	0.98	1.03	0.77	1.82	1.2	0.88
HV6G9	43977	KIAA0182 protein	0.92	1.2	0.42	0.53	0.89	0.91	1.06	0.71	2.5	1.24	1.2	0.89	0.98	1.97	1.28	1.41	0.47	1.03	1.04	0.75	1.1	0.77
HV6G10	112131	KIAA0180 protein	1.4	1.56	1.16	0.95	2.52	3.17	1.22	0.96	1.42	1.14	0.95	1.36	1.67	1.14	1.78	2.61	1.46	1.47	1.5	1.32	1.04	1.89
HV6G11	753987	ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase)-like 1	0.87	2.54	1.27	1.68	1.58	1.47	1.35	1.34	1.21	1.11	0.62	1.02	1.11	1.69	2.48	0.68	0.98	1.32	1.09	0.55	0.75	0.84
HV6G12	34616	KIAA0176 protein	1.96	2.69	1.2	1.7	3.16	4.12	1.65	2.47	2.7	2.29	1.3	1.88	1.82	1.52	1.59	1.94	1.8	2.23	2.12	3.11	2.01	3.06
HV6H1	812975	KIAA0172 protein	1.16	2.06	0.34	0.54	0.83	0.24	0.32	0.21	1.6	0.25	0.23	0.2	0.87	0.42	0.57	0.43	0.57	1.28	0.29	0.18	0.23	0.45
HV6H2	212704	KIAA0170 gene product	1.97	5.66	2.57	2.02	3.76	2.18	2.74	2.52	2.3	2.48	1.67	1.31	2.11	3.2	1.39	2.49	2.66	2.37	2.35	1.65	1.71	2.3
HV6H3	30885	KIAA0156 gene product	0.88	1.88	1.05	1.46	1.54	1.13	1.14	1.23	1.14	0.9	1.1	0.88	1.01	1.15	1.3	0.77	1.02	0.98	1.05	1.39	1.18	1.34
HV6H5	812167	KIAA0154 protein	0.98	1.99	0.81	1.18	1.15	1.01	1.43	1.12	2.13	0.95	0.59	0.52	1.4	1.2	1.15	1.06	0.86	1.69	1.31	0.71	0.75	1.44
HV6H6	34106	KIAA0153 protein	1.21	3.15	1.01	2.26	2.3	2.49	1.51	1.5	1.53	1.16	1.48	1.92	1.49	2.36	1.11	1.68	1.89	1.12	1.41	2.09	1.35	1.71
HV6H7	742007	KIAA0146 protein	1.12	1.8	1.18	1.12	2.08	0.71	0.98	1.66	1.82	0.92	0.72	0.94	1.8	1.55	0.99	0.95	4.14	1.49	1.49	1.14	0.66	1.6
HV6H9	563451	serine threonine protein kinase	0.93	2.04	1.15	1.45	1.5	1.18	2.04	1.81	1.59	2.47	1.24	1.65	1.7	1.08	1.99	2.43	0.94	1.32	1.86	1.35	0.85	1.24
HV6H10	245198	KIAA0130 gene product	1.17	2.38	0.91	1.62	1.86	1.31	4.18	1.92	1.91	3.37	2	2.06	1.62	2.3	3	2.73	1.68	1.9	3.62	2.59	2.28	4.04
HV6H11	143966	KIAA0128 protein	1.75	2.39	1.11	2.26	1.81	1.89	1.42	1.71	2	1.6	2.05	2.08	1.64	2.24	1.1	1.4	1.45	1.37	2.93	1.65	1.54	1.43
HV6H12	823715	KIAA0127 gene product	1.33	1.43	1.07	2.14	2.21	1.31	1.06	1.2	1	1.4	0.68	1.01	1.24	1.23	1.35	4.58	1.64	1.36	1.85	0.98	1.24	1.51
HV7A2	251135	dolichyl-diphosphooligosaccharide-protein glycosyltransferase	1.09	0.54	1.36	0.87	0.85	0.95	0.82	0.69	0.35	0.71	0.84	0.88	0.72	0.63	1.27	1.2	0.85	0.65	0.63	0.89	1.07	1.1
HV7A3	211206	gene predicted from cDNA with a complete coding sequence	0.83	1.18	0.9	1.43	1.36	0.79	1.35	1.07	1.11	1.27	0.93	0.73	0.77	1.21	0.73	1.15	0.99	1.57	0.68	1.13	1.06	1.48
HV7A4	768324	KIAA0107 gene product	1.03	1.01	1.01	0.86	1.33	0.74	1.15	0.74	0.68	0.99	0.57	0.89	1	1.33	0.85	1.32	1.43	0.58	0.49	0.4	0.29	1.16
HV7A6	753313	Lysosomal-associated multispanning membrane protein-5	3.95	11.41	17.21	8.79	8.5	6.18	7.9	35.55	9.38	9.04	3.81	7	4.64	6.87	3.39	3.26	4.01	3.63	15.1	9.45	8.07	5.75
HV7A7	713653	KIAA0081 protein	1.31	1.39	1.5	1.21	1.52	0.9	0.94	1.18	0.77	1.34	1.1	1.03	0.78	1	0.85	1.1	1.36	1.29	2	0.37	1.25	1.21
HV7A9	563403	"proteasome (prosome, macropain) 26S subunit, non-ATPase, 5"	2.31	1.47	1.14	1.55	1.61	0.9	1.26	1.54	1.86	1.86	1.14	0.55	0.95	1.14	1.46	1.69	1.3	0.89	0.78	0.74	1.26	1.99
HV7A10	51532	KIAA0069 protein	2.14	1.35	1.77	1.5	0.9	0.66	1.67	1.03	1.08	1.57	1.24	1.38	1.51	1.78	1.03	1.33	1.37	2.21	1.23	1.79	1.24	1.54
HV7A12	753692	actin-binding LIM protein	1.31	0.63	0.16	0.65	1.22	0.65	0.61	0.21	0.2	0.56	0.4	0.27	0.76	0.45	1.01	1.18	0.54	0.56	0.56	0.32	0.88	1.08
HV7B3	823900	centaurin beta2	2.74	1.52	1.68	2.25	1.01	1.11	1.06	1.61	1.26	0.82	0.74	1.15	1.08	1.58	0.47	0.56	1.74	0.9	1.44	1.28	0.84	1.16
HV7B4	203347	"clathrin, heavy polypeptide-like 2"	1.84	1.65	1.27	1.81	2.06	1.01	5.22	1.68	4.75	5.07	1.37	2.12	1.51	1.85	1.48	2.03	1.7	0.84	4.04	1.37	1.95	3.08
HV7B7	687990	PAK-interacting exchange factor alpha	1.89	5.13	5.88	3.32	5	7.03	4.99	7.98	3.47	2.8	2.76	8.61	3.91	4.03	2.25	2.65	2.11	4.2	10.28	6.89	4.34	7.72
HV7B9	666377	zinc finger protein 161	1.05	2.69	2.08	2.3	2.24	1.11	3.52	2.89	2.25	3.92	1.77	1.14	0.78	1	1.22	1.47	1.72	1.07	5.79	4.76	6.79	1.91
HV7B11	823851	AE-binding protein 1	4.69	14.6	20.15	4.26	16.92	7.91	5.84	5.71	11.46	11.42	7.5	4.67	5.33	10.05	3.56	5.68	5.59	9.52	19.29	8.02	3.43	12.61
HV7B12	813460	proprotein convertase subtilisin/kexin type 7	1.39	1.84	1.72	0.82	1.61	0.7	1.19	1.03	1.66	0.9	0.35	0.86	1.56	1.19	0.94	1.29	1.33	1.21	1.34	0.4	0.87	0.85
HV7C3	120881	"proteasome (prosome, macropain) subunit, alpha type, 4"	2.54	5.27	11.31	3.09	4.6	5.2	4.06	8.85	4.9	4.81	2	4.2	4.57	11.08	2.37	1.9	2.9	4.83	11.34	7.18	6.29	9.55
HV7C4	361565	glutamate dehydrogenase 1	0.53	0.35	0.31	0.79	0.68	0.61	0.48	0.62	0.46	0.45	0.6	0.89	1.49	0.74	0.87	0.64	0.43	0.4	0.39	1.41	0.32	0.9
HV7C5	550355	protein kinase C-like 2	1.23	2.04	1.01	1.63	3.18	1.48	0.99	1.08	0.76	1.42	0.96	0.91	0.83	0.73	0.79	0.99	1.66	0.67	0.91	0.41	0.57	0.82
HV7C6	361943	Meis1 (mouse) homolog	1.87	3.35	2.87	2.3	3.01	1.7	2.65	2.53	3.59	1.73	0.57	1.51	2.92	1.76	1.32	2.25	1.49	1.23	1.83	0.67	1.36	2
HV7C7	325062	"solute carrier family 20 (phosphate transporter), member 1"	0.6	1.6	0.84	1.01	1.07	0.8	0.77	0.68	0.56	2.02	0.97	1.06	0.76	0.52	0.89	0.89	0.83	0.62	2.65	2.85	1.43	1.86
HV7C8	345348	"PR domain containing 2, with ZNF domain"	2.29	2.25	1.26	1.77	2.27	1.95	1.67	2.06	2.61	1.48	0.94	2.42	2.22	1.57	1.56	1.71	1.99	1.52	2	1.13	1.43	1.88
HV7C9	592359	"Ke4 gene, mouse, human homolog of"	1.07	3.83	1.86	1.61	2.66	2.03	2.3	1.84	1.79	2.76	1.69	0.6	1.09	0.98	1.47	2.54	2.14	1.5	2.2	2.03	2.55	2.49
HV7C10	119530	"potassium inwardly-rectifying channel, subfamily J, member 15"	0.66	1.3	0.69	0.61	1.43	0.75	1.11	0.86	1.99	0.93	0.84	1.75	0.47	0.52	4.31	1.41	0.97	0.6	1.72	0.29	0.47	0.5
HV7C12	811920	"interleukin 11 receptor, alpha"	1.92	1.67	1.26	1.87	2.22	1.5	1.64	1.65	1.5	1.43	1.47	1.25	1.28	1.34	1.29	2.05	1.07	1.69	1.38	1.19	1.28	1.32
HV7D1	204148	"ribosomal protein S6 kinase, 90kD, polypeptide 3"	1.18	2.01	1.71	1.48	1.77	1.23	0.8	1.33	1.64	0.97	1.25	0.97	1.54	0.54	0.79	0.75	0.68	0.97	1.12	0.99	0.87	0.84
HV7D2	45542	Human insulin-like growth factor binding protein 5 (IGFBP5) mRNA	5.33	25.74	16.15	17.8	18.81	5.69	5.73	12.58	19.6	20.92	7.22	8.26	5.33	10.69	3.62	3.22	1.73	15.38	25.92	12.5	16.77	42.35
HV7D3	810282	"inositol 1,3,4-triphosphate 5/6 kinase"	0.31	0.75	0.43	0.58	0.63	0.43	0.89	0.52	1	0.9	1.09	0.57	0.83	0.75	0.62	0.61	0.36	0.59	1.08	0.65	0.69	0.83
HV7D4	136744	speckle-type POZ protein	1.23	2.65	1.87	2	1.69	1.13	3.82	2.35	2.18	3.1	1.72	2.06	2.16	3.41	1.44	1.71	1.6	2.45	2.7	1.24	1.4	3.04
HV7D5	44975	isopentenyl-diphosphate delta isomerase	0.96	2.28	0.95	4.06	1.51	5.57	1.52	1.55	1.63	1.25	1.45	2.07	0.99	1.06	2.2	2.02	1.66	1.69	1.07	1.17	0.79	0.94
HV7D6	160793	"discs, large (Drosophila) homolog 1"	3.57	6.51	2.99	3.59	3.7	1.69	2.43	2.4	2.89	1.3	0.6	2.65	1.35	1.07	0.96	1.46	1.71	1.26	2.53	1.66	0.95	2.08
HV7D7	358457	heterogeneous nuclear ribonucleoprotein H1 (H)	0.98	1.32	0.82	1.71	1.01	1	1.32	0.97	1.26	0.85	0.79	1.22	1.03	1.26	1.26	0.81	0.87	0.96	1.37	1.24	0.86	1.2
HV7D8	768562	zinc finger protein homologous to Zfp103 in mouse	1.1	2.84	0.75	0.82	2.32	0.92	1.37	1.85	2.99	1.35	1.01	1.7	1.32	1.23	1.54	2.45	0.92	0.83	1.01	1.09	1.54	1.15
HV7D9	813149	"H2B histone family, member Q"	3.56	8.63	8.54	3.79	3.67	1.93	3.56	4.71	11.18	2.79	4.64	2.75	1.85	6.1	1.18	2.13	2.73	4.4	4.88	3.76	2.69	4.62
HV7E1	769645	N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2	1.59	1.95	2.55	2.2	2.14	1.63	2.75	1.95	2.66	2.78	2.23	1.75	2.31	2.13	1.21	1.63	1.3	1.5	2.6	2.9	1.91	2.91
HV7E2	134270	Human hbc647 mRNA sequence	1.09	0.55	0.65	0.94	1.22	0.67	0.74	0.69	0.59	0.58	0.33	0.63	0.88	1.98	0.65	1.03	1.13	0.51	0.28	0.69	0.22	1.08
HV7E4	248531	GUANINE-MONOPHOSPHATE SYNTHETASE	4.26	2.7	1.84	1.94	2.67	1.95	1.57	1.49	1.31	1.16	0.69	0.88	0.9	1.2	1.3	1.74	2.67	2.07	0.7	0.54	1.69	0.98
HV7E5	360168	RAB interacting factor	1.79	1.97	2.07	2.36	2.48	1.49	2.14	3.94	3.38	1.78	1.41	1.4	0.95	1.88	1.73	1.54	1.75	1.47	2.13	1.55	1.74	2.35
HV7E6	234191	"Human guanine nucleotide exchange factor mRNA, complete cds"	2.95	2.39	1.76	2.64	2.37	1.08	1.79	1.84	1.08	1.03	0.86	1.04	1.52	0.68	0.87	2.62	1.22	0.72	1.3	1.05	1.15	1.77
HV7E9	753285	glycogenin	2.5	2.26	1.43	1.86	2.5	1.53	1.32	2.05	2.99	1.79	1.31	1.04	0.97	1.16	0.99	1.33	1.84	2.87	1.18	0.83	1.58	1.99
HV7E10	769676	glutathione S-transferase Zeta 1 (maleylacetoacetate isomerase)	1.3	0.76	0.76	0.84	1.47	0.55	2.01	0.77	0.69	2.19	0.67	0.4	0.99	1.82	0.66	2.27	0.54	0.85	1.33	0.98	1.01	1.22
HV7E12	809588	"gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)"	2.45	1.08	2.28	2.67	1.95	0.56	1.21	0.57	0.67	1.31	0.51	0.82	0.5	0.76	1.86	1.53	1.34	1.02	0.15	0.39	0.61	0.71
HV7F1	194364	"Homo sapiens g16 protein (g16) mRNA, complete cds"	1.63	2.07	3.13	3.12	2.01	2.17	3.26	2.15	2.1	2.25	1.62	3.22	3.31	4.23	1.01	1.84	1.22	2.55	4.39	2.94	2.12	3.73
HV7F3	823663	"fragile X mental retardation, autosomal homolog 2"	0.72	1.31	2.42	2.29	1.33	0.86	1.12	0.98	1	0.82	1.06	0.5	0.74	0.78	0.55	0.84	1	1.01	1.46	0.95	1.78	0.9
HV7F4	289551	"fragile X mental retardation, autosomal homolog 1"	1.68	1.45	0.72	0.93	1.62	0.98	0.77	0.83	1.05	1.15	0.66	1.14	1.07	0.74	0.87	1	1.83	1.12	2.87	1.68	1.72	2.16
HV7F7	741139	eyes absent (Drosophila) homolog 2	3.54	5	3.57	2.49	4.33	5.67	5.49	5.92	3.42	3.36	1.92	5.99	1.84	1.17	0.75	1.8	2.17	0.94	7.42	12.05	3.41	43.51
HV7F8	301122	extracellular matrix protein 1	0.75	0.82	4.34	0.8	1.83	0.62	3.05	3.68	1.98	3.14	1.62	0.74	2.17	6.71	2.08	1.34	0.82	1.44	6.4	0.67	1.71	1.7
HV7F12	755975	dystroglycan 1 (dystrophin-associated glycoprotein 1)	1.13	1.04	1.72	0.61	1.32	1.46	1.3	0.59	0.78	1.36	0.67	0.73	0.75	0.9	0.52	1.05	0.89	1.37	0.68	1.28	0.57	1.2
HV7G2	249705	ESTs	1.34	2.43	2.02	1.45	1.47	1.11	1.38	1.04	1.45	1.37	0.49	0.73	0.86	1.73	0.83	1.59	1.07	1.97	1.41	0.49	0.62	1.23
HV7G4	24032	CASP2 and RIPK1 domain containing adaptor with death domain	0.88	0.97	0.61	0.84	2.01	2.69	1.22	1.69	1.77	1.44	0.67	0.6	1.51	0.77	0.69	1.43	1.09	1	0.95	1.83	1.09	1.06
HV7G5	768496	cytokine receptor induced by latent Epstein-Barr virus infection	2.06	4.4	1.82	2.82	2.56	2.08	2.9	2.47	4.39	2.63	2.39	1.89	1.78	2.26	1.79	2.31	1.86	2.49	2.39	1.72	1.69	2.12
HV7G6	229579	Golgi apparatus protein 1	1.87	1.69	1.59	1.36	3.24	1.63	1.17	1.85	1.78	1.2	0.63	1.37	1.11	1.29	1.11	2.25	1.81	1.52	1.08	0.35	0.97	0.86
HV7G7	30170	"caspase 3, apoptosis-related cysteine protease"	0.86	1.47	1.51	1.24	1.47	1.29	0.99	1.05	1.81	1.71	1.41	1.68	0.63	0.69	0.76	1.36	1.03	0.42	0.96	0.88	1.02	0.89
HV7G8	769921	ubiquitin carrier protein E2-C	3.21	2.12	1.98	1.48	1.7	2.77	2.14	0.72	3	2.19	0.96	1.21	0.76	3.58	1.77	2.26	1.95	6.6	1.49	1.2	0.67	0.89
HV7G9	767798	"ATX1 (antioxidant protein 1, yeast) homolog 1"	0.5	1.79	1.09	0.94	0.93	0.87	1.17	1.16	1.53	1.28	1.32	0.92	0.83	1.52	0.88	0.96	0.84	0.72	1.06	1.07	1.4	0.94
HV7G10	28098	"Human clones 23667 and 23775 zinc finger protein mRNA, complete cds"	1.04	1.29	1.4	1.57	1.64	1.22	1.47	1.45	1.12	1.68	1.08	1.03	1.32	1.37	1.31	1.74	1.14	0.82	1.88	1.13	0.94	1.05
HV7G11	113298	Human clone A9A2BRB6 (CAC)n/(GTG)n repeat-containing mRNA	1.01	4	1.38	1.57	1.96	1.12	2.05	1.38	1.53	1.93	0.7	0.93	1.53	1.78	1.21	2.12	0.99	0.81	2.51	1.38	0.89	1.79
HV7H2	666658	Human clone A9A2BR11 (CAC)n/(GTG)n repeat-containing mRNA	2.62	1.77	3.51	2.97	2.23	1.59	1.38	1.81	1.52	1.51	0.54	1.61	2.11	1.02	1.79	1.4	1.62	1.94	4.07	2.72	1.77	3.45
HV7H3	204614	Human clone 23933 mRNA sequence	0.65	1.29	0.97	1.02	1.25	0.9	0.97	0.69	0.48	0.95	1.08	0.68	0.88	0.47	0.61	0.68	1.13	0.76	0.54	1.22	1.13	0.7
HV7H5	126406	Human clone 23907 mRNA sequence	0.76	2.33	1.01	2.79	2.1	2.02	1.79	1.08	2.09	1.76	1.58	1.71	1.17	0.75	1.53	1.63	1.45	0.6	2.73	1.11	1.63	2.66
HV7H7	563201	Human clone 23865 mRNA sequence	1.09	2.96	1.44	2.86	2.3	1.09	1.66	2.22	0.95	0.99	1.15	1.49	1.14	0.99	1.06	1.62	1.8	0.76	2.94	2.14	2.12	2.52
HV7H9	767069	Human clone 23815 mRNA sequence	2.72	5.12	2.55	6.36	3.24	3.5	2.65	5.5	0.95	2.91	3.18	3.39	2.64	1.76	1.28	2.63	1.81	1.14	2.59	2.1	1.97	3
HV7H11	771173	"Human clone 23732 mRNA, partial cds"	1.26	2.53	1.66	1.47	1.86	1.2	1.71	0.98	1.2	0.79	0.89	0.64	0.73	1.5	0.95	1.08	1.48	2.81	1.46	0.58	0.83	1.12
HV7H12	248039	Human clone 23722 mRNA sequence	1.61	1.28	1.41	1.29	1.61	1.05	1.17	1.43	0.98	1.24	0.95	1.34	1.9	1.47	1.34	1.63	0.97	1.31	0.88	0.74	1.13	0.67
HV8A1	201687	Homo sapiens mRNA; cDNA DKFZp586F1822 (from clone DKFZp586F1822)	1.81	0.73	2.65	1.28	0.61	0.53	1.12	1.97	3.38	1.37	0.74	1.86	1.39	1.8	1.26	0.95	0.54	2.09	0.75	1.14	0.95	0.69
HV8A3	180244	"calcium channel, voltage-dependent, alpha 1I subunit"	0.8	0.77	1.49	1.26	1.04	0.76	0.72	1.04	1.27	0.76	0.76	0.68	0.81	1.17	0.9	0.76	0.55	1.26	0.53	0.41	0.59	0.77
HV8A4	770884	"Homo sapiens Tax interaction protein 1 mRNA, partial cds"	1.02	0.54	0.78	0.53	1.07	0.53	0.89	1.08	0.44	0.79	1.08	0.38	0.56	0.51	0.89	0.76	0.58	0.56	0.62	0.53	0.89	0.69
HV8A8	669471	Human clone 23589 mRNA sequence	2.37	2.63	4.03	3.16	2.92	1.47	2.24	2.78	4.36	1.87	1.45	2.73	2.02	1.84	1.9	2.76	2.14	1.72	2.59	1.82	0.98	2.01
HV8A9	73268	carboxypeptidase D	0.87	0.68	0.9	0.81	0.81	0.48	0.87	0.83	0.9	1.12	0.7	0.84	0.88	0.67	2.21	1.66	0.48	0.6	0.67	1.62	0.98	1.22
HV8A10	309032	"Human cleavage and polyadenylation specificity factor mRNA, complete cds"	5.51	4.46	7.68	4.24	5.22	3.11	3.21	2.87	1.69	3.78	2.43	0.86	2.6	1.07	1.62	3.57	2.21	0.92	2.29	4.03	1.38	0.16
HV8A11	41929	Clathrin assembly lymphoid-myeloid leukemia gene	2.15	1.08	0.78	1.36	1.45	0.88	1.3	1.53	1.11	1.36	1.07	0.66	0.9	0.72	0.81	1.14	0.54	0.65	0.96	0.41	0.96	0.78
HV8B1	292806	chromosome segregation 1 (yeast homolog)-like	0.78	0.57	1.55	1.09	0.36	1.2	0.43	0.68	0.45	0.76	1.11	0.95	0.63	0.3	0.82	0.65	0.86	0.38	1.45	2.31	0.8	1.15
HV8B2	230271	Human chromosome 3p21.1 gene sequence	0.97	1.22	1.05	1.09	1.4	0.88	1.22	1.01	0.86	1.35	1.08	1.29	1.4	1.55	0.79	1.03	0.81	0.65	0.65	1.07	0.58	1.16
HV8B3	770377	Homo sapiens mRNA; cDNA DKFZp434E071 (from clone DKFZp434E071)	0.56	1.07	0.92	0.62	0.8	0.61	0.93	1.5	2.37	0.65	0.92	1.06	0.73	0.96	0.52	0.7	0.36	1.01	0.95	0.99	1.18	1.04
HV8B10	265680	coxsackie virus and adenovirus receptor	4.86	2.51	0.85	2.72	3.47	3.39	2.37	3.19	1.61	3.49	1.85	0.89	2.2	1.33	1	2.71	2.37	1.26	4.22	2.33	1.93	0.71
HV8B11	756666	"protein phosphatase 1, catalytic subunit, alpha isoform"	1.57	1.4	0.74	1.23	1.17	1.06	1.16	1.01	1.06	5.36	1.03	0.96	0.73	1.17	1.61	1.06	0.57	1.88	1.63	1	1.22	1.05
HV8B12	110467	caveolin 2	0.37	0.11	0.2	0.13	0.26	0.19	0.12	0.14	0.11	0.15	0.12	0.12	0.35	0.21	0.23	0.3	0.15	0.2	0.15	0.08	0.12	0.13
HV8C2	510702	intestinal carboxylesterase; liver carboxylesterase-2	0.78	1.52	0.66	0.81	1.63	1.35	0.9	0.97	1.22	0.99	0.75	0.45	0.63	0.89	0.41	1.02	1.48	0.59	0.73	0.22	0.33	0.37
HV8C3	549073	"capping protein (actin filament) muscle Z-line, alpha 2"	0.62	1.01	1.39	1.18	0.75	0.8	0.51	0.93	0.86	0.84	0.77	0.53	0.8	0.5	0.77	0.59	0.46	0.62	0.72	0.78	0.54	0.78
HV8C4	813426	"Homo sapiens mRNA for GS3955, complete cds"	1.89	7.69	5.74	3.99	3.82	2.32	3.17	5.24	7.44	2.13	1.64	2.64	3.32	3.18	3.26	2.32	1.83	7.43	11.94	1.3	3.28	4.55
HV8C7	133178	v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1	1.8	2.03	1.22	1.46	1.48	2.14	0.72	0.85	0.77	1.22	0.5	0.83	1.17	1.54	1.3	0.91	1.21	0.88	0.74	0.77	0.84	0.9
HV8C8	753587	"butyrophilin, subfamily 3, member A3"	2.62	10.27	3.25	3.62	3.85	5.11	4.7	5.4	3.99	5.12	3.06	5.21	3.58	4.2	2.56	3.45	2.14	2.63	5.76	0.94	3.24	3.28
HV8C9	233909	"butyrophilin, subfamily 2, member A1"	0.89	2.77	1.93	1.35	1.66	1.65	1.45	1.43	1.22	2.11	1.66	1.31	1.56	1.25	1.01	0.92	1	1.33	1.98	1.58	1.72	1.89
HV8C10	188036	bullous pemphigoid antigen 1 (230/240kD)	0.35	0.78	0.31	0.4	2.34	2.87	1.07	1.06	0.58	0.2	0.33	0.28	2.57	2.73	0.35	1.15	0.48	0.4	0.71	0.14	0.27	0.82
HV8C11	179276	fatty acid synthase	0.63	1.38	0.92	0.65	2.2	0.61	1.05	1.15	0.93	0.92	0.88	0.9	2.05	2.04	1.53	0.58	0.58	0.84	0.95	0.75	0.61	0.81
HV8D1	204335	CD24 antigen (small cell lung carcinoma cluster 4 antigen)	1.14	0.81	0.09	1.89	1.62	4.86	0.52	1.94	0.31	0.33	0.95	1.64	0.43	0.24	1.02	1.74	1.39	0.31	1.07	0.58	0.5	0.83
HV8D3	77636	betaine-homocysteine methyltransferase	0.49	0.86	3.42	0.35	0.86	0.34	0.49	1.63	9.12	0.22	0.22	1.07	0.94	2.29	0.62	0.46	0.87	1.53	4.41	1.71	2.74	3.32
HV8D4	376516	cell division cycle 4-like	0.96	0.73	0.41	0.53	0.93	0.64	1.16	1.18	2.57	0.77	1.17	1.35	1.29	1.43	0.86	1.15	1.02	0.46	1.11	1.16	0.7	1.27
HV8D5	24642	phosphodiesterase I/nucleotide pyrophosphatase 2 (autotaxin)	1.56	3.2	28.03	5.93	3.26	5.54	4.16	1056.27	1660.49	3.14	1.36	1.51	3.06	1.74	1.02	1.55	1.04	1.59	3.5	1.78	1.75	9.06
HV8D6	667598	PC4 and SFRS1 interacting protein 1	2.71	4.13	2.39	3.55	2.55	1.72	1.74	1.55	2.13	1.32	0.75	1.42	1.44	1.41	0.65	1.17	1.99	1.48	1.12	0.86	0.8	1.06
HV8D7	470179	Homo sapiens clone 24810 mRNA sequence	1.09	2.13	1.39	1.51	1.9	1.02	1.42	1.59	1.54	0.94	0.64	1.24	0.97	1.83	0.94	0.81	0.88	1.34	1.58	2.13	2.25	1
HV8D8	123802	microfibrillar-associated protein 1	0.98	1.67	0.97	0.96	1.59	1.22	1.28	1.43	1.74	1.12	0.84	0.96	1.15	1.41	0.87	0.96	0.77	0.77	0.54	0.76	0.69	0.97
HV8D9	50413	armadillo repeat gene deletes in velocardiofacial syndrome	0.98	2.74	2.14	1.54	2.37	1.37	3.5	3.06	7.29	2.13	1.48	1.61	1.58	1.51	1.32	2.43	0.96	1.95	7.15	4.28	3.27	5.16
HV8D11	204755	"splicing factor, arginine/serine-rich 11"	1.96	4.02	1.58	2.28	1.57	1.7	0.82	1.29	1.69	0.81	1.05	0.8	1.32	1.6	0.96	2.04	1.83	1.91	3.7	1.12	1.32	2.58
HV8E2	183462	"mannosidase, alpha, class 2C, member 1"	1.49	2.55	1.52	1.24	1.93	1.24	2.12	1.4	1.63	1.74	1.29	1.32	2.13	2.16	0.84	1.84	1.18	1.9	3.15	1.38	2.4	2.12
HV8E3	245422	adducin 1 (alpha)	1.64	1	3.09	1.72	1.55	0.58	3.21	2.45	3.25	1.48	1.42	1.76	1.46	2.11	1.38	1.02	0.58	1.19	1.48	1.27	1.76	2.52
HV8E4	23831	"aldolase C, fructose-bisphosphate"	0.77	1.19	1.24	0.53	0.85	0.42	0.96	0.63	1.2	0.97	0.68	0.4	1.01	0.65	0.69	0.99	0.52	0.79	0.31	1.2	0.82	0.58
HV8E8	135538	RE1-silencing transcription factor	2.85	4.68	3.83	2.74	4.46	2.23	2.9	3.31	2.5	2.99	2.75	2.22	1.18	1.94	1.36	3.25	2.06	1.45	1.28	0.86	0.72	1.2
HV8F2	509588	"TATA box binding protein (TBP)-associated factor, RNA polymerase II, J, 20kD"	1.57	1.2	0.92	1.31	1.24	1.05	1.15	0.96	0.84	1.36	0.8	0.86	1.28	1.53	0.86	1.05	1.17	0.88	0.81	0.45	0.67	1.03
HV8F3	365930	"TATA box binding protein (TBP)-associated factor, RNA polymerase II, F, 55kD"	0.85	1.05	0.71	0.88	0.73	0.66	1.07	0.72	0.87	1	0.98	0.95	0.47	1.24	0.57	0.59	0.81	1.12	0.63	1.15	0.8	0.74
HV8F7	756488	TAR (HIV) RNA-binding protein 2	0.88	1.93	2	1.62	3	0.82	2.03	1.84	2.69	1.83	1.38	1.68	1.14	2.18	1.23	1.2	1.31	1.91	1.92	0.97	1.48	1.7
HV8F8	293576	TAR DNA-binding protein-43	2.6	1.72	1.37	1.72	1.74	1.46	1.57	1.47	1.3	1.61	1.41	1.61	1.7	2.17	1.55	1.8	1.74	2.11	1.12	0.77	1.05	1.46
HV8F9	26910	"Human T54 protein (T54) mRNA, complete cds"	1.71	1.49	2	1.55	2.74	1.72	1.42	1.62	1.84	5.01	1.36	1.14	0.93	1.33	1.06	0.89	2.16	2.59	1.62	1.23	1.5	1.47
HV8F10	810506	"serine/threonine kinase 3 (Ste20, yeast homolog)"	1.06	1.26	1.13	0.95	1.53	0.79	0.88	0.85	0.94	1.28	0.93	0.97	1.36	0.53	0.78	1.02	1.51	0.61	1.97	2.17	0.98	2.75
HV8F11	50680	smg GDS-ASSOCIATED PROTEIN	1.07	1.16	1.82	1.61	0.92	0.86	1.1	1.89	1.32	4.26	0.87	1.08	0.77	1.78	0.9	0.5	0.95	0.88	1.94	0.55	0.85	1.25
HV8G1	360047	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3"	0.93	2.22	3.57	5.84	2.1	0.97	1.56	0.91	5.3	1.41	1.8	1.74	2.43	2.38	1.15	0.77	0.79	3.31	1.93	1.5	1.42	2.95
HV8G3	160838	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2"	1.13	1.27	0.99	1.07	1.2	1.07	1.42	0.89	1.78	1.34	1.37	1.35	1.14	1.98	1.07	0.68	0.71	1.44	1.85	1.09	1.49	1.5
HV8G4	293325	FYN-binding protein (FYB-120/130)	1.38	4.21	0.95	2.44	1.95	2.7	1.24	1.76	1.03	2.13	2.08	1.78	1.24	1.09	1.14	2.27	1.93	0.75	2.62	0.69	0.89	1.18
HV8G8	726637	t-complex-associated-testis-expressed 1-like	1.4	1.38	0.93	1.26	1.55	0.95	3.31	1.68	1.21	1	1.15	1.14	1.41	1.07	1.19	1.66	1.42	0.4	1.35	0.96	0.87	1.17
HV8G9	25588	"CUG triplet repeat, RNA-binding protein 1"	1.19	2.5	0.92	1.65	2.01	1.76	1.37	1.33	1.89	1.84	1.56	1.28	1.43	1.61	1.35	1.25	1.56	2.26	2.2	1.67	1.73	2.08
HV8G10	567265	mutS (E. coli) homolog 6	0.97	1.2	1.07	1.48	1.81	1.11	0.99	1.31	0.99	0.82	1.07	1.59	1.81	1.54	0.57	1.48	2.04	0.87	1.27	0.62	1.27	1.07
HV8G11	562983	ralA-binding protein	1.59	1.41	0.9	1.1	1.25	1.28	1.23	1.06	0.9	0.96	1.48	0.88	1.07	0.71	1.11	0.61	0.91	0.63	1.21	1.45	1.48	1.18
HV8H1	179804	"PWP2 (periodic tryptophan protein, yeast) homolog"	1.26	0.98	0.92	1.04	1.04	1.51	0.65	1.69	2.65	0.52	0.32	1.32	1.08	0.82	0.96	0.47	1.3	0.93	3.53	3.53	3.25	2.95
HV8H2	360079	amplified in osteosarcoma	1.02	0.94	1.42	0.86	1.36	0.95	1.44	1.84	1.29	1.26	1.64	1.89	1.05	0.96	0.96	1.07	0.89	0.86	1.09	0.99	1.62	1.16
HV8H3	28012	O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase)	1.55	2.42	1.25	1.77	2.12	1.98	1.18	0.9	1.31	0.84	1.13	1.08	1.71	1.32	1.04	1.02	0.78	1.16	1.2	0.96	0.95	1.28
HV8H7	810316	KIAA0631 protein	0.74	1.43	1.18	0.95	1.82	1.09	0.78	1.01	1.84	0.79	0.66	0.82	0.81	1.05	1.03	0.93	0.93	0.66	1.44	0.73	0.95	0.99
HV8H8	293859	Putative prostate cancer tumor suppressor	1.33	1.69	0.57	0.82	1.1	0.41	0.93	0.74	0.93	0.66	0.38	1.13	1.06	1	0.69	0.94	0.81	0.7	0.92	0.22	0.4	0.44
HV8H12	131595	"melanoma antigen, family A, 10"	1.95	3.91	1.71	2.23	3.29	1.52	1.75	2.77	2.85	2.14	1.89	3.22	2	2.44	1.15	1.68	1.83	2	3.89	1.63	2.22	3.24
HV9A1	292388	Homo sapiens clone 24636 mRNA sequence	1.91	2.34	1.94	1.99	1.91	0.92	2.2	2.01	2.63	2.28	1.07	2.08	1.24	2.47	1.92	1.79	1.47	2.27	1.11	1.06	0.76	1.84
HV9A3	282310	"protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1"	3.08	1.35	1.6	1.91	1.67	1.41	0.81	1.68	0.95	1.27	1.42	2.11	1.47	1.96	2.75	0.84	1.03	1.81	3.02	1.94	1.98	2.78
HV9A5	245330	"Human Krueppel-related zinc finger protein (H-plk) mRNA, complete cds"	2.11	1.18	4.37	2.35	3.41	0.98	2.42	18.77	3.9	2.06	2.01	3.28	2.52	2.38	1.02	1.15	1.43	0.89	1.93	0.95	1.86	5.26
HV9A6	307553	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog	2.44	3.96	3.6	3.06	5.82	1.48	3.79	6.58	4.57	1.7	0.74	2.38	1.5	1.97	1.5	2.65	2.04	1.95	1.91	1.38	2.05	3.13
HV9A7	201890	apoptosis inhibitor 2	0.6	2.36	0.72	2.08	1.79	1.73	0.86	0.82	0.43	1.77	0.65	0.55	0.76	1.25	0.91	0.93	5.27	0.85	1.37	0.38	0.65	1.17
HV9A8	34852	apoptosis inhibitor 1	1.67	1.54	0.74	1.2	1.67	1.29	0.85	1	0.58	0.82	0.65	0.62	0.96	0.75	0.84	1.34	3.64	0.76	0.51	0.63	0.49	0.97
HV9A9	345208	"ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)"	1.64	1.92	1.6	1.99	1.3	1.33	0.93	1.37	0.96	1.53	1.46	0.85	0.98	0.78	1.22	1.11	1.52	1.48	0.52	1.21	1.27	0.93
HV9A10	128783	peroxisome biogenesis factor 13	1.79	1.14	0.96	1.75	1.96	1.1	1.68	1.74	1.05	0.86	0.59	1.08	0.98	1.08	1.4	3.21	1.5	0.99	0.85	0.76	1.26	1.38
HV9A11	811911	RNA binding motif protein 4	1.47	1.41	1	1.76	1.58	0.95	1.45	1.26	1	1.38	1.47	1.08	0.7	0.75	1.27	1.29	0.91	1.61	0.99	1.27	1.72	1.48
HV9B3	741815	ring finger protein 5	1.79	1.74	2.35	2.26	1.16	0.91	1.51	1.65	1.71	1.79	1.45	1.19	1.26	2.74	1.03	1.25	0.91	1.99	2.07	1.52	1.92	3.38
HV9B8	293820	transmembrane protein 1	1.59	2.09	0.69	1.73	1.75	1.01	1.27	1.17	1.68	1.47	1.29	1.4	1.36	1.4	1.15	1.6	1.48	1.37	1.46	1.21	0.87	1.48
HV9B9	563598	"Human GABA-A receptor pi subunit mRNA, complete cds"	3.88	4.58	1.72	3	7.72	5.81	1.24	1.72	1.63	1.79	1.43	0.71	3.53	0.9	1	1.08	6.32	6.8	1.77	1.12	3.01	1.15
HV9B10	209137	"gamma-aminobutyric acid (GABA) A receptor, epsilon"	2.11	0.42	0.56	0.44	2.16	1.59	1.83	0.16	0.4	0.64	0.81	0.15	0.43	0.61	0.39	0.76	0.47	0.45	0.35	0.12	1.43	0.27
HV9B11	823614	thymine-DNA glycosylase	1.13	2	1.72	2.67	1.66	1.04	1.44	1.85	1.76	1.6	1	1.36	0.87	1.3	1.53	1.26	1.7	1.05	4.03	1.34	1.88	1.2
HV9C3	300482	far upstream element (FUSE) binding protein 3	1.18	1.34	1.13	1.05	1.06	0.76	1.11	1.28	1.64	1.18	0.76	0.72	1.01	1.07	1.32	0.68	0.85	0.58	0.82	0.85	1.91	0.92
HV9C4	123400	KH-type splicing regulatory protein (FUSE-binding protein 2)	2.05	5.39	1.6	2.38	1.97	2.08	2.04	1.87	2.5	1.58	1.86	1.55	1.85	2.73	1.81	2.65	2.1	3.1	2.4	1.47	1.58	2.06
HV9C5	308588	FK506-binding protein 8 (38kD)	1.47	1.44	0.74	1.05	0.93	1.52	0.75	1.29	0.64	0.9	1.46	0.76	0.73	0.66	0.83	0.75	1.37	0.81	1.44	2.4	2.31	1.48
HV9C8	361097	ubiquitin-conjugating enzyme E2D 3 (homologous to yeast UBC4/5)	1.22	0.77	0.76	0.88	0.78	1.1	0.61	0.89	0.64	0.85	0.76	0.81	1.16	0.81	1.28	1	1.07	0.6	0.4	0.65	0.42	0.8
HV9C9	754538	DR1-associated protein 1 (negative cofactor 2 alpha)	0.94	1.49	0.73	1.28	1.44	1.11	1.24	1.43	1.98	1.52	1.35	0.91	0.7	1.1	1.14	1.14	1.11	1.94	1.13	0.78	1.6	0.9
HV9C10	327150	dedicator of cyto-kinesis 1	1.15	2.16	1.37	0.96	3.05	0.98	1.53	1.56	1.45	1.23	0.5	2.91	2.21	1.97	0.6	1.48	1.47	1.33	1.25	0.82	0.99	1.2
HV9C12	771206	"polymerase (DNA directed), delta 2, regulatory subunit (50kD)"	2.25	2.12	1.17	1.42	2.3	1.72	1.58	1	1.62	1.81	1.09	2.21	1.17	2.05	1.23	2.56	1.32	2.08	0.84	1.3	0.82	1.02
HV9D4	813675	"Human D9 splice variant B mRNA, complete cds"	2.78	3.02	0.97	1.94	2.37	1.55	2.2	2.92	4.69	2.76	2.47	2.47	2.05	3.29	2.17	3.4	2.56	4.87	7.22	6.31	5.24	8.8
HV9D5	280236	myotubularin related protein 6	0.75	2.34	1.22	1.3	1.45	0.89	0.42	0.96	2.33	0.58	0.53	0.68	1.01	0.79	0.78	0.62	0.84	0.66	1.72	0.74	1.08	0.71
HV9D6	51737	retinoblastoma-binding protein 8	1.57	1.4	0.9	1.35	1.08	1.15	0.62	0.52	0.53	0.67	0.32	0.53	1.69	1.64	0.56	0.94	0.86	0.69	2.65	0.98	0.94	1.61
HV9D7	754355	"sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A"	2.39	2.73	1.25	1.97	2.5	1.65	2.23	3.26	5.45	2.72	3.24	2.26	1.7	2.13	1.56	2.76	2.38	4.2	4.39	5.05	3.01	3.66
HV9D9	204214	"CDC6 (cell division cycle 6, S. cerevisiae) homolog"	1.56	3.12	2.26	2.52	2.18	2.2	5.05	1.82	3.25	6	1.13	1.57	0.88	1.36	1.96	5.07	2.06	2.42	3.08	1.45	1.59	2.22
HV9D11	364329	CREB binding protein (Rubinstein-Taybi syndrome)	0.76	2.95	1.47	1.21	1.99	0.82	1.33	1.66	2.15	1.1	1.37	1.24	1.17	1.3	0.87	0.96	0.79	1.95	1.49	0.87	1.3	1.35
HV9E1	109265	ESTs	1.78	1.48	1.43	1.64	2.17	1.13	1.34	1.85	1.4	1.55	1.06	1.05	1.19	1.72	0.94	0.85	1.26	1.23	1.21	0.6	0.72	1.48
HV9E2	548957	"general transcription factor II, i, pseudogene 1"	2.15	1.77	1.72	2.39	2.23	2.65	1.57	1.43	1.33	1.11	1.81	1.21	1.34	1.97	0.92	2.02	1.05	1.99	0.92	1.27	0.79	1.68
HV9E3	212198	"tumor protein p53-binding protein, 2"	2.24	1.81	2.17	3.08	2.33	2.34	1.42	1.51	1.16	1.2	1.34	0.91	1.09	1.79	0.76	1.32	2.6	2.21	0.83	1.1	0.97	1.48
HV9E4	213136	B-cell translocation gene 2 (pheochromacytoma cell-3)	1.27	2.02	1.15	2.5	2.58	1.69	2.24	1.52	1.64	1.66	1.61	3.26	3.87	2.03	0.63	1.77	1.33	0.66	7.28	5.85	1.67	9.87
HV9E5	46284	putative gene product	1.6	1.41	2.41	2.27	2.63	1.32	1.8	3.01	2.11	1.65	1.89	3.24	3.85	2.91	2.05	1.4	1.12	2.15	2.64	1.36	1.39	2.66
HV9E6	175123	mitogen-activated protein kinase 7	1.88	1.89	3.94	1.88	2.93	1.1	2.93	2.37	1.85	1.13	1.19	1.72	2.09	1.71	0.83	2.06	1.12	1.35	1.15	1.3	1.42	2.53
HV9E7	139540	KIAA0704 protein	2.1	1.12	0.92	1.09	1.32	0.82	0.71	0.7	0.39	0.99	0.55	0.32	0.6	0.53	0.63	0.78	0.63	0.76	0.87	0.59	0.73	1.09
HV9E8	813184	"tumor necrosis factor, alpha-induced protein 1 (endothelial)"	1.04	2.02	1.1	1.22	2.57	1.02	2.1	2	1.53	1.53	0.58	1.45	0.92	1.81	0.84	1.7	1.41	0.64	2.54	1.85	1.59	2.7
HV9E9	37234	mitogen-activated protein kinase kinase kinase kinase 2	2.81	1.37	1.66	1.98	2.58	2.18	1.82	3.12	3.32	2.09	1.78	2.48	0.98	1.41	0.8	1.62	1.58	2.48	2.28	1.13	2.09	1.87
HV9E10	810974	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 3"	4.98	4.4	5.79	6.24	5.03	2.57	4.62	10.81	10.27	3.05	0.88	3.87	2.34	2.67	2.25	2.72	3.05	3.06	2.01	2.23	1.86	2.74
HV9E12	35077	"nuclear protein, marker for differentiated aortic smooth muscle and down-regulated with vascular injury"	0.66	0.83	0.62	0.52	0.89	0.43	0.46	0.39	0.68	0.35	0.69	0.36	0.98	0.61	0.56	0.67	0.76	0.73	1.02	0.92	0.92	0.65
HV9F2	813707	regulator of G-protein signalling 16	4.24	10.78	2.52	4.88	7.67	4.7	7.6	10.33	3.45	8.58	2.49	6.92	5.81	13.71	3.71	2.98	2.81	13.81	30.74	8.81	7.95	21.78
HV9F6	127519	26S proteasome-associated pad1 homolog	1.29	1.39	1.04	0.88	1.47	1.43	1.06	0.88	1.16	0.87	1	1.64	1.06	1.1	1.77	1.4	1.8	1.96	2.62	1.25	1.28	1.85
HV9F7	361048	"Human 100 kDa coactivator mRNA, complete cds"	0.69	0.83	0.74	1.17	0.79	0.71	0.51	0.75	0.49	0.67	0.74	0.44	0.67	0.62	1.16	0.57	0.81	1.14	0.99	0.62	1.15	0.83
HV9F8	810734	Human 1.1 kb mRNA upregulated in retinoic acid treated HL-60 neutrophilic cells	0.76	0.56	0.29	0.43	0.77	0.62	1.08	1.05	1.29	1.13	0.8	1.31	1.12	1.46	1.09	0.9	0.3	0.98	0.75	0.76	0.46	1
HV9F10	248454	"protein disulfide isomerase related protein (calcium-binding protein, intestinal-related)"	0.78	1.72	2.18	1.38	2.01	1.34	1.38	1.28	1.29	2.43	1.61	1.39	0.96	1.15	1.76	2.76	2.34	2.25	1.48	0.82	1.46	1.07
HV9F12	564846	nuclear matrix protein p84	2.01	3.62	1.68	2.47	2.85	2.42	1.61	1.46	2.27	2.28	0.95	1.2	1.63	2.79	1.18	2.13	2.31	1.34	1.48	1.16	1.06	1.46
HV9G1	296679	"ESTs, Moderately similar to cadherin 12 [H.sapiens]"	2.11	3.09	3.01	2.4	3.08	2.91	2.57	3.9	3.14	2.03	0.99	3.11	2.84	4.66	1	2.15	1.15	1.37	2.28	1.1	1.48	1.51
HV9G2	202535	metallothionein 1G	1.53	0.71	0.5	0.42	0.8	0.42	0.67	0.68	0.65	0.69	0.47	0.91	1.92	1.41	1.33	1.62	1.17	2.1	0.6	0.3	0.78	0.53
HV9G3	327304	"Human (H326) mRNA, complete cds"	1.56	2.66	1.1	1.57	2.4	1.35	2.06	1.5	1.96	1.52	0.98	1.03	1.63	3.25	1.15	1.15	1.14	1.9	1.7	1.55	1.76	1.87
HV9G4	812105	transmembrane protein	1.26	2.9	6.78	2.03	2.08	1.67	2.04	2.05	2.44	1.43	0.57	2.64	1.29	1.7	1.32	1.85	1.8	5.05	1.1	0.53	0.69	1.09
HV9G6	135773	"Homo sapiens TTAGGG repeat binding factor 1 (hTRF1-AS) mRNA, alternatively spliced, complete cds"	2.35	3.98	1.85	2.32	3.25	2.71	2.63	1.74	3.58	2.04	0.8	2	2.36	2.9	1.93	2.63	1.87	2.51	1.24	1.25	0.88	2.38
HV9G7	756847	suppressin (nuclear deformed epidermal autoregulatory factor-1 (DEAF-1)-related)	1.57	2.04	1.56	1.74	2.23	1.93	1.06	1.12	1.29	1.66	1.23	1.39	1.5	1.57	1.26	1.23	1.57	1.25	1.43	1.17	0.99	0.45
HV9G8	193067	splicing factor (CC1.3)	1.78	1.91	1.02	1.02	1.95	1.13	0.98	0.87	1.17	0.88	0.59	1.73	1.89	1.71	1.01	1.77	1.19	1.51	2.17	1.31	0.8	1.89
HV9G9	156045	secretory carrier membrane protein 3	1.57	2.77	1.33	2.04	1.97	1.93	2.04	2.12	1.7	1.75	1.73	1.18	0.91	1.56	1.08	1.47	2.06	2.9	1.67	2.06	2.08	1.66
HV9G10	135527	ESTs	1.8	1.87	0.97	1.56	2.73	1.69	1.73	1.66	1.5	1.59	1.55	1.06	1.19	0.98	0.96	1.64	1.73	0.83	1.53	1.53	1.73	1.18
HV9G11	49860	"pyruvate dehydrogenase kinase, isoenzyme 2"	0.86	1.47	1.24	1.04	1.88	0.97	1.43	1.31	0.65	1.61	1.58	2.09	0.93	0.8	0.69	1.29	0.42	0.77	1.03	1.84	0.56	0.91
HV9H2	243321	ESTs	1.45	1.87	1.18	1.77	2.37	1.2	1.36	1.49	1.1	1.11	1.13	0.84	1.48	1.55	1.24	1.99	2.02	0.86	1.65	1.35	1.02	1.48
HV9H3	46897	phosphomevalonate kinase	2.36	2.09	1.14	1.83	1.99	1.3	2.31	1.17	1.77	1.71	1.75	1.56	1.27	2.71	1.07	1.51	0.99	2.61	1.39	1.46	1.42	1.87
HV9H5	41356	"protein phosphatase 2, regulatory subunit B (B56), alpha isoform"	2.23	1.88	1.12	2.21	2.24	2.1	1.17	1.86	1.58	1.69	1.57	1.73	1.53	3.38	1.45	1.36	0.47	1.03	2.65	2.09	1.64	2.45
HV9H6	26578	"pescadillo (zebrafish) homolog 1, containing BRCT domain"	0.92	2.92	1.38	1.46	1.69	1.76	1.42	1.2	1.33	1.78	1.22	0.7	1.08	0.96	1.31	1.25	2.11	1.96	1.2	1.85	1.56	2.04
HV9H7	293104	phytanoyl-CoA hydroxylase (Refsum disease)	1.33	2.24	2	2.5	1.63	2.68	0.54	0.97	1.43	0.72	0.98	1.75	1.37	1.22	0.9	1.54	1.08	1.53	0.92	1.25	0.82	0.81
HV9H8	124753	peroxisomal membrane protein 1-like	1.32	2.44	1.95	1.99	2.46	1.45	1.9	1.83	2.19	1.86	0.89	1.72	1.9	2.49	1.67	1.79	0.99	0.94	2.14	1.97	1.5	2.16
HV9H9	347434	nucleolar autoantigen (55kD) similar to rat synaptonemal complex protein	1.5	4.84	3.97	2.16	5.64	1.43	3.67	7.9	7.12	2.24	2.28	3.77	1.79	2.98	1.14	2.25	3.3	2.4	2.85	2.76	2.18	2.37
HV10A5	752652	"transcription factor 7-like 2 (T-cell specific, HMG-box)"	2.2	3.88	2.94	2.52	3.06	1.58	2.07	2.02	1.31	3	2.33	0.42	1.64	1.14	0.96	2.08	1.78	6.84	0.98	0.97	1.49	2.58
HV10A6	770192	"lectin, galactoside-binding, soluble, 9 (galectin 9)"	4.04	11.5	7.92	5.78	5.98	4.5	7.56	21.27	4.72	6.99	3.51	3.65	3.33	4.23	3.04	4.95	2.66	3.04	9.09	3.87	6.06	5.08
HV10A8	129865	serine/threonine kinase 15	2.41	1.75	1.92	1.54	1.41	1.97	2	1.02	2.25	2.73	0.44	1.75	0.73	1.91	1.71	1.79	1.5	2.27	0.81	1.33	1.18	1.18
HV10B1	109221	KIAA0286 protein	1.86	3.26	3.02	3.31	1.64	1.57	3.15	2.21	2.26	2.21	1.28	2.26	1.54	2.9	1.72	1.5	2.17	2.79	1.34	0.69	0.92	1.04
HV10B3	123980	HYA22 protein	1.37	2.1	1.62	3.03	1.73	1.29	1.21	1.28	1.36	1.59	1.67	0.81	1.59	0.9	0.84	1.33	1.12	1.35	3.47	2.77	1.48	2.73
HV10B5	37491	thyroid receptor interacting protein 10 (CDC42-interacting protein)	0.61	0.76	0.5	1.23	0.72	0.58	0.54	0.52	0.48	0.61	0.7	0.34	0.34	0.45	0.56	0.57	0.54	0.58	0.52	0.28	0.67	0.6
HV10B6	129146	cytochrome c oxidase subunit VII-related protein	0.99	0.84	0.84	1.43	1.21	1.04	1.06	0.85	0.76	1.11	1.03	1.22	1.24	0.78	1.35	1.57	1.13	1.49	0.47	0.83	0.85	0.95
HV10B9	300590	ATP binding protein associated with cell differentiation	1.15	0.51	1.2	0.79	0.33	0.6	0.41	1.18	0.95	0.63	2.08	0.98	0.7	0.6	0.92	0.51	1.27	1.57	0.71	0.69	0.8	0.87
HV10B11	754479	"hypothetical protein, expressed in osteoblast"	3.11	2.72	5.53	5	1.84	2.89	5.63	7.4	3.47	4.4	2.96	3.67	1.71	3.83	1.47	2.67	2.29	3.14	3.97	1.15	2.91	4.61
HV10C3	165857	"inositol polyphosphate-4-phosphatase, type II, 105kD"	0.24	1.25	0.72	0.7	1.16	0.64	1.33	0.95	0.93	2.31	1.38	1.11	0.51	0.69	0.47	1.03	0.91	0.13	1.6	0.79	0.33	1.31
HV10C7	359395	"N-ethylmaleimide-sensitive factor attachment protein, gamma"	1.75	4.07	3.28	2.31	3.15	2.27	1.56	2.55	1.76	1.98	1.21	1.65	1.32	0.85	1.21	2.42	1.98	1.04	2.93	1.97	1.62	1.91
HV10C9	129644	spectrin SH3 domain binding protein 1	0.94	0.78	1.08	1.29	1.1	1.18	0.6	0.98	1	1.15	0.94	1	1	0.78	1.07	0.63	1	1.54	1.23	0.76	0.89	0.99
HV10C10	770910	E74-like factor 3 (ets domain transcription factor)	0.48	0.6	0.11	0.21	0.59	0.7	0.32	0.4	0.37	0.38	0.33	0.64	0.45	0.33	0.58	1.12	0.45	0.23	1.99	1.27	0.44	1.53
HV10C11	380394	"eukaryotic translation initiation factor 1A, Y chromosome"	1.42	1.31	1.9	0.99	1.76	0.88	1.09	0.62	2.44	1.01	0.84	1.55	1.24	1.99	1.07	1	1.11	1.81	3.27	5.55	1.46	3.13
HV10C12	144932	"deleted in oral cancer (mouse, homolog) 1"	1.44	2.77	1.37	3.14	1.76	0.9	1.32	1.97	1.39	0.79	1.51	1.32	1.15	1.14	1.49	2.32	2.24	3.62	0.67	0.58	0.77	0.62
HV10D2	823691	cyclin G2	0.39	1.19	0.6	0.51	1.13	0.79	1.85	0.97	0.55	2.27	0.87	0.58	1.07	0.88	0.71	0.95	0.55	0.39	0.65	0.64	0.44	1.41
HV10D3	248371	"coatomer protein complex, subunit alpha"	1.68	1.14	1.81	0.48	3.16	1.98	0.73	2.38	0.95	1.34	2.51	2.05	0.94	1.33	1.46	2.19	2.39	2.24	1.59	1.43	1.86	1.53
HV10D4	813171	DKFZP566C134 protein	2.44	5.43	2.94	2.38	4.05	2.02	2.58	2.56	3.51	2.02	0.99	2.18	1.84	3.3	1.28	2.49	1.51	2.62	1.47	1.05	1.11	0.92
HV10D5	150314	lysophospholipase I	0.84	1.64	0.88	1.1	1.72	0.8	1.1	1.09	1.74	1.29	0.98	0.82	1.36	1.13	2.04	1.13	1.19	0.89	0.69	0.99	0.56	0.81
HV10D6	187266	"Homo sapiens clone 23689 mRNA, complete cds"	1.29	5.29	1.28	3.31	6.76	2.21	3.46	4.71	5.75	4.66	2.87	1.69	4.63	3.78	2.28	3.77	1.39	1.69	3.75	1.13	4.04	3.35
HV10D7	823679	chromosome 18 open reading frame 1	2.43	8.01	9.35	15.68	5.95	4.17	5.16	12.19	5.02	3.69	3.13	6.16	3.54	8.66	1.28	2.06	2.64	3.16	5.59	4.15	3.37	9.69
HV10D8	246524	"CHK1 (checkpoint, S.pombe) homolog"	1.77	3.48	3.1	2.93	2.41	1.74	1.54	1.72	2.55	1.52	0.57	1.01	1.21	1.12	1.28	2.09	1.61	2.98	1.37	0.54	0.92	0.9
HV10D9	243343	"chaperonin containing TCP1, subunit 2 (beta)"	1.11	0.73	1.84	0.47	0.53	0.41	0.55	1.33	10.38	0.37	0.32	1.99	1.48	1.99	1.41	0.58	0.98	2.45	3.1	1.19	1.68	2.2
HV10D12	137836	apoptosis-related protein 15	2.05	2.97	0.86	1.39	2.02	1.8	1.34	1.76	1.58	1.31	0.95	1.8	1.22	1.63	1.39	1.11	1.6	1.32	0.95	0.74	0.51	0.84
HV10E1	470930	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (S.cerevisiae CHL1-like helicase)	2.08	5.99	2.31	2.91	2.94	1.55	1.96	1.32	2.59	1.75	1.57	2.12	1.18	1.76	1.08	1.72	2.76	3.78	2.44	2.07	2.31	1.79
HV10E2	283301	KIAA0914 gene product	0.65	0.94	1.59	0.67	1.64	0.37	1.07	0.37	0.37	0.72	0.3	0.35	0.83	0.57	0.37	2.26	1.02	0.43	0.93	0.22	0.52	0.85
HV10E6	755416	"MAD (mothers against decapentaplegic, Drosophila) homolog 5"	2.03	2.6	2.07	2.17	2.77	0.73	4.87	0.63	1.84	2.48	0.59	1.79	2.12	1.29	1.28	2.25	1.24	1.01	1.42	1.16	0.89	1.19
HV10E8	347373	"transcription elongation factor B (SIII), polypeptide 1 (15kD, elongin C)"	1.98	2.01	1.15	1.13	1.33	0.66	1.59	0.83	1.63	1.54	0.68	1.03	1.12	1.15	1.38	1.68	1.03	1.27	0.65	0.97	0.95	1.19
HV10E9	42118	"purinergic receptor P2X, ligand-gated ion channel, 4"	1.9	1.21	1.67	2.25	1.14	1.35	1.02	3.28	2.56	2.31	1.59	4.25	2.54	4.04	1.41	0.93	1.26	9.56	9.09	6.74	5.69	8.7
HV10E11	377152	NADH dehydrogenase (ubiquinone) Fe-S protein 4 (18kD) (NADH-coenzyme Q reductase)	0.54	0.42	0.46	0.36	0.63	0.22	0.59	0.58	0.48	0.63	0.43	0.62	0.64	0.82	0.4	0.61	0.2	0.72	0.29	0.39	0.58	0.79
HV10F6	813591	peroxisomal acyl-CoA thioesterase	1.35	1.01	0.97	0.75	1.8	1.55	1.85	0.93	1.37	1.53	1.2	0.76	0.93	1.15	0.55	1.55	1.09	0.83	1.5	1.53	1.07	1
HV10F7	198917	Homo sapiens GT212 mRNA	1.03	1.88	0.85	1.52	1.67	1.51	1.38	2.02	2.33	1.54	1.52	1.79	1.36	1.99	0.89	1.5	1.29	1.89	1.49	1.46	1.46	2.53
HV10F8	771084	"beclin 1 (coiled-coil, myosin-like BCL2-interacting protein)"	0.77	1.56	1.72	0.81	1.39	0.89	1.06	1.48	2.44	0.99	0.65	1.84	1.26	2.1	0.8	1.3	0.99	0.95	0.89	0.84	0.81	1.4
HV10F9	813714	CASP8 and FADD-like apoptosis regulator	1.48	0.85	1.95	1.67	0.92	1.08	0.95	2.2	3.24	1.49	1.92	1.55	1.93	0.94	1.07	0.74	1.29	2.47	1.44	0.72	1.52	1.22
HV10F12	359982	BCL2/adenovirus E1B 19kD-interacting protein 3	0.8	0.96	1.53	1.54	1.07	0.55	2.02	0.78	0.53	3.24	0.71	0.89	1.18	1.19	1.5	1.45	1.22	1.88	1.11	0.77	0.75	0.92
HV10G1	30502	reticulon 1	0.69	1.08	0.47	0.69	0.7	0.59	0.7	1.18	0.8	1.03	0.93	0.83	0.52	1.39	0.82	0.74	0.94	0.49	1.04	1.36	1	1.33
HV10G2	139573	ubiquitin-conjugating enzyme E2 variant 1	0.94	1.15	0.54	0.67	1.31	0.65	0.99	1.23	1.17	0.85	0.83	1.07	0.74	1.72	1.2	1.25	0.97	0.59	0.95	1.03	1.01	1.11
HV10G3	811842	signal recognition particle 72kD	1.36	3.83	1.45	1.58	1.45	1.76	1.25	1.54	0.94	1.61	1.06	1.19	0.8	1.16	1.23	2.37	2.32	0.96	0.94	0.75	0.56	1.05
HV10G4	243580	chromodomain helicase DNA binding protein 2	2.77	3.67	1.51	2.28	2.76	1.49	2.43	1.67	2.52	1.9	1.03	2.74	1.74	1.46	1.07	2.4	1.9	1.88	1.14	0.47	0.7	0.74
HV10G5	262996	chromodomain helicase DNA binding protein 1	1.28	4.15	1.41	2.22	3.19	1.47	1.84	2.09	1.49	2.01	0.9	1.01	1.78	2	0.9	1.73	1.63	1.07	3.21	1.5	1.63	3.39
HV10G6	130820	protein encoded by CAG trinucleotide repeats	2.02	2.81	1.36	1.78	1.99	1.25	1.8	2.02	3.36	1.76	0.79	1.23	1.93	2.73	0.96	2.37	1.73	1.84	2.86	1.04	0.99	1.49
HV10G7	203351	Golgi vesicular membrane trafficking protein p18	1.08	1.62	1.22	1.37	1.9	1.35	1.03	1.5	0.95	1.71	1.04	1.02	1.09	1.28	1.1	1.5	1.22	1.22	1.46	0.94	0.99	1.44
HV10G8	340558	"actin related protein 2/3 complex, subunit 5 (16 kD)"	1.33	0.92	1.42	0.97	1	0.88	0.64	1.04	0.49	0.75	1.04	0.66	0.47	0.71	0.85	0.98	1.33	0.52	0.91	0.87	0.77	1.01
HV10G9	202904	"splicing factor, arginine/serine-rich 7 (35kD)"	1.67	3.54	1.74	3.78	1.71	1.65	1.45	0.93	1.71	1.39	1.27	2.31	1.96	2.29	1.49	1.55	1.04	2.83	2.88	1.44	2.02	2.36
HV10G11	358850	transmembrane trafficking protein	0.91	0.74	1.15	1.02	0.62	0.58	0.62	0.73	0.57	0.88	0.9	0.91	1.12	0.76	1.48	0.8	0.35	0.5	0.76	1.2	0.9	1.05
HV10G12	138991	"collagen, type VI, alpha 3"	5.65	11.25	18.29	12.06	15.06	8.72	6.6	4.32	18.27	18.33	7.79	8.41	6.25	12.19	4.02	7.09	5.2	24.01	23.65	6.35	3.99	15.97
HV10H6	363103	high-mobility group (nonhistone chromosomal) protein 2	2.14	5.51	4.58	2.96	3	1.89	2.68	1.51	4.86	2.52	0.84	2.3	1.91	2.86	1.72	1.97	1.85	3.09	1.3	0.93	0.67	0.99
HV10H7	129506	structure specific recognition protein 1	1.12	4.16	2.06	1.66	2.47	1.69	1.47	1.57	2.96	1.42	1.24	1.07	1.25	0.7	0.88	1.41	1.67	1.21	1.42	1.56	2.78	2.47
HV10H8	211780	hexosaminidase B (beta polypeptide)	1.44	1.08	0.88	1.37	1.72	1.17	1.16	1.79	0.87	1.2	1.2	1.06	1.71	1.45	1.2	1.46	1.09	0.7	0.76	0.71	0.73	0.72
HV10H9	23185	"hexabrachion (tenascin C, cytotactin)"	0.77	1.08	1.09	0.89	1.28	1.55	1.64	1.95	1.82	1.18	1.11	0.98	1.41	1.02	1.7	0.72	0.82	0.7	0.92	0.81	1.01	1.25
HV10H10	150623	"Human silencing mediator of retinoid and thyroid hormone action (SMRT) mRNA, complete cds"	1.08	1.62	0.99	1.15	1.63	1.06	1.36	1.65	1.15	1.17	1.77	1.43	1.27	1.03	0.89	1.03	1.24	0.92	3.29	1.96	1.6	0.45
HV10H11	327350	heterogeneous nuclear ribonucleoprotein A2/B1	1.26	1.19	1.23	1.4	1.24	1.12	1.4	1.17	1.12	0.96	0.76	1.21	1.21	1.93	1.35	1.11	0.86	1.51	1.24	0.64	0.63	1.08
HV10H12	767828	Hermansky-Pudlak syndrome	1.35	1.91	0.77	1.63	1.99	1.46	2.13	1.64	0.87	1.3	1.55	1	1.68	2.02	1.18	1	1.74	1.24	1.99	1.55	1.44	1.19
HV11A2	811827	N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1	1.89	1.71	0.85	2.06	1.48	1.76	1.05	1.72	1.44	1.73	1.01	2.04	2.84	1.37	1.54	2.58	1.78	1.17	1.6	2.77	1.6	1.5
HV11A5	124824	ribosomal protein L10a	0.7	0.57	0.64	0.65	0.62	0.39	0.59	0.3	0.25	0.67	0.63	0.44	0.86	0.77	0.67	0.6	0.45	1.1	0.34	0.42	0.44	0.59
HV11A6	770066	KIAA0056 protein	3.92	2.85	1.9	2.55	2.13	1.51	1.69	1.05	1.78	1.88	1.7	1.11	1.8	1.78	1.67	3.2	1.58	2.76	0.92	0.78	0.87	0.98
HV11A10	153411	Human HLA-DR alpha-chain mRNA	5.8	48.41	21.72	14.13	21.85	11.63	10.19	8.91	14.91	22.17	8.76	3.97	6.71	15.24	4.01	7.79	7.36	14.6	11.34	11.34	1.97	13.36
HV11A11	256664	"H2A histone family, member X"	3.67	3.22	2.6	1.78	1.04	1.62	1.81	1.26	1.87	2.63	1.56	0.93	0.99	1.96	1.1	1.7	0.88	3.35	1.22	1.19	1.24	1.3
HV11A12	66317	"H1 histone family, member 2"	4.19	5.07	6.83	1.47	1.44	3.3	3.3	1.86	5.4	5.36	1.9	1.85	0.96	8.87	1.04	1.54	3.41	5.56	1.2	2.85	1.2	7.08
HV11B1	121621	heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)	1.15	1.24	1.11	1.69	0.83	1.4	0.81	0.99	0.39	0.91	1.25	0.88	1.07	1.31	1.09	0.91	1.09	1.61	2.4	1.66	1.52	1.91
HV11B8	823901	UV radiation resistance associated gene	2.92	2.38	0.75	1.31	2.98	1.66	1.45	1.95	1.73	2.1	1.54	2.26	2.44	2.12	1.35	1.9	2.34	2.56	2.94	1.61	2.13	2.89
HV11B9	301018	serine/threonine kinase 9	1.44	1.31	2.65	1.99	1.41	0.89	1.57	2.31	2.1	4.71	1.32	2.3	1.6	3.07	1.08	0.61	1.19	3.44	2.21	0.8	1.48	4.28
HV11B10	295729	translational inhibitor protein p14.5	0.85	1.97	1.25	1.51	1.96	0.76	1.2	0.89	1.42	1.86	0.72	1	1.17	0.97	1.09	1.73	1.59	0.92	1.89	1.78	0.77	1.73
HV11B12	301849	"eukaryotic translation initiation factor 4 gamma, 3"	1.07	1.26	1.18	1.07	1.4	1.29	1.23	1.25	1.28	1.5	0.82	1.32	1.55	1.44	1.53	1.72	1.24	1.18	2.21	0.92	1.15	2.74
HV11C1	108667	"pre-mRNA splicing factor SF3a (120 kDa subunit), similar to S. cerevisiae PRP21"	0.82	1.47	1.34	1.33	1.29	1.16	0.82	1.49	1.4	1.42	1.04	1.03	1.23	1.17	0.48	0.64	0.75	1.4	1.19	1.33	1.54	1.37
HV11C2	668442	"discoidin domain receptor family, member 2"	2.47	5.44	8.11	6.72	7.06	3.61	6.31	10.95	6.79	3.67	2.42	5.05	5.39	7.83	2.18	3.64	3.45	13.25	6.31	1.23	2.75	6.49
HV11C3	295798	progesterone binding protein	2.26	2.53	1.79	1.98	1.98	1.55	1.1	2.03	2.09	1.86	1.64	1.08	1.45	1.67	1.46	0.83	1.03	1.26	2.42	1.45	1.49	1.77
HV11C5	813854	H.sapiens mRNA for pur alpha extended 3'untranslated region	0.86	1.35	1.11	0.75	1.05	0.82	1.09	1.5	1.58	1.23	0.68	1.34	1.43	1.91	1.16	0.43	0.61	0.86	0.88	0.64	1.05	1.27
HV11C8	234011	plakophilin 2	0.72	1.67	0.44	0.94	0.88	1.93	0.73	0.7	0.62	0.72	0.33	0.82	0.78	0.66	0.65	1.32	2.14	0.76	0.46	0.19	0.54	0.46
HV11C9	813536	"phosphoinositide-3-kinase, class 3"	0.98	1.61	1.38	1.06	1.75	1.66	1.04	1.09	1.16	1.11	0.61	0.75	1.03	1.33	0.98	0.62	0.67	0.65	0.79	0.32	1.33	0.68
HV11C10	589433	RNA 3'-terminal phosphate cyclase	1.51	2.05	0.98	1.27	1.26	1.7	0.87	0.95	1.24	0.95	0.8	0.96	1.33	1.14	1.3	1.39	1.19	1.11	1.58	0.79	0.85	1.34
HV11C11	210862	"Peroxisomal acyl-coenzyme A oxidase [human, liver, mRNA, 3086 nt]"	2.28	2.37	1.46	1.68	2.66	2.85	1.35	1.9	1.35	1.75	2	1.78	1.78	1.64	1.97	1.27	1.7	2.9	1.59	1.21	1.71	1.51
HV11C12	27548	nucleoporin 153kD	1.36	2.47	1.68	1.92	1.53	2.33	1.1	1.25	0.93	1.62	1.27	1.31	1.65	1.26	0.78	1.95	1.93	1.24	1.05	1.32	0.83	1.43
HV11D1	234562	SC35-interacting protein 1	1.03	1.27	1.62	1.98	1.47	1.76	1.24	1.58	2.23	1.09	0.57	1.33	1.42	0.95	1.15	0.91	1.22	0.99	1.49	1.35	0.93	1.16
HV11D2	134476	synaptobrevin-like 1	1.67	2.74	1.1	1.53	2.02	0.61	1.22	2.09	1.07	1.17	1.28	1.46	1.15	1.16	1.34	1.53	1.3	0.86	1.17	1.39	0.83	0.73
HV11D5	809353	interferon regulatory factor 3	0.81	1.35	0.74	0.72	1.34	0.68	1.04	0.84	1	0.67	0.86	1.27	0.87	1.59	0.72	0.87	0.6	0.97	1.35	0.77	0.72	1.14
HV11D7	525518	ubiquitin specific protease 7 (herpes virus-associated)	0.63	1.22	0.68	0.91	1.12	1.04	1	0.93	0.93	1.11	1.02	1.26	1.13	0.75	0.92	0.8	0.98	1.19	0.83	1.26	0.86	0.87
HV11D9	243741	diubiquitin	2.02	31.9	4.61	11.21	5.02	7.73	10.64	104.36	0.95	7.43	4.39	7.59	4.78	5.25	1.1	3	5.06	2.84	11.87	1.41	3.69	1.18
HV11D10	810791	"Human cyclin G1 interacting protein (1500GX1) mRNA, complete cds"	1.19	1.19	1.27	0.9	1.24	0.75	0.88	1.11	1.04	1	0.68	0.96	0.92	1.38	0.81	1.32	0.86	0.84	3.11	1.73	0.76	2.13
HV11D11	547058	cyclin G1	0.17	0.28	0.16	0.32	0.35	0.29	0.2	0.22	0.15	0.22	0.21	0.21	0.42	0.31	0.38	0.29	0.32	0.2	0.15	0.25	0.18	0.23
HV11E1	752732	bleomycin hydrolase	1.3	2.83	2.96	2.24	1.88	1.35	2.05	2.83	3.5	1.67	1.16	2.41	1.71	2.68	1.25	1.97	1.41	2.88	1.11	0.86	1.07	3.58
HV11E2	154465	biphenyl hydrolase-like (serine hydrolase)	1.58	2.08	1.86	1.51	2.14	1.7	1.85	1.37	2.25	2.13	1.44	1.84	1.98	2.05	1.66	3.05	1.51	1.55	1.11	1.69	0.89	1.73
HV11E3	132012	puromycin-sensitive aminopeptidase	0.73	0.73	0.68	1.1	0.62	0.58	0.51	0.95	0.9	0.58	0.56	0.6	0.78	0.88	0.31	0.83	0.34	0.63	0.42	0.74	0.66	0.79
HV11E6	194214	TG-interacting factor (TALE family homeobox)	1.7	1	0.69	0.57	1.09	0.82	0.97	1.11	0.96	1.05	0.82	1.23	0.99	1.42	1.17	0.84	0.71	0.84	0.91	0.74	0.83	1.29
HV11E7	823930	"actin related protein 2/3 complex, subunit 1A (41 kD)"	0.82	1.01	0.8	0.73	0.67	0.42	0.52	0.4	0.65	0.64	0.41	0.27	0.47	0.7	0.67	0.62	0.35	0.82	0.63	0.24	0.44	0.68
HV11E8	366558	Ran GTPase activating protein 1	2.59	1.93	1.39	1.78	2.1	2.57	1.9	1.52	2.03	1.62	1.64	1.36	1.62	2.02	1.72	2.01	1.64	1.74	1.82	2.89	2.21	1.76
HV11E9	365060	"RAB11A, member RAS oncogene family"	1.11	1.09	0.49	0.97	0.8	0.82	0.72	1.43	0.92	0.89	0.7	0.75	0.87	1.46	1.07	0.64	0.57	0.94	2.06	0.61	1.13	1.47
HV11E10	469686	"Ric (Drosophila)-like, expressed in many tissues"	1.2	1.75	1.57	2.17	2.69	1.39	2.02	1.9	1.31	1.59	1	1.26	0.88	1.21	0.84	1.73	1.42	2.26	0.77	0.52	0.98	1.21
HV11E11	234237	pirin	2.05	1.18	2.32	1.34	2.66	0.88	0.95	1.33	1.97	1.51	1.27	2.12	0.66	0.66	0.42	1.25	1.56	2.18	1.03	0.87	1.01	2.4
HV11E12	177621	"retinoid X receptor, beta"	1.59	1.72	1.28	1.04	1.59	0.81	1.59	1.15	1.45	1.06	0.83	1.17	1.52	1.68	0.66	1.69	1.62	1.06	1.13	1.38	1.22	1.83
HV11F2	812251	mitogen-activated protein kinase-activated protein kinase 2	2.25	3.14	1.39	1.93	3.23	1.48	1.96	2.57	3.99	1.85	2.08	2.28	1.55	3.75	1.09	2.11	2.02	2.2	1.55	1.51	1.27	1.96
HV11F3	727292	macrophage-associated antigen	2.5	2.81	4.11	3.67	2.71	3.27	3.09	6	3.12	5.36	2.44	3.4	3	4.45	1.41	0.87	2.23	3.3	9.85	2.5	4.24	3.95
HV11F4	21738	"L-3-hydroxyacyl-Coenzyme A dehydrogenase, short chain"	2.38	1.45	1.28	1.5	2.21	1.93	1.12	1.16	1.08	1.88	1.42	0.94	1.26	1.81	1.22	1.8	1.39	1.57	4.62	2.42	1.72	6.13
HV11F5	72050	"chloride channel, nucleotide-sensitive, 1A"	1.3	1.1	0.61	0.91	0.98	0.77	0.85	0.93	0.95	1.45	0.77	0.92	0.93	0.79	0.77	0.63	0.89	1	0.83	0.56	0.64	0.94
HV11F6	754046	DNA segment on chromosome X (unique) 9879 expressed sequence	3.39	6.15	1.5	2.06	2.51	1.76	4.21	2.79	2.27	4.15	2.7	2.25	1.55	2.18	1.5	3.26	1.47	2.77	2.74	4.45	1.47	4.35
HV11F7	810040	ITBA1 gene	1.99	3.12	2.49	2.15	2.03	1.08	1.75	1.99	1.97	3.71	1.26	1.49	1.53	3.25	1.05	0.72	0.74	2.76	2.22	1.94	1.22	0.89
HV11F8	154749	dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase)	2.48	1.87	0.86	1.33	1.91	1.33	1.12	1.23	1.16	1.74	1.3	1.67	1.83	1.37	1.49	2.36	1.15	1.61	1.01	0.83	1.34	1.43
HV11F9	813751	"sialyltransferase 4C (beta-galactosidase alpha-2,3-sialytransferase)"	1.31	1.47	1.87	1.87	1.78	0.61	1.23	1.16	1.41	1.88	0.96	0.72	0.59	0.46	1.06	0.77	1.15	2.47	0.67	0.67	0.96	0.72
HV11F10	813158	developmentally regulated GTP-binding protein 2	0.91	1.35	1.29	0.92	1.57	1.38	1.28	0.92	1.35	1.79	1.06	1.54	1.18	1.22	0.81	1.66	1.28	1.58	1.67	1.83	1.27	2.32
HV11F11	299154	"phosphatidylinositol glycan, class K"	1.64	0.75	1.42	2.42	0.96	0.96	0.84	1.42	1.63	0.79	0.92	0.82	1.77	1.87	1.25	0.55	0.91	0.7	1.21	1.16	1.19	1.29
HV11F12	770216	ankyrin repeat-containing protein	1.34	5.84	2.18	2.44	3.99	2.12	3.11	2.07	2.27	3.2	2.25	1.86	1.74	2.71	1.33	3.64	3.27	3.34	1.94	2.77	1.77	3.19
HV11G1	251019	"cadherin 1, E-cadherin (epithelial)"	1.39	0.71	0.12	0.41	0.5	0.55	0.57	1.36	1.12	0.59	0.8	1.22	0.67	1.27	1.01	0.6	0.71	1.01	1.42	0.84	0.6	1.24
HV11G2	471266	DiGeorge syndrome critical region 6	2.03	3.17	2.54	1.74	2.47	2.04	2.74	2.37	3.64	2.31	2.58	2.33	1.85	2.47	1.68	3.84	2.19	2.53	2.95	2.76	1.78	2.23
HV11G3	755239	methyltransferase-like 1	0.6	1.31	0.74	1.09	0.52	0.62	1.61	0.86	0.74	1.47	0.86	0.64	0.89	1.06	1.42	0.69	0.95	2.48	0.78	0.51	0.79	1.13
HV11G4	341246	"ClpP (caseinolytic protease, ATP-dependent, proteolytic subunit, E. coli) homolog"	1.2	1.06	0.44	0.42	0.79	1.03	0.83	0.65	0.9	1.24	0.96	1.16	1.05	1.4	0.8	0.96	1.09	1.11	0.78	1.3	0.87	0.91
HV11G5	26711	Homo sapiens mRNA; cDNA DKFZp586F0221 (from clone DKFZp586F0221)	2.2	2.01	1.29	1.39	1.55	1.28	1.73	1.56	1.4	2.08	1.03	1.43	1.14	1.12	1.16	0.77	1.3	1.17	1.08	1.66	0.71	1.51
HV11G6	254321	nuclear DNA-binding protein	1.57	1.46	1.01	1.94	1.59	1.57	1.13	1.35	1.1	0.95	0.99	1.68	1.39	1.5	1.22	1.43	1.22	0.94	0.81	0.67	0.69	1.12
HV11G9	809992	"proteasome (prosome, macropain) 26S subunit, non-ATPase, 2"	2.02	1.52	0.95	1.06	1.3	1.25	1.08	1.42	1.56	0.95	1.18	1.08	0.9	1.11	1.26	0.63	1.36	1.43	0.93	0.95	0.76	1.05
HV11G11	184365	ESTs	2.33	2.3	1.15	1.46	2.01	1.4	1.9	2.05	2.57	1.71	1.51	1.38	1.87	2.31	1.2	1.35	0.78	1.3	1.61	0.93	1.55	1.63
HV11G12	210317	"RAB11B, member RAS oncogene family"	1.6	2.08	0.98	1.77	1.95	3.34	1.45	2.4	1.32	1.66	2.04	1.7	1.88	1.3	1.38	1.83	1.95	2.5	1.32	3.65	1.82	2.03
HV11H2	549146	stimulated trans-acting factor (50 kDa)	0.93	1.95	0.42	1.26	1.25	1.25	1.42	1.51	0.61	1.1	1.28	0.85	1.03	0.87	0.84	0.82	0.72	0.31	1.31	0.3	0.67	0.71
HV11H3	241880	H.sapiens Sp17 gene	0.89	3.48	1.54	1.96	2.96	1.11	1.14	1.11	6.5	1.18	1.1	1.01	1.11	0.82	0.81	1.04	0.84	1.16	1.24	1.28	0.92	1
HV11H4	810813	S100 calcium-binding protein A2	0.3	0.13	0.1	0.06	0.18	0.11	0.17	0.16	0.12	0.12	0.13	0.27	0.22	0.34	0.31	0.18	0.08	0.21	0.09	0.01	0.03	0.05
HV11H5	177737	purine-rich element binding protein A	0.92	1.59	0.87	0.65	1.38	0.78	1.13	1.36	1.41	0.98	0.86	1.22	1.3	1.93	0.87	0.9	0.78	0.88	1.26	0.62	0.62	1.31
HV11H8	511066	poly(A) polymerase	1.26	1.75	0.87	1.79	1.58	2.04	0.93	1.26	0.94	1.7	0.86	1.3	1.79	1.06	1.37	1.21	0.55	1.07	2.36	2.03	1.26	1.83
HV11H9	194182	Homo sapiens mRNA for leptin receptor gene-related protein	1.26	1.05	0.46	0.77	0.83	0.87	0.64	1.44	0.99	0.7	0.84	0.76	1.13	0.75	1.12	0.81	0.68	0.63	0.89	0.45	0.62	0.98
HV11H10	275871	nucleosome assembly protein 1-like 1	0.67	0.57	0.92	0.99	0.8	0.65	0.56	0.7	0.41	0.7	0.58	0.82	1.05	0.83	0.57	0.86	0.69	0.94	0.51	0.63	0.37	0.77
HV11H11	470175	mature T-cell proliferation 1	1.36	3.82	1.54	0.94	1.77	0.89	0.96	1.36	2.8	0.8	0.8	0.92	1.09	1.43	0.81	0.98	0.52	1.2	1.89	0.77	0.54	0.83
HV11H12	41591	meningioma (disrupted in balanced translocation) 1	1.09	4.41	2.49	1.84	2.94	2.06	2.41	4.04	1.74	1.97	1.19	1.64	1.86	1.89	0.95	1.67	1.44	1.1	2.43	1.48	2.15	4.06
HV12A4	755037	"interleukin 13 receptor, alpha 1"	2.32	1.51	1.89	1.5	2.42	1.55	2.49	2.78	1.82	1.73	1.6	1.94	1.83	1.1	2.58	2.73	1.22	0.72	1.26	1.69	1.34	1.97
HV12A6	33690	pre-mRNA cleavage factor Im (68kD)	1.52	1.47	0.97	1.24	1.26	1.08	1.34	1.08	0.7	0.98	0.69	0.75	1.15	0.94	1.07	1.51	1.15	0.98	0.65	1.55	1.04	1.22
HV12A7	810986	hemochromatosis candidate gene V	0.97	1.07	1.04	0.98	1.34	1.03	1.13	1.61	1.11	1.15	1.11	1	0.87	1.2	0.91	1.53	1.21	1.21	0.92	1.52	1.48	1.76
HV12A9	50506	mitogen-activated protein kinase 6	1.37	0.87	0.88	1.28	1.08	1.03	0.7	1.02	0.46	0.89	0.55	0.42	0.53	0.66	1.21	1.06	1.19	0.77	0.45	0.34	0.81	0.5
HV12A10	768299	butyrate response factor 1 (EGF-response factor 1)	0.79	0.96	1.71	0.83	1.69	0.53	0.84	0.75	0.38	0.75	0.74	0.5	1.26	0.96	0.77	1.81	0.63	0.73	1.25	0.27	0.53	1.28
HV12A11	144834	microtubule-associated protein 7	3.81	2.71	0.74	2.56	2.45	3	1.65	2.32	3.69	1.34	1.21	2.65	1.59	1.59	1.88	3.28	1.49	2.61	2.93	0.7	1.76	2.22
HV12B4	563444	forkhead (Drosophila)-like 5	1.3	1.63	1.94	1.43	1.34	1.31	1.56	1.34	1.2	1.5	1.13	2.44	1.15	1.26	1.26	1.71	1.36	1.56	1.09	1.07	0.91	0.94
HV12B9	71606	natural killer cell group 7 sequence	3.14	10.81	3.2	2.58	3.19	6.16	3.81	3.82	2.48	3.49	3.15	4.49	1.6	2.58	1.54	2.17	3.9	1.81	23.35	4.54	7.11	6.3
HV12B10	308041	peanut (Drosophila)-like 1	4.49	6.27	5.43	6.1	7.29	3.03	5.22	6.74	12.7	7.03	2.78	6.32	3.47	5.56	2.19	4.09	3.36	0.94	4.09	7.42	3.68	6.55
HV12C2	245920	glycogen synthase 2 (liver)	1.21	4.25	1.4	1.01	2.6	5.18	2.73	2.38	6.98	2.59	0.35	2.49	1.54	2.32	0.49	1.83	1.78	3.11	2.92	1	1.14	1.64
HV12C3	45632	glycogen synthase 1 (muscle)	0.28	0.59	0.76	0.49	0.56	0.72	0.52	0.46	0.79	0.91	0.86	0.43	0.35	0.46	0.46	0.45	0.53	0.4	0.52	0.89	0.42	0.41
HV12C4	248261	"glycine dehydrogenase (decarboxylating; glycine decarboxylase, glycine cleavage system protein P)"	1.61	3.5	1.18	3.9	3.87	1.22	2.99	4.48	2.82	2.04	0.76	7.1	1.49	2.48	1.35	2.18	1.9	2.31	2.69	4.25	1.68	1.04
HV12C5	136235	glutathione S-transferase pi	0.75	0.3	0.65	0.74	0.34	0.58	0.38	0.28	0.1	0.36	0.25	5.38	0.28	0.22	1.11	0.83	0.55	0.92	0.17	0.08	0.74	0.1
HV12C6	811792	glutathione synthetase	0.95	0.59	0.53	0.51	0.89	0.56	0.84	0.82	1	0.82	0.76	0.6	0.7	0.83	0.83	2.1	0.67	0.69	1.11	0.43	0.59	0.76
HV12C7	823928	glutathione S-transferase theta 2	0.39	0.95	0.45	1	1.6	0.34	0.55	0.38	0.63	0.89	1.01	0.35	0.72	0.72	0.7	1.38	0.33	0.69	0.79	1.03	0.49	0.55
HV12C8	713922	glutathione S-transferase M1	2.37	7.03	6.71	2.5	3.94	3.88	2.67	3.92	1.85	2.21	1.68	2.55	4.71	6.98	1.35	2	2.07	3.15	3.26	5.74	1.73	2.38
HV12C12	276449	"glucuronidase, beta"	2.39	2.45	1.52	1.61	2	2.18	1.36	1.97	1.59	1.78	1.55	1.74	1.76	2.19	1.25	2.35	1.58	1.07	3.79	2.94	2.55	2.55
HV12D1	753775	guanosine monophosphate reductase	0.49	2.23	0.97	0.42	1.04	0.45	1.06	1.13	0.95	0.79	1.1	1.67	1.6	0.83	0.92	0.73	0.6	1.18	0.94	0.38	0.55	0.63
HV12D3	122636	"glucose-6-phosphatase, catalytic (glycogen storage disease type I, von Gierke disease)"	0.71	2.01	0.69	0.79	0.95	1.44	0.76	0.62	0.77	0.75	0.6	0.86	0.61	1.2	0.9	1.26	0.92	1.09	1.59	0.85	1.84	1.12
HV12D4	741474	glucose phosphate isomerase	0.77	1.71	0.74	0.68	0.8	1.49	0.67	0.59	0.83	0.65	0.49	0.84	0.43	1.23	0.94	1.24	0.93	1.61	0.92	0.52	1.03	0.6
HV12D6	127509	"glucan (1,4-alpha-), branching enzyme 1 (glycogen branching enzyme, Andersen disease, glycogen storage disease type IV)"	0.42	0.62	0.32	0.38	0.67	0.34	0.5	0.54	0.33	0.46	0.36	0.34	0.49	0.57	0.42	0.66	0.41	0.25	0.43	0.18	0.26	0.33
HV12D7	51362	general transcription factor IIB	0.95	1.61	0.64	0.86	1.23	1	0.78	2.02	0.85	0.9	0.83	0.66	0.79	0.7	0.75	0.8	0.73	0.69	0.89	0.54	1.09	1.05
HV12D9	823859	ESTs	0.85	2.78	4.05	2.23	2.68	0.7	5.13	8.15	2.66	3	3.47	0.61	1.43	3.55	0.98	1.15	0.91	1.41	2.1	0.8	1.67	1.34
HV12D11	35185	"gamma-aminobutyric acid (GABA) A receptor, beta 1"	0.36	0.62	0.52	0.52	0.51	0.36	0.4	0.45	0.43	0.24	0.69	0.55	0.77	0.62	0.54	0.59	0.78	0.76	0.78	1.23	0.85	0.71
HV12D12	197888	"guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1"	0.88	1.68	0.4	2.08	1.15	0.75	1.17	2.49	0.85	0.76	0.69	0.84	1.18	1.28	0.9	0.85	0.92	1.2	0.87	0.37	0.46	0.74
HV12E2	756480	N-myristoyltransferase 1	1.09	1.09	0.57	0.79	0.94	1.13	0.92	1.1	0.89	0.73	0.7	0.9	1.02	0.89	0.68	1.31	0.99	0.84	0.47	0.68	0.67	0.92
HV12E3	134748	glycine cleavage system protein H (aminomethyl carrier)	0.82	0.92	0.72	0.75	0.95	0.67	0.48	0.56	0.6	0.64	0.43	0.51	0.42	0.86	0.48	0.71	0.86	1.34	0.59	0.44	0.55	0.61
HV12E4	768443	microsomal glutathione S-transferase 1	0.47	0.17	0.34	0.25	0.62	0.64	0.27	0.07	0.08	0.17	0.2	0.26	0.19	0.39	0.33	0.82	0.62	0.33	0.49	0.05	0.49	0.49
HV12E8	173228	"glia maturation factor, beta"	1.5	0.61	1.21	1.07	1.02	0.76	0.77	0.92	0.45	0.64	0.38	0.8	0.93	0.81	0.93	1.45	0.57	0.63	0.47	0.57	0.43	0.81
HV12E9	214990	"gelsolin (amyloidosis, Finnish type)"	2.99	0.8	1.22	1.62	1.74	0.89	1.1	1.95	1.34	1.37	1.45	0.7	1.48	0.86	1.05	1.16	0.93	0.97	1.61	0.55	1.99	2.41
HV12E10	230218	"GCN5 (general control of amino-acid synthesis, yeast, homolog)-like 1"	1.9	1.04	1.57	0.91	1.35	0.99	2.37	1.58	1.98	2.05	1.31	1.09	1.1	2.04	0.66	1.9	0.91	1.12	1.43	0.89	1.16	1.63
HV12E11	562927	leucine rich repeat (in FLII) interacting protein 1	1.12	1.23	1.31	1.31	1.48	1.51	0.99	1.23	0.68	1.25	1.03	0.52	0.97	0.54	1.12	1.14	1.29	0.61	0.7	0.74	1.35	0.91
HV12E12	214068	GATA-binding protein 3	1.37	3.17	0.25	0.46	3.11	2.19	6.28	6.91	4.36	8.13	4.69	4.28	4.5	7.12	1.02	1.44	2.02	1.1	5.58	5.11	0.91	7.6
HV12F2	221092	"GA-binding protein transcription factor, beta subunit 2 (47kD)"	1.44	2.1	1.51	1.89	2.58	2.26	2.01	1.83	1.8	1.89	1.2	1.42	1.62	2.27	1.61	1.61	1.46	1.89	2.45	1.73	1.23	1.71
HV12F3	260325	"GA-binding protein transcription factor, alpha subunit (60kD)"	1.44	1.64	2.25	1.65	0.77	1.04	1.27	1.48	1.49	0.97	1.08	1	1.59	0.74	0.88	0.92	1.85	0.57	4.61	2.05	1.94	3.02
HV12F4	183200	fumarylacetoacetate	0.95	1.19	1.03	1.02	1.72	0.67	1.45	1.99	1.64	2.13	1.25	1.44	2.05	2.38	0.79	1.44	1.57	0.81	1.35	1.77	2.92	2.44
HV12F5	469412	fumarate hydratase	0.66	1.57	1.27	2.22	1.65	1.41	0.83	0.98	0.55	0.83	1.09	0.58	0.5	1.33	0.88	1.36	2.26	1.23	0.86	0.96	1.27	1.03
HV12F7	308437	"fucosidase, alpha-L- 1, tissue"	2.19	2.92	3.28	3.23	2.5	4.36	3.39	3.88	4.09	3.12	3.72	3.54	2.47	2.84	1.96	3.12	1.86	1.32	6.54	2.29	4.55	4.02
HV12F8	669419	Friedreich ataxia	2.27	4.47	1.78	2.52	3.13	1.42	1.62	1.57	2.19	3.88	1.71	1.02	2.02	3.28	1.09	4.77	2.31	0.94	2.15	0.72	0.88	1.33
HV12F11	131839	folate receptor 1 (adult)	4.24	2.74	5.04	2.26	4.17	0.9	2.19	1.82	1.7	2.14	1.22	0.72	1.59	0.56	0.88	1.83	1.85	0.76	2.78	1.42	2.22	2.35
HV12G1	197525	flavin containing monooxygenase 5	0.92	2.61	2.49	1.23	2.43	1.74	2.94	4.05	2.85	2.49	1.21	3.29	2.08	2.52	1.25	1.12	1	0.86	1.17	0.44	0.58	0.64
HV12G2	139009	fibronectin 1	0.53	0.42	1.66	0.72	1.28	1.58	1.14	0.93	1.01	2.12	1.99	0.76	1.13	1.54	1.32	0.68	0.53	0.71	2.08	0.6	1.69	1
HV12G3	811162	fibromodulin	0.58	4.42	8.72	3.8	7.05	3.52	8.34	10.58	4.03	3.15	3.83	1.85	1.32	2.51	1.21	1.95	2.02	0.75	3.16	0.96	2.27	1.89
HV12G4	752631	"fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism)"	2.18	4.3	2.75	2.34	4.91	1.61	5.67	9.64	12.07	3.76	1.59	3.13	2.3	2.66	1.49	6.09	2.03	4.47	6.41	9.37	4.71	5.31
HV12G8	767851	fibrillin 1 (Marfan syndrome)	1.12	0.68	1.84	1.73	2.58	1.33	1.57	5.17	1.49	1.78	2.62	1.38	1.57	1.21	1.55	1.68	0.98	0.41	2.54	0.62	1.82	2.02
HV12G9	66728	ferrochelatase (protoporphyria)	0.71	1.78	0.96	1.39	1.65	0.72	0.53	0.96	0.66	1.45	1.14	1.03	0.71	0.41	0.76	1.08	1.04	0.35	1.67	0.99	0.79	1.11
HV12H1	143519	FK506-binding protein 2 (13kD)	0.95	1.74	0.87	0.93	1.54	0.84	1.29	1.47	1.87	1.37	1.23	1.54	0.75	1.79	1.45	1.4	0.41	1.68	2.32	0.72	1.36	1.84
HV12H3	302292	exostoses (multiple) 2	0.76	1.77	1.76	0.66	2.43	0.74	0.83	1.58	1.19	1.03	1.17	0.81	0.85	1.13	0.79	1.36	1.54	1.24	1.28	0.63	1.32	1.1
HV12H4	135449	Ewing sarcoma breakpoint region 1	1.41	2.68	1.4	1.27	1.83	1.13	2.15	1.93	1.72	2.05	1.24	1.46	0.89	1.82	1.84	1.68	1.25	1.55	0.96	0.65	0.81	1.18
HV12H5	665774	eukaryotic translation initiation factor 4E	0.62	1.2	1.15	1.34	1.14	0.9	0.71	1.19	1.26	0.99	1.22	0.81	0.89	0.64	1.32	1.21	1.18	0.57	0.59	0.83	0.97	0.95
HV12H6	209296	ESTs	1.3	3.71	2.02	1.44	1.17	1.06	2.45	1.51	3.16	1.26	0.39	1.18	1.21	1.66	0.66	1.15	0.91	1.34	1.62	0.63	0.94	1.13
HV12H7	34849	eukaryotic translation elongation factor 2	0.33	0.63	0.48	0.54	0.47	0.36	0.35	0.49	0.41	0.24	0.68	0.56	0.69	0.6	0.52	0.51	0.73	0.64	0.76	1.25	0.69	0.8
HV13A1	124597	"enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase"	2.42	2.29	2.09	1.88	2.29	0.89	1.6	1.87	2.24	2.23	0.86	2.07	1.14	1.25	0.16	1.28	1.3	1.32	1.54	1.2	0.79	1.2
HV13A2	366834	envoplakin	2.86	2.07	0.25	0.82	2	1.95	1.38	1.68	3.47	2.08	1.6	0.89	1	1.36	0.73	2.5	1.78	1.96	2.46	1.42	2.06	2.52
HV13A8	809939	mitogen-activated protein kinase 3	1.98	1.08	0.78	0.9	1.42	1.06	1.31	1.26	1.5	1.19	1.32	1.49	1.38	1.24	0.55	1.53	0.67	0.83	0.85	1.89	1.14	1.49
HV13A9	813678	"solute carrier family 1 (glial high affinity glutamate transporter), member 3"	2.75	0.91	2.69	2.85	1.45	1.67	0.94	1147.23	2.37	2.69	2.1	1.03	1.14	1.56	1.33	1.01	0.66	1.14	3.03	0.88	1.4	0.78
HV13A10	811999	eukaryotic translation termination factor 1	0.8	1.13	0.69	0.6	1.33	0.44	0.82	0.6	1.54	0.95	0.82	1.13	0.73	1.4	0.61	1.69	1.35	1.21	0.74	0.39	0.48	0.91
HV13A11	241412	E74-like factor 1 (ets domain transcription factor)	1.41	0.95	1.27	1.52	1.44	0.91	0.74	1.58	1.04	1.09	1.32	0.63	0.92	1.53	0.93	0.84	0.78	0.74	0.82	0.75	1.4	1.23
HV13A12	138936	erythrocyte membrane protein band 7.2 (stomatin)	4.74	1.96	0.83	2.74	2.94	1.75	1.68	3.69	16.83	2.05	2.92	1.61	3.46	1.71	1.54	1.82	1.76	0.84	3.66	0.72	1.15	2.15
HV13B1	232612	"lectin, mannose-binding, 1"	2.91	5.82	4.13	2.61	3.25	1.79	2.34	2.44	2.35	1.57	0.94	3.12	1.57	3.28	1.6	1.23	1.81	4.07	4.24	0.76	2.13	4.06
HV13B2	184175	KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1	0.84	0.53	1.34	0.48	0.97	0.45	0.87	0.67	0.76	0.62	0.77	1.02	0.79	0.82	0.79	1.29	0.71	0.86	0.63	0.69	0.68	0.75
HV13B3	22411	Duffy blood group	1.98	0.57	0.34	0.84	1.41	0.28	0.27	1.07	0.28	0.64	0.54	1.82	1.56	7.67	2.58	0.57	0.81	4.23	4.31	5.45	2.21	1.44
HV13B4	753104	"dopachrome tautomerase (dopachrome delta-isomerase, tyrosine-related protein 2)"	1.02	0.41	0.27	0.45	1.27	0.18	0.38	0.85	0.3	0.44	0.42	0.46	2.16	0.69	0.79	0.45	0.27	0.65	1.61	0.19	0.74	1.42
HV13B5	35828	diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor)	0.58	0.62	1.58	0.72	0.94	0.44	0.42	1.81	0.95	1	3.26	0.69	1.64	0.71	0.7	0.76	0.65	0.83	2.56	0.51	1.1	0.72
HV13B8	813648	"dihydrolipoamide dehydrogenase (E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex, branched chain keto acid dehydrogenase complex)"	0.56	1.07	0.72	1.31	1.08	0.98	0.52	0.41	0.57	0.79	0.63	0.53	0.98	0.76	0.83	1.02	1.04	0.78	0.85	0.61	0.83	0.74
HV13B9	196992	"aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)"	0.24	0.41	0.22	0.25	0.35	0.05	0.15	0.13	0.21	0.25	0.17	0.12	0.19	0.15	0.21	0.8	0.05	0.27	0.2	0.07	0.93	0.23
HV13B11	810156	deoxythymidylate kinase	1.32	2.68	1.09	1.16	0.95	0.85	1.08	0.83	0.91	1.05	1	0.5	0.85	1.84	1.81	0.66	1.01	2.3	0.99	0.93	1.5	1.04
HV13B12	125722	deoxyguanosine kinase	2.09	1.63	0.76	1.43	1.99	1.17	1.54	1.3	1.42	1.9	1.06	1.2	1.23	1.32	0.68	2.11	1.04	1.69	0.97	0.88	0.96	1.25
HV13C1	43198	deoxycytidine kinase	2.05	3.78	2.66	2.98	2.8	2.6	1.36	1.97	1.47	2.68	1.52	11.43	1.39	2.56	1.63	1.97	1.82	1.86	2.43	1.74	2.75	0.92
HV13C2	45291	dentatorubral-pallidoluysian atrophy (atrophin-1)	1.93	1.27	1.68	0.95	1.34	0.99	1.45	1.58	1.72	1.57	1.09	1.49	0.97	1.9	1.97	1.85	0.76	1.19	0.69	0.56	0.97	1.15
HV13C3	510679	decorin	1.14	1.06	1.48	2.18	1.27	1.71	1.07	1.55	0.62	1.51	1.5	1.49	1.12	0.86	2.09	2.39	1.64	1.33	2.04	1.54	1.41	1.43
HV13C4	128126	"decay accelerating factor for complement (CD55, Cromer blood group system)"	1.46	1.74	1.06	1.71	2.09	1.34	2.33	4.24	2.36	1.9	1.15	1.49	1.59	1.88	2.14	1.74	1.48	1.55	1.69	0.94	1.22	1.5
HV13C5	753447	damage-specific DNA binding protein 2 (48kD)	0.92	0.67	0.52	0.48	0.65	0.45	0.55	0.73	0.74	1.16	0.79	0.41	0.86	0.86	0.83	0.67	0.26	0.66	1.73	0.92	1.56	1.69
HV13C6	33826	mitogen-activated protein kinase kinase 1	0.71	0.58	0.48	0.62	0.54	0.88	0.39	0.74	0.59	0.81	0.53	0.45	0.64	0.68	0.64	0.63	0.63	0.4	0.43	0.27	0.51	0.39
HV13C7	810053	"heat shock protein, neuronal DNAJ-like 1"	1.48	1.22	0.7	0.73	1.06	1.02	1.01	1.01	1.87	0.94	1.29	1.57	1.23	1.05	1.36	0.81	0.62	1.28	7.12	3.95	5.07	4.36
HV13C8	809916	zinc finger protein 144 (Mel-18)	1.38	3.52	3.06	2.68	2.27	1.66	1.34	2.63	2.59	1.71	1.79	2.01	1.84	3.53	2.78	2.22	1.45	1.85	1.83	1.64	1.27	2.33
HV13C9	810057	cold shock domain protein A	0.78	0.87	0.42	1.16	0.65	0.73	0.51	0.38	0.24	0.47	0.54	0.31	1.1	0.44	0.88	0.5	0.94	1.07	0.2	0.22	0.26	0.42
HV13C10	26811	X-ray repair complementing defective repair in Chinese hamster cells 4	1.06	4.01	1.84	1.35	3.44	2.9	1.84	1.59	1.43	1.05	0.83	1.04	1.28	1.94	0.81	1.71	1.69	0.82	1.42	0.63	0.65	1.39
HV13C11	741769	"polymerase (DNA directed), beta"	1.17	3.28	1.28	1.52	1.64	1.7	1.24	2.74	6.52	1.45	1	1.7	1.27	2.2	1.37	1.59	0.93	2.05	2.29	0.72	1.5	2.02
HV13C12	276547	DNA (cytosine-5-)-methyltransferase 1	1.78	4.86	1.9	2.89	2.69	3.48	1.77	1.93	2.69	1.47	1.86	1.61	1.98	3.1	1.69	2.25	2.72	3.79	2.2	2.3	1.58	1.92
HV13D1	292463	"excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome))"	1.27	3.1	1	1.13	1.66	1.35	0.82	1.22	1.19	0.84	0.88	0.98	0.89	0.84	0.7	0.88	1.13	0.56	0.79	0.58	1.31	0.99
HV13D2	810039	defender against cell death 1	1.54	1.49	1.58	0.95	1.34	0.96	1.56	1.81	1.64	1.59	1.08	1.44	0.88	1.59	1.93	1.79	0.71	1.14	0.76	0.56	0.85	1.06
HV13D3	160126	cytochrome c oxidase subunit X (heme A: farnesyltransferase)	0.7	4.58	1.56	1.19	2.11	0.95	1.42	1.4	1.49	0.84	1.04	0.61	1.18	1.14	0.85	1.33	1.23	1	1.01	0.61	1.18	0.95
HV13D4	196189	cytochrome b-5	1.38	1.48	1.13	1.25	1.87	2.18	2.56	1.83	2.74	2.14	2.33	3.36	2.08	4.13	1.77	3.09	0.92	1.04	1.48	0.74	2.64	4.68
HV13D5	284620	ESTs	0.99	0.6	1.24	0.54	0.31	0.35	0.5	0.62	4.02	0.23	0.33	1.16	1.14	1.6	1.11	0.4	0.65	0.89	2.42	1.65	1.25	1.96
HV13D11	810321	cysteinyl-tRNA synthetase	0.69	2.06	1.09	1.14	2.18	0.7	1.29	1.35	3.79	1.01	0.84	0.86	0.71	1.14	0.71	0.93	0.8	1.32	1.33	0.7	1.22	0.72
HV13E6	28475	"crystallin, zeta (quinone reductase)"	2.25	1.47	0.74	2.26	1.55	2.22	1.3	1.59	1.89	1.06	1.23	0.62	1.45	2.21	0.33	1.98	1.55	1.36	0.96	1.15	0.68	2.13
HV13F11	245853	"clathrin-associated/assembly/adaptor protein, large, beta 1"	0.53	1.5	0.95	1.01	1.06	0.85	1.01	1.13	0.87	1.06	1.05	1.93	0.98	0.63	2.41	0.83	0.69	0.54	0.51	1.27	0.97	0.87
HV13G6	727526	centromere protein E (312kD)	2.78	3.32	2.04	1.64	1.59	1.23	1.91	1.69	2.96	1.47	0.25	1.12	0.79	2.51	0.67	1.81	1.96	2.53	1.84	0.65	0.71	1.61
HV13G7	771196	Rho GTPase activating protein 1	1.42	1.4	0.9	1.05	1.42	1.12	1.69	2.28	2.48	1.39	1.77	1.47	1.08	2.11	0.96	1.06	0.53	2.67	6.11	1.36	1.83	2.31
HV13G9	243202	cathepsin E	1.56	2.34	2.73	2.29	1.38	2.84	2.21	12.89	4.91	1.81	3.18	3.29	2.77	2.02	1.34	1.7	1.38	1.98	2.95	1.59	2.79	3.7
HV13G10	264117	cathepsin D (lysosomal aspartyl protease)	1.43	1.4	0.72	1.28	1.45	2.97	1.26	2.69	1.6	1.43	1.79	1.32	1.76	1.65	2.29	1.92	1.41	1.06	1.91	0.89	1.35	2.11
HV13G12	122091	"casein kinase 2, alpha 1 polypeptide"	1.27	2.12	0.88	1.02	1.57	4.03	1.34	0.87	1.28	1.05	2.54	1.29	1.11	1.04	1.59	2.02	1.41	1.21	2.37	0.86	1.05	1.6
HV13H2	241348	carboxyl ester lipase (bile salt-stimulated lipase)	2.02	2.17	1.98	2.34	1.78	1.48	1.31	1.29	1.54	1.16	0.61	2.41	1.64	0.79	1.27	1.38	1.33	0.69	1.14	2.02	1.42	1.3
HV13H3	51865	carbonic anhydrase II	0.16	0.21	0.11	0.26	0.29	0.15	0.46	0.13	0.2	0.11	0.19	0.22	0.11	0.2	0.29	0.16	0.11	0.12	0.45	0.42	0.26	0.79
HV13H4	275738	carbonic anhydrase I	0.27	0.4	0.15	0.29	0.5	0.17	0.62	0.13	0.32	0.12	0.18	0.27	0.2	0.3	0.35	0.29	0.14	0.17	1.17	1.07	0.58	1.45
HV13H6	511521	calnexin	0.67	0.56	0.66	0.88	0.93	0.79	0.77	0.99	0.52	1.41	1.17	1.57	1.12	0.84	1.97	0.68	1.88	0.47	0.5	1.01	0.71	0.81
HV13H8	810408	"Human calcineurin B mRNA, complete cds"	0.83	0.53	0.63	0.37	0.79	0.49	0.91	0.71	0.91	0.79	0.86	0.88	0.64	0.91	0.69	1.37	0.98	0.58	0.7	0.64	0.6	0.64
HV13H9	301976	"protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma)"	0.48	1.25	1.3	0.89	2.1	0.75	0.78	1.5	3.83	0.45	0.59	1.17	1.21	1.05	0.77	0.62	0.67	1.23	1.76	0.85	1.15	0.77
HV13H12	46182	CTP synthase	2.2	1.53	2.23	3.01	2.25	2.58	0.76	1.5	1.09	0.93	1.15	1.2	1.12	1.15	1.23	1.69	2.13	1.79	1.65	1.43	1.42	0.51
HV14A4	183337	"major histocompatibility complex, class II, DM alpha"	3.32	11.18	5.35	4.93	7.06	6.36	5.4	5.84	7.33	7.42	5.22	4.63	3.94	4.89	2.76	3.15	2.72	1.46	14.32	4.61	7.61	8.92
HV14A6	115292	"ESTs, Highly similar to CAMPATH-1 ANTIGEN PRECURSOR [H.sapiens]"	1.71	1.1	0.42	1	1.81	1.08	1.25	1.01	1.58	1.21	0.63	1	1.03	1.23	0.63	1.82	1.02	1.01	1.28	0.72	1.51	1.72
HV14A7	810899	CDC28 protein kinase 1	2.54	2.4	1.28	2.63	2.23	1.64	1.62	0.99	0.86	1.44	1.35	0.87	0.59	1.81	0.8	1.1	1.69	4.16	0.61	0.8	1.1	1.26
HV14A8	727251	CD9 antigen (p24)	1.2	0.75	0.5	1.24	1.14	1.1	1.78	1.29	1.32	1.39	1.46	1.27	1.28	0.74	0.63	1.94	1.21	1.9	0.94	1.29	0.91	1.95
HV14A9	771258	"CD8 antigen, alpha polypeptide (p32)"	1.99	3.23	1.65	2.01	2.88	4.31	2.03	3.52	3.44	2.12	6.21	5.64	1.83	1.9	1.77	1.7	1.4	2.02	5.43	0.72	2.68	1.95
HV14A10	208001	"CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344)"	0.61	0.52	0.91	0.28	1.08	0.22	0.54	0.5	0.26	0.42	0.41	0.45	0.74	0.51	0.52	0.69	0.55	0.5	0.73	0.22	0.54	0.35
HV14A12	813552	"CD47 antigen (Rh-related antigen, integrin-associated signal transducer)"	2.9	7.43	1.48	1.88	3.44	2.47	2.74	1.49	1.78	2.22	1.54	1.43	1.75	1.75	1.56	1.57	2.36	2.56	2.24	1.38	1.39	2.06
HV14B4	243816	"CD36 antigen (collagen type I receptor, thrombospondin receptor)"	1.49	4.26	1.39	2.71	8.02	1.75	7.2	2.4	2.99	18.64	2.09	2.15	7.82	5.09	1.6	3.3	1.96	2.47	4.42	3.63	2.57	5.17
HV14B6	265874	nuclear factor I/C (CCAAT-binding transcription factor)	3.34	2.28	0.83	1.31	5.81	1.45	1.95	1.41	1.22	0.99	2.4	2.97	2.74	3.51	0.93	2	0.91	1.63	2.17	3.51	2.01	3.05
HV14B7	123926	cathepsin K (pycnodysostosis)	1.31	1.21	2.02	2.71	3.05	2.31	3.18	9.47	2.36	3.44	5.2	3.07	4.02	4.21	3.25	0.96	2.24	0.61	8.72	3.05	7.76	8.86
HV14B9	211548	"carboxypeptidase N, polypeptide 2, 83kD"	1.41	1.78	1.47	2.04	1.76	1.5	1.09	1.43	0.83	1.24	1.44	0.75	0.63	0.76	1.28	1.16	1.93	1.09	4.37	2.66	3.01	2.13
HV14B10	262231	calreticulin	1.91	1.22	1.32	1.44	1.78	0.76	0.98	1.1	0.67	1.03	1.69	0.71	0.98	0.73	1.6	1.94	2.21	1.04	1.04	2.2	1.89	1.5
HV14B12	274638	"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"	2.9	6.22	2.11	3.45	5.24	3.26	3.64	3.08	1.88	3.41	2.09	1.38	1.81	1.01	1.25	1.91	2.25	1.93	3.95	3.42	2.66	2.71
HV14C1	241365	mannan-binding lectin serine protease 1 (C4/C2 activating component of Ra-reactive factor)	0.5	0.68	0.36	0.67	0.79	0.67	0.78	0.62	0.56	0.68	0.64	0.5	0.57	0.88	1	0.4	0.35	0.68	0.93	0.61	0.75	0.61
HV14C4	756163	breakpoint cluster region	1.58	5.25	1.12	1.54	3.24	2.27	2.43	2.18	2.55	2.2	1.66	1.58	1.63	2.16	2.2	3.67	4	5.25	3.55	3.1	3.25	4.17
HV14C6	753301	biliary glycoprotein	1.4	2.93	0.78	1.37	3.8	2.12	1.09	1.19	1.16	1.6	1.15	2.64	2.99	4.14	1.71	3.57	1.67	6.14	2.24	1.03	1.69	1.21
HV14C8	194384	basic transcription factor 3	0.57	0.4	0.54	0.54	0.65	1.86	0.82	0.55	0.56	0.71	0.57	0.51	1.02	1.32	0.62	0.72	0.67	0.88	0.43	0.41	0.41	0.77
HV14C10	767753	"regulatory factor X, 5 (influences HLA class II expression)"	1.32	4.02	1.4	2.29	2.85	2.26	3.44	1.72	1.66	2.53	0.88	1.4	1.85	2.8	0.92	1.91	3.22	2.25	2.02	1.35	1.24	1.54
HV14C12	132373	basonuclin	0.29	0.55	0.35	0.23	0.81	0.21	0.27	0.33	0.3	0.29	0.33	0.51	0.38	0.47	0.93	0.54	0.91	0.39	0.6	0.19	0.29	0.45
HV14D1	811942	"general transcription factor IIH, polypeptide 1 (62kD subunit)"	0.84	1.98	0.92	1.19	2.01	0.66	0.88	1.06	1.09	0.72	0.74	0.53	0.91	0.77	0.76	0.89	0.96	0.72	0.62	0.62	0.54	0.65
HV14D2	810444	"tumor necrosis factor, alpha-induced protein 2"	0.71	1.54	0.24	0.54	0.71	1.24	0.56	0.62	0.45	0.51	0.73	0.71	0.7	0.63	0.53	0.53	1.37	0.44	5.71	2.62	1.71	2.62
HV14D5	753897	autocrine motility factor receptor	1.08	1.34	0.84	0.51	1.16	1.09	0.68	2.54	2.23	1.03	1.14	2.66	1.38	1.36	1.02	1.17	0.73	0.5	1.28	0.9	0.79	0.85
HV14D6	682528	"spinocerebellar ataxia 1 (olivopontocerebellar ataxia 1, autosomal dominant, ataxin 1)"	0.97	3.91	3.65	1.96	3.43	1.39	2.26	4.61	2.85	2.34	1.73	1.87	2.23	2.93	1.63	2.65	1.47	1.39	1.75	0.69	1.58	0.56
HV14E5	563673	antiquitin 1	1.05	1.29	1.05	1.22	1.3	0.4	0.55	0.72	0.6	0.74	1.04	0.53	0.84	0.89	0.57	0.58	1.2	0.69	0.65	0.74	1.07	1.13
HV14E7	810117	annexin A11	0.62	0.5	0.29	0.5	0.58	0.66	0.64	0.71	0.32	0.69	0.73	0.35	0.4	0.4	0.27	0.46	0.52	0.36	0.52	0.69	0.48	0.6
HV14E8	666879	annexin A8	3.41	0.17	0.09	0.43	0.29	1	0.42	0.36	0.17	0.12	0.11	0.06	0.3	0.39	0.19	0.41	0.31	0.26	0.22	0.08	0.23	0.12
HV14E9	49352	annexin A7	0.84	0.71	0.68	1.31	0.86	0.96	0.76	0.84	0.44	0.98	1.2	0.63	0.82	0.63	0.72	0.87	0.82	0.61	0.58	1.82	1.18	1.48
HV14E10	755506	annexin A4	0.98	0.48	0.32	0.94	0.76	1.17	0.56	0.71	0.33	0.43	0.66	0.36	0.7	0.56	0.78	0.75	0.91	0.37	0.42	0.6	0.82	0.73
HV14E11	208718	annexin A1	0.53	0.21	0.4	0.25	0.49	0.53	0.16	0.26	0.17	0.21	0.21	0.08	0.31	0.17	0.32	0.17	0.46	0.13	0.16	0.04	0.12	0.12
HV14F1	240249	amyloid beta (A4) precursor-like protein 2	1.07	0.69	0.88	1.09	1.05	1.2	0.55	0.79	0.28	0.91	1.3	0.61	0.83	0.3	0.7	0.9	0.76	0.85	0.97	3.23	1.91	1.05
HV14F5	813651	"aminolevulinate, delta-, synthase 1"	1.23	1.91	1.52	1.75	1.35	1.66	1.19	1.27	1.45	1.71	1.38	1.36	1.15	0.7	1.3	0.7	0.96	0.84	1.65	0.88	1.43	0.68
HV14F7	823775	"guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3"	1.57	1.66	2.05	2.23	1.19	1.32	1.46	1.33	1.17	1.59	0.8	0.75	0.59	0.84	1.34	0.75	0.91	1.76	2.01	0.8	1.42	2.02
HV14F10	122159	"collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant)"	5.71	25.44	12.05	13.67	16.47	9.51	5.55	3.4	13.12	20.7	8.65	8.73	6.07	14.95	3.78	6.85	6.72	11.01	48.06	9.48	22.51	67.8
HV14F12	36387	"aldehyde dehydrogenase 9 (gamma-aminobutyraldehyde dehydrogenase, E3 isozyme)"	3.11	2.33	0.79	2.49	2.63	1.6	1.53	1.63	1.53	1.86	1.27	1.8	2.11	3.23	0.98	1.34	1.8	1.99	1.13	0.86	0.99	1.61
HV14G1	813711	"alcohol dehydrogenase 5 (class III), chi polypeptide"	0.79	2.13	1.72	0.96	2.31	1.1	1.26	1.73	1.64	1.27	1.08	0.89	1.29	1.09	1.02	0.85	0.96	1.21	1.75	0.61	0.66	1.04
HV14G5	813280	adenylosuccinate lyase	0.97	1.62	1.42	1.55	1.6	1.35	1.01	1.09	1.18	1.01	1.02	0.79	1.41	1.72	1.17	0.81	1.03	1.82	0.74	0.62	0.95	0.83
HV14G6	124127	adenosine monophosphate deaminase (isoform E)	1.27	2.37	1.17	1.32	2.67	1.5	1.68	2.55	1.84	2.03	0.85	1.22	1.42	1.25	0.45	1.99	1.14	0.76	2.11	1.18	1.21	1.56
HV14G7	128243	adenosine kinase	0.44	1.56	0.59	0.73	1.15	0.58	0.62	0.42	0.4	0.92	0.62	0.36	0.48	0.52	0.55	0.59	0.44	0.36	0.67	0.43	0.35	0.54
HV14G8	812083	adenomatosis polyposis coli	0.86	1.56	0.65	1.29	1.93	1.02	1.05	1.12	1.13	1.37	0.65	0.6	1.32	1.16	1.09	1.25	1.45	0.63	1.03	0.59	0.65	0.78
HV14G12	298155	"acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain"	0.84	0.62	0.55	0.65	0.67	0.65	0.32	0.54	0.57	0.41	0.35	0.46	0.96	0.62	0.86	1.02	0.77	0.39	0.32	0.21	0.31	0.55
HV14H2	51448	activating transcription factor 3	1.08	0.72	0.44	0.85	1.66	0.75	0.3	1.33	0.32	0.93	0.77	0.89	1.59	0.41	0.6	0.85	1.39	0.52	1.6	0.78	0.84	0.6
HV14H3	26617	activated leucocyte cell adhesion molecule	0.14	0.41	0.15	0.24	0.28	0.32	0.22	0.48	0.35	0.61	0.41	0.35	0.46	0.46	1.07	0.49	0.4	0.24	0.6	2.19	0.9	0.53
HV14H6	262932	"aconitase 2, mitochondrial"	0.55	0.53	0.51	0.67	1.11	1.1	0.5	0.75	1.1	0.59	0.96	0.77	0.88	0.97	1.16	0.94	1.16	0.61	0.58	0.65	0.62	0.72
HV14H11	222181	"ATPase, Ca++ transporting, cardiac muscle, slow twitch 2"	0.96	1.85	0.85	1.6	1.35	0.94	1.26	1.8	1.38	1.3	0.96	0.98	0.72	0.85	1.48	1.5	1.28	1	1.44	1.5	1.52	1.41
HV14H12	813712	"ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1"	0.58	0.99	0.69	0.73	0.67	0.68	1.6	0.61	0.75	1.52	0.53	0.45	0.47	0.72	0.91	0.7	1.04	0.73	0.34	0.2	0.34	0.5
HV15A6	701112	"xeroderma pigmentosum, complementation group C"	0.91	0.52	0.3	0.83	0.93	0.44	0.79	0.67	0.55	0.57	0.55	0.77	1.31	0.99	0.74	0.99	0.7	0.53	0.28	0.78	0.33	0.7
HV15A9	815816	"vitamin D (1,25- dihydroxyvitamin D3) receptor"	1.62	1.91	1.11	1.56	2.26	0.99	1.65	2.08	1.27	2.79	1.9	0.85	1.38	1.04	0.7	1.35	1.39	0.84	4.87	1.54	2.36	2.99
HV15A10	841203	vinculin	1.14	0.87	2.52	1.46	1.93	0.95	1.58	3.01	0.7	1.46	1.49	0.78	1.26	0.9	0.74	1.52	1.34	0.84	1.11	0.77	0.86	1.25
HV15A11	840511	vimentin	1.96	7.17	2.55	4.76	5.35	3.74	4.07	4.34	2.82	5.99	4.84	1.72	2.01	1.75	1.61	3.06	3.63	3.11	7.48	4.14	5.51	2.78
HV15B2	77133	SHC (Src homology 2 domain-containing) transforming protein 1	0.57	0.43	0.49	0.29	1	0.36	0.64	0.63	0.63	0.8	0.5	0.38	0.64	1.61	0.53	0.81	0.56	1.05	0.69	0.22	0.45	0.5
HV15B5	795847	jun activation domain binding protein	0.6	1.05	0.83	1.99	1.12	0.43	0.67	0.6	1.38	0.68	0.6	0.65	0.51	0.55	1.1	0.78	1.18	0.8	0.5	1.21	0.79	1.25
HV15B6	783729	v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	1.28	2.08	0.55	0.5	1.31	1.77	4.38	1.92	1.6	4.59	6.08	1.96	1.56	1.54	2.01	4.42	1.46	0.78	1.63	4.41	2.57	2.98
HV15B7	897642	v-abl Abelson murine leukemia viral oncogene homolog 1	1.05	2.45	1.21	2.09	1.51	0.95	1.75	2.23	1.99	1.3	1.14	0.86	0.94	1.28	1.26	1.28	1.14	1.22	1.6	1.05	1.41	1.08
HV15B9	714106	"plasminogen activator, urokinase"	1.3	1.77	1.18	2.09	1.86	1.09	3.4	7.38	3.67	3.46	2.16	1.21	1.54	2.4	2.1	1.42	1.74	2.24	3.74	0.62	3.13	3.16
HV15B10	760344	uridine monophosphate synthetase (orotate phosphoribosyl transferase and orotidine-5'-decarboxylase)	1.68	1.77	1.09	1.81	2.54	1.72	1.79	1.13	1.83	1.79	1.28	1.31	1.26	0.97	0.87	1.57	2	1.2	1.06	1.25	1.61	1.26
HV15B11	841292	ubiquitin-conjugating enzyme E2I (homologous to yeast UBC9)	1.08	1.9	0.9	1.61	1.86	1.19	1.44	1.21	1.47	1.66	1.32	1.01	0.86	1.24	1.15	1.09	1.3	1.73	1.48	0.74	1.02	1.39
HV15B12	826254	ubiquitin-conjugating enzyme E2H (homologous to yeast UBC8)	0.99	1.21	0.83	1.11	1.33	1.48	1.46	1.36	1.37	1.36	1.39	0.85	1.22	1	1.17	1.66	2.28	0.84	2.27	2.37	1.19	1.92
HV15C1	898138	ubiquitin-conjugating enzyme E2B (RAD6 homolog)	0.49	1.12	0.64	0.71	1.32	0.69	1.22	0.95	1.02	1.3	1.55	0.87	0.67	1.16	0.47	0.61	1.42	1.03	3.74	1.88	1.68	2.65
HV15C3	898262	ubiquitin-activating enzyme E1 (A1S9T and BN75 temperature sensitivity complementing)	0.98	1.42	0.92	0.83	1.32	0.92	1.14	1.03	1.05	1.02	1.22	0.6	0.7	1.11	0.85	1.02	1.84	0.72	0.77	0.73	0.92	0.72
HV15C4	840325	ESTs	2.4	3.05	1.65	1.42	2.73	1.79	1.7	2.28	2.4	1.98	1.28	1.45	1.21	2.09	1.62	1.16	1.68	1.79	3.46	1.98	1.19	1.71
HV15C5	782800	"ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1"	0.8	0.87	0.6	0.52	0.89	0.84	0.42	0.72	0.6	0.62	0.75	0.67	0.58	0.74	0.92	0.9	1.08	0.84	0.5	0.7	0.56	0.63
HV15C6	208161	"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide"	0.91	0.71	0.52	0.64	0.71	0.86	0.82	1.03	1.26	0.68	0.56	1.38	0.88	0.88	1.03	1.09	0.94	0.55	0.71	0.74	0.41	0.66
HV15C8	24415	tumor protein p53 (Li-Fraumeni syndrome)	2.34	4.44	1.12	1.46	2.22	1.36	2.32	2.61	1.49	1.6	2.72	0.93	1.48	0.85	0.96	2.84	4.84	1.74	1.4	0.84	1.07	1.13
HV15C10	841149	"transforming growth factor, beta receptor II (70-80kD)"	0.22	0.18	0.29	0.24	0.59	0.23	0.23	0.38	0.2	0.23	0.42	0.18	0.57	0.36	0.43	0.37	0.28	0.22	0.29	0.08	0.23	0.2
HV15C11	486208	"transforming growth factor, beta 3"	1.54	5.03	4.08	2.86	6.04	1.81	5.25	9.12	3.71	3.45	4.2	3.46	4.63	6.5	1.04	4.6	1.44	2.29	6.69	1.85	3.14	6.89
HV15C12	841703	"transferrin receptor (p90, CD71)"	0.96	0.68	0.56	0.83	0.78	1.72	0.47	0.65	0.58	0.7	0.46	0.47	0.79	0.69	0.97	0.69	2.04	0.41	1	0.66	0.45	0.48
HV15D2	843159	"transcription factor 12 (HTF4, helix-loop-helix transcription factors 4)"	0.96	2.08	1.52	2.43	1.94	1.6	1.55	3.11	1.11	1.56	1.12	0.94	1.64	1.25	1.05	1.41	1.71	1.15	1.13	0.95	1.17	1.16
HV15D3	526657	"transcription elongation factor B (SIII), polypeptide 3 (110kD, elongin A)"	0.54	0.43	0.73	0.69	1.84	0.43	1.19	2.59	0.56	0.73	1.11	0.39	1.91	1.45	1.32	0.49	0.41	0.92	1.12	0.24	0.44	1.25
HV15D4	825470	"ESTs, Highly similar to topoisomerase II alpha {C-terminal} [H.sapiens]"	2.64	4.28	1.74	1.91	1.35	1.39	3.24	1.87	2.06	2.56	0.64	1.53	1.58	2.13	1.23	2.46	1.91	1.44	1.29	0.7	1.06	1.51
HV15D5	842846	tissue inhibitor of metalloproteinase 2	0.43	1.92	2.6	2.01	1.79	0.99	2.02	3.5	1.46	1.96	3.13	0.82	0.86	0.54	0.87	1.15	1.81	0.79	1.61	1.79	1.98	0.98
HV15D6	795330	"thyroid hormone receptor, alpha (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog)"	0.99	2.35	0.78	0.96	2.2	0.75	2.58	1.47	1.74	1.65	0.78	1.21	1.36	1.53	1.17	2.08	1.88	1.1	1.26	0.95	0.91	1.01
HV15D10	712641	megakaryocyte stimulating factor	1.91	2.97	1.4	2.68	2.42	1.62	2.24	1.89	1.59	1.25	0.73	1.28	1.38	2.67	0.86	2.32	1.89	1.6	2.03	1.56	1.27	2.08
HV15D12	789376	thioredoxin reductase 1	0.6	0.76	0.57	0.5	0.7	0.46	1.02	0.38	0.7	1.15	0.49	0.97	0.4	0.56	0.6	1.1	0.7	0.59	0.39	0.64	0.93	0.42
HV15E4	840567	transmembrane 4 superfamily member 1	5.56	1.05	1.12	2.48	2.72	3.7	0.68	2.16	0.14	0.25	0.41	0.46	0.98	0.69	1.33	1.06	4.05	2.71	0.84	0.34	1.97	1.17
HV15E5	612274	"tubulin, alpha 1 (testis specific)"	2.07	1.01	1.45	1.49	0.98	0.8	1.2	1.02	0.6	1.44	0.81	0.75	0.62	0.7	0.98	0.97	0.61	0.84	0.49	0.63	0.91	0.65
HV15E7	784841	heterogeneous nuclear protein similar to rat helix destabilizing protein	2.51	1.82	1.23	1.33	2.73	0.89	1.39	1.23	1.2	1.22	1.21	1.06	1.3	0.93	0.84	1.62	2.59	1.71	0.93	0.62	0.88	1.27
HV15E9	79898	"transducin-like enhancer of split 1, homolog of Drosophila E(sp1)"	2.61	2.69	1.8	2.17	2.23	1.3	1.5	1.5	1.02	1.68	1.41	0.48	0.88	1.94	1.48	1.76	1.78	1.17	0.81	0.4	1.34	0.81
HV15E12	840788	"Thymosin, beta 10"	1.59	1.54	0.76	0.83	1.36	1.04	1.32	0.82	0.78	1.02	0.75	0.96	0.53	0.83	1.01	1.82	0.85	1.55	1.29	0.48	1.41	1.01
HV15F3	787857	syntaxin 5A	1.35	1.96	2.29	2.98	1.79	1.89	1.56	1.84	1.29	1.85	1.87	1.63	0.9	1.11	1.56	1.58	1.4	1.71	1.96	2.6	2.56	2.27
HV15F9	950489	"superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))"	1	0.93	0.75	1.27	0.82	0.7	0.99	1.2	1.69	1.19	0.98	1.49	0.82	1.3	0.56	1.33	1.54	1.09	1.12	0.73	1.04	1.24
HV15F10	797016	"succinate dehydrogenase complex, subunit B, iron sulfur (Ip)"	0.92	0.49	0.49	0.72	0.73	1.11	0.77	0.59	0.68	0.62	0.75	0.75	0.79	0.76	0.97	0.95	1.45	0.65	0.33	0.58	0.74	0.6
HV15F11	80915	"succinate dehydrogenase complex, subunit A, flavoprotein (Fp)"	1.22	1.52	1.04	1.65	1.04	1.18	0.77	0.63	0.69	1.15	2.43	0.67	0.85	0.85	1.35	1.13	1.12	1.08	0.77	0.8	1.15	0.83
HV15G1	897822	spleen tyrosine kinase	4.43	7.8	5.68	6.62	6.75	4.21	4.51	21.37	5.71	5.42	3.51	2.96	2.26	3.18	1.07	3.82	4.23	1.83	2.32	0.93	1.49	1.56
HV15G3	76362	"spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)"	1.74	1.61	0.77	1.4	1.41	1.47	1.19	1.43	1.97	1.26	1.52	0.89	0.92	1.35	0.9	1.01	0.79	0.93	1.6	0.65	1.2	1.48
HV15G4	785574	sorting nexin 1	0.89	1.04	0.87	3.18	1.39	1.44	0.98	1.7	1.53	1.01	1.28	1.18	1.47	1.98	0.83	1.14	0.91	1.13	1.96	0.77	1.51	1.3
HV15G5	950482	small nuclear ribonucleoprotein polypeptides B and B1	0.81	1.23	0.85	1.02	0.92	0.94	1.03	0.82	1	1.23	2.07	0.66	0.67	1.1	1.12	2.02	0.58	1.39	1.31	1.14	1.3	0.91
HV15G6	74119	SNRPN upstream reading frame	1.56	1.77	0.55	2.11	2.81	1.18	2.18	2.15	3.04	2.99	2.55	4.36	2.34	2.54	0.98	4.09	1.78	9.28	3.56	2.59	2.46	2.01
HV15G7	827156	small nuclear ribonucleoprotein polypeptide B''	0.85	1.88	1.23	0.94	1.58	0.87	1.38	1.26	1.41	1.23	0.93	0.85	0.64	1.09	1.79	2.03	1.4	0.99	1.24	0.65	0.82	0.95
HV15G8	125183	single-stranded DNA-binding protein	1.04	1.5	0.98	1.23	1.4	1.05	1.12	0.97	1.34	1.15	0.75	0.61	0.95	1.44	0.88	2.09	1.32	1.44	0.78	0.36	0.58	0.65
HV15G9	785616	"signal sequence receptor, alpha (translocon-associated protein alpha)"	1.21	1.47	1.54	2.09	1.38	1.82	1.04	1.37	0.63	1.82	1.8	1.34	1.12	1.24	2.02	2.28	1.6	1.08	0.96	1.35	1.79	1.25
HV15G10	898242	signal recognition particle receptor ('docking protein')	2.76	1.59	1.15	1.3	1.63	1.58	1.42	1.45	1.59	1.47	1.7	1.63	1.65	2.01	1.6	2.94	1.14	2.82	1.13	0.5	1.34	0.99
HV15G11	950430	signal recognition particle 54kD	1.78	1.61	1.49	1.4	1.39	1.13	1.25	1.97	1.36	1.47	1.06	1.57	0.95	1.26	1.41	1.96	0.97	0.81	0.98	0.81	1.09	1.01
HV15H1	897906	"sialyltransferase 1 (beta-galactoside alpha-2,6-sialytransferase)"	0.6	2.22	0.79	2.3	2.03	3.16	1.21	1.17	0.59	1.92	3	1.03	1.11	0.39	1.27	1.64	1.91	0.7	2.12	0.85	1.92	1.75
HV15H2	840636	serum response factor (c-fos serum response element-binding transcription factor)	1.22	2.87	2.2	1.17	1.57	1.1	1.45	1.4	1.51	1.17	1	0.87	2.22	1.84	0.77	1.85	1.58	3.76	1.43	0.57	1.89	1.17
HV15H4	418126	U2(RNU2) small nuclear RNA auxillary factor 1 (non-standard symbol)	2.45	4.32	1.82	2.1	2.6	0.91	1.57	1.52	1.93	1.65	0.99	1.9	1.85	2.38	1.32	1.85	2.25	2.04	5.04	1.5	3.11	2.93
HV15H5	773618	SON DNA binding protein	0.93	1.38	0.94	1.19	1.35	1.06	1.28	1.4	1.21	1.1	1.21	1.09	0.94	0.93	0.65	0.96	1.17	0.66	0.8	0.85	0.83	1
HV15H8	840691	"signal transducer and activator of transcription 1, 91kD"	2.98	12.47	1.88	5.49	3.51	5.95	4.72	5.21	3.39	6.68	4.25	6.21	2.05	2.77	2.39	2.75	3.14	3.57	4.96	4.08	4.68	4.64
HV15H9	950607	SET translocation (myeloid leukemia-associated)	0.88	0.92	0.55	1	0.76	0.54	0.58	0.74	0.81	0.57	0.75	0.5	0.73	0.74	0.83	0.85	0.67	0.64	0.52	0.72	0.5	0.96
HV15H10	491066	"activin A receptor, type I"	1.1	2.78	1.56	1.24	2.46	1.01	2.1	2.91	2.26	1.45	0.73	2.31	1.79	2.24	1.74	1.33	1.57	1.68	1.25	0.42	1.53	1.25
HV15H11	713382	PCTAIRE protein kinase 1	1.67	1.88	1.37	1	1.66	1.63	1.09	1.68	1.37	1.14	1.72	0.81	0.96	1.06	0.77	1.24	2.83	0.93	1.03	1.4	1.34	1.18
HV15H12	795241	"protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha)"	1.44	2.51	2.27	1.71	1.23	0.69	2.14	1.57	2	1.13	0.52	1.64	1.96	2.82	1.31	1.31	1.62	2.29	2.05	2.19	1.35	2.5
HV16A1	840364	S-adenosylhomocysteine hydrolase	1.13	0.65	0.63	0.62	0.79	0.44	0.49	0.48	0.66	0.6	0.62	0.64	0.74	0.57	0.64	1.02	0.78	1	0.71	0.65	0.73	0.86
HV16A7	788511	"ribosomal protein S6 kinase, 90kD, polypeptide 1"	1.17	0.75	0.46	0.44	0.52	0.65	0.5	0.4	0.73	0.59	0.69	0.41	0.84	1.08	0.71	0.59	0.38	0.44	0.79	0.3	0.84	0.81
HV16A8	66686	ribosomal protein L10	0.64	1.27	0.82	0.55	0.82	0.73	0.77	0.59	0.35	0.98	0.85	0.77	1.33	0.68	1	0.88	0.63	1.13	0.93	1.06	0.76	1.97
HV16A9	208001	"CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344)"	0.87	0.49	0.72	0.26	0.75	0.16	0.33	0.4	0.19	0.31	0.35	0.43	0.65	0.54	0.24	0.41	0.67	0.57	0.4	0.19	0.27	0.31
HV16A10	32684	ribosomal protein L32	1.55	1.8	1.26	0.87	1.86	0.66	1.32	0.55	0.78	1.44	1.01	1.39	1.65	1.5	0.59	1.27	0.97	1.59	1.41	0.62	0.76	1.99
HV16A11	897835	oxidase (cytochrome c) assembly 1-like	1.04	0.86	0.64	0.69	0.61	0.62	0.59	0.61	0.35	0.86	0.58	0.6	0.78	0.71	1.24	0.69	0.22	0.57	0.62	0.6	1.07	0.72
HV16A12	210887	suppression of tumorigenicity 13 (colon carcinoma) (Hsp70-interacting protein)	0.9	0.86	0.95	0.91	1.21	0.96	0.75	0.75	0.73	0.75	0.9	1.08	1.74	1.04	0.56	1.06	1.22	0.88	0.39	0.31	0.45	0.81
HV16B1	166195	ribonuclease/angiogenin inhibitor	0.77	0.46	0.77	0.86	0.58	0.43	0.25	0.93	2.82	0.6	1.89	0.54	0.81	0.73	0.58	0.35	0.77	0.71	0.81	2.13	1.15	0.96
HV16B5	784593	ESTs	0.57	0.46	0.5	0.39	0.42	0.28	0.21	0.37	0.43	0.2	0.26	0.15	0.54	0.17	0.55	0.35	0.32	0.54	0.28	0.4	0.27	0.12
HV16B6	741379	small membrane protein 1	1.65	0.88	1.16	1.09	1.02	1.29	1.02	1.23	0.75	1.23	1.21	1.26	1.26	1.25	1.19	1.17	1.1	0.73	1.74	0.94	1.32	0.92
HV16B7	45525	ESTs	1.3	1.95	1.48	1.44	1.42	1.34	1.42	1.61	1.14	1.29	1.38	1.25	1.26	2.02	1.36	1.46	1.6	1.81	1.67	1.99	2.2	1.5
HV16B8	256260	replication factor C (activator 1) 3 (38kD)	2.93	3.21	0.64	1.23	2.87	1.73	1.37	0.88	1.62	1.89	1.16	1.49	0.78	2.33	1.28	1.92	1.94	2.13	4.18	2.09	1.73	2.11
HV16B9	841384	"discoidin domain receptor family, member 1"	2.73	1.37	1.69	1.51	0.77	0.98	0.79	1.54	0.97	0.8	1.28	1.32	1.09	1.66	1.38	0.93	1.59	0.84	1.23	1.16	1.4	1.57
HV16B11	827132	"ESTs, Highly similar to HSPC022 [H.sapiens]"	0.54	1.44	0.86	1.29	0.8	1.5	0.78	0.72	0.61	0.9	1.31	0.81	0.77	1.06	0.79	0.44	0.59	0.48	2.34	0.2	1.45	0.72
HV16B12	740554	radixin	2.02	1.68	0.81	1.21	1.91	1.64	0.57	0.72	0.79	1.12	1.1	0.88	1.28	0.6	0.8	1.65	3.44	1.21	4.39	1.79	1.38	2.72
HV16C1	509484	RD RNA-binding protein	1.6	1.23	1.88	1.32	0.96	1.36	1.1	1.5	1.96	1.31	1.66	1.53	1.23	1.94	1.22	1.19	1.45	2.35	1.3	1.86	1.9	1.51
HV16C2	108815	RYK receptor-like tyrosine kinase	1.58	0.67	0.58	0.73	1.1	0.76	0.57	0.59	0.42	0.86	0.8	0.63	1.11	0.92	1.24	0.76	1.02	0.68	0.82	0.44	0.49	0.86
HV16C3	773319	"ribosomal protein S6 kinase, 70kD, polypeptide 1"	2.38	1.5	1.68	1.76	1.14	1.03	2.9	1.2	3.4	2.61	1.06	1.49	1.49	1.98	1.34	0.93	0.83	2.55	2.11	0.84	1.36	1.38
HV16C4	773599	retinoblastoma-binding protein 4	3.22	1.65	1.56	1.54	1.15	1.23	1.19	1.53	1.28	0.86	1.43	1.82	1.8	2.35	1.74	1.74	2.32	0.92	1.2	1.01	1.14	1.76
HV16C5	795888	retinoblastoma-binding protein 2	1.38	3.09	2.56	2.12	1.92	1.53	2.16	1.74	2.42	1.58	1.53	1.71	1.58	1.74	1.3	1.18	1.49	4.24	1.68	0.59	0.66	1.48
HV16C6	525566	ESTs	2.3	1.49	1.1	1.31	1.39	1.63	1.23	1.31	1.19	1.16	1.89	1.61	1.52	2.16	1.03	1.43	1.63	1.87	1.58	1.84	1.66	2
HV16C7	898148	IQ motif containing GTPase activating protein 1	1.12	1.19	1.12	0.93	1.49	1.11	1.1	1.19	1.04	0.76	0.88	0.8	1.23	1.81	1.03	0.51	0.84	1.3	0.83	0.33	0.78	0.92
HV16C10	79520	"RAB2, member RAS oncogene family"	1.33	1.01	0.99	0.82	1.3	1.07	0.83	1.23	1.46	0.84	0.96	1.19	1.54	1.09	1.04	1.49	1.38	1.05	0.49	0.67	0.62	1.21
HV16C12	826077	pyruvate dehydrogenase (lipoamide) beta	1.09	1.02	0.92	1.01	1.38	1.1	1.45	1.39	1.46	1.03	0.94	1.41	1.41	2.22	0.96	1.45	1.53	0.97	0.91	0.78	0.53	2.18
HV16D1	80374	pyruvate dehydrogenase (lipoamide) alpha 1	1.15	0.76	0.96	0.73	0.52	0.42	0.54	0.61	0.95	0.3	0.49	0.72	0.68	0.98	0.8	0.8	0.9	1.23	1.07	0.67	0.64	0.91
HV16D2	588500	pyrroline-5-carboxylate synthetase (glutamate gamma-semialdehyde synthetase)	1.99	2.89	0.97	1.53	2.14	1.24	2.3	2.15	1.37	1.91	1.74	1.37	1.21	2.21	1.62	1.7	2.59	2.29	1.81	1.09	1.44	1.6
HV16D3	773215	runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene)	1.04	0.91	1.08	1.02	1.31	0.61	1.25	2.16	3.09	0.67	0.88	1.04	1.12	2.06	1.24	0.6	0.4	1.31	1.2	0.7	1.11	1.73
HV16D4	207029	"prothymosin, alpha (gene sequence 28)"	2.65	3.31	1.66	2.42	1.9	2.12	1.46	1.49	1.17	2.52	1.82	1.66	1.86	2.91	2.33	1.19	1.94	3.26	2.24	0.83	1.35	2.14
HV16D9	897788	"protein tyrosine phosphatase, receptor type, F"	2.24	3.24	0.51	1.4	1.71	1.59	1.4	1.7	1.96	1.08	1.12	1.46	1.37	1.6	1.59	1.63	1.41	2.74	3.74	2.18	2.05	3.5
HV16D11	774502	"protein tyrosine phosphatase, non-receptor type 12"	1.4	2.25	1.12	1.34	1.6	1.4	0.81	1.8	2.09	0.95	0.57	0.83	1.08	1.53	1.39	0.85	0.64	1.35	1.45	0.71	1.16	1.09
HV16E3	950445	"protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform"	0.8	0.68	0.63	0.53	0.51	0.26	0.62	0.57	0.66	0.62	0.55	0.87	0.76	0.88	0.64	0.52	0.55	0.63	0.42	0.55	0.62	0.78
HV16E4	756666	"protein phosphatase 1, catalytic subunit, alpha isoform"	2.3	1.48	0.72	1.17	1.14	1.21	1.61	1.05	1.46	1.77	1.21	0.98	1.03	1.46	1.67	2.18	0.75	1.81	1.55	1.38	1.41	1.75
HV16E7	897669	protein kinase C substrate 80K-H	0.74	1.06	1.15	0.98	1.17	0.96	0.71	0.86	0.86	0.79	0.99	0.83	0.92	0.88	0.8	1.06	0.62	1.11	0.97	0.99	1.12	1
HV16E8	155434	"proteasome (prosome, macropain) subunit, alpha type, 2"	1.6	0.94	0.93	1.08	1.14	1.21	1.05	0.75	1.05	1.14	0.83	1.9	0.85	1.08	1.41	2.08	1.12	1.05	0.82	1.82	1.32	2.28
HV16E9	843134	prostatic binding protein	1.63	1.77	0.73	1.84	0.85	1.09	0.88	1.21	1.22	0.86	1.22	1.07	0.96	1.48	1.16	1.24	0.89	1.97	1.65	1.29	0.92	1.69
HV16E10	824568	"kallikrein 3, (prostate specific antigen)"	0.95	1.93	0.66	1.44	1.39	1.22	1.03	0.95	0.93	0.93	1.22	0.44	1.22	1.32	0.58	1.72	1.32	1.52	1.01	2.8	1.36	2.31
HV16F3	789182	proliferating cell nuclear antigen	1.16	0.68	0.86	0.93	0.53	0.85	0.58	0.49	0.41	0.61	0.95	0.52	0.4	0.67	1.1	1.01	0.34	0.76	0.36	0.58	0.56	0.45
HV16F5	42313	ESTs	0.92	1.45	0.92	1.46	0.69	0.84	2.76	1.18	0.97	2.79	1.39	0.96	0.95	1.04	1.25	0.92	1.19	1.99	0.8	1.22	1.55	1.17
HV16F7	838802	"procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide 1"	0.5	0.9	2.96	1.19	0.92	0.39	1.4	1.17	0.68	1.82	0.86	0.52	0.99	1.08	0.57	0.79	0.58	0.94	0.62	1.29	0.61	1.07
HV16F8	789253	presenilin 2 (Alzheimer disease 4)	1.59	1.65	0.84	1.51	2.02	1.59	1.38	1.58	1.2	1.77	1.56	2.75	1.9	2.25	0.67	1.93	1.68	1.21	2.18	2.57	1.89	2.22
HV16F9	740130	polymerase (RNA) II (DNA directed) polypeptide A (220kD)	2.03	2.43	1.75	1.77	1.85	1.21	1.83	1.94	2.66	1.51	1.55	1.95	0.83	2.91	1.65	1.54	1.35	4.78	2.74	2.16	2.85	1.7
HV16F10	785605	KIAA0220 protein	1.17	2.27	1.02	1.58	1.22	1.11	1.42	0.69	1.26	0.94	1.07	2.03	2.64	2.54	1.17	1.3	1.01	1.33	2.37	1.58	1.77	1.95
HV16G1	67654	platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog)	1.41	1.15	1.66	1.26	1.36	1.42	2.27	1.62	4.67	1.71	1.68	2.3	1.63	2.51	1.46	0.94	0.84	3.3	2.81	2.47	1.68	2.27
HV16G3	70692	"plasminogen activator inhibitor, type II (arginine-serpin)"	0.25	0.87	0.43	0.23	0.41	0.11	0.22	0.26	0.71	0.26	0.19	0.18	0.45	0.4	0.9	0.2	0.1	0.32	0.77	0.2	0.37	0.42
HV16G4	898123	"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"	2.18	1.41	0.93	1.45	1.16	1.43	0.84	0.71	0.68	0.69	1.19	0.78	1.19	0.88	0.8	1.37	1.76	1.06	0.84	0.81	0.9	0.79
HV16G5	503097	phosphoribosyl pyrophosphate synthetase 2	2.7	2.3	1.5	1.25	1.58	1.14	0.89	1.63	1.61	1.14	0.92	1.02	1.58	2.25	1.22	1.27	1.41	7.03	0.93	0.72	0.61	0.78
HV16G8	897673	phosphogluconate dehydrogenase	1.42	0.78	0.62	0.98	1.05	2.11	0.87	0.49	0.44	1.1	1.17	1.32	0.72	0.73	1.61	1.66	1.14	0.99	0.52	1.06	1.96	1.15
HV16G10	950682	"phosphofructokinase, platelet"	0.99	1.23	0.53	0.97	0.57	1.65	0.46	0.25	0.36	0.43	0.33	0.21	0.51	0.52	0.82	0.95	0.64	1.49	0.22	0.27	0.35	0.17
HV16G12	788136	"phosphodiesterase 4B, cAMP-specific (dunce (Drosophila)-homolog phosphodiesterase E4)"	0.88	4.21	2.06	3.7	4.21	1.79	1.81	3.41	1.08	1.83	1.81	1.23	2.83	2.2	1.83	3.45	5.92	1.99	1.94	0.45	1.1	1.5
HV16H1	842784	"phosphate carrier, mitochondrial"	0.43	0.54	0.71	0.71	0.49	0.51	0.6	0.59	0.33	0.51	0.44	0.53	0.61	0.48	0.68	0.56	0.71	0.79	0.42	0.49	0.74	0.45
HV16H2	788518	"peroxisomal membrane protein 3 (35kD, Zellweger syndrome)"	0.82	1.27	0.61	1.14	0.57	0.55	0.88	0.99	0.58	1.1	0.74	0.79	1.29	0.53	0.96	0.75	1.11	0.48	0.9	1.21	0.53	0.94
HV16H5	898198	sialomucin CD164	0.69	0.94	0.77	1.48	1.35	2.49	0.87	1.53	0.52	1.14	1.19	1.48	1.26	0.78	1.7	1.52	0.84	0.34	0.81	0.57	1.55	1.44
HV16H7	773254	splicing factor proline/glutamine rich (polypyrimidine tract-binding protein-associated)	1.21	1.09	1.37	1.46	1.14	1.23	0.82	0.99	0.63	0.71	1.01	1.04	1.14	1.04	1.16	1.01	1.06	0.91	2.56	2.89	1.94	3.86
HV16H10	897952	"proteasome (prosome, macropain) subunit, alpha type, 5"	1.82	1.67	1.32	0.97	1.02	1.52	1.34	0.98	1.25	1.95	1.07	0.96	0.97	1.36	1.21	1.36	2.17	1.4	0.61	0.48	1.06	1.07
HV17A1	79629	"chemokine (C-X-C motif), receptor 4 (fusin)"	2.77	4.19	3.99	2.55	5.62	4.2	2.82	4.1	3.27	2.73	5.46	5.52	3.16	4.18	2.08	2.61	4.85	8.4	16.89	1.49	3.52	7.95
HV17A3	897646	"splicing factor, arginine/serine-rich 4"	1.83	1.79	2.08	1.73	1.6	1.28	1.22	1.33	1.23	1.26	1.32	1.2	1.25	1.41	1.2	0.98	0.94	1.46	1.16	0.55	0.85	1.21
HV17A4	950092	Homo sapiens mRNA; cDNA DKFZp566L0424 (from clone DKFZp566L0424)	1.99	2.56	1.66	1.72	2.02	1.31	1.69	1.12	1.17	1.41	1.02	1.01	1.67	2.8	1.51	1.98	1.49	2.48	1.37	0.63	0.88	1.31
HV17A5	80399	"splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor)"	1.4	1.82	1.42	1.89	1.33	1.02	2.67	1.03	1.5	2.33	1.14	0.96	1.14	1.91	1.36	1.41	0.92	2.23	1.71	1.03	1.57	2.18
HV17A6	811108	thyroid hormone receptor interactor 6	0.51	1.36	0.87	0.88	0.75	0.61	0.74	0.63	0.34	0.62	0.52	0.38	0.74	0.55	0.38	0.75	0.58	1.02	0.8	0.39	0.39	0.52
HV17A7	80549	pre-B-cell leukemia transcription factor 2	1.26	1.6	1.13	1.21	1.37	0.99	1.23	1.21	1.21	1.28	1.32	0.89	1.03	1.14	0.48	1.05	0.86	1.46	2.88	1.7	2.35	2.98
HV17A8	192694	"POU domain, class 2, transcription factor 1"	1.72	2.88	1.58	1.72	2.33	1.4	2.76	2.02	2.5	1.78	1.04	1.5	1.38	2.27	1.29	2.13	1.23	1.56	2.18	0.96	1.53	2.11
HV17A10	82991	phosphodiesterase I/nucleotide pyrophosphatase 1 (homologous to mouse Ly-41 antigen)	1.91	8.49	5.23	5.38	5.35	1.56	21.08	20.96	36.48	3.4	0.61	7.58	2.77	3.79	2.61	1.53	1.53	3.29	6.95	1.71	3.57	5.28
HV17A12	725677	ESTs	0.66	3.55	1.31	1.98	2.71	0.96	2.6	1.7	1.87	1.76	1.01	0.35	0.99	0.78	0.4	1.9	2.06	1.22	1.31	0.89	1.06	1.19
HV17B1	796646	ornithine decarboxylase 1	0.41	3.11	1.73	1.37	1.45	1.1	1.19	0.57	0.45	2.46	0.99	0.86	0.83	0.53	1.1	0.72	1.33	2.57	0.91	0.35	0.83	0.63
HV17B2	783696	ornithine aminotransferase (gyrate atrophy)	0.9	1.86	0.93	1.81	2.05	1.93	1.48	1.1	1.06	1.16	1.65	0.83	1.75	1.03	0.75	1.61	2.49	1.79	0.67	1.03	0.61	1.18
HV17B3	81518	apelin; peptide ligand for APJ receptor	1.38	1.92	1.8	1.96	1.77	0.83	1.52	1.88	2.16	1.72	1.15	1.48	0.98	1.52	1.13	0.86	0.91	1.18	2.6	2.45	1.65	2.76
HV17B4	40042	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1"	1.42	1.63	1.16	1.1	1.65	1.2	1.5	1.57	1.56	1.8	1.02	1.56	1.36	1.33	1.85	1.84	1.89	1.26	1.68	0.96	1.18	1.61
HV17B5	611956	karyopherin alpha 1 (importin alpha 5)	0.66	1.5	1.37	1.94	1.36	0.81	1.31	1.23	1.11	1.14	0.93	0.53	0.94	0.49	0.75	0.87	1.15	1.13	0.95	0.64	0.64	0.98
HV17B6	789357	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)	1.54	1.8	1.07	1.36	1.96	15.2	1.39	1.74	1.09	1.35	1.6	1.02	1.6	2.07	0.93	0.92	2.08	0.94	0.96	0.64	0.77	0.99
HV17B8	784278	nuclear antigen Sp100	1.83	4.14	0.91	1.59	3.27	1.93	2.68	2.41	2.59	2.22	1.35	2.02	1.69	2.26	1.07	3.18	2.24	1.7	2.11	0.53	1.03	1.7
HV17B9	712683	NCK adaptor protein 1	1.68	1.48	1.68	1.72	1.41	0.91	0.92	1.18	0.88	1.43	1.29	0.88	0.56	0.48	0.89	0.91	1.5	1.86	1.89	1.16	1.29	1.51
HV17B11	33045	ESTs	3.18	2.37	3.27	2.46	2.59	1.3	6.94	7.79	11.85	4.61	2.24	1.01	0.86	4.39	1.07	1.35	2.55	1.67	2.17	0.82	0.7	2.43
HV17B12	784876	"internexin neuronal intermediate filament protein, alpha"	1.31	1.11	1.62	1.32	1.69	1.15	1.15	0.89	1.47	1.1	1.03	1	1.03	1.1	1.39	1.7	1.17	1.56	1.95	1.08	1.79	1.68
HV17C1	839623	neuroblastoma RAS viral (v-ras) oncogene homolog	0.9	1.66	1.51	1.23	1.18	1.1	0.85	1.09	0.83	0.67	0.99	0.6	0.7	0.74	1.02	1.31	1.19	1.05	1.21	0.56	0.61	1.06
HV17C5	774751	"neural precursor cell expressed, developmentally down-regulated 4"	0.55	1.79	0.9	0.65	1.42	0.52	1	1.25	0.89	1.12	0.41	0.45	0.58	0.88	0.5	0.63	0.55	0.34	2.07	0.72	0.53	0.8
HV17C6	810859	natural killer cell transcript 4	3.97	21.34	1.85	5.91	7.57	6.06	6.3	7.4	3.64	9.39	3.1	6.76	4.69	4.34	2.06	4.52	8.15	9.62	19.67	6.57	5.68	10.41
HV17C7	814615	"methylene tetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase"	1.92	2.66	0.77	2.32	1.61	1.59	1.21	1.05	1.21	1.74	0.92	1.18	0.69	1.23	2.18	2.03	1.36	1.87	1.15	0.67	1.64	1.3
HV17C8	701481	"myxovirus (influenza) resistance 2, homolog of murine"	4.6	12.89	7.16	7.44	6.74	3.87	7.19	10.56	6.25	5.23	3.24	5.93	2.72	2.87	1.46	4.64	5.41	4.89	15.35	8.05	8.86	10.69
HV17C9	815542	"myxovirus (influenza) resistance 1, homolog of murine (interferon-inducible protein p78)"	5.24	26.9	8.86	8.66	10.25	8.43	9.21	12.27	3.11	14.26	7.2	6.85	4.18	12.68	2.44	7.6	7.71	13.19	13.24	10.63	6.31	15.18
HV17D2	68103	"myosin, light polypeptide 1, alkali; skeletal, fast"	1.16	1.06	2.05	1.07	1.28	0.86	1.46	1.99	1.75	1.37	1.16	1.7	0.98	1.6	0.96	1.54	1.16	1.11	1.51	0.91	3.55	0.98
HV17D5	740457	murine leukemia viral (bmi-1) oncogene homolog	0.75	2.09	2.5	1.75	1.49	1.78	1.09	1.95	0.65	2.26	2	1.27	1.22	1.51	0.85	0.94	1.55	0.33	2.65	4.47	1.44	2.56
HV17D7	840687	"mucin 1, transmembrane"	0.82	0.3	0.15	0.19	0.3	0.36	0.63	0.34	0.35	0.48	0.24	0.42	0.66	3.11	0.73	0.33	0.09	0.36	0.16	0.52	0.68	1.53
HV17D9	796994	"membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen)"	0.59	1.78	0.46	1.36	1.84	1.12	0.99	2.2	1.24	1.03	1.1	1.49	1.2	2.08	1.55	1.45	1.84	0.56	0.79	1.97	1.19	1.75
HV17D10	46916	matrix metalloproteinase 16 (membrane-inserted)	1.97	10.43	13.4	14.43	3.26	1.58	5.64	0.63	31.94	2.75	0.5	3.32	2.38	5.12	1.08	1.31	2.06	7.79	15.16	1.3	2.74	4.14
HV17D12	824704	mannose phosphate isomerase	0.98	1.14	1.55	1.25	1.35	0.79	0.95	0.68	0.96	0.65	1.06	0.82	1.02	1.22	1.63	1.58	0.73	1.35	1.12	0.87	1.55	0.86
HV17E4	842989	"myosin, light polypeptide 6, alkali, smooth muscle and non-muscle"	0.77	0.75	1.84	0.74	1.11	0.77	1.7	1.48	1.06	1.62	1.24	1.32	0.86	1.28	0.73	1.33	0.6	1.12	0.97	1.13	1.44	1.28
HV17E5	713469	"MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A)"	1.18	1.48	2.27	1.84	2.27	0.76	0.9	1.34	1.05	1.6	0.86	1.15	1.14	0.69	0.93	0.93	1.01	0.79	2.42	0.86	1.5	2.37
HV17E7	949914	glutamyl-prolyl-tRNA synthetase	1.41	2.09	1.21	1.82	2.03	1.13	1.31	1.32	1.76	1.27	1.11	0.82	0.95	2.18	1.14	1.14	2.36	2.6	1.23	0.68	0.77	1.61
HV17E12	786067	cell division cycle 25B	1.32	0.76	1.74	1.22	0.89	0.75	0.99	0.57	0.61	0.63	1	0.51	0.83	0.9	1.65	1.78	0.45	1.39	0.57	0.47	1.18	0.51
HV17F2	49710	lysosomal-associated membrane protein 1	2.67	2.59	0.67	1.93	3.48	2.55	2.66	2.8	2.11	2	1.56	3.9	3.44	3.69	2.8	4.37	2.41	2.77	3.75	3	1.94	1.95
HV17F3	842785	low density lipoprotein-related protein-associated protein 1 (alpha-2-macroglobulin receptor-associated protein 1)	0.7	0.86	0.92	0.99	0.95	0.67	1.05	0.99	1.1	1.36	1.29	0.87	0.57	0.81	0.77	0.76	0.91	0.6	0.91	1	1.06	1.29
HV17F4	82734	"fatty-acid-Coenzyme A ligase, long-chain 1"	0.99	0.33	0.24	0.33	0.44	0.42	0.33	0.27	0.35	0.47	0.44	0.31	0.69	0.38	0.77	0.8	0.45	0.36	0.38	0.23	0.34	0.32
HV17F5	725266	"ligase I, DNA, ATP-dependent"	1.73	1.96	1.5	1.12	1.63	1.11	1.46	1.29	1.43	1.14	1.69	1.89	1.11	2.3	1.48	0.96	1.55	2.37	2.39	1.16	1.08	1.46
HV17F6	814095	leukotriene A4 hydrolase	0.59	1.07	0.64	0.81	0.97	0.94	0.84	0.57	0.82	1.01	0.79	0.85	0.9	0.85	0.56	1.21	1.13	0.94	0.95	0.39	0.5	1.12
HV17F7	194182	Homo sapiens mRNA for leptin receptor gene-related protein	1.09	0.87	0.57	0.54	0.85	0.82	0.75	1.26	0.93	1	0.9	0.6	0.69	0.66	0.92	0.69	0.85	0.77	1.37	0.61	1.03	1.42
HV17F8	767202	latent transforming growth factor beta binding protein 2	2.12	1.44	1.55	2.94	5.19	2.3	5	5.11	5.35	5.17	2.34	2.53	3.36	4.12	2.09	1.15	2.09	2.11	3.82	0.97	2.68	5.23
HV17F9	839594	ribosomal protein L38	2.24	2.68	1.83	1.51	2.61	2.43	1.64	2.04	1.9	1.68	1.76	1.35	0.73	0.91	1.12	1.43	1.88	2.22	2.28	1	1.6	1.33
HV17F10	815501	lamin B2	1.98	3.46	1.26	2.47	3.15	2.83	3.33	2.94	2.21	3.69	2.19	1.04	0.8	1.66	1.23	2.31	2.4	1.5	1.51	0.72	1.08	0.77
HV17F11	774471	"laminin, beta 1"	0.58	2.81	4.28	2.59	1.96	0.9	1.92	2.66	2.29	1.56	0.94	0.9	1.11	1.69	0.98	1.27	1.49	1.78	1.15	0.34	1.75	0.84
HV17G4	898237	HLA-B associated transcript-3	1.29	2.39	1.24	1.1	1.96	1.28	1.85	1.22	1.96	1.77	1.37	1.23	1.26	2.29	1.49	2.37	1.89	1.87	1.6	1.18	1.24	1.35
HV17G6	897781	keratin 8	0.36	0.38	0.27	0.16	0.3	0.69	1	1.09	0.64	2.02	1.18	0.79	0.98	0.82	0.98	0.65	0.58	0.35	1.97	3.02	0.72	1.42
HV17G7	592540	"keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types)"	0.42	0.14	0.21	0.18	0.2	0.12	0.17	0.18	0.12	0.09	0.12	0.2	0.38	0.34	0.28	0.17	0.07	0.27	0.09	0.09	0.12	0.12
HV17G8	810131	keratin 19	3.7	1.33	0.27	1.44	1.65	4.29	2.33	2.1	2.38	3.75	2.02	2.77	4.52	6.52	2.58	2.06	3.07	5.13	2	1.55	0.76	2.06
HV17G9	842980	developmentally regulated GTP-binding protein 1	0.36	2.55	2.06	1.34	1.63	1.4	1.35	1.37	1.43	1.65	1.21	0.86	0.82	1.46	1.38	1.27	1.45	2.55	0.98	1.18	1.58	1.58
HV17G12	488413	kinesin family member 5B	2.49	4.87	1.85	2.74	3.69	2.46	1.62	1.83	2.59	1.74	0.82	3.04	1.7	1.1	1.74	2.16	1.94	1.96	1.9	1.26	0.9	0.9
HV17H1	126320	junction plakoglobin	0.82	0.81	0.21	0.4	0.52	0.94	0.49	1.6	1.02	0.24	0.65	0.82	0.47	0.69	0.45	0.83	0.66	0.78	0.62	1.42	0.93	0.96
HV17H2	767784	jun D proto-oncogene	1.46	4.15	1.4	1.51	2.17	1.52	1.71	2.24	2.89	1.73	1.73	2.25	1.72	2.59	1.6	2.04	1.62	1.77	2.6	1.59	1.56	2.33
HV17H3	726147	mitogen-activated protein kinase kinase 4	0.74	1.86	1.36	1.02	1.54	0.85	1.31	1.3	1.94	0.88	0.92	0.9	0.92	0.59	0.78	0.96	1.06	0.94	1.32	1.19	1.11	1.41
HV17H4	714453	interleukin 4 receptor	1.21	1.31	0.68	1	1.65	1.45	1.24	1.4	1.14	1.07	1.38	0.97	1.12	1.52	0.83	1.2	1.13	0.73	2.02	0.98	1.84	1.43
HV17H7	488019	"interleukin 15 receptor, alpha"	1.34	1.96	0.56	0.89	1.25	1.81	1.42	2.13	0.58	1.06	1.51	2.26	1.42	1.85	1.27	0.83	1.18	1.04	3.09	1.3	2.12	2.33
HV17H8	84295	interleukin 1 receptor antagonist	1.93	1.31	0.63	0.9	1.26	1.95	1.52	1.19	1.04	1.09	0.86	1.91	0.72	2.48	1.36	1.13	1.61	1.59	1.78	2.47	1.99	3.27
HV17H9	782513	"interferon, alpha-inducible protein (clone IFI-6-16)"	2.9	8.19	4.11	3.28	3.95	2.58	4.89	5.49	6.04	5.28	3.64	4.5	2.19	5.19	2.1	4.43	2.87	3.46	4.48	2.91	3.17	5.69
HV17H10	740476	interferon regulatory factor 1	1.74	2.84	1.51	2.29	1.86	2.21	3.17	2.48	2.28	2.57	1.26	5.28	1.92	1.45	1.66	1.89	2.04	1.01	12.86	5.79	6.77	8.96
HV17H11	773332	"integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)"	0.81	2.82	2.07	1.59	2.43	1.37	1.39	1.5	1.31	1.28	1.25	1.06	0.92	1.47	1.24	1.15	1.24	1.04	1.28	0.83	1.04	1.13
HV17H12	784319	ESTs	1.32	1.58	1.81	1.66	1.42	1.33	1.58	1.71	1.26	1.84	1.11	1.28	1.71	1.58	1.23	1.82	1.76	0.86	5.75	5.24	4.6	6.61
HV18A1	753620	insulin-like growth factor binding protein 6	0.52	0.33	0.44	0.29	0.38	0.16	0.25	0.22	0.3	0.26	0.31	0.33	0.72	0.4	0.59	0.27	0.12	0.46	0.53	0.17	0.35	0.25
HV18A2	79712	insulin-like growth factor 2 receptor	1.95	2.01	2.55	1.94	2.45	1.8	2.89	2.51	1.66	2.25	1.57	1.75	1.95	1.78	1.96	2.3	1.46	2.55	3.25	1.2	3.73	3.33
HV18A4	427812	insulin receptor	2.81	4.32	2.38	3.25	5.04	1.91	4.2	6.06	5.05	3.39	0.96	2.72	3.97	6.01	2.69	2.2	1.82	4.35	3.76	2.75	3.2	5.19
HV18A5	703964	inositol polyphosphate phosphatase-like 1	1.94	2.66	1.56	1.72	2.19	2.01	1.92	1.38	1.58	2.65	1.84	1.31	1.54	2.03	1.59	1.89	1.23	2.11	2.01	1.34	1.81	2.91
HV18A6	789369	"inhibitor of DNA binding 4, dominant negative helix-loop-helix protein"	2.64	1.67	2.69	4.72	3.19	2.31	2.81	2.9	1.29	3.24	1.69	2.09	2.6	1.58	1.25	2.22	1.99	2.34	1.44	0.8	1.43	1.7
HV18A7	214441	immunoglobulin mu	1.03	5.37	0.64	2.22	2.59	5.59	4.62	1.49	1.65	10.75	4.07	1.37	3.01	2.36	2.3	1.67	1.37	1.66	3.81	1.27	3.71	2.23
HV18A8	71434	proline-serine-threonine phosphatase interacting protein 1	1.27	5.01	1.83	1.61	2.56	2.61	4.63	5.17	3.48	5.15	1.74	3.76	1.93	3.85	1.61	2.06	1.35	1.06	1.89	1.3	1.78	2.88
HV18A9	843287	myeloid cell leukemia sequence 1 (BCL2-related)	1.03	0.6	1.39	1.33	0.91	1.17	0.51	0.94	0.04	0.88	1.08	0.45	1.68	0.58	0.95	0.57	0.74	0.38	0.91	1.86	2.13	1.48
HV18A10	80948	Human Ig J chain gene	1.56	7.39	1.53	5.76	6.06	9.17	6.42	5.69	5.79	3.04	5.43	6.46	6.3	8.59	3.44	4.22	1.95	1.63	10.29	1.28	4.4	9.24
HV18B2	75923	"Human zinc finger protein mRNA, complete cds"	1.96	7.12	7.43	5.67	7.45	1.97	5.19	8.96	20.66	5.29	1.93	4.28	5.45	4.92	1.46	2.67	1.69	2.04	2.79	0.55	1.09	3.03
HV18B3	843094	ubiquitin-like 1 (sentrin)	0.81	1.48	1.03	1.63	1.57	1.07	1.04	1.05	1.03	0.94	0.91	1.03	0.8	0.91	0.9	0.91	1.35	1.14	0.64	0.74	0.98	1.11
HV18B5	80708	ubiquitin fusion degradation 1-like	0.9	1.4	1.76	1.82	1.76	0.89	1.1	1.4	1.79	1.58	1.24	1.23	0.74	1.19	1.36	1.78	1.36	1.81	1.52	0.78	1.47	0.9
HV18B6	77391	TNF receptor-associated factor 2	2.15	5.85	1.07	2.01	3.26	3.33	3.12	1.83	3.05	2.88	1.93	2.14	2.45	4.07	0.43	2.76	2.62	1.4	7.2	3.38	2.18	4.19
HV18B7	897570	heat shock protein 75	0.71	1.26	0.55	1.25	1.09	0.74	0.69	0.67	0.7	0.91	0.94	0.79	1.15	0.92	0.83	0.61	1.39	1.52	0.86	1.05	0.78	0.97
HV18B8	825585	tubulin-specific chaperone e	1.02	3.1	1.01	2.41	2.02	2.09	2.57	1.63	2.29	1.98	1.31	1.72	1.33	2.26	1.24	2.06	2.25	2.39	2.48	1.19	1.33	2.46
HV18B9	86220	"tryptophan 2,3-dioxygenase"	1.68	0.56	2.11	1.64	0.55	0.85	0.55	5.16	4.78	1.39	2.38	2.37	1.07	1.97	1.51	1	0.91	1.59	2.46	1.33	1.71	1.95
HV18B11	897670	Human transposon-like element mRNA	1.14	1	1	1.09	0.96	0.81	0.76	1.32	1.01	0.99	0.94	0.87	0.92	0.93	1.16	0.64	0.63	0.95	0.57	0.77	0.72	0.69
HV18B12	814696	karyopherin (importin) beta 2	1.42	2.64	1.5	1.72	2.76	1.11	1.52	1.28	1.51	2.29	1.51	1.03	1.26	1.46	1.11	1.48	2.27	1.29	2.01	0.76	1.06	1.29
HV18C2	897982	"eukaryotic translation initiation factor 3, subunit 8 (110kD)"	0.85	0.74	1.43	0.93	1.38	0.33	0.84	0.7	1.21	0.89	0.89	0.55	1.22	1.29	0.58	1.23	0.82	1.34	0.53	0.37	0.75	0.41
HV18C3	843249	NGFI-A binding protein 1 (ERG1 binding protein 1)	0.86	1.55	0.83	1.07	1.38	0.97	0.53	0.46	0.45	0.85	0.89	0.43	0.89	0.45	0.85	0.72	1.06	0.48	0.95	1.02	1.35	0.77
HV18C4	950574	"H3 histone, family 3B (H3.3B)"	1.96	2.44	1.51	1.64	2.41	1.75	2.01	2.06	2.03	2.09	1.49	1.49	2.47	2.38	1.25	2.07	1.41	2.06	3.96	1.05	1.36	1.42
HV18C6	712840	"Human signal transducer and activator of transcription Stat5B mRNA, complete cds"	1.66	3.68	1.35	1.85	2.68	2.97	1.9	3.42	3.16	1.85	1.39	2.62	3.85	1.78	1.07	2.35	1.9	1.49	3.36	2.98	1.64	2.5
HV18C7	843067	transcription factor CP2	1.23	2.49	1.17	1.61	2.18	1.64	1.44	1.4	1.31	1.92	1.97	1.35	1.38	1.33	1.18	1.9	1.81	1.32	1.63	0.72	1.79	1.45
HV18C8	770868	NGFI-A binding protein 2 (ERG1 binding protein 2)	1.69	8.11	1.93	2.76	3.36	6.87	5.77	3.67	4.25	8.55	3.99	1.59	2.15	1.71	1.87	2.85	2.15	2.97	4.6	1.64	2.24	4.14
HV18C9	366728	"thymidine kinase 2, mitochondrial"	1.12	1.04	1.38	0.8	0.74	0.66	0.63	1.65	2.3	1.6	1.98	1.42	1.23	1.57	1.14	0.43	0.28	0.92	1.57	0.99	0.89	2.81
HV18C10	725274	tetratricopeptide repeat domain 1	1.03	1.27	0.56	0.82	1.29	0.78	1.04	1.15	1.46	1.07	1.05	1.35	0.95	1.62	0.99	1.14	1.21	0.83	0.59	0.36	0.67	0.71
HV18C11	898109	Homo sapiens BAC clone RG459N13 from 7p15	1.37	1.07	0.98	1.07	1.06	1.21	1.03	1.38	1.42	0.96	0.71	1.49	1.09	1.72	1.42	1.64	0.55	0.89	1.26	0.84	0.6	0.92
HV18C12	81599	ubiquitin specific protease 14 (tRNA-guanine transglycosylase)	1.55	1.77	1.68	1.23	1.3	1.34	0.97	1.55	1.51	1.11	1.28	1.86	1.29	2.21	1.33	1.79	1.79	1	0.72	0.82	0.68	1.19
HV18D1	757961	ESTs	1.69	6.47	7.13	4.98	5.95	2	4.27	8.97	17.09	5.11	3.15	1.99	2.6	2.99	1.6	3.42	1.79	3.09	3.17	1.42	1.82	3.2
HV18D2	843248	ESTs	1.09	0.75	0.92	0.84	1.21	0.8	0.75	1.07	1.09	0.69	1.07	0.76	0.9	0.9	1.07	1	0.9	0.57	0.65	0.77	0.96	0.8
HV18D3	231355	vesicle-associated membrane protein 2 (synaptobrevin 2)	1.06	2.15	1.07	1.49	1.71	1.37	1.5	1.8	1.4	0.98	1.48	1.28	1.81	1.48	0.82	1.15	1.01	1.17	1.53	1.23	1.22	1.26
HV18D5	712668	JAK binding protein	0.75	4.29	1.04	1.55	1.76	1.53	1.18	1.24	1	2.04	1.61	0.91	0.82	1.31	0.83	1.33	1.39	2.11	2.87	0.84	1.81	1.21
HV18D7	839552	nuclear receptor coactivator 1	0.84	2.72	1.56	2.31	2.03	2.35	2.1	2.06	1.71	1.92	2.03	1.36	1.15	1.74	1.04	1.64	2.39	0.45	2.73	1.59	1.46	2.01
HV18D8	898265	"splicing factor, arginine/serine-rich 5"	1.18	1.34	0.92	1.38	1.66	0.96	1.67	1	0.94	1.02	0.93	1.06	1.96	1.74	0.93	1.18	0.81	0.6	1.18	1.03	0.63	1.1
HV18D9	824041	"splicing factor, arginine/serine-rich 9"	0.78	1.1	0.82	1.1	0.64	0.66	0.95	1.27	1.64	0.74	0.94	1.01	1.04	1.14	1.06	0.89	0.89	1.57	0.88	1	0.54	0.8
HV18D10	39593	somatostatin	1.27	1.8	0.91	1.18	1.55	1.07	1.18	1.5	1.24	1.26	1.01	1.63	1.58	1.8	0.87	1.07	1.64	1.31	3.69	1.8	1.92	3.14
HV18D11	842894	"ATPase, Na+/K+ transporting, beta 3 polypeptide"	1.92	0.61	0.77	0.53	0.5	0.46	0.33	0.41	0.59	0.26	0.3	0.47	0.32	0.32	0.53	0.27	0.57	0.59	0.41	0.41	0.53	0.31
HV18D12	823819	small acidic protein	0.82	1.17	0.69	1.06	1.82	0.75	1.07	1.33	0.81	0.98	1.06	0.98	0.94	1.2	0.63	0.71	1.34	0.8	0.88	0.71	0.71	1.06
HV18E1	813266	four and a half LIM domains 1	1.94	0.47	1.48	1.16	0.88	0.3	0.56	1.39	1.9	0.45	0.43	2.71	3.87	3.49	1.59	0.35	1.46	2.85	1.79	0.91	1.48	3.56
HV18E2	825013	H.sapiens mRNA for PHAPI2a protein	1.94	2.72	1.1	1.69	1.24	0.66	1.15	1.07	1.2	0.62	0.46	0.93	1.62	1.74	1.31	1.16	1.63	2.69	1.1	0.63	0.65	1.39
HV18E3	80772	"Human silencing mediator of retinoid and thyroid hormone action (SMRT) mRNA, complete cds"	0.73	1.04	0.9	1.05	0.88	0.51	0.87	1.39	1.02	0.75	1.05	0.84	0.81	0.94	0.75	0.76	0.51	1.38	1.09	0.8	0.82	0.81
HV18E4	826405	"inositol polyphosphate-5-phosphatase, 145kD"	1.45	1.83	1.95	1.96	2.61	2.25	2.39	3.64	1.78	2.31	1.83	2.14	2.8	2.17	1.32	2.04	1.47	1.32	1.86	1.13	1.5	1.9
HV18E5	843076	signal transducing adaptor molecule (SH3 domain and ITAM motif) 1	1.34	1.43	1.64	1.56	1.9	1.23	1.03	0.99	1.1	1.03	1.03	0.94	1.04	0.91	0.94	1.37	1.16	1.44	0.69	0.85	1.56	0.88
HV18E6	823590	sialyltransferase	5.08	2.07	1.37	2.9	3.81	2.93	4.68	5530.69	7.62	2.42	1.16	4.18	1.66	4.62	2.22	3.03	2.67	3.94	5.4	4.09	2.18	6.25
HV18E7	592801	"serine palmitoyltransferase, subunit II"	2.6	1.76	1.13	1.69	2.18	2.21	1.43	1.5	1.68	1.2	1.81	1.54	1.65	1.75	1.67	1.34	1.57	1.74	2.18	1.5	1.58	1.62
HV18E8	840702	SELENOPHOSPHATE SYNTHETASE ; Human selenium donor protein	2.28	2.93	3.9	3.46	2	4.47	1.8	1.74	1.3	1.67	1.06	1.93	1.49	1.3	1.49	2.18	2.14	2.78	0.98	2.3	1.54	1.65
HV18E11	841044	ribosomal protein L28	0.66	0.72	0.66	0.44	0.61	0.29	0.56	0.36	0.42	2.04	0.51	0.63	0.68	0.79	0.49	0.71	0.52	1.03	0.93	0.23	0.41	0.73
HV18E12	949940	ribosomal protein L27a	0.88	1.32	1.02	0.66	1.18	0.39	0.97	0.57	0.49	1.26	0.61	0.44	0.9	0.75	0.66	0.96	0.76	1.21	0.64	0.34	0.48	1.02
HV18F2	838389	unc119 (C.elegans) homolog	1.31	1.42	0.33	0.4	1.39	0.84	0.78	0.6	2.17	0.96	0.52	2.17	1.58	1.99	0.94	1.31	0.91	1.04	2.53	1.57	1.17	1.74
HV18F4	47853	aldehyde dehydrogenase 4 (glutamate gamma-semialdehyde dehydrogenase; pyrroline-5-carboxylate dehydrogenase)	2.36	1.59	1.4	1.19	2.88	1.58	2.55	1.98	2.68	4.14	2.46	3.2	2.24	1.51	1.07	2.88	1.36	1.02	5.55	2.51	1.82	2.92
HV18F5	843426	ubiquitin specific protease 11	2.53	3.08	2.02	2.12	2.36	1.73	1.8	2.24	1.55	2.09	1.66	1.38	2.25	1.28	1.18	1.52	1.56	5.14	1.44	0.87	1.64	1.8
HV18F6	758468	"Homo sapiens clone 23777 putative transmembrane GTPase mRNA, partial cds"	2.89	2.42	0.98	1.57	1.52	1.94	1.54	1.26	1.76	1.39	0.82	1.21	1.44	0.93	1.03	1.68	1.76	1.02	1.43	1.45	1.88	1.08
HV18F9	75415	histidine triad nucleotide-binding protein	0.51	0.66	0.33	0.45	0.43	0.34	0.48	0.42	0.54	0.36	0.58	0.48	0.48	0.66	0.66	0.53	0.41	0.69	0.43	0.45	0.46	0.55
HV18F10	712577	holocytochrome c synthase (cytochrome c heme-lyase)	1.3	1.2	1.06	1.41	0.94	0.41	0.71	0.95	0.82	1.19	0.69	0.95	0.87	0.69	1.4	1.41	1.58	0.88	1.6	1.01	0.56	0.55
HV18F11	786083	ubiquitin-conjugating enzyme E2 variant 2	1.15	0.86	1.4	1.2	0.82	0.35	0.54	0.97	0.78	0.65	0.68	0.72	0.64	0.48	1.35	0.96	0.69	0.95	0.46	0.69	0.52	0.55
HV18F12	700699	putative T1/ST2 receptor binding protein	1.39	2.03	1.15	0.99	1.85	1.04	1.23	1.16	1.29	1.75	1.29	1.14	1.03	1.66	0.96	1.14	1.09	1.36	2.55	1.4	1.12	1.78
HV18G2	811899	"Human proteinase activated receptor-2 mRNA, 3'UTR"	0.85	0.87	0.24	0.24	0.69	0.46	0.33	1.04	1.98	1.15	0.3	0.62	0.48	0.69	0.34	0.26	1.76	0.42	1.48	0.46	0.37	0.9
HV18G3	825442	"protein tyrosine phosphatase type IVA, member 2"	1.09	1.53	1.62	1.16	1.71	1.39	1.75	1.43	1.35	1.31	1.8	1.78	1.9	2.93	1.22	1.65	1.84	1.32	1.6	0.78	0.78	2.56
HV18G5	796268	"protein phosphatase 1, regulatory (inhibitor) subunit 1A"	1.82	2.03	1.45	1.74	1.77	1.57	1.46	1.58	1.07	1.58	1.72	0.86	1.6	1.51	1.31	1.92	1.39	1.17	1.78	0.86	1.49	1.55
HV18G6	814595	protein kinase C binding protein 1	0.5	0.55	0.39	0.32	0.57	0.3	0.67	0.72	1.73	0.62	0.53	0.72	0.88	1.13	1.24	1.05	0.27	0.47	0.76	0.42	0.46	0.72
HV18G7	510396	mitogen-activated protein kinase kinase kinase 12	1.51	2.12	1.83	1.79	2.5	1.87	2.45	2.06	2.49	2.03	2.03	2.05	2.23	2.63	1.36	2.77	1.29	1.54	2.58	1.57	1.44	2.43
HV18G9	897956	melanoma antigen preferentially expressed in tumors	3.74	1.99	8.57	4.69	1.35	0.38	5.74	1.03	6.82	11.15	0.62	1.6	1.92	1.99	1.29	0.25	1.74	10.69	1.68	0.65	1.05	1.8
HV18G10	712604	pre-B-cell colony-enhancing factor	1.38	2.04	0.91	1.69	2.03	1.72	0.87	1.07	0.56	0.94	0.81	0.59	3.75	1.77	2.81	2	1.35	1.68	1.48	0.49	0.75	0.86
HV18G11	898328	early development regulator 2 (homolog of polyhomeotic 2)	2	1.8	2.28	1	1.35	1.43	1.26	1.8	1.25	1.17	1.5	0.92	1.25	1.87	1.62	0.84	0.72	1.66	1.52	0.9	1.29	1.46
HV18G12	781362	"plectin 1, intermediate filament binding protein, 500kD"	0.68	0.56	0.51	0.21	0.57	0.36	0.65	0.6	0.61	0.52	0.52	0.35	0.8	0.77	0.66	0.5	0.26	0.72	0.44	0.56	0.46	0.62
HV18H3	898062	"cell division cycle 20, S.cerevisiae homolog"	1.71	1.72	1.57	1.39	1.32	1.31	1.18	0.58	1.27	1.52	0.59	0.51	0.59	1.97	1.24	1.2	1.34	2.57	0.53	0.42	0.6	0.59
HV18H5	700302	"Homo sapiens osteoclast stimulating factor mRNA, complete cds"	1.6	1.4	0.85	1.45	1.22	1.21	0.86	1.58	0.59	0.83	1.41	0.73	1.16	1.04	1.19	1.16	1.17	0.58	1.8	0.61	1.08	1.26
HV18H7	79624	"interferon-induced protein 41, 30kD"	2.25	4.98	1.63	2.45	3.6	2.94	3.12	3.59	2.65	4.4	3.09	2.68	1.47	2.35	1.3	5.09	2.44	1.53	3.93	1.73	3.03	4.34
HV18H8	785816	"Homo sapiens clone 23711 unknown mRNA, partial cds"	2.27	2.26	1.39	3.73	2.99	1.46	1.86	0.74	0.88	1.28	0.84	0.81	2.14	0.88	0.78	1.64	1.83	2.91	2.46	0.83	0.82	1.1
HV18H9	416959	nuclear factor I/B	2.08	2.21	1.21	3.11	2.22	1.24	1.38	0.61	2.17	0.93	0.58	0.69	2.02	0.63	0.88	0.84	1.2	2.89	1.9	0.54	0.61	0.93
HV18H10	767994	"striatin, calmodulin-binding protein"	1.23	2.05	1.25	0.9	1.65	0.62	1.36	1.94	1.55	1.12	0.61	1.23	1.13	1.53	1.99	0.95	0.61	0.89	2.55	1.63	1.81	1.97
HV18H11	823851	AE-binding protein 1	1.27	1.48	1.62	0.71	1.44	0.59	1.64	2.07	1650.17	0.96	0.79	1.43	1.14	1.84	2.05	0.74	0.38	1.55	2.5	1.32	1.72	2.13
HV19A3	51463	neuronal apoptosis inhibitory protein	2.72	0.82	6.93	4.07	3.38	0.59	0.88	2.12	3.34	1.76	0.99	1.8	3.02	2.78	2.74	0.69	2.1	4.09	1.72	0.73	1.61	1.55
HV19A4	49630	ESTs	0.91	0.39	0.14	0.18	0.51	0.46	0.43	0.22	0.2	0.37	0.41	1.04	2.29	1.78	0.46	0.76	0.39	0.52	0.42	0.48	0.74	0.8
HV19A6	841498	"Homo sapiens mRNA for myosin regulatory light chain, complete cds"	1.03	0.87	0.89	0.57	0.8	0.7	0.76	0.81	0.91	0.69	0.74	0.52	0.63	0.95	0.67	0.59	0.59	0.76	0.74	0.61	0.55	0.66
HV19A7	841308	"myosin, light polypeptide kinase"	3.25	1.34	12.25	4.3	6.11	1.04	1.07	18.08	3.4	2.61	1.77	1.95	3.35	3.93	1.99	0.74	2.71	4.53	5.69	1.18	2.38	3.72
HV19A9	490306	multispanning membrane protein (70kD)	1.39	1.33	1.53	1.19	1.14	0.74	1.03	1.55	1.68	1.49	1.07	1.4	0.89	1.45	1.46	1.11	0.57	1.03	1.31	1.48	2.22	1.95
HV19A10	949928	zinc finger protein 220	1.28	2.87	1	1.31	1.87	1.02	1.46	1.38	4.7	1.41	1.26	1.1	1.4	1.48	1.19	2.12	1.21	1.61	1.09	1.12	1.2	1.49
HV19A11	814701	"MAD2 (mitotic arrest deficient, yeast, homolog)-like 1"	1.49	1.11	1.8	1.84	1.19	1.45	1.07	0.97	1.04	1.4	0.8	0.61	0.78	0.98	1.26	0.81	1.71	3.46	0.45	0.51	0.34	0.61
HV19B1	363086	"creatine kinase, mitochondrial 1 (ubiquitous)"	0.8	0.86	0.44	0.2	1.38	0.24	0.32	0.24	0.76	0.26	0.36	0.18	0.49	0.31	0.83	0.61	0.17	0.26	0.42	0.28	0.5	0.44
HV19B2	289818	methylmalonate-semialdehyde dehydrogenase	1.56	2.19	2.33	1.89	3.19	1.24	1.66	1.26	1.4	2.91	1.86	1.67	2.5	3.49	1.14	2.51	1.86	1.13	3.17	1.12	0.83	1.79
HV19B3	713782	a disintegrin and metalloproteinase domain 15 (metargidin)	0.91	0.75	0.18	0.36	0.64	0.39	0.61	0.27	0.44	0.59	0.49	0.32	0.46	1.02	0.97	0.62	0.25	0.7	0.52	0.25	0.77	0.54
HV19B4	843321	keratin 7	0.32	0.19	0.11	0.13	0.3	0.41	0.29	0.15	0.1	0.31	0.29	0.1	0.29	0.36	0.59	0.44	0.32	0.37	0.2	0.12	0.45	0.24
HV19B6	877651	"rcd1 (required for cell differentiation, S.pombe) homolog 1"	1.5	2.41	1.1	1.64	2.98	1.96	1.46	1.15	1.71	2.7	2.01	1.53	1.96	1.34	1.05	1.7	1.8	1.63	2.68	0.88	1.33	1.23
HV19B9	897563	KIAA0864 protein	1.79	1.41	1.97	1.06	1.65	0.71	0.79	1.56	1.04	0.91	0.78	0.78	1.35	0.84	1.14	0.59	2.42	2.12	1.61	0.64	0.96	1.23
HV19B10	824511	zinc finger protein homologous to Zfp161 in mouse	1.94	1.83	0.83	1.08	2.39	1.53	1.26	1.22	1.35	1.11	1.1	1.24	1.56	1.46	1.23	1.58	2.08	0.96	1.4	2.08	1.5	2.18
HV19B11	263200	"Human mRNA for unknown product, partial cds"	1.11	1.65	2.39	1.87	1.8	0.69	0.9	0.9	0.66	0.95	1	0.42	0.45	0.33	0.56	0.89	1.75	1.01	1.48	0.62	0.96	0.85
HV19B12	898305	"neuroblastoma candidate region, suppression of tumorigenicity 1"	0.83	0.71	0.22	0.38	0.67	1.04	1.2	1.49	0.83	1.09	1.7	0.55	1.09	1.08	0.45	0.52	0.61	0.94	1.05	0.4	0.89	1.2
HV19C1	789204	translocation protein 1	1.49	1.59	1.42	0.88	0.85	0.76	0.89	1.66	2.1	1.15	0.69	1.13	1.23	2.03	1.43	0.48	0.99	1.32	1.44	0.89	0.74	1.35
HV19C2	814636	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2"	2.31	7.15	1.1	2.01	2.32	1.02	1.58	1.76	1.36	1.26	0.88	0.68	2.74	2.63	1.23	1.5	1.63	2.16	0.94	0.34	0.46	1.68
HV19C5	784126	thiosulfate sulfurtransferase (rhodanese)	0.89	1.67	1.15	1.28	1.55	1.3	0.83	0.8	1.44	1.28	1.43	0.77	1.03	1.56	0.83	0.94	0.81	2.01	0.84	1.19	1.15	1.02
HV19C8	843110	GDP dissociation inhibitor 1	1.63	2.13	1.23	1.22	1.56	1.31	1.4	1.94	1.74	1.22	1.3	1.59	1.38	1.74	1.2	1.51	1.4	1.15	2.71	1.58	1.12	1.5
HV19C11	772220	for protein disulfide isomerase-related	1.99	3.93	4.42	2.18	3.99	3.02	2.21	3.7	2.71	2.2	2.01	2.24	1.37	3.12	2.18	2.44	2.41	3.45	1.96	0.9	1.84	1.95
HV19C12	784830	D123 gene product	1.07	2.46	1.54	2.46	1.13	2.17	0.86	0.73	0.92	0.79	0.97	0.98	0.92	0.82	1.15	1.84	1.93	1.82	0.56	0.49	0.51	0.62
HV19D1	843352	"proteasome (prosome, macropain) subunit, beta type, 7"	1.08	1.54	0.88	0.86	0.82	0.65	0.97	0.96	1.7	0.67	0.76	0.74	0.64	0.94	0.82	1.07	0.93	0.98	0.84	1.08	0.67	0.97
HV19D2	758662	"proteasome (prosome, macropain) 26S subunit, non-ATPase, 9"	1.47	2.23	0.99	1.98	1.45	1.22	1.64	2.27	1.83	1.53	1.39	1.26	1.4	1.75	0.97	1.05	1.37	2.67	1.97	1.42	0.96	1.64
HV19D3	843028	mesothelin	0.42	0.29	0.14	0.07	0.16	0.17	0.17	0.09	0.16	0.07	0.09	0.14	0.32	0.26	0.27	0.11	0.04	0.12	0.08	0.05	0.06	0.06
HV19D4	841617	"Human mRNA for ornithine decarboxylase antizyme, ORF 1 and ORF 2"	0.82	1.14	0.56	0.85	0.77	1.12	1.25	1.43	1.25	1.52	1.21	1.52	0.96	1.37	0.98	0.92	0.93	0.76	1.1	1.55	1.47	1.73
HV19D6	840524	"golgi autoantigen, golgin subfamily b, macrogolgin (with transmembrane signal), 1"	1.55	2.03	1.39	1.21	2.46	1.36	1.31	2.47	1.57	1.29	1.02	1.5	1.47	1.71	0.91	1.62	1.47	0.93	1.31	1.15	1.33	1.36
HV19D7	841620	dihydropyrimidinase-like 2	0.76	0.62	0.77	1.07	1.04	0.38	0.35	0.62	0.74	0.5	0.59	0.58	0.91	0.73	0.65	0.45	0.44	1.35	0.65	0.46	1.03	0.85
HV19D8	760298	"protease, cysteine, 1 (legumain)"	1.78	4.12	3.11	3.37	3.34	2.77	2.54	4.35	3.42	3.31	4	1.9	1.72	2.03	2.18	3.22	1.72	1.85	2.77	1.91	2.52	2.1
HV19D9	796757	"clathrin-associated/assembly/adaptor protein, small 3 (22kD)"	0.51	1.24	0.62	0.87	1.07	0.51	0.61	0.68	0.94	0.74	0.67	0.62	0.48	0.72	0.87	0.6	0.73	0.63	0.41	0.38	0.5	0.89
HV19D12	824352	RAD23 (S. cerevisiae) homolog B	1.32	2.39	0.88	1.53	1.3	0.78	1.61	1.78	2.06	0.99	1.17	0.95	1.18	2	1.58	1.87	1.54	2.1	0.68	0.81	0.76	1.03
HV19E1	824117	vaccinia related kinase 2	1.75	1.23	1.41	2.68	1.38	1.31	0.87	1.56	0.94	0.83	0.7	1.13	1.2	1.19	0.46	1.12	0.85	1.04	1.24	0.83	0.87	1.46
HV19E2	724387	small nuclear ribonucleoprotein polypeptide C	1.45	1.99	2.13	1.64	1.81	0.98	1.7	1.27	1.98	1.73	1.16	1.09	1.14	1.81	1.01	2.82	2.05	1.8	0.58	1.02	0.84	1.34
HV19E3	788832	prostate differentiation factor	1.9	0.88	2.94	2.03	0.95	0.84	0.91	3.67	2.76	1.49	1.18	3.73	1.49	2.08	1.41	0.55	0.95	1.61	0.72	1.15	0.83	2.13
HV19E5	35191	stromal cell-derived factor 2	0.94	1.04	1.12	1.07	1	0.65	0.73	1.4	1.38	1.17	1.01	1.25	0.69	1.16	1.27	1.15	0.75	1.82	0.55	1.11	1.42	1
HV19E6	842863	N-myc downstream regulated	2.06	1.65	2.29	2.02	3.23	1.75	3	0.68	0.81	2.6	0.85	0.78	1.3	0.79	2.59	2.79	1.65	1.36	1.17	1.56	0.61	1.01
HV19E8	841689	"ATPase, H+ transporting, lysosomal (vacuolar proton pump), subunit 1"	2.19	2.86	0.9	0.85	1.47	1.34	2.25	2.24	3.26	1.88	2.41	1.99	1.22	1.85	0.97	2.63	0.95	1.17	2.39	2.72	1.75	3.57
HV19E9	627541	"fucosyltransferase 8 (alpha (1,6) fucosyltransferase)"	1.26	0.84	1.91	1.85	3.24	1.14	0.88	3.36	1.41	0.76	1.55	3.03	1.73	2.78	1.63	0.29	0.92	1.11	6.8	4.83	3.16	6.53
HV19E10	78869	"cell membrane glycoprotein, 110000M(r) (surface antigen)"	1.19	1.62	1.08	1.02	1.64	1.36	1.58	1.28	2.65	1.39	0.68	1.85	0.83	1.09	0.91	1.76	1.24	1.2	1.57	1.86	1.57	1.36
HV19E11	52646	KIAA0377 gene product	0.59	0.92	0.67	1.2	0.96	0.76	0.75	0.76	1.08	0.95	0.59	0.63	0.57	0.86	0.66	0.76	0.35	0.51	0.63	0.89	0.98	1.06
HV19F1	49873	KIAA0362 protein	1.1	1.86	2.14	1.6	1.1	0.84	1.41	1.39	1.28	1.29	1.15	0.93	0.69	1.34	0.87	1.45	1.5	1.83	0.74	1.05	0.95	1.05
HV19F3	502067	KIAA0342 gene product	2.45	1.83	1.7	1.52	0.6	0.87	0.79	2.46	2.69	1.44	1.18	2.13	1.74	2.04	1.77	0.46	1.12	1.64	2.86	1.72	1.97	2.23
HV19F4	773233	ESTs	3.88	3.2	2.39	1.13	3.64	4.12	3.07	3.28	2.97	4.33	2.14	6.34	3.7	2.54	1.77	2.71	2.31	2.27	4.17	5.13	2.33	3.65
HV19F5	795805	KIAA0332 protein	2.11	2.25	2.13	1.69	1.15	0.93	1.11	1.67	1.2	0.95	0.53	0.7	0.79	0.86	0.85	0.84	1.7	1.49	2.23	0.86	1.29	1.3
HV19F7	502909	KIAA0326 protein	0.86	1.64	1.4	1.57	1.26	0.8	1.14	1.65	1.52	1.09	1.27	1	0.67	0.94	0.66	0.77	0.91	1.07	1.38	0.99	1.49	1.49
HV19F9	755891	KIAA0317 gene product	0.97	2.12	2.36	2.39	1.71	0.93	1.45	1.3	0.95	1.08	1.08	1.06	0.61	0.92	1.02	0.9	1.23	1.2	1.78	0.94	1.71	1.58
HV19F11	824895	KIAA0313 gene product	0.9	2.22	2.48	2.83	1.92	1.09	2.01	2.14	2.41	3.02	2.24	0.84	1.4	1.06	0.99	1.15	0.91	0.85	4.66	1.8	2.29	2.3
HV19F12	783681	upstream regulatory element binding protein 1	1.65	1.3	0.83	0.87	1.01	1.31	1.04	0.76	1.02	1.1	1.1	0.9	1	1.06	0.88	1.4	2.9	1.13	0.92	0.78	0.8	0.96
HV19G1	786672	guanine nucleotide exchange factor for Rap1	3.5	4.18	2.67	1.5	3.3	1.72	1.81	2.75	7.56	1.44	1.08	2.97	2.48	4.26	1.17	1.23	1.62	5.46	2.39	1.04	1.96	2.71
HV19G2	826668	KIAA0274 gene product	0.83	1.47	0.58	0.98	1.66	2.33	1.13	1.28	1.06	1.22	1.21	1.42	1.22	1.1	0.83	1.55	0.81	0.57	1.26	0.54	0.78	1.17
HV19G6	843133	KIAA0264 protein	0.74	1.16	0.48	0.84	1.08	0.84	1.13	1.03	0.93	0.95	0.93	0.58	0.99	0.92	0.92	1.24	0.92	0.75	1.28	0.78	0.52	0.76
HV19G7	825451	vesicle docking protein p115	2.25	2.42	1.18	1.2	1.27	1.03	1.33	1.52	1.67	1.14	0.62	1.14	0.9	1.43	1.15	0.99	0.49	0.94	1.19	0.47	1.12	1.11
HV19G8	82976	KIAA0251 protein	0.97	1.68	0.52	0.98	1.06	0.91	0.9	0.96	1.8	1.3	1.3	1.61	1.36	2.03	0.99	1.87	1.81	1.97	1.35	0.8	0.99	1.12
HV19G9	32231	KIAA0246 protein	1.74	1.51	3.14	2.32	2.51	2.01	2.27	1.55	1.33	2.47	1.43	1.19	1.19	1.17	1	1.43	1.07	2.47	1.61	1.42	1.72	1.58
HV19G10	788203	KIAA0157 protein	0.98	2.21	0.76	1.65	2.05	1.04	1.67	1.36	1.13	1.51	0.75	1.55	0.92	1.45	0.8	1.54	1.63	1.39	1.38	0.66	0.68	1.45
HV19G11	795989	"solute carrier family 23 (nucleobase transporters), member 2"	1.05	1.94	1.43	1.03	2.22	0.86	0.88	1.13	1.32	1.62	1.23	0.9	1.22	1.08	0.93	1.04	0.64	1.22	1.55	1.15	1.08	1.22
HV19G12	591465	KIAA0233 gene product	1.2	1.52	0.37	0.77	1.79	1.17	0.81	0.67	0.88	1.15	1.33	0.8	0.33	1.76	0.65	1.27	2.08	1.54	2.21	1.53	1.55	0.93
HV19H1	753321	KIAA0232 gene product	0.63	1.99	0.94	0.57	2.32	0.47	1.61	1.92	2.31	0.97	0.73	0.89	1.13	1.95	0.9	0.96	0.33	0.9	1.29	1.29	0.83	1.73
HV19H3	950369	KIAA0225 protein	1.25	3.08	1.62	3.74	2.55	1.48	1.64	1.34	3.59	1	0.88	0.94	1.12	1.63	0.93	1.83	1.5	1.58	1.14	0.63	0.77	0.78
HV19H4	49404	KIAA0218 gene product	1.76	3.1	2.53	2.72	2.94	1.52	2.16	1.74	2.57	1.97	2.02	2.07	1.81	1.6	1.34	1.72	1.93	1.29	1.74	1.09	1.27	1.63
HV19H5	824044	KIAA0217 protein	0.28	0.18	0.09	0.12	0.27	0.4	0.3	0.09	0.07	0.2	0.3	0.14	0.22	0.27	0.53	0.34	0.23	0.29	0.23	0.11	0.55	0.19
HV19H6	781222	TGFB1-induced anti-apoptotic factor 1	0.69	1.35	0.51	0.72	1.2	0.97	0.87	1.05	1.13	0.91	0.86	0.84	0.86	0.81	0.88	1.45	0.67	0.69	0.72	0.5	1.05	0.71
HV19H7	49117	KIAA0215 gene product	2.02	2.71	2.37	1.92	2.61	4.57	2.07	7.32	4.88	1.89	1.58	2.57	1.65	2.02	0.97	1.32	2.72	1.35	2.31	2.13	1.89	2.45
HV19H9	703846	KIAA0210 gene product	0.91	1.25	0.76	0.94	1.16	1.02	0.69	0.84	0.98	0.81	0.97	0.96	0.77	0.86	0.61	0.79	0.89	0.84	0.9	0.69	0.84	0.91
HV19H10	565379	growth factor receptor-bound protein 10	2.7	4.08	3.92	8.25	4.87	1.47	2.61	5.11	4.64	2.24	2.6	6.54	2.32	3.47	1.78	1.76	1.63	5.92	3.24	2.44	1.75	2.37
HV19H12	815781	heat shock 105kD	0.86	1.37	0.49	0.98	1.6	1.61	1.23	1.07	1.41	1.06	0.96	1.34	0.71	2.07	1.33	1.2	1.24	1.24	1.9	0.71	1.05	1.55
HV20A1	814792	ubiquitin specific protease 10	1.03	0.96	1.03	0.96	1.05	0.83	0.71	0.81	0.71	0.93	0.94	0.55	0.65	1	0.59	0.95	0.96	1.93	0.5	0.51	0.75	1.2
HV20A2	783698	KIAA0188 protein	0.61	1.46	0.54	0.55	0.84	0.69	0.49	0.22	0.4	0.39	0.29	0.27	0.62	0.56	0.42	0.98	0.46	0.85	0.52	0.13	0.38	0.45
HV20A3	837905	KIAA0183 protein	1.68	1.86	1.45	2.01	2.07	0.96	1.49	1.97	2.07	1.37	1.18	0.85	1.19	2.23	1.36	1.17	2.14	2.26	1	0.55	2.85	1.13
HV20A6	173309	KIAA0164 gene product	2.43	2.2	0.98	1.69	2.2	1.15	1.94	1.23	1.21	0.89	0.34	1.22	2.05	1.71	1.02	1.33	1.4	1.28	1.44	0.93	0.99	1.56
HV20A7	180195	suppressor of Ty (S.cerevisiae) 6 homolog	0.69	1.35	1.09	1.32	1.37	0.94	1.14	1.53	1.25	1.25	1.1	0.9	0.83	0.77	0.99	1.05	0.85	0.93	0.87	1.39	1.89	1.27
HV20A8	826137	KIAA0160 protein	1.57	2.95	1.77	2.42	2.39	1.31	2.66	1.8	1.3	1.98	0.33	1.29	1.38	2.16	1.55	2.4	2.1	1.94	0.78	0.94	0.63	1.2
HV20A9	840620	KIAA0152 gene product	0.88	1.12	0.95	1.35	1.42	0.72	0.82	1.05	1.35	1.09	0.98	0.91	1.53	1.37	1.53	1.06	0.95	2.09	0.65	1.03	0.76	1.04
HV20A10	245015	KIAA0144 gene product	1.54	1.92	1.3	1.68	2.01	1.6	2	1.33	1.41	1.38	1.33	1.01	1.22	1.66	1.02	2.01	2.13	2.01	0.94	1.43	1.55	1.48
HV20A11	815530	PAK-interacting exchange factor beta	2.05	2.79	2.87	1.71	2.15	1.59	1.41	1.79	1.56	1.19	1.34	1.58	1.38	1.28	1.18	1.39	1.1	1.1	1.07	0.76	1.41	1.7
HV20B6	526184	KIAA0118 protein	1	0.42	0.77	0.69	2.11	0.69	1.46	2.85	0.78	1.12	1.18	0.56	3.16	2.27	0.52	0.8	0.53	1.3	1.32	0.21	0.43	1.27
HV20B7	80504	Nef-associated factor 1	0.55	0.7	1.07	2.37	0.8	0.91	0.6	0.89	0.64	0.97	1.22	0.66	0.66	0.7	0.7	0.61	0.87	0.64	0.66	0.78	0.98	0.7
HV20B8	562867	KIAA0112 protein	2.91	2.97	2.49	2.08	2.72	2.07	2.27	2.6	3.35	2.53	3.36	3.26	3.31	4.15	2.61	1.6	2.36	3.43	3.13	0.89	0.55	1.25
HV20B9	897983	"anti-oxidant protein 2 (non-selenium glutathione peroxidase, acidic calcium-independent phospholipase A2)"	0.85	1.56	0.89	1.83	1.01	0.96	1.11	1.09	0.82	1.26	0.62	0.85	0.81	1.07	0.63	1.1	1.82	0.81	0.59	0.67	0.61	0.84
HV20B10	898095	gene predicted from cDNA with a complete coding sequence	1.04	0.82	1.23	1.42	1.73	1.31	1.01	1.06	1.33	1.52	1.2	0.9	1.34	0.54	0.29	1.59	1.05	0.61	0.57	0.51	0.83	0.58
HV20B11	841501	KIAA0102 gene product	2.25	2.45	1.84	2.68	1.56	1.52	1.24	1.84	1.56	1.54	1.27	1.71	1.3	1.29	1.32	1.54	1.25	1.16	1.25	0.79	1.28	1.66
HV20B12	342640	KIAA0101 gene product	0.94	1.5	0.65	1.15	0.98	0.88	1.01	0.65	1.48	1.03	0.51	0.65	0.6	2.5	1.11	1.2	0.76	2.29	1	0.31	0.45	0.77
HV20C1	898032	KIAA0097 gene product	1.23	1.77	0.8	1.45	1.32	1.47	0.76	1.32	1.39	1.34	1.29	1.11	0.81	1.38	0.85	1.47	1.99	2.6	1.16	1.49	1.03	1.17
HV20C2	784504	"site-1 protease (subtilisin-like, sterol-regulated, cleaves sterol regulatory element binding proteins)"	1.27	0.77	0.77	0.51	1.1	0.73	0.95	0.8	1.03	1.08	1.14	0.88	1.1	1.41	0.63	0.99	0.95	1.17	0.97	1.16	0.76	0.88
HV20C3	788721	KIAA0090 protein	1.43	1.64	1.39	1.22	1.47	1.25	0.73	1.01	0.74	1.07	1.09	1.16	0.86	1.05	1.26	0.85	0.94	1.62	1.23	0.97	1.17	1.48
HV20C4	840333	KIAA0089 protein	1.76	2.64	1.1	2.3	2.56	2.67	3.52	3.53	2.29	2.96	2.46	1.66	3.82	5.67	1.29	3.17	0.91	1.6	2.9	2.11	1.31	3.31
HV20C5	229537	KIAA0088 protein	0.92	1.5	1.17	1.04	1.85	0.93	1.04	1.47	1.23	1.44	1.42	1.06	0.8	1.3	1.1	1.54	0.97	2.07	1.25	0.76	1.2	1.32
HV20C7	815529	KIAA0084 protein	1.34	2.14	1.29	1.52	2.65	1.7	1.51	2.59	2.71	1.75	1.88	1.16	1.43	2.73	1.41	1.67	1.46	1.53	7.82	2.65	4.65	4.85
HV20C8	825293	KIAA0082 protein	1.69	2.73	1.74	1.55	2.63	1.33	2.11	1.89	2.93	1.73	1.39	2.2	2.02	2.84	1.98	2.88	1.53	2.1	2.04	1.64	1.85	1.72
HV20C10	84955	"Sec24p, S. Cerevisiae, homolog of"	1.18	1.1	0.6	0.86	1.32	0.95	1.65	1.19	1	1.82	0.79	1.28	1.49	1.57	1.44	1.64	1.43	0.99	1.23	1.29	0.9	1.31
HV20C11	725223	KIAA0077 protein	1.4	1.84	1.73	2.61	2.22	1.2	1.3	1.46	1.17	1.53	1.49	1.3	1.25	1.37	1.15	2.3	2.42	1.76	1.63	0.65	1.97	1.25
HV20C12	740122	KIAA0076 gene product	2.14	2.59	1.65	1.42	2.78	1.51	2.17	1.98	2.95	2.14	1.39	2.32	2.49	3.5	1.37	3.38	2.18	5.89	2.46	1.96	2.08	1.82
HV20D1	815503	KIAA0071 protein	0.48	1.33	0.87	0.97	0.95	0.55	0.46	0.67	0.55	0.54	0.57	0.46	0.59	0.75	0.56	0.55	0.53	0.55	0.6	0.61	0.51	0.66
HV20D2	842818	lysyl-tRNA synthetase	1	0.87	0.58	0.59	1.72	0.89	0.68	0.85	0.89	0.79	0.72	0.74	0.4	0.91	0.82	1.46	1.1	1.15	0.39	0.2	0.45	0.4
HV20D3	897840	KIAA0068 protein	0.76	1.2	0.57	1.38	1.29	1.03	0.64	1.09	0.92	0.69	1.15	0.89	0.7	0.78	0.87	0.68	1.82	0.8	0.75	0.94	1.21	0.79
HV20D4	79229	KIAA0063 gene product	1.53	2.04	2.08	1.85	2.78	2.22	1.35	2.09	1.95	1.01	1.33	1.27	0.93	1.23	1.35	1.31	1.98	3.1	1.71	1.17	2.35	2.32
HV20D5	85093	KIAA0062 protein	0.35	0.71	0.57	0.99	1.01	0.55	0.42	1.22	0.42	0.5	0.7	0.47	0.58	0.55	0.64	0.58	1.09	1.08	0.8	0.41	0.6	0.6
HV20D6	84820	KIAA0057 gene product	1.88	3.85	4.61	3.43	8.44	2.43	3.68	6.48	7.51	2.68	1.53	2.1	2.12	2.3	1.22	2.03	2.45	2.63	2.65	1.1	3.86	2.03
HV20D7	814054	KIAA0040 gene product	0.6	2.98	0.96	1.11	2.15	2.97	2.35	4.68	3.96	1.51	2.35	1.39	2.33	6.47	1.57	1.35	0.83	1.03	6.63	1.59	1.72	4.14
HV20D8	825265	"DNA polymerase delta, subunit 3"	2.98	5.27	1.62	3.62	1.35	1.78	1.87	1.78	2.25	1.7	0.7	1.66	1.53	1.66	0.74	1.56	1.56	1.15	1.51	0.97	1.85	1.63
HV20D9	512133	adenylate cyclase 7	2.55	6.34	2.4	4.83	4.79	3.44	2.95	7.29	7.79	2.81	3.33	2	1.88	1.93	1.26	2.44	3.08	1.7	4.08	1.7	3	2.89
HV20D10	843016	nucleolar phosphoprotein p130	1.62	3.06	1.94	3	3	1.08	2	1.68	1.88	1.58	0.71	1.57	1.88	2.24	1.08	1.73	2.37	2.82	1.66	1.07	1.96	1.59
HV20D11	788444	KIAA0033 protein	0.71	1.02	0.77	0.83	1.34	0.52	1.02	1.63	0.86	0.7	0.77	0.84	0.94	1.36	0.76	0.87	0.66	0.67	1.34	1.15	0.73	1.86
HV20D12	704697	KIAA0032 gene product	0.94	1.26	0.84	0.86	1.71	0.99	0.88	1.16	0.9	0.71	0.96	0.6	1.3	1.39	0.73	1.38	0.78	0.46	2.12	0.97	1.18	1.43
HV20E2	825271	KIAA0029 protein	1.18	2.7	1.31	1.67	2.76	1.61	1.49	1.17	1.68	1.26	1.14	1.11	1.4	1.13	1.14	1.98	1.69	1.37	1.21	1.3	1.19	1.49
HV20E3	811930	KIAA0020 gene product	2.42	6.63	1.71	2.8	2.41	1.12	1.16	1.4	1.12	1.81	0.72	0.58	1.31	1.73	0.59	0.84	1.97	5.36	1.06	0.36	0.99	1.17
HV20E5	840878	KIAA0018 gene product	0.78	0.29	0.25	0.68	0.61	1.08	0.62	1.15	1.06	0.63	0.85	0.76	1.15	1.18	1.71	1.06	0.21	0.46	1.13	0.51	0.97	1.61
HV20E6	713862	KIAA0010 gene product	1.15	1.37	0.82	1.23	1.66	0.83	1.36	1.18	1.38	0.93	0.59	0.56	1.19	1.3	1.21	1.65	1.3	1.27	0.59	0.69	0.92	1.13
HV20E7	814319	KIAA0009 gene product	0.67	1.18	1.75	2.21	1.4	0.89	1.12	1.09	1.21	1.05	1.05	0.86	0.99	0.92	2.54	1	1.67	1.04	0.4	1.04	0.87	1.02
HV20E8	686172	KIAA0008 gene product	2.73	2.03	3.22	2.11	2.32	0.9	1.71	0.73	1.33	1.26	0.27	0.81	0.91	2.27	1.37	2.09	1.1	2.5	0.8	0.49	0.52	1.03
HV20E9	773922	KIAA0005 gene product	0.36	0.46	0.51	0.6	0.73	0.33	0.5	0.63	1.11	0.7	0.45	1.12	0.51	1.17	0.74	0.62	0.46	0.53	0.66	0.33	0.48	0.58
HV20E10	773188	ESTs	2.2	2.44	2.36	2.72	3.26	1.6	3.04	3.51	1.78	1.54	1.05	2.22	2.19	1.19	0.81	2.09	1.71	1.13	1.12	2.34	1.08	0.23
HV20E12	796680	"solute carrier family 35 (CMP-sialic acid transporter), member 1"	0.73	0.93	0.49	1.45	2.21	0.94	1.6	0.68	1.16	1.17	0.83	1.48	1.48	1.23	1.45	2.38	0.99	0.86	0.71	0.53	1.05	1.11
HV20F1	825224	"RAE1 (RNA export 1, S.pombe) homolog"	0.85	1.54	1.32	1.77	0.94	1.26	1.23	1.43	1.72	1.19	0.89	1.92	0.47	0.8	1.04	0.96	0.95	1.3	1.1	0.93	1.31	1.06
HV20F3	81394	lysophospholipase-like	1.85	2	1.41	2.02	2.21	2.46	1.56	5.31	2.96	1.81	1.71	1.02	0.98	0.94	1.77	0.82	1.14	1.23	2.02	1.53	2.96	2.85
HV20F4	814409	lysophosphatidic acid acyltransferase alpha	0.75	1.16	1.41	0.93	1.42	0.64	1.49	0.93	1.47	1.33	1.18	0.83	1.18	1.19	0.97	1.18	1.09	1.25	0.82	1.04	0.71	0.9
HV20F8	613126	ubiquitin specific protease 13 (isopeptidase T-3)	2.59	2.44	1.96	2	2.54	1.53	1.83	0.72	2.58	2.1	0.92	1.06	0.99	3.2	1.99	2.14	1.79	1.78	1.35	0.4	0.42	0.68
HV20F9	824602	"interferon, gamma-inducible protein 16"	0.67	4.59	1.12	2.59	2.51	2.13	1.93	3.2	1.6	2.16	1.98	1.08	1.47	1.19	1.14	1.46	2.48	0.81	1.71	0.46	1.31	1.16
HV20F11	758037	human immunodeficiency virus type I enhancer-binding protein 1	1.28	3.93	2.76	2.7	3.44	1.89	2.01	2.45	1.9	2.65	1.52	1.49	1.28	2	1.27	1.27	1.85	1.18	2.12	1.17	1.79	1.91
HV20F12	72391	"sortilin-related receptor, L(DLR class) A repeats-containing"	4.7	5.55	1.31	5.23	4.94	3.57	4.12	4.75	3.64	5.38	2.42	3.98	4.02	3.85	2.01	3.56	2.49	2.1	5.58	2.62	3.92	5.49
HV20G1	814546	"pleckstrin homology, Sec7 and coiled/coil domains 1(cytohesin 1)"	1.44	1.7	1.19	0.97	1.22	0.92	0.83	1.28	1.03	1.09	0.89	1.16	1	1.33	1.19	0.83	0.81	1.81	2.08	1.93	2.58	1.72
HV20G2	826204	flightless I (Drosophila) homolog	0.83	0.73	0.68	0.75	0.92	1	0.71	0.83	0.72	0.86	1.29	0.83	1.01	0.86	0.84	0.95	1.08	0.66	0.67	0.73	0.91	0.7
HV20G3	726236	paired mesoderm homeo box 1	0.92	1.8	0.9	0.92	1.67	0.65	1.62	2.12	1.38	1.55	1.16	0.83	0.93	1.39	0.81	0.7	0.82	1.35	1.64	0.42	1.09	1.27
HV20G4	789091	"H2A histone family, member L"	2.59	5.22	2.81	1.51	2.56	2.16	1.82	3.7	3.96	1.35	2.1	2.38	1.65	5.18	1.04	1.4	3.09	3.18	2.33	3.41	1.29	4.6
HV20G5	80924	HARS-related	1.05	1.58	0.5	0.76	1.21	0.8	0.8	1.18	0.93	1.03	0.96	0.72	0.83	1.15	1.46	0.94	1.07	1.72	0.87	0.56	1.36	1.01
HV20G6	810703	high density lipoprotein binding protein	1.59	1.58	0.57	0.78	1.63	1.17	1.12	1.18	0.97	1.09	1.36	0.85	1.15	1.49	1.61	1.71	1.66	1.75	0.87	0.49	1.23	0.89
HV20G7	949934	heterogeneous nuclear ribonucleoprotein A0	0.75	1.6	0.91	1.34	1.15	0.65	0.9	1.2	0.99	0.96	0.94	0.9	1.47	0.98	1.4	0.95	0.87	1.01	1.03	0.93	1.38	1.3
HV20G8	786084	chromobox homolog 1 (Drosophila HP1 beta)	1.48	2.61	1.72	3	2.04	1.25	1.59	2.34	2.35	1.67	0.82	2.33	1.92	3.04	2.34	2.98	2.24	3.03	1.9	0.76	1.12	1.43
HV20G9	71545	mitogen-activated protein kinase kinase kinase kinase 1	0.9	5.9	1.31	3.11	3.28	2.48	2.44	3.02	2.08	2.76	2.05	1.41	1.86	1.77	1.33	1.71	2.42	1.09	1.9	0.54	1.28	1.43
HV20G10	809838	heat shock 70kD protein 2	1.94	2.29	1.36	1.96	1.62	1.23	1.47	1.98	2.24	1.52	0.99	1.26	1.43	1.96	1.12	2.35	2.23	1.45	2.13	2.02	0.71	3.09
HV20G11	52629	calcium/calmodulin-dependent protein kinase I	1.81	3.4	2.41	1.93	2.87	1.69	2.07	1.99	2.97	2.92	2.31	2.42	3.54	3.67	0.86	2.36	1.78	2.41	3.39	1.35	2.51	3.34
HV20H2	131867	guanine nucleotide regulatory protein (oncogene)	1.29	1.75	0.52	1.11	1.92	1.68	0.9	1.18	1.29	0.85	0.91	1.77	1.15	1.21	1.15	1.07	1.48	3.45	1.68	1.11	0.71	1.47
HV20H4	898218	insulin-like growth factor binding protein 3	0.31	0.66	1.48	0.31	1.28	0.34	0.9	0.67	0.37	0.43	0.52	0.49	0.31	0.3	0.39	0.49	0.31	0.21	1.36	0.32	0.64	0.64
HV20H5	796137	"golgi autoantigen, golgin subfamily a, 4"	1.57	1.69	0.82	1.62	1.47	1.37	1.04	1.73	0.92	0.94	0.66	0.94	0.95	1.2	1.03	1.02	0.83	1.38	0.72	0.54	0.49	0.7
HV20H6	774036	glutathione-S-transferase like	0.99	1.33	0.53	0.76	1.58	0.89	1.2	1.17	0.97	0.95	0.99	0.7	0.98	1.26	1.3	1.24	1.05	1.42	0.83	0.5	1.07	0.82
HV20H7	713647	tetraspan 3	0.59	1.69	1.73	0.75	0.89	0.69	0.79	0.94	1.63	0.88	0.97	0.94	1.09	0.51	1.13	1.01	1.48	0.64	0.59	0.47	0.58	1.18
HV20H8	684661	Rev interacting protein	1.09	2.56	2.08	1.9	2.12	1.15	1.41	2.7	1.55	1.16	0.58	1.71	1.99	1.83	1.13	1.5	0.92	1.88	1.1	0.63	1.91	0.94
HV20H9	812155	"Rab geranylgeranyltransferase, beta subunit"	0.92	2.06	0.74	1.11	1.17	1.06	1.43	1	2.04	1.05	0.62	0.44	1.16	1.12	1.2	1.35	0.93	1.39	1.17	0.57	0.73	1.38
HV20H12	563444	forkhead (Drosophila)-like 5	1.43	1.5	1.37	1.04	1.76	1.26	1.08	1.15	1.19	0.98	0.84	2.39	1.3	1.48	1.53	1.37	1.32	1.5	0.97	1.01	0.81	0.83
HV21A4	839682	ESTs	1.68	1.44	1.43	1.33	1.73	1.3	2.22	1.81	1.89	2.63	0.78	1.48	1.17	1.04	1.36	2.29	1.8	1.72	1.49	1.24	0.92	1.37
HV21A5	770992	enhancer of zeste (Drosophila) homolog 2	2.42	0.81	1.71	2.95	0.76	1.23	0.71	0.57	1.2	1.6	0.8	0.96	0.59	1.51	1.32	0.62	0.97	3.53	3.03	2.36	2.22	2.36
HV21A7	841691	ESTs	0.41	0.5	0.78	0.92	1.03	0.49	0.4	0.44	0.52	0.68	1.1	0.52	0.6	0.51	0.54	0.47	0.55	0.57	0.26	0.35	0.25	0.41
HV21A9	686164	"diacylglycerol kinase, zeta (104kD)"	1.17	0.57	0.89	1.15	0.8	0.66	0.45	1.42	1.54	1	1.53	0.82	1.08	1.33	0.9	0.55	0.64	1	1.71	1.25	1.06	1.65
HV21A12	842806	cyclin-dependent kinase 4	1.49	2.03	1.81	1.58	1.54	1.41	1.75	1.62	1.45	0.62	1.32	1.27	1.49	1.6	1.64	1.02	0.91	3.8	1.43	0.56	1.3	1.41
HV21B2	843139	copine I	1.08	1.09	0.91	0.79	2.16	0.99	1.12	0.91	1.72	1.42	1.31	0.84	0.93	0.79	0.53	1.59	0.99	0.95	1.07	0.94	0.91	0.69
HV21B4	785575	interferon gamma receptor 2 (interferon gamma transducer 1)	1.92	2.19	1.24	1.35	2.45	1.54	1.79	1.36	1.37	1.77	1.54	1.56	1.44	2.6	1.88	1.9	1.66	1.33	2.86	1.62	1.64	2.63
HV21B7	827013	"tumor protein 53-binding protein, 1"	1.44	0.86	1.04	0.94	3.32	0.74	0.7	1.5	1.6	0.89	1.36	1.17	0.69	1.42	0.99	0.68	0.65	0.97	1.24	0.77	1.32	1.38
HV21B11	79353	"protein phosphatase 4, regulatory subunit 1"	0.61	0.85	0.87	0.51	0.81	0.52	0.35	0.6	0.47	0.54	0.95	0.27	0.35	0.39	0.78	0.41	0.25	0.33	0.41	0.44	0.62	0.5
HV21B12	785371	N-myristoyltransferase 1	1.39	1.55	0.59	0.46	3.09	1.39	1.08	1.17	0.86	4.11	3.42	1.72	1.66	1.75	1.01	0.73	2.41	1.43	1.49	1.37	1.31	1.87
HV21C3	740344	Human clone 23773 mRNA sequence	1.52	1.99	1.12	1.91	2.36	1.5	1.48	1.29	1.82	1.92	1.98	1.26	1.14	1.31	1.24	1.76	2.23	2.47	0.98	0.91	1.16	0.89
HV21C5	814776	Human clone 23721 mRNA sequence	0.52	0.95	0.7	1.5	0.7	0.83	0.4	0.63	1.14	0.84	1.46	0.84	1	0.84	1.32	0.41	0.75	1.21	0.5	0.84	0.44	0.79
HV21C6	838716	cytochrome c oxidase subunit 11	1.09	1.14	0.66	1.35	1.43	1.15	2.93	1.5	0.95	3.17	1.15	1.23	1.65	1.44	1.43	1.85	1.55	1.32	1.01	1	0.95	2.04
HV21C12	774071	Clathrin assembly lymphoid-myeloid leukemia gene	2.02	1.66	0.74	1.15	2.36	1.72	1.51	1.75	1.57	1.28	1.72	0.77	1.28	0.96	1.12	1.63	0.91	0.71	1.11	0.47	1.01	0.68
HV21D1	760282	Human chromosome 8 BAC clone CIT987SK-2A8 complete sequence	0.69	2.74	0.66	1.27	1.49	0.74	0.64	0.63	1.45	0.56	1.91	0.92	0.8	1.19	0.39	1.34	0.57	1.35	1.27	0.74	0.79	1.5
HV21D2	840882	"Human chromosome 17q12-21 mRNA, clone pOV-2, partial cds"	0.95	1.33	0.49	0.75	1.3	0.91	0.99	1.08	1.13	0.94	0.74	1.26	1.23	1.64	0.5	1.23	0.85	1.03	1.19	1.04	0.75	1.39
HV21D3	782497	Human Chromosome 16 BAC clone CIT987SK-A-362G6	0.67	1.56	1.2	1.7	1.72	0.92	1.27	1.37	1.61	1.13	1.15	2.92	1.21	3.87	0.9	1.02	2.94	1.27	1.13	0.85	0.69	2.68
HV21D4	826622	Human Chromosome 16 BAC clone CIT987SK-A-362G6	1.13	2.03	1.63	1.49	1.99	1.13	1.3	1.78	1.91	1.38	0.88	1.67	1.79	1.93	0.98	1.02	0.91	1.59	1.75	0.98	1.17	2.1
HV21D5	180298	protein tyrosine kinase 2 beta	0.44	0.56	0.42	0.34	0.64	0.34	0.36	0.59	0.57	0.18	0.61	0.24	0.33	0.31	0.38	0.25	0.22	0.29	0.59	0.3	0.65	0.45
HV21D6	785793	"capping protein (actin filament) muscle Z-line, alpha 1"	1.24	1.17	0.68	0.91	0.86	1.18	1.37	1	0.58	1.85	1.06	0.61	0.75	0.88	1.02	0.91	1.97	0.56	1.48	0.65	1.28	1.49
HV21D8	753587	"butyrophilin, subfamily 3, member A3"	1.8	9.37	2.65	3.74	4.28	4.41	4.45	3.77	3.41	2.77	2.57	5.07	3.01	3.62	2.23	1.83	0.91	2.72	4.67	0.93	2.86	3.5
HV21D11	40562	"sarcoglycan, beta (43kD dystrophin-associated glycoprotein)"	1.15	0.21	0.12	0.08	0.92	0.98	0.17	0.14	0.48	0.08	0.4	0.68	0.79	0.68	0.74	0.58	0.91	1.05	0.91	0.67	0.84	0.81
HV21E5	789232	"proteasome (prosome, macropain) 26S subunit, non-ATPase, 4"	1.72	0.71	1.46	1.37	0.76	0.96	1.09	0.89	1.04	1.14	1.22	1.22	1.28	1.33	0.94	0.56	0.91	1.41	1.33	0.84	1.11	1.61
HV21E6	795543	thioredoxin peroxidase (antioxidant enzyme)	1.51	0.67	2.38	0.75	1.37	0.51	0.9	0.59	1.21	1.24	0.85	0.63	0.75	0.87	0.93	1.91	2.1	1.42	0.37	0.45	0.43	0.67
HV21E7	839890	poly(rC)-binding protein 1	1.08	0.57	2.46	0.73	0.83	0.46	0.72	0.45	0.61	1	1.04	0.46	0.62	0.89	0.88	0.82	1.34	1.26	0.51	0.42	0.46	0.59
HV21E8	713886	calponin 2	2	0.88	1.49	0.95	2.16	1.3	1.64	2.05	1.69	1.47	1.55	1.69	2.3	2.06	1.17	1.51	0.47	1.05	1.53	0.36	1.74	3.04
HV21E11	773344	"solute carrier family 16 (monocarboxylic acid transporters), member 2 (putative transporter)"	0.46	0.57	0.83	1.02	0.96	0.39	0.86	1.17	1.17	1.29	0.97	0.57	0.72	0.5	1.47	0.57	0.91	0.66	0.42	0.79	1.63	0.77
HV21E12	788745	novel RGD-containing protein	0.5	0.68	0.7	0.69	0.97	0.43	0.68	0.96	0.88	1.14	0.59	0.45	0.54	0.62	0.36	1.02	0.44	0.6	0.48	0.4	0.34	0.7
HV21F1	768453	ESTs	2.2	3.07	1.14	2.16	2.2	1.73	1.99	1.99	2.57	2.76	2.19	1.79	1.17	1.88	1.87	1.79	2.64	2.84	1.87	1.86	1.96	2.1
HV21F3	73381	"general transcription factor IIA, 1 (37kD and 19kD subunits)"	0.66	1.11	0.65	1.28	1.38	1.03	0.75	1.04	1	2.3	1.33	0.56	0.53	1.03	0.8	0.85	1.23	1.08	0.79	0.41	1.34	0.72
HV21F4	841261	"TATA box binding protein (TBP)-associated factor, RNA polymerase II, C1, 130kD"	1.53	1.72	1.13	1.07	2.74	1.41	1.29	1.01	1.24	1.72	0.9	1.37	1.29	1.38	0.83	1.32	1.91	1.13	4.05	2.16	1.96	6.01
HV21F5	47908	"Human TB1 gene mRNA, 3' end"	0.75	0.75	1.45	1.1	2.4	0.69	0.54	1.1	1.63	0.82	1.61	0.52	0.99	0.58	0.84	0.53	0.89	0.46	1.39	1.6	0.87	1.04
HV21F6	756968	ephrin-B1	0.8	0.9	1.51	0.43	0.95	0.67	0.6	0.67	0.85	1.34	1.02	0.42	0.77	0.77	0.5	0.75	0.91	0.65	1.29	1.1	0.64	1.1
HV21F7	841679	calcium and integring binding protein (DNA-dependent protein kinase interacting protein)	0.91	1.15	0.78	0.62	1.44	0.78	1.38	0.99	0.92	1.24	1.29	1	1.17	2.56	1.14	0.71	0.79	1.24	1.96	0.77	2.37	1.54
HV21F9	825085	suppression of tumorigenicity 14 (colon carcinoma)	1.27	1.34	0.31	0.66	1.04	0.69	0.81	0.73	0.46	0.9	1.32	0.58	0.54	0.55	1.43	0.87	0.62	1.19	3.78	2.64	3.42	2.74
HV21G2	687397	Ras suppressor protein 1	2.33	2.73	1.81	1.2	1.9	1.74	0.96	1.42	1.63	1.65	1.28	1.37	1.44	1.28	1.36	1.58	2.3	3.07	1.15	0.52	0.92	0.98
HV21G4	711959	polymerase (RNA) III (DNA directed) (62kD)	1.68	1.51	0.95	1.09	2	1.2	1.21	1.22	1.64	1.59	0.58	1.61	2.15	3.35	1.5	1.94	2.16	2.37	1.07	0.62	0.82	1.38
HV21G5	760299	regulated in glioma	2.59	1.03	2.89	1.34	1.22	1.44	1.91	0.63	2.88	0.63	1.52	4.54	3.92	9.46	1.56	0.35	1.06	4.54	6.25	2.62	3.2	5.65
HV21G6	814378	"serine protease inhibitor, Kunitz type, 2"	1.02	0.98	0.19	0.41	0.93	1.76	0.8	0.72	1.02	0.76	1.14	1.38	0.59	0.71	0.72	1.46	0.81	0.67	0.8	0.73	0.66	1.11
HV21G8	788190	hyaluronoglucosaminidase 2	0.98	0.96	0.8	0.86	2.12	1.08	1.27	1.23	0.98	1.22	1.33	1.15	1.42	1.42	1.34	1.44	0.72	1.46	1.22	1.9	1.09	1.28
HV21G9	788566	Purkinje cell protein 4	0.96	1.77	1.18	1.38	1.44	0.94	1.1	1.23	1.19	1.45	1.47	1.25	1.05	1.14	1	0.89	0.67	0.9	1.44	0.97	2.18	1.5
HV21G11	824426	ribosomal protein S23	1.01	2.48	1.34	1.56	1.6	1.62	1.37	1.5	1.62	2.14	2.21	0.6	0.87	1.4	1.22	0.86	0.92	2.13	1.33	0.84	1.21	1.11
HV21G12	39808	"phosphoinositide-3-kinase, regulatory subunit, polypeptide 1 (p85 alpha)"	1.88	1.26	0.61	1.97	2.34	1.98	1.22	1.09	0.68	0.83	2.81	0.53	2.56	1.26	1.96	2.06	0.91	1.2	0.84	0.37	1.57	1.33
HV21H2	73531	nitrogen fixation cluster-like	2.04	2.53	3.69	1.74	1.8	2.13	1.11	1.57	1.61	1.16	0.74	1.48	1.24	1.25	1.04	1.39	1.7	2.48	2.14	1.03	1.5	1.72
HV21H3	950578	"Human NADH:ubiquinone oxidoreductase subunit B13 mRNA, complete cds"	0.66	2.06	1.42	1.78	1.75	1.27	1.04	1.48	1.63	1.02	0.83	0.85	1.13	1.68	0.67	1.12	1.64	1.55	1.15	0.86	0.95	1.16
HV21H6	897806	"hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)"	1.31	0.72	0.73	0.61	0.91	1.08	0.57	0.99	0.43	0.75	0.74	0.51	0.56	0.4	1.72	0.72	0.83	0.31	1.29	1.12	1.38	1.11
HV21H7	781097	"neurotrophic tyrosine kinase, receptor-related 1"	1.37	0.69	0.56	0.76	0.82	1.31	0.72	1.04	1.45	0.66	0.64	1.53	0.87	0.84	1.49	0.62	0.51	1.18	1.06	0.76	1.15	1.14
HV21H8	712049	suppression of tumorigenicity 16 (melanoma differentiation)	1.51	1.24	0.61	1.13	1.44	1.74	0.99	1.25	1.38	1.48	1.19	1.97	0.7	1.05	1.68	1.03	0.91	1.13	1.75	1.08	1.43	2.08
HV21H9	292388	Homo sapiens clone 24636 mRNA sequence	1.02	1	0.18	0.26	2.1	0.81	0.33	2.12	0.49	0.69	0.52	2.02	1	1.91	1.72	0.72	1.61	2.16	0.88	0.96	0.76	1.36
HV22A2	840517	"proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)"	0.81	1.74	0.61	1.04	1.45	1.2	0.83	1.02	1	1.07	0.86	1.07	1.05	1.15	0.72	1.65	1.27	1.18	0.69	0.9	0.67	0.89
HV22A4	48631	"potassium voltage-gated channel, shaker-related subfamily, beta member 2"	1.4	2.33	0.93	1.35	1.82	1.54	1.36	1.3	1.46	1.48	1.71	1.91	1.7	2.19	0.62	1.71	0.91	1.73	5.76	1.65	4.48	2.54
HV22A5	842906	JTV1 gene	1.55	0.92	0.63	1.39	1.24	1.67	0.87	1.2	1.12	1.32	1.24	1.51	0.92	0.98	1.23	1.85	0.75	1.86	0.67	1.54	0.97	1.37
HV22A6	781018	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1"	1.33	2.48	1.58	1.5	1.55	1.52	1.71	1.61	1.29	2.09	1.65	0.96	1.11	1.39	1.42	2.71	1.4	2.61	1.12	1.44	1.58	1.49
HV22A7	711680	"zinc finger protein, subfamily 1A, 1 (Ikaros)"	1.64	0.97	1.26	1.56	1.24	1.52	0.61	0.93	0.61	1.05	1.19	0.64	1.4	1.3	1.4	0.83	0.93	1.17	0.59	0.67	0.76	1.12
HV22A8	564803	forkhead (Drosophila)-like 16	2.63	7.69	3.22	5.02	4.06	2.59	2.33	1.44	2.3	1.93	1.36	1.65	1.56	2.82	1.29	2.88	3.51	10.29	1.6	1.99	1.14	1.62
HV22A9	843069	ESTs	0.89	1.14	1.1	1.88	1.2	0.98	0.84	1.32	1.39	1.02	1.05	1.12	0.9	1.01	1.01	0.87	1.27	1.98	0.76	0.98	1.32	1.07
HV22A10	898317	cullin 4A	1.83	2.77	1.34	1.44	1.58	1.77	1.05	1.33	0.82	0.94	1.1	1.83	1.1	1.26	1.13	1.54	1.6	0.82	0.79	1	1.2	1.49
HV22A11	841093	cullin 1	0.8	1.08	0.81	1	1.19	0.77	0.8	0.9	0.73	0.92	0.74	0.75	0.76	0.84	0.59	0.77	0.98	0.98	0.52	0.46	0.59	0.81
HV22A12	704532	N-myc (and STAT) interactor	2.29	3.88	1.83	2.88	2.96	2.38	2.43	2.83	1.82	2.31	1.66	2.56	2.7	2.31	1.41	2.58	2.23	1.36	3.91	1.51	2.69	3.08
HV22B1	144777	HS1 binding protein	1.03	1.55	1.13	1.4	1.59	1.09	1.15	1.11	1.3	1.31	1.32	1.4	0.54	2.13	1.19	1.09	0.89	2.75	1.24	0.84	1.45	1.39
HV22B3	814117	ESTs	0.84	0.96	0.77	1.88	0.93	0.77	0.77	0.7	0.41	0.75	0.65	0.45	0.75	0.51	0.77	0.71	1.25	0.99	0.57	0.95	0.48	0.67
HV22B4	826350	"spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)"	2.46	2.15	0.95	1.45	1.72	1.38	1.51	2.02	2.8	2.23	2.94	1.96	1.29	1.47	1.35	2.63	2.77	0.94	2.59	7.19	3.97	2.59
HV22B6	785745	GS2 gene	0.93	0.93	1.06	0.66	1.62	0.7	0.92	0.88	1.12	0.88	1.29	0.7	1.19	1.37	0.34	1.99	0.85	0.48	1.3	0.67	0.48	1.18
HV22B8	841332	Rho GDP dissociation inhibitor (GDI) beta	0.72	1.63	1.41	1.69	1.83	3.19	1.47	1.83	1.18	2.34	2.28	1.31	1.44	2.13	0.98	2.27	2.43	0.53	4.32	1.16	2.84	2.81
HV22B9	788574	"GCN5 (general control of amino-acid synthesis, yeast, homolog)-like 2"	1.1	2.77	1.41	1.84	1.69	1.74	1.47	1.76	1.95	1.75	1.33	1.48	1.61	1.63	0.6	0.98	1.59	1.63	2.31	3.79	1.77	2.74
HV22B10	788645	Ras-GTPase-activating protein SH3-domain-binding protein	1.11	1.78	0.88	1.13	1.1	1.14	1.2	0.97	0.93	1.45	1.02	1.24	1.08	1.24	1.1	1.17	1.73	0.93	0.89	0.72	0.71	1.07
HV22B11	79022	FBJ murine osteosarcoma viral oncogene homolog B	0.93	1.39	0.78	1.03	1.74	0.95	0.89	0.91	0.83	0.95	1.07	0.78	1.58	1.26	0.82	0.86	0.75	1.46	1.24	0.55	0.7	1.2
HV22B12	795738	guanine nucleotide binding protein 10	0.48	0.49	0.44	0.62	0.81	0.48	0.53	0.69	1.04	0.76	0.48	0.53	0.54	0.62	0.35	0.9	0.89	0.55	0.6	0.53	0.35	0.55
HV22C1	739126	tissue specific transplantation antigen P35B	1.4	2.4	0.49	0.72	1.84	1.64	2.04	0.8	1.17	1.56	1.52	0.48	0.73	1.57	1.42	0.93	0.51	1.04	0.86	0.83	1.27	1.89
HV22C3	815285	protein with polyglutamine repeat	1.57	2.67	1.08	1.63	1.88	2.78	1.32	1.38	1.36	0.9	1.95	1.16	0.97	1.28	1.05	0.88	1.51	2.38	1.77	1.72	1.63	1.77
HV22C4	754538	DR1-associated protein 1 (negative cofactor 2 alpha)	1.22	1.46	0.68	1.11	0.96	1.14	1.36	3.87	1.85	1.6	1.53	1.46	1.14	1.52	1.32	1.8	1.65	1.98	1.26	0.76	0.88	0.93
HV22C6	814465	postmeiotic segregation increased 2-like 3	2.39	2.82	1.62	2.47	2.48	2.29	1.99	1.91	1.64	2.53	1.69	2.49	2.36	3.12	0.74	2.18	2	2.83	3.08	0.2	1.49	1.99
HV22C7	591907	ESTs	0.8	1.37	0.71	0.94	1.03	1.14	0.73	1.39	0.9	1.01	1.22	0.83	0.65	0.98	1.03	0.72	0.94	1.59	1.59	0.67	1.28	1.32
HV22C8	712848	MAP-kinase activating death domain	1.41	2.56	0.85	1.53	2.5	1.73	2.09	2.18	3.29	2.52	2.03	1.19	2.17	2.77	1.18	3.26	2.02	1.67	3.61	1.71	2.26	2.44
HV22C9	843312	KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3	1.09	2.53	1.61	1.55	1.75	1.49	1.42	4.36	1.42	1	3	1.7	3.05	4.04	2.59	2.26	1.33	3.13	14.12	5.38	3.08	5.54
HV22C10	740914	C-terminal binding protein 1	1.4	1.72	0.89	1.22	1.25	0.85	1.58	1.03	1.39	1.35	1.31	1.11	1.48	1.94	1.28	1.78	1.56	0.92	1.16	1.09	1.04	1.31
HV22C12	788247	cullin 2	1.73	3.02	1.42	2	1.97	1.69	1.36	1.41	1.61	1.18	0.96	1.83	2.06	2.08	1.02	2.18	2.08	1.54	0.94	0.49	0.43	0.78
HV22D1	772261	mitogen-activated protein kinase 14	0.7	1.29	1.45	1.17	2.36	0.84	1.16	1.32	1.57	0.85	0.86	0.87	0.77	1.06	1.1	1.06	1.14	1.06	1.03	0.88	1.08	0.88
HV22D2	824382	COP9 homolog	0.23	0.18	0.22	0.2	0.42	0.18	0.23	0.32	0.25	0.19	0.28	0.41	0.36	0.47	0.51	0.27	0.3	0.35	0.26	0.14	0.19	0.18
HV22D3	741841	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (S.cerevisiae CHL1-like helicase)	1.42	5.13	1.86	2.92	3.58	1.69	1.46	1.46	2.54	1.34	1.13	2.29	1.55	1.93	1.2	1.39	1.49	3.37	2.6	1.9	1.54	1.5
HV22D5	669435	prefoldin 4	1.21	3.97	1.92	1.41	1.95	1.25	1.87	1.16	16.46	1.13	0.51	1.98	0.91	1.38	1.06	1.35	1.06	1.77	1.84	0.9	1.4	1.57
HV22D6	814478	BCL2-related protein A1	2.54	12.27	2.44	5.07	3.81	3.09	2.58	2.87	1.88	2.44	1.76	2.99	1.85	3.61	1.78	2.21	5.57	2.95	2.55	2.35	1.81	1.95
HV22D7	162208	"actin related protein 2/3 complex, subunit 2 (34 kD)"	0.77	1.42	0.76	1.05	1	1.04	0.87	1.5	1.06	0.85	1.22	1.15	0.74	1.04	1.18	0.77	1.18	1.63	1.25	0.44	0.97	0.98
HV22D8	897814	peroxisome biogenesis factor 1	1.37	2.63	1	2.5	2.3	1.76	1.33	2.31	1.66	1.31	1.23	1.43	0.68	1.33	1.18	2.06	1.57	1.12	1.9	1.44	1.19	1.48
HV22D9	810552	B-cell associated protein	0.45	1.11	0.47	0.88	0.51	0.84	0.64	0.64	0.55	0.62	0.76	0.57	0.67	0.43	0.45	0.5	1.2	1.18	0.5	0.96	0.82	0.78
HV22D11	897774	adenine phosphoribosyltransferase	1.08	1.39	1.51	1.18	2.2	1.04	1.13	1.49	1.1	1.33	1.19	1.33	0.89	1.27	1.23	0.8	1.68	1.25	1.01	0.63	0.98	0.86
HV22E2	416833	FK506-binding protein 5	0.18	0.27	0.28	0.15	0.18	0.12	0.13	0.12	0.06	0.15	0.14	0.08	0.33	0.39	0.22	0.34	0.32	0.2	0.05	0.11	0.08	0.14
HV22E4	46154	BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)	1.05	1.61	1.28	1.37	1.92	1.59	1.94	1.08	1.14	1.9	1.75	0.97	1.06	1.02	0.81	2.22	1.2	0.65	1.26	2.8	1.29	1.48
HV22E5	814306	tumor protein D52	1.31	3.11	0.63	2.37	1.29	0.77	2.02	4.03	3.86	2.6	1.89	2.56	3.05	1.32	1.95	1.78	1.68	3.06	2.89	4.94	2.81	6.13
HV22E7	711450	nuclear matrix protein p84	1.57	2.09	2.2	2.22	2.07	1.69	1.08	1.52	1.63	1.25	0.93	1.39	0.83	2.8	1.45	0.97	1.24	1.74	1.24	1	1.79	1.54
HV22E8	897594	"RNA-binding protein S1, serine-rich domain"	1.25	1.72	0.82	1.06	1.28	1.47	0.99	0.97	1.09	0.99	1.44	1.08	1.29	0.98	0.88	1.35	1.27	1.45	0.79	1.66	1.05	1.18
HV22E9	826166	Human (clone CTG-B43a) mRNA sequence	1.11	1.11	1.14	1.35	1.16	1.03	0.95	1.42	1.45	1.28	1.29	0.93	0.79	0.9	0.78	0.68	0.97	1.38	0.6	0.87	0.89	0.94
HV22E10	767345	"ESTs, Moderately similar to cadherin 12 [H.sapiens]"	1.99	2.87	1.84	3.04	4.81	1.42	3.71	2.77	2.33	2.59	0.96	2.45	3.99	6.67	1.33	3.37	0.91	1.04	5.51	1.16	1.89	1.43
HV22E11	897636	SEC13 (S. cerevisiae)-like 1	1.4	0.93	1.58	0.89	1.36	0.84	0.95	1.01	0.92	1.08	1.49	1.44	0.71	1.04	0.9	0.78	1.13	1.49	0.72	0.5	1.77	0.81
HV22E12	897690	tumor rejection antigen (gp96) 1	1.35	1.9	2.12	1.49	1.97	1.27	1.64	1.68	1.13	1.97	0.88	1.68	1.27	1.81	1.71	2.13	2.44	2.24	0.74	0.46	0.7	0.86
HV22F1	628955	forkhead (Drosophila) homolog 1 (rhabdomyosarcoma)	0.23	0.42	0.28	0.36	0.53	0.31	0.35	0.53	0.33	0.38	0.84	0.2	0.5	0.44	0.61	0.25	0.22	0.37	0.36	0.19	0.36	0.42
HV22F3	809648	zinc finger protein 162	1.06	2.73	1.51	1.89	2.14	1.24	1.93	1.73	1.54	1.68	1.64	1.33	1.65	2.22	1.54	1.28	1.16	2.6	1.28	0.81	1.09	1.42
HV22F5	781704	thyroid hormone receptor interactor 7	3.4	2.04	1.02	2.54	1.02	1.02	0.83	0.67	0.46	0.77	0.61	1.17	0.65	0.53	0.95	1.39	1.11	0.7	0.76	0.35	1.06	0.7
HV22F6	785334	thyroid hormone receptor interactor 4	1.49	2.12	0.85	1.31	2.19	1.73	1.54	1.28	1.32	1.46	2.17	1.37	1.19	2.12	0.76	0.73	1.52	1.18	2.51	0.63	1.35	1.28
HV22F7	824906	thyroid hormone receptor interactor 3	0.98	1.2	0.67	0.95	0.99	0.9	1.28	1.16	0.85	1.31	1.32	0.92	0.69	1.3	2.05	0.77	0.91	1.15	0.59	0.9	0.66	0.95
HV22F9	840818	"filamin B, beta (actin-binding protein-278)"	0.27	0.34	0.3	0.68	0.58	0.41	0.59	0.56	0.51	0.6	0.61	0.65	0.78	0.93	0.43	0.26	0.89	0.4	0.33	1.17	0.22	0.82
HV22F10	712341	"ESTs, Highly similar to ribonuclease 6 precursor [H.sapiens]"	2.03	4.41	1.86	2.49	2.97	2.14	2.67	2.43	1.91	4.02	2.92	3.19	2.77	3.4	1.54	3.84	2.26	1.98	5.95	1.58	2.12	2.49
HV22F11	897632	"requiem, apoptosis response zinc finger gene"	0.75	1.7	1.14	1.7	1.7	2.44	1.4	1.48	1.29	1.53	1.78	1.43	0.87	0.83	1	1.25	1.26	1.67	1.28	2.09	2.06	1.51
HV22G1	781019	paraoxonase 2	0.28	0.43	0.69	0.4	0.72	0.41	0.34	0.53	0.42	0.54	0.57	0.33	0.51	0.88	0.68	0.32	0.32	0.48	0.49	0.23	0.61	0.55
HV22G3	782692	"phosphatidylinositol 4-kinase, catalytic, beta polypeptide"	0.62	2.57	1.1	1.57	1.82	1.83	1.11	1.08	1	1.18	1.24	0.75	0.75	1.41	0.87	1.09	0.75	1.4	1.41	1.37	1.22	1.38
HV22G4	897910	osteoblast specific factor 2 (fasciclin I-like)	3.9	2.02	0.8	5.53	6.16	2.97	5.92	10.28	6.98	9.38	4.91	5.07	4.67	6.66	2.67	4.03	2.81	1.95	6.22	2.07	6.73	6.56
HV22G8	815534	integrin cytoplasmic domain-associated protein 1	1.25	3.66	2.23	1.27	1.53	2.16	1.28	1.36	1.08	1.12	0.4	1.07	0.91	1.29	1.05	1.45	1.98	1.77	0.82	0.24	0.82	0.9
HV22G9	684634	karyopherin (importin) beta 1	1.13	2.35	1.26	2.49	1.47	1.21	1.25	1.57	1.31	1.24	0.96	1.2	1.13	1.44	0.87	1.74	1.14	1.9	2.08	0.72	1.28	1.55
HV22G10	814731	aryl hydrocarbon receptor-interacting protein	2.3	1.35	0.67	1.26	1.37	1.41	1.34	1	1.16	1.74	1.49	1.19	1.16	1.42	1.28	1.74	1.6	1.45	1.22	0.69	0.9	1.16
HV22H3	784360	echinoderm microtubule-associated protein-like	1.12	4.41	14.91	4.02	6.16	2.31	3.54	1831.39	1506.35	2.42	2.03	2.23	3.37	2.35	1.88	1.67	1.58	0.66	2.59	0.88	1.27	2.3
HV22H4	429182	"dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit"	1.04	0.89	0.95	0.97	1.39	1.75	0.78	0.71	1.2	0.73	0.8	2.05	0.68	0.91	0.83	1.24	1.62	0.83	0.5	0.7	0.29	0.49
HV22H6	949932	"Major histocompatibility complex, class II, Y box-binding protein I; DNA-binding protein B"	1.25	1.85	1.68	1.85	1.45	1.49	0.9	0.8	1.06	0.95	0.96	0.76	0.6	0.53	1.42	1.36	1.51	2.04	0.55	0.24	0.54	0.5
HV22H8	713080	CDC-like kinase 2	2.33	3.16	1.51	2.51	3.59	1.76	2.17	1.73	2.23	1.66	1.35	2.02	1.45	4.19	1.23	1.91	1.82	3.14	4.67	1.82	3.26	3.36
HV22H12	825583	RNA-binding protein (autoantigenic)	1.35	1.16	0.75	0.89	1.42	1.83	1.2	0.89	1.18	1.16	0.88	1.18	1.06	0.98	1.28	1.23	1.57	0.94	1.66	1.63	1.43	1.29
HV23A1	783629	"ESTs, Highly similar to AUTOANTIGEN NGP-1 [H.sapiens]"	2.55	1.66	4.01	2.36	2.03	1.74	1.42	1.45	2.27	1.49	1.74	1.67	1.49	2.29	2.36	2.26	1.98	2.45	1.95	1.34	1.48	1.99
HV23A2	789011	"angio-associated, migratory cell protein"	1.07	2.1	0.73	1.4	1.93	1.14	2.09	1.47	2.43	1.45	1.41	1.51	1.06	1.4	0.89	1.87	1.3	2.13	1.19	1.72	1.91	2.13
HV23A3	788107	amphiphysin-like	1.05	1.29	1.7	1.39	1.35	0.88	1.09	1.15	1.64	1.22	1.15	0.87	1.09	1.16	1.22	1.26	0.81	1.29	1.89	1.3	1.65	1.96
HV23A4	774082	achaete-scute complex (Drosophila) homolog-like 1	1.25	1.3	1.3	1.25	1.42	0.97	1.51	1.14	1.11	1.46	1.06	1.07	1.44	1.93	1.26	1.71	1.15	1.46	2.07	1	0.89	1.1
HV23A5	711768	lysophospholipase II	1.68	0.89	1.17	1.07	1.46	1.29	0.98	0.62	0.54	0.82	1.5	0.55	1.12	1.43	1.41	0.75	1.2	1.11	0.4	0.67	0.71	1.05
HV23A8	824591	heterogeneous nuclear ribonucleoprotein F	2.06	2.92	1.15	1.77	2.1	1.51	2.15	1.15	0.94	1.65	0.99	1.43	1.42	2.24	1.69	2.13	2.38	1.58	0.82	1.16	0.76	1.7
HV23A12	626502	"actin related protein 2/3 complex, subunit 1B (41 kD)"	0.47	1.55	0.85	0.55	1.27	0.87	1.3	0.91	0.9	1.25	1.05	0.46	0.64	0.66	0.75	1.07	0.51	0.75	0.63	0.33	0.76	0.78
HV23B1	786607	transcription elongation factor A (SII)-like 1	0.66	0.94	0.92	1.28	1.27	0.59	0.94	3.04	0.76	0.96	1.28	3.03	1.5	1.11	0.78	0.67	0.69	0.35	1.04	1.15	0.87	1.15
HV23B2	786202	Homo sapiens (clone s153) mRNA fragment	1.13	0.99	0.88	1	1.38	8.88	0.86	0.97	0.89	1.91	1	0.93	0.89	1.83	1.54	1.32	1.01	0.94	1.02	0.6	0.5	1.02
HV23B3	796253	polymerase (RNA) II (DNA directed) polypeptide J (13.3kD)	1.04	1.92	2.87	1.42	1.59	1.21	1.45	1.21	1.35	3.23	2.07	1.09	1.02	1.78	1.45	1.08	1	1.99	2.14	1.28	1.19	1.5
HV23B4	727390	presenilin 1 (Alzheimer disease 3)	1.4	1.25	1.12	1.05	1.12	0.98	1.35	0.89	1.53	2.17	1.37	0.91	1.21	1.79	0.72	1.28	1.16	0.94	1.86	1.26	1.6	2.04
HV23B6	783645	"Homo sapiens (clone S164) mRNA, 3' end of cds"	1.6	2.45	1.41	2.19	1.88	1.51	1.37	1.35	0.74	3.09	0.94	1.39	2.69	2.9	1.2	1.57	1.68	1.67	5.96	3.03	1.91	3.87
HV23B8	79254	MHC class I region ORF	2.02	2.92	1.2	1.56	2.37	1.56	1.78	1.16	1.06	2.37	1.16	1.61	1.32	2.23	1.01	1.84	2.17	1.69	2.29	1.79	1.16	3.08
HV23B9	236305	histidyl-tRNA synthetase	0.76	1.37	0.66	1.91	1.48	0.52	0.78	0.93	1.41	1.39	1.78	0.88	1.13	1.61	0.63	0.8	1.24	1.06	1.14	0.47	1.15	1.16
HV23B11	782811	high-mobility group (nonhistone chromosomal) protein isoforms I and Y	0.6	2.22	0.3	0.69	2.32	0.7	0.89	0.41	0.6	1.61	1.15	0.33	0.63	0.77	0.57	0.66	1.68	0.78	0.46	0.25	0.47	0.5
HV23B12	840158	hexokinase 1	1.07	1.17	0.84	0.71	1.25	1.07	1.06	1.02	0.72	1.17	1.17	0.71	0.97	1.02	0.72	1.51	1.27	0.93	1.43	1.26	0.75	1.42
HV23C2	511586	heterogeneous nuclear ribonucleoprotein A1	1.1	1.53	0.92	0.75	1.45	0.97	0.91	0.89	0.9	1.12	1.09	0.96	1.37	1.81	1.42	1.41	1.99	1.21	0.97	0.52	0.7	1.02
HV23C3	75009	EphB4	1.18	1.88	1.38	1.53	1.82	1.79	0.9	1.1	0.78	1.43	1.82	0.6	1.27	1.46	1.48	1.02	0.91	1.78	1.31	0.74	0.89	0.73
HV23C8	781341	heat shock 10kD protein 1 (chaperonin 10)	0.84	2.13	0.85	1.28	2.84	1.3	1.86	0.95	1.69	3.04	0.97	1.54	1.32	1.49	1.5	1.8	1.81	3.72	2.29	0.78	0.88	1.66
HV23C12	26566	"ESTs, Weakly similar to rotated abdomen protein [D.melanogaster]"	2.82	1.28	1.07	1	1.46	0.73	0.56	0.93	1.63	1.15	0.76	1.46	1.79	2.34	1.54	1.48	0.91	1.04	2.41	3.05	1.92	3.34
HV23D1	135083	"glucose regulated protein, 58kD"	0.83	1.77	1.79	0.74	2.22	1.19	0.95	1.42	1.21	1.29	1.43	1.02	0.99	1.28	1.5	1.69	1.01	0.88	0.92	0.52	0.63	0.95
HV23D2	275871	nucleosome assembly protein 1-like 1	0.68	0.7	0.72	1.08	1.13	0.85	0.85	0.83	0.55	0.88	0.68	0.89	1	0.75	0.53	0.92	0.87	0.87	0.62	0.53	0.65	0.64
HV23D4	212165	"thioredoxin-dependent peroxide reductase 1 (thiol-specific antioxidant 1, natural killer-enhancing factor B)"	1.9	1.39	0.5	1.17	2.52	1.61	0.94	0.75	1.29	1.09	0.53	0.79	0.96	1.57	1.03	0.97	1	1.05	0.97	1.2	0.5	0.69
HV23D6	814508	"protein phosphatase 1, regulatory subunit 7"	1.39	1.86	0.58	0.9	2.94	1.57	1.04	1.19	1.17	1.69	0.88	0.83	1.13	2.06	1.3	0.89	1.66	1.27	1.59	0.66	1.42	1.49
HV23D7	898073	"transmembrane protein (63kD), endoplasmic reticulum/Golgi intermediate compartment"	0.66	1.85	1.96	1.44	1.73	1.07	1.53	2.86	1.13	1.7	2.35	1.33	0.89	0.68	1.66	1.93	2.45	1.47	1.89	1.61	3.27	1.5
HV23D9	770377	Homo sapiens mRNA; cDNA DKFZp434E071 (from clone DKFZp434E071)	0.65	1.57	0.49	0.64	1.77	1.06	1.26	1.21	2.39	1.25	2.02	1.2	0.94	1.17	0.66	0.82	1.84	0.94	1.05	1.05	1.43	1.07
HV23D10	760231	"Homo sapiens clone 24650 ubiquitin hydrolase mRNA, partial cds"	1.45	1.27	1.4	0.84	1.65	1.28	0.96	1.12	1.27	0.77	0.92	0.75	1.21	1.55	1.11	1.09	1.39	0.83	1.19	0.9	1.34	1.52
HV23D11	48398	cell division cycle 25B	0.87	1.25	1.24	1.53	1.32	1.75	0.7	0.71	0.61	1.64	2.27	0.46	0.65	0.5	1.55	1.97	0.91	0.73	1.69	2.73	2.54	1.04
HV23E2	754358	ESTs	0.94	0.9	0.32	1.46	2.17	0.47	3.49	5.63	5.3	1.52	1.49	1.12	0.9	2.44	0.63	1.76	1.48	0.98	0.67	0.14	0.4	2.64
HV23E3	704299	"tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome)"	1.29	1.47	0.87	0.9	1.44	1.01	1.02	0.64	0.68	0.62	1.76	0.91	1.13	1.64	0.91	0.76	0.91	0.98	1.44	2.15	1.3	1.45
HV23E4	565235	spermine synthase	1.27	0.85	0.76	0.84	1.52	0.72	1.34	0.57	1.73	1.11	0.86	0.97	0.76	0.99	0.94	1.54	1.7	1.47	1.06	0.75	0.57	1.46
HV23E5	785459	smoothelin	1.08	1.39	4.25	1.63	2.24	0.77	1.74	1.85	2.11	1.47	1.67	1.07	0.9	1.73	1.52	1.69	0.81	2.65	1.83	1.02	2.19	1.62
HV23E6	815287	H.sapiens mRNA for skeletal muscle abundant protein	1.44	1.47	0.82	1.13	1.56	0.78	1.9	1.08	1.37	1.17	0.87	1.94	1.32	2.18	0.99	1.1	0.91	0.31	2.4	1.36	1.2	1.21
HV23E7	530814	"selenoprotein P, plasma, 1"	2.93	1.66	7.2	4.82	6.91	2.34	2.77	5.19	2.14	2.23	3.63	2.62	4.69	4.35	1.65	3.18	0.9	1.11	5.35	4.18	2.77	6.5
HV23E8	840821	"signal sequence receptor, delta (translocon-associated protein delta)"	2.31	1.37	1.01	1.24	1.69	1.42	1.83	1.14	1.35	1.39	1.19	1.55	1.28	1.75	2.67	1.85	1.31	1.06	1.53	2.48	1.91	2.5
HV23E9	753700	Ras-related GTP-binding protein	1.27	1.73	0.97	0.96	1.52	0.68	0.72	0.95	0.73	0.76	0.95	0.56	0.98	1.31	0.61	0.62	0.8	0.96	0.59	0.62	0.43	0.94
HV23E11	826459	"protein phosphatase 6, catalytic subunit"	1.39	1.26	0.98	1.32	1.24	1.38	1.12	1.29	1.51	0.99	1.09	0.74	1.11	1.29	1.07	1.43	0.81	1	0.83	1	1.04	1.9
HV23F2	877644	papillary renal cell carcinoma (translocation-associated)	1.61	1.86	0.63	1.33	1.89	1.37	1.18	1.15	0.71	2.24	1.62	1.16	1.03	1.92	0.75	1.59	1.82	2.37	1.6	1.73	1.7	2.05
HV23F3	772951	"phosphorylase kinase, beta"	0.59	0.76	0.59	1.24	1.08	0.65	0.5	0.6	0.82	0.76	1.51	0.78	1.09	0.82	0.61	0.76	0.91	0.52	1.49	0.29	1	0.62
HV23F4	625923	phosphoenolpyruvate carboxykinase 2 (mitochondrial)	2.48	1.97	1.09	1.4	1.89	1.78	1.73	1.38	2.34	2.16	1.19	1.81	1.97	2.18	2.09	2.08	1.28	1.55	1.57	1.78	2.52	2.13
HV23F5	843319	HIV-1 Rev binding protein	0.59	1.42	0.6	1.06	1.67	1.48	0.46	0.83	0.63	1.6	1.93	0.75	0.85	0.66	1.85	2.51	1.24	0.96	0.48	0.48	1.43	0.6
HV23F6	950689	"T-cell activation protein, EB1 family"	4.76	2.15	0.88	1.6	1.83	1.72	1.1	1.55	0.84	2.77	1.42	3.38	3.04	3.6	2.64	2.26	2.34	3.29	3.32	1.22	3.3	3.22
HV23F7	773724	Fas (TNFRSF6)-associated via death domain	1.88	1.38	1.02	2.1	1.79	1.33	1.11	1.45	1.57	1.93	2.18	1.22	0.97	1.79	2.79	1.37	1.09	1.12	0.95	1.28	1.15	1.04
HV23F8	814765	A kinase (PRKA) anchor protein 1	1.82	2.01	0.72	1.52	1.68	1.57	1.82	1.24	1.19	2.35	1.18	1.26	1.85	1.78	1.01	2.16	1.74	2.65	3.01	1.84	2.08	3.46
HV23F10	591266	FAT tumor suppressor (Drosophila) homolog	0.89	1.66	1.03	0.9	1.68	1.44	1.02	0.94	0.73	1.79	0.78	0.25	0.88	0.31	1.06	1.71	1.44	0.44	4.31	0.47	3.44	2.12
HV23F12	842928	SULT1C sulfotransferase	1.96	1.87	0.95	1.03	1.95	1.12	1.02	1.2	1.57	1.47	1.15	1.56	1.8	1.87	1.43	1.6	1.59	3.5	1.3	1.57	0.98	2.27
HV23G2	877613	"dynactin 1 (p150, Glued (Drosophila) homolog)"	1.74	1.7	0.78	1.2	2.86	1.6	0.9	1.39	1.62	0.59	1.43	1.81	1.83	2.2	1.41	1.48	2.12	1.51	1.11	0.83	1.37	2.02
HV23G3	897971	"coatomer protein complex, subunit beta"	1.01	0.87	0.57	0.87	1.3	1.37	0.77	1.24	0.58	1.57	1.67	0.81	1.04	1.04	1.01	0.91	1.76	0.81	0.65	0.55	0.7	0.84
HV23G4	796996	immunoglobulin (CD79A) binding protein 1	0.81	1.36	0.77	0.44	3.11	1.19	0.64	0.65	0.73	2.71	1.19	0.43	1.02	1.35	0.63	1.09	2.08	0.58	0.37	0.26	0.32	0.62
HV23G6	812266	"mannosidase, alpha, class 1A, member 2"	3.46	2.32	1.4	1.13	4.05	1.93	0.87	1.34	1.42	2.55	0.86	4.99	2.68	3.47	2.06	1.6	0.91	4.93	2.92	0.6	1.24	3.18
HV23G9	788493	ESTs	1.36	1.41	1.03	1.24	1.36	0.77	0.94	1.22	1.43	0.93	0.89	1.03	0.97	0.65	1.42	1.23	1.24	0.83	0.52	0.94	1.18	0.95
HV23G10	753381	"COPII protein, homolog of s. cerevisiae SEC23p"	1.71	1.1	2.56	1.01	1.08	0.82	1.16	2.18	1.35	1.14	0.52	0.99	1.06	1.43	1.06	1.15	0.75	0.77	0.61	0.29	0.39	1.07
HV23G11	813410	polymerase (RNA) II (DNA directed) polypeptide K (7.0kD)	1.24	1.29	1.69	1.87	1.72	1.57	1.58	1.54	2.43	1.81	1.61	1.81	0.93	0.84	1.76	1.68	2.17	1.12	0.95	1.48	0.9	1.57
HV23G12	897626	"RAB7, member RAS oncogene family"	1.42	0.89	0.8	0.92	1.58	1.05	0.81	1.48	1.31	1.38	1.28	1.18	1.46	1.08	1.29	1.3	1.09	1.07	0.7	1.2	0.87	1.36
HV23H1	667883	ESTs	1.28	0.52	0.42	0.55	0.72	0.68	0.52	0.87	0.5	0.23	0.43	0.41	0.93	0.5	0.51	0.31	0.3	0.84	1.13	0.68	0.4	0.49
HV23H2	843070	nucleoporin 88kD	2.51	1.81	1.09	1.04	1.73	0.95	1.11	1.23	0.9	0.73	0.66	2.12	1.94	0.81	0.98	0.98	1.23	0.8	1.58	2.22	1.77	1.15
HV23H3	897901	ESTs	3.13	1.32	0.71	1.03	1.36	1.13	0.85	1.1	0.85	0.79	1.28	2.16	1.64	0.5	0.88	0.9	1.93	0.42	1.86	3.14	1.61	1.67
HV23H4	826135	serine threonine protein kinase	1.97	1.39	0.95	1.01	0.86	1.35	0.98	1	0.99	1.09	0.72	1.53	1.35	0.89	1.04	0.98	1.47	0.71	2.39	1.37	1.52	1.69
HV23H7	784744	M-phase phosphoprotein 6	1.33	1.85	0.77	1.15	1.69	1.65	1.18	1.14	1.19	1.01	2.81	0.58	0.98	1.34	1.22	1.66	0.91	1.36	0.69	0.76	1.7	0.77
HV23H9	815294	"protein tyrosine phosphatase, receptor type, c polypeptide-associated protein"	1.35	1.77	1.94	1.33	1.92	1.19	1.54	2.07	1.38	1.49	1.94	0.98	1.18	1.41	1.28	1.1	1.1	0.96	2.71	2.29	5.44	1.86
HV23H12	74566	"exportin 1 (CRM1, yeast, homolog)"	1.67	0.92	1.31	1.26	1.15	1.02	0.71	1.5	1.06	0.83	0.75	0.92	1.13	0.9	1.29	0.84	1.54	0.73	1.78	1.36	1.06	1.15
HV24A2	567414	"nuclear transcription factor Y, beta"	0.97	0.94	0.63	0.82	1.27	0.77	0.66	0.79	0.95	1.01	0.62	0.61	1.14	0.86	0.63	0.8	2.11	0.92	0.39	0.92	0.51	0.75
HV24A3	898108	adenovirus 5 E1A binding protein	1.16	0.96	1.25	2.56	0.59	1.23	1.2	1.03	2.02	1.1	1.11	1.66	1.28	1.84	0.61	0.52	0.72	3.51	0.85	0.52	0.63	1.02
HV24A4	840606	hydroxysteroid (17-beta) dehydrogenase 4	0.8	1.07	0.62	0.67	1.27	0.41	0.64	1.25	1.65	0.86	0.79	0.79	1.13	1.71	0.75	0.97	0.87	0.56	1.02	0.36	0.89	1.57
HV24A7	591281	lung resistance-related protein	0.27	0.38	0.28	0.28	0.36	0.42	0.55	0.67	0.36	0.39	0.64	0.33	0.37	0.38	0.38	0.32	0.13	0.41	0.8	0.62	1.31	0.94
HV24A8	782449	poly(rC)-binding protein 2	0.78	1.18	0.93	0.96	0.94	0.8	0.81	0.99	1.21	0.98	1.25	0.9	1.23	1.05	1.09	1.05	1.12	1.22	0.57	0.79	0.73	0.89
HV24A9	782543	ESTs	0.93	1.24	1	1.43	0.88	0.99	0.85	0.91	0.95	0.86	1.12	1.08	1.19	1.18	0.87	0.83	0.67	2.18	0.82	0.84	0.7	1.26
HV24A10	773192	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 1	1.03	1.5	1.04	0.93	2.15	1.09	0.83	0.97	0.88	1.43	0.91	0.97	0.88	1.27	1.06	3.01	1.72	1.71	0.63	0.39	0.83	1.42
HV24A12	814460	surfeit 5	2.64	0.98	0.72	0.65	1.65	0.87	0.81	0.8	1.06	0.77	0.97	1.09	1.64	1.82	1.33	1.52	0.91	0.94	0.92	1.93	1	1.19
HV24B3	825478	zinc finger protein 146	1.23	1.33	1.39	1.7	2.3	1.54	0.62	1.01	0.97	0.6	1.03	1.09	0.73	0.93	1.05	0.9	1.18	1.22	1.09	1.01	1.46	1.24
HV24B4	825577	steroidogenic acute regulatory protein related	1.56	1.65	1.12	1.03	2.49	1.44	2.15	1.82	1.27	2.47	3.28	2.02	1.55	1.98	3.53	1.92	1.98	1.63	6.48	4.95	2.76	3.16
HV24B5	898312	TNF receptor-associated factor 4	0.41	1.03	0.77	0.69	0.66	0.53	0.69	0.83	0.67	0.65	1.35	0.68	0.4	0.66	0.97	0.77	0.45	0.74	0.77	1.03	1.81	0.78
HV24B6	811870	"dynein, cytoplasmic, light intermediate polypeptide 2"	1.11	2.26	1.06	1.8	2.29	1.97	1.47	1.97	1.35	3.32	2.96	1.55	1.09	1.35	0.85	1.55	1.64	0.96	2.16	0.81	1.08	1.14
HV24B7	825296	"brefeldin A-sensitive, peripheral Golgi protein"	0.8	1.57	1.08	1.33	1.24	1	1.25	1.2	0.76	1.08	1.64	1.1	1	2.43	1.28	0.87	0.75	1.73	1.41	1.13	0.87	1.42
HV24B10	813520	EphB3	3.9	2.46	2.37	2.1	3.52	1.18	1.45	1.79	1.2	2.79	2.04	1.54	3	1.59	1.31	1.91	2.5	0.94	2.47	0.91	1.06	1.73
HV24B11	786675	"epididymis-specific, whey-acidic protein type, four-disulfide core"	0.35	0.28	0.21	0.17	0.76	0.15	0.18	0.28	0.42	0.13	0.49	1.19	0.4	0.88	0.32	0.18	0.42	0.29	0.63	0.73	0.57	2.52
HV24C1	898253	"reticulocalbin 2, EF-hand calcium binding domain"	1.12	1.13	2.7	1.97	0.78	1.1	0.59	1.47	1.86	1.38	0.87	1.04	0.92	1.62	0.86	1.15	1.44	1.82	1.47	0.62	1.12	0.9
HV24C5	796341	H. sapiens RNA for CLCN3	0.65	1.01	0.83	0.77	1.37	1.09	0.67	1.08	1.4	0.7	0.9	2.49	0.77	0.65	1.09	0.88	0.78	0.57	0.77	0.66	0.8	0.78
HV24C7	840600	"guanine nucleotide binding protein (G protein), beta polypeptide 1"	1.28	1.79	1.36	1.05	1.32	1.59	1.25	1.89	1.7	1.01	1.88	1.09	0.89	0.88	1.11	0.83	1.25	0.91	1.16	1.13	1.85	1.6
HV24C9	788654	growth factor receptor-bound protein 2	2.31	1.47	1.67	1.3	1.14	0.76	1.74	2.92	1.74	3.6	2.66	2.53	1.39	1.16	1.58	0.62	0.53	1.7	2.81	3.41	2.44	2.24
HV24D2	700527	glutaredoxin (thioltransferase)	0.47	1.44	0.38	0.86	1.56	0.94	0.85	1.08	0.6	1.55	1.06	0.87	0.63	1.39	0.29	0.71	0.91	0.44	1.03	0.21	0.89	1.46
HV24D3	841370	"glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)"	0.54	0.8	0.49	0.46	0.78	0.5	0.7	1.05	1.28	0.39	0.51	0.99	0.4	0.96	0.45	0.49	0.48	0.35	0.7	0.65	0.63	0.46
HV24D4	51702	"glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)"	0.68	1.32	0.41	1.08	1.82	1.18	0.97	0.59	0.81	0.62	1.33	0.84	0.74	1.3	1.07	0.45	0.91	0.98	0.77	0.95	0.87	0.73
HV24D6	711961	"general transcription factor IIF, polypeptide 1 (74kD subunit)"	1.03	2.24	0.96	1.33	2.31	1.52	1.7	1.69	1.32	1.19	1.48	1.26	1.38	1.01	1.02	0.99	0.91	1.12	2.46	1.79	1.13	2.3
HV24D9	81289	"actin, gamma 2, smooth muscle, enteric"	1.01	1.14	3.11	1.21	1.36	1.44	1.67	3.05	0.63	0.78	0.58	0.92	1.16	1.23	1.28	0.79	0.78	1.58	1.02	1.59	2.2	1.29
HV24D10	415698	galactosylceramidase (Krabbe disease)	1.57	2.45	1.41	1.22	1.93	1.29	1.62	1.71	1.81	1.09	1.07	1.28	1.32	2.19	1.75	1.35	2.06	1.32	1.02	0.62	0.92	1.02
HV24E1	703479	"DNA segment, numerous copies, expressed probes (GS1 gene)"	1.16	0.59	2.26	2	2.43	1.14	0.82	2.02	1.8	1.97	1.75	1.68	1.17	1.12	1.25	0.44	1.16	1.06	5.13	2.41	5.38	2.53
HV24E3	795173	GM2 ganglioside activator protein	0.85	0.6	0.62	0.49	0.92	0.71	0.72	0.74	0.69	0.95	1.33	0.78	0.63	0.85	0.67	0.65	0.31	0.54	1.64	0.62	1.94	1.18
HV24E6	789318	cyclin C	0.6	0.96	0.57	1.65	1.71	1.5	0.73	0.7	1.69	1.23	0.71	0.78	0.98	0.7	1.13	1.78	1.41	0.77	0.54	0.4	0.77	0.37
HV24E7	840384	G-rich RNA sequence binding factor 1	1.87	1.3	0.99	1.12	0.85	0.79	0.8	1	1.39	1.01	1.06	0.75	0.88	0.8	1.62	0.67	0.7	0.91	0.99	0.93	0.74	1.32
HV24E9	814260	follicular lymphoma variant translocation 1	1.14	0.8	0.98	0.89	1.07	0.69	0.66	1.01	0.93	2.25	0.9	0.8	0.89	1.31	0.77	0.98	0.55	1.86	0.66	0.4	0.6	1.05
HV24E10	376875	flavin containing monooxygenase 1	1.64	2.36	1.46	1.34	1.94	1.08	1.73	1.94	1.66	1.69	1.36	1.12	0.92	2.15	1.87	1.97	0.95	1.58	1.16	0.89	1.18	1.37
HV24E11	814526	ESTs	3.18	1.27	2.04	2.89	2.04	2.47	0.71	1.34	2.51	3.76	2.1	4.11	1.65	1.73	1.85	0.55	1.92	4.29	4.64	2.42	3.49	2.24
HV24F2	139009	fibronectin 1	0.69	0.29	1.22	0.68	1.19	1.62	1.66	4.25	1.96	2.31	1.85	1.01	1.18	1.91	0.77	0.39	0.43	0.88	1.86	0.93	1.43	1.01
HV24F3	784224	fibroblast growth factor receptor 4	1.15	1.24	1.82	1.37	1.52	1.46	1.76	2.86	2.82	1.68	2.46	1.96	1.33	2.94	2.47	1.45	0.97	1.71	3.11	2.07	2.73	1.97
HV24F5	566887	chromobox homolog 3 (Drosophila HP1 gamma)	1.19	1.64	1.44	1.64	1.07	1.63	0.68	0.95	0.83	0.63	1.31	1.14	0.74	0.99	1.13	1.09	0.67	1.52	0.79	0.68	0.69	0.83
HV24F7	122159	"collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant)"	5.03	4.93	17.83	10.68	15.78	8.17	6.51	7.61	9.47	14.4	7.91	6.75	6.16	10.49	2.96	3.38	7.48	19.09	56.8	11.32	28.55	52.33
HV24F8	80410	"farnesyl diphosphate synthase (farnesyl pyrophosphate synthetase, dimethylallyltranstransferase, geranyltranstransferase)"	2.22	2.21	1.42	2	2.87	2.75	1.63	1.2	0.88	2.91	1.87	1.24	1.15	3.44	1.46	2.33	2.36	0.94	1.17	0.6	1.35	1.17
HV24F11	81331	fatty acid binding protein 5 (psoriasis-associated)	3.34	6.97	2.99	4.53	2.99	1.88	1.76	1.54	1.67	2.22	1.63	0.77	1.41	2.23	1.01	0.68	3.44	4.74	1.93	0.7	1.49	1.72
HV24F12	841698	exostoses (multiple) 1	0.88	1.35	0.8	0.99	3.06	2.22	0.89	0.92	0.87	2.33	1.65	0.4	0.72	0.7	1.24	1.5	4.89	0.85	0.61	0.53	0.77	1.09
HV24G1	204614	Human clone 23933 mRNA sequence	0.83	0.88	1.28	0.9	0.74	1.25	0.83	0.63	0.97	0.48	0.95	0.71	1.46	0.75	1.05	1.46	0.66	0.85	1.05	1.05	1.12	0.69
HV24G3	80500	esterase D/formylglutathione hydrolase	1.22	1.88	1.2	0.79	1.94	1.01	1.05	1.13	1.9	0.7	1.16	1.03	0.91	1.5	1.04	1.58	0.64	1.29	2.22	1.13	0.77	1.02
HV24G5	796198	ESTs	0.65	0.72	0.45	0.42	0.85	0.5	0.33	0.82	0.6	0.34	0.57	0.46	0.4	0.31	0.57	0.44	0.62	0.4	0.96	0.48	2.03	1.08
HV24G7	704290	endothelin converting enzyme 1	1.57	0.98	1.41	0.86	1.5	2.94	0.98	1.33	0.91	1.27	1.71	2.4	1.07	0.88	1.54	0.82	0.64	0.83	3.32	4.82	3.68	3.79
HV24G8	774409	endoglin (Osler-Rendu-Weber syndrome 1)	4.11	4.85	2.94	3.48	2.15	2.01	2.31	2.83	1.98	1.08	2.04	3.85	5.4	4.03	2.79	2.74	1.86	6.4	3.05	0.13	0.98	1.95
HV24G9	71672	"electron-transfer-flavoprotein, alpha polypeptide (glutaric aciduria II)"	0.43	0.78	0.57	0.4	0.71	1.84	0.54	0.57	0.55	1.85	1.09	0.41	0.52	0.94	1.09	0.59	0.84	0.56	0.88	0.44	1.45	0.66
HV24G10	840944	early growth response 1	0.79	0.7	0.24	0.36	0.66	0.24	0.47	0.71	0.36	0.63	0.55	0.24	1.89	0.72	0.49	0.26	0.23	0.63	0.44	0.12	0.38	0.47
HV24H2	843140	KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2	2.45	1.54	1.2	1.47	1.8	1.7	1.73	3.09	2.01	1.85	1.08	3.02	1.62	2.56	1.73	1.03	0.91	2.82	1.56	1.02	1.12	1.85
HV24H3	328802	elastase 3B	1.26	0.84	0.95	0.61	1.97	0.81	0.67	1.27	2.41	0.36	0.6	1.14	0.96	1.41	1.04	0.48	0.94	1.43	2.63	0.92	0.91	1.62
HV24H4	786048	"E2F transcription factor 4, p107/p130-binding"	0.87	1.65	0.84	1.19	1.89	1.49	0.9	1.31	1.28	0.66	0.98	0.74	0.74	1	0.59	0.78	0.91	0.78	0.83	0.54	0.58	0.53
HV24H5	950367	"adenosine deaminase, RNA-specific"	1.93	1.6	1.67	1.64	2.14	1.89	2.15	2.34	1.82	1.39	1.59	2.13	1.21	2.78	1.27	1.32	2.05	2.77	2.8	1.96	3.27	3.09
HV24H9	195753	dihydrolipoamide branched chain transacylase (E2 component of branched chain keto acid dehydrogenase complex; maple syrup urine disease)	1.33	1.03	1.03	0.55	2.01	1.27	0.98	1.49	1.35	0.43	0.57	1.08	1.24	1.06	1.23	0.71	0.91	1.3	1.42	0.76	1.01	1.15
HV24H10	815564	dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)	0.88	1.24	0.72	0.83	2.25	1.57	1.14	0.96	1.23	0.9	1.47	0.5	0.93	1.2	0.9	1.28	1.95	0.84	0.87	0.53	0.67	0.71
HV24H11	815555	"diacylglycerol kinase, alpha (80kD)"	0.35	0.89	0.38	0.47	1.61	0.58	0.4	0.51	0.46	0.24	0.55	0.37	0.45	0.45	0.53	0.41	0.91	0.32	0.5	0.15	0.39	0.33
HV25A2	784777	dCMP deaminase	0.98	1.05	0.66	0.83	1.14	0.75	0.85	1.01	0.89	0.68	0.9	0.79	0.98	0.94	0.53	1.47	0.87	0.58	0.53	0.93	1.04	1
HV25A5	45641	mitogen-activated protein kinase kinase 3	0.55	0.89	0.88	1.14	1.09	0.8	0.67	0.86	1.1	0.88	1.03	0.77	1.04	0.58	1.31	0.96	0.73	1.55	1.12	0.76	1.77	1.09
HV25A6	824031	"heat shock protein, DNAJ-like 2"	1.76	2.6	1.48	1.93	2.26	0.98	1.85	1.5	1.28	1.67	0.86	1.42	1.3	1.35	1.21	1.02	2.04	2.14	0.76	0.68	0.76	1.53
HV25A7	810787	heat shock 40kD protein 1	0.98	0.99	0.45	0.65	0.73	0.51	0.48	0.57	0.7	0.49	0.53	1.09	0.51	0.77	0.7	0.43	0.31	1.68	0.56	0.39	0.42	0.71
HV25A10	767817	polymerase (RNA) II (DNA directed) polypeptide F	1.7	1.99	2.14	1.37	1.78	1.76	1.42	1.04	1.7	1.29	0.92	0.99	0.77	1.7	0.74	1.45	1.34	2.57	0.91	0.46	0.83	1.16
HV25A11	666425	"phospholipase C, gamma 1 (formerly subtype 148)"	0.87	1.03	1.23	1.42	1.31	0.48	1.04	0.81	1.1	1.11	0.68	0.91	0.75	1.41	0.95	1.2	0.79	1.22	0.9	0.69	0.87	0.96
HV25B1	51666	"excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing)"	1.03	2.06	1.68	1.57	1.59	2.33	1.67	2.3	1.38	3.02	3.03	1.56	0.79	0.82	1.2	1.1	1.93	1.21	4.69	2.7	4.69	1.94
HV25B5	838373	"DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 9 (RNA helicase A, nuclear DNA helicase II; leukophysin)"	0.95	1.23	1.09	2.08	1.2	1.3	0.81	0.88	0.63	1.31	1.56	0.69	0.76	0.75	0.96	0.7	1.57	0.9	1.17	2.22	1.8	1.82
HV25B6	66564	"3-hydroxybutyrate dehydrogenase (heart, mitochondrial)"	2.96	3.65	0.87	1.63	2.43	1.79	1.83	1.17	1.23	2.88	1.56	2.2	1.8	2.46	0.91	2.66	2.44	0.44	1.57	3.41	0.98	1.38
HV25B7	666128	D component of complement (adipsin)	2.73	1.86	2.28	1.45	3.46	1.21	1.44	1.77	1.1	1.72	1.44	1.15	0.91	0.92	1.1	1	3.66	2.65	2.35	1.17	1.92	2.25
HV25B8	753862	protease inhibitor 6 (placental thrombin inhibitor)	1.49	0.86	1.01	1.02	1.04	0.61	1.35	0.46	0.5	1.5	0.67	0.8	1.18	0.97	0.54	0.93	0.53	1.49	0.48	0.56	0.66	0.8
HV25B9	842860	"interleukin 10 receptor, beta"	2.67	1.68	2.48	1.31	3.49	1.07	1.46	2.61	1.01	1.73	1.52	1.28	1.28	1.33	1.11	0.89	3.22	2.18	2.92	1.11	2.86	2.51
HV25B11	40017	cytochrome c-1	0.87	0.42	0.88	1.49	0.82	0.75	0.39	0.77	0.43	0.74	0.44	0.81	0.53	0.61	1.41	1.15	0.97	1.05	0.61	0.43	0.49	0.51
HV25C1	739901	"cytochrome P450, 51 (lanosterol 14-alpha-demethylase)"	1.15	2.84	1.96	1.83	1.84	4.02	2.32	4.23	2.52	3.84	2.98	1.47	1.15	1.14	1.48	1.58	1.24	1.32	4.3	2.46	3.88	2.04
HV25C2	782760	"cytochrome P450, subfamily I (dioxin-inducible), polypeptide 1 (glaucoma 3, primary infantile)"	1.12	1.42	6.03	3.15	4.85	2.01	2.33	1.5	2.74	1.35	1.98	1.83	0.84	1.33	0.79	2.96	1.56	1.16	1.52	0.49	1.28	1.6
HV25C3	949938	cystatin C (amyloid angiopathy and cerebral hemorrhage)	1.67	2.3	1.55	1.25	2.27	1.87	0.77	1.44	1.27	1.32	1.19	1.58	2.82	2.11	1.11	0.68	1.31	2.19	4.59	1.71	2.79	4.52
HV25C4	795296	cyclin H	1.6	1.61	0.98	1.2	1.09	1.21	1.65	2.06	2.86	1.69	0.39	1.56	2.29	2.63	1.3	1.01	1.5	1.68	1.56	1.29	0.81	1.55
HV25C5	841641	cyclin D1 (PRAD1: parathyroid adenomatosis 1)	0.73	0.53	0.36	0.58	1.1	0.44	1.93	2.75	3.23	2.73	1.1	2.31	1.65	2.2	2.46	0.51	0.39	2.48	2.45	2.6	1.25	2.77
HV25C6	950690	cyclin A2	2.61	1.61	0.87	1.67	1.7	2.48	1	0.81	1.16	1.37	0.91	1.04	0.83	3.08	1.61	1.57	1.7	2.32	5.49	4.37	3.23	6.36
HV25C7	701751	cut (Drosophila)-like 1 (CCAAT displacement protein)	0.63	2.86	1.95	2.02	2.29	1.21	1.55	3.04	1.7	2.66	1.86	0.86	0.95	0.98	1.22	1.33	1.06	1.17	1.64	1.47	1.21	1.15
HV25C8	839736	"crystallin, alpha B"	4	1.81	3.53	2.02	8.23	0.34	0.79	0.94	0.67	0.74	0.81	0.73	1.5	0.85	0.31	1.03	4.59	4.36	0.77	0.15	0.3	0.54
HV25C11	898092	connective tissue growth factor	0.75	0.48	0.75	0.68	1.5	0.43	1.05	2.72	0.58	0.91	1.04	0.46	2.9	2.01	1.31	0.48	0.39	1.21	0.92	0.17	0.5	1.12
HV25D1	85497	complement component 2	1.3	8.11	3.77	2.78	3.59	2.95	3.23	14.63	0.95	3.29	2.09	2.85	1.27	2.08	1.57	1.79	1.64	1.73	3.14	1.1	2	2.11
HV25D8	142788	collagen-binding protein 2 (colligen 2)	2.17	2.5	3.57	3.42	4.64	1.09	3.18	5.28	2.7	2.41	2.01	2.04	1.39	2.31	1.47	1.99	1.66	2.02	2.56	0.86	2.19	2.28
HV25D9	810632	"collagen, type VI, alpha 2"	1.38	3.41	2.06	1.78	2.41	1.5	2.14	2.66	0.95	1.48	1.4	1.59	1.43	1.74	1.46	1.43	1.86	1.55	2.01	1.02	1.17	1.83
HV25D11	839991	"collagen, type I, alpha 2"	1.16	2.22	2.47	1.94	3.12	1.49	1.82	3.02	1.48	2.12	1.76	2.83	1.07	1.61	0.61	1.44	1.7	1.62	2.95	2.57	3.69	4.19
HV25D12	758148	"coagulation factor VIIIc, procoagulant component (hemophilia A)"	1.68	3.44	1.97	2.2	2.76	1.83	1.96	2.6	2.14	1.74	1.12	1.8	2.21	2	1.28	2.29	1.78	1.18	3.56	1.24	1.17	1.79
HV25E1	714426	"cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kD"	1.86	1.11	1.68	1.44	1.32	0.97	0.9	2	1.09	1.23	1.14	1.33	1.12	1.67	0.92	0.64	0.88	1.46	1.03	0.55	0.68	1.07
HV25E2	796984	"cytochrome b-245, beta polypeptide (chronic granulomatous disease)"	3.05	5.57	5.32	5.73	6.09	6.31	4.48	6.01	2.67	6.47	3.43	5.82	6.98	6.44	3.02	2.88	2.83	2.16	10.82	4.14	3.45	4.08
HV25E3	724615	chromosome condensation 1	1.33	1.22	0.73	1.2	1.15	1.02	0.76	0.79	0.7	1.18	1.03	0.55	0.53	0.62	0.7	0.61	1.19	1.07	1	0.87	1.14	1.06
HV25E4	756211	"cholinergic receptor, nicotinic, epsilon polypeptide"	1.03	2.01	1.18	0.78	1.95	0.84	1.52	0.94	1.59	1.15	0.87	0.74	0.96	1.25	0.99	1.67	0.62	1.41	1.74	0.58	1.06	1.21
HV25E5	898258	chimerin (chimaerin) 1	0.38	0.61	1.59	1.02	1.12	0.47	0.7	1.02	1.1	0.89	0.7	0.22	0.43	0.34	0.67	0.53	0.47	0.42	0.56	0.39	0.72	0.54
HV25E8	825335	"spastic paraplegia 7, paraplegin (pure and complicated autosomal recessive)"	2.33	2.42	2.15	1.86	3.47	0.99	2.45	2.23	1.91	1.71	0.9	1.73	1.7	1.45	1.24	1.66	2.05	1.87	2.61	1.23	1.49	2.3
HV25E10	898286	"cell division cycle 2, G1 to S and G2 to M"	3	1.1	2.17	2.63	2.17	1.11	2.11	0.68	1.01	1.83	0.48	0.98	0.61	2.62	1.26	1.34	1.64	1.73	0.67	1.13	0.44	1.14
HV25E12	687875	cathepsin S	2.01	11.43	10.82	9.06	6.4	4.53	10.9	21.29	12.29	8.52	3.38	5.48	2.71	3.99	2.5	3.16	2.67	1.94	12.07	2.21	3.44	5.86
HV25F1	841470	cathepsin H	0.67	1.16	0.37	0.58	0.89	0.17	0.34	0.34	0.19	0.17	0.57	0.2	0.19	0.27	0.55	0.2	1.19	1.01	1.01	0.67	0.68	0.9
HV25F3	774754	"catenin (cadherin-associated protein), beta 1 (88kD)"	3.38	2.04	2.67	2.06	2.87	2.08	1.51	3.43	1.43	1.41	2.34	2.39	2.47	2.68	1.55	1.1	1.6	6.08	1.03	0.65	0.54	1.04
HV25F5	795840	carboxypeptidase E	0.81	1.92	1.23	1.96	1.58	0.81	1.19	1.04	1.31	2.01	1.43	0.73	0.78	1.04	1.13	0.88	0.86	1.45	1.57	0.51	1.17	0.93
HV25F9	511521	calnexin	0.57	0.5	0.83	1.12	0.87	0.73	0.53	1.07	0.49	0.78	0.79	1.16	0.68	0.58	1.94	0.52	1.08	0.49	0.47	0.93	0.7	0.83
HV25F12	69672	"cadherin 5, VE-cadherin (vascular epithelium)"	1.71	1.55	0.62	1.26	2	1.98	1.25	1.29	0.86	2.17	1.32	1.84	1.47	2.23	0.59	1.83	1.97	0.76	4.7	1.82	1.73	1.76
HV25G1	773301	"cadherin 3, P-cadherin (placental)"	0.69	1.21	0.22	0.3	0.77	0.26	0.2	0.33	0.22	0.36	0.38	0.17	0.23	0.33	0.53	0.19	1.07	0.92	1.22	0.6	0.85	0.14
HV25G2	838568	cytochrome c oxidase subunit VIc	0.67	0.68	1.39	0.95	0.83	1.12	1.72	3.15	2.77	1.16	1.65	1.68	0.93	2.2	1	1.04	0.84	0.44	4.19	3.31	1.36	6.53
HV25G3	840894	cytochrome c oxidase subunit VIa polypeptide 1	0.9	0.83	0.5	0.97	0.41	0.44	0.64	1.34	1.08	0.9	0.72	0.7	0.5	1.08	0.93	0.69	0.51	1.38	1.31	1.32	0.85	0.99
HV25G4	51814	cystatin B (stefin B)	2.2	1.96	0.73	1.46	1.55	1.71	1.3	1.07	1.15	1.27	1.05	1.28	1.02	1.46	1.56	1.62	2.44	2.22	0.99	0.5	0.96	0.62
HV25G5	789049	"nuclear receptor subfamily 2, group F, member 1"	1.7	3.5	1.59	2.13	2.75	1.17	1.39	1.69	1.89	2.29	0.88	1.5	1.9	1.78	1.14	1.22	1	1.83	1.42	0.6	0.85	1.67
HV25G7	950096	archain 1	2.61	2.52	1.38	1.23	1.61	1.17	1.06	1.6	1.38	1.5	1.41	1.32	1.33	1.92	1.33	1.06	1.95	2.27	1.05	0.45	1.08	0.88
HV25G8	77805	"coatomer protein complex, subunit beta 2 (beta prime)"	3.67	2.05	1.2	1.4	1.66	1.28	1.53	2.05	1.94	1.6	1.46	1.8	1.22	2.28	1.8	1.92	1.71	2.92	1.24	0.48	0.85	0.94
HV25G12	897655	sperm specific antigen 2	1.14	1.21	0.86	1.38	2.92	0.99	1.26	0.97	2	1.1	1.09	1.07	1.73	2.62	1.17	1.61	1.6	2.48	1.15	0.52	0.88	0.97
HV25H1	897531	melanoma adhesion molecule	0.27	0.63	0.81	0.51	0.87	1.45	0.77	2.36	0.77	0.72	1.46	0.55	0.37	0.45	0.69	0.29	0.91	0.19	2.84	5.84	4.63	1.72
HV25H3	725454	CDC28 protein kinase 2	1.52	3.41	1.58	1.93	1.55	1.11	1.68	0.56	1.63	1.25	0.66	0.57	0.8	1.79	1.2	0.87	2.13	4.08	0.99	0.62	0.51	0.64
HV25H4	843049	minichromosome maintenance deficient (S. cerevisiae) 4	2.17	2.16	1.51	2.19	1.98	1.03	1.19	1.25	1.16	1.11	1.4	0.89	1.37	1.54	2.14	1.74	2.18	3.45	2.67	1.66	2.99	1.48
HV25H5	840978	CD81 antigen (target of antiproliferative antibody 1)	1.14	2.37	1.85	1.49	1.54	0.93	1.81	2.31	1.5	1.67	2.04	1.04	1.7	1.05	1.26	0.98	1.15	1.07	0.91	0.89	0.75	0.68
HV25H6	795827	testis-specific kinase 1	2.73	2.21	1.43	2.9	3.32	1.71	3.33	3.42	3.52	2.24	0.88	2.05	1.66	2.86	1.55	2.01	2.06	3.5	4.68	3.4	2.62	2.98
HV25H8	739183	CD68 antigen	1.32	3.41	2.96	2.73	2.37	3.43	3.47	3.81	3.18	4.64	4.29	2.13	1.29	1.28	1.48	2.59	2.49	0.95	4.58	2.3	4.51	1.9
HV25H9	490368	"CD58 antigen, (lymphocyte function-associated antigen 3)"	2.11	2.27	1.51	1.47	2.42	0.9	1.01	1.65	0.95	0.92	0.83	0.73	0.93	0.95	1.25	1.31	1.28	0.96	2.13	1	1.34	1.49
HV25H11	713145	CD44 antigen (homing function and Indian blood group system)	0.8	0.86	0.36	0.85	0.86	1.98	0.35	0.84	0.33	0.61	1.16	1.32	1.55	0.78	1.26	1.09	1.17	0.39	1.19	1.83	1.36	0.63
HV26A3	193913	v-yes-1 Yamaguchi sarcoma viral related oncogene homolog	0.84	2.63	1.9	1.92	3.3	2	1.41	1.74	0.96	2.21	2.22	0.8	1.14	0.77	1.1	1.51	3.17	1.22	1.79	0.56	1.45	1.13
HV26A5	258589	v-rel avian reticuloendotheliosis viral oncogene homolog	2.43	3.13	2.3	2.31	3.5	2.43	2.53	2.88	2.68	2.94	2.53	2.94	2.66	3.61	1.14	2.85	1.64	2	5.33	1.1	1.16	3.62
HV26A6	322617	v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein)	0.61	0.88	0.71	0.63	1.5	1.08	1.13	1.53	0.75	1.42	1.5	0.74	0.87	0.75	1.04	1.34	0.81	0.48	0.73	0.73	0.63	1.08
HV26A7	267634	v-raf-1 murine leukemia viral oncogene homolog 1	1.3	1.1	1.5	1.13	1.37	0.88	0.96	0.96	0.85	1.1	1.26	1.1	0.78	1.01	0.79	0.84	0.91	1.08	1.22	0.64	0.97	1.04
HV26A8	207618	v-raf murine sarcoma 3611 viral oncogene homolog 1	1.58	1.98	1.15	1.23	2.16	1.45	2.12	1.48	1.54	2.22	1.35	1.2	1.51	1.86	1.12	2	2	1.17	1.24	1.28	1.2	2.18
HV26A9	760148	uroporphyrinogen decarboxylase	1.21	0.57	1.56	1.23	0.77	0.48	0.95	1.31	2.26	1.27	0.57	1.16	0.92	1.47	0.83	0.58	0.62	1.42	0.69	0.56	1.12	0.99
HV26A10	785845	transcription factor 6-like 1 (mitochondrial transcription factor 1-like)	1.59	1.45	1.59	2.36	1.82	1.42	1.61	1.5	0.93	1.74	1.22	1.02	1.6	1.38	1.19	1.58	1.97	1.92	1.42	1.13	1.04	1.32
HV26A11	191664	thrombospondin 2	3.24	0.91	6.72	8.8	4.96	2.07	4.73	9.19	15.87	8.13	5.45	4.69	4.9	9.11	3.32	0.91	2.03	6.17	9.08	1.87	4.39	8.23
HV26A12	712641	megakaryocyte stimulating factor	1.72	2.38	1.4	2.52	2.2	1.6	1.75	1.49	1.88	1.48	0.91	1	1.32	2.38	0.87	2.39	1.71	2.06	1.53	1.03	0.9	1.85
HV26B1	305606	EphA1	1.11	1.67	0.69	2.25	2.16	1.45	1.45	1.26	1.85	1.74	1.85	1.13	1.13	1.25	1.16	1.67	0.91	1.39	1.78	0.58	0.86	1.27
HV26B2	278808	spleen focus forming virus (SFFV) proviral integration oncogene spi1	1.97	6.21	1.03	2.96	6.05	2.92	3.52	2.04	3.09	4.66	3.79	2.62	3.09	2.75	1.25	5.05	2.52	1.18	7.86	1.79	2.64	4.16
HV26B3	109179	Sp2 transcription factor	1.45	7.43	1.36	5.11	7.16	3.59	4.21	3.76	5.37	7.02	3.81	1.91	1.45	1.47	0.68	3.34	2.68	0.65	3.18	0.58	1.2	2.29
HV26B4	712840	"Human signal transducer and activator of transcription Stat5B mRNA, complete cds"	2	2.5	0.66	1.36	3.44	1.57	1.7	1.33	1.27	2.53	1.85	1.52	1.77	1.48	0.77	2.11	1.4	0.46	5.02	0.63	3.57	3.34
HV26B5	711826	KIAA0019 gene product	1.45	2.64	1.45	2.87	2.49	3.14	0.99	1.13	0.91	2.34	1.5	0.74	1.07	0.87	1.53	1.68	1.99	1.95	1.29	0.8	1	1.1
HV26B6	897596	ribosomal protein L5	1.28	2	0.71	0.78	1	0.48	1.01	0.43	0.57	0.96	0.51	0.49	1.36	1.12	0.74	0.78	1.05	1.7	0.51	0.16	0.25	1.09
HV26B7	172440	"RAB6, member RAS oncogene family"	1.57	1.16	0.76	1.8	1.46	1.36	0.69	1.46	0.73	1.21	1.35	1.38	0.95	0.5	2.3	1.2	1.44	0.53	1.36	1.47	1.21	1.56
HV26B8	950445	"protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform"	0.8	0.88	0.85	0.66	0.98	0.42	1.12	0.87	0.98	0.82	0.89	1.12	0.92	1.03	0.71	0.87	0.85	0.83	0.64	0.66	0.45	1.01
HV26B9	950710	"propionyl Coenzyme A carboxylase, alpha polypeptide"	0.99	0.69	1.45	1	0.92	0.61	0.55	1.55	1.54	0.94	3.52	1.5	1.05	0.85	1.04	1.04	0.76	1.03	2.02	0.59	1.19	0.91
HV26B10	128302	parathymosin	1.54	2.3	2.54	2.55	1.13	1.34	2.34	2.38	1.71	2.69	2.01	1.96	2.34	2.18	1.25	1.32	2.06	4.1	1.33	1.2	1.15	1.56
HV26B11	730410	lymphocyte-specific protein tyrosine kinase	3.04	2.01	1.94	2.89	1.02	1.5	1.42	2.83	2.67	1.9	1.83	3.93	1.82	1.94	0.77	1.04	1.15	0.64	7.35	1.67	4.53	5.89
HV26B12	135083	"glucose regulated protein, 58kD"	1.05	2.43	1.98	1.45	2.24	1.26	1.49	1.6	1.95	1.84	1.96	1.15	0.97	1.74	1.39	1.66	1.8	1.17	1.17	0.48	0.99	1.26
HV26C1	85805	"retinol-binding protein 4, interstitial"	1.28	1.54	0.68	1.68	2.23	2.03	1.19	1.36	0.83	3.1	2.23	1.16	1.18	1.53	1.64	1.39	1.71	1.21	1.82	0.57	1.24	1.08
HV26C2	773305	opioid-binding protein/cell adhesion molecule-like	1.74	4.15	0.99	2.19	5.69	2.5	2.28	2.18	1.88	4.08	1.79	2.27	2.09	2.41	1.64	3.89	0.91	1.81	4.03	1	1.43	2.05
HV26C4	297392	metallothionein 1L	3.37	0.5	0.5	0.69	1.07	0.32	0.89	0.63	0.65	0.95	0.43	0.57	1.39	1.23	1.27	0.79	0.58	1.76	0.57	0.16	0.37	0.4
HV26C5	80109	"major histocompatibility complex, class II, DQ alpha 1"	3.37	5.45	3.68	8.32	10.77	9.61	8.51	10.76	5.18	12.77	6.35	8.22	6.91	10.84	2.04	5.28	4.84	4.55	15.16	5.09	5.74	3.87
HV26C6	789069	lysyl oxidase	1.82	2.07	1.26	3.03	3.91	3.03	3.08	2.91	2.09	3.46	2.26	2.17	2.89	2.88	2.19	2.41	1.76	2.96	3.52	1.14	2.45	1.94
HV26C7	110788	lymphocyte-specific protein 1	2.48	7.88	3.43	3.47	6.69	4.46	5.02	5.9	6.66	5.12	4.31	3.18	3.97	6.16	1.69	3.97	2.47	3.34	6.91	1.88	4.7	4.34
HV26C8	782513	"interferon, alpha-inducible protein (clone IFI-6-16)"	1.52	3.99	1.52	2.05	2.74	1.85	2.82	1.85	2.29	2.46	2.38	2.02	1.79	2.66	1.65	2.61	2.15	2.5	2.45	1.28	1.29	2.66
HV26C9	115281	CD79A antigen (immunoglobulin-associated alpha)	1.21	1.43	1.27	1.44	1.79	2.18	1.16	2.13	1.95	1.46	1.26	1.82	2.86	1.74	1.47	0.61	1.05	2.09	2.74	1.05	3.12	2.18
HV26C11	242578	trophinin-assisting protein (tastin)	1.91	1.86	1.95	1.66	1.23	1.63	2.04	0.63	2.49	1.04	0.85	1.9	1.03	2.17	1.34	0.89	0.75	3.33	1.44	1.09	1.44	1.28
HV26C12	156386	flotillin 2	1.91	2.37	1.84	1.6	1.94	1.54	2.15	1.56	2.26	2.44	1.42	1.83	1.61	2.35	1.66	2.49	2.36	2.56	1.41	0.84	1.43	1.34
HV26D1	897880	"chaperonin containing TCP1, subunit 4 (delta)"	0.95	0.86	0.58	1.98	0.9	1.12	0.58	0.93	0.49	0.61	0.77	0.77	0.76	0.56	0.99	1.67	1.29	0.73	0.28	0.44	0.67	0.56
HV26D2	154093	CBF1 interacting corepressor	1.2	2.72	1.6	2.46	3.26	1.95	1.89	2.4	2.37	1.93	0.86	1.86	1.82	1.7	0.82	3.12	1.94	1.38	3.76	3.26	1.54	2.38
HV26D6	85840	nicotinamide N-methyltransferase	2.38	1.45	0.97	2.36	4.66	1.81	3.84	5.93	3.38	3.02	1.76	1.26	1.43	2.82	1.84	1.71	1.1	3.96	2.96	2.67	2	2.74
HV26D7	951117	serine hydroxymethyltransferase 2 (mitochondrial)	0.91	1.68	1.04	1.04	1.29	0.73	1.8	1.02	0.9	1.29	0.96	0.59	0.61	1.07	1.11	1.2	1.51	1.75	0.89	0.48	0.88	0.81
HV26D8	951233	"proteasome (prosome, macropain) subunit, beta type, 3"	1.28	2.05	1.06	1.23	1.72	1.26	1.94	2	1.85	1.22	1.2	1.88	1.25	1.9	1.97	2.06	1.66	1.82	1.19	1.31	0.85	1.64
HV26D9	797059	nucleosome assembly protein 1-like 3	1.19	1.21	2.32	0.64	0.83	0.65	0.8	1.59	1.16	0.32	1.36	1.73	1.71	1.92	0.88	0.49	1.18	2.55	2.34	0.86	1.71	2.02
HV26D10	781050	prefoldin 5	0.89	1.42	1.11	1.08	1.18	0.86	0.8	1.47	1.18	1.09	1.03	1.36	1.28	1.56	0.95	0.9	1.19	1.07	1.02	0.64	1.49	1.25
HV26D11	814119	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 8 (RNA helicase)	0.8	1.82	1.24	1.21	1.2	0.98	0.92	1.5	1.76	0.43	0.57	1.29	0.82	0.99	0.67	0.7	0.69	1.18	1.13	0.85	1.06	1.13
HV26D12	83363	protein-L-isoaspartate (D-aspartate) O-methyltransferase	0.87	1.17	0.81	1.08	1.23	1.21	0.92	0.93	1.12	1.2	1.01	1.27	0.98	0.65	1.16	0.9	1.31	0.81	0.76	0.7	0.8	0.67
HV26E1	788486	"apyrase, lysosomal"	0.97	1.48	1.35	1.63	1.72	1.08	1.21	1.02	1.9	1.18	1.17	0.85	0.81	1.22	0.54	1.42	1.22	0.72	1.11	0.5	1.07	1.52
HV26E2	155575	erythrocyte membrane protein band 4.1-like 1	0.87	0.83	0.39	0.57	1.29	0.54	1.12	0.75	1.37	0.83	0.79	0.68	0.7	0.58	0.47	1.48	0.77	0.59	0.55	0.39	0.34	0.95
HV26E3	240505	KIAA0323 protein	1.48	1.82	1.05	1.35	1.45	0.93	1.3	1.27	1.39	1.64	1.12	1.29	1.41	1.53	1.24	1.34	0.66	0.91	1.38	1.02	1.14	1.69
HV26E4	772111	KIAA0300 protein	3.54	2.52	1.84	4.23	3.88	2.22	5.32	1167.04	2.26	2.2	0.97	1.13	1.78	3.24	2.41	2.65	1.58	1.7	2.05	1.26	1.91	2.27
HV26E5	510760	KIAA0226 gene product	1.28	0.55	1.14	0.83	0.62	0.36	0.53	0.59	0.52	0.55	0.34	0.51	0.37	0.49	0.61	0.94	0.62	0.49	0.59	0.97	0.35	0.42
HV26E6	785963	KIAA0191 protein	0.95	1.11	1.16	1.12	1.62	0.97	0.92	0.62	0.81	0.8	0.52	0.57	1.14	0.88	0.74	1.39	0.93	0.8	0.35	0.37	0.47	0.74
HV26E7	758365	conserved gene amplified in osteosarcoma	1.86	2.36	1.38	1.79	1.33	1.12	1.28	1.72	1.09	1.28	1.58	0.94	0.74	1.18	1.08	1.77	2.19	2.43	1.01	1.15	1.01	1.13
HV26E8	233581	huntingtin-interacting protein 2	1.26	1.2	1.09	0.92	1.49	1.02	1.88	1.35	1.31	1.79	0.86	1.05	1.31	1.15	1.17	1.65	1.4	1.78	1.42	0.7	0.77	1.3
HV26E9	788421	"MAD (mothers against decapentaplegic, Drosophila) homolog 4"	0.99	0.65	1.89	1.6	0.77	0.65	0.53	0.89	0.62	0.81	0.64	0.55	1.01	1.11	0.57	0.72	0.85	1.1	0.46	0.38	0.93	0.8
HV26E10	239877	histone deacetylase 3	0.64	0.86	0.75	1.11	1.09	0.69	0.95	1.03	1.33	1.06	0.92	0.74	0.84	0.77	0.7	1.43	0.92	0.74	0.85	1	1.05	1.2
HV26E11	842939	"adenosine deaminase, RNA-specific, B1 (homolog of rat RED1)"	1.92	0.87	1.76	1.63	1.1	0.8	1.04	2.05	1.84	1.25	0.99	1.29	1.32	2.3	1.23	0.8	0.7	2.31	5.26	2.27	2.86	5.51
HV26E12	544639	ESTs	1.03	0.53	1.2	1.48	1.28	0.74	0.55	0.56	1.56	0.58	0.29	0.21	0.58	0.58	0.63	1.11	1.5	1.04	0.71	0.33	0.63	0.83
HV26F1	130843	EST	2.84	2.4	1.41	1.94	1.97	2.74	1.52	2.48	5.98	1.22	2.83	5.12	1.78	6.74	0.93	1.58	2.78	2.12	5.26	0.77	2.16	2.7
HV26F3	85394	phosphatidic acid phosphatase type 2b	1.07	2.7	1.87	2.25	3.81	2.11	1.68	2.63	2.49	3	3.23	1	1.75	2.1	1.77	1.87	1.53	1.36	3.05	0.7	2.56	2.31
HV26F5	632074	Human clone 23586 mRNA sequence	1.76	3.8	1.24	2.02	3.27	2.1	1.77	1.95	1.71	3.24	2.17	1.28	2.1	2.03	1.65	2.23	2.21	1.96	2.48	0.86	1.93	1.52
HV26F6	358531	Jun activation domain binding protein	1.35	0.82	1.27	0.93	2.03	0.37	0.69	1.28	0.82	0.98	0.74	1.01	2.33	0.96	1.01	1.14	0.67	1	0.92	0.33	0.66	1.34
HV26F7	785744	milk fat globule-EGF factor 8 protein	0.75	0.95	1.71	1.69	1.96	0.6	0.61	1.18	0.63	0.46	0.85	0.3	0.82	0.58	0.61	0.45	2.25	2.6	0.55	0.28	0.73	0.5
HV26F8	627542	biliverdin reductase A	1.29	1.45	1.13	0.83	1.86	1.19	2.01	1.66	2.13	2.13	1.26	3.26	0.68	4.14	1.71	2.86	1.05	0.89	3.07	0.6	1.46	3.26
HV26F9	594743	pericentriolar material 1	0.81	0.87	1.19	1.47	0.9	0.72	0.59	1.24	0.87	0.82	0.79	0.83	0.75	0.79	0.44	0.96	0.47	0.57	3.06	1.01	1.1	1.7
HV26F10	203132	"tumor necrosis factor (ligand) superfamily, member 10"	5.91	10.26	2.2	2.22	3.53	6.64	6.29	10.64	3.94	8.09	3.63	4.86	4.94	5.07	3.54	3.71	2.65	1.53	6.31	2.98	2.65	6.68
HV26F11	146577	TGFB inducible early growth response	0.92	1.28	1.01	0.71	0.75	0.54	0.63	1.35	0.43	0.85	1.1	0.41	0.82	0.45	0.99	0.69	0.51	0.52	1.44	0.97	1.33	1.03
HV26F12	235155	"Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide"	4.62	23.59	12.26	2.9	9.6	8.6	6.62	10.97	14.27	12.5	4.26	5.9	5.56	7.41	2.25	5.12	4.29	6.47	14.75	4.68	5.67	8.87
HV26G1	83120	"RNA-binding protein S1-1, human homolog of"	1.21	2.27	1.02	1.24	1.41	1.79	1.17	0.87	1.22	1.51	1.16	0.83	1.11	1.82	1.05	1.42	1.76	1.9	2.07	1.01	1.6	1.8
HV26G2	740914	C-terminal binding protein 1	1.41	1.85	0.85	1.26	1.81	0.97	1.89	1.4	1.91	1.8	1.6	1.04	1.55	2.14	1.33	2.01	0.94	0.97	1.18	1.2	1.09	1.68
HV26G3	632137	CD27-binding (Siva) protein	1.61	2.79	1.17	1.61	1.71	1.76	1.59	1.23	1.67	1.61	1.29	1.07	1.41	1.69	1.46	2.16	1.87	1.88	1.13	0.87	1.82	1.16
HV26G4	789049	"nuclear receptor subfamily 2, group F, member 1"	1.68	2.67	1.25	2.36	2.81	1.28	2.01	1.76	2.68	2.22	0.94	1.66	1.93	2.09	0.95	3.14	1.62	2.21	0.75	0.25	0.37	1.9
HV26G6	207358	"solute carrier family 2 (facilitated glucose transporter), member 1"	1.43	0.45	1.21	0.77	0.66	0.41	0.68	0.59	0.81	0.51	0.37	0.6	0.39	0.55	0.8	1.09	0.49	0.56	0.47	0.87	0.22	0.36
HV26G8	62277	Homo sapiens retinoic acid-inducible endogenous retroviral DNA	1.13	1.86	1.01	1.17	1.4	0.87	1.23	1.4	2.28	0.52	0.95	1.27	1.3	1.85	1.18	1.56	1.21	1.62	1.7	0.71	1.1	0.53
HV26G10	294487	"Homo sapiens nuclear antigen H731-like protein mRNA, complete cds"	1.4	1.91	0.94	1.02	1.93	1.61	1.18	1.05	0.86	1.2	1.07	1.5	2.11	0.96	0.67	1.5	1.44	0.45	2.17	1.02	1.77	2.3
HV26G11	841282	secreted frizzled-related  protein 4	2.13	3.9	5.5	4.99	4.79	5.52	6.33	14.65	2.18	3.01	5.49	4.34	5.71	7.38	3.16	2.35	0.64	4.22	4.04	1.34	2.71	6.64
HV26H1	788185	"tumor necrosis factor receptor superfamily, member 10b"	0.97	2.05	1.01	1.24	1.56	1.3	0.85	1.06	7.67	0.96	1.57	0.64	0.9	0.57	0.91	1.29	1.99	0.47	1.52	0.87	1.26	1.23
HV26H2	502369	programmed cell death 5	1.78	3.48	1.58	1.9	2.04	2.06	1.48	1.2	1.75	1	0.72	1.48	1.07	1.68	0.97	2.45	2.28	2.23	0.75	0.66	1.05	1.2
HV26H3	745347	LPS-induced TNF-alpha factor	0.96	2.58	1.69	2	2.48	2.65	0.7	2.94	0.93	2.51	2.96	0.76	1.16	0.54	1.18	1.92	3.65	1.52	1.51	0.76	0.97	0.83
HV26H4	859359	quinone oxidoreductase homolog	0.71	0.98	0.55	0.57	0.93	0.44	0.96	0.72	0.77	0.54	0.5	0.52	0.78	0.79	0.73	1.09	0.36	0.69	0.69	0.35	0.41	0.54
HV26H5	48285	p53-induced protein	1.34	0.82	1.1	0.92	0.79	0.58	0.79	0.92	0.76	0.6	0.47	0.66	0.48	0.6	0.91	0.93	0.66	0.6	0.7	0.86	0.48	0.43
HV26H6	275180	KIAA0220 protein	1.57	1.88	1.08	1.45	1.49	1.12	1.8	1.28	1.86	1.16	0.92	2.17	1.84	2.01	1.8	1.09	0.91	1.65	1.67	1.79	1.55	1.01
HV26H7	589751	Tat-interacting protein (30kD)	0.81	1.39	0.7	1.44	1.75	1.01	1.04	0.91	0.6	1.08	1.03	0.5	0.56	0.62	0.78	1.31	1.36	0.99	1.01	0.82	1.08	0.73
HV26H8	236305	histidyl-tRNA synthetase	0.76	1.52	0.76	0.8	1.6	0.59	1.6	1.29	2.01	1	0.78	1.24	0.95	1.72	0.58	1.26	0.93	1.05	1.29	0.62	1.81	1.06
HV26H9	840158	hexokinase 1	0.82	1.15	0.75	0.53	0.87	0.58	0.97	0.95	2.11	0.46	0.53	0.95	0.97	1.79	0.95	0.79	0.55	1.05	0.9	0.96	0.69	0.86
HV26H11	814526	ESTs	2.85	2.44	3.27	4.93	2.15	4.14	3.15	3.68	1.75	1.53	1.13	4.17	1.75	1.57	1.64	0.95	2.53	3.05	4.58	2.91	2.94	2.48
HV26H12	785293	similar to rat HREV107	0.77	2.02	0.58	0.73	1.5	2.08	1.25	1.07	1.65	1.64	1.48	1.28	2.33	1.21	0.96	0.52	1.02	0.4	1.21	1.46	0.64	2.07
HV27A1	214162	metallothionein 1H	1.18	0.5	0.52	0.44	0.92	0.49	0.41	0.3	0.32	0.84	0.53	0.64	0.89	0.98	1.01	0.93	0.58	1.41	0.68	0.38	0.56	0.49
HV27A5	42076	TRK-fused gene (NOTE: non-standard symbol and name)	0.85	1.19	0.91	0.71	0.99	1.14	0.4	1.17	0.7	0.62	1.14	0.83	0.57	0.68	0.87	0.6	0.85	1.67	0.34	0.51	0.74	0.58
HV27A6	127925	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 18 (Myc-regulated)	1.41	2.21	1.46	2.08	3.04	2.07	1.13	1.31	1.22	2.55	1.34	1.41	1.7	1.27	1.49	3.26	2.51	2.65	1.22	1.7	1.04	1.45
HV27A8	38763	S-phase response (cyclin-related)	2.86	2.06	1.58	2.03	2.49	1.4	1.72	1.14	0.77	1.55	1.37	1.46	1.76	1.57	1.37	2.12	1.81	1.92	1.08	1.09	0.71	1.18
HV27B5	129392	ESTs	1.4	2.44	1.32	1.85	1.68	1.43	1.94	1.72	2.53	1.76	2.65	1.22	0.84	1.46	1.17	1.06	1.01	2.99	4.28	2.35	2.77	2.85
HV27B7	66953	"ESTs, Moderately similar to unknown [M.musculus]"	0.95	2.05	1.92	1.55	1.97	1.02	1.59	1.49	1.54	1.03	1.16	0.74	1.08	1.08	0.64	0.83	1.55	1.83	1.63	1.04	1.44	1.19
HV27B8	123614	"ESTs, Weakly similar to unknown [H.sapiens]"	0.99	1.48	0.53	1.05	2.4	1.31	1.48	1.6	2.36	1.54	3.04	1.57	1.07	2.44	1	2.2	1.11	0.44	1.61	3.84	1.85	1.46
HV27B10	137236	KIAA0970 protein	1.38	1.66	0.75	1.56	2.22	1.72	0.99	1.11	1.14	1.42	0.94	1.24	1.16	1.43	1.23	1.35	1.49	0.36	1.6	0.83	0.78	1.18
HV27B11	246749	"ESTs, Weakly similar to trg [R.norvegicus]"	0.91	1.63	1.6	1.63	1.11	1.11	0.73	1.3	1.18	0.78	1.39	0.72	0.76	0.66	0.86	1	0.91	1.38	0.63	0.46	0.58	0.7
HV27C3	135608	"ESTs, Weakly similar to OXYSTEROL-BINDING PROTEIN [H.sapiens]"	0.49	1.21	0.89	0.52	0.99	1.42	0.56	0.48	0.81	0.89	0.81	0.34	0.41	0.3	3.39	0.89	0.63	0.35	2.39	2.06	1.12	2
HV27C4	140100	"ESTs, Weakly similar to PROBABLE PEROXISOMAL ENOYL-COA HYDRATASE [M.musculus]"	0.51	1.14	0.44	0.98	0.64	1.96	0.43	0.7	0.5	0.4	0.39	0.65	0.67	0.67	0.51	0.97	0.88	0.17	0.47	0.15	0.48	0.39
HV27C5	382773	histone deacetylase 3	1.55	2.99	1.47	3.25	2.63	1.75	3.25	3.02	2.12	1.88	1.87	3.35	2.82	3.16	2.06	2.13	0.92	2.7	1.93	0.92	0.63	1.29
HV27C6	246035	ESTs	2.1	2.05	0.73	3.88	1.12	0.47	1.12	3.02	1.7	0.92	0.61	0.67	1.02	1.6	0.86	1.05	0.99	1.29	2.9	0.68	1.12	1.56
HV27C9	366341	"ESTs, Weakly similar to HYPOTHETICAL UOG-1 PROTEIN [H.sapiens]"	2.08	1.52	1.72	1.19	1.34	2.25	1.59	1.93	2.31	4.5	1.31	1.98	2.02	0.91	1.47	0.81	0.53	1.16	5.44	2.07	3.06	4.57
HV27C10	140354	"ESTs, Moderately similar to !!!! ALU SUBFAMILY SP WARNING ENTRY !!!! [H.sapiens]"	1.17	1.8	0.6	1.03	1.77	1.15	1.54	1.27	1.61	1.43	0.96	1.57	1.6	2.33	1.74	2.22	1.16	0.83	1.87	1.61	1.12	1.54
HV27C11	26566	"ESTs, Weakly similar to rotated abdomen protein [D.melanogaster]"	2.39	1.88	0.83	1.17	1.81	1.49	1.17	1.26	2.83	4	1.96	1.24	1.78	1.68	1.34	1.04	0.84	1.08	2.02	2.29	1.86	2.33
HV27D2	194006	ESTs	0.97	1.65	0.5	0.68	1.57	0.43	1.1	1.38	1.64	0.65	0.69	1.46	1.31	1.9	0.97	0.78	0.76	1.8	1.25	0.52	0.74	0.98
HV27D9	246543	"ESTs, Weakly similar to reverse transcriptase related protein [H.sapiens]"	1.92	6.22	3.24	2.83	4.85	2.28	2.91	8.39	0.95	1.98	0.79	1.85	1.85	2.14	0.92	1.99	2.4	1.29	3.2	1.56	1.32	2.65
HV27D10	471196	integral membrane protein 2C	1.23	0.79	2.57	0.76	2.19	1.17	1.36	1.45	1.23	1.6	1.36	0.55	0.72	0.59	0.95	2.85	1.48	0.98	0.91	0.25	0.88	0.38
HV27D11	565493	MKP-1 like protein tyrosine phosphatase	1.15	0.66	1.22	0.69	1.73	1.05	1.41	0.92	0.86	0.79	0.96	0.49	0.92	0.59	0.85	0.93	0.58	0.82	0.97	0.47	0.88	0.62
HV27E3	66535	"Homo sapiens ornithine decarboxylase antizyme 2 (OAZ2) mRNA, complete cds"	0.85	0.95	1.84	1.72	1.27	1.16	0.55	1.61	1.11	1.25	1.33	1.04	0.89	0.81	0.92	0.91	0.74	1.08	1.22	2.3	1.92	1.97
HV27E10	137638	ESTs	3.63	11.63	6.73	6.32	6.89	2.91	2.96	3.89	1.7	2.65	1.9	2.25	3.31	2.79	2.34	3.24	2.82	3.52	1.83	1.31	1.63	3.08
HV27E12	165921	centrosome associated protein	2.01	1.02	1.03	0.8	1.09	0.86	1.03	0.47	1.57	1.17	0.75	0.79	0.94	1.06	0.61	1.82	0.87	0.77	0.9	0.49	0.62	0.8
HV27F7	684940	ESTs	1.1	1.63	1.56	1.74	1.26	1.42	0.84	1.48	1.1	1.64	0.81	0.82	1.08	0.71	0.86	0.9	1.76	1.1	1.21	0.77	1.21	0.3
HV27F8	251875	"ESTs, Highly similar to myelin gene expression factor 2 [H.sapiens]"	1.54	1.91	0.71	1.13	1.84	0.92	1.37	1.25	1.95	1.57	1.03	0.95	1.44	1.26	0.91	1.23	1.2	1.03	0.78	1.26	1.22	1.41
HV27F9	161950	KIAA1082 protein	0.76	1.13	0.97	1.29	1.37	0.75	1.09	0.89	0.88	1.07	1.06	0.65	0.85	1.2	0.84	0.69	0.99	1.05	0.75	0.76	0.86	0.98
HV27F10	110503	"ESTs, Weakly similar to similar to S. cerevisiae hypothetical protein YKL166 [C.elegans]"	0.81	1.12	0.44	0.62	1.27	1.8	0.79	0.44	0.97	0.91	0.62	0.52	0.73	1.06	0.49	0.94	0.99	0.84	0.81	0.25	0.72	0.61
HV27G1	66774	ESTs	1.21	2.32	2.02	1.34	1.47	1.59	0.85	1.42	1.56	1.16	0.84	0.65	1.11	1.28	0.72	0.69	0.83	0.8	1.24	1.09	0.68	1.07
HV27G2	344672	ESTs	1.39	2.67	1	1.71	2.21	1.21	2.94	1.65	1.79	3.13	0.65	1.77	1.37	1.93	0.82	1.5	1.38	0.94	1.36	0.51	0.8	1.16
HV27G3	233365	"ESTs, Moderately similar to alternatively spliced product using exon 13A [H.sapiens]"	2.84	2.14	1.91	3.14	1.89	2.68	1.72	2.28	1.77	1.54	1.54	1.57	1.81	1.84	1.64	1.08	0.88	2.14	1.23	0.98	1.15	1.55
HV27G4	230562	KIAA0670 protein	1.43	2.07	1.19	1.15	1.1	1.05	1.34	0.99	1.79	1.02	1.28	1.67	1.56	2.48	1.58	1.57	0.92	1.22	2.17	0.9	1.29	1.2
HV27G5	201986	ESTs	0.83	1.23	1.48	0.89	1.05	1.14	1.03	1.12	1.28	1.07	0.85	0.88	1.26	0.78	1.11	0.61	0.94	0.82	3.58	2.83	2.1	3.14
HV27G7	141627	"ESTs, Weakly similar to F55A12.9 [C.elegans]"	0.78	0.66	1.64	0.46	0.76	0.45	1.15	0.54	0.51	1.5	0.74	0.63	0.73	1.14	1.06	0.44	0.57	0.72	2.92	1.96	2.21	2.26
HV27G8	202213	Homo sapiens mRNA; cDNA DKFZp586I0523 (from clone DKFZp586I0523)	1.37	1.8	1.6	0.84	1.88	0.91	1.27	1.95	1.53	1.15	1.02	1.28	1.65	1.93	1.06	1.19	0.83	1.18	1.4	1.19	0.99	1.34
HV27G9	292719	"ESTs, Highly similar to unknown [H.sapiens]"	1.1	1.25	1.23	1.24	1.1	1.01	0.75	1.11	1.18	2.47	1.19	1.16	1.02	1.33	1.1	0.64	0.65	1.12	1.37	0.63	0.88	1.4
HV27G10	248649	"ESTs, Weakly similar to coded for by C. elegans cDNA CEESW58F [C.elegans]"	2.48	2.45	0.84	1.78	1.47	1.4	1.44	1.31	1.71	1.46	0.4	2.23	1.96	1.13	1.26	2.06	1.47	1.24	2.4	1.69	1.49	2.03
HV27G11	137581	"ESTs, Weakly similar to NG22 [M.musculus]"	0.8	1.19	0.56	0.85	1.5	1.88	0.35	0.85	1.1	0.92	1.72	0.91	0.88	0.89	0.95	0.72	0.98	1.21	1.65	1.71	1.77	1.51
HV27H1	310356	"ESTs, Highly similar to angiopoietin-related protein [H.sapiens]"	0.48	0.67	0.71	0.42	0.98	0.13	0.42	0.17	1.54	0.39	0.18	0.28	1.32	1.24	0.84	0.5	0.19	2.19	0.63	0.36	0.75	0.47
HV27H8	136449	ESTs	1.54	3.03	6.54	1.91	4.15	1.37	2.3	3.89	5.46	1.86	1.99	2.94	3.2	3.55	1.12	2.05	0.91	2.94	4.01	2.73	2.17	2.81
HV27H10	843426	ubiquitin specific protease 11	2.66	1.45	0.86	1.39	2.12	1.27	1.31	1.2	0.83	0.88	0.94	1.77	2.2	1.51	1.65	1.58	0.91	5.32	2.11	0.95	1.87	1.98
HV28A1	199158	DKFZP586D2223 protein	0.74	1.05	1.09	1.45	1.48	0.8	0.7	0.97	0.8	0.95	0.86	0.74	0.83	1.13	0.73	0.91	0.87	3.08	0.66	0.81	0.92	1.07
HV28A6	66336	"PTPRF interacting protein, binding protein 2 (liprin beta 2)"	2.82	9.15	3.05	5.96	6.05	3.25	4.43	9.88	5.76	4.71	4.4	3.44	3.75	5.31	2.77	4.06	1.72	2.96	4.41	2.17	3.41	5.58
HV28A9	292512	ESTs	1.29	4.61	1.82	1.69	2.09	1.45	1.05	1.21	1.03	1.17	1.38	0.86	1.44	1.35	1.38	1.58	1.21	1	1	1.41	0.93	0.24
HV28A10	321605	Human Chromosome 16 BAC clone CIT987SK-A-61E3	0.72	0.83	0.66	0.84	1.31	0.43	1.1	0.5	0.82	0.58	0.72	1.19	1.62	1.01	0.23	1.2	0.64	1.15	0.46	0.84	1.18	0.7
HV28A12	243155	ESTs	2.83	2.84	1.05	1.98	2.18	1.22	1.96	1.51	2.41	1.4	1.11	1.9	1.67	1.91	1.44	1.69	2.05	2.64	1.59	2.38	1.75	2.13
HV28B1	144977	vitamin A responsive; cytoskeleton related	0.47	1.22	0.6	1.02	0.81	0.92	0.62	1	0.4	0.65	0.95	0.73	0.96	0.73	0.95	0.69	0.89	0.48	0.64	0.39	0.47	0.93
HV28B3	346134	"ESTs, Highly similar to calcium-regulated heat stable protein CRHSP-24 [H.sapiens]"	2.43	2.4	1.29	1.58	1.8	2.03	1.8	2.25	1.66	3.26	1.67	1.44	1.16	1.92	1.85	1.07	0.95	2.83	2.3	2.6	2.4	1.52
HV28B6	214731	KIAA0601 protein	1.43	1.23	0.91	1.63	1.26	1.63	0.76	0.74	0.86	1.03	0.86	0.99	1.29	1.27	1.18	1.21	1.69	1.4	0.85	0.66	0.76	1.26
HV28B7	208531	"ESTs, Weakly similar to CGI-69 protein [H.sapiens]"	1.14	1.59	0.74	1.47	1.14	1.27	1.1	1.96	0.8	1.46	1.74	1.35	1.07	1.29	0.69	1	0.86	0.86	1.52	1.77	0.96	1.55
HV28B8	141845	KIAA0544 protein	1.39	0.95	0.63	1.07	3.67	0.99	1.34	1.42	1.72	1.51	0.93	0.86	1.76	2.74	0.83	2.14	1.39	1.42	1.3	0.8	0.44	1.73
HV28B9	812266	"mannosidase, alpha, class 1A, member 2"	3.58	4.21	3.32	2.55	2.78	2.05	2.09	1.76	2.84	2.34	2.35	3.85	1.71	3.01	1.35	1.6	1.67	3.55	2.91	0.75	1.28	2.43
HV28B10	202919	tropomyosin 4	2.18	1.41	1	1.18	1.48	1.52	1.39	0.98	1.35	1.14	1.42	0.97	1.18	1.27	1.32	1.34	1.89	1.74	1.45	1.14	1.46	2.1
HV28C2	204211	ESTs	1.29	1.07	0.58	0.84	1.54	1.68	0.71	0.59	0.4	2.83	1.05	0.78	0.8	0.48	1	0.94	1.39	0.32	2.96	1.75	1.75	2.18
HV28C6	377191	"ESTs, Weakly similar to cDNA EST yk266c4.5 comes from this gene [C.elegans]"	1.24	1.03	0.84	0.96	1.01	1.08	1.26	0.95	1.52	1.15	0.69	1.02	1.49	0.8	1.51	1.32	1.46	1.18	0.58	1.23	0.6	0.95
HV28C8	197791	Chromosome 1 specific transcript KIAA0491	1.89	2.61	1.25	1.06	1.34	1.58	1.09	1.65	1.65	1.41	1.16	0.99	1.65	1.16	1.68	2.3	1.57	1.04	0.79	0.58	0.77	1.02
HV28C10	322794	"ESTs, Weakly similar to C10G11.5 [C.elegans]"	1.18	1.37	1.34	1.04	1.66	1.05	1.49	1.31	1.47	1.6	1.71	1.42	1.32	1.31	1.21	1.8	0.83	1.34	1.62	0.79	0.84	1.75
HV28C11	66354	"ESTs, Highly similar to NY-REN-37 antigen [H.sapiens]"	0.83	1.12	0.87	1.79	1.38	1.23	0.96	1.21	0.61	1.82	1.25	0.79	1.33	1.09	0.89	1.11	1.31	0.8	1.09	0.97	0.65	0.93
HV28C12	196866	"ESTs, Weakly similar to ORF YDL040c [S.cerevisiae]"	2.49	2.28	1.7	2.44	2.41	2.16	1.83	1.62	2.03	1.88	1.29	2.12	2.31	2.15	1.88	2.75	2.78	2.36	0.9	0.4	0.32	0.62
HV28D2	198312	KIAA0719 gene product	1.49	1.37	0.99	1.46	1.6	1.46	1.21	1.76	1.27	1.08	1.26	1.84	1.21	1.4	1.41	1.26	2	1.5	8.79	4.53	4.29	4.47
HV28D3	230235	GTP-binding protein	1.26	4.94	1.19	3.63	1.31	3.34	1.44	1.38	1.64	1.06	1.08	1.36	0.89	1.02	1.16	1.05	1.71	3.24	1.03	0.86	0.66	0.94
HV28D4	310493	"fatty-acid-Coenzyme A ligase, long-chain 3"	1.11	1.71	0.54	0.89	2.18	0.67	0.96	1.12	0.95	0.92	0.71	1.66	1.26	1.57	2.07	1.17	1.54	1.29	0.59	0.81	0.73	0.88
HV28D7	361485	"ESTs, Weakly similar to KIAA0167 protein [H.sapiens]"	0.92	2.17	0.93	1.46	1.92	1.25	1.33	1.47	2.08	1.38	1.58	0.95	1.15	1.63	1.14	1.29	1.42	1.27	2.75	1.61	1.97	2.19
HV28D8	108658	KIAA1025 protein	1.29	3.99	4.28	5.13	1.48	1.92	3.81	5.54	4.33	2.6	1.13	3.47	2.73	5.01	1.15	1.7	2.86	2.62	6.95	4.39	1.8	4.88
HV28D9	128351	"ESTs, Weakly similar to WD40 protein Ciao 1 [H.sapiens]"	1.32	1.65	1.34	1.35	1.28	1.07	1.16	1.57	1.33	0.93	1.34	1.12	1.03	0.99	1	1.09	1.37	0.6	1.31	1.67	1.83	0.98
HV28D11	134523	microtubule-associated protein like echinoderm EMAP	0.66	0.94	0.27	0.39	1.02	0.51	0.82	0.63	0.57	0.45	1.03	1.49	0.94	1.01	0.57	0.85	1.25	1.07	1.12	0.54	0.53	0.87
HV28E3	292731	"ESTs, Weakly similar to hypothetical protein [H.sapiens]"	3.42	1.36	2.79	2.41	1.4	1.66	2.02	1.74	3.03	1.37	1.23	2.4	1.65	1.83	0.95	0.74	1.38	1.79	1.68	0.54	0.83	1.16
HV28E5	198509	Homo sapiens clone 23596 mRNA sequence	0.92	1.05	1.57	1.01	1.55	0.82	1.05	0.99	0.8	0.64	0.86	0.62	0.81	0.9	0.63	0.67	0.92	1.22	0.91	0.66	1.07	1.39
HV28E6	66894	ESTs	1.83	1.92	0.97	1.16	1.56	0.78	1.68	1.21	1.55	1.3	1.14	1.39	1.17	1.26	0.97	1.41	1.62	1.53	1.12	1.05	0.86	1.54
HV28E8	140289	ESTs	0.91	0.96	0.87	1.18	1.38	0.88	1.36	0.89	0.91	0.82	0.74	0.87	0.82	1.22	1.01	1.2	0.69	0.98	0.63	0.48	0.57	1.21
HV28E10	205049	"ESTs, Weakly similar to hsp 27 [H.sapiens]"	1.33	1	1.54	1.26	4.21	1.87	3.25	10.49	13.87	2.19	2.51	6.08	4.21	1.58	1.14	2.71	2.04	2.25	3.09	3.48	1.08	1.83
HV28E11	201274	KIAA0549 protein	1.03	1.42	2.05	1.95	2.4	1.75	1.94	1.88	2.92	1.7	2.79	1.4	1.42	2.98	1.18	1.27	1.44	0.68	1.85	0.6	1.75	2.34
HV28E12	137353	peflin	1.86	1.15	1.43	1.11	1.49	1.24	1.52	1.58	1.11	1.29	1.43	1.47	1.61	1.79	0.97	1.71	1.82	1.14	0.95	1.36	1	1.74
HV28F1	132142	ESTs	2.21	2.66	1.64	2.59	2.47	1.73	3.26	2.71	2.96	2.05	1.17	3.28	2.64	2.15	1.17	1.97	1.97	1.21	2.16	1.58	1.7	2.91
HV28F4	124629	DKFZP586F0222 protein	2.13	0.82	1	1.38	1.26	0.98	1.3	0.78	0.7	1.51	0.98	0.96	1.44	1.13	0.89	1.45	1.44	0.74	0.87	1.26	0.72	1.27
HV28F5	161992	Homo sapiens mRNA; cDNA DKFZp564E1616 (from clone DKFZp564E1616)	0.46	0.32	0.31	1.27	0.54	0.31	0.32	0.93	0.32	0.4	0.74	0.42	0.7	0.53	0.3	0.27	0.27	0.24	0.25	0.43	0.24	0.37
HV28F6	191882	ESTs	1.28	2.18	0.72	1.2	1.64	1.32	1.33	1.25	1.58	1.74	1.42	1.05	1.79	1.96	0.95	1.81	2.11	1.28	3.53	2.34	2.25	3.25
HV28F7	129355	ESTs	1.64	1.78	1.07	1.84	1.33	0.84	0.9	1.32	1.4	1.87	2.15	1.28	1.44	1.56	0.91	1.23	1.76	1.3	1.12	0.83	1.1	1
HV28F9	549016	"ESTs, Moderately similar to R27216_1 [H.sapiens]"	1.46	1.94	1.06	1.52	1.89	1.13	1.08	1.69	1.66	1.4	1.59	1.49	1.06	1.64	1.19	1.26	1.38	1.33	1.79	0.96	1.13	1.15
HV28F10	145132	mannose-P-dolichol utilitzation defect 1	0.85	1.04	0.81	0.81	1.73	0.76	1.57	0.94	1.52	1.38	1.13	1.08	1.04	1.63	0.62	1.23	0.8	1.22	1.5	1.12	1.24	1.23
HV28F11	199610	"ESTs, Weakly similar to KIAA0605 protein [H.sapiens]"	0.41	0.83	0.65	2.15	1	0.5	0.56	0.55	0.42	0.99	1.03	0.4	0.79	0.51	0.58	0.51	0.48	0.77	0.82	0.25	0.97	0.35
HV28F12	290422	zinc finger protein 216	1.51	1.58	1.16	1.81	2.14	1.15	1.14	1.11	1.31	1.08	1.26	1.02	1.89	1.4	1.52	2.06	1.65	0.77	2.28	1.6	1.32	0.48
HV28G1	122077	"Homo sapiens clone 24483 unknown mRNA, parital cds"	1.19	1.14	0.54	1.42	0.97	1.03	0.75	1.46	1.02	0.97	1.47	1.19	0.97	1.58	0.93	0.88	1.3	1.21	0.81	0.86	0.97	1.49
HV28G8	202034	"ESTs, Highly similar to 45kDa splicing factor [H.sapiens]"	2.1	5.59	1.4	3.12	2.72	3.01	2.05	1.46	2.14	1.78	1.34	1.77	2.34	2.19	1.2	2.42	2.02	4.47	2	0.94	0.96	1.53
HV28G9	121533	"ESTs, Weakly similar to MMSET type I [H.sapiens]"	1.43	4.23	1.38	1.5	2.57	2.08	2.43	1.92	5.06	2.36	1.54	2.33	1.54	2.13	1.14	1.64	1.54	1.55	2.36	1.22	1.02	2.07
HV28G10	299085	"ESTs, Weakly similar to RNA splicing-related protein [R.norvegicus]"	1.71	1.64	0.99	1.41	1.41	1.21	1.24	1.47	1.11	1.06	1.02	1.21	1.73	1.83	1.75	1.5	1.53	1.36	1.44	0.77	0.86	1.52
HV28H4	120362	"ESTs, Moderately similar to 67A9.b [D.melanogaster]"	1.55	1.3	0.68	0.71	1.13	0.82	0.88	0.67	0.92	0.6	0.61	0.57	1.03	1.3	0.96	0.98	0.99	0.47	2.77	1.87	1.9	2.39
HV28H5	124405	"ESTs, Highly similar to CGI-103 protein [H.sapiens]"	1.83	1.19	0.43	0.5	1.28	1.53	0.85	0.63	0.94	0.58	0.73	1.25	0.62	0.59	0.84	0.68	0.39	0.5	1.39	0.88	0.79	1.01
HV28H6	144915	"Homo sapiens clone 24856 mRNA sequence, complete cds"	1.74	1.84	1.29	1.25	2.13	1.12	1.67	1.68	2.46	1.29	0.68	1.56	2.13	2.29	1.22	1.04	1.71	2.34	6.66	1.38	2.38	2.89
HV28H11	246541	ESTs	1.04	1.18	1.45	1.3	1.7	1.23	0.88	0.63	1.45	0.87	1.37	1.05	1.15	1.01	0.92	1.04	1.84	1.35	0.98	0.97	1.19	1.04
HV29A3	232908	"ESTs, Highly similar to CGI-106 protein [H.sapiens]"	0.49	0.66	0.61	0.74	0.54	0.59	0.76	0.47	0.86	0.75	0.53	0.52	0.6	0.65	0.36	0.45	0.88	0.75	1.38	0.9	1.35	1.32
HV29A6	126412	androgen receptor associated protein 54	0.6	0.61	0.35	0.42	0.9	0.55	0.54	0.63	0.89	0.47	0.74	0.86	0.8	0.62	0.68	0.72	1.14	0.45	1	2.17	1.2	2.06
HV29A7	359713	"ESTs, Weakly similar to 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [H.sapiens]"	0.75	0.7	1.11	0.84	1.27	0.45	0.69	0.5	2.11	1	0.81	1.16	1	0.95	1.28	0.77	0.36	0.68	1.2	1.17	0.79	2.14
HV29B2	244205	ESTs	2.73	1.61	0.4	1.09	1.97	1.05	1.12	1.01	2.61	0.68	0.46	1.6	1.71	2.06	1.64	1.67	1.76	1.65	2.1	0.25	2.1	2.09
HV29B3	121625	ESTs	2.28	0.83	0.86	1.29	3.03	1.36	1.36	1.48	2.44	1.3	1.78	1.22	1.08	1.28	1.89	0.48	1.97	1.65	2.31	1.19	1.36	1.68
HV29B5	66694	"ESTs, Weakly similar to X-linked retinopathy protein [H.sapiens]"	1.64	0.79	2.06	1.63	1.36	0.89	0.34	1.43	2.66	0.53	0.62	1.35	1.16	0.93	1.59	0.76	1.28	2.27	2.44	1.67	1.45	1.37
HV29B9	110519	ESTs	2.98	0.73	4.95	1.53	1.1	0.45	0.56	1.74	3.45	0.47	2.1	3.61	2.27	2.31	0.91	0.54	1.57	0.89	8.68	4.15	3.51	5.4
HV29C1	197474	ESTs	1.79	0.51	0.23	0.23	1.31	0.69	0.55	0.75	1.77	0.97	0.59	1.45	1.81	1.89	0.89	0.35	0.91	1.01	2.54	0.69	1.2	1.58
HV29C2	241824	ESTs	1.4	2.24	1.1	0.87	1.97	0.37	0.81	1.35	2.32	0.77	0.76	1.98	1.98	2.82	2.19	0.61	2.17	3.65	3.2	0.86	1.54	1.93
HV29C3	247233	ESTs	1.43	0.62	0.26	0.26	1.16	0.58	0.46	1.29	2.09	0.74	0.34	1.94	1.7	2.26	0.97	0.4	3.32	3.3	4.96	1.64	2.11	2.98
HV29C6	213527	ESTs	1.92	0.69	0.4	0.43	2.84	0.57	1.57	0.82	1.84	0.9	0.43	1.48	2.09	2.34	0.88	0.64	0.91	3.24	2.55	1.45	1.26	2.44
HV29C7	247925	Homo sapiens mRNA for DRIM protein	1.65	1.04	1.83	1.23	1.66	0.8	0.47	0.63	2.65	0.54	0.53	2.45	1.1	2.27	1.28	0.42	0.81	3.19	2.43	0.88	1.3	1.76
HV29C8	292207	EST	1.74	0.71	0.34	0.35	2.26	0.62	0.83	1.26	1.73	1.58	0.44	1.98	1.42	2.22	0.94	0.64	2.01	2.71	2.23	0.6	1.12	1.92
HV29C9	113488	ESTs	1.29	0.66	1.43	0.55	1.81	0.52	0.73	1.66	2.49	0.61	0.43	2.06	2.01	2.32	1.22	0.26	0.94	2.04	2.96	1.02	1.21	2.28
HV29C10	195947	"ESTs, Weakly similar to !!!! ALU SUBFAMILY J WARNING ENTRY !!!! [H.sapiens]"	1.35	0.71	0.37	0.39	2.07	0.78	3.15	1.21	1.8	0.63	0.38	2.69	1.9	3.72	2.3	1.16	0.91	2.98	2.19	0.39	1.02	1.39
HV29C12	344757	"ESTs, Weakly similar to !!!! ALU SUBFAMILY J WARNING ENTRY !!!! [H.sapiens]"	1.58	0.7	0.4	0.65	1.79	1.33	1.11	1.18	1.93	0.84	0.4	2.11	1.67	3.8	0.96	0.85	0.91	2.98	0.14	0.04	0.05	0.06
HV29D1	295939	"ESTs, Weakly similar to !!!! ALU CLASS C WARNING ENTRY !!!! [H.sapiens]"	1.04	0.81	0.31	0.64	0.88	0.47	1.24	0.85	1.19	0.51	0.79	1.19	0.46	0.73	2.17	0.89	0.81	2	1.72	0.33	0.86	1.26
HV29D2	141854	"ESTs, Weakly similar to !!!! ALU SUBFAMILY J WARNING ENTRY !!!! [H.sapiens]"	1.68	1.3	0.57	0.7	1.11	0.56	1.37	1.07	1.94	0.5	0.57	3.58	0.71	1.58	1.77	1.15	1.28	2.31	1.87	0.38	1.29	1.33
HV29D3	208161	"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide"	0.68	0.49	0.69	0.79	0.66	1.02	0.5	0.84	1.23	0.71	0.95	1.41	0.61	0.69	0.9	0.75	0.95	0.73	0.72	0.92	0.56	0.68
HV29D5	211878	ESTs	1.65	0.73	1.48	0.57	1.33	0.44	0.23	1.11	2.55	0.19	1.79	2.11	1.71	2.64	1.58	0.46	0.61	1.86	1.7	0.87	0.86	1.52
HV29D7	243260	ESTs	2.89	1.21	3.28	3.27	1.49	2.23	1.4	2.49	2.91	0.37	0.64	2.13	0.85	0.62	1.24	0.53	1.86	1.31	1.5	1.37	1.4	1.46
HV29D10	137417	"ESTs, Weakly similar to reverse transcriptase [M.musculus]"	2.11	1.51	0.39	0.9	1.53	1.04	2.09	1.46	3.89	0.79	0.55	1.33	1.8	1.83	1.64	0.49	0.84	2.16	8.49	5.5	4.64	10.86
HV29D11	128738	"ESTs, Highly similar to transcription elongation factor TFIIS.h [H.sapiens]"	3.04	0.59	1.95	1.75	1.11	1.99	0.08	1.84	2.67	0.69	0.57	3.93	2.28	5.84	1.93	0.8	2.69	3.22	5.18	1.19	1.35	3.08
HV29D12	245585	"ESTs, Moderately similar to !!!! ALU SUBFAMILY SQ WARNING ENTRY !!!! [H.sapiens]"	0.94	0.59	0.46	1.16	0.94	0.94	0.96	1.32	2.37	0.37	0.85	1.79	1.53	0.85	1.13	0.38	0.91	1.92	5.1	3.31	4.34	3.48
HV29E3	356707	"ESTs, Weakly similar to unnamed protein product [H.sapiens]"	1.19	0.9	0.77	1.42	1.98	0.97	1.64	0.7	1.79	0.69	1.24	1.59	0.88	1.9	1.21	0.62	1.13	1.25	1.25	0.95	1.11	1.22
HV29E6	786048	"E2F transcription factor 4, p107/p130-binding"	1.07	0.9	0.54	0.69	0.94	0.79	0.77	0.76	0.9	0.62	0.78	0.71	0.73	1.1	0.68	1.57	0.94	0.84	0.78	0.61	0.84	0.59
HV29E7	340722	"Homo sapiens t(3;5)(q25.1;p34) fusion gene NPM-MLF1 mRNA, complete cds"	3.13	0.72	1.73	1.92	1.07	1.49	0.27	1.97	0.95	0.62	0.72	1.73	0.65	0.38	1.05	0.25	1.34	1.21	0.7	1.11	0.47	1.11
HV29E8	35191	stromal cell-derived factor 2	1.11	0.8	0.61	0.6	1.14	0.65	1.14	0.82	2.06	0.68	0.71	1.6	1.1	1.67	1.63	0.75	1.15	1.68	1.34	1.47	1.62	1.13
HV29E10	208993	"ESTs, Moderately similar to similar to thymidine diphosphoglucose 4,6-dehydratase [C.elegans]"	1.02	0.67	0.38	0.59	1.58	0.75	0.66	0.76	6.93	0.59	0.49	1.33	1.25	0.81	1.04	0.54	3.52	1.96	0.41	0.9	0.54	0.3
HV29E11	345128	"ESTs, Moderately similar to rhotekin [M.musculus]"	1.6	0.53	0.74	1.01	0.86	0.72	0.27	1.13	1.28	0.95	0.83	0.87	0.82	1.01	0.61	0.27	0.97	1.09	1.02	1.54	1.51	1.51
HV29E12	197933	ESTs	1.33	0.55	0.37	0.77	2.89	0.7	1.01	0.73	2.47	0.74	0.46	2.28	1.31	1.59	1	0.91	2.5	0.94	2.15	1.07	1.16	1.8
HV29F1	194986	ESTs	1.07	0.81	0.54	0.71	1.72	0.86	0.87	1.15	1.75	0.84	1.28	0.61	0.86	1.31	0.55	0.54	1.99	1.23	3.85	1.8	1.47	2.6
HV29F2	141677	pregnancy specific beta-1-glycoprotein 11	3.53	2.46	1.31	2.78	3.61	1.72	2.02	2.09	3.75	2.04	0.88	3.69	5.32	4.52	1.5	1.45	1.91	3.5	6.76	1.77	4.73	7.02
HV29F3	247901	"ESTs, Moderately similar to 17-beta-hydroxysteroid dehydrogenase type 7 [M.musculus]"	1.9	0.76	0.68	0.88	2.37	1.44	1.44	1.02	1.96	0.99	1.32	2.05	1.19	2.4	1.69	1.05	1.51	1.52	4.53	2.68	2.39	4.43
HV29F4	240702	"ESTs, Weakly similar to striatin [M.musculus]"	1.19	1.68	0.88	0.68	1.37	0.77	0.9	0.89	2.85	0.77	0.76	1.3	0.92	1.49	0.85	1.18	1.25	1.52	1.73	0.61	1.85	1.37
HV29F6	129502	"ESTs, Moderately similar to ninein [M.musculus]"	2.04	0.73	0.46	0.54	2.31	1.42	0.9	0.71	1.25	0.87	2.01	1.76	1.59	2.14	0.59	0.72	1.71	0.66	3.06	1.05	1.1	1.56
HV29F7	192481	KIAA0921 protein	3.09	0.65	1.07	1.64	0.88	1.07	0.32	1.64	2.34	0.64	2.99	1.79	1.45	0.52	1.05	0.44	1.01	0.48	1.82	3.69	2.13	1.64
HV29F8	364840	"ESTs, Moderately similar to mouse Dhm1 protein [M.musculus]"	0.96	0.63	0.62	0.62	0.85	0.78	0.73	0.77	0.82	0.71	1.22	0.65	1.14	1.1	0.87	1.14	1.16	0.47	0.41	0.46	0.65	0.63
HV29F9	137063	ESTs	3.23	0.55	3.26	1.14	1.13	0.42	0.2	1.96	2.84	0.37	2.31	1.66	1.53	1.86	1.64	0.61	1.83	1.78	2.52	0.82	0.93	1.71
HV29F11	739625	KIAA0973 protein	1.13	0.95	2.62	2.01	1.06	2.44	1.18	2.74	3.19	2.37	3.3	1.52	0.88	0.9	1.47	0.95	1.68	1	5.65	2.62	5.65	9.35
HV29F12	366580	fibrogenic lymphokine	1.22	1.4	0.72	0.99	1.1	1.72	1.44	1.62	1.73	1.51	1.73	1.22	1.4	1.32	1.07	1.14	1.75	1.01	1.75	1.47	2.65	1.34
HV29G1	156211	"ATPase, H+ transporting, lysosomal (vacuolar proton pump), beta polypeptide, 56/58kD, isoform 1"	1.15	0.6	0.26	0.38	1.81	0.86	0.81	0.77	1.87	1.37	0.83	1.37	1.66	1.92	1.4	0.94	0.91	1.52	2.28	0.83	1.28	1.74
HV29G2	47043	ESTs	3.36	4.52	2.02	2.11	3.04	1.46	3.4	3.4	3.69	2.51	1.11	3.7	6.75	8.44	1.37	1.42	3.08	6.04	9.11	5.27	5.55	9.34
HV29G3	297148	"ESTs, Moderately similar to TRANSLATION INITIATION FACTOR EIF-2B ALPHA SUBUNIT [H.sapiens]"	1.68	0.61	0.37	0.35	1.8	0.83	0.49	1.28	1.37	0.78	0.35	2.05	1.57	1.39	1.15	0.45	0.91	1.95	2.54	0.99	1.48	1.67
HV29G5	123087	tumor susceptibility gene 101	0.8	0.76	0.83	0.53	1.71	0.18	0.23	1.06	2.41	0.3	0.28	0.73	0.95	0.99	0.85	0.27	0.4	0.72	1.54	0.7	0.98	0.99
HV29G6	240589	ESTs	1.23	0.91	0.53	0.85	2.57	1.47	1.04	0.87	2.05	0.73	0.5	1.22	1.42	1.52	0.98	1.18	1.92	0.57	3.13	0.85	1.21	1.48
HV29G7	306484	"cofactor required for Sp1 transcriptional activation, subunit 6 (77kD)"	1.75	1.14	1.45	1.42	1.69	1.39	0.81	1.54	2.08	0.91	1.13	1.28	1.1	0.95	1.18	0.76	0.89	1.06	1.41	0.79	0.83	1.17
HV29G9	122063	"solute carrier family 7 (cationic amino acid transporter, y+ system), member 7"	2.1	0.65	2.26	0.97	1.58	2.02	1.91	1.81	2.11	0.52	2.38	3.38	2.43	3.6	0.75	0.28	0.91	1.02	4.25	1.24	2.88	2.11
HV29G10	194468	"ESTs, Moderately similar to Ala-glyoxylate aminotransferase 2 [R.norvegicus]"	1.76	0.63	0.29	0.3	2.31	0.48	0.75	1.36	2.33	0.64	0.36	1.95	1.56	2.16	0.62	0.54	2.68	2.47	1.99	0.21	0.51	1.31
HV29G12	361656	"ESTs, Moderately similar to Rabin3 [R.norvegicus]"	1.31	0.68	0.27	0.3	0.88	0.46	0.35	0.61	1.61	0.25	0.33	0.96	1.12	1.12	1.04	0.43	1.3	1.1	0.77	0.26	0.53	0.32
HV29H3	235056	Homo sapiens clone 24432 mRNA sequence	0.98	0.53	0.42	0.68	1.26	0.88	0.58	1.23	2.05	0.71	0.76	0.77	0.62	0.9	0.53	0.64	1.05	0.58	0.96	1.06	0.82	0.59
HV29H4	199995	ESTs	1.44	1.02	1	0.9	1.17	0.61	0.71	1.2	1.61	0.4	0.54	1.6	1.39	1.66	1.09	0.79	0.92	1.3	2.05	1.17	1.34	1.29
HV29H5	897901	ESTs	2.48	0.81	1.01	1	0.96	0.94	0.54	1.04	2.31	0.43	0.81	2.13	1.42	0.41	0.76	0.59	0.61	0.43	2.17	2.9	1.25	1.89
HV29H7	245426	"ESTs, Highly similar to Ran-binding protein 2 [H.sapiens]"	2.93	0.74	20.15	2.96	1.96	2.45	3.48	2.6	2.39	1.06	2.66	4.89	4.67	5.45	2.28	0.96	2.48	4.09	7.74	4.36	4.58	7.04
HV29H8	321354	"ESTs, Weakly similar to partial CDS [C.elegans]"	1.42	0.63	0.42	0.64	0.92	0.7	0.77	1.54	1.17	0.57	0.76	1.33	1.42	1.09	0.96	0.5	0.91	0.69	0.62	0.37	0.56	0.71
HV29H10	292519	"ESTs, Moderately similar to PUTATIVE PEROXISOMAL ANTIOXIDANT ENZYME [M.musculus]"	0.46	0.45	0.47	0.3	0.47	0.37	0.55	0.41	0.79	0.35	0.42	0.58	0.5	0.65	0.56	0.44	1.11	0.74	0.53	0.21	0.6	0.39
HV29H11	246620	"ESTs, Weakly similar to double-stranded RNA-binding nuclear protein DRSBP76 [H.sapiens]"	0.52	0.5	0.5	0.35	0.47	0.45	0.33	0.51	1.69	0.23	0.58	0.78	0.6	0.81	0.45	0.33	0.4	0.79	0.7	0.38	0.76	0.56
HV30A3	300474	"adaptin, gamma"	1.2	0.71	0.69	0.89	1.04	0.72	0.53	1.03	0.98	0.79	0.93	1	0.6	0.62	0.86	0.62	0.48	0.81	0.53	0.93	0.77	0.49
HV30A4	309894	DKFZP547G1110 protein	0.85	1.03	0.56	0.83	1.36	0.73	0.89	0.74	1.1	0.59	0.93	0.88	1.29	1.41	0.56	1.05	0.69	0.96	0.78	1.13	1.27	1.29
HV30A5	344282	"ESTs, Highly similar to CGI-03 protein [H.sapiens]"	1.75	0.72	1.53	2.29	1.56	1.88	0.71	1.13	0.82	0.96	1	0.95	1.3	0.73	1.36	0.56	1.05	1.23	1.6	2.01	1.85	2.52
HV30A6	153743	"ESTs, Moderately similar to /prediction"	1.69	2.13	1.23	1.97	2.37	1.62	1.83	1.36	1.45	1.5	1.7	1.41	1.32	2.03	1.16	2.21	1.97	2.69	0.96	1.06	1.55	1.64
HV30A7	123425	"ESTs, Weakly similar to EGF repeat transmembrane protein [M.musculus]"	2.18	1.05	1.34	2.19	1.48	1.89	0.86	1.29	1.97	1.28	0.81	0.78	1.4	1.44	0.86	0.55	0.67	1.21	1.32	0.68	0.96	1.3
HV30A10	246869	zinc finger protein 207	1.53	1.19	0.87	1.14	1.21	1	1.2	1.19	0.91	1.11	0.72	1.23	1.29	1.47	1.56	1.39	1.29	1.25	0.5	0.77	0.71	0.85
HV30B1	297086	sequence-specific single-stranded-DNA-binding protein	1.66	1.55	1.47	1.36	1.34	0.86	0.92	1.48	0.91	0.71	2.52	1.18	1.21	1.4	1.05	0.93	1.12	1.73	3.84	3.02	2.84	1.02
HV30B3	142259	tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains; Huntingtin interacting protein L	1.04	1.4	1.37	1.81	0.73	3.1	0.87	1.84	1.62	0.88	1.43	1.55	1.39	0.85	0.9	0.86	1.3	1.29	1.29	0.59	0.79	1.05
HV30B5	242823	ESTs	1.46	1.41	1.15	1.59	1.51	1.16	0.91	1.52	1.38	1.34	2.42	1.35	1.03	1.23	1.23	0.81	0.97	1.92	1.23	0.85	1.16	1.25
HV30B6	196148	"ESTs, Moderately similar to !!!! ALU SUBFAMILY SQ WARNING ENTRY !!!! [H.sapiens]"	1.21	1.78	0.87	1.24	3.39	1.5	1.64	1.29	1.15	1.74	1.26	1.41	2	0.86	2.34	2.09	0.91	0.78	1.35	0.8	1.34	1.21
HV30B11	127243	ESTs	2.21	2.06	1.56	2.11	1.54	1.84	1.34	2.14	1.76	1.88	2.08	1.62	1.5	2.81	1.44	1.27	1.32	1.3	2.08	1.17	1.18	0.59
HV30B12	66792	"ESTs, Highly similar to Arf-like 2 binding protein BART1 [H.sapiens]"	1.72	1.25	0.77	0.79	1.11	0.84	0.75	1.29	1.11	1.08	1.06	1.25	1.22	1.36	0.66	1.22	1.12	0.84	1.53	1.09	0.98	1.6
HV30C2	124719	ESTs	1.81	2.4	2.82	2.55	2.96	1.19	3.05	4.24	8.22	1.74	1.58	5.12	2.92	2.85	1.93	2.62	1.17	8.43	4.53	2.91	1.2	1.67
HV30C9	124090	"ESTs, Highly similar to breakpoint cluster region protein 2 [H.sapiens]"	0.84	1.49	1.15	1.14	2.37	1.28	1.06	1.46	1.17	1.73	1.78	1	1.21	1.28	1.03	1.16	1.25	0.75	3.26	2.45	1.99	1.94
HV30C11	130781	KIAA0557 protein	1.1	1.38	1.06	1.05	1.99	1.21	1.91	1.98	1.96	2.8	2.37	2.26	1.93	2.09	1.07	1.2	1.25	2.02	2.33	2.11	1.09	2.17
HV30D5	45525	ESTs	0.95	2.23	1.84	1.87	2.15	1.48	1.26	1.97	2.14	1.27	1.51	1.37	1.39	1.98	1.59	1.84	2.19	1.38	1.48	2.03	1.61	1.63
HV30D9	246661	DKFZP564A122 protein	1.54	2.21	4.27	2.27	2.75	1.84	2.86	2.85	2.2	1.77	1.71	1.72	2.75	1.79	2.37	2.34	1.59	2.16	4.13	2.42	2.76	3.35
HV30D12	362742	"ESTs, Moderately similar to PROFILIN I [H.sapiens]"	1.08	1.15	0.93	0.81	1.18	0.95	1.23	0.86	0.78	0.75	0.75	0.96	1.2	1.32	1.23	0.92	1.01	1.29	1.87	0.77	1.04	0.91
HV30E2	344251	"ESTs, Weakly similar to Containing ATP/GTP-binding site motif A(P-loop): Similar to C.elegans protein(P1:CEC47E128);Similar to Mouse alpha-mannosidase(P1:B54407) [H.sapiens]"	1.24	0.87	0.67	0.63	1.6	0.8	0.95	0.81	1.01	0.97	1.04	0.94	1.03	1.29	0.91	2	0.71	1.2	0.94	0.44	0.75	0.63
HV30E7	358162	"Human clone 23627 mRNA, complete cds"	2.05	1.97	1.55	2.1	2.34	2.1	1.11	1.27	2.51	1.91	1.62	1.67	1.57	2.82	1.87	1.17	1.15	4	1.93	1.53	1.9	2.24
HV30E9	236055	DKFZP564M2423 protein	1.84	1.92	1.2	2.24	1.07	1.92	0.62	1.03	0.75	0.98	1.04	0.91	1.4	1.14	1.36	1.19	1.71	1.84	0.73	0.56	0.95	1.22
HV30E10	239958	DKFZP586G1822 protein	1.96	2.47	2.08	2.35	2.46	1.87	1.81	1.28	1.86	1.62	1.36	1.53	1.68	1.96	1.17	2.24	1.16	3.22	1.84	1.61	1.57	2.16
HV30E12	469704	KIAA0917 protein	2.44	2.98	1.71	1.54	2.04	0.95	1.87	1.85	1.75	1.6	0.52	2.28	1.44	1.97	2.35	1.58	1.09	1.66	1.08	0.52	0.87	1.22
HV30F3	235164	putative transmembrane protein	1.33	1.3	0.84	1.32	1.24	1.23	1.13	1.14	1.25	1.52	2.05	0.98	0.38	0.5	1.25	0.8	1.05	2.6	1.08	1.51	1.43	2.02
HV30F4	43878	"splicing factor 30, survival of motor neuron-related"	1.26	1.06	0.84	1.21	1.53	0.9	1.12	0.72	0.83	0.98	1.02	0.72	1.1	0.96	0.8	1.35	1.48	1.11	0.94	0.69	0.6	0.87
HV30F5	347687	"cell division cycle 42 (GTP-binding protein, 25kD)"	1.74	1.6	2.16	1.98	1.57	0.85	1.15	1.66	1.68	1.28	2	0.86	1.07	1.11	0.91	0.85	1.52	1.69	1.32	0.61	0.87	2.09
HV30F8	204111	Homo sapiens clone 24706 mRNA sequence	1.37	1.78	0.59	0.78	1.64	0.95	1.32	0.76	1.66	1.59	1.2	0.94	1.28	1.25	1.04	1.51	1.4	0.64	2.21	1.17	0.65	1.21
HV30F9	282051	"ESTs, Highly similar to melanoma ubiquitous mutated protein [H.sapiens]"	1.08	2.57	1.95	2.4	2.68	1.78	3.18	2.5	2.81	2.22	3.91	2.45	2.04	2.78	1.16	1.49	1.94	1.69	3.14	1.61	2.25	3.7
HV30F10	207107	"ESTs, Moderately similar to CALDESMON [H.sapiens]"	1.21	2.42	2.09	1.85	5.68	1.22	2.89	3.1	1.79	1.97	1.16	0.92	2.6	3.24	1.36	2.34	2.77	4.19	7.57	1.49	5.12	6.43
HV30G4	321247	retinoblastoma-like 2 (p130)	1.66	1.18	0.49	0.78	1.18	0.84	1.05	1.13	1.3	0.94	0.67	1.5	1.63	1.47	1.11	1.54	0.95	0.83	0.93	0.45	0.56	1.03
HV30G5	263040	"ESTs, Moderately similar to !!!! ALU SUBFAMILY SP WARNING ENTRY !!!! [H.sapiens]"	1.1	0.92	0.59	0.78	0.85	0.82	0.38	0.88	0.59	0.68	0.99	1.22	0.81	0.66	0.93	0.48	0.64	0.65	0.73	0.8	0.91	0.76
HV30G8	50765	Homo sapiens mRNA; cDNA DKFZp586C1723 (from clone DKFZp586C1723)	1.35	1.84	1.44	2.72	2.02	1.42	1.28	2.38	1.41	1.84	0.89	1.43	1.96	1.81	2	2.85	1.77	1.36	3.03	3.47	2.25	1.02
HV30G11	248256	ESTs	1.07	1.35	1.52	1.97	2.2	2.18	1.23	1.91	1.33	1.51	2.22	1.16	0.77	1.01	1.88	3.52	1.52	1.76	2.18	1.31	2.02	1.32
HV30G12	303035	KIAA0463 protein	1.99	1.8	0.63	0.93	2.07	0.95	1.49	1.19	1.86	1.3	0.43	1.04	1.19	1.49	1.17	1.81	1.36	1.09	1.72	1.04	0.99	2.1
HV30H1	137535	transcriptional intermediary factor 1	1.49	3.14	2.64	3.1	2.41	2.93	1.6	2.25	1	1.64	1.16	1.39	1.51	2.03	1.62	2.39	1.74	2.05	9.24	2.48	2.24	2.87
HV30H3	324745	"ESTs, Weakly similar to Sec22 homolog [R.norvegicus]"	1.55	3.08	1.6	1.39	1.75	1	1.43	1.93	0.95	0.97	1.14	1.19	1.25	1.44	1.19	1.02	1.09	1.43	1.44	0.6	0.75	1.09
HV30H5	108422	Homo sapiens mRNA; cDNA DKFZp586F1318 (from clone DKFZp586F1318)	0.54	2.1	0.6	0.83	1.16	1.03	0.39	0.35	0.49	0.27	0.38	0.5	0.78	0.81	0.76	0.44	0.8	0.54	0.53	0.49	0.67	0.99
HV30H7	250519	KIAA0801 gene product	0.79	2.2	1.04	1.3	1.47	0.86	0.85	1.08	0.81	0.71	0.65	0.96	1.01	0.91	0.74	0.76	1.51	0.7	1.1	1.2	0.75	1.14
HV30H8	22711	ESTs	0.7	0.87	0.69	0.77	1.92	0.79	0.96	0.89	0.89	0.91	1.39	0.9	1.01	0.98	0.95	1.9	1.29	0.53	1.77	0.61	1.31	0.93
HV30H9	79520	"RAB2, member RAS oncogene family"	1.11	1.03	1.19	0.92	1.41	1.02	0.81	1.51	1.33	0.82	1.04	1.49	1.44	1.04	1.53	0.81	1.01	0.84	1.1	1.11	1.2	1.56
HV30H12	345055	"ESTs, Moderately similar to dithiolethione-inducible gene-1 [R.norvegicus]"	2.02	1.42	0.77	0.93	1.66	0.84	1.34	0.8	0.71	1.16	0.65	1.09	1.31	1.4	0.9	1.33	0.98	0.64	2.94	1.28	1.03	2.3
HV31A4	785816	"Homo sapiens clone 23711 unknown mRNA, partial cds"	1.06	2.12	1.42	1.92	2.2	1.38	1.61	1.09	1.05	0.99	0.9	0.7	1.26	1.51	1.01	1.7	1.19	1.62	0.86	0.73	0.71	1.43
HV31A7	143039	ESTs	0.77	1.25	1.04	1.86	2.14	0.91	1.67	1.17	1.65	1.05	0.95	0.98	1.06	1.85	1.14	0.94	1.05	1.25	0.85	0.52	0.84	1.06
HV31A8	112906	"protein phosphatase 1, regulatory subunit 10"	1.08	1.57	1.22	1.29	1.88	1.37	3.08	1.38	1.71	1.97	1.3	0.83	1.29	2.48	1.77	2.77	1.13	1.76	2.23	1.36	1.71	0.57
HV31A9	243151	ESTs	1.46	1.96	1.85	1.51	2.3	1.3	1.7	1.02	1.59	1.85	1.27	1.59	1.24	1.9	1.2	1.97	1.38	1.57	1.52	0.68	0.79	1.36
HV31A10	325102	ESTs	0.67	1.8	1.97	1.28	2.34	0.78	2.5	0.94	0.91	1.95	1.15	0.72	1.1	1.68	0.79	2.01	1.49	2.28	1.13	0.56	0.6	0.8
HV31A11	109153	"coatomer protein complex, subunit alpha"	1.71	2.02	1.25	1.82	2.05	2.73	1.47	0.98	1.22	1.39	1.62	1.48	0.83	0.43	1.45	1.33	2.11	1.06	2.71	1.68	1.55	1.62
HV31B1	244147	biglycan	4.39	4	9.73	2.42	8.47	5.83	5.54	8.66	8.1	7.19	6.34	5.75	5.79	8.87	3.21	3.85	2.9	11.71	25.7	8.18	8.84	22.94
HV31B3	292515	UDP-N-acteylglucosamine pyrophosphorylase 1; Sperm associated antigen 2	1.65	2.46	0.8	2.12	1.52	1.15	0.92	1.36	1.09	1.07	1.06	0.99	0.97	1.72	1.66	1.38	2.01	2.58	0.91	0.63	0.93	1.69
HV31B5	66952	zinc finger protein 205	1.12	2.1	1.58	1.53	2.06	1.19	1.24	1.49	1.51	1.45	1.33	1.49	1.03	1.8	0.92	1.4	1.91	1.22	2.53	1.42	1.58	2.01
HV31B6	144951	ESTs	1.24	1.78	1.08	1.2	2.73	2.26	1.68	1.4	1.39	1.39	1.4	1.8	1.98	1.29	1.59	2.02	2.41	1.2	2.33	1.13	1.06	2.69
HV31B9	112158	"ESTs, Weakly similar to TRANSCRIPTIONAL REPRESSOR CTCF [H.sapiens]"	0.95	2.29	1.12	1.67	1.86	1.14	1.56	2.05	1.67	2.44	1.38	1.5	1.13	1.51	0.89	2.36	0.97	1.08	3	1.61	3.05	1.92
HV31B11	144926	ESTs	3.41	2.47	1.06	1.72	1.54	1.93	1.6	1.22	1.26	1.55	1.11	0.83	0.64	0.9	1.27	1.36	0.89	1.51	0.86	0.58	1.14	0.74
HV31B12	245099	neuroblastoma RAS viral (v-ras) oncogene homolog	1.22	1.31	1.77	1.6	1.29	1.28	1.07	1.25	1.06	1.06	0.9	1.25	1.04	0.83	1.28	2.67	1.8	1.23	0.86	0.47	0.77	1.18
HV31C1	124116	"ESTs, Highly similar to CGI-76 protein [H.sapiens]"	1.47	1.97	1.59	2.05	2.51	3.03	1.55	1.94	1.04	2.07	1.79	1.79	1.73	1	1.59	1.76	1.86	1.23	1.91	1.16	2.22	1.45
HV31C2	134172	ESTs	1.13	1.89	0.87	1.26	1.3	1.1	1.23	1.86	1.62	1.05	1.7	1.3	1.35	1.65	1.51	1.87	1.23	1.74	1.06	0.84	1.04	1.41
HV31C4	129610	ESTs	4.83	5.01	2.72	3.29	3.73	1.41	2.84	5.65	2.89	1.25	0.76	7.46	3.63	14.93	3.44	1.89	3.27	9.1	8.27	1.46	3.2	3.61
HV31C8	137387	ESTs	1.06	1.88	1.22	1.04	1.19	0.73	1.34	1.51	1.43	1.02	1.61	1.48	1.57	1.8	1.2	3.33	1.19	0.73	1.57	1.32	0.33	1.47
HV31C9	153779	ESTs	1.27	2.14	1.29	1.94	2.21	1.55	1.83	1.61	1.57	1.45	1.64	1.08	0.95	1.24	1.05	1.83	1.96	1.58	2.61	1.06	1.37	1.9
HV31C10	298833	Homo sapiens mRNA; cDNA DKFZp586B1024 (from clone DKFZp586B1024)	1.66	1.62	1.89	1	2.03	1.04	1.8	1.94	1.65	1.76	1.3	1.41	1.73	1.7	0.89	1.32	0.98	0.67	1.87	1.29	0.79	1.71
HV31C11	141314	ribosomal protein S25	2.79	5.71	2.16	4.67	6.76	3.2	5.85	7.83	3.43	3.52	5.62	2.37	2.62	5.54	1.5	2.97	3.26	3.35	3.36	1.47	3.37	3.83
HV31C12	307882	tubulin-specific chaperone a	0.89	1.03	0.57	0.96	1.13	0.87	1.38	0.98	1.12	0.99	0.85	0.78	0.86	1.37	0.83	1.93	0.83	1.39	0.85	0.46	0.64	1.06
HV31D1	122194	"chaperonin containing TCP1, subunit 4 (delta)"	1.26	1.56	0.86	2.33	1.24	1.36	0.93	0.96	0.73	0.9	0.88	1.01	1.02	0.65	1.43	1.25	1.49	0.68	1.36	1.05	1.47	1.02
HV31D2	248856	EST	1.61	2.51	1.47	2.08	1.85	2.01	1.92	3.32	1.97	1.54	0.86	2.05	2.11	1.42	1.54	1.57	0.91	0.81	2.97	1.88	1.53	2.31
HV31D4	179336	"succinate dehydrogenase complex, subunit A, flavoprotein (Fp)"	2.68	1.82	1.26	1.28	1.68	1.2	1.37	1.09	1.25	0.94	1.5	1.35	1.72	1.62	1.44	1.34	1.67	1.91	1.4	1.41	0.89	1.13
HV31D5	308478	ESTs	1.55	3.9	1.63	0.59	2.19	1.33	4.19	0.97	5.41	2.96	4.74	1.21	1.41	1.69	0.64	1.3	2.07	1.4	3.97	2.19	1.29	1.3
HV31D6	204737	"slug (chicken homolog), zinc finger protein"	0.32	0.55	1.85	0.63	0.69	0.21	0.45	0.89	0.45	0.31	0.38	0.25	0.77	0.68	0.86	0.5	0.18	0.38	0.36	0.12	0.28	0.33
HV31D7	346299	"ESTs, Highly similar to vacuolar sorting protein 4 [H.sapiens]"	1.04	2.17	2.04	1.43	2.04	1.08	1.24	2.9	2.24	1.33	1.43	1.01	0.71	1.02	1.12	1.1	1.73	2.24	1.17	0.54	0.81	0.89
HV31D8	198904	"ESTs, Moderately similar to SIGNAL RECOGNITION PARTICLE RECEPTOR BETA SUBUNIT [M.musculus]"	2.37	2.07	1.47	1.67	2.87	1.07	1.95	2.24	3.13	1.18	0.92	1.96	1.13	1.71	1.53	1.87	1.16	1.49	1.36	0.64	1.09	1.43
HV31D9	232946	serum/glucocorticoid regulated kinase	0.7	1.17	0.9	1.21	2.1	0.66	0.34	0.71	1.12	0.66	0.82	0.49	0.9	0.52	0.71	1.15	0.54	0.36	1.03	0.48	0.53	0.68
HV31D10	141959	Homo sapiens mRNA; cDNA DKFZp566J2446 (from clone DKFZp566J2446)	0.97	2.66	1.34	1.13	1.57	0.7	3.01	3.99	6.21	1.58	0.83	3.39	2.16	3.71	1.19	1.81	1.34	0.91	3.05	6.62	1.29	6.22
HV31E5	144881	calumenin	1.49	2.16	3.09	1.96	3.13	1.32	1.73	3.51	1.91	1.73	1.96	0.8	0.7	1.41	1.44	1.4	3.13	4.3	1.97	0.56	1.23	1.6
HV31E6	145513	regulator of mitotic spindle assembly 1	2.38	2.11	1.88	1.95	2.48	1.09	3.18	3.42	2.78	1.37	0.7	2.23	2.53	2.95	2.07	1.94	1.75	2.06	2.6	1.98	2.02	3.65
HV31E7	321189	DKFZP586H0723 protein	0.55	0.85	1.71	1.27	1.24	0.98	0.94	1.51	0.56	1.18	1.25	0.97	0.77	0.81	0.95	0.92	0.83	0.73	0.6	0.54	0.66	0.81
HV31E8	115111	"ESTs, Weakly similar to RAS-RELATED PROTEIN RAB-5A [H.sapiens]"	0.78	1.41	0.65	0.91	1.57	0.85	2.46	1.36	2.34	1.84	0.98	1.47	1.14	1.75	1.34	1.74	1.04	1.12	1.92	1.13	1.38	0.62
HV31E9	308989	"ESTs, Weakly similar to RAS-RELATED PROTEIN RAB-11A [H.sapiens]"	0.8	0.77	0.12	0.64	1.01	0.91	0.71	0.53	0.63	0.51	0.65	0.47	0.39	0.92	0.51	0.74	0.47	0.96	3.42	1.17	1.07	2.03
HV31E10	130100	oncogene TC21	0.5	0.56	0.32	0.53	1.08	0.5	0.63	0.33	0.29	0.86	0.31	0.13	0.58	0.38	0.43	1.17	1.19	0.61	0.24	0.29	0.3	0.27
HV31E11	341269	Homo sapiens mRNA for TSC-22-like protein	1.24	1.61	1.33	1.35	1.66	1.13	2.28	1.01	1.23	2.26	0.85	0.98	0.71	1.32	0.97	1.58	1.14	1.43	1.72	0.74	0.84	1.21
HV31E12	825470	"ESTs, Highly similar to topoisomerase II alpha {C-terminal} [H.sapiens]"	2.2	4	3.22	2.46	1.71	2.13	7.85	2.23	2.67	8.76	0.53	1.66	0.84	4.38	1.14	3.5	2.44	4.48	0.56	0.84	0.48	1.02
HV31F3	210698	"ESTs, Weakly similar to putative lung tumor suppressor [H.sapiens]"	1.13	1.14	0.76	2.41	1.19	0.57	0.42	0.67	0.53	0.78	0.79	0.36	1.71	0.41	0.98	0.72	1.21	0.76	1.74	0.76	1.11	0.93
HV31F4	358456	Sec61 gamma	1.59	1.22	1.65	1.02	1.75	1.18	1.56	1.91	1.04	1.29	0.85	1.33	0.81	1.4	1.34	2.25	1.51	1.51	0.69	0.53	0.68	1.58
HV31F7	363569	prostaglandin E receptor 4 (subtype EP4)	1.24	1.54	1.17	1.2	1.84	1.02	1.27	1.56	1.65	1.19	1.14	1.12	0.9	1.38	1.26	1.28	1.31	1.74	1.79	1.28	2.18	1.75
HV31F8	34689	thioredoxin reductase beta	0.77	1.24	0.82	0.79	1.66	1	1.36	0.85	1.39	1.28	1.17	1	1.34	1.06	0.92	2.14	0.93	1.3	1.58	1.76	1.29	1.28
HV31F9	308682	"ATP-binding cassette, sub-family F (GCN20), member 2"	0.72	1.72	1.24	1.57	1.55	1.28	0.99	1.53	1.18	1.47	1.41	0.96	0.87	0.75	1.11	1.28	1.71	1.25	1.19	1.18	1.37	1.17
HV31F12	112576	ESTs	1.78	2.16	1.01	1.07	2.61	1.31	1.96	1.23	2.18	2.51	0.79	1.09	1.26	2.6	0.88	1.57	1.48	1.42	1.81	0.75	0.84	1.76
HV31G1	67074	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 16	1.09	2	1.26	1.34	1.74	1.34	1.47	1.89	1.55	1.51	1.45	1.22	1.32	2.21	1.27	1.6	1.51	1.56	1.71	1.22	1.21	1.28
HV31G6	241900	peptidylprolyl isomerase A (cyclophilin A)	1.66	1.6	0.84	1.03	1.46	1.65	1.32	1.18	1.34	1.32	0.9	1.81	1.26	1.89	1.6	1.73	1.27	1.7	0.95	0.71	0.73	1.01
HV31G9	138775	"ESTs, Highly similar to OVARIAN GRANULOSA CELL 13.0 KD PROTEIN HGR74 [H.sapiens]"	1.19	2.04	3.22	1.62	2.34	0.29	1.02	2.94	2.34	0.62	1.51	1.74	1.03	1.2	0.53	1.51	1.61	1.73	1.11	1.19	1.02	1.77
HV31G12	130371	nucleoporin 155kD	2.6	2.35	1.98	2.87	1.85	1.44	1.47	1.47	1.9	1.64	0.72	1.51	1.7	2.23	1.22	1.89	2.19	2.14	1.24	0.8	0.97	1.19
HV31H7	364469	"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (14.5kD, B14.5a)"	0.63	1.43	0.43	0.68	0.62	0.72	0.93	0.81	1.83	0.77	0.91	0.71	0.77	1.24	0.75	0.75	0.62	1.67	1.18	1.59	0.75	1.02
HV31H8	470861	"NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 (17kD, B17)"	1.69	1.24	0.86	1.39	1.35	0.66	1.47	1.12	1.04	0.77	0.6	0.89	0.74	1.02	0.52	1.61	1.07	0.76	0.38	0.72	0.53	0.7
HV31H10	358333	"Homo sapiens incomplete cDNA for a mutated allele of a myosin class I, myh-1c"	1.18	1.59	3.51	2.36	2.51	0.8	1.73	4.49	2.05	1.45	0.75	1.55	1.09	0.66	1.71	1.49	2.27	0.62	6.07	6.55	4.07	4.33
HV32A2	143306	lymphocyte-specific protein 1	1.52	1.16	1.45	1.36	2.34	1.24	1.54	2.32	1.62	1.21	1.75	1.34	1.79	1.26	0.8	1.41	1.61	1.76	1.76	1.13	1.96	1.75
HV32A3	356992	"ESTs, Moderately similar to LEYDIG CELL TUMOR 10 KD PROTEIN [R.norvegicus]"	1.79	1.2	1.21	1.36	1.09	1.19	0.76	0.98	1.45	1.05	1.02	0.86	0.65	1.3	0.72	0.99	0.56	1.79	1.35	1.2	0.98	1.23
HV32A4	154482	"protease inhibitor 2 (anti-elastase), monocyte/neutrophil"	0.81	1.77	0.55	1.02	1.63	1.79	1.16	1.21	1.34	1.18	1.25	1.14	1.14	1.16	0.87	1.42	0.89	0.54	1.22	0.8	1.05	1.26
HV32A5	108395	"discs, large (Drosophila) homolog 5"	0.29	0.33	0.34	0.4	1.23	0.22	0.72	0.44	0.55	0.69	0.36	0.34	0.44	0.89	0.38	0.46	0.16	0.76	0.28	0.32	0.21	0.75
HV32A8	32996	"Homo sapiens mRNA for H-2K binding factor-2, complete cds"	1.15	1.61	1.39	1.01	1.89	1.29	1.33	1.13	1.71	1.84	1.4	0.99	1.43	1.37	1.17	1.76	1.28	0.79	1.1	1.17	1.08	1.26
HV32A9	129725	"ESTs, Highly similar to J KAPPA-RECOMBINATION SIGNAL BINDING PROTEIN [M.musculus]"	0.87	1.53	1.1	0.77	1.21	0.82	0.86	1.06	1.01	1.63	1.45	1.17	0.87	1.78	1.56	1.73	0.56	1.47	1.41	1.03	1.48	1.02
HV32A10	144916	ESTs	1.31	1.67	1.03	1.59	2.98	2.16	2	2.09	2.05	2.81	1.66	2.89	2	2.59	0.82	1.86	1.35	0.51	4.36	1.4	2.77	4.08
HV32A11	290124	interferon gamma receptor 2 (interferon gamma transducer 1)	1.43	0.8	1.38	1.48	1.65	0.98	0.81	1.74	1.57	1.47	1.7	1.73	1.72	2.26	1.66	0.92	1.04	1.06	1.5	1.29	2.15	1.63
HV32A12	244764	ESTs	0.86	1.47	2.24	1.27	2.15	1.03	2.26	2.85	2.03	1.63	2.37	1.46	1.71	2.36	1.57	1.84	2.55	3.29	2.48	1.35	2.63	2.35
HV32B1	179232	"Homo sapiens SID6-8061 mRNA for pyrophosphatase, complete cds"	0.43	0.39	0.29	0.59	0.36	0.41	0.28	0.26	0.14	0.42	1.75	0.34	0.38	0.39	0.66	0.59	0.52	0.55	0.34	0.52	0.4	0.55
HV32B3	125788	"ESTs, Moderately similar to !!!! ALU SUBFAMILY SB1 WARNING ENTRY !!!! [H.sapiens]"	1.5	1.2	2.01	1.2	0.98	0.63	0.39	1.75	2.88	0.99	5.21	1.02	1.28	3.06	1.07	0.99	0.91	1.23	2.98	1.24	1.55	3.01
HV32B5	295923	"ESTs, Highly similar to ORF is homologous to hypothetical 9.8 kD protein ZK652.3 of Caenorhabditis elegans, sp>P34661 [H.sapiens]"	1.48	1.72	1	1.84	1.24	1.42	1.11	1.86	1.19	1.35	2.67	0.96	1.1	0.86	1.68	1.13	1.02	0.57	1.83	2.52	1.55	2.43
HV32B7	198960	Novel gene on chromosome 20	0.96	0.87	0.44	0.68	0.59	0.96	0.75	0.65	0.95	0.49	1.36	0.56	0.67	0.85	0.86	0.43	0.25	0.91	0.64	0.86	0.59	0.58
HV32B8	346545	"ESTs, Highly similar to LAMININ BETA-1 CHAIN PRECURSOR [H.sapiens]"	1.27	0.88	0.36	0.79	0.81	1.21	0.87	0.81	1.13	0.98	1.09	0.7	1.12	0.95	0.57	0.79	0.46	0.89	1.06	1.05	0.67	0.77
HV32B9	293977	ESTs	1.05	1.66	1.63	1.5	1.3	1.17	0.9	0.97	0.87	0.85	1.98	0.89	1.06	0.7	1.05	0.75	1	1.6	0.87	1.05	1.1	1.15
HV32B11	293921	RAD23 (S. cerevisiae) homolog A	1.1	1.42	1.13	1.54	1.55	0.95	1.26	1.6	1.83	1.42	3.45	1.48	1.57	2.58	1.26	0.84	1.3	1.25	3.96	2.07	2.45	3.71
HV32B12	342994	ESTs	1.62	2.24	0.68	1.44	2.86	0.85	1.12	1.33	1.53	1.87	1.13	1.29	1.85	2.07	0.55	1.44	1.75	1.65	1.46	0.79	0.94	0.93
HV32C1	205993	"ESTs, Highly similar to ORF [H.sapiens]"	0.79	0.84	0.87	0.95	0.86	0.95	0.44	1.21	2.32	1.06	0.82	1.4	0.88	0.91	0.91	0.54	0.88	0.79	1.6	1.72	1.59	1.81
HV32C2	125148	ESTs	2.28	6.83	0.87	1.6	1.98	1.09	1.52	0.86	1.17	2.57	1.13	1.24	1.73	2	1.15	1.55	1.79	2.3	1.28	0.73	0.62	1.2
HV32C3	201819	"ESTs, Weakly similar to ORF YOL002c [S.cerevisiae]"	1.18	1.11	0.75	1.17	0.82	0.94	1.15	1.42	2.2	1	1.21	1.21	0.77	1.81	1.57	1.07	0.94	0.99	1.36	1.77	1.11	1.89
HV32C5	345423	DKFZP564M112 protein	0.82	1.12	0.97	1.06	1.15	1.06	0.59	1.02	1.48	1.52	0.86	0.97	0.98	0.73	1.07	0.68	0.51	1.14	1.67	1.8	1.18	1.74
HV32C6	244974	ESTs	1.15	1.43	0.71	2.43	1.03	1.42	1.07	1.19	1.17	1.05	0.88	0.9	0.96	1.17	0.94	1.18	1.19	1.1	1.07	0.6	0.81	1
HV32C7	307843	ESTs	2.15	4.09	2.13	1.6	2.52	2.03	1.37	0.81	1.73	1.95	0.73	0.66	1.36	1	1.62	0.78	0.91	2.88	1.03	1	0.82	1.37
HV32C9	308633	ESTs	1.71	2.23	1.54	1.26	1.21	1.39	1.16	0.88	1.83	2.18	0.65	0.81	1.37	2.99	1.05	0.4	0.55	1.9	1.42	0.74	0.59	1.04
HV32C10	121275	EST	0.81	0.54	0.96	0.68	0.83	0.46	0.72	1.18	0.69	0.57	0.54	0.71	0.74	1.27	0.73	1.34	0.55	0.41	0.61	0.38	0.43	0.73
HV32C11	365098	ESTs	0.61	0.44	0.93	0.56	0.75	0.58	0.42	1.09	0.68	0.7	0.56	0.59	0.65	0.94	0.67	0.72	0.28	0.42	0.36	0.36	0.46	0.74
HV32D3	283398	Homo sapiens mRNA; cDNA DKFZp564E153 (from clone DKFZp564E153)	2.1	1.76	13.92	1.68	1.44	2.28	2.81	13.64	0.95	1.29	1.06	4.29	5.03	6.08	1.94	0.84	1.86	4.93	3.29	0.84	1.39	2.15
HV32D8	191978	"ATP synthase, H+ transporting, mitochondrial F0 complex, subunit f, isoform 2"	0.66	1.56	1.23	1.24	1.12	0.87	1.09	0.71	1.12	0.93	0.72	0.57	0.56	0.94	0.6	0.84	1.66	1.05	0.88	0.51	0.7	0.61
HV32D9	251250	"ESTs, Moderately similar to associated to Golgi apparatus [H.sapiens]"	3.14	2.86	3.2	2.26	2.43	1.56	2.06	3.01	3.66	1.47	2.07	3.84	2.45	3.08	1.88	1.9	2.03	2.11	2.56	0.84	1.05	1.78
HV32D10	628418	glycerol-3-phosphate dehydrogenase 1 (soluble)	1.45	1.87	1.28	2.46	3.8	0.89	1.04	1.35	1.64	0.91	1.06	0.59	0.38	0.47	0.56	1.28	3.12	2.81	0.99	0.79	0.93	0.64
HV32D11	246722	CAG repeat domain	1.08	1.61	1.1	2.13	2.3	0.72	0.89	0.64	1.33	1.36	0.81	0.52	0.37	0.39	0.62	0.9	3.38	2.23	2.47	1.1	1.37	0.92
HV32D12	207255	"ATP-binding cassette, sub-family F (GCN20), member 3"	1.78	1.92	0.74	1.54	2.25	1.53	1.55	1.25	1.92	0.71	1.4	2.04	0.97	1.78	1.14	1.22	2.17	1.86	3.22	1.96	1.62	2.27
HV32E3	358736	"ESTs, Highly similar to G1 TO S PHASE TRANSITION PROTEIN 1 HOMOLOG [H.sapiens]"	0.59	0.58	1.22	1.09	1.01	1.07	0.54	1.04	0.51	1.25	0.88	0.97	1.23	0.83	0.85	0.65	1.56	1.77	0.58	0.69	0.76	1.01
HV32E4	366570	"ESTs, Highly similar to G1 TO S PHASE TRANSITION PROTEIN 1 HOMOLOG [H.sapiens]"	0.76	1.44	0.84	0.97	1.59	1.64	0.99	0.79	1.75	1.38	1.22	1.16	1.52	0.82	1.08	1.34	2.55	1.76	0.51	0.64	0.72	0.68
HV32E8	307532	"eukaryotic translation initiation factor 4A, isoform 2"	3.21	3.06	1.95	2.54	2.5	1.83	1.53	1.54	1.31	2.21	1.97	2.56	2.18	1.65	1.33	2.15	2.1	0.8	2.85	5.78	2.91	2.11
HV32E11	842980	developmentally regulated GTP-binding protein 1	0.37	1.82	2.18	1.36	1.37	1.33	1.01	1.13	1.32	1.51	1.09	0.91	0.93	1.44	1.42	1.04	1.12	2.24	0.52	0.65	1	1.04
HV32E12	470061	seven in absentia (Drosophila) homolog 2	3.5	3.71	1.69	2.39	3.42	1.62	3.22	3.21	4.51	2.99	1.7	3.54	3.54	6.32	1.32	1.82	2.67	4.64	1.86	5.97	2.08	4.54
HV32F1	295831	"ESTs, Highly similar to CGI-26 protein [H.sapiens]"	0.69	0.66	0.76	0.71	0.6	0.67	0.32	0.53	0.3	0.37	3.54	0.36	0.4	0.46	0.51	0.97	0.45	0.43	0.5	0.24	0.38	0.44
HV32F2	141623	"Homo sapiens leucine aminopeptidase mRNA, complete cds"	1.51	7.52	1.09	2.84	2.93	2.96	3.13	2.44	2.04	3.96	2.75	2.03	1.81	2	1.84	2.16	2.29	1.1	2.47	1.2	1.47	1.97
HV32F3	129446	"Homo sapiens chromosome 19, cosmid F22329"	0.87	0.38	0.21	0.19	0.28	0.19	0.14	0.08	0.35	0.18	3.28	0.11	0.25	0.2	0.64	0.74	0.04	0.24	0.56	0.53	0.33	0.13
HV32F4	376515	"ESTs, Weakly similar to gene 9306 protein [H.sapiens]"	1.41	3.32	1.27	1.92	2.47	2.1	1.54	1.53	1.24	2.19	1.47	1.25	1.13	2.5	0.96	1.63	1.97	1.81	1.45	0.82	0.9	1.69
HV32F5	66327	"ESTs, Moderately similar to complement receptor 1 [H.sapiens]"	1.31	2.37	3.82	2.89	1.41	1.99	1.17	6.34	6.83	3.01	3.29	1.99	1.57	2.59	1.49	1.01	1.29	1.3	5.36	3.79	3.04	4.18
HV32F6	292833	"ESTs, Highly similar to COMPLEMENT C1Q SUBCOMPONENT, C CHAIN PRECURSOR [H.sapiens]"	4.83	24.02	11.71	7.93	13.04	8.79	8.06	10.9	11.09	16.25	6.65	7.32	5.17	13.71	3.12	6.19	3.66	10.79	31.9	15.31	5.31	16.94
HV32F8	741841	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (S.cerevisiae CHL1-like helicase)	2.28	7.03	1.6	2.98	4.68	2.05	2.09	1.21	2.15	3.03	1.57	2.94	2.07	2.72	1.31	2.2	3.02	3.99	2.15	2.23	2.11	1.84
HV32F11	327094	"ESTs, Highly similar to multifunctional calcium/calmodulin-dependent protein kinase II delta2 isoform [H.sapiens]"	1.51	1.62	1.92	1.81	1.29	1.42	0.93	1.52	1.02	1.34	2.21	0.4	1.16	0.43	1.03	0.92	1.67	0.81	2.22	1.36	2.19	2.86
HV32F12	289288	"Homo sapiens mRNA for putative Ca2+-transporting ATPase, partial"	2.49	1.64	0.89	1.59	3.01	2.37	1.4	1.53	1.63	1.58	1.29	1.33	1.5	2.18	1.34	1.57	1.89	1.31	1.38	0.84	1.21	1.32
HV32G1	66714	"Human cell division control-related protein 2b (hcdcrel2b) mRNA, complete cds"	4.34	2.99	6.31	3.18	1.85	1.62	2.05	1.91	3.37	1.67	1.67	2.9	3.31	4.94	1.38	0.85	1.67	4.88	4.6	2.28	2.46	4.61
HV32G3	196005	"ESTs, Highly similar to AQUAPORIN 3 [H.sapiens]"	2.23	1.25	0.67	0.9	0.89	0.73	1.24	0.55	0.81	0.83	0.96	0.47	1.65	3.68	0.9	2.11	0.3	1.45	1.24	0.76	0.96	2.01
HV32G4	134948	ESTs	0.73	1.69	0.15	0.28	1.27	0.6	1.82	0.74	0.77	2.11	1.23	0.56	1.65	1.78	0.75	1.05	0.69	0.4	0.93	0.52	0.19	1.22
HV32G5	293579	"ESTs, Weakly similar to M130 antigen [H.sapiens]"	0.9	2.13	1.88	0.7	2.38	0.74	0.67	0.88	2.22	1.11	1.33	0.72	0.83	0.64	0.85	1.97	0.44	0.96	1.55	0.86	1.94	1.22
HV32G6	295710	ESTs	2.98	4.34	0.92	2.27	1.7	2.45	1.89	0.95	1.53	1.8	1.06	1.46	1.2	3.86	1.8	1.6	0.91	5.31	2.87	1.06	1.2	1.74
HV32G7	194161	"actinin, alpha 4"	1.2	1.59	0.44	0.58	1.09	1.75	0.51	1	0.65	0.73	0.78	1.04	0.63	0.81	0.64	0.64	0.78	1.04	0.81	0.34	0.62	0.51
HV32G8	109316	alpha-1-antichymotrypsin	2.12	7.25	0.61	3.19	6.66	0.63	2.04	2.87	7.77	1.96	1.55	3.61	3.62	5.98	0.91	1.73	3.6	7.11	4.54	6.3	2.15	10.21
HV32G9	201757	3-prime-phosphoadenosine 5-prime-phosphosulfate synthase 2	1.51	2.05	2.32	0.98	1.74	1.9	1.04	2.6	1.94	3.91	1.85	2.11	1.18	1.04	1.96	1.46	1.08	0.71	1.62	6.74	3.86	1.79
HV32G10	244911	ribosomal protein L39	1.47	1.97	0.8	0.99	1.51	0.88	1.59	0.97	0.86	1.25	0.88	1.5	1.33	1.54	0.78	1.7	1.23	1.28	0.83	0.51	0.45	0.84
HV32G12	366389	DKFZP564A122 protein	1.38	2.07	2.13	1.71	3.01	1.35	3.1	1.83	2.36	1.87	1.03	1.75	3.02	3.71	2.68	3.11	1.07	3.38	4.31	1.76	2.35	3.37
HV32H1	110772	chromosome 14 open reading frame 2	0.45	0.79	0.79	0.78	0.64	0.42	0.72	0.64	0.62	0.55	0.27	0.43	0.44	0.79	0.47	0.39	0.46	0.68	1	0.56	0.59	0.82
HV32H3	210646	"protein kinase, AMP-activated, gamma 2 non-catalytic subunit"	0.17	0.42	0.15	0.28	0.28	0.15	0.14	0.12	0.01	0.06	0.16	0.14	0.28	0.2	0.22	0.21	0.13	0.16	0.23	0.17	0.27	0.21
HV32H4	214565	ribosomal protein S14	0.4	0.84	0.46	0.45	1.08	0.7	0.96	0.45	0.49	0.77	0.78	0.56	0.79	0.85	0.54	0.37	1.84	0.6	0.34	0.33	0.43	0.6
HV32H5	245531	"ESTs, Highly similar to 3-HYDROXYISOBUTYRATE DEHYDROGENASE PRECURSOR [R.norvegicus]"	0.31	0.74	0.71	0.73	0.82	0.77	0.49	0.58	1.67	0.37	0.52	0.68	0.61	0.46	0.33	1.1	0.45	0.73	0.39	0.35	0.29	0.44
HV32H6	128208	Homo sapiens mRNA; cDNA DKFZp586I1420 (from clone DKFZp586I1420)	1.94	4.08	1.05	2.42	2.61	1.94	2.97	1.97	4.66	2.26	1.62	2.73	2.04	3.71	1.57	2.4	1.86	2.1	4.51	1.7	2.01	3.29
HV32H9	66815	"ESTs, Moderately similar to alternatively spliced product using exon 13A [H.sapiens]"	3.36	8.94	4.84	5.61	4.69	6.41	6.61	8.48	15.29	7.37	3.33	5.69	3.1	4.76	1.99	3.08	3.92	1.79	9.08	0.81	5.42	8.19
HV32H10	42258	ESTs	1.5	2.55	3.49	3.99	3.33	1.59	2.51	3.98	3.24	1.71	1.64	4.58	3.87	3.05	1.9	1.71	2.1	8.24	2.07	2.07	1.3	1.8
HV32H11	66697	ESTs	1.35	2.73	1.42	1.38	1.36	1.15	1	0.98	0.95	1.32	0.88	1.24	1.24	1.25	1.85	1.13	1.16	1.13	1.18	1.44	0.88	1.21
HV32H12	66316	ESTs	1.09	3.03	0.28	0.99	1.49	1.54	0.89	1.19	0.74	0.43	1.08	1.75	1.11	1.94	1.64	0.47	2.29	2.22	2.87	1.43	1.29	1.7
HV33A8	66555	ESTs	1.65	2.38	1.5	1.34	2.81	1.22	2.49	1.52	2.89	1.82	1.22	2.19	1.67	2.06	1.59	3.14	1.54	3.64	1.53	1.98	2.15	1.58
HV33B1	66582	ESTs	1.94	1.89	1.17	1.37	1.48	1.33	1.37	1.4	1.07	1.27	1.57	1.46	1.78	2.04	1.29	0.71	1.15	1.8	2.01	0.97	1.38	1.58
HV33B2	66584	DKFZP727A071 protein	1.74	2.55	0.78	1.35	3.03	1.66	1.6	0.96	1.17	3.05	1.04	1.16	1.27	1.58	1	1.91	2.69	0.57	3.13	0.97	1.06	2.07
HV33B5	66608	ESTs	1.48	0.86	1.54	2.51	1.83	1.2	1.84	2.2	2.48	1.33	1.28	1.76	2.22	2.77	0.66	1.2	1.89	1.94	2.2	0.69	1.93	1.63
HV33C4	66975	ESTs	1.87	4.41	1.42	2.88	4.85	2.11	2.95	1.57	2.58	3.89	1.51	2.3	2.26	3.47	2.13	3.16	2.35	3.45	10.11	2.98	3.36	5.74
HV33C8	67070	ESTs	1.19	1.5	0.46	0.65	1.62	0.8	1.07	0.94	0.95	0.91	0.9	1.28	1.58	1.84	1.2	1.14	1.19	0.82	1.25	0.72	0.64	1.06
HV33D4	40721	ESTs	1.61	2.01	1.27	1.8	2.2	1.63	1.62	1.69	1.42	1.42	0.87	1.21	2.01	1.81	1.02	1.57	2.06	0.85	2.25	1.8	1.01	1.85
HV33D5	154654	"ESTs, Highly similar to IROQUOIS-CLASS HOMEODOMAIN PROTEIN IRX-3 [M.musculus]"	1.34	1.77	0.96	1.09	1.79	0.55	1.2	1.26	1.34	0.78	1.94	1.65	2.4	3.06	1.58	1.72	1.74	1.82	3.46	0.83	0.88	1.61
HV33D7	173878	ESTs	1.9	2.15	1	1.18	1.65	1.33	1.49	1.3	4.47	1.29	1.18	1.23	1.33	1.46	1.21	0.89	0.67	0.87	1.25	1.11	0.65	0.98
HV33D8	293901	ESTs	1.05	1.93	1.54	1.86	2.02	0.88	1.59	1.89	1.79	1.09	0.7	1.75	1.73	1.55	0.97	1.38	2.09	1.76	1.04	1.56	1.51	1.69
HV33D9	196038	"ESTs, Weakly similar to !!!! ALU SUBFAMILY J WARNING ENTRY !!!! [H.sapiens]"	1.2	2.52	2.09	3.8	2.9	1.72	1.72	2.53	3.06	1.48	1.56	1.28	1.67	1.42	1.23	1.04	0.91	1.8	1.32	0.74	1.13	1.16
HV33D10	111981	"interferon, alpha-inducible protein (clone IFI-6-16)"	3.05	2.95	1.05	1.38	2.46	1.65	1.39	1.18	1.32	0.98	0.69	1.75	1.99	1.09	1.09	0.99	2.04	0.54	1.81	1.58	0.91	2.48
HV33D11	242706	ESTs	0.63	0.55	0.89	0.64	0.97	0.69	0.86	1.11	0.89	0.81	1.97	1.14	0.66	0.59	1.15	0.73	0.62	0.48	0.71	1.15	0.86	0.88
HV33D12	340840	"ESTs, Weakly similar to alternatively spliced product using exon 13A [H.sapiens]"	0.9	1.1	0.8	1.05	1.48	0.89	1.87	2.12	2.23	0.97	0.81	1.65	1.31	1.9	0.54	0.74	2.1	1.28	2.02	0.97	1.21	1.58
HV33E2	290308	ESTs	2.08	2.29	0.93	1.53	1.62	1.01	1.23	1.22	1.69	1.08	0.56	1.37	1.79	2.27	1.33	1.23	1.59	1.32	0.88	0.84	0.72	1.39
HV33E3	202901	ESTs	1.6	1.37	0.73	1.47	1.21	0.57	0.86	1.54	3.03	1.18	1.47	0.77	0.96	1.13	0.98	1.18	0.55	0.95	1.49	1.24	1.29	1.65
HV33E6	122150	ESTs	1.47	1.08	0.44	0.89	1.11	1.32	0.69	0.87	0.53	0.72	0.84	1.4	1.04	0.66	1.37	1.1	1.05	0.51	0.8	1.55	1.24	1.61
HV33E7	123255	"ESTs, Highly similar to CGI-49 protein [H.sapiens]"	2.79	3.11	3.17	2.18	2.95	5.48	3.91	4.11	4.71	2.5	3.8	3.85	2.34	7.61	1.04	1.43	3.08	2.18	5.08	1.52	1.52	5.49
HV33E8	261587	ESTs	2.52	2.21	1.27	1.6	2.63	0.99	2.72	1.94	3.38	4.23	0.51	2.42	2.07	2.24	2.15	0.93	0.91	1.31	2.56	1.24	1.04	2.35
HV33E9	159166	KIAA1067 protein	1.91	1.34	1.29	1.69	1.36	0.95	1.28	1.83	2.63	1.02	2.19	1.24	1.33	1.8	1.11	1.08	1.72	2.21	2.25	2.6	2.89	2.72
HV33E10	740554	radixin	1.75	1.54	0.95	1.21	1.93	1.28	0.83	0.6	0.61	1	0.39	0.6	0.95	0.58	0.92	1.71	3.64	0.93	0.8	0.87	0.61	1.19
HV33E11	151261	ESTs	0.63	0.9	0.68	1.62	1.12	0.79	0.83	0.99	0.74	0.68	1.29	1.05	0.9	0.61	0.46	0.6	1.03	1.12	0.54	1.67	1.16	0.81
HV33E12	67037	"ESTs, Weakly similar to !!!! ALU SUBFAMILY SQ WARNING ENTRY !!!! [H.sapiens]"	2.36	1.22	3.48	1.86	2.8	1.19	3.31	2.27	2.35	1.39	1.72	2.84	2.43	3.16	0.79	2.42	0.86	0.91	3.26	0.41	1.29	2.25
HV33F2	66919	ESTs	1.89	3.99	1.12	2.77	2.71	1.46	2.81	1.72	2.38	2.15	1.65	1.69	1.7	3.1	1.97	3.11	1.91	3.41	3.38	1.21	1.83	2.75
HV33F3	280837	Human Chromosome 16 BAC clone CIT987SK-A-101F10	0.49	1.06	0.87	1.22	0.87	0.52	0.89	0.76	0.6	0.7	1.01	0.97	1.21	1.04	0.84	0.56	1.04	1.07	0.63	0.55	1.1	0.81
HV33F4	144894	"Homo sapiens clone 23967 unknown mRNA, partial cds"	0.83	1.03	0.44	0.92	1.37	0.86	1.43	0.74	0.79	1.78	0.97	0.65	1.33	1.23	0.73	1.31	0.83	1.01	1.14	0.83	0.78	1.11
HV33F5	292232	"ESTs, Highly similar to CGI-69 protein [H.sapiens]"	2.9	2.95	1.94	2.26	2.29	1.39	1.96	2.22	1.68	1.83	1.52	2.77	1.42	2.64	0.89	1.76	1.82	3.15	3.91	2.65	1.82	2.39
HV33F6	363146	ESTs	1.94	2.14	0.85	1.65	2.63	1.51	1.48	1.26	1.33	1.49	1.35	1.41	1.28	1.28	1.17	1.97	1.45	1.26	2.05	1.05	0.74	1.97
HV33F7	211813	serine proteinase inhibitor	1.15	1.25	0.62	1.88	0.88	0.54	1.09	1.05	1.44	1.71	0.72	0.66	0.99	0.82	1.01	1.01	0.82	0.66	1.58	1.15	0.88	1.19
HV33F8	123262	"ESTs, Moderately similar to alternatively spliced product using exon 13A [H.sapiens]"	0.68	1.19	0.99	0.71	1.56	0.65	1.22	0.72	1.34	1.32	0.69	0.52	1.36	0.92	1.21	1.19	0.72	1.16	0.63	0.43	0.43	0.72
HV33F9	234036	Homo sapiens clone 23765 mRNA sequence	1.16	1.64	1.38	1.94	1.71	1.1	1.24	2.58	2.39	1.72	1.55	1.61	1.7	1.75	1.01	1.5	0.94	0.77	1.68	1.08	1.45	1.87
HV33F10	240033	ESTs	1.73	2.85	0.78	1.7	3.78	2.45	2.12	0.96	1.36	3.64	0.96	2.8	2.76	2.74	1.54	1.3	1.75	2.79	3.2	1.65	1.46	2.69
HV33F11	66977	"ESTs, Highly similar to CGI-103 protein [H.sapiens]"	1.86	0.9	0.44	1.39	0.73	1.61	0.68	0.64	0.77	0.65	0.73	1.25	0.43	0.29	0.67	0.76	0.25	0.35	1.12	0.69	0.68	0.66
HV33F12	245485	ESTs	1.75	1.44	0.96	1.08	2.44	1.07	1.72	0.96	1.28	1.07	1.13	1.78	1.78	2.27	0.63	2.17	0.91	0.92	2.57	0.53	1.28	1.85
HV33G4	200599	Homo sapiens clone 25186 mRNA sequence	1.69	4.63	1.6	3.44	8.68	2.8	3.01	4.66	3.03	2.2	2.44	5.71	4.14	4.63	2.65	4.29	2.42	4.91	9.63	3.54	4.02	7.33
HV33G7	132527	ESTs	1.41	1.84	1.22	1.3	1.63	0.63	0.93	1.46	1.22	0.74	1.08	0.79	1.13	1.79	0.93	0.6	1.68	1.44	1.13	0.8	0.58	1.08
HV33G9	203350	KIAA0561 protein	1.49	2.64	0.92	1.11	1.95	1.67	1.02	1.28	1.58	2.08	1.59	1.63	1.46	1.39	1.46	0.74	1.05	1.13	2.24	0.99	1.19	1.39
HV33G10	357091	ESTs	2.03	4.23	1.41	1.46	5	1.75	2.29	3.14	3.66	1.47	1.65	3.4	2.91	4.71	2.45	2.12	3.23	6.12	4.1	2.81	1.83	3.51
HV33G12	282378	ESTs	0.5	0.79	0.37	0.36	1.76	0.41	0.6	0.51	0.92	0.64	0.35	0.41	0.8	0.6	0.88	0.68	0.74	0.69	1.09	0.33	0.44	1.13
HV33H1	246703	chromosome X open reading frame 5	2.63	1.32	0.78	1.03	1.11	0.95	1.02	1.47	1.05	0.48	1.37	1.29	1.63	2.06	0.83	0.35	0.91	1.46	1.49	0.55	0.51	1.06
HV33H3	203544	ESTs	0.64	2.43	1.62	1.07	1.27	1.2	0.85	1.02	0.88	0.81	1.03	0.94	1.4	1.16	1.09	0.97	2.11	0.85	0.74	1.44	0.61	0.91
HV33H7	324255	ESTs	1.21	1.47	1.38	1.45	1.32	0.77	0.71	1.29	1.03	0.62	0.56	1.01	1.41	1.37	0.93	0.63	1.17	1.5	0.89	0.77	0.77	0.96
HV33H8	136073	ESTs	2.19	3.12	1.25	2.03	2.3	2.34	1.53	1.98	2.06	1.41	1.16	1.68	1.66	2.02	1.5	1.66	2.07	3.73	2.95	1.61	1.54	2.79
HV33H9	201483	Homo sapiens clone 24655 mRNA sequence	2.52	2.83	2.66	3.95	3.89	1.79	2.38	2.25	8.79	1.48	4.55	2.83	1.86	1.73	1.63	2.36	0.59	4.01	2.47	2.72	2.46	2.41
HV33H10	345090	ESTs	0.92	1.6	1.05	1.13	1.62	1	1.09	1.07	1.49	1.17	0.51	1.21	1.62	1.32	1.4	3.54	1.91	1.2	0.77	0.73	0.94	0.81
HV33H11	111721	Homo sapiens mRNA; cDNA DKFZp434O071 (from clone DKFZp434O071)	0.77	1.2	0.95	0.81	2.05	0.94	0.68	1.28	1.19	0.85	0.92	1.09	0.8	0.63	0.73	1.1	1.36	1.24	1.04	0.8	0.67	0.88
HV34A1	293191	ESTs	1.17	2.41	1.92	1.45	2.1	1.04	1.75	1.15	1.89	1.49	1.72	1.84	0.88	1.55	0.72	1.15	1.43	2.31	1.44	0.6	1.56	1.5
HV34A3	111492	KIAA0614 protein	0.8	1.13	0.65	1.36	1.58	0.94	0.85	0.55	0.96	1.77	1.56	1.02	0.95	0.9	1.06	0.65	0.91	0.94	1.59	2.3	1.72	1.95
HV34A4	195051	ESTs	0.94	0.95	1	0.48	1.19	0.52	1.24	1.01	0.96	1.1	0.5	0.63	0.82	1.02	0.8	1.42	0.91	0.63	0.52	0.65	1.03	1.21
HV34A5	277274	Homo sapiens clone 25232 mRNA sequence	1.97	1.57	1.07	1.71	2.83	1.2	1.42	0.89	1.2	1.18	2.31	1.83	1.61	1.32	1.33	1.11	0.91	1.33	1.47	1.14	1.43	1.57
HV34A6	108801	ESTs	1.44	2.46	1.72	1.9	1.97	1.37	3.24	1.99	1.56	2.1	0.77	1.74	1.39	1.76	1.03	2.45	1.79	1.03	1.8	0.7	0.72	1.58
HV34A7	144924	DKFZP586G0522 protein	0.8	1.19	0.37	0.86	1.93	1.03	0.88	0.87	0.65	1.14	0.88	0.43	0.82	0.9	1.15	0.94	0.99	2.21	1.6	0.3	1.77	1.11
HV34A9	121252	ESTs	1.26	0.5	0.82	1.06	0.69	0.71	0.4	1.09	0.75	0.98	1.05	1.03	0.65	0.45	0.49	0.42	0.63	0.54	0.61	0.87	0.74	1.06
HV34A11	416833	FK506-binding protein 5	0.14	0.27	0.16	0.16	0.27	0.12	0.14	0.12	0.07	0.14	0.24	0.1	0.31	0.32	0.19	0.22	0.14	0.21	0.14	0.11	0.08	0.13
HV34B3	209624	"deiodinase, iodothyronine, type I"	0.83	1.37	0.75	2.15	1.68	1.28	1.32	1.76	1.59	1.99	1.47	1.28	0.71	0.83	1.19	0.96	1.43	1.72	2.01	1.93	1.24	1.34
HV34B4	247655	ESTs	0.4	0.35	0.2	0.3	0.65	0.35	0.42	0.33	0.78	0.42	0.37	0.32	0.39	0.32	0.49	0.81	0.53	0.39	0.58	0.29	0.48	0.41
HV34B7	34302	ESTs	1.14	2.01	1.67	1.51	2.33	1.37	1.7	1.69	1.62	2.77	2.26	1.48	1.13	1.01	1.27	1.89	1.91	1.34	2.37	1.98	2.16	1.7
HV34B8	142139	"ESTs, Highly similar to sorting nexin 9 [H.sapiens]"	0.84	1.08	1.37	1.22	2.31	1.34	2.68	2.23	2.62	2.76	1.59	2.3	2.78	2.31	1.44	2.49	1.03	1.2	2.16	0.79	1.08	1.91
HV34B9	233308	ESTs	1.44	0.9	1.63	1.77	0.72	1.07	0.56	4.1	4.28	1.88	2.48	2.16	2.25	2.19	1.37	0.77	0.68	1.14	2.41	0.87	1.44	1.69
HV34B11	197676	KIAA0871 protein	0.63	0.66	0.7	0.53	0.62	0.57	0.63	0.75	0.72	0.44	2.67	0.61	0.64	0.67	0.71	0.54	0.52	0.75	0.57	0.4	0.7	0.59
HV34B12	306806	ESTs	1.83	1.13	0.41	0.6	1.5	1.25	0.57	0.92	4.17	1.5	0.99	0.91	1.2	1.47	0.85	1.68	1.93	0.55	1.12	1.01	1.09	0.79
HV34C2	144797	"ESTs, Moderately similar to secretory protein containing thrombospondin motifs [M.musculus]"	2.15	6.48	3.98	4.17	6.42	2.09	4.74	2.88	14.39	1.01	0.84	5.89	7.19	6.28	0.99	3.71	6.21	6.39	4.56	3.08	2.46	4.3
HV34C3	121577	Homo sapiens clone 24921 mRNA sequence	2.16	1.83	1.13	1.53	3.26	1.41	2.38	3.28	1.27	1.88	2.01	0.7	1.14	2.02	0.97	1.03	1.76	2.36	1.77	0.68	1.11	1.23
HV34C4	206816	ESTs	2.45	9.07	1.53	3.18	2.99	2.05	2.2	3.96	4.7	0.24	1.37	6.72	4.22	9.08	1.04	2.58	0.91	7.91	6.49	1.58	3.04	3.14
HV34C6	241988	ESTs	1.01	1.45	0.78	1.09	1.7	1.03	2.11	0.96	1.22	0.5	1.13	1.46	1.92	2.05	1.11	1.16	0.65	1.84	2	2.09	1.14	1.89
HV34C7	295410	ESTs	1.01	2.51	0.71	0.86	2.77	1.38	1.69	1.12	1.8	2.25	1.24	0.89	0.95	0.95	0.87	1.07	1.15	1.28	1.69	1.04	0.94	1.6
HV34C10	113048	ESTs	1.24	0.96	1.11	0.82	1.55	1.01	1.02	0.76	0.74	1.87	0.85	0.97	1.03	0.67	0.79	1.26	0.91	0.51	1.84	1.01	1.38	1.9
HV34C11	236129	Homo sapiens mRNA; cDNA DKFZp434B1935 (from clone DKFZp434B1935)	1.57	0.95	0.82	0.92	1.01	1.29	1.97	1.53	1.52	1.2	1.43	2.26	1.56	0.94	1.35	0.53	0.72	0.99	2.05	2.18	2.15	2.03
HV34C12	196650	ESTs	1.31	2.15	0.76	1.17	1.36	1.34	1.86	1.65	2.18	1.22	1.5	1.34	1.23	3.07	1.26	2.07	1.05	1.72	3.33	1.26	1.72	2.38
HV34D1	29063	Homo sapiens clone 23620 mRNA sequence	0.43	0.71	0.38	0.36	0.94	0.76	0.75	0.72	0.99	0.83	0.59	0.59	0.49	0.26	0.56	0.19	0.91	0.35	0.63	0.46	0.4	0.83
HV34D5	138929	Homo sapiens mRNA; cDNA DKFZp564H0764 (from clone DKFZp564H0764)	0.99	1.79	1.53	1.42	2.02	1.01	0.93	1.58	1.19	0.9	0.95	0.77	0.9	0.81	1.04	0.74	1.24	1.5	1.3	0.34	0.63	0.8
HV34D6	366156	sialyltransferase	1.02	1.6	1.84	1.11	1.77	0.76	2.26	2.22	3.02	1.47	0.78	2.32	1.04	1.81	1.15	1.92	1.63	1.42	3.09	1.12	1.61	1.71
HV34D7	143227	ESTs	0.61	1.36	0.78	0.59	1.8	0.6	0.86	1.05	1.16	1.23	1.23	0.81	0.88	0.91	0.91	0.77	0.69	1.2	0.75	0.65	1.01	0.85
HV34D8	281114	Human mRNA for TI-227H	0.66	1.3	0.95	0.74	1.47	0.46	1.09	0.94	1.13	0.68	0.46	0.97	1.17	1.34	1.06	1.26	1.38	0.74	1.26	0.6	1.02	1.17
HV34D9	120561	ESTs	1.15	0.64	1.24	0.64	1.11	0.76	0.41	1.33	2.03	0.37	2.32	2.22	1.45	0.93	1.05	0.42	0.72	1.33	1.7	0.79	1.27	1.39
HV34D10	244955	spindle pole body protein	1.41	3.46	1.34	1.65	3.73	1.87	1.32	1.19	1.32	1.04	1	2.1	1.62	1.79	1	0.79	1.84	1.16	0.94	0.65	0.85	1.12
HV34D11	139138	"ESTs, Moderately similar to TRF1-interacting ankyrin-related ADP-ribose polymerase [H.sapiens]"	1.55	3.44	3.53	1	3.35	0.79	2.57	1.9	0.95	1	0.64	2.04	1.56	0.88	1.2	0.8	0.64	0.9	2.26	1.72	1.38	1.56
HV34E4	66406	ESTs	2.4	2.87	1.32	2.02	2.03	1.82	2.39	0.82	2.13	1.77	0.59	1.36	0.78	2.68	1.88	1.78	2.26	4.1	1.29	0.83	1.2	1.34
HV34E5	142076	ESTs	0.97	1.24	0.84	1.22	1.59	1.54	1.01	0.95	0.78	0.93	0.98	0.48	0.88	1.16	0.88	0.99	1.75	1.61	1.35	0.68	1.22	1.59
HV34E9	36607	ESTs	0.58	0.63	0.6	0.79	0.57	0.53	0.65	0.7	1.11	0.79	0.75	0.7	0.56	1.21	0.77	0.74	0.4	0.71	0.63	0.79	0.78	0.9
HV34E10	142944	ESTs	0.63	0.46	1.98	0.59	1.09	0.34	0.42	0.45	0.35	0.4	0.42	0.5	0.49	0.51	0.38	0.81	0.73	0.34	0.66	0.22	0.39	0.49
HV34F1	274529	ESTs	0.31	0.88	0.48	1.55	0.83	0.93	0.46	0.61	0.48	1.29	0.69	0.57	0.31	0.2	0.3	1.11	1.03	0.24	1.74	1.3	1.37	0.79
HV34F5	309092	"APG5 (autophagy 5, S. cerevisiae)-like"	0.79	1.4	0.73	1.53	2.16	1.44	0.93	1.25	0.69	1.96	1.06	0.8	0.69	0.49	1	1	1.86	0.66	1.01	0.39	0.8	0.74
HV34F6	201301	ESTs	1.45	1.86	1.05	1.39	3.02	1.18	1.76	1.41	1.57	1.37	0.81	1.04	1.35	1.31	1.51	1.05	1.41	1.87	1.72	0.29	0.83	0.86
HV34F9	293177	ESTs	1.81	1.2	1.72	1.31	1.11	0.74	0.8	1.99	2.56	0.9	2.06	1.66	1.51	1.71	1.48	0.95	1.17	1.33	1.72	0.75	1.07	1.47
HV34F10	83210	"complement component 8, beta polypeptide"	1.06	1.48	1.03	1.13	1.24	0.94	1.82	1.6	1.36	1.77	1.35	1.1	1.52	1.44	1.26	1.49	1.38	1	1.02	0.68	0.93	1.05
HV34F11	232658	ESTs	0.68	1	0.99	0.86	0.82	0.81	0.76	0.83	0.81	0.85	1.67	1.01	1.3	1.04	1.04	0.55	0.64	1.17	1	0.62	0.65	0.93
HV34G2	345047	ESTs	1.97	4.57	1.73	1.01	2.7	1.01	2.17	1.49	3.51	0.3	0.61	2.48	2.5	2.22	0.78	1.94	0.91	4.01	2.48	0.83	1.02	1.88
HV34G4	144042	"ESTs, Weakly similar to Rga [D.melanogaster]"	1.14	1.67	1.22	1.36	1.76	1.05	1.85	2.03	1.65	0.26	1.05	1.68	1.44	2.14	1.29	1.78	0.89	1.44	1.45	0.68	0.85	1.16
HV34G6	47853	aldehyde dehydrogenase 4 (glutamate gamma-semialdehyde dehydrogenase; pyrroline-5-carboxylate dehydrogenase)	2.02	1.37	1.01	0.87	1.74	1.01	1	1.46	2.69	1.11	1.4	2.61	2.07	1.46	0.83	0.93	0.91	0.95	4.93	1.95	1.58	2.59
HV34G9	66552	ESTs	0.83	0.79	1.42	0.85	0.96	0.86	1.04	1.01	2.18	0.67	1.55	1.43	1.49	1.38	1.19	0.45	0.3	1.26	2.5	1.11	1.61	2.71
HV34G10	42313	ESTs	0.88	1.58	0.61	1.46	0.83	1.05	3.17	1.06	1.12	3.36	1.63	1.28	1.2	1.28	1.51	1.74	2	1.64	0.94	1.04	1.21	1.28
HV34G11	38465	ESTs	1.37	1	0.98	0.88	0.88	0.61	1.16	0.88	1.79	1	0.68	0.85	1.07	0.85	1.15	0.66	0.75	1.14	1.18	0.65	0.7	1.07
HV34H1	297102	ESTs	0.83	2.18	0.86	1.46	2.04	1.37	1.04	1.21	0.95	1.21	0.88	0.97	0.9	0.86	1.12	0.62	1.41	0.92	0.89	0.77	0.71	0.94
HV34H2	234331	ESTs	0.73	1.83	0.49	1.57	1.67	1.3	1.24	1.33	1.7	0.84	0.6	1.07	1.38	1.74	1.05	0.91	1.93	1.29	1.91	1.01	1.65	1.89
HV34H4	133820	KIAA0630 protein	1.47	2.56	2.4	1.82	1.81	1.35	2.28	2.45	2.84	1.93	0.68	2.11	1.66	1.88	1.51	1.33	2	1.34	1.28	0.86	0.81	1.16
HV34H5	135561	ESTs	0.76	2.3	1.07	0.64	1.49	1.21	1.06	1.36	1.96	1.38	1.05	1.14	1.11	1.55	0.93	1.03	0.91	1.11	1.78	1.51	1.15	1.44
HV34H7	247818	ESTs	1.5	2.06	1.72	2.23	3.43	2.07	1.69	1.14	1	1.01	0.62	1.46	0.83	0.73	1.23	1.58	0.91	2.55	0.88	0.58	0.67	0.83
HV34H8	243817	ESTs	1.03	1.07	1.6	0.66	0.42	0.41	0.79	1.15	3.08	0.78	0.29	1.87	1.51	1.55	0.91	1.36	1.89	0.81	0.9	1.15	0.6	1.1
HV34H11	283897	ESTs	1.82	0.88	1.29	1.09	1.61	1.14	1.08	2.91	3.52	0.59	0.83	1.16	1.19	1.91	1.03	0.53	1.24	0.71	1.11	1.38	0.65	1.43
HV34H12	245195	"ESTs, Moderately similar to myotonic dystrophy kinase-related Cdc42-binding kinase MRCK-beta [R.norvegicus]"	0.8	1.28	0.74	0.98	3.37	1.09	1.56	1.25	1.36	1.06	1.35	1.16	1.24	1.49	0.97	0.77	1.65	0.85	1.12	0.75	0.81	1
HV35A5	230196	ESTs	1.71	1.19	1.17	1.44	2.25	1.23	0.35	0.95	1.79	1.34	1.95	2.27	2.15	5.35	1.55	0.4	0.91	1.86	2.74	0.61	1.48	2.69
HV35B1	244847	ESTs	1.1	1.28	0.4	0.54	0.58	1.4	0.38	0.62	0.62	0.44	2.76	0.44	0.76	0.48	0.92	0.55	0.52	0.73	1.82	0.64	0.61	0.98
HV35B2	108265	ESTs	0.83	1	0.54	0.55	2.09	1.03	0.92	0.82	0.81	3.39	1.09	0.79	1.16	1.15	0.48	1.9	1.42	0.84	0.85	0.64	0.49	1.13
HV35B6	108351	ESTs	2.88	2.79	0.61	1.56	5.33	2.87	2	1.56	1.09	2.87	3.15	5.39	4.5	5.4	2.26	2.49	0.91	4.34	2.63	4.47	2.79	4.75
HV35B7	110094	ESTs	1.15	1.12	1.21	1.04	1.39	1.04	1.02	1.3	0.85	2.59	4.01	3.17	2.12	3.92	1.96	0.25	1.65	1.75	2.65	1.08	2.09	0.8
HV35C1	247803	ESTs	0.99	1.16	0.62	0.71	1.03	1.42	0.43	1.08	1.2	1.23	1.76	0.93	1.06	1.2	1.08	0.41	0.83	1.27	1.47	0.86	0.72	1.3
HV35C9	294973	low density lipoprotein receptor-related protein 6	2.18	0.64	1.11	1.07	2.03	1.76	1.96	1.4	1.29	1.86	1.98	3.24	2.54	2.12	0.88	0.73	1.4	12.71	1.9	0.85	0.69	1.79
HV35D1	123408	KIAA1096 protein	2.23	0.86	1.82	0.68	0.94	1.49	0.94	1.64	2.61	0.32	0.61	2.31	1.58	1.25	1.36	0.26	1.38	1.56	2.8	1	1.27	2.47
HV35D9	275802	ESTs	1.61	1.46	3.01	1.95	2.32	2.23	2.16	2.12	1.79	1.37	0.5	2.3	3.21	3.07	2.49	1.44	0.7	2.17	2.76	1.28	2.14	2.11
HV35E9	297439	ESTs	1.14	1.2	0.71	1.56	2.01	1.09	0.89	0.87	1.11	1.09	1.18	1.27	0.81	1.06	1.05	0.58	0.91	1.44	0.65	0.68	1.23	1.54
HV35F5	144902	ESTs	1.6	3.18	1.31	2.15	2.16	1.72	1.76	1.87	2.72	2.24	4.74	2.38	1.98	2.52	1.29	1.74	1.39	2.85	4.05	1.34	2.46	2.6
HV35F6	251461	ESTs	2.49	1.96	0.36	2.42	6.66	2.85	1.05	1.75	0.72	4.84	2.12	2.11	3.12	1.17	1.31	2.85	1.61	2.95	3.08	1.87	1.41	3.08
HV35H5	121270	ESTs	1.19	1.7	0.77	1.07	1.29	0.8	1.16	1.14	0.95	2.5	0.83	0.8	1.07	1.19	0.76	0.52	1.47	1.07	1.02	0.77	1.02	0.88
HV36A2	245745	ESTs	1.69	3.95	1.32	2.66	4.88	0.84	2.14	1.39	1.57	1.78	1.12	0.95	2.31	2.46	1.36	1.34	0.91	5.33	1.39	0.98	1.4	2.51
HV36A12	245885	"ESTs, Weakly similar to !!!! ALU SUBFAMILY J WARNING ENTRY !!!! [H.sapiens]"	1.02	1.72	1.59	1.41	1.99	1.13	3.29	2.08	1.88	2.5	0.38	0.98	1.52	1.7	1.25	2.12	0.91	1.2	0.8	0.68	0.55	0.92
HV36B8	139354	ESTs	0.48	0.38	0.69	0.22	0.79	0.69	0.94	0.86	1.88	1.68	0.94	1.03	0.46	0.99	0.55	0.66	1.18	0.32	1.31	0.96	0.79	1.39
HV36B9	140171	ESTs	2.24	2.31	2.31	1.42	2.26	1.59	1.33	1.79	2.08	3.33	2.67	2.25	1.76	1.84	1.74	1.47	1.61	1.39	3.38	1.9	1.99	2.63
HV36E4	198605	ESTs	0.63	1.28	0.83	0.76	1.91	0.68	1.32	0.78	1.26	1.01	1.3	0.52	1.02	0.83	0.81	2.38	1.28	0.79	1.02	0.78	0.75	1.1
HV36F2	111571	"ESTs, Highly similar to HP1-BP74 protein [M.musculus]"	3.4	2.39	0.99	2.5	3.63	2.59	1.34	1.33	0.75	2.76	1.39	2.06	2.35	1.61	2.04	1.82	0.91	0.87	6.88	5.1	2.74	5.92
HV36F3	295985	ESTs	0.3	1.03	0.7	1.66	1.59	0.62	0.44	0.75	0.53	0.9	0.46	0.2	0.53	0.3	0.39	0.55	1.88	3.49	0.85	0.26	0.37	0.52
HV36G3	129293	ESTs	0.56	1.27	0.73	0.7	1.96	0.8	0.93	0.88	0.7	1.59	1.02	0.76	0.82	0.89	0.84	0.61	0.91	0.6	1.33	1.01	0.71	1.06
HV36G4	111765	ESTs	2.07	2.01	0.52	1.32	2.44	1.51	1.1	2.03	1.82	2.96	1.29	2.9	1.58	1.92	1.85	2.08	2.14	2.44	3.7	3.27	2.39	2.1
HV36G8	111391	ESTs	1.65	1.57	0.46	0.62	2.32	1.28	1.22	1.1	1.34	2.85	0.91	1.76	1.71	1.76	1.07	1.25	0.91	1.3	1.79	1.65	1.17	1.42
HV36G10	244154	KIAA0875 protein	1.2	1.42	0.55	0.93	2.37	1.18	1.18	1.59	1.13	2.04	1.07	1.3	1.73	1.93	1.22	1.85	0.91	2.16	1.36	1.39	0.9	1.4
HV37B1	161195	DKFZP434D1335 protein	1.4	2.6	1.13	1.62	2.04	2.38	0.97	1.24	1.29	1.76	1.3	1.24	1.04	0.95	1.21	1.33	1.79	2.09	1.06	0.82	1.02	1.27
HV37B2	130243	ESTs	1.09	0.66	0.27	0.4	1.17	1.19	0.84	0.59	1.49	3.29	0.63	0.28	0.41	0.44	0.51	1.26	0.91	0.43	1.12	0.35	0.62	0.72
HV37B3	111006	ESTs	0.7	0.7	0.49	0.79	1.48	0.68	0.87	1.23	1.25	1.97	1.1	1	0.85	0.94	0.83	1.75	0.94	1.09	0.76	0.69	0.7	0.85
HV37B4	293569	ESTs	1	1.17	0.38	0.65	1.59	1.42	1.43	0.93	1.16	1.02	1.08	1.5	4.03	4.23	0.91	1.18	0.91	0.59	2.43	1.16	0.53	3.47
HV37B5	234398	ESTs	1.8	0.99	0.96	0.96	0.53	0.87	0.58	1.35	1.67	0.97	3.9	0.79	1.21	2.01	1.28	0.47	0.37	1.68	1.48	0.69	0.82	1.62
HV37B9	203469	KIAA0697 protein	2.15	1.39	1.15	1.16	0.81	0.72	0.94	1.39	1.11	0.91	2.25	1.19	1.54	1.36	1.42	0.57	1.02	1.37	2.38	0.9	1.06	1.58
HV37B11	206544	ESTs	3.12	1.98	1.3	2.18	1.25	1.96	0.6	1.92	1.2	1.44	3.44	3.8	3.11	2.38	1.19	0.57	0.91	3.12	5.23	1.34	2.24	3.68
HV37D3	120695	putative mitochondrial outer membrane protein import receptor	1.48	1.76	1.24	1.23	4.18	2.78	1.94	1.5	1.28	0.55	1.14	2.54	1.26	0.66	1.01	0.93	0.91	0.8	2.67	1.48	1.29	1.9
HV37D7	294881	ESTs	1.14	0.81	0.72	0.42	1.04	0.51	1.55	1.18	0.95	0.19	0.26	0.61	0.89	1.38	0.66	0.18	0.55	1.65	0.95	0.79	0.86	0.87
HV37E9	121159	DKFZP434H132 protein	0.83	1.08	0.96	0.89	3.32	0.66	0.29	1.36	1.53	1.1	0.92	0.55	0.82	0.8	1.28	0.38	0.91	1.19	1.56	0.69	1.68	1.32
HV37F2	137793	ESTs	3.26	5.74	0.55	1.97	5.33	2.16	4.37	1.38	4.31	4.66	1.24	7.58	2.96	15.06	0.64	3	0.91	9.12	22.76	6.82	5.54	17.86
HV37F7	130276	Homo sapiens mRNA; cDNA DKFZp586H0324 (from clone DKFZp586H0324)	0.89	1.04	1.03	1.04	1.12	0.82	0.76	1.7	1.3	0.9	2.92	1.05	0.99	1.47	1.7	0.74	0.9	1.47	0.83	0.62	2.47	0.99
HV37F9	121501	ESTs	1.58	1.23	1.4	1.63	0.92	0.9	0.8	1.95	1	0.72	3.07	2.66	1.43	2.11	1.37	1.42	0.58	2.12	2.6	0.82	1.22	1.69
HV37G1	214165	ESTs	1.97	3.76	1.52	2.28	4.07	2.86	4.45	2.48	1.89	4.51	2.54	3.5	1.67	2.32	1.06	2.25	0.91	1.97	2.85	1.21	1.68	2.52
HV37G2	121459	ESTs	1.56	1.11	0.75	0.57	1.18	0.82	0.35	0.67	1.71	0.54	0.98	2.48	1.36	2.18	1.09	0.92	0.91	2.05	1.94	0.87	0.67	1.21
HV37H7	121736	EST	2.22	0.51	1.02	0.36	1.63	0.8	1.52	1.44	0.95	0.21	0.38	2.54	2.75	2.02	1.55	0.31	0.39	2.97	1.83	0.77	1.05	1.56
HV37H11	139113	ESTs	3.22	1.89	1.06	1.34	0.99	1.39	2.22	2.2	0.95	1.2	1.08	1.28	1.77	2.02	2.25	1.48	0.44	2.11	1.51	1.31	1.5	1.54
HV38A1	134525	cullin 3	1.12	0.9	0.98	1.32	1.52	0.85	0.69	1.25	1.48	1.04	1.08	1.27	1.55	1.79	1.18	0.66	0.81	1.65	1.19	0.69	0.89	1.39
HV38A2	121994	ESTs	1.49	1.88	1.03	1.78	2.11	1.08	1.3	1.45	1.83	1.5	1.13	1.8	1.97	2.03	1.37	1.93	1.48	2.03	1.06	0.8	0.83	1.54
HV38A5	357970	DKFZP564B0769 protein	0.84	1.29	0.95	1.98	1.7	1.14	1.08	0.76	0.69	0.9	0.41	0.88	1.61	1.18	0.67	0.58	0.96	0.7	1.15	0.39	0.57	1
HV38A6	296444	ESTs	0.66	1.59	0.7	1.48	4.39	0.73	2.6	1.74	3.32	1.9	0.98	3.34	1.76	1.23	0.44	1.9	1.52	2.88	2.86	1.66	0.88	2.09
HV38B2	122295	ESTs	2.11	2.99	0.73	1.2	3.32	1.29	1.94	1.61	1.97	2.57	1.13	1.21	2.24	1.76	1.54	1.91	2.4	1.84	1.88	1.52	0.73	2.54
HV38B11	122397	ESTs	1.91	1.57	1.83	1.75	2.06	1.23	0.75	1.24	1.34	1.07	1.07	1.05	0.89	1.95	1.62	1.19	1.45	2.18	2.68	1.46	1.91	1.49
HV38C1	122443	KIAA1052 protein	2.16	1.86	1.52	0.97	3.38	3.43	2.89	1.93	1.56	6.44	1.48	3.32	1.86	3.53	1.17	1.48	2.21	0.94	2.38	0.98	1.29	1.56
HV38C5	123405	ESTs	0.89	1.07	0.57	0.55	1.03	0.98	0.63	0.76	0.96	0.89	1.07	1.02	0.8	0.89	1.13	0.58	0.55	1.01	1.2	0.74	0.82	0.87
HV38D1	244686	ESTs	2.03	1.67	1.13	1.8	3.84	2.68	2.67	4.96	4.52	2.21	1.22	3.83	2.62	2.37	1.17	1.47	0.83	1.71	1.95	0.79	0.93	1.83
HV38D11	123441	ribosomal protein L7a	0.51	1.13	0.92	1.13	1.35	0.94	0.85	0.84	0.61	0.78	1.25	0.59	0.55	0.43	0.69	0.89	1.9	0.54	1.67	1.1	0.98	0.89
HV38E8	198874	ESTs	1.01	1.45	0.81	1.16	2.14	0.57	1.63	0.98	1.37	1.22	0.61	1.94	2.05	1.59	1.08	1.79	1.13	1.08	1.12	0.97	0.76	1.55
HV38E9	244062	ESTs	2.87	1.51	1.5	1.44	1.83	1.74	3.05	1.77	2.21	2.34	2.45	3.66	2.15	2.45	3.5	3.24	0.44	4.86	2.51	0.93	1.69	2.43
HV38F6	124179	ESTs	1.82	4.35	2.51	1.41	3.28	1.48	2.7	1.66	2.28	3.18	1.5	1.46	2.1	3.36	2.13	2.52	2.13	3.38	1.72	1.06	0.81	1.6
HV38F9	233688	a disintegrin and metalloproteinase domain 12 (meltrin alpha)	1.87	1.36	2.95	1.82	2.95	2.57	2.11	8.22	1.85	2.77	3.02	3	3.23	4.33	2.86	1.45	0.91	1.19	3.74	1.11	3.57	2.25
HV38G4	245442	ESTs	1.18	1.22	0.5	0.86	1.64	0.96	1.16	1.18	0.87	1.31	1.03	1.03	2.1	1.95	0.85	0.99	1.41	1.08	0.77	0.94	0.63	1.11
HV38H6	128785	ESTs	2.79	3.63	1.5	3.14	3.31	2.02	3.17	2.08	3.15	2.26	1.45	3.63	3.05	3.76	3.18	2.41	2.14	3.98	2.9	1.4	1.6	2.64
HV39A1	126221	tumor protein D52-like 2	1.03	1.27	0.83	0.95	1.95	0.74	1.36	0.56	0.99	0.91	1.18	1.07	0.43	0.6	0.75	0.37	1.31	0.87	1.46	1.03	1.12	0.84
HV39B5	126650	ESTs	3.12	2.99	1.9	2.06	4.26	2.08	1.56	1.79	1.21	3.4	3.01	1.7	1.45	4.62	1.26	1.64	0.91	2.23	2.16	1.14	0.88	2.06
HV39B12	126887	ESTs	1.47	1.61	0.32	0.6	2.05	1.21	0.65	1.27	1.62	0.69	1.25	1.11	1.41	1.74	1.15	1	0.91	1.68	1.86	0.75	0.96	1.22
HV39C2	341821	"ESTs, Moderately similar to RAS-RELATED PROTEIN RAB-23 [M.musculus]"	1.86	1.32	0.64	1.09	2.64	1.82	1.06	1.37	2.05	1.6	0.82	1.87	2.27	2.53	0.99	1.52	1.84	2.47	1.75	0.64	0.69	1.29
HV39C4	125589	ESTs	1.2	1.7	0.78	0.78	2.35	1.31	1.41	1.51	1.45	1.16	1.21	1.01	1.02	1.38	1.18	1.63	1.66	1.4	1.25	0.88	1.1	1.05
HV39D2	127099	"ESTs, Moderately similar to atypical PKC specific binding protein [R.norvegicus]"	1.61	2.07	1.19	2.02	1.47	2.61	1.4	1.23	1.28	1.05	0.49	2.51	1.54	1.4	1.35	1.33	0.91	1.77	0.94	0.89	0.82	0.87
HV39D7	143759	ESTs	0.67	0.9	0.34	0.68	2.15	0.64	0.55	0.62	1.02	0.69	0.71	0.58	0.59	0.66	1.06	0.58	0.91	0.5	0.56	0.4	0.4	0.57
HV39D10	210688	adenylate cyclase 9	1.02	0.86	0.79	0.61	0.98	0.53	2.34	1.09	1.37	1.21	0.67	1.13	1.37	1.2	0.75	0.86	0.91	1.07	0.77	1.08	0.68	1.37
HV39D11	230224	ESTs	1.23	1.57	1.61	2.21	3.26	1.39	0.89	1.17	2.32	1.59	0.94	1.6	1.81	1.56	0.69	1.06	1.36	1.92	1.19	0.53	0.55	1.17
HV39D12	127409	ESTs	1.35	0.71	0.98	0.65	0.63	0.59	0.76	1.45	1.59	0.32	0.49	0.87	1.72	2.17	2.23	0.92	0.91	2.86	1.4	0.76	1.35	1.54
HV39G6	345670	ESTs	3.86	1.65	1.88	0.63	2.39	1.42	1.25	2.71	1.46	2.35	1.05	5.08	5.29	5.04	0.9	3.46	0.91	13.09	3.26	0.99	2.08	2.64
HV39H3	130004	ESTs	2.59	3.97	2.57	5	3.94	3.54	3.53	1.62	2.07	1.57	2.06	2.7	2.08	7.79	1.51	1.52	0.91	5.79	2.98	2.22	1.94	2.78
HV39H8	243291	ESTs	0.97	1.2	0.94	0.86	0.97	0.57	0.95	1.62	0.94	0.58	0.34	0.7	1.39	2.14	0.82	0.61	2.13	0.73	0.76	0.55	0.59	0.76
HV39H9	299737	Homo sapiens clone 24411 mRNA sequence	0.88	1.29	0.89	1.79	2.63	1.15	1.16	1.73	1.07	1.34	1	1.23	1.86	1.27	0.99	1.23	0.91	1.19	1.38	0.8	0.81	1.11
HV39H12	203514	ESTs	1.81	0.73	1.08	0.9	0.8	0.73	0.75	1.23	1.63	0.42	0.4	1.89	2.19	1.37	0.97	0.84	1.19	1.08	1.89	1.17	1.02	1.4
HV40A2	156023	ESTs	1.04	1.22	0.49	0.6	1.19	0.88	0.8	1.03	1.33	0.6	0.99	1.27	1.22	1.63	0.81	0.95	0.91	1.09	0.95	1.25	1.16	1.74
HV40A3	292171	ESTs	2	0.52	0.85	1.35	0.63	1.05	0.32	0.63	2.78	0.96	0.6	3.15	1.86	1.61	1.08	0.47	1.38	4.74	1.98	2.02	1.91	2.27
HV40A7	138374	ESTs	1.08	0.77	1.22	1.01	1.26	0.71	0.55	1.18	1.06	0.98	1.25	0.99	1.07	0.93	0.94	0.51	0.85	0.98	0.62	0.67	0.68	0.98
HV40A9	138304	"inositol 1,4,5-triphosphate receptor, type 2"	1.98	0.59	1.54	1.42	1.97	0.93	0.26	1.01	2.34	1.52	1.74	1.88	3.69	2.94	1.38	0.42	0.86	10.63	2.79	2.09	1.31	3.09
HV40A12	292236	ESTs	1.79	1.39	0.89	1.35	2.13	1.06	1.08	1.1	0.93	1.11	1.06	1.67	1.97	1.42	1	1.3	0.91	0.84	1.15	0.97	1.33	1.36
HV40B1	301752	ESTs	1.69	0.5	0.81	0.78	0.7	0.43	0.16	1.35	2.58	0.62	0.73	2.47	1.89	2.65	1.17	0.43	0.75	3.42	3.19	1.01	1.37	1.99
HV40B2	138589	Homo sapiens clone 24538 mRNA sequence	1.5	1.89	1.11	1.54	2.91	1.4	1.43	1.33	1.66	2.73	1.08	1.08	1.97	2.09	1.45	2.5	1.33	1.09	2	0.88	0.69	1.24
HV40B3	128617	ESTs	2.31	1.17	1.77	1.23	1.57	1.17	0.59	2	2.93	1.97	3.68	3.48	1.89	3.74	1.39	0.6	0.91	3.63	2.78	0.85	1.12	1.62
HV40B6	128679	ESTs	1.3	1.96	2.01	1.48	3.84	1.49	2.41	2.95	1.67	3.39	2.96	1.91	2.71	4.81	2.48	1.35	1.67	2.32	3.09	1.46	2.51	2.76
HV40B8	128695	ESTs	1.81	4.05	1.03	1.95	5.29	7.02	3.32	4.32	2.3	4.52	2.84	3.63	2.29	3.15	3.56	6.85	0.91	1.22	5.49	2.22	4.06	5.11
HV40B12	129817	KIAA0615 gene product	1.4	1.46	0.4	0.86	5.22	1.75	0.82	0.8	1.47	2.87	0.78	1.42	1.83	1.06	1.12	1.59	1.85	0.89	1.61	0.97	1.18	1.34
HV40C1	129840	ESTs	2.19	0.83	0.96	0.87	1.14	0.91	0.41	0.95	2.27	0.94	0.17	0.89	1.81	1.42	1.12	0.36	0.74	2.64	2.02	1.36	0.95	2.04
HV40C3	358543	ESTs	1.5	1.47	1.76	1.61	1.02	0.93	0.85	1.11	1.51	0.85	0.88	1.07	1.6	1.64	0.85	0.49	0.88	2.18	1.09	0.69	0.57	0.96
HV40C10	137971	ESTs	1.6	0.73	0.35	0.72	1.58	1.29	1.09	1.04	1.42	2.3	0.79	2.09	1.34	1.95	1.03	1.44	0.91	2	1.25	0.89	0.88	1.5
HV40C12	294496	ESTs	0.93	1.15	0.23	0.58	1.13	0.89	0.63	0.7	1.05	0.75	0.61	0.65	1.58	1.01	1.5	0.95	1.53	0.85	0.32	0.35	0.43	0.65
HV40D1	296155	ESTs	1.78	0.46	0.98	0.47	0.91	0.32	0.44	0.82	2.19	0.13	1.54	1.48	1.34	2.3	1.7	0.17	0.91	6.49	1.55	1.04	0.91	1.3
HV40D2	130057	ESTs	0.46	0.98	0.68	0.9	2.1	0.46	1.08	0.83	1.19	0.93	0.88	2.43	3.4	2.79	0.75	0.74	0.91	0.7	0.88	7.11	0.58	0.84
HV40D5	364873	ESTs	1	0.66	0.61	0.73	1.06	0.58	0.82	1.02	1.64	1.06	0.46	1.36	1.26	1.35	0.8	0.65	0.72	0.82	0.51	0.56	0.47	0.75
HV40D9	292939	ESTs	0.95	0.59	0.93	0.7	0.92	0.91	0.7	1.05	0.81	0.52	1.07	1.36	1.91	1.19	0.68	0.57	0.91	0.73	1.28	1.21	0.88	1.32
HV40F2	137456	"ESTs, Highly similar to tbx3 [H.sapiens]"	4.12	2.19	1.23	2.76	4.91	1.72	2.45	5.14	1.18	2.54	3.09	6.95	5.65	6.38	2.07	1.65	1.74	2.96	12.37	6.59	2.21	7.92
HV40F6	133180	ESTs	3.47	3.46	1.08	2.18	4.28	5.87	2.03	1.32	1.4	3.97	1.28	2.42	1.95	2.97	1.66	1.72	2.12	1.77	2.54	1.07	0.73	1.79
HV40F7	130572	ESTs	1.43	1.07	1.72	1.71	1.5	1.28	0.68	1.26	1.62	1.18	2.59	1.29	1.39	1.34	1.06	0.59	1.25	0.84	1.47	0.82	0.91	1.24
HV40G1	131316	ESTs	2.19	1.4	1.41	1.78	1.23	0.91	0.77	1.03	2.61	1	0.36	1.12	1.83	4.55	0.91	0.44	1.3	4.07	1.36	0.66	0.51	1.34
HV40G2	131318	"ESTs, Highly similar to similar to insulin receptor substrate BAP2 [H.sapiens]"	1.39	1.48	0.57	1.54	2.13	1.26	1.04	1.04	0.89	0.77	0.77	0.95	1.05	0.96	1.85	1.82	1.31	0.74	3.62	1.48	2.12	1.92
HV40G7	131050	Homo sapiens mRNA; cDNA DKFZp564H122 (from clone DKFZp564H122)	1.14	0.84	0.76	0.54	1.12	0.76	0.77	1.05	1.17	1.22	0.85	1.13	0.79	1.14	1.12	0.65	0.53	0.69	0.98	0.55	0.43	1.5
HV40H5	136772	ESTs	1.21	0.82	0.76	0.42	1.05	0.6	1	0.75	2.74	0.41	0.36	0.72	1.01	1.3	1.25	0.92	0.91	0.86	0.66	0.45	0.39	0.68
HV40H6	131563	ESTs	0.8	0.98	0.37	0.43	1.06	0.39	1.24	0.77	0.8	0.63	0.81	0.35	0.84	0.52	0.25	0.75	0.91	0.49	0.33	0.26	0.22	0.4
HV40H7	143322	ESTs	0.7	0.7	0.17	0.45	0.83	0.26	0.48	0.21	0.1	0.07	0.17	0.22	0.82	0.43	0.28	0.3	1.14	0.72	0.2	0.14	0.23	0.2
HV40H9	136317	"tumor necrosis factor receptor superfamily, member 12 (translocating chain-association membrane protein)"	2.02	0.92	4.98	2.8	7.2	2.41	3.28	3.38	50.04	3.74	2.57	3	4.39	4.58	2.4	0.97	0.41	3.34	3.4	0.99	1.48	2.72
HV40H11	233318	ESTs	2.35	1.72	1.59	1.73	1.62	1.89	1.22	1.49	2.52	0.81	0.56	2.59	2.39	3.09	1.28	0.6	0.45	2.43	2.28	1.33	0.96	1.82
HV41A3	132285	ESTs	0.83	1.2	1.23	1.55	1.9	0.92	0.7	1.25	2.02	1.75	0.95	0.82	1.11	1.54	0.89	0.7	1.56	1.67	0.97	0.77	0.57	0.99
HV41A4	133331	"ESTs, Moderately similar to !!!! ALU SUBFAMILY SC WARNING ENTRY !!!! [H.sapiens]"	3.57	2.94	3.59	2.79	4.58	1.96	2.67	4.37	11.25	2.8	1.52	3.19	3.37	2.08	2.1	2.19	0.91	2.83	3.36	2.29	3.4	3.75
HV41A11	139217	ESTs	1.13	1.51	0.86	1.12	1.69	0.99	0.68	0.72	1.2	0.85	1.2	1	1.13	0.77	1.08	0.74	0.91	1.06	0.79	0.58	0.91	0.81
HV41B7	133197	"ESTs, Weakly similar to CROL BETA [D.melanogaster]"	1.24	1.3	1.46	1.69	1.77	1.16	0.57	1.24	0.86	1.42	1.05	0.51	1.21	0.76	0.87	1.1	1.09	0.44	1.46	1.73	0.84	1.04
HV41C8	133534	EST	3.53	1.59	0.72	1.48	1.02	0.39	0.53	0.62	0.4	0.67	0.45	0.18	0.36	0.46	0.51	1.26	1.39	0.9	0.55	0.17	0.23	0.42
HV41C10	133519	KIAA0615 gene product	2.25	1.59	0.74	0.78	1.97	2.1	0.76	1.55	1.18	1.57	0.72	3.59	2.68	2.39	1.12	1.17	0.91	1.97	2.82	0.69	1.63	2.08
HV41C12	135240	ESTs	1.23	2	0.49	0.79	2.79	1.31	1.27	1.36	1.3	0.82	0.49	1.11	1.48	1.01	0.83	1.5	0.91	0.56	1.75	1.31	0.93	1.39
HV41D2	135303	ESTs	1.73	1.68	0.44	1.5	2.19	1.47	1.69	1.37	1.7	0.83	0.56	0.86	1.5	1.57	1	2.08	1.99	0.68	0.89	0.47	0.71	0.84
HV41D3	234376	Homo sapiens mRNA; cDNA DKFZp564F112 (from clone DKFZp564F112)	2.38	2.95	1.98	3.33	3.49	1.81	3.97	4.88	0.95	4.54	1.88	3.28	2.91	5.7	2.41	2.72	1.28	1.29	5.99	2.19	3.45	3.79
HV41D12	134495	ESTs	1.13	1.23	0.74	1.15	0.98	1	1.65	1.62	1.3	0.7	0.3	1.61	1.2	1.75	1.52	1.34	0.91	0.96	0.87	0.99	1.16	1.06
HV41E1	134829	Homo sapiens mRNA; cDNA DKFZp434E033 (from clone DKFZp434E033)	0.68	0.66	0.74	0.84	0.99	0.34	0.66	1.24	0.69	0.91	1.34	0.35	1.39	0.83	0.53	0.47	0.61	0.45	1.22	1.4	0.73	1.09
HV41E4	134439	p21 (CDKN1A)-activated kinase 2	3.39	3.62	1.81	2.9	2.93	2.55	2.18	2.24	2.58	3.84	0.89	1.91	1.57	1.6	1.3	1.77	0.91	1.2	1.65	1.82	1.2	2.1
HV41E7	138550	"ESTs, Moderately similar to neurofibromatosis type 2 [M.musculus]"	0.82	2.33	7.15	1.17	1.37	0.78	2.57	1.92	1.17	1.43	1.41	1.47	0.91	1.5	0.84	2.34	0.91	1.37	1.25	1.31	0.92	1.85
HV41F9	136301	ESTs	1.04	1.29	0.98	1.66	1.83	1.19	0.94	1.13	1.51	0.97	0.69	0.81	0.91	0.88	0.76	1.02	0.91	0.51	1	0.76	0.8	0.99
HV41G7	234150	myotubularin related protein 4	1.73	2.43	1.75	3.86	2.45	2.3	3.84	2.61	3.48	4.84	2.37	2.06	1.42	1.64	1.23	1.79	1.68	2.72	2.86	2.72	2.9	2.67
HV41G9	136730	ESTs	1.16	2.32	1.9	1.82	2.18	1.36	1.24	1.26	1.91	1.31	0.96	0.61	0.87	0.85	1.06	0.86	1.54	1.07	0.82	0.98	0.69	1.09
HV41G10	136598	ESTs	1.49	4.34	1.07	1.41	3.42	1.6	1.66	2.38	2.48	0.89	0.46	1.74	2.17	2.72	1.48	1.56	1.5	1.72	2.04	0.69	1.34	1.63
HV41H1	234617	ESTs	2.04	9.94	1.67	4.09	5.93	2.18	2.79	1520.24	0.95	1.73	1.02	3.45	1.83	1.6	1.01	2.43	1.73	2.2	3.27	1	0.66	1.44
HV41H2	682555	insulin-like growth factor 1 receptor	1.44	3.28	1.01	2.41	4.81	1.55	2.93	3.93	2.89	2.35	1.62	3.74	3	4.93	0.51	2.81	0.91	2.38	0.94	1.89	0.76	1.83
HV41H8	144762	ESTs	1.13	1.48	0.49	0.87	1.16	0.81	1.03	1.22	1.04	0.91	0.37	0.67	0.89	0.83	1.17	0.98	1.56	0.42	0.66	0.43	0.49	0.73
HV42A2	234425	ESTs	1.77	0.9	0.58	1.13	1.93	0.77	1.26	2.31	1.38	1.02	0.56	1.64	2.11	1.6	1.52	1.4	1.87	0.81	1.05	1.52	0.98	1.84
HV42A10	137506	"ESTs, Highly similar to similar to Dvl-1 product encoded by GenBank Accession Number U10115 [M.musculus]"	2.02	1.85	1.78	1.86	2.32	1.46	1.77	1.23	1.36	1.59	1.64	1.3	1.99	1.44	0.82	1.19	1.43	1.89	1.49	1.44	1.7	1.73
HV42A12	293599	"ESTs, Highly similar to ORF [H.sapiens]"	1.13	1.11	0.56	0.97	1.71	1.01	0.85	0.91	0.69	1	1.08	1.49	1.47	1.13	0.95	2.53	0.91	0.99	1.33	1.27	1.03	1.55
HV42B3	193381	ESTs	0.9	1.86	0.8	1.58	2.32	1.38	1.01	1.04	1.65	1.78	1.75	0.87	1.25	1.07	0.7	1.68	0.91	1.64	2.24	1.16	1.2	1.97
HV42B6	138104	ESTs	0.83	0.55	0.15	0.24	1.25	0.79	0.57	0.44	1	2.03	0.49	0.83	0.63	0.96	0.41	0.78	0.71	0.57	1.53	0.66	0.61	1.53
HV42B9	138141	"Homo sapiens mRNA from chromosome 5q21-22, clone:A3-A"	0.82	0.53	0.75	0.86	0.97	0.68	0.31	1.37	0.5	0.59	1.97	0.62	1.17	0.54	1.13	0.43	0.79	0.37	1.18	2.27	1.03	1.28
HV42C1	233547	ESTs	0.78	1.71	0.73	0.57	2.84	0.96	0.98	1.15	0.96	2.73	1.76	0.89	1.17	1.09	0.95	0.95	2.58	0.74	1.92	1.16	0.84	0.39
HV42C2	207850	ESTs	1.33	1.3	0.54	0.58	2.31	1.55	0.84	0.92	1.38	1.43	0.62	1.37	2.04	2	1.04	0.91	0.91	2.78	1.4	0.79	0.87	1.61
HV42C6	154795	ESTs	1.15	1.13	0.56	0.41	1.25	1.11	0.43	0.67	1.28	0.78	1.29	1.81	1.69	3.33	1.95	1.09	1.29	3.15	2.75	0.83	1.12	2.03
HV42C7	140852	ESTs	1.08	3.57	0.39	2.43	4.48	2.39	0.99	0.61	0.93	1.96	1.67	0.7	1.91	1.52	1.22	1.69	0.91	0.94	1.7	0.54	0.98	1.26
HV42C8	240938	"Homo sapiens brain and nasopharyngeal carcinoma susceptibility protein NSG-x mRNA, partial cds"	1.54	2.08	0.71	0.58	1.36	0.92	0.85	0.67	1.5	0.56	0.77	1.87	2.44	4.73	2	0.96	0.91	6.34	3.17	0.58	1.45	1.52
HV42C9	202514	ESTs	3.48	1.94	2.78	2.95	2.62	2.75	0.69	1.19	3.25	1.47	2.22	4.43	3.13	6.02	1.78	1.77	0.85	7.16	3.55	1.26	2.74	2.28
HV42D1	121546	"Human mRNA for ornithine decarboxylase antizyme, ORF 1 and ORF 2"	1.82	1.24	0.95	2.7	3.4	1.62	1.08	1.13	0.96	0.94	1.7	1.96	1.12	1.1	0.93	0.61	1.7	2.09	2.23	1.1	1.67	1.79
HV42D5	154138	ESTs	1.12	1.45	1.19	1.07	2.52	0.84	1.24	1.66	1.54	1.37	1.14	1.04	1.2	1.35	0.9	0.7	0.91	1.21	0.83	0.85	0.53	0.88
HV42D7	198451	ESTs	0.88	0.75	0.44	0.61	0.8	0.82	0.76	1.01	0.89	0.92	0.82	1	0.73	0.96	0.97	0.53	1.23	0.6	0.71	0.79	0.56	0.62
HV42D9	366966	ESTs	0.67	0.61	1.22	0.92	0.74	0.3	0.6	0.63	0.93	0.46	0.04	0.33	1.13	1.23	0.79	0.49	0.33	0.52	0.51	0.45	0.43	0.68
HV42E5	139835	UDP-glucose dehydrogenase	1.39	1.62	1.74	1.57	3.1	1.23	4.22	3.84	4.38	2.99	3.81	3.84	3.75	5.74	1.93	1.62	1.83	3.83	1.5	6.97	1.29	7.97
HV42F7	138579	ESTs	1.21	3.33	0.81	1.53	2.36	1.7	1.74	1.36	1.05	2.64	1.09	1.65	1.93	1.98	1.06	3.15	0.91	1.14	2.74	0.99	1.25	2.19
HV42F9	138672	ESTs	1.9	0.92	1.14	1.24	1.31	0.72	0.63	3.71	3.65	1.31	3.9	2.02	2.15	2.48	1.41	1.22	0.78	1.45	2.62	1.33	1.02	1.85
HV42G2	139331	"ESTs, Weakly similar to coded for by C. elegans cDNA CEESW58F [C.elegans]"	2.39	1.74	0.7	1.28	2.11	1.56	0.72	0.97	2.56	2.34	0.89	1.94	2.1	1.28	1.57	1.69	1.86	1.32	1.34	0.78	0.8	1.07
HV42G9	139689	ESTs	0.66	0.65	1.74	0.83	0.77	0.77	0.61	0.98	0.82	1.03	1.65	0.52	1.3	1.08	1	0.08	0.91	0.78	1.06	0.34	0.43	0.82
HV42G11	139705	ESTs	1.91	1.21	0.8	1.17	1.39	2.22	0.75	1.09	1.03	0.78	1.38	1.68	1.03	1.1	1.15	0.18	0.45	1.32	1.14	0.88	0.68	1.17
HV42G12	139957	ESTs	2.55	1.67	0.45	0.74	3.28	1.92	2.05	1.06	1.12	1.2	1	1.76	1.81	2.28	2	1.15	0.91	3.01	2.35	2.52	2.21	1.78
HV42H3	139883	ESTs	1.47	2.32	1.38	2.35	3.42	1.58	1.91	3.72	0.95	2.08	0.93	1.32	1.54	1.45	0.79	1.24	2.11	1.62	1.13	0.5	0.65	1
HV42H7	246292	ESTs	0.64	1.93	0.92	1.15	2.24	1.12	1.77	1.58	1.58	1.53	2.86	1.22	1.57	1.53	0.96	0.97	1.89	1.27	1.59	0.83	0.81	1.45
HV43A9	140966	ESTs	0.4	0.64	0.49	0.61	1.05	0.28	0.41	0.55	0.44	0.51	0.26	0.2	0.68	0.46	0.32	0.3	0.48	0.46	0.99	0.3	0.36	0.44
HV43A10	140921	ESTs	0.92	1.55	1.38	1.33	2.39	0.87	1.84	1.41	1.8	1.45	0.7	1.02	1.6	2.36	1.66	2.31	1.17	1.98	4.25	1.05	2.93	2.48
HV43B2	140301	ESTs	1.19	1.1	1.13	1.42	2.63	0.72	3.18	6.42	3.27	3.32	1.52	1.18	1.27	3.06	1.48	1.37	1.68	1.47	3.89	0.61	1.4	3.22
HV43B3	471372	ESTs	1.81	1.32	1.22	1.27	1.01	1.15	0.55	2.04	2.28	0.91	1.5	2.26	1.9	2.52	1.37	0.93	1.1	1.32	2.21	0.87	0.87	2.11
HV43B5	138337	ESTs	0.96	0.74	0.93	0.78	0.44	0.33	0.34	1.12	2.24	0.39	1.75	0.54	1.01	1.14	0.51	0.52	0.82	0.97	1.43	0.29	0.87	0.81
HV43C2	138477	ESTs	1.94	1.94	0.6	1.82	2.01	1.19	2.6	2.17	1.6	1.7	1.15	1.47	1.68	1.92	1.92	1.98	1.59	1.13	2.89	1.45	1.84	2.05
HV43C3	141453	ESTs	3.73	2.03	1.7	1.17	2.18	2.38	0.89	5.27	3.62	1.56	2	4.93	6.85	7.22	1.27	0.68	1.46	5.75	3.26	2.97	1.63	2.75
HV43C8	142442	"ESTs, Moderately similar to fetal globin inducing factor [M.musculus]"	1.86	2.25	0.57	1.5	1.8	1.64	1.77	1.35	1.09	1.81	0.67	1.3	1.49	1.31	1.38	1.91	1.66	0.89	1.99	0.99	1.05	1.3
HV43C9	142532	ESTs	1.31	1.87	1.24	1.09	1.97	1.5	0.94	1.45	0.94	1.28	1.16	0.58	1.01	2.72	0.76	0.86	0.84	1.11	1.79	0.63	1.2	1.39
HV43D3	241482	ESTs	1.52	0.79	0.77	0.52	1.31	1.34	0.26	1.29	1.79	0.27	0.52	0.38	1.09	0.48	0.87	0.52	0.91	0.61	0.86	0.42	0.78	0.66
HV43D9	144905	ESTs	1.56	1.65	1.59	1.42	1.1	0.94	0.89	1.29	1.27	1.14	0.66	1.43	1.04	1.09	1.25	1.22	0.64	1.14	1.03	0.6	0.59	0.85
HV43D10	143748	"phospholipase C, gamma 1 (formerly subtype 148)"	1.98	1.42	0.91	1.58	2.83	0.74	2.48	1.76	3.71	1.36	1.01	1.44	1.18	1.26	1.15	2.8	0.91	1.45	2.36	1.38	1.1	1.05
HV43D12	143962	"ESTs, Weakly similar to unknown [D.melanogaster]"	1.2	1.13	0.64	1.33	1.9	1.14	1.26	1.05	1.33	1.03	0.52	1	1.51	1	0.85	0.99	0.91	0.96	2.19	2.11	1.86	1.71
HV43E1	248535	ESTs	0.7	0.48	1.16	0.66	1.31	0.39	0.35	1.05	0.5	0.6	0.65	0.48	0.57	0.89	0.56	0.48	0.25	0.45	0.66	0.32	0.48	0.72
HV43E4	143887	"serine protease, umbilical endothelium"	3.06	1.4	1.77	3.68	5.15	1.91	4.87	6.1	3.73	4.77	5.36	4.22	2.85	5.03	2.79	3.21	2.34	1.2	7.27	6.48	4.16	4.5
HV43E5	262920	endothelial differentiation-related factor 1	1.02	0.61	0.81	1.42	1.12	1.28	0.56	1.09	1.11	1.27	1.24	1.14	1.03	0.65	1.18	0.47	0.89	0.61	0.66	2.44	0.87	2.24
HV43E6	154477	ESTs	1.46	1.29	0.9	1.22	1.9	0.82	1.47	0.89	1.41	0.8	0.64	2.14	1.87	1.97	1.08	1.18	1.56	1.1	1.4	1.12	0.88	1.92
HV43E8	322759	"small nuclear RNA activating complex, polypeptide 5, 19kD"	1.45	2.76	1.37	1.99	2.6	1.88	2.1	1.95	2.68	2.08	1.33	1.46	1.58	1.95	1.37	2.5	1.66	1.96	2.18	1.28	2.07	2.1
HV43F2	139250	ESTs	0.97	1.77	0.51	1.22	2.04	2.06	0.84	0.98	0.91	1.39	0.66	0.5	0.78	0.69	1.32	2.1	1.06	0.61	2.21	0.8	1.17	1.83
HV43F3	288658	ESTs	0.53	1.25	0.93	0.73	1.63	1.11	0.32	1.19	0.77	0.48	1.6	0.69	1.38	1.08	0.88	0.95	0.6	0.72	0.92	1.24	0.78	1.14
HV43F4	295577	ESTs	1.8	5.05	0.35	1	3.41	1.06	1.93	1.3	1.47	2.55	1.52	1.18	1.26	2.2	0.85	1.79	2.01	1.44	2.93	2.1	1.03	2.06
HV43F8	160485	ESTs	2.9	6.18	4.4	2.46	5.34	4.24	4.26	6.02	1.23	2.05	2.13	4.39	6.02	4.98	1.97	5.93	3.1	7.96	4.55	1.22	2.92	3.83
HV43F12	197775	ESTs	0.8	1.63	0.71	0.73	2.34	1.1	1.54	1.13	1.27	1.05	1.12	1.66	2.31	2.18	0.97	1.34	1.13	0.95	2.09	1.04	0.54	2.43
HV43G5	209167	ESTs	1.13	1.45	1.03	0.95	1.44	1.51	0.63	1.06	1.05	1.9	0.93	1.01	0.71	0.72	1.03	0.68	0.72	0.66	1.15	0.71	0.84	0.92
HV43G6	202740	ESTs	0.99	0.94	0.48	0.54	1.23	0.68	0.92	1.12	1.27	0.89	0.49	0.85	1.29	1.44	1.06	0.97	0.91	0.41	1.34	0.54	0.58	1.09
HV43H4	204179	ESTs	1.16	1.34	1.07	1.54	1.55	1.24	1.18	1.26	1.46	0.87	0.9	1.31	1.72	1.72	1.11	0.82	0.91	0.63	0.9	0.86	0.8	1.02
HV43H7	243294	"surfactant, pulmonary-associated protein D"	1.73	1.55	0.94	1.27	0.94	0.86	1.59	1.47	2.03	0.91	1.16	1.01	1.13	1.06	1.23	0.89	0.42	1.22	1.23	1.24	1.32	0.97
HV43H9	295229	ESTs	2.02	2.67	3.55	3.14	0.68	1.8	4	1.9	4	1.96	0.99	2.78	2.16	2.88	1.18	1.11	1.53	3.04	2.45	1.07	0.84	1.84
HV44B3	234380	ESTs	1.97	2.86	1.13	1.12	3.27	1.21	1.4	1.27	2.18	2.02	2.47	1.98	2.02	3.81	1.4	1.19	1.56	4.19	2.88	1.24	1.43	2.07
HV44B4	293328	Homo sapiens clone 24859 mRNA sequence	2.79	3.94	1.17	2.17	4.31	2.9	1.84	1.83	1.45	2.31	1.72	1.91	1.41	1.45	2.78	2.86	2.49	1.79	3.91	1.62	1.67	3.45
HV44B12	193546	ESTs	1.9	1.83	0.66	1.1	1.64	1.91	1.14	0.8	0.93	1.11	0.89	0.98	1.52	1.41	0.78	1.96	1.8	2.03	1.98	0.48	0.73	0.78
HV44C4	211758	ribosomal protein S23	1.3	0.94	0.14	1.18	1.71	0.49	0.3	0.22	0.49	0.33	0.26	0.33	0.52	0.57	0.74	0.81	1.3	0.7	0.47	0.25	0.24	0.46
HV44D1	242687	ESTs	0.79	0.76	0.67	1.16	0.91	1.04	0.4	2.13	0.47	0.5	1.17	0.98	1.27	0.53	1.25	1.03	0.91	0.46	0.8	0.87	0.66	0.79
HV44D9	194965	ESTs	0.66	3.25	0.8	1.75	1.66	1.74	1.07	2.2	0.95	1.29	0.86	1.34	0.76	0.71	0.52	0.64	1.28	0.46	1.64	0.29	0.54	1.12
HV44H1	195852	"lectin, galactoside-binding, soluble, 8 (galectin 8)"	0.69	1.39	0.83	1.57	0.97	1.55	1.09	2.06	1.73	1.02	0.7	1.17	1.24	1.91	1.76	1.08	0.91	1.16	1.57	1.32	0.87	1.84
HV44H5	243360	ESTs	1.03	1.37	1.22	1.49	1.07	0.78	1.75	4.31	3.09	1.27	0.76	1.49	1.14	1.61	1.08	1.14	0.91	1.66	2.04	0.79	0.86	1.56
HV44H8	196345	LIM protein (similar to rat protein kinase C-binding enigma)	1.51	1.42	1.24	1.37	0.75	1.37	1.65	2.25	1.36	1.05	0.26	1.63	1.64	1.39	1.75	2.07	0.91	1.48	1.45	0.81	1.69	1.49
HV44H11	290054	ESTs	1.92	4.49	3.97	2.52	2.85	1.12	1.83	2.81	3.3	1.35	1.61	1.33	2.1	2.2	1.25	1.08	2.12	2.58	2.11	0.81	0.93	1.52
HV45A7	196849	"ESTs, Highly similar to NY-REN-37 antigen [H.sapiens]"	0.79	0.62	0.9	1.13	1.19	0.64	0.26	1.11	1.24	1.35	0.43	0.86	1.22	1.25	0.58	0.69	0.63	0.75	1.16	1	0.75	1.14
HV45D5	213969	ESTs	1.92	0.69	2.1	0.54	0.94	0.33	0.5	1.36	0.95	0.15	0.91	2.67	3.58	0.79	1.32	0.36	1.42	3.56	1.41	0.5	0.81	1.31
HV45D6	198011	ESTs	0.89	1.11	0.37	0.96	1.87	0.72	1.13	0.95	1.47	0.61	1.34	0.66	2.57	2.26	1.74	0.56	2.61	3.84	0.78	0.24	0.54	0.67
HV45D8	232837	preferentially expressed in colorectal cancer	2.27	1	1.26	1.63	1.24	1.53	0.82	1.25	0.66	0.5	1.39	0.85	0.38	0.97	2	0.77	1.65	2.5	1.08	1.98	1.18	1.36
HV45D11	199624	ESTs	1.87	0.88	1.89	1.08	2.32	1.26	0.75	0.63	2.15	1.21	0.67	2.15	2.55	1.97	1.26	0.78	0.93	0.81	1.31	0.91	0.77	1.1
HV45F3	359411	methyl-CpG binding domain protein 4	1.85	2.21	1.07	1.81	2.42	1.76	1.27	2.01	1.62	1.79	0.94	0.9	1.18	1.49	0.86	1.63	1.61	1.02	1.43	0.54	1.09	1.03
HV45F7	207016	ESTs	2.31	1.51	1.55	1.38	1.06	1.14	0.83	3.71	0.95	1.11	2.52	3.72	1.82	2.13	1.68	0.53	1.15	3.45	2.93	1.42	1.76	2.32
HV45G8	200847	ESTs	0.89	1.11	0.35	0.45	1.9	0.45	0.88	0.64	0.9	1.34	0.69	0.87	1.37	1.28	0.84	0.97	1.6	0.53	0.79	0.64	0.43	0.87
HV45G11	201393	ESTs	1.12	1.38	1	1.1	1.97	2.64	1.01	1.15	1.02	3.28	0.77	1.08	0.93	0.9	1.05	1.12	0.91	1.13	2.1	0.76	1	1.25
HV46A12	109123	ESTs	1.66	4.71	1.24	3.11	4.91	1.19	5.64	1.99	1.59	6.96	1.13	2.66	1.7	5.23	1.48	1.72	1.65	0.98	3.56	0.38	1.36	4.49
HV46C8	202931	ESTs	1.63	1.38	0.39	1.11	1.2	0.14	1.97	0.92	0.82	1.3	0.43	1.37	2.64	2.52	0.91	1.65	0.91	2.12	2.37	0.52	0.86	1.46
HV46D7	244086	ESTs	0.36	0.53	0.38	0.29	0.49	0.24	0.32	0.48	0.59	0.73	0.25	0.55	0.95	0.62	0.81	0.39	0.28	0.49	0.99	0.53	0.42	0.69
HV46E7	244310	ESTs	0.32	0.5	0.53	0.8	0.95	0.39	0.78	0.64	0.2	0.53	1.08	0.39	1.16	0.45	0.59	0.53	0.24	0.16	1.42	1.84	1.66	3.6
HV46F1	204638	ESTs	1.03	1.27	1.07	0.81	1.17	1.24	0.73	1.05	0.78	0.94	2.09	0.9	0.96	1.26	0.76	0.55	0.91	0.92	0.91	0.52	0.81	1.07
HV46F7	205490	"protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform"	2.96	2.59	1.91	1.37	1.83	1.58	1.38	1.33	1.3	2.09	1.11	0.81	1.29	0.88	1.09	1.21	0.91	0.99	2.66	1.16	1.57	1.88
HV46G1	294018	ESTs	1.09	1.4	1.22	0.72	1.35	1.3	0.84	1.34	1.08	0.89	0.88	1.26	1.15	1.31	0.92	0.69	0.75	1.14	1.1	0.6	0.74	1.19
HV46G8	206683	ESTs	1.44	1.43	0.4	1.23	2.09	0.93	1.49	1.22	1.9	1.1	0.45	1.29	2.09	2.93	0.85	1.51	1.35	1.32	2.77	0.59	0.74	2.06
HV46H1	296132	A kinase (PRKA) anchor protein 11	0.95	0.94	0.99	0.89	0.86	1.09	0.79	1.54	0.83	0.33	0.55	0.98	1.12	0.99	0.87	0.53	0.36	1.03	0.7	0.55	0.55	1.02
HV47A4	208375	ESTs	0.81	0.55	0.15	0.09	0.88	0.46	0.35	0.1	0.17	0.3	0.25	0.41	0.57	0.55	0.26	0.92	0.91	0.24	0.39	0.12	0.16	0.3
HV47C12	211747	ESTs	1.4	1.6	0.67	0.55	1.67	1.1	0.53	0.86	1.65	0.22	0.48	1.6	2.11	2.74	0.9	1.38	1.74	2.38	1.43	0.62	1.16	1.31
HV47D11	244267	ESTs	1.09	1.15	0.48	1.35	3.23	0.74	1.53	1.15	1.29	1.13	1.52	1.63	1.86	2.04	1.58	0.49	1.96	1.04	1.11	1.04	0.78	1.27
HV47G7	233719	ESTs	1.09	1.46	0.58	0.72	2.11	1.37	0.83	0.9	1.33	1.66	1.46	1.83	1.96	1.98	0.84	0.72	0.91	1.5	1.67	0.64	1.05	1.21
HV47H5	240637	"Human DNA sequence from clone 167A19 on chromosome 1p32.1-33. Contains three genes for novel proteins, the DIO1 gene for type I iodothyronine deiodinase (EC 3.8.1.4, TXDI1, ITDI1) and an HNRNP A3 (Heterogenous Nuclear Ribonucleoprotein A3, FBRNP) pseudogene. Contains ESTs, STSs, GSSs, genomic marker D1S2661, ca and ct repeat polymorphisms and three putative CpG islands"	1.29	0.83	0.72	1.15	1.44	1.16	0.59	1.29	1.12	0.96	1.57	0.73	1.05	0.7	0.83	0.41	2.49	1.17	0.69	0.74	0.47	0.89
HV47H7	295992	jumonji (mouse) homolog	0.56	1.09	0.7	0.94	1.91	1.38	1.2	1.2	0.86	0.77	2.06	0.91	1.26	1.51	1.22	0.68	2.18	1.14	1.78	0.68	0.94	1.29
HV48A3	292308	Homo sapiens mRNA; cDNA DKFZp727C191 (from clone DKFZp727C191)	2.63	0.56	2.58	2.03	1.07	0.8	0.44	5.96	3.7	1.83	1.32	2.23	2.47	2.88	1.55	0.48	1.04	1.93	3.22	1.55	1.66	2.14
HV48A9	240674	"ESTs, Weakly similar to transformation-related protein [H.sapiens]"	0.8	0.69	1.99	1.71	1.25	0.91	0.55	1.79	3.02	1.61	1.09	1.53	1.28	1.69	1.26	0.55	0.87	2.14	2.2	1.46	1.65	2.32
HV48C2	242087	ESTs	1.76	2.5	0.98	2.52	3.3	1.87	3.29	2.11	4.07	1.69	0.78	2.42	3.53	3.3	1.54	2.26	1.8	1.61	2.54	1.07	1.38	1.97
HV48C3	230251	EST	0.88	0.96	0.93	1.21	0.75	0.85	0.66	0.8	0.86	1.8	0.89	1.18	1.19	0.87	1.14	0.67	0.61	1.75	0.77	0.68	0.95	0.88
HV48C5	242780	"ESTs, Highly similar to KIAA0554 protein [H.sapiens]"	1.68	2.39	2.01	1.41	2.06	1.47	2.14	3.84	3.98	1.59	1.19	2.34	2.13	3.27	1.52	0.51	1.46	2.23	3.48	1.06	1.82	2.36
HV48C7	242797	DKFZP586I1419 protein	2.6	1.12	2.43	0.61	1.87	1.44	0.59	3.2	0.95	1.06	0.7	1.83	2.45	1.12	1.32	0.42	1.9	5.03	4.76	2	2.82	4.36
HV48C8	242698	ESTs	1.49	1.6	0.33	0.7	1.61	0.72	0.57	0.88	1.1	0.53	0.47	0.51	2.16	0.89	1.27	1.31	1.16	2.17	0.58	0.26	0.44	0.57
HV48C9	243088	ESTs	1.36	2.29	2.28	1.01	1.71	1.73	1.67	1.55	2.51	1.55	1.06	0.85	1.07	0.92	1.38	0.69	0.7	1.63	1.64	1.63	0.65	1.62
HV48C10	243113	ESTs	1.62	1.08	0.67	0.74	1.07	0.64	1.58	1.02	1.16	1.24	0.57	1.06	1.37	1.91	0.85	1.7	0.86	1.99	0.98	0.5	0.9	0.99
HV48D1	243230	ESTs	2.21	0.72	1.8	0.55	1.13	0.96	0.64	1.18	0.95	0.57	1.6	2.21	2.43	2.46	1.25	0.78	1.39	1.55	1.75	1.01	1.04	1.35
HV48D10	244227	ESTs	0.72	1.31	0.6	1.41	1.19	0.41	3.19	1.33	2.15	2.69	1.43	2.03	1.52	2.45	1.31	1.63	1.57	1.6	1.74	1.23	1.07	1.49
HV48D12	245409	"ESTs, Weakly similar to alternatively spliced product using exon 13A [H.sapiens]"	1.79	2.03	2.23	1.47	2.41	1.17	2.39	2.55	2.43	1.49	1.25	1.76	1.47	2.29	1.55	2.11	1.86	1.84	1.24	0.83	0.91	1.09
HV48E1	295140	ESTs	1.23	0.75	1.59	1.51	0.89	0.81	0.81	0.79	1.64	1.74	0.56	0.73	1.36	1.01	0.77	0.54	0.76	0.88	0.86	0.53	0.58	0.87
HV48E2	260619	ubiquitin specific protease 12	1.4	1.48	1.03	1.44	1.65	1.43	0.96	1.12	0.75	0.9	0.93	1.42	1.97	1.28	1.92	1.31	1.61	1.14	1.33	1.24	0.82	1.59
HV48E4	282980	ESTs	0.75	1.07	0.53	1.18	1.08	0.39	2.81	1.09	1.39	2.27	0.98	2.03	2.12	2.48	1.48	1.9	1.13	1.86	1.27	1.5	1.12	1.96
HV48E5	300972	ESTs	1.04	0.62	0.75	1.14	1.55	0.69	0.4	0.73	1.1	0.68	0.55	0.65	1.12	1.32	0.49	0.59	0.52	0.66	0.87	0.41	0.7	1
HV48E6	309045	ESTs	0.93	0.9	0.79	0.97	1.67	0.9	0.86	1.13	0.44	0.96	0.74	0.69	1.11	0.81	0.84	1.21	1.71	0.35	1.2	1.32	0.75	1.27
HV48E9	308231	"Homo sapiens incomplete cDNA for a mutated allele of a myosin class I, myh-1c"	0.69	0.62	2.57	1.84	1.13	0.68	0.48	2.41	1.9	1.17	0.94	0.6	0.84	0.41	1.2	0.45	0.9	0.75	1.66	1.78	1.22	1.67
HV48E10	366085	ESTs	3.06	5.3	2.32	1.72	4.26	3.31	2.86	2.56	3.42	2.46	2.34	2.61	2.69	5.03	1.54	1.75	1.86	6.33	3.1	2.1	2.06	4.2
HV48F2	243524	ESTs	1.13	1.24	0.85	1.08	1.26	0.97	0.9	1.27	1.07	1.56	1.39	0.95	1	1.07	0.84	1.24	0.71	0.81	1.27	0.39	0.68	1.1
HV48F7	296180	retinitis pigmentosa 2 (X-linked recessive)	2.04	0.68	1.76	0.8	0.55	0.69	0.45	2.8	32.3	0.44	1.18	1.88	1.78	2.46	1.32	0.47	1.52	1.25	3.11	1.66	1.81	1.91
HV48F11	243878	ESTs	1.75	0.67	1.44	0.77	0.69	0.88	0.43	2.01	1.97	0.65	0.55	1.38	1.24	1.41	1.25	0.49	1.33	1.43	1.44	0.59	0.74	0.95
HV48G2	239708	"ESTs, Weakly similar to alternatively spliced product using exon 13A [H.sapiens]"	1.92	2.27	0.97	3.23	3.65	2.44	2.82	4.93	4.37	1.22	0.92	3.51	2.45	3.43	1.73	3.02	1.72	4.29	2.26	1.32	1.46	2.07
HV48G4	213871	ESTs	2.03	2.45	0.91	2.24	3.06	2.66	3.46	2.19	3	2.7	0.57	5.37	2.43	3.22	2.08	2.83	3.61	3.99	1.94	1.72	2.51	2.16
HV48G6	275176	ESTs	1.37	2.4	0.56	1.38	3.23	0.97	2.86	1.4	2.82	0.83	0.66	2.61	1.64	2.27	0.76	2.17	0.91	3.17	2.02	0.75	0.82	1.35
HV48G7	243641	EST	2.04	1.59	1.72	0.47	1.13	0.18	1.03	1.92	1.99	0.66	0.45	2.66	1.76	3.34	1.57	0.29	0.75	1.53	2.78	0.87	1.35	2.07
HV48G10	243653	ESTs	0.81	0.93	0.43	0.71	0.99	0.72	0.85	0.66	0.59	0.8	0.31	0.64	0.98	0.72	0.79	1.14	1.03	0.72	1.29	0.52	0.62	1.02
HV48H3	284341	SH3-binding domain glutamic acid-rich protein	2.19	0.64	5.19	0.49	1.53	0.72	0.29	1.43	0.95	0.34	0.35	4.38	3.96	4.69	1.07	0.56	0.85	13.86	2.03	0.89	1.33	1.91
HV49D3	292364	ESTs	1.02	1.76	1.1	1.56	1.44	1.04	1.94	1.77	0.95	0.78	1.15	1.26	1.3	1.26	1.06	1.83	1.24	1.04	1.2	0.68	0.68	1.27
HV49D5	292654	DKFZP434B168 protein	2.13	2.72	1.71	2.77	1.18	1.45	1.02	2.01	1.89	1.02	1.2	1.53	1.03	1.23	1.08	1.6	2.5	1.23	1.45	0.77	0.96	1.35
HV49F7	293500	ESTs	0.55	0.9	1.19	1.76	1.4	0.37	0.56	0.77	0.4	0.82	0.65	0.21	1.44	0.65	0.76	1.84	0.98	1.74	0.57	0.26	0.54	0.56
HV49F12	293727	ESTs	2.19	2.09	1.52	1.31	2.24	2.14	1.74	0.75	1.77	1.85	1.65	1.48	1.46	3.85	1.36	1.52	1.9	4.76	2.12	0.84	0.88	1.16
HV49G6	295483	ESTs	5.26	3.42	0.75	1.48	3.18	2.25	2.22	1.47	3.6	3.64	2.73	6.81	6.27	5.56	3.75	5.42	2.11	16.19	11.91	7.5	4.87	6.87
HV49H11	296597	"Human DNA sequence from clone 341E18 on chromosome 6p11.2-12.3. Contains a Serine/Threonine Protein Kinase gene (presumptive isolog of a Rat gene) and a novel alternatively spliced gene. Contains a putative CpG island, ESTs and GSSs"	0.82	2.49	1.28	1.28	1.26	1.01	1.05	1.29	1.51	0.75	1.3	1.56	1.67	1.68	1.14	1.08	1.82	1.24	1.24	1.3	0.93	1.3
HV50C1	130916	"ESTs, Moderately similar to !!!! ALU CLASS A WARNING ENTRY !!!! [H.sapiens]"	0.8	0.74	0.59	0.67	1.47	0.93	0.89	0.95	0.97	0.88	0.88	0.47	1.03	0.95	0.43	0.9	0.81	0.96	0.78	0.46	0.69	0.62
HV50C11	139818	KIAA0669 gene product	1.72	0.99	1.6	0.98	1.59	0.85	0.77	1.4	1.56	0.71	0.7	0.76	1.01	1.14	1.1	0.78	0.63	1.64	2.13	0.8	1.52	1.47
HV50D3	244343	"ESTs, Moderately similar to !!!! ALU SUBFAMILY J WARNING ENTRY !!!! [H.sapiens]"	3.19	25.86	1.04	3.76	5.76	1.68	0.7	7.02	2.75	2.69	1.92	1.74	2.56	2.97	0.87	1.47	2.69	2.71	2.22	0.52	0.54	1.43
HV50F2	234468	ESTs	1.67	0.79	0.85	0.95	1.23	1.6	0.86	0.71	0.78	1.26	1	0.61	1.3	1.27	0.87	1.08	1.02	1.05	0.48	0.75	0.64	0.76
HV50F4	345751	Homo sapiens mRNA; cDNA DKFZp564E1922 (from clone DKFZp564E1922)	1.54	1.78	1.02	1.3	2.05	1.34	1.17	1.78	1.53	1.36	1.67	1.49	2.07	1.9	1.68	1.75	1.51	1.17	1.18	0.34	0.8	1.78
HV50F6	209381	ESTs	2.12	4.12	1.08	1.34	1.86	2.07	1.35	1.65	1.93	3.36	1.22	3.71	4.41	8.2	2.12	1.36	0.91	3.39	4.99	3.92	2.17	5.69
HV50G8	193182	"transforming, acidic coiled-coil containing protein 1"	0.54	0.93	0.69	0.76	1.29	0.43	0.74	0.89	2.39	0.44	0.99	0.6	0.81	0.41	0.56	1.38	0.93	0.34	0.74	0.76	0.46	0.68
HV50G10	591653	"ESTs, Highly similar to non-ocogenic Rho GTPase-specific GTP exchange factor [H.sapiens]"	1.45	2.56	1.46	1.95	3.8	2.39	1.76	2.62	1.76	1.22	2.98	1.82	2.24	1.49	1.48	2.5	2.71	2.31	3.2	0.72	1.5	1.69
HV50G11	200302	"ESTs, Weakly similar to protein Htf9C [M.musculus]"	1.1	2.76	1.3	1.07	1.88	1.5	1.73	1.25	1.91	1.29	0.96	1.35	1.35	2.03	1.04	1.48	1.07	3.28	3.92	1.79	2.16	2.19
HV50H5	233274	KIAA0483 protein	1.47	1.9	1.17	2.02	3.04	1.37	1.11	1.16	0.89	1.51	2.13	0.83	1.23	1.15	1.05	1.04	0.91	0.88	0.84	1.1	0.79	1.22
HV50H9	200307	"ESTs, Moderately similar to !!!! ALU SUBFAMILY SQ WARNING ENTRY !!!! [H.sapiens]"	0.5	0.7	0.62	1.15	0.75	0.36	0.64	0.64	0.38	0.62	1.11	0.83	0.89	0.62	0.68	0.39	0.59	0.95	0.57	0.69	0.45	0.6
HV51A7	200402	ESTs	1.52	0.89	0.66	1.03	1.36	0.34	0.92	0.62	1.54	0.77	0.7	0.39	0.48	0.93	0.96	0.41	0.79	1.93	0.31	0.47	0.6	0.45
HV51A10	299815	ESTs	1.73	2.72	0.74	0.85	2.18	2.04	1.06	0.72	1.04	0.91	0.68	1.22	0.7	1.72	0.96	1.07	1.51	1.16	0.78	0.56	1.16	1.68
HV51A12	814270	polymyositis/scleroderma autoantigen 1 (75kD)	2.73	2.3	1.23	1.57	2.35	1.94	1.11	0.82	1.35	1.15	0.58	1.03	1.22	2.34	1.5	1.76	0.91	2.3	0.78	0.6	0.48	0.97
HV51B3	244637	Homo sapiens mRNA full length insert cDNA clone EUROIMAGE 45620	0.84	1.1	0.29	1.41	1.16	1.15	1.04	2.15	1.49	1.18	1.46	0.94	1.26	1.79	1.1	0.65	0.6	1.16	1.2	0.6	0.94	1.65
HV51B9	246546	ESTs	0.8	0.93	1.26	1.02	1.15	1.04	0.98	1.16	1.33	1.33	1.19	0.85	1.04	1.3	1.24	0.85	1.08	1.13	1.93	1.54	1.55	1.31
HV51C1	126229	"ESTs, Highly similar to KIAA0445 protein [H.sapiens]"	1.56	1.62	0.9	1.21	1.49	1.73	1.11	1.04	1.56	1.15	1.13	1.67	1.55	1.44	1.13	0.85	0.87	1.66	1.81	0.95	1.67	1.84
HV51C4	324342	ESTs	4.14	7.99	0.95	3.24	4	3.61	2.47	3.96	1.68	3.32	2.99	2.61	2.84	3.88	0.77	3.47	2.72	1.43	3.45	1.16	2.15	1.32
HV51C5	203547	clone 686 protein	1.12	1.38	0.86	0.76	1.33	0.93	0.8	0.83	1	0.57	0.7	1.12	1	0.96	1.34	0.71	0.44	0.88	1.19	0.68	0.74	1.26
HV51C7	299093	ESTs	1.4	1.76	1.23	1.04	1.87	1.65	1.43	0.85	1.28	0.79	1.2	1.04	1.42	1.96	1.16	0.97	1.13	2.25	2.65	1.89	1.35	2.09
HV51C10	143310	KIAA0871 protein	3.62	3.59	0.59	2.17	2.44	1.62	2.17	2.19	2.24	1.03	0.78	2.44	2.36	5.19	2.42	1.74	0.91	1.84	3.47	0.7	1.16	1.88
HV51C11	139278	cyclin T2	1.07	1.96	1.1	1.15	3.8	1.22	1.34	1.28	1.24	1.58	1.65	1.77	1.45	2.05	1.47	0.69	0.51	1.56	2.84	0.73	1.16	1.92
HV51D1	246686	"ESTs, Weakly similar to 62D9.p [D.melanogaster]"	1.17	1.02	0.77	0.89	1.22	0.89	1.09	0.87	1.22	0.69	0.86	1	0.76	1.07	0.97	0.6	1.05	1.16	0.76	0.82	0.72	0.86
HV51D11	233550	Homo sapiens mRNA; cDNA DKFZp586H2223 (from clone DKFZp586H2223)	1.27	1.08	0.92	1.04	1.53	1.23	1.51	2.24	1.53	1.33	1.09	2.78	2.4	4.78	1.4	0.86	1.61	1.08	2.03	1.35	1.1	2.01
HV51E5	126219	"ESTs, Highly similar to ring finger protein [H.sapiens]"	1.48	1.06	1.13	1.38	1.81	1.18	0.93	1.33	1.31	1.47	1.63	1.48	1.6	1.55	1.38	0.7	0.66	0.84	2.72	4.02	2.39	4.4
HV51E7	232670	"ESTs, Highly similar to CGI-118 protein [H.sapiens]"	1.9	1.23	0.6	1.9	1.32	1.1	1.01	0.84	1.2	1.37	0.92	1.29	0.63	0.98	2.71	0.91	0.85	1.86	0.78	0.51	0.77	0.99
HV51E8	309583	ESTs	1.61	5.86	0.03	0.44	3.33	5.87	0.28	0.16	0.09	0.26	0.63	0.2	0.21	0.17	0.62	0.51	0.95	0.23	0.87	0.25	0.49	0.53
HV51E10	244277	"ESTs, Moderately similar to alternatively spliced product using exon 13A [H.sapiens]"	1.4	2.52	1.61	1.53	2.38	1.16	3.16	3.18	2.48	2.55	1.23	1.73	1.43	3.05	1.65	1.81	1.59	2.51	2.24	1.05	1.67	3.01
HV51F1	296030	ESTs	0.95	1.51	0.54	1.23	1.35	1.36	0.96	0.58	1.05	1.64	1.71	0.57	0.8	0.68	0.86	0.64	0.75	0.91	1.06	1.12	1.5	1.83
HV51F5	308163	ESTs	1.38	0.55	0.51	0.72	1.29	0.81	0.58	0.77	0.46	0.56	1.45	0.42	0.98	0.52	0.76	0.44	1.28	0.58	0.43	0.33	0.34	0.55
HV51F6	357120	"ESTs, Weakly similar to proline-rich protein MP3 [M.musculus]"	1.33	1.91	0.86	1.16	2.28	1.27	1.28	1.33	1.17	1.43	1.44	1.37	1.47	2.32	0.83	1.37	1.48	1.16	0.92	0.83	1.12	1.19
HV51G1	360885	ADP-ribosylation factor 6	1.45	0.96	1.46	1.19	0.98	1.22	1.12	0.89	1.01	1.22	0.9	0.79	0.78	0.89	1.29	0.51	0.71	0.49	0.81	1.35	0.86	0.93
HV51G2	469952	"transferrin receptor (p90, CD71)"	1.92	1.67	0.57	0.86	1.44	1	1.31	0.95	0.92	0.69	0.97	1.32	1.27	1.55	0.87	1.13	0.78	1.26	0.66	0.32	0.49	0.87
HV51G3	133236	ESTs	1.87	3.18	1.02	2.34	4.23	3.51	1.17	1.56	1.39	1.49	1.74	1.23	1.78	1.04	1.04	1.1	2.97	3.41	2.3	1.16	1.02	2.43
HV51G6	130895	ESTs	2.59	4.05	1.29	1.84	2.29	2.46	7.1	4.06	5.7	7.75	2.89	5.02	2.97	5.3	1.06	3.49	2.02	4.06	8.18	7.35	2.75	7.22
HV51G7	136560	"Homo sapiens mRNA for KIAA0453 protein, partial cds"	1.61	1.28	0.77	0.88	1.22	1.37	0.65	0.82	0.96	0.84	1.27	0.96	1.32	1.18	1	1.32	0.39	0.78	1.59	0.9	1.48	1.46
HV51H1	301082	ESTs	1.66	1.07	3.56	1.06	4.52	2.64	0.85	2.87	0.95	1.69	1.2	3.4	2.25	2.22	1.56	0.91	1.28	1.18	3.25	4.05	2.46	3.26
HV51H4	296616	ESTs	0.97	0.65	0.97	0.47	1.23	0.4	0.95	3.24	1.08	0.62	0.74	2.08	1.73	2.09	0.74	0.64	0.55	0.78	0.39	0.36	0.23	0.5
HV51H11	233071	EST	1.16	1.29	2.02	2.27	3.7	2.21	2.26	17.47	1282.04	1.61	1.47	1.39	2.18	1.72	1.87	2.03	0.52	2.63	2.52	0.95	2	3.22
HV52A4	139376	ESTs	1.99	0.86	1.34	1.01	2.51	1	1.6	1	2.01	2.21	1.42	1.44	1.7	1.21	2.2	2.53	0.91	1.33	1.16	3.21	1.96	2.08
HV52A6	138865	ESTs	0.84	1.76	0.79	1.31	2.11	0.61	0.74	0.76	0.99	0.79	0.52	0.71	0.96	1.11	0.77	1.17	0.91	1.32	0.82	0.49	0.82	0.9
HV52A9	140655	"ESTs, Highly similar to proteasome [H.sapiens]"	1.62	0.32	0.42	0.44	1.55	0.82	0.96	0.78	1.49	1.18	0.57	0.41	1.07	0.78	0.55	1.02	0.91	0.66	0.39	0.5	0.41	1.07
HV52A8	141192	KIAA0989 protein	0.98	0.54	1.72	0.45	1.37	0.55	0.56	0.56	0.82	0.79	0.63	1.16	1.17	1.43	1.09	0.24	0.53	1.18	1.53	1.17	1.07	2.02
HV52A11	241113	ESTs	1.7	1.13	0.75	0.96	3.01	1.4	1.01	0.79	2.12	1.31	1.2	1.12	1.48	2.61	1.04	0.58	0.91	1.6	2.53	1.19	1.39	2.52
HV52B6	343737	ESTs	1.22	1.98	0.9	1.05	1.86	2.46	1.25	1.62	0.85	2.08	1.3	0.92	1.86	2.08	1.41	1.28	2.13	1.27	1.09	0.48	0.87	1.36
HV52B7	753381	"COPII protein, homolog of s. cerevisiae SEC23p"	1.28	1.11	2.87	1.26	1.68	1.35	0.63	2.43	0.77	1.31	2.38	0.78	1.07	1.18	0.83	0.65	0.91	0.82	0.63	0.3	1.41	0.92
HV52B11	143756	"ESTs, Weakly similar to KIAA0681 protein [H.sapiens]"	2.95	4.45	2.08	2	2.64	2.48	1.92	2.27	1.91	2.88	3	1.7	1.36	3.14	1.29	1.79	1.82	3.22	2.52	1.51	1.35	1.99
HV52D1	232789	polymerase (RNA) II (DNA directed) polypeptide J (13.3kD)	1.1	2.18	2.2	1.57	1.36	1.22	1.4	1.39	1.67	1.51	1.05	1	1.08	1.57	1.25	1.57	1.17	1.78	2.27	1.19	0.86	1.54
HV52E2	246194	ESTs	1.08	1.29	1.28	0.77	1.63	1.12	0.78	0.83	0.63	0.96	0.92	1.17	1.28	1.09	1.45	1.52	1.26	1.3	0.95	0.53	0.85	0.93
HV52E6	292770	ESTs	3.54	3.38	1.25	2.59	3	1.42	2.97	1.85	2.54	1.78	1.01	1.89	2.04	4.44	1.2	1.54	1.81	3.55	2.67	1.48	2.66	3.11
HV52E12	840404	"ESTs, Weakly similar to !!!! ALU SUBFAMILY J WARNING ENTRY !!!! [H.sapiens]"	1.67	1.36	1.6	1.31	1.81	1.29	1.6	1.69	1.19	1.98	0.86	1.33	1.35	1.47	1.25	1.48	1.18	1	1.98	1.14	0.9	1.13
HV52F3	296162	"amiloride-sensitive cation channel 2, neuronal"	1.76	2.3	0.74	1.3	1.98	1.76	0.87	1.25	1.81	2.47	1.67	1.08	1.4	1.84	1.04	1.21	0.91	1.26	1.23	1.08	0.95	1.05
HV52F5	796198	ESTs	2.44	1.84	0.63	0.95	3.19	1.32	0.97	1.68	1.23	1.53	1.37	1.52	1.44	3.53	0.88	1.03	0.91	2.41	1.93	1.13	1.97	2.04
HV52F10	235008	ESTs	2.14	1.94	1.62	1.86	2.97	2.57	1.96	1.67	1.54	1.11	1.99	3.19	2.29	2.68	1.91	3.22	2.35	3.66	1.52	1.53	0.93	1.72
HV52G1	344352	ESTs	1.43	1.57	1.06	0.98	1.39	1.1	0.62	0.77	0.93	1	1	0.58	0.92	0.95	0.97	0.7	0.36	1.08	0.89	0.41	0.62	0.86
HV52G9	130835	ESTs	1.07	3.08	0.36	0.57	1.82	1.44	1.49	1.97	10.41	1.5	0.98	0.81	1.3	1.8	0.65	1.25	0.91	0.33	3.06	2.48	0.91	2.02
HV52G8	140635	ESTs	1.07	0.73	0.52	0.5	1.09	0.6	1.28	3.8	2.3	1.55	1.17	4.15	1.1	1.88	0.72	1.03	0.42	0.98	1.77	1.9	0.72	1.76
HV52G11	125685	"ESTs, Weakly similar to !!!! ALU CLASS B WARNING ENTRY !!!! [H.sapiens]"	1.2	1.23	0.73	0.65	1.5	1.1	1.14	1.59	1.36	1.32	1.56	1.11	1.03	1.37	1.01	0.63	0.86	0.78	2.31	1.39	1.25	1.8
HV52H1	774082	achaete-scute complex (Drosophila) homolog-like 1	1.66	1.15	0.65	1.49	1.5	1.04	1.49	1.76	1.27	1.24	1.34	0.81	1.2	0.83	0.97	1.35	0.91	0.61	0.95	0.42	0.82	0.74
HV52H5	470846	pre-mRNA cleavage factor Im (25kD)	1.23	0.9	0.64	0.83	0.62	1.02	0.75	0.55	0.47	0.83	0.9	0.83	0.66	0.56	0.56	0.82	1.22	0.31	0.57	0.5	0.44	0.48
HV52H7	129071	ESTs	1.27	1.83	1.36	1.24	1.47	1.58	1.72	1.62	0.93	0.75	2.03	1.12	1.75	1.32	1.05	1.15	0.91	1.28	1.08	0.83	1.04	1.14
HV52H11	247081	DKFZP586J0917 protein	1	1.17	0.64	0.59	2.18	1.04	1.28	1.15	1.26	0.96	1.34	1.12	1.48	1.22	0.86	0.65	1.33	0.51	2.17	0.88	1.06	1.72
HV52H12	161993	"CCAAT/enhancer binding protein (C/EBP), beta"	1.54	2.04	1.14	0.93	2.44	1.42	1.49	1.03	1.41	1.07	0.89	1.01	1.65	1.44	1.33	1.67	1.25	2.42	0.8	0.48	0.66	0.53
HV53A3	825842	S-adenosylmethionine decarboxylase 1	0.94	2.21	0.93	2	4.1	2.16	1.55	0.81	0.57	1.09	0.77	0.75	0.83	0.71	0.99	1.08	1.99	1.81	1.11	0.39	0.98	1.31
HV53B2	124271	ESTs	1.5	2.7	0.25	0.78	1.8	2.22	1.73	1.42	3.2	1.32	2.16	1.22	1.73	2.65	1.37	2.19	1.89	2.36	2.65	2.65	1.57	3.6
HV53B5	130610	putative type II membrane protein	1.44	1.1	1.5	1	0.52	1.01	0.84	0.85	1.58	1.17	3.32	1.9	1.11	1.83	1.8	0.54	0.72	2.93	1.54	1.48	1.43	1.44
HV53B9	208699	EST	0.73	2.05	1.74	1.27	0.98	1.36	0.97	1.71	1.12	1.27	2.48	0.73	0.64	0.7	1.05	0.77	1.18	0.9	1.6	0.67	1.19	0.87
HV53C1	144870	ESTs	1.39	2.37	0.69	1.21	1.87	1.44	0.92	1.53	1.15	0.99	1.25	0.88	1.49	1.61	0.89	0.88	1.51	1.1	1.08	0.39	0.59	0.91
HV53C4	172783	"ESTs, Weakly similar to period clock protein [M.musculus]"	1.48	3.96	1.7	1.7	3.19	1.48	2.04	2.44	3.28	1.01	1.94	1.19	1.78	2.37	0.89	2.53	2.05	3.97	1.84	1.65	1.08	1.48
HV53C5	160573	TGF beta receptor associated protein -1	1.35	1.08	0.86	0.85	1.4	1.18	0.43	1.69	0.95	1.05	1.49	2.06	1.42	1.35	1.1	1.18	2.88	2.1	2.73	1.28	1.47	2.14
HV53C8	232586	EST	1.59	0.72	0.51	0.52	1.12	0.7	0.77	1	0.97	1.22	0.74	1.27	1.17	1.7	0.93	1.35	1.54	1.94	0.99	0.28	0.56	0.35
HV53D4	234537	ESTs	1.61	2.84	1.51	1.36	1.4	0.99	1.86	1.91	2.28	1.79	1.14	1.73	0.99	1.55	1.85	1.64	0.82	1.11	0.73	0.8	1	1.06
HV53D5	113300	ESTs	1.06	0.91	2.37	1.25	1.27	1.09	1.93	1.57	2.36	0.45	1.62	1.14	0.94	0.52	1.01	0.56	1.11	1.55	1.19	1.26	1.07	1.19
HV53D7	143661	ESTs	0.17	0.45	0.21	0.11	0.88	0.11	0.36	0.44	0.95	0.19	0.38	0.68	0.79	0.62	0.45	0.24	0.09	0.14	0.33	0.09	0.15	0.57
HV53D8	813410	polymerase (RNA) II (DNA directed) polypeptide K (7.0kD)	1.27	1.32	1.68	1.91	1.45	1.58	1.74	1.86	2.96	1.23	1.4	2.17	1.02	0.86	1.88	1.03	2.15	0.89	0.71	1.36	0.76	1.29
HV53D9	240208	DKFZP434O125 protein	1.47	1.05	0.89	1.16	1.04	1.01	0.82	0.99	0.95	0.5	0.76	0.73	0.87	0.74	0.97	0.85	1.01	1.36	0.94	1.04	0.72	1.03
HV53D10	142586	"ESTs, Weakly similar to Yel007c-ap [S.cerevisiae]"	0.97	0.85	0.73	0.57	1.27	0.78	0.98	0.97	0.84	0.96	1.11	0.93	0.72	1.36	1.33	0.75	1	0.66	0.39	0.51	0.44	0.58
HV53E2	143169	ESTs	0.25	0.05	1.72	0.05	0.7	0.14	0.27	0.07	0.26	0.43	0.33	0.56	1.52	0.65	1.2	1.9	0.08	0.36	0.17	0.39	0.76	0.84
HV53E6	131887	ESTs	3.66	3	1.21	1.18	5.67	1.32	3.36	3.71	2.85	1.73	1.76	2.59	4.03	13.4	2.68	5.11	1.4	4.53	16.61	2.79	6.56	6.51
HV53E7	132066	"ESTs, Weakly similar to B cell antigen receptor Ig beta associated protein 1 [M.musculus]"	1.25	1.06	1.19	1.14	1.16	1.72	1.39	1.45	2.27	1.66	0.93	3.07	0.94	1.03	1.04	0.93	0.66	1.68	1.25	1.69	1.08	1.81
HV53E8	121251	ESTs	2.34	1.2	2.36	1.14	2.06	1.37	1.82	1.29	1.98	2.32	1.59	1.77	2.09	1.32	0.99	1.77	1.8	1.92	1.23	3.14	1.15	1.66
HV53E9	135220	ESTs	1.12	0.8	0.78	1.2	2.06	1.12	0.55	1.36	1.41	0.88	1.38	1.77	1.16	1.16	0.7	0.68	0.67	1.49	1.57	2.15	1.19	1.99
HV53E10	769846	"ESTs, Highly similar to SECRETORY CARRIER-ASSOCIATED MEMBRANE PROTEIN 2 [H.sapiens]"	1.07	0.87	0.4	0.71	0.98	0.99	1.08	0.98	0.88	0.87	1.12	0.71	0.89	0.97	0.76	1.32	0.93	0.78	1.79	1.1	1.7	1.27
HV53E12	229580	ESTs	1.62	1.76	0.63	1.6	1.59	1.98	1.26	1.36	1.43	1.06	1.28	1.6	1.09	1.41	0.81	1.5	0.84	1.17	1.5	1.33	1.07	1.17
HV53F3	811890	KIAA0204 gene product	0.59	1.24	0.58	1.6	1.91	0.83	0.98	1.06	0.92	1.44	0.35	0.66	0.9	1.32	0.63	1.23	0.74	0.56	0.88	0.62	0.35	0.79
HV53F9	130120	"ESTs, Highly similar to NSAP1 protein [H.sapiens]"	0.84	1.34	0.92	2.53	1.61	2.06	1.2	0.67	0.5	1.54	1.77	1.1	1.01	0.78	1.27	1.3	1.4	1.05	1	0.86	0.86	0.89
HV53G1	133972	"RAB2, member RAS oncogene family"	1.23	0.99	1.06	0.83	1.66	1.13	0.86	1.56	1.7	1.16	1.21	1.08	1.5	1.15	1.61	1.4	1.25	0.91	0.75	0.69	0.79	1.12
HV53G5	139680	ESTs	2.16	3.34	1.53	1.57	3.67	1.18	1.99	2.44	0.95	3.5	1.46	6.92	1.75	10.87	1.59	1.28	1.12	7.07	9.31	2.81	3.67	10.07
HV53G7	141684	ESTs	0.42	0.74	0.42	0.43	0.6	0.15	0.27	0.16	1.29	0.16	0.09	0.12	0.15	0.19	0.36	0.19	0.18	0.19	0.59	0.24	0.34	0.92
HV53G9	243546	insulin-like growth factor binding protein 6	2.29	1.99	1.05	1.63	2.41	1.12	0.97	1.75	1.26	1.19	0.91	0.93	2.05	2.65	0.87	0.86	1.11	2.64	2.31	2.1	1.29	2.38
HV53G12	347224	ESTs	1.54	1.51	0.98	0.85	2.17	0.87	1.67	1.28	1.5	1.11	1.18	0.99	1.52	1.37	0.76	2.1	1.5	0.76	1.08	0.73	0.82	1.13
HV53H3	136180	ESTs	1	1.04	0.69	1.28	2.55	0.94	0.98	0.86	0.98	0.73	0.52	0.41	0.92	1.03	1.56	0.91	1.82	0.55	0.55	0.45	0.72	0.56
HV53H5	142067	"Homo sapiens clone 25077 mRNA sequence, complete cds"	0.72	2.04	1.69	1.34	1.37	0.79	1.6	1.45	1.88	1.18	1.58	0.78	1.09	1.62	0.69	0.73	0.77	1.48	1.92	1.63	0.75	1.67
HV53H6	142851	ESTs	0.8	1.85	0.88	1.29	1.88	0.79	1.17	1.84	2.13	0.69	1.2	1.49	1.23	0.72	1.26	1.17	1.75	0.89	1.67	4.35	2.19	2.05
HV53H8	212542	Homo sapiens mRNA; cDNA DKFZp586J2118 (from clone DKFZp586J2118)	1.64	2.78	1.01	2.61	4.02	2.51	4.5	3.58	3.19	3.15	3.35	5.75	2.05	7.64	1.86	2.69	2.26	1.96	4.59	6.5	2.42	8.92
HV53H9	135688	GATA-binding protein 2	1.12	1.08	2.17	1.35	6.7	0.98	125.34	8.36	2.26	0.81	0.9	6.12	1.53	1.21	0.94	1.05	0.45	1.21	5.14	0.66	1.17	2.77
HV53H12	284592	"platelet-derived growth factor receptor, alpha polypeptide"	1.03	4.21	1.87	2.58	4.47	1.76	1.4	1.26	0.88	1.04	1.22	0.75	1.3	1.1	1.45	0.99	3.6	4	0.84	0.56	1.18	0.7
HV54A1	22074	"thyroid hormone receptor, alpha (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog)"	1.56	0.69	0.94	1.02	1.06	0.61	0.57	1.17	1.12	1.56	1.3	0.82	1.44	1.28	1.89	0.55	0.83	1.26	0.7	0.95	0.67	1.25
HV54A2	110503	"ESTs, Weakly similar to similar to S. cerevisiae hypothetical protein YKL166 [C.elegans]"	0.66	0.78	0.46	1.57	1.11	0.4	0.83	0.41	0.54	0.52	0.38	0.43	0.54	0.98	1	1.21	0.91	1.21	0.93	0.24	1.3	1.58
HV54A3	141768	v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	1.04	1.37	0.51	0.48	0.91	1.33	1.75	1.43	1.57	3.28	5.16	1.63	1.23	2.06	2.67	4.02	0.58	1.31	1.45	2.49	2.29	2.81
HV54A5	35236	"RAB5A, member RAS oncogene family"	1.12	0.88	1.56	1.08	1.3	0.9	0.78	0.85	0.93	1.15	1.59	1.24	0.79	0.82	0.96	0.55	1.35	1.07	0.98	0.87	0.85	1.07
HV54A6	38763	S-phase response (cyclin-related)	2.76	1.86	1.2	1.74	3.12	1.51	1.66	1.16	0.68	1.81	1.26	1.43	1.71	1.55	1.44	1.95	2.02	1.83	2.13	1.47	0.98	1.51
HV54A8	42076	TRK-fused gene (NOTE: non-standard symbol and name)	1.2	1.42	0.76	0.68	1.42	1.54	0.73	1.3	0.72	0.79	1.3	1.01	0.82	0.93	1	1.04	1.68	1.53	0.4	0.61	0.95	0.69
HV54A9	42706	"thyroid hormone receptor, alpha (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog)"	0.77	2.12	1.22	1.33	1.84	1.06	1.04	0.73	0.97	1.51	1.99	0.77	1.19	2.6	0.83	0.73	0.89	1.33	4.69	2.23	2.96	0.72
HV54B3	172440	"RAB6, member RAS oncogene family"	1.24	0.84	0.57	1.85	0.99	1.43	0.61	1.12	1.68	2.1	1.34	1.17	0.78	0.41	2.54	0.43	0.94	0.45	1.66	3.32	1.49	2.19
HV54B5	180902	ESTs	0.81	1.13	0.8	1.13	1.74	1.07	1	1.63	0.99	2.15	1.43	0.49	0.76	1.2	1.45	0.61	0.91	1.51	0.98	2.32	2.34	1.74
HV54B6	1035182	"purinergic receptor P2X, ligand-gated ion channel, 4"	2.72	2.19	1.42	1.42	3.99	1.85	1.19	1.39	1.2	2.76	1.65	5.02	4.91	6.01	2.49	1.48	2.32	5.94	10.9	5.82	3.48	6.6
HV54B8	193913	v-yes-1 Yamaguchi sarcoma viral related oncogene homolog	0.99	3.48	2.27	1.4	3.52	1.67	1.3	1.59	0.93	2.24	1.52	0.96	1.27	0.98	1.2	1.39	2.48	1.33	2.18	0.66	1.76	1.06
HV54B10	207618	v-raf murine sarcoma 3611 viral oncogene homolog 1	1.74	2.2	1.64	1.21	2.08	1.79	1.17	1.23	0.81	2.35	1.24	1.29	1.54	1.96	1.16	1.64	1.97	1.24	1.45	1.47	1.35	1.91
HV54C2	244652	SET translocation (myeloid leukemia-associated)	1.2	1.08	0.48	0.99	1.01	0.69	0.94	0.94	1.13	0.63	0.97	0.7	1.07	1.09	0.93	1.06	0.64	0.76	0.37	0.55	0.43	0.71
HV54C3	258589	v-rel avian reticuloendotheliosis viral oncogene homolog	1.89	2.77	1.37	2.18	4.2	3.24	2.21	3.88	0.83	2.84	1.7	2.98	2.72	3.57	1.1	1.48	0.91	1.68	3.85	0.68	1.12	1.82
HV54C5	267431	"FYN oncogene related to SRC, FGR, YES"	0.8	2.11	1.74	2.53	3.37	2.03	1.45	1.94	1.2	1.63	2.01	1.39	1.35	1.04	0.81	0.77	0.91	1.25	1.92	0.55	1.24	1.39
HV54C6	267634	v-raf-1 murine leukemia viral oncogene homolog 1	1.46	1.13	1.04	1.04	1.45	1.04	0.95	0.87	1.08	1.28	1.28	1.5	1.19	1.2	0.76	1.03	1.38	1	1.11	0.62	0.87	0.78
HV54C9	273435	v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1	1.3	1.53	0.75	1.09	1.48	2	0.55	0.79	0.59	1.37	1.37	0.42	0.87	0.93	1.12	0.73	1.3	0.86	0.44	0.48	0.75	0.68
HV54D3	285226	jun D proto-oncogene	1.12	3.62	1.25	1.5	1.62	1.36	1.62	2.18	2.46	1.32	1.25	1.98	2.23	1.9	0.93	1.6	1	1.11	2.29	1.49	1.43	2.44
HV54D5	293715	DKFZP564B163 protein	0.81	0.59	0.69	1.25	0.95	0.97	0.76	1.25	0.85	0.74	0.95	1.04	0.87	0.69	1.02	0.72	1.11	0.92	0.61	0.54	0.67	0.8
HV54D6	302369	NCK adaptor protein 1	2.12	0.95	0.7	1.68	1.66	1.18	0.87	1.13	1.59	0.87	1.26	0.71	0.94	0.67	0.86	0.8	1.47	1.69	0.68	0.65	0.49	0.66
HV54D8	309776	CASP8 and FADD-like apoptosis regulator	1.07	1.49	0.49	1.58	3.33	2.01	1.34	1.57	1.07	1.83	1.41	1.95	2.39	1.19	1.52	1.39	0.91	1.85	1.09	0.7	1.33	1
HV54D9	309864	jun B proto-oncogene	1.27	0.87	0.23	0.53	0.92	0.51	0.26	1.46	0.36	0.49	0.71	0.56	1.69	0.6	0.63	0.43	0.99	0.36	0.55	0.23	0.34	0.53
HV54D10	321189	DKFZP586H0723 protein	0.68	0.79	1.57	1.44	1.4	1.27	1.02	1.71	0.66	0.99	1.43	1.36	1.32	1.22	1.57	1.34	1.73	0.69	0.68	0.61	0.71	0.81
HV54D11	322617	v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein)	0.56	0.47	0.49	0.59	0.77	0.9	0.84	3.12	0.96	0.8	1.3	0.61	0.77	0.61	0.85	0.6	1.4	0.41	0.6	0.59	0.6	0.75
HV54E2	342069	"RAB2, member RAS oncogene family"	1.29	0.85	1.19	0.83	1.39	1.05	0.84	1.17	0.78	1.02	1.02	0.86	1.03	0.76	1.51	1.63	1.36	0.92	1.21	0.94	1.2	1.47
HV54E3	343320	platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog)	1.17	0.76	1.17	1	1.76	1.57	1.27	2.09	2.38	2.22	2.23	1.99	1.37	2.27	1.84	0.55	0.84	2.72	2.95	2.26	1.69	2.51
HV54E5	358531	Jun activation domain binding protein	1.12	0.62	1.2	0.78	1.29	0.27	0.49	1.05	0.63	0.67	0.64	0.78	2.59	0.74	0.95	0.6	0.28	1.05	0.88	0.3	0.73	1.08
HV54E6	380620	presenilin 2 (Alzheimer disease 4)	1.34	1.05	0.77	1.26	2.76	1.73	1.66	1.65	1.13	1.39	1.38	2.39	1.79	2.1	0.81	1.81	1.28	1.42	2.61	2.98	2.07	2.26
HV54E7	413633		0.46	0.95	1.39	1.05	1.48	0.47	0.52	0.69	0.33	0.62	0.81	0.46	1.05	0.72	0.63	1	0.5	0.72	0.79	0.26	0.67	0.82
HV54E8	416280		1.08	1.06	0.71	0.97	1.34	0.99	0.74	0.8	0.59	1.03	0.66	0.76	1.78	1.04	1.16	1.05	1.19	1.33	0.83	0.88	0.86	0.88
HV54E9	417226	v-myc avian myelocytomatosis viral oncogene homolog	0.59	1.11	0.43	1.37	0.63	0.63	0.42	0.36	0.25	0.4	0.29	0.29	1.95	0.7	0.83	0.14	1.62	1.47	0.12	0.62	0.22	0.4
HV54E11	429574	"caspase 3, apoptosis-related cysteine protease"	0.78	0.81	0.83	0.6	0.86	0.7	0.77	0.67	0.87	0.87	0.93	0.78	0.69	0.59	0.76	0.49	0.83	0.53	0.64	0.65	0.92	0.76
HV54F3	586698	macrophage stimulating 1 receptor (c-met-related tyrosine kinase)	0.7	1.22	0.32	0.52	1.23	1.18	0.96	0.31	0.65	1.5	0.68	0.15	0.84	3.08	1.12	0.47	0.91	1.53	0.79	0.47	0.9	1.13
HV54F8	783697	BCL2/adenovirus E1B 19kD-interacting protein 3	0.67	0.97	1.38	0.86	1.22	1.24	1.74	0.67	0.47	2.23	0.87	0.77	1.29	0.94	1.52	1.45	1.52	1.8	0.58	0.83	0.79	0.53
HV54G8	161583	EST	1.18	2.12	0.97	1.61	2.23	2.48	2.1	2.59	1.55	2.58	2.07	2.25	1.82	3.14	1.34	2.26	0.8	0.92	2.07	0.55	1.23	1.75
HV54G10	240961	"Human desmoplakin mRNA, 3' end"	2.22	0.64	0.21	1.5	0.68	1.27	0.78	0.79	1.21	1	0.36	1.27	0.49	1.38	1.57	1.07	1.42	1.49	0.29	1.07	0.58	0.69
HV54G11	136814	ESTs	0.88	1.27	0.66	0.81	1.24	0.94	0.98	1.32	0.87	1.42	0.8	1.15	0.93	1.35	1.36	0.96	0.95	1	0.82	0.75	0.53	0.87
HV54H9	154323	ESTs	0.48	0.58	0.1	0.31	0.54	0.1	0.45	0.52	1.04	0.24	0.37	0.51	0.77	0.72	0.5	0.4	0.53	0.69	0.37	0.66	0.37	0.48
HV54H11	232826	"actin related protein 2/3 complex, subunit 3 (21 kD)"	0.73	0.71	0.36	0.55	0.65	0.75	0.68	1.05	0.81	0.71	0.91	0.78	0.67	0.9	0.69	0.72	1.34	0.68	0.79	0.72	0.58	0.58
UG1A5	21652	"catenin (cadherin-associated protein), alpha 1 (102kD)"	0.13	0.25	0.2	0.37	0.42	0.44	0.53	0.65	0.32	0.68	0.72	0.53	0.37	0.49	0.38	0.35	0.66	0.37	0.41	0.67	0.76	0.6
UG1A6	21656	"TATA box binding protein (TBP)-associated factor, RNA polymerase II, F, 55kD"	1.21	0.75	1.64	0.87	1.59	0.99	0.89	1.11	1.08	0.93	0.56	1.3	1.54	1.03	1.8	2.65	1.53	1.35	1.32	1.37	1.32	1.6
UG1A7	22012	ADP-ribosylation factor 3	1.16	1.7	0.84	1.3	1.53	0.55	0.5	0.73	1.61	0.77	0.69	0.44	1.06	1.3	0.95	0.71	1.3	0.76	1.04	0.42	0.99	1
UG1A8	21810	ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase)	2.58	1.79	3.37	3.5	2.91	1.82	1.98	2.08	2.65	1.88	1.34	2.07	1.89	3.65	1.63	2.73	3.8	2.72	0.9	2.05	1.25	1.73
UG1A10	22040	"matrix metalloproteinase 9 (gelatinase B, 92kD gelatinase, 92kD type IV collagenase)"	1.23	0.59	1.27	1.3	1.55	1.21	1.42	1.72	1.3	1	1.18	1.36	1.16	0.87	0.93	1.43	1.33	1.04	1.61	1.31	0.78	1.39
UG1A11	22230	"collagen, type V, alpha 1"	1.84	1.47	1.97	2.03	1.97	1.33	1.3	1.39	1.67	1.09	1.54	1.13	0.99	1.1	1.1	1.21	1.64	2.59	1.26	0.88	1.22	1.62
UG1A12	22260	cytochrome c-1	0.41	0.67	0.62	0.4	1.14	0.75	0.54	0.61	0.36	1.18	0.53	0.31	0.32	0.38	0.42	1.01	1.5	0.64	1.73	0.62	1.04	0.36
UG1B3	22379	"CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344)"	0.44	0.39	0.45	0.34	0.82	0.17	0.22	0.49	0.18	0.49	0.41	0.45	0.61	0.44	0.44	0.27	0.47	0.5	0.45	0.25	0.35	0.3
UG1B5	22493	ribosomal protein L26	1.28	2.46	1.31	1.64	2.39	1.28	1.15	2.14	3.88	1.5	2.94	1.82	1.07	1.25	0.67	1.95	1.86	2.17	3.25	2.26	1.35	1.96
UG1B7	22568	mitogen-activated protein kinase 6	1.07	1.07	1.01	1.5	1.41	1.18	0.83	1.15	0.75	1.12	0.97	0.63	1.09	1.13	1.07	0.94	1.34	1.22	0.8	0.55	1.15	0.82
UG1B8	22589	Lysosomal-associated multispanning membrane protein-5	3.54	20.08	15.87	10.03	9.07	8.17	8.09	10.02	10.33	8.92	5.57	6.2	4.6	10.06	3.45	5.07	7.27	7.01	14.48	6.01	6.92	10.76
UG1B9	22589	Lysosomal-associated multispanning membrane protein-5	3.69	16.1	9.71	3.72	15.06	8.79	6.96	10.74	9.82	10.87	7.37	5.97	2.16	9.81	2.86	5.18	3.66	4.77	22.56	7.55	9.36	12.7
UG1B10	22611	"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"	1.99	1.57	1.72	2.19	2.51	2.09	1.46	1.76	1.45	1.47	1.85	1.12	1.13	1.19	1.4	1.61	2.61	1.49	1.54	1.08	2.17	1.25
UG1B11	22798	"splicing factor, arginine/serine-rich 7 (35kD)"	1.55	5.97	2.31	2.65	3.47	2.09	1.57	2.15	1.83	2.13	1.68	1.76	1.37	2.09	1.14	2.15	1.75	1.88	2.21	1.55	2.18	1.78
UG1C1	23014	mitogen-activated protein kinase 1	1.07	1.27	1.32	1.46	1.39	1.16	0.62	1.26	0.66	0.91	1.18	1.01	1.31	0.62	1.29	1.02	1.11	1.15	0.6	0.93	0.91	0.75
UG1C2	23019	"guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1"	1.17	1.69	1.76	1.32	1.33	1.17	0.88	1.06	1	1.2	1.12	1.53	1.23	0.98	1.3	0.97	1.03	1.13	1.41	1.44	0.87	0.86
UG1C3	23073	fibroblast growth factor 2 (basic)	0.68	0.72	0.78	0.69	1.63	0.46	0.6	0.75	0.47	0.66	0.73	0.57	0.89	0.84	0.96	0.37	0.46	0.73	0.53	0.36	0.55	0.58
UG1C5	23185	"hexabrachion (tenascin C, cytotactin)"	3.2	1.68	2.92	3.06	6.76	5.94	5.76	8.6	2.52	4.06	4.26	1.58	4.96	6.93	1.92	2	2.71	3.03	3.4	1.28	3.87	3.39
UG1C6	23332	putative protein	1.23	2.22	1.38	1.59	2.26	1.89	1.99	2.74	1.47	2.21	2	1.29	1.94	1.72	1.95	2.04	1.69	1.48	1.09	0.89	1.13	1.41
UG1C7	23346	"secreted protein, acidic, cysteine-rich (osteonectin)"	5.65	22.33	8.51	14.47	19.25	10.41	4.78	3.78	13.89	21.72	8.59	4.94	5.95	8.39	3.7	6.72	5.9	18.27	32.7	18.12	5.2	22.78
UG1C8	23692	v-raf murine sarcoma 3611 viral oncogene homolog 1	1.4	2.24	1.49	1.5	2.82	2.09	2.23	2.03	2.06	2.53	1.97	1.18	1.73	1.74	1.12	2.51	2.6	1.15	1.33	1.68	1.25	1.84
UG1C9	23731	peptidylglycine alpha-amidating monooxygenase	0.52	0.78	0.71	0.65	1.33	0.28	0.84	1.72	0.37	0.79	0.92	0.39	0.5	0.48	0.58	0.55	1.28	0.51	0.95	0.37	0.67	0.69
UG1C11	23831	"aldolase C, fructose-bisphosphate"	0.63	1.57	1.05	0.77	0.95	1.45	1.06	0.95	0.97	1.92	1.02	0.76	0.72	0.56	0.79	1.77	0.99	0.62	0.71	1.06	0.79	0.65
UG1C12	23866	cyclin-dependent kinase 4	1.77	2.02	2	1.73	1.88	1.62	2.04	1.59	1.92	1.1	1.48	1.34	1.57	1.4	1.48	2.27	2.6	3.18	0.96	1.44	1.27	1.24
UG1D1	24110	"tumor necrosis factor receptor superfamily, member 1B"	1.63	1.37	1.31	1.41	1	1.18	0.95	1.4	0.89	0.99	1.28	1.07	1.4	1.01	1.19	1.83	2.24	0.68	0.96	0.74	1.47	0.9
UG1D2	24145	adenylyl cyclase-associated protein	1.05	0.64	1.5	0.98	1.18	1.23	0.92	1.61	0.98	0.89	1.58	0.95	0.74	0.74	1	1.52	0.91	0.59	0.79	0.53	0.97	0.94
UG1D3	24269	"protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)"	0.96	1.36	1.39	1.01	0.72	1.07	0.93	1.64	1.08	1.09	1.59	1.25	1.34	0.53	1.36	0.79	1.02	0.5	0.67	2.75	1.29	1
UG1D4	24392	HLA-B associated transcript-3	0.98	1.01	0.94	0.93	1.56	0.9	1.28	1.48	0.78	1.07	1.2	1.2	1.4	1.31	0.66	1.1	1.02	0.97	0.74	0.89	0.73	0.86
UG1D5	24588	"hemoglobin, gamma A"	1.41	2.15	1.43	1.57	1.84	1.41	2.04	4.61	2.64	1.68	2.39	1.37	1.81	1.81	1.43	0.89	1.44	1.06	1.32	1.12	1.13	1.37
UG1D7	24638	"RAP1A, member of RAS oncogene family"	1.4	1.01	1.71	1.35	1.2	1.15	1.59	2.09	1.09	1.82	1.22	1.05	1.61	1.17	1.45	0.6	1.17	0.85	1.02	0.4	0.85	1.11
UG1D8	24642	phosphodiesterase I/nucleotide pyrophosphatase 2 (autotaxin)	1.36	5	12.65	4.09	4.63	3.26	3.27	4.01	2.51	2.91	2.2	1.81	3.36	2.89	1.77	2.69	1.93	1.47	1.31	0.67	1.16	1.94
UG1D9	24652	CD34 antigen	1.52	3.22	3.72	4.64	6.54	2.57	2.93	8.98	4.95	3.08	3.43	3.82	2.92	2.43	2.75	1.92	2.37	1.99	4.44	3.14	3.85	6.34
UG1D10	24886	"core-binding factor, runt domain, alpha subunit 2; translocated to, 1; cyclin D-related"	1.11	1.12	1.73	1.47	2.17	1.04	1.61	2.04	1.04	1.14	1.24	1.1	1.48	1.18	1.19	1.64	1.58	0.79	0.92	0.44	1.27	1.17
UG1D11	24899	dystroglycan 1 (dystrophin-associated glycoprotein 1)	0.83	0.88	0.47	0.54	1.18	1.25	0.98	0.66	0.49	1.03	0.91	0.61	0.64	0.64	0.52	0.42	0.84	1.29	0.57	1.11	0.52	0.92
UG1D12	24927	damage-specific DNA binding protein 2 (48kD)	1.17	0.97	0.94	0.95	1.06	0.85	1.12	0.96	0.98	0.9	0.85	0.89	1.16	1.09	0.77	1.55	1.19	0.97	0.68	0.74	0.69	0.77
UG1E3	25169	ADENOMATOUS POLYPOSIS COLI-BINDING PROTEIN EB1	1.13	0.78	1.06	0.99	1.14	0.95	0.92	1.01	0.89	0.95	1.2	1.14	0.89	0.85	1.29	1.44	1.09	1.11	0.71	1.13	1.01	0.9
UG1E4	25400	transcription factor 4	1.39	1.32	1.08	2.87	3.49	2.18	3.16	4.27	2.08	3.84	2.11	1.71	2.91	2.73	1.85	1.8	1.48	1.3	4.04	1.37	1.99	3.19
UG1E6	25495	KIAA0077 protein	1.64	1.36	2.38	2.6	2.38	1.53	1.4	1.61	1.09	1.17	0.82	1.47	1.72	1.53	1.57	2.13	2.29	1.43	1.87	0.99	2.11	2.37
UG1E7	25517	biotinidase	1.58	1.39	1.19	1.47	1.93	1.31	1.15	1.5	1.99	1.2	1.86	1.3	1.23	1.2	0.93	1.1	1.37	1.45	1.15	0.95	1.26	1.64
UG1E8	25584	ubiquinol-cytochrome c reductase core protein II	0.42	0.22	0.49	0.62	0.47	0.33	0.43	0.36	0.24	0.36	0.44	0.41	0.84	0.49	0.58	0.48	0.53	0.52	0.28	0.43	0.59	0.41
UG1E9	25725	farnesyl-diphosphate farnesyltransferase 1	0.41	0.37	0.29	0.66	0.52	0.6	0.37	0.41	0.24	0.4	0.5	0.41	0.52	0.56	0.88	0.9	0.38	0.52	0.31	0.35	0.6	0.47
UG1F1	26082	very low density lipoprotein receptor	1.25	1.95	1.12	1.61	2.04	1.58	1.15	1.09	0.8	1.09	1.27	0.97	1.05	1.01	1.06	0.92	0.94	1.58	0.77	0.69	1.32	0.94
UG1F2	26087	glutathione S-transferase theta 1	1.76	5.34	1.71	2.14	2.77	2.56	1.63	3.18	2.01	2.1	2.37	1.24	1.55	1.45	1.17	2.21	2.42	1.35	0.77	0.65	0.62	0.97
UG1F3	26129	"inter-alpha (globulin) inhibitor, H2 polypeptide"	1.62	1.16	0.69	0.95	1.87	1.28	0.6	1.01	0.67	0.61	0.91	1.15	1.23	1.14	1.11	0.7	1.35	1.05	1.09	0.93	1.22	1.2
UG1F4	26128	TNF receptor-associated factor 4	1.68	1.62	0.8	1.2	1.73	1.41	1	0.61	1.24	1.1	1.47	1.51	1.51	1.54	1.29	1.49	1.88	1.33	1.07	1.18	1	1.55
UG1F5	26147	annexin A11	1.59	1.33	0.85	1.08	1.96	1.43	0.91	1.62	1	1.48	1.55	1.21	1.48	1.52	1.1	0.92	1.29	1.12	1.12	1.06	1.22	1.33
UG1F6	26184	"phosphofructokinase, platelet"	1.21	1.22	0.57	1.02	0.66	1.59	0.57	0.35	0.46	0.59	0.67	0.44	0.7	0.61	0.94	0.92	0.88	1.43	0.38	0.41	0.48	0.47
UG1F7	26286	"mannose receptor, C type 1"	0.9	2.52	2.39	1.55	4.93	4.97	1.47	3.77	1	1.75	2.72	1.04	1.75	1.13	0.95	1.59	1.76	0.99	1.22	0.8	2.22	1.3
UG1F8	26366	"glucose regulated protein, 58kD"	0.52	1.26	1.11	1.46	1.08	1.71	1.31	1.01	0.88	1.95	0.88	0.68	0.91	0.84	0.39	1.23	2.88	0.7	0.54	0.61	2.23	0.66
UG1F9	26483	"heat shock 90kD protein 1, alpha"	1.12	1.49	0.96	1.24	1.88	1.26	1.2	1.25	1.24	1.38	1.61	1.5	1.08	1.31	0.94	1.48	1.28	0.74	1.15	0.96	1.22	1.07
UG1F10	26531	"transcription elongation factor A (SII), 1"	1.25	1.16	1.04	1.33	1.35	0.94	0.98	0.94	0.82	1.37	0.98	1.06	1.57	1.07	1.21	1.63	1.18	1.26	0.59	0.58	0.95	0.73
UG1F11	26541	"MAD2 (mitotic arrest deficient, yeast, homolog)-like 1"	1.35	1.65	1.35	1.38	1.67	1.85	1.17	0.76	1.03	2.41	1.09	0.71	0.65	1.28	1.49	1.78	2.53	2.65	0.67	0.82	0.65	0.8
UG1F12	26572	"myristoylated alanine-rich protein kinase C substrate (MARCKS, 80K-L)"	1.32	3.11	3.91	2.64	4.08	2.08	2.17	3.36	2.55	2.42	2.34	2.32	1.49	2.03	2.08	3.78	2.36	1.61	2.11	0.62	3.28	2.71
UG1G2	26593	"complement component 1, r subcomponent"	2.39	10.41	6.78	7	10.49	5.69	7.32	8.69	4.81	8.86	4.42	4.72	4.9	7.19	2.8	4.37	5.92	8.48	8.83	1.79	3.68	6.15
UG1G4	26789	"laminin, gamma 1 (formerly LAMB2)"	0.78	0.7	1.37	1.22	1.93	0.64	1.02	1.93	0.83	1.01	1.4	0.86	1.53	1.43	0.64	1.11	1.14	0.96	0.68	0.64	0.79	1.18
UG1G6	26922	deoxyhypusine synthase	1.02	1.17	0.6	1	1.17	1.46	1.07	1.12	1.77	1.05	1.04	0.68	0.95	0.88	0.78	1.25	0.68	1.18	0.66	0.66	0.65	0.73
UG1G7	27230	"protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), alpha isoform"	0.7	1.07	0.83	1.11	0.98	0.78	0.76	1.29	0.54	1.1	1.02	0.78	0.71	0.59	0.79	0.94	0.74	0.81	0.66	0.45	0.76	0.88
UG1G9	27473	"ceroid-lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease)"	0.68	1.19	0.48	1.01	1.06	1.31	1.18	1.26	1.44	1.03	1.33	0.89	0.97	1.04	0.76	0.45	0.78	0.74	0.91	2.97	2.01	1.31
UG1G10	27511	KIAA0092 gene product	1.44	1.2	0.78	1.08	1.18	1.06	1.18	0.65	0.68	0.9	0.75	0.8	1.24	1.37	1.15	1.06	1.12	1.28	0.56	0.4	0.45	0.75
UG1G11	27549	heterogeneous nuclear ribonucleoprotein A1	0.56	0.96	0.94	0.97	0.67	0.69	1.08	0.54	0.39	0.79	0.63	0.52	0.77	0.87	0.66	0.88	0.91	1	0.55	0.36	0.42	0.8
UG1G12	27624	"coatomer protein complex, subunit alpha"	2.88	2.41	1.6	2.12	2.4	2.51	2.15	2.12	1.73	1.46	2.09	2.03	1.54	2.13	1.83	2.72	3.92	3.49	1.08	1.12	1.77	1.22
UG1H3	27794	poly(rC)-binding protein 1	1.55	2.57	1.73	1.84	1.22	1.55	1.28	1.87	1.4	1.36	2	1.29	1.64	1.34	1.65	0.93	1.25	1.68	0.7	0.84	0.89	0.97
UG1H4	27815	"Creatine transporter [human, brainstem/spinal cord, mRNA, 2283 nt]"	0.95	2.3	1.7	1.31	1.63	0.62	1.64	1.29	1.28	1.56	1.66	1.13	0.94	1	0.58	1.83	1.76	0.78	0.82	0.46	0.66	1.17
UG1H5	27818	esterase D/formylglutathione hydrolase	0.91	1.33	0.47	0.88	0.95	0.59	0.76	0.92	0.48	0.66	0.83	0.38	1.12	0.78	0.75	0.54	0.62	0.42	0.39	0.51	0.39	0.51
UG1H6	27848	acetyl-Coenzyme A acyltransferase 1 (peroxisomal 3-oxoacyl-Coenzyme A thiolase)	0.8	0.77	0.51	0.63	0.84	0.7	1.02	0.89	0.66	0.82	1.22	0.89	0.92	0.69	0.13	0.89	0.39	0.71	0.94	0.77	0.56	0.95
UG1H7	27927	polymyositis/scleroderma autoantigen 2 (100kD)	1.07	0.94	0.85	1.15	1.05	1.27	1.09	1.08	0.75	1	1.33	0.8	0.79	0.76	0.98	0.78	1.52	1.4	0.92	0.82	1.12	1.21
UG1H8	28089	"Homo sapiens neuron-specific protein gene, last exon, clone D4S234"	1.66	1.92	1.43	2.18	1.34	1.83	2.49	1.27	2.02	2.72	1.24	0.86	0.72	1.17	1.42	1.84	1.58	1.57	1.43	0.35	0.91	1.14
UG1H9	28116	"karyopherin alpha 2 (RAG cohort 1, importin alpha 1)"	1.79	2.36	0.93	1.98	0.85	1.69	2.11	0.91	2	3.2	1.41	0.76	0.72	0.93	1.45	0.9	2.24	1.56	0.64	1.11	0.89	0.92
UG1H11	28309	"phosphatidylinositol 4-kinase, catalytic, alpha polypeptide"	0.84	2.26	1.5	1.24	1.92	1.21	1.93	1.57	1.63	1.04	1.58	1.03	1.23	1.08	1.18	1.27	1.55	1.99	1.4	0.92	0.97	0.75
UG1H12	28410	"Human AMP deaminase isoform L (AMPD2) mRNA,  exons 6-18, partial cds"	1.33	1.28	1.64	1.24	1.7	1.03	1.14	1.54	1.33	0.69	0.85	0.92	0.81	1.25	0.56	1.16	1.4	1.21	1.07	0.91	1.04	1.4
UG2A1	28573	P glycoprotein 1/multiple drug resistance 1	0.94	0.56	1.27	0.85	0.99	0.65	0.42	1.11	0.88	0.68	0.74	1.15	1.03	0.92	0.73	0.42	0.71	1.13	0.81	0.71	0.89	0.66
UG2A2	28595	leukotriene A4 hydrolase	0.69	0.7	1.02	0.94	0.88	0.84	0.8	0.84	0.43	0.89	0.79	0.76	1.39	0.93	0.71	1	0.59	0.7	0.9	0.66	1.13	1
UG2A3	28776	"clathrin, heavy polypeptide-like 2"	1.15	0.86	1.1	1.37	0.81	0.94	2.45	1.41	1.93	4.54	1.44	1.07	0.71	0.86	0.99	1.07	0.66	1.69	0.83	0.8	1.39	1.46
UG2A4	28985	"N-acetylgalactosaminidase, alpha-"	1.17	1.16	2.3	1.12	2.06	1.57	2.06	2.03	1.8	1.59	1.93	1.29	1.47	1.61	1.33	1.95	1.11	1	3.71	1.53	2.26	1.71
UG2A5	29054	"ARP1 (actin-related protein 1, yeast) homolog A (centractin alpha)"	0.72	0.71	1.07	1.05	0.94	0.78	1.26	1.31	1.42	1.37	1.29	0.75	0.8	0.94	1.01	0.82	0.52	1.05	1.15	1.26	1.35	1.47
UG2A6	29204	"phosphatidylinositol glycan, class H"	1.27	1.46	1.33	1.43	1.91	1.15	1.68	1.19	1.59	1.23	1.36	0.82	1.05	1.43	1.54	1.97	1.28	1.11	1.04	1.05	1	0.88
UG2A7	29234	regucalcin (senescence marker protein-30)	0.8	0.87	1.18	1.11	0.73	0.87	0.69	0.72	0.63	0.91	0.92	0.66	0.81	0.78	0.95	0.77	0.6	1.11	0.6	1.11	0.93	1.02
UG2A8	29435	APEX nuclease (multifunctional DNA repair enzyme)	1.12	0.88	1.39	1.03	0.74	0.88	0.93	0.8	0.63	1.08	0.9	0.73	0.87	0.92	0.92	1.4	0.73	0.89	0.48	0.96	0.99	0.92
UG2A9	29438	X-ray repair complementing defective repair in Chinese hamster cells 1	0.99	0.95	1.25	1.05	0.77	0.94	0.68	0.88	0.84	0.93	0.98	0.81	0.8	0.92	0.84	0.71	0.57	0.69	1.15	0.99	1.56	0.68
UG2A10	29627	"ligase I, DNA, ATP-dependent"	1.62	1.71	1.18	1.55	1.66	1.18	1.36	0.88	0.99	1.02	1.13	1.26	1.58	1.54	1.61	1.58	1.69	1.39	1.27	1.24	1.17	1.27
UG2A11	29629	"striatin, calmodulin-binding protein"	0.93	0.93	0.81	1.01	0.91	0.57	0.61	0.89	0.8	0.7	0.73	0.85	0.81	1.13	1.6	0.71	0.46	1.04	0.85	0.79	0.92	0.94
UG2A12	29640	"proteasome (prosome, macropain) 26S subunit, non-ATPase, 8"	1.66	0.84	0.7	0.79	0.86	2.42	0.87	0.79	0.74	0.71	1.01	1.2	0.53	0.83	0.73	1.4	1.12	1.1	0.54	0.95	1.24	0.75
UG2B1	29799	ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase)	0.77	0.87	2.45	0.91	1.16	0.65	0.73	1.16	0.62	0.68	1.19	1.09	1.31	1.4	0.72	0.79	0.48	0.77	0.92	0.46	0.84	1.08
UG2B2	30012	hevin	0.7	1.05	6.37	0.73	4.22	1.38	1.99	3.8	0.91	1.59	1.31	1.1	2.89	2.55	0.68	1.86	0.95	0.72	1.21	0.55	0.93	1.39
UG2B3	30149	"alkaline phosphatase, liver/bone/kidney"	0.31	0.46	2.13	0.63	0.79	0.39	0.58	0.78	0.27	0.53	0.79	0.5	0.88	1.03	0.66	0.44	0.32	0.52	0.6	0.3	0.66	0.72
UG2B4	30272	"solute carrier family 9 (sodium/hydrogen exchanger), isoform 1 (antiporter, Na+/H+, amiloride sensitive)"	1.41	1.09	1.7	0.88	1.71	1.22	1.19	1.03	1.38	2.13	1.38	1.44	1.16	1.17	1	1.21	1	0.74	2.72	1.36	2.04	1.03
UG2B5	30543	"transporter 1, ABC (ATP binding cassette)"	0.67	0.84	0.6	0.68	0.77	1.01	0.83	0.92	0.86	0.64	1.05	0.76	0.6	0.71	0.91	0.64	0.4	1.01	1.01	0.76	0.93	1.13
UG2B6	30573	galactosylceramidase (Krabbe disease)	1.05	1.75	1.65	1.7	2.75	2.01	0.99	1.96	1.5	2.07	1.74	1.82	1.85	2.35	1.44	1.55	1.44	0.97	1.63	1.92	1.1	1.51
UG2B7	30578	ornithine aminotransferase (gyrate atrophy)	0.73	1.5	0.88	1.71	1.37	1.88	0.99	1.18	0.73	0.95	1.76	0.76	1.29	0.81	1.01	0.79	1.47	1.72	0.74	1.02	0.69	1.24
UG2B8	30588	mannose-6-phosphate receptor (cation dependent)	1.13	2.15	0.94	1.6	1.41	1.51	1.04	1.17	0.96	1.5	1.43	1.29	1.73	1.24	1.18	1.5	2.2	1.87	1.26	1.07	1.07	1.31
UG2B9	30592	stress-induced-phosphoprotein 1 (Hsp70/Hsp90-organizing protein)	0.92	2.1	1.28	1.57	1.61	1.49	1.37	1.44	1.91	2.1	1.41	1.12	0.7	1.02	1.43	1.06	1.16	2.38	1.14	0.88	1.52	1.12
UG2B10	30622	transient receptor potential channel 1	1.07	1.4	2.16	1.27	1.48	1.03	0.9	1.14	0.75	1.55	1.06	0.76	1.35	1.47	1.14	0.89	1.41	1.09	1.39	0.76	0.55	1.04
UG2B12	30664	aspartylglucosaminidase	0.48	0.63	0.47	0.89	0.5	0.53	0.48	0.45	0.25	0.84	0.46	0.43	0.8	0.65	0.56	0.5	0.6	0.91	0.51	0.52	0.33	0.51
UG2C1	30691	ribosomal protein L5	0.89	1.07	0.75	0.71	0.76	1.06	0.62	0.84	0.82	0.78	0.99	0.96	0.66	0.87	0.89	1.1	0.71	1.1	0.89	1.08	0.94	0.92
UG2C2	30730	argininosuccinate synthetase	0.47	0.3	0.22	0.21	0.39	0.3	0.34	0.08	0.14	0.38	0.26	0.36	0.39	0.5	0.62	0.44	0.5	0.41	0.21	0.2	0.57	0.26
UG2C3	30802	seryl-tRNA synthetase	0.8	1.38	1.22	0.69	1.08	1.01	0.81	1.57	2.64	1.11	0.83	0.82	0.8	0.73	0.95	0.65	0.55	0.72	0.97	1.04	0.94	0.99
UG2C4	30852	GDP dissociation inhibitor 1	2.06	3.23	1.22	1.07	1.72	1.49	2.21	2.64	3.41	1.98	2.01	1.9	1.44	1.68	1.46	2.04	0.94	1.56	2.85	3.02	1.84	2.28
UG2C5	30885	KIAA0156 gene product	0.84	1.4	0.82	1.31	1	1.2	1.18	1.56	1.29	1.11	1.38	0.8	0.85	0.94	1.01	0.76	0.87	1.38	1.22	1.34	1.32	1.33
UG2C6	30970	prostatic binding protein	1.33	3.78	0.71	2.24	0.94	1.11	1.25	1.69	1.54	1	1.59	1.04	1.89	1.34	1.29	1.77	1.41	1.06	0.82	0.84	1.26	0.77
UG2C7	30966	decorin	1.84	3.09	1.31	11.75	15.8	7.34	7.91	7.86	22.55	14.49	8.21	6.71	3.44	2.34	2.26	3.6	4.98	0.71	10.46	3.87	5.41	7.16
UG2C9	31061	protein kinase C substrate 80K-H	0.91	1.77	0.88	0.83	1.33	1.12	0.85	1.11	1.02	0.73	0.95	0.98	0.89	1.02	1.1	0.9	0.49	1.28	0.85	0.66	0.94	0.87
UG2C12	31143	"ribosomal protein, large, P0"	0.37	0.66	0.59	1.01	0.59	0.34	0.68	0.44	0.35	0.52	0.51	0.42	0.75	0.55	0.31	0.63	0.64	0.94	0.55	0.54	0.41	0.53
UG2D1	31155	steroidogenic acute regulatory protein related	0.97	1.01	1.43	1.11	1.37	1.35	2.41	1.98	1.89	1.65	2.75	1.07	0.71	1.1	1.07	2.6	1.08	0.83	1.33	1.3	1.12	0.9
UG2D2	31154	"mal, T-cell differentiation protein"	0.86	1.14	0.83	0.97	1.29	1.1	1.36	1.3	0.93	1.1	1.53	0.69	0.91	0.81	0.97	1.03	1.15	1.1	0.53	0.71	0.73	0.57
UG2D3	31169	"capping protein (actin filament) muscle Z-line, alpha 2"	0.8	0.76	1.07	1.06	0.86	0.95	0.61	1.13	0.74	0.53	0.75	0.6	0.72	0.49	1.06	0.72	0.48	0.72	0.67	1.16	0.68	0.69
UG2D4	31164	"epoxide hydrolase 1, microsomal (xenobiotic)"	1.09	0.95	1	1.15	1.42	1.39	0.82	1.41	0.89	0.95	1.19	0.67	1.09	0.64	0.83	0.61	1.13	0.7	1	0.88	0.94	1.08
UG2D6	31238	"thioredoxin-dependent peroxide reductase 1 (thiol-specific antioxidant 1, natural killer-enhancing factor B)"	1.57	0.99	0.62	1.12	0.73	0.95	0.86	0.86	1.27	0.59	1.14	0.65	0.86	1.32	0.92	0.63	0.85	0.96	0.62	0.95	0.41	0.58
UG2D7	31242	"protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform"	0.44	0.39	0.38	0.42	0.41	0.23	0.38	0.71	0.52	0.22	0.34	0.46	0.64	0.44	0.58	0.47	0.22	0.52	0.29	0.24	0.27	0.42
UG2D8	31355	"inhibitor of DNA binding 1, dominant negative helix-loop-helix protein"	0.79	1.14	1.08	0.76	1.46	1.19	1.04	0.99	0.85	0.83	1.24	0.99	0.89	0.95	0.87	0.6	1.34	0.94	0.75	0.57	0.75	0.79
UG2D9	31454	ubiquitin B	1.16	0.92	1.8	1.04	0.77	1.4	1.48	1.33	0.77	1.15	1.29	1.69	1.06	0.97	1.44	1.18	1.25	1.18	1.05	1.44	1.24	1.22
UG2D10	31456	KIAA0088 protein	1.28	1.08	1.46	1.17	1.47	1.45	1.22	1.6	1.16	1.47	1.46	1.49	1.12	1.12	1.2	1.51	1.51	1.5	0.95	1.03	1.18	0.97
UG2D12	31863	SON DNA binding protein	1.36	0.84	1.01	0.93	0.99	1.33	0.98	1.02	1.8	0.96	1.08	1.41	0.96	1.07	1.09	1.32	1.04	0.81	0.8	0.66	0.93	1.01
UG2E1	31852	"protein phosphatase 2, regulatory subunit B (B56), delta isoform"	1.13	1.05	1.58	1.22	1.16	1.09	1	1.13	1.54	1.39	1.2	1.06	0.76	1.34	0.99	1.11	0.97	2.92	1.34	1.72	1.54	1.37
UG2E2	31855	syntaxin 5A	1.46	1.61	1.22	1.24	1.92	1.73	1.55	1.37	1.25	1.56	1.62	1.54	1.07	1.47	1.41	2.27	1.38	2.7	2.42	1.64	1.83	1.71
UG2E3	31988	"protein phosphatase 1, catalytic subunit, alpha isoform"	1.24	0.9	0.67	1.06	0.81	1.08	1.14	0.9	0.77	1.39	1.12	0.73	0.66	0.79	1.37	0.91	0.49	1.46	1	1.34	1.32	1.12
UG2E4	32141	"farnesyltransferase, CAAX box, alpha"	0.69	1.35	0.56	1.1	1.03	0.93	0.73	0.73	0.95	0.68	0.74	0.64	0.7	0.81	1.09	1.49	0.99	0.86	0.79	0.73	0.83	0.68
UG2E5	32198	"ATPase, H+ transporting, lysosomal (vacuolar proton pump), subunit 1"	1.08	1.3	0.8	0.8	1.13	1.09	1.1	1.42	1.56	1.33	1.85	1.44	0.81	0.87	1.02	0.96	0.46	0.9	1.94	3.73	1.59	1.96
UG2E6	32304	Ca2+-dependent activator protein for secretion	1.05	0.84	1.11	1.07	1.65	1	1.25	0.92	0.8	0.96	1.26	0.94	1.2	0.81	0.77	1.14	1.32	1.05	1.4	1.16	0.86	1.09
UG2E8	32409	transgelin 2	0.56	0.81	1.33	1.19	1.25	0.53	0.78	0.85	0.36	0.77	0.7	0.49	0.7	0.59	0.7	1.2	1.61	1.14	0.57	0.44	0.71	0.45
UG2E9	32407	"phosphorylase kinase, gamma 2 (testis)"	0.71	0.91	1.47	1.2	1.3	0.82	0.81	1.41	1.84	1.64	1.29	1.12	1.04	1.33	0.71	0.71	0.72	1.19	1.16	0.94	1.22	1.27
UG2E10	32438	"ATPase, Na+/K+ transporting, beta 1 polypeptide"	1.34	2.56	0.84	1.59	1.89	1.1	1.75	1.11	1.17	1.09	1.12	1.5	0.82	0.96	0.67	2.52	1.62	0.55	1.13	1.28	1.38	1.58
UG2E11	32427	"protein phosphatase 2A, regulatory subunit B' (PR 53)"	2.85	2.97	5.28	3.74	3.08	1.37	1.73	4.31	2.24	2.23	3.04	2	2.56	1.84	1.06	1.5	2.56	2.04	1.47	1.85	1.38	0.59
UG2F1	32609	"laminin, alpha 4"	0.77	0.88	0.66	1	0.87	0.95	0.85	1.16	1	0.98	1.82	0.49	0.67	0.74	0.83	0.77	0.57	1.41	0.59	0.76	1.14	0.97
UG2F2	32615	nucleosome assembly protein 1-like 1	1.13	1.12	1.11	1.65	1.42	0.97	0.99	1.26	1.28	1.2	0.94	1.23	1.52	1.13	1.01	1.44	1.23	1.22	0.69	0.65	0.76	1.06
UG2F3	32626	testis-specific kinase 1	0.52	0.96	0.54	1.13	0.82	0.99	1.07	0.9	0.67	1.08	1.27	0.74	0.76	0.55	0.82	0.96	0.85	1.41	0.6	0.7	0.68	0.96
UG2F5	32649	"ATPase, H+ transporting, lysosomal (vacuolar proton pump) 31kD"	0.99	0.95	0.93	0.72	0.8	0.91	0.87	1.58	1.3	0.72	1.25	0.77	0.56	0.86	0.84	0.77	0.64	1.31	0.61	0.89	0.72	0.66
UG2F6	32644	glucose-6-phosphate dehydrogenase	0.47	0.59	0.45	0.38	0.51	0.6	0.44	0.53	0.52	0.46	0.72	0.51	0.59	0.65	0.39	0.88	0.43	0.46	0.5	0.36	0.42	0.37
UG2F7	32658	"clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed prostate message 2, apolipoprotein J)"	1.29	10.34	6.74	5.76	7.31	5.36	3.13	6.92	4.05	6.39	4.54	2.34	3.16	2.78	1.73	2.1	2.93	4.65	5.85	4.44	3.77	2.52
UG2F8	32682	vimentin	2.06	6.77	4.12	4.77	5.22	3.4	3.28	3.87	4.04	5.72	4.36	2.55	2.36	2.42	1.78	2.67	4.82	2.34	2.24	2.64	3.46	1.84
UG2F9	32684	ribosomal protein L32	1.58	2.04	4.06	1.88	2.24	1.39	1.82	2.39	1.72	2.22	1.9	1.57	1.47	1.79	1.54	0.82	1.54	2.55	1.93	0.94	1.91	1.64
UG2F10	32717	huntingtin (Huntington disease)	1.6	1.97	3.94	2.01	3.22	1.93	2.37	2.31	3.24	3.3	2.32	1.58	1.32	2.33	0.94	2.1	2.15	1.14	2.05	1.18	1.3	1.55
UG2F11	32707	"protein phosphatase 1, regulatory subunit 7"	0.86	1.43	0.52	0.87	1.21	1	0.81	0.94	0.76	1	1.23	0.51	0.83	1.06	1	0.58	0.77	0.92	1.48	1.17	2.23	1.89
UG2F12	32750	paraoxonase 1	2.29	1.02	3.6	2.69	2.56	2.59	0.72	0.93	0.81	1.84	1.54	1.38	3.33	1.51	1.24	1.64	1.3	1.11	2.02	2.06	1.8	3.16
UG2G1	32774	phosphoprotein enriched in astrocytes 15	0.87	1.14	0.87	1.24	1.27	1.49	0.77	1.28	0.83	1.01	1.2	0.87	0.99	1.21	1.02	0.9	0.74	1.37	0.69	1.21	0.93	1.11
UG2G2	32790	"mutS (E. coli) homolog 2 (colon cancer, nonpolyposis type 1)"	1.25	1.36	1.14	2.52	1.36	1.97	1.04	1.32	0.79	1.14	0.82	0.93	1.19	0.96	0.99	2.98	1.98	1.28	0.49	0.57	0.56	0.71
UG2G3	32822	"spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)"	0.54	0.82	0.44	0.83	0.65	0.9	0.78	0.73	0.45	0.9	1.1	0.75	0.94	0.62	0.81	0.88	0.86	1.16	0.66	0.89	0.68	0.91
UG2G4	32875	Death associated protein 3	0.84	2.08	0.62	1.67	1.63	1.49	1.28	0.97	0.95	1.45	1.5	1.21	1.53	1.24	1.05	1.57	2.32	2.23	0.64	0.66	0.84	0.94
UG2G5	32898	"enoyl Coenzyme A hydratase, short chain, 1, mitochondrial"	0.64	0.97	0.71	0.67	0.74	0.97	1.24	0.81	0.47	1.25	1.19	0.73	0.97	0.87	0.88	0.82	0.46	1.44	0.62	0.77	0.9	0.93
UG2G6	33008	"aldo-keto reductase family 1, member B1 (aldose reductase)"	0.36	0.75	0.57	0.24	0.37	0.31	0.25	0.36	0.25	0.24	0.42	0.37	0.43	0.49	0.5	0.67	0.3	0.3	0.38	0.21	0.33	0.22
UG2G7	33045	ESTs	1.48	3.24	2.42	2.47	2.49	3.26	3.31	4.48	3.6	3.69	2.93	2.93	2.05	2.09	1.54	1.57	1.63	1.62	2.09	2.43	1.58	1.46
UG2G8	33183	ribophorin II	2.11	1.05	1.61	1.37	1.45	1.63	1.74	1.39	1.25	2.12	1.89	1.69	1.46	1.34	1.73	2.28	1.42	1.07	1.37	1.94	1.22	0.96
UG2G9	33176	cathepsin H	1.07	1.93	2.5	1.78	1.39	2.67	1.58	1.76	2.46	2.15	2.08	1.16	0.72	0.87	1.14	1.15	2.29	0.63	1.9	0.75	1.18	1.11
UG2G10	33267	insulin-like growth factor binding protein 2 (36kD)	1.67	1.93	5.56	4.63	6.81	2.08	4.67	4.87	8.64	8.13	3.63	1.51	1.19	1.36	0.85	4.11	4.91	0.91	1.78	1.05	1.13	1.23
UG2G11	33274	"neuroblastoma candidate region, suppression of tumorigenicity 1"	1.18	0.85	0.59	0.77	0.93	1.3	1.01	1.73	0.83	1.22	1.76	1.01	1.22	1.27	1.1	0.55	0.69	0.91	0.82	1.15	1	1.06
UG2G12	33415	glutathione peroxidase 3 (plasma)	1.5	2.19	2.45	5.11	7.22	3.97	2.74	2.5	1.9	10.74	3.02	1.38	1.15	1.87	0.73	2.55	1.64	1.39	1.32	1.13	1.01	1.2
UG2H2	33477	emopamil-binding protein	1.1	0.84	0.36	0.75	0.67	1.32	1.03	0.54	0.59	0.78	0.7	0.64	1.05	0.76	0.94	0.65	1.33	1.08	0.36	0.47	0.48	0.59
UG2H3	33525	eukaryotic translation elongation factor 1 gamma	0.59	0.75	0.54	0.73	0.56	0.7	0.65	0.46	0.26	0.63	0.63	0.59	0.78	0.49	0.77	0.74	0.94	1.07	0.38	0.58	0.51	0.7
UG2H4	33620	KIAA0100 gene product	0.74	0.89	0.38	0.97	0.9	0.84	0.76	0.62	0.48	0.95	0.84	0.78	1.19	0.66	0.88	0.59	0.84	1.26	0.35	0.48	0.51	0.88
UG2H5	33632	"glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)"	0.74	0.79	0.57	0.86	0.59	0.69	0.88	0.64	0.5	0.68	0.61	0.75	1.05	0.75	1.04	0.73	0.47	0.93	0.53	0.75	0.53	0.73
UG2H6	33643	"glutamate decarboxylase 2 (pancreatic islets and brain, 65kD)"	0.89	0.98	0.73	0.69	1.02	0.76	0.94	1.02	0.8	0.62	0.86	0.71	0.78	0.76	0.9	0.57	1.02	0.64	0.53	0.56	0.58	0.5
UG2H7	33690	pre-mRNA cleavage factor Im (68kD)	1.31	1.27	1.13	1.26	1	1.34	2.1	2.19	2.6	1.44	1.37	1.05	1.07	0.97	1.16	1.16	0.91	0.89	0.93	1.4	0.86	1.04
UG2H8	33692	"aldehyde dehydrogenase 2, mitochondrial"	4.58	4.83	3.4	5.59	3.3	5.91	3.19	4.77	4.06	5.15	3.84	3.88	3.6	3.14	2.53	3.56	3.52	0.99	4.4	5.03	3.47	0.63
UG2H9	33794	"ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1"	0.62	1.18	0.46	1.35	0.57	1.5	0.65	0.53	0.26	0.4	0.61	0.85	0.61	0.68	0.77	1.18	0.81	1.27	0.42	0.46	0.45	0.49
UG2H10	33803	hypothetical protein	1.6	1.8	1.61	1.76	1.79	1.56	1.41	1.82	1.44	1.4	1.43	1.09	2.01	1.47	1.23	1.67	1.35	1.1	0.79	0.7	0.82	0.99
UG2H11	33831	"DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 9 (RNA helicase A, nuclear DNA helicase II; leukophysin)"	1.17	1.59	1.03	1.83	1.07	1.1	1.13	1.21	0.78	0.85	1.2	0.94	1.13	1.16	0.83	1.28	0.89	1.08	0.77	0.86	0.83	1.08
UG2H12	33943	"galactosidase, beta 1"	1.16	0.78	1.23	0.93	1.25	1.25	0.95	1.16	0.59	1.12	1.59	1.13	0.96	0.98	0.8	1.05	0.84	0.76	0.72	1.26	0.86	0.82
UG3A3	34005	interferon gamma receptor 2 (interferon gamma transducer 1)	1.26	1.42	1.21	1.53	1.55	1.28	1.31	1.93	1.42	1.77	2.05	1.11	1.32	1.82	1.52	1.17	1.63	1.25	1.59	1.49	1.95	1.58
UG3A4	34141	HLA-B associated transcript-2	1.65	2.8	1.36	1.69	1.96	1.63	1.94	1.37	1.82	2.09	1.9	1.38	1.6	2.13	1.57	2.6	1.73	1.96	1.36	1.5	1.67	1.62
UG3A6	34247	cell division cycle 2-like 1 (PITSLRE proteins)	1.95	2.24	1.01	1.37	1.78	1.15	1.45	1.02	1.51	1.13	1.18	0.97	1.34	1.19	1.08	1.83	1.14	1.01	1.51	1.21	2.02	1.58
UG3A8	34304	"general transcription factor IIE, polypeptide 2 (beta subunit, 34kD)"	0.85	1.79	0.97	1.19	1.22	0.69	0.97	1.01	1.1	1.01	0.94	0.61	1.06	0.74	0.72	1.37	1.02	1.45	0.44	0.23	0.41	0.58
UG3A9	34327	v-fos FBJ murine osteosarcoma viral oncogene homolog	0.63	0.78	1.31	0.9	0.75	0.39	0.41	0.99	0.5	0.64	0.64	0.4	1.35	0.68	0.39	0.5	0.39	0.61	0.69	0.33	0.72	0.59
UG3A10	34357	"actin, beta"	1.3	1.2	1.43	0.96	1.32	1.1	0.86	1.18	0.89	1.2	1.45	0.9	1.56	1.13	0.99	0.92	0.97	1.31	0.51	0.46	0.88	0.85
UG3A11	34349	high-mobility group (nonhistone chromosomal) protein 14	1.25	1.2	1.13	1.15	1.04	0.85	1.06	0.91	0.89	1.06	1.31	1.07	0.93	1.41	0.74	1.14	1.13	0.89	0.9	0.7	0.99	1.03
UG3A12	34355	"calmodulin 2 (phosphorylase kinase, delta)"	2.59	1.27	1.62	3.31	2.3	2.38	1.45	2.25	1.25	1.65	1.88	1.62	1.58	1.75	1.31	3.68	2.15	1.86	1.09	1.08	1.16	1.81
UG3B1	34396	"Human 90-kDa heat-shock protein gene, cDNA, complete cds"	0.79	1.77	1.31	1.19	1.39	1.04	1.2	1.28	1.21	2.11	1.48	1.18	1.05	1.22	1.28	0.99	1.42	2.26	1.33	1.55	1.34	1.64
UG3B2	34537	"guanine nucleotide binding protein (G protein), beta polypeptide 1"	1.58	1.9	1.4	1.23	1.09	1.35	0.98	1.36	1.39	1.23	1.58	1.3	1.35	1.15	1.78	1.24	1.83	1.08	1.03	1.21	1.32	1.37
UG3B3	34555	Sjogren syndrome antigen B (autoantigen La)	1.01	1.84	1.15	1.61	1.31	1.06	0.93	1.05	0.95	1.57	0.68	1.05	1.13	1.18	1.01	2.53	0.91	1.45	0.98	0.75	0.52	0.71
UG3B4	34606	"major histocompatibility complex, class I, E"	1.34	4.19	1.38	1.97	1.98	2.47	1.96	1.8	1.05	3.29	2.86	2.79	2.45	2.38	1.12	1.91	1.66	1.32	3.14	0.69	2.23	2.37
UG3B5	34637	"tumor necrosis factor receptor superfamily, member 7"	1.54	3.36	1.61	1.58	3.11	5.66	2.63	4.2	1.88	3.29	3.13	3.11	1.94	1.76	1.5	2.78	0.91	2.02	2.75	1.05	2.77	2.45
UG3B6	34647	"non-metastatic cells 1, protein (NM23A) expressed in"	1.27	2	0.91	1.56	0.94	1.07	2.25	0.78	1.25	1.96	1.21	1.6	0.95	1.83	0.45	1.48	1.79	0.94	1.24	0.87	1.31	1.77
UG3B7	34662	signal recognition particle 9kD	1.32	0.9	0.93	1.4	1.9	0.99	0.64	1.02	0.89	0.81	0.93	0.87	0.81	1.15	1	0.67	1.24	0.76	0.8	0.96	0.77	0.97
UG3B8	34660	Ras-related GTP-binding protein	1.17	1.52	0.85	1.8	1.24	1.45	0.88	0.98	0.83	1.38	0.76	1.02	1.29	1.26	0.72	1.19	1.34	1.78	0.54	0.63	0.59	0.86
UG3B9	34671	corticotropin releasing hormone	1.09	1.19	0.87	0.96	1.29	0.92	0.65	1.3	0.75	0.77	1.15	0.87	1.33	1.1	0.35	0.76	0.96	1.21	0.75	0.5	0.96	0.9
UG3B10	34761	KIAA0108 gene product	0.88	0.87	0.74	0.45	0.6	0.92	0.51	0.88	0.71	0.67	0.69	1.18	1.17	0.76	0.85	0.71	0.46	0.79	0.67	0.7	0.79	1.05
UG3B12	34945	"Tu translation elongation factor, mitochondrial"	0.61	0.93	0.6	0.76	0.69	0.55	0.68	0.58	0.59	0.61	0.74	0.69	1.02	0.62	0.29	0.72	0.79	0.82	0.29	0.84	0.82	0.91
UG3C1	34974	"platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit (45kD)"	0.88	0.77	0.91	0.65	1.24	1.02	0.76	1.22	0.61	0.8	0.96	0.99	1.25	0.83	1.36	0.53	0.43	0.98	0.68	0.98	0.66	0.9
UG3C2	35110	GM2 ganglioside activator protein	1.14	1.02	0.76	0.78	1.35	0.88	1.07	1.31	1.05	1.07	1.01	1.13	1.37	1.3	1.36	1.1	0.94	0.84	1.15	0.58	0.68	0.8
UG3C3	35284	"protein phosphatase 5, catalytic subunit"	0.82	1.26	0.76	0.68	0.83	0.64	0.59	0.72	1.22	0.69	0.78	1.17	0.93	1.18	1.86	0.76	0.64	1.36	2.33	0.85	0.61	1.2
UG3C4	35297	"Human protein phosphatase 2A beta subunit mRNA, complete cds"	0.86	1.21	0.77	0.96	1.21	1.07	1.21	1.15	1.03	1.11	0.91	1.01	0.94	1.11	0.95	1.63	1.15	0.92	0.59	0.52	0.52	0.56
UG3C5	35313	"ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide"	0.53	0.35	0.84	0.53	0.35	0.61	0.46	0.56	0.4	0.68	0.59	0.65	0.79	0.6	0.97	0.45	0.5	0.72	0.48	0.68	0.57	0.44
UG3C6	35320	guanine nucleotide regulatory protein (oncogene)	1.49	2.2	0.56	2.29	1.66	1.68	1.4	1.73	1.09	1.45	1.37	1.63	1.61	1.17	1.5	1.67	1.32	2.18	1.18	1.38	0.94	1.72
UG3C8	35559	methionine-tRNA synthetase	1.08	1.17	0.84	1.4	1.3	1.41	1.38	1.22	1.5	1.37	1.72	1.79	1.09	1.19	1.27	2.03	1.4	1.62	1.54	0.99	1.32	1.23
UG3C9	35609	Homo sapiens mRNA; cDNA DKFZp434E071 (from clone DKFZp434E071)	0.78	1.09	0.43	0.55	1.26	0.93	0.67	1.26	1.31	1.02	1.06	1.13	1.22	0.97	1.07	0.49	0.51	1.17	0.84	0.98	1.1	0.96
UG3D1	35850	"enolase 2, (gamma, neuronal)"	2.23	2.22	3.94	2.25	1.24	1.42	3.32	4.73	3.66	1.99	1.36	2.64	1.46	1.37	0.89	1.35	2.1	6.78	1.54	2.17	1.61	1.72
UG3D2	35865	annexin A6	1.28	1.66	1.4	1.2	1.85	1.21	1.88	2.13	2.09	1.76	1.72	1.84	1.84	2	1.38	1.62	1.75	1.34	0.77	1.01	0.67	1.04
UG3D4	36007	zinc finger protein 133 (clone pHZ-13)	0.95	1.05	0.78	0.69	1.3	0.67	1.36	1.02	1.22	0.8	0.86	0.94	1.08	0.97	0.82	1.48	0.8	0.68	0.78	1.22	0.88	1.02
UG3D5	36060	"proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)"	1.41	2.91	1.36	1.18	1.29	2.22	2.59	2.71	2.01	3.49	2.42	2.31	1.73	2.12	1.08	1.59	1.1	0.72	1.36	1.6	1.62	2
UG3D6	36109	KIAA0123 protein	1.31	0.81	0.38	0.71	0.72	1.19	1	0.73	1.01	0.83	0.96	0.52	0.83	0.77	0.69	1.17	0.68	0.45	0.55	0.9	0.61	0.55
UG3D7	36191	fibronectin 1	0.5	0.19	1.63	0.6	0.87	1.49	1.19	2.07	1.05	1.65	2.36	0.81	0.98	1.19	0.77	0.44	0.4	0.38	1.15	0.96	1.2	0.67
UG3D8	36202	ribosomal protein L29	0.65	0.88	0.47	0.61	0.72	0.52	1.32	0.37	0.48	1.07	0.58	0.54	0.89	0.56	0.32	0.83	0.38	0.48	0.53	0.53	0.32	0.8
UG3D11	36393	acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl Coenzyme A thiolase)	0.98	1.07	1.77	1.43	1.16	2.11	1.28	1.34	1.34	0.98	1	1.11	1.25	1.07	1.22	1.86	0.93	1.63	0.71	0.54	0.9	0.79
UG3D12	36560	"amyloid beta (A4) precursor protein (protease nexin-II, Alzheimer disease)"	0.79	0.59	0.8	0.58	0.9	0.61	0.63	0.66	0.58	0.45	0.79	0.58	1.36	0.96	0.49	1.18	1.17	0.75	0.53	0.6	0.59	0.93
UG3E1	36593	N-acylaminoacyl-peptide hydrolase	0.8	1.55	0.8	0.97	1.72	0.91	1.18	1.17	2.03	1.58	1.68	0.96	0.84	1.15	0.91	1.04	1.14	1.29	1.11	2.12	1.27	1.19
UG3E2	36676	ribosomal protein L13	1.46	1.73	0.98	1	1.97	1.36	1.56	1.24	1.33	1.81	1.41	1.56	1.69	1.69	1.57	2	2.03	2	1.13	1.16	1.3	1.45
UG3E3	36681	immunoglobulin mu	2.51	4.06	2.17	1.85	4.58	5.58	2.95	3.05	3.99	3.96	4	2.96	2.29	3.62	2.2	2.59	1.37	3.69	2.26	0.89	0.53	1.95
UG3E5	36717	"tumor necrosis factor, alpha-induced protein 1 (endothelial)"	1.13	1.2	0.95	1.17	1.2	1.18	1.37	1.7	1.33	1.71	1.29	1.56	0.93	1.44	1.36	1.05	0.87	1.02	1.15	1.02	1.6	1.55
UG3E6	36775	"hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit"	1.07	1.06	0.88	0.84	1.07	1.17	0.71	0.68	0.56	0.88	1.03	0.88	1.15	0.87	0.95	0.86	0.84	0.96	0.66	0.38	0.67	0.76
UG3E7	36796	glycogenin	1.66	1.35	1.72	1.14	1.51	1.43	0.87	1.45	1.31	1.31	1.47	0.95	1.2	0.96	0.83	0.86	1.66	1.57	1.07	1.11	1.65	1.1
UG3E9	36844	interleukin 1 receptor antagonist	0.83	1.42	1.1	1.13	1.2	2.7	0.93	1.2	1.31	1.63	1.11	0.82	0.93	1.02	0.44	1.13	1.58	1.35	1.43	0.75	1.2	1.34
UG3E10	36904	cold inducible RNA-binding protein	0.93	0.9	0.62	1.29	1.43	1.01	1.75	1.28	1.27	1.38	1.84	1.47	1.83	1.82	0.89	1.55	0.99	0.72	0.84	2.7	1.32	2.6
UG3E11	36916	"major histocompatibility complex, class I, C"	2.13	7.46	2.38	4.74	3.83	6.91	3.54	4.2	2.58	10.95	6.48	5.16	2.86	4	1.8	2.83	3.76	2.25	8.13	3.92	6.69	6.22
UG3E12	36922	"DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 5 (RNA helicase, 68kD)"	1.58	1.02	1.42	2.18	1.79	2.1	0.7	3.05	1.23	1.57	1.13	1.19	1.34	1.59	1.49	2.92	1.94	0.83	1.12	1.96	1	1.39
UG3F1	36927	high density lipoprotein binding protein	1.46	1.79	1.33	1.09	1.88	1.15	1.2	1.51	1.48	1.66	1.24	0.98	1.54	1.33	1.66	0.97	1.17	1.98	2.18	1.43	2.99	2.03
UG3F2	36950	"phosphofructokinase, liver"	1.93	2.18	1.98	1.78	2.34	4.67	1.42	1.88	1.7	2.35	1.89	2.41	1.78	4.36	2.41	2.15	2.08	6	1.64	1.31	1.32	1.96
UG3F3	36983	"guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3"	1.22	1.29	1.58	1.67	0.86	1.38	1.01	1.25	0.76	1.63	0.94	0.66	0.7	0.67	1.26	0.57	1.29	1.08	0.86	0.56	0.99	0.83
UG3F6	37118	motor protein	1.16	1.11	0.56	1.54	1.17	1.83	0.76	0.8	0.87	1.8	0.95	1.03	1.25	1.25	0.61	1.52	1.09	1.37	0.62	0.53	0.59	0.78
UG3F7	37145	"ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1, cardiac muscle"	0.96	0.38	0.76	0.8	0.62	0.83	0.39	0.6	0.29	0.54	0.5	0.85	1.06	0.73	0.42	0.37	0.39	0.79	0.57	0.58	1.21	0.75
UG3F8	37196	accessory proteins BAP31/BAP29	1.37	1.61	0.8	0.7	1.24	1.65	1.09	1.06	1.18	1.54	1.42	1.15	0.86	1.18	0.65	1.25	0.99	1.05	1.02	1.3	0.93	1.19
UG3F9	37230	phospholipid transfer protein	1.41	2.1	3.98	1.27	4.02	2.2	2.02	2.11	1.62	3.4	2.16	1.43	1.43	1.44	1.07	1.4	1.72	1.34	1.09	1.1	2.09	1.01
UG3F11	37234	mitogen-activated protein kinase kinase kinase kinase 2	0.95	1.74	0.92	1.4	2.02	1.62	1.1	1.89	1.35	1.76	1.44	0.92	0.72	0.92	0.69	1.54	1.28	1.01	0.89	0.87	0.91	0.78
UG3F12	37269	peptidase D	1.27	1.23	1.15	0.99	1.5	1.27	0.96	1.23	0.92	1.45	1.37	1.59	0.82	1.22	0.49	1.16	1.3	1.04	2.31	0.85	1.67	1.69
UG3G1	37347	"CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)"	3.64	26.96	8.56	11.57	14.82	8.97	5.08	7.01	11.13	15.52	7.49	2.94	5.71	7.74	2.59	5.07	5.04	5.33	9.81	6.03	3.64	7.04
UG3G2	37366	"Homo sapiens clone 24703 beta-tubulin mRNA, complete cds"	2.08	2.03	2.15	2.56	2.31	2.59	1.97	2.34	1.94	1.82	2.35	1.36	1.32	1.74	2.07	2.23	2.14	1.79	1.98	1.99	1.43	1.51
UG3G3	37380	"collagen, type I, alpha 1"	1.02	3.54	7.22	6.82	7.71	4.51	6.32	6.27	8.01	7.55	4.78	1.63	1.67	1.53	1.74	2.91	3.35	2.03	1.82	1.96	1.89	1.56
UG3G4	37435	carbonyl reductase 1	1.43	2.82	0.85	1.6	2.46	2.22	2.34	2.52	2.89	2.19	1.29	3.22	1.76	2.8	1.16	3.11	1.11	1.82	3.28	1.94	2.12	2.15
UG3G5	37433	oxidase (cytochrome c) assembly 1-like	0.86	0.89	0.65	0.77	0.71	0.7	0.75	0.89	0.54	0.86	0.82	0.59	0.96	0.72	1.14	0.59	0.44	0.68	0.64	0.48	0.72	0.57
UG3G6	37451	"creatine kinase, brain"	1.58	1	0.94	1.16	1.36	1.05	1.08	1.35	1.31	1.84	0.2	0.65	0.73	0.8	1.37	1.89	0.58	1.02	0.58	0.67	0.99	0.64
UG3G7	37477	MYC promoter-binding protein 1	1.26	0.24	1.28	0.47	0.4	0.65	0.34	0.33	0.24	0.55	0.42	0.26	0.63	0.41	1.39	0.23	0.9	0.64	0.39	0.49	0.92	0.27
UG3G8	37485	carboxypeptidase E	1.26	1.3	0.77	1.14	1.65	1.06	0.94	1.35	1.17	1.97	1.19	0.76	1.26	0.91	1.06	1.5	1.47	0.74	0.99	0.56	0.67	0.87
UG3G10	37513	"survival of motor neuron 1, telomeric"	1.51	1.19	0.79	1.07	1.47	1.43	1.34	1.3	1.11	1.54	1.2	1.12	1.46	2.08	1.09	1.41	1.24	1.19	1.56	1	1.04	1.34
UG3G11	37622	methylmalonyl Coenzyme A mutase	1.02	1.61	1.03	1.3	1.55	0.91	1.32	1.27	1.12	1.16	1.23	1.19	1.14	1.41	1.17	2.04	1.13	1	0.73	0.72	0.83	0.7
UG3H2	37760	KIAA0095 gene product	1.84	1.93	1.3	1.46	1.54	1.46	1.14	1.4	1.31	0.98	1.25	1.15	0.92	1.13	1.35	1.94	1.81	1.23	0.9	0.87	1.01	0.78
UG3H4	37797	ubiquitin C	1.05	0.77	1.68	0.65	0.81	0.55	1.38	1.42	1.01	1.55	1.22	0.89	1.38	1.56	1.3	0.94	1.07	1.52	0.64	1.57	0.82	0.65
UG3H5	37892	"Human mRNA for rod photoreceptor protein, complete cds"	0.93	1.08	1.21	0.8	0.85	0.73	1.29	0.67	0.95	0.9	1.01	1.33	1.04	1.13	0.65	1.24	1.14	0.72	0.77	1.11	0.79	0.82
UG3H8	37964	nuclear matrix protein p84	1.2	1.52	1.52	1.33	1.89	1.24	1.18	1.38	1.73	0.87	0.84	1.37	1.01	1.85	1.04	1.67	1.69	0.84	0.72	1.19	0.75	1.12
UG3H9	38397	"phosphate carrier, mitochondrial"	0.49	0.34	0.28	0.31	0.44	0.43	0.37	0.54	0.36	0.26	0.49	0.44	0.48	0.41	0.7	0.36	0.33	0.3	0.3	0.37	0.34	0.39
UG3H10	38393	connective tissue growth factor	0.76	0.98	0.95	0.79	1.2	0.97	1.2	1.4	1.23	1.16	1.19	1.17	1.47	0.31	0.15	1.51	1.15	0.42	2.7	1.11	2.04	3.35
UG3H12	38500	"protein tyrosine phosphatase, non-receptor type 12"	1.42	1.57	1.04	1.47	1.74	1.57	1.33	1.66	1.46	1.3	1.08	1.02	1.36	1.54	1.23	1.51	1.06	1.51	1.38	0.69	0.87	1.16
UG4A6	38829	"protein tyrosine phosphatase, receptor type, R"	1.82	1.73	1.28	2.11	2.61	1.87	2.55	2.57	1.96	2.44	2.19	1.98	1.82	2.11	1.54	4.01	2.14	1.68	2.09	1.93	2	2.24
UG4A7	38840	growth arrest-specific 6	1.13	1.83	1.14	1.18	2	1.59	1.15	0.94	1.26	1.11	1.43	1.02	1.04	1.42	1.13	1.83	1.84	0.81	1.05	0.96	1.4	0.64
UG4B1	39093	methionine aminopeptidase; eIF-2-associated p67	0.39	0.58	0.72	1.07	0.97	0.62	0.48	0.88	0.57	0.95	0.66	0.83	0.37	0.51	0.65	0.75	0.96	0.39	0.37	0.4	0.39	0.45
UG4B2	39148	fibromodulin	2.37	1.77	4.09	2.63	5.22	2.97	3.73	5.88	2.68	3.98	2.76	4.17	4.38	1.42	5.29	2.38	2.17	2.67	10.44	1.88	4.37	4.38
UG4B3	39159	phosphoglycerate mutase 1 (brain)	0.86	1.03	1.29	0.91	2.6	0.93	1.28	2.27	1.06	1.04	1.9	1.17	1.06	1.47	1.12	1.19	1.23	1.14	1.77	0.95	2.24	1.5
UG4B4	39169	CD81 antigen (target of antiproliferative antibody 1)	1.21	2.37	1.62	1.33	1.94	1.02	1.6	1.84	1.36	1.46	2.23	1.16	1.81	1.07	1.12	1.47	1.02	1.25	0.69	0.97	0.9	0.66
UG4B5	39173	DiGeorge syndrome critical region gene 2	0.88	1.62	0.89	1.16	2.43	1.04	1.31	1.3	1.06	1.6	1.9	0.76	0.87	0.91	1.21	1.1	1.12	1.44	1.01	1.23	1.49	1.15
UG4B6	39195	B-cell CLL/lymphoma 7b	1.54	1.73	1.14	1.65	2.88	2.12	1.57	1.38	1.68	1.42	1.28	1.03	1.29	1.6	1.22	1.34	0.77	1.72	1.38	1.25	1.47	1.37
UG4B7	39205	transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	0.89	1.47	0.92	1.18	2.12	1.74	1.56	1.5	0.94	1.08	1.6	0.78	0.79	1.14	1.21	1.62	1.63	1.46	1.15	1.14	3.3	1.27
UG4B8	39270	breakpoint cluster region	1.11	2.68	1.03	1.89	2.93	2.61	2.25	2.51	2.14	1.92	1.47	1.09	1.56	1.36	1.41	2.76	2.87	2.87	1.57	1.85	1.74	1.88
UG4B9	39285	glutamate dehydrogenase 1	0.44	0.41	0.32	0.68	0.5	0.28	0.44	0.59	0.59	0.37	0.59	0.67	0.79	0.7	0.57	0.4	0.21	0.48	0.36	0.78	0.31	0.62
UG4B10	39380	somatostatin	1.2	1.38	0.92	0.7	3.12	1.22	1.2	0.86	1.26	3.79	1.29	1.09	1.28	1.7	0.93	0.94	1.26	1.7	1.34	2.33	1.36	1.19
UG4C2	39728	KIAA0005 gene product	0.38	0.38	0.46	0.6	0.94	0.5	0.6	0.71	1.12	0.81	0.64	1.2	0.67	0.82	0.92	0.84	0.66	0.5	0.47	0.58	0.52	0.55
UG4C3	39781	CD63 antigen (melanoma 1 antigen)	0.42	0.59	1.45	0.6	0.83	0.63	1.2	1.57	1.16	1.13	1.27	0.96	0.7	1.07	0.96	0.64	0.59	0.84	1.35	0.96	1.56	1.52
UG4C4	39796	3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase (hydroxymethylglutaricaciduria)	1.37	1.18	0.96	1.03	2.56	1.26	1.26	1.8	1.27	1.25	1.46	1.6	2.39	2.26	1.79	1.69	1.42	1.42	1.23	1.26	2.82	1.94
UG4C5	39827	"adenosine deaminase, RNA-specific"	1.78	2.72	1.5	2.34	3.23	2.17	2.6	2.7	1.69	2.18	3.17	2.16	1.83	2.23	1.77	2.4	2.79	2.72	1.62	1.98	2.68	2.88
UG4C6	39861	ribonuclease/angiogenin inhibitor	1.42	0.69	0.77	1.45	1.43	1.1	1.87	1.92	1.1	1.33	1.51	1.32	1.37	2.22	1.21	1.06	0.99	1.41	1.84	0.76	2.02	1.64
UG4C7	39876	"cholinergic receptor, nicotinic, epsilon polypeptide"	0.94	1.18	0.74	0.79	0.99	0.99	0.96	1.13	1.27	0.98	1.15	0.7	0.74	0.95	1.09	1.2	0.8	0.9	0.89	0.84	0.96	1.02
UG4C9	39903	"solute carrier family 2 (facilitated glucose transporter), member 1"	0.91	0.42	0.9	0.63	0.44	0.37	0.3	0.98	0.44	0.43	0.31	0.49	0.25	0.32	0.65	0.53	0.32	0.36	0.42	1.29	0.34	0.35
UG4C10	39965	transgelin	3.32	2.77	4.77	3.76	8.19	3.72	4.58	5.26	7.1	8.34	5.65	3.94	5.12	7.31	2.34	3.95	3.83	9.33	8.23	1.82	4.95	7.25
UG4C11	39993	"superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))"	0.85	0.69	0.69	0.73	0.58	0.71	0.93	0.92	1.51	0.83	0.94	1.59	0.75	1.14	0.53	1.19	1.02	1.03	1.13	0.9	0.87	1.25
UG4D3	40110	"transthyretin (prealbumin, amyloidosis type I)"	1.2	1.59	2.12	2.17	1.77	1.71	2.51	2.79	2.46	2.2	1.67	1.46	1.18	1.35	1.61	1.1	1.87	2.14	1.13	1.42	1.63	1.23
UG4D4	40111	transcription factor 8 (represses interleukin 2 expression)	1.86	1.45	1.25	1.45	5.41	0.57	1.83	2.06	1.05	1.16	1.63	4.26	5.96	7.94	3.38	1.97	1.42	1.87	3.74	0.65	8.07	7.37
UG4D5	40151	apolipoprotein D	1.33	2.96	10.22	7.4	19.12	1.61	6.36	8.6	6.98	5.2	7.86	5.69	6.95	9.31	3.54	5.53	8.26	4.59	5.18	8.82	11.2	13.1
UG4D6	40205	cathepsin B	1.12	0.85	0.87	1.08	1.13	2.1	1.65	2.14	1.17	2.09	1.58	1.13	0.61	0.74	0.85	1.17	1.08	0.91	1.17	0.86	1.79	0.68
UG4D7	40276	ubiquitin-conjugating enzyme E2A (RAD6 homolog)	1.01	1.1	1.68	0.92	1.18	0.97	1.08	1.37	1.13	0.79	1.29	0.93	0.83	0.8	0.9	0.8	0.74	0.42	0.91	1.21	0.86	0.95
UG4D8	40304	"succinate dehydrogenase complex, subunit A, flavoprotein (Fp)"	1.61	0.97	1.23	1.13	1.14	1.14	0.99	1.07	0.76	0.8	2.29	0.94	1.25	0.95	1.53	1.65	1.18	0.84	0.57	0.72	0.74	0.68
UG4D9	40360	"eukaryotic translation initiation factor 2B, subunit 5 (epsilon, 82kD)"	1.62	1.41	1.11	0.88	1.11	0.72	1.5	1.45	1.65	0.84	1.52	1.74	1.12	1.61	1.19	0.92	0.76	1.45	1.88	0.91	0.91	1.82
UG4D11	40440	"ATPase, Ca++ transporting, plasma membrane 1"	0.86	0.83	1.77	1.68	1.63	1.05	1.43	2.26	1.43	0.94	0.86	1.24	1.14	1.07	1.01	1.53	0.78	1.15	1.6	0.73	0.83	1.1
UG4D12	40442	damage-specific DNA binding protein 1 (127kD)	0.84	1.03	0.22	0.64	1.99	1.14	0.79	1.19	0.81	1.55	1.52	1.17	1.08	0.9	1.21	0.46	0.91	1.28	0.64	1.27	1.11	1.06
UG4E2	40562	"sarcoglycan, beta (43kD dystrophin-associated glycoprotein)"	1.58	1.59	2.92	1.94	2	1.28	1.9	1.78	1.42	1.52	0.79	0.87	1.14	0.86	0.93	1.45	1.21	1.17	0.79	0.58	1	0.88
UG4E4	40764	"synuclein, alpha (non A4 component of amyloid precursor)"	2.34	5.99	6.13	6.1	6.2	5.2	5.78	7.52	5.5	8.11	2.71	4.64	4.54	4.86	2.71	3.66	3.21	3	9.27	3.99	7.42	4.45
UG4E5	40765	Human HLA-DR alpha-chain mRNA	1.84	7.09	5.94	3.92	5.19	5.88	4.72	6.84	4.74	7.85	3.73	4.87	2.71	3.64	2.88	3.37	3.53	2.77	5.92	2.67	5.78	3.66
UG4E7	40874	"tubulin, gamma polypeptide"	1.35	1.53	1.12	1.1	1.18	1.53	0.98	1.28	1.42	1.19	1.12	1.04	0.92	1.21	0.9	1.45	1.4	1.47	1.02	2.19	1.39	1.35
UG4E9	40911	"H2A histone family, member Z"	1.07	0.82	1.21	1.1	0.61	0.72	0.87	0.6	1.04	1.1	0.77	0.58	0.52	1.13	1.4	0.55	0.82	1.55	0.36	0.65	0.72	0.77
UG4E10	40959	adenine nucleotide translocator 2 (fibroblast)	0.98	0.46	0.47	0.59	0.66	0.67	0.62	0.43	0.25	0.69	0.89	0.47	0.67	0.64	1.17	1.08	0.64	0.61	0.3	0.84	0.41	0.5
UG4E11	40991	Jun activation domain binding protein	2.03	1.03	2.69	1.96	1.45	1.91	1.19	2.11	2.02	1.29	1.25	2.44	1.5	1.69	2.05	1.47	0.66	1.16	0.86	1.49	0.83	1.34
UG4F1	41208	bone morphogenetic protein 1	0.36	0.65	0.83	0.95	1.22	0.46	0.85	1.69	0.73	1.38	1.08	0.48	0.47	0.51	0.55	0.45	0.33	0.43	1.13	0.49	0.92	0.7
UG4F3	41356	"protein phosphatase 2, regulatory subunit B (B56), alpha isoform"	1.8	2.05	1.22	2.07	3.47	2.12	1.51	2.37	2.02	1.84	2	1.82	1.18	2.78	1.37	2.19	1.87	0.86	2.16	2.21	1.68	2.19
UG4F4	41392	"FYN oncogene related to SRC, FGR, YES"	2.57	1.89	1.64	2.15	2.58	2.26	2.09	2.97	2.44	2.47	2.07	2.28	1.86	1.71	1.83	2.15	1.78	1.72	2.22	2.68	2.15	2.54
UG4F5	41439	cofilin 1 (non-muscle)	0.61	1.01	1.52	1.42	1.75	1.24	1.34	1.56	1.04	1.67	1.8	0.86	0.48	0.8	1.51	1.23	1.05	1.94	0.91	1.01	1.16	0.95
UG4F6	41452	spermidine/spermine N1-acetyltransferase	0.42	0.8	0.83	0.57	0.98	0.52	0.7	0.63	0.62	0.78	0.71	0.46	0.54	0.61	1.31	1.27	0.66	0.41	0.93	0.28	1.08	0.57
UG4F7	41511	"eukaryotic translation initiation factor 2, subunit 2 (beta, 38kD )"	0.76	1.1	0.63	1.13	1.54	0.93	0.71	0.82	0.86	0.97	0.76	0.65	0.52	0.66	0.91	1.67	1.29	1.1	0.57	0.53	0.62	0.7
UG4F8	41559	ESTs	1.57	1.66	1.24	1.25	1.48	1.91	1.45	1.45	1.25	1.9	1.33	1.11	1.02	1.06	1.84	1.92	1.62	1.26	0.96	1.87	0.96	0.87
UG4F9	41773	nuclear receptor coactivator 4	0.9	1.4	1.12	1.15	2.12	1.06	0.96	1.57	1.79	0.9	2.34	0.9	1	1.12	1.17	0.94	0.77	1.82	1.94	0.95	1.04	1.6
UG4F10	41796	nuclear receptor interacting protein 1	0.63	0.99	0.73	0.75	1.74	1.27	1.25	1.83	1.94	2.29	1.62	1.3	1.27	3.05	1.29	1.44	3.22	0.61	0.81	0.88	0.89	0.99
UG4G1	41857	nuclear transport factor 2 (placental protein 15)	0.65	1.32	1.09	0.62	1.42	0.78	0.86	1.03	0.96	1.02	0.92	0.54	0.39	0.58	0.57	0.58	0.95	0.85	1.16	0.6	1.33	0.73
UG4G2	41918	"membrane protein, palmitoylated 1 (55kD)"	1.05	1.56	1.14	1.44	1.89	1.69	1.43	1.73	1.26	1.78	1.55	1.36	1.35	0.98	0.95	1.59	1.44	0.75	1.28	1.01	1.52	0.91
UG4G3	42020	polymerase (RNA) II (DNA directed) polypeptide B (140kD)	1.35	2.24	1.63	1.95	2.49	1.9	1.97	2.41	1.93	1.88	1.95	1.13	1.23	1.53	1.43	1.86	1.74	1.22	1.55	1.16	1.39	1.56
UG4G4	42058	growth factor receptor-bound protein 2	2.74	2.46	1.5	2.38	2.17	2.44	2.27	3.96	3.76	2.36	3.44	2.72	2.06	1.28	1.44	2.4	3.52	1.82	2.98	3.71	2.37	2.83
UG4G5	42059	"dihydrolipoamide dehydrogenase (E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex, branched chain keto acid dehydrogenase complex)"	0.3	0.82	0.6	0.93	0.78	0.84	0.38	0.55	0.34	0.66	0.58	0.34	0.51	0.38	0.65	0.85	0.88	0.42	0.46	0.52	0.61	0.55
UG4G6	42088	putative receptor protein	1.06	1.1	1.09	1.02	1.43	1.05	1.18	1.1	1.04	1.01	1.05	1.08	0.98	0.97	1.33	1.87	1.16	1.31	1.35	1.18	1.76	1.17
UG4G7	42096	"chaperonin containing TCP1, subunit 3 (gamma)"	0.93	2.27	0.65	1.58	1.36	1.42	1.35	0.9	1.11	1.31	1.4	0.77	0.83	1.34	1.17	1.46	1.85	2.27	0.65	0.6	1.13	1.16
UG4G8	42130	"complement component 1, q subcomponent binding protein"	1.82	0.92	0.79	1.16	1.4	2.02	0.77	1.23	1.19	0.35	1.25	0.94	1.11	1.08	1.09	1.41	1.76	0.72	1.01	1.01	1.2	0.9
UG4G10	42284	alanyl-tRNA synthetase	1.61	1.48	0.88	1.36	1.72	1.34	1.12	1.86	1.03	1.31	1.29	1.74	0.78	1.16	1.41	1.7	1.3	2.45	0.78	0.71	1.29	0.67
UG4H5	42576	ubiquitin-activating enzyme E1 (A1S9T and BN75 temperature sensitivity complementing)	0.81	1.13	0.79	0.71	1.38	0.97	1.18	0.81	0.93	0.86	1.35	0.74	0.85	0.88	0.85	0.69	2.13	1.01	1.06	0.79	1.35	1.34
UG4H7	42648	transketolase (Wernicke-Korsakoff syndrome)	0.2	0.26	0.11	0.17	0.31	0.27	1.05	0.15	0.15	0.26	0.38	0.26	0.22	0.17	0.25	0.16	0.18	0.15	0.15	0.32	0.22	0.18
UG4H8	42677	dCMP deaminase	0.85	0.98	0.66	0.86	0.97	0.64	0.79	1.16	1.01	0.59	1.06	0.82	1.03	0.58	0.49	1.51	1.08	0.35	0.59	0.98	0.94	0.76
UG4H10	42777	G1 to S phase transition 1	0.64	0.85	0.57	0.81	1.77	1.21	1.25	0.79	0.95	1.53	1.11	1.42	1.26	0.82	1.07	0.51	1.41	1.4	0.58	0.52	0.58	0.66
UG4H11	42844	peroxisome receptor 1	0.82	0.68	1.13	1.68	1.41	1.07	1.16	1.37	2.19	0.28	0.62	1.61	1.68	0.78	0.56	0.99	1.36	1.69	0.9	1.16	1.2	2.43
UG4H12	42888	"interleukin enhancer binding factor 2, 45kD"	2.58	2.02	2.06	2.64	2.28	2.9	1.41	1.17	0.91	1.21	1.56	1.35	1.34	1.77	1.49	1.04	3.13	2.36	0.54	0.76	1.55	1.05
UG5A1	42894	nuclear phosphoprotein similar to S. cerevisiae PWP1	0.91	1.31	1.32	1.68	1.23	0.95	0.96	1.32	0.99	0.88	0.95	1.32	0.7	0.88	0.66	0.9	0.89	3.34	1.87	1.03	1.36	1.58
UG5A6	43021	histidyl-tRNA synthetase	0.71	0.71	0.43	0.58	0.81	0.55	0.91	0.68	0.9	0.79	0.86	0.71	0.75	0.94	0.66	1.08	0.94	0.8	0.78	0.72	1.21	0.96
UG5A7	43060	KIAA0097 gene product	1.18	1.73	1	1.47	1.15	1.73	0.97	1.09	1.48	1.24	1.35	1.02	0.77	1.55	0.78	1.33	1.76	3.03	0.9	1.11	0.9	1.13
UG5A8	43092	"antigen identified by monoclonal antibodies 12E7, F21 and O13"	0.43	0.39	0.81	0.41	0.59	0.35	0.64	0.31	0.26	0.76	0.33	0.35	0.58	0.66	1.03	0.85	0.7	0.65	0.29	0.34	0.37	0.36
UG5A9	43110	tumor rejection antigen (gp96) 1	0.74	1.18	2	1.19	1.13	0.92	0.86	1.29	0.86	1.28	0.8	1.13	0.99	0.86	1.28	1.05	1.63	1.38	0.58	0.61	0.73	0.66
UG5A10	43129	"phospholipase C, gamma 1 (formerly subtype 148)"	1.19	0.79	0.57	1.03	1.3	0.86	1.03	0.87	0.95	1.4	0.76	0.96	1.08	1.32	1.07	1.28	0.91	1.05	0.7	0.81	0.76	0.84
UG5A12	43229	proliferating cell nuclear antigen	1.3	0.64	0.74	0.9	1.01	1.24	0.75	0.56	0.47	0.94	0.86	0.72	0.8	1.09	0.74	1.5	0.93	0.85	0.59	0.69	0.53	0.7
UG5B1	43231	"proteasome (prosome, macropain) 26S subunit, non-ATPase, 2"	1.57	1.21	1.09	1.09	1.02	1.12	0.93	1.27	1.25	0.76	1.3	1.24	0.62	0.81	1.14	0.7	1.09	1.66	0.78	1.11	0.85	1
UG5B2	43338	heterogeneous nuclear ribonucleoprotein C (C1/C2)	1.51	1.65	1.14	1.27	1.11	1.27	0.84	0.91	0.98	0.97	1.16	1.14	1.43	1.47	1.29	1.16	1.22	1.41	1.58	1.08	1.01	1.84
UG5B3	43241	"eukaryotic translation initiation factor 4A, isoform 2"	1.49	1.62	0.83	1.33	0.99	1.57	0.95	1.13	0.97	1	1.24	1.09	1.02	1.39	1.14	0.71	0.92	1.1	0.92	1.22	1.26	1.44
UG5B4	43409	ephrin-B2	1.25	1.34	0.57	0.97	1.93	1.39	0.56	0.94	0.66	1.17	1.44	0.74	0.79	0.51	0.63	0.83	2.35	0.62	1.91	0.53	0.84	1.64
UG5B5	43504	"thyroid hormone receptor, alpha (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog)"	1.26	0.84	0.9	1.04	1.11	0.85	0.78	1.31	0.94	1.11	1.19	0.79	1	0.82	1.04	1	0.73	0.7	0.64	0.85	0.66	0.92
UG5B6	43541	protein tyrosine kinase 2 beta	0.43	0.64	0.17	0.39	0.75	0.98	1.73	0.28	0.32	0.64	0.86	0.32	0.47	0.39	0.46	0.4	0.23	0.34	0.59	0.24	0.67	0.46
UG5B7	43549	"pyruvate kinase, muscle"	0.39	0.36	0.67	0.27	0.3	0.29	0.37	0.4	0.28	0.35	0.63	0.45	0.43	0.57	0.72	0.25	0.53	0.57	0.56	0.28	0.53	0.3
UG5B8	43550	lactate dehydrogenase A	0.53	0.32	0.55	0.32	0.43	0.23	0.42	0.27	0.19	0.47	0.22	0.33	0.8	0.69	1.11	0.53	0.54	0.56	0.45	0.43	0.51	0.33
UG5B9	43563	"cytochrome P450, subfamily XXVIIA (steroid 27-hydroxylase, cerebrotendinous xanthomatosis), polypeptide 1"	1.21	1.03	0.89	0.88	1.26	1.95	1.23	1.1	1.11	1.34	1.33	1.28	1.07	1.01	1.36	0.8	2.17	2.25	0.8	1.12	2.04	1.36
UG5B12	43631	"X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining; Ku autoantigen, 80kD)"	1.11	0.87	0.78	1.46	1.36	1.04	1.02	0.95	0.84	1.3	1.22	1.15	1.41	1.22	1.09	1.25	1.6	1.06	0.55	0.64	0.89	0.92
UG5C1	43711	"steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)"	1.69	1.34	2.82	2.52	4.34	2.33	1.95	2.67	1.48	1.98	2.73	2.12	2.56	2.47	1.32	1.49	1.55	2.99	1.84	1.48	2.05	2.07
UG5C2	43719	"protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform"	1.37	1.44	1.82	1.5	2.59	1.31	1.52	2.03	1.17	1.28	1.79	1.43	2.23	2.1	1.5	1.26	1.47	1.67	1.06	0.86	1.05	1.24
UG5C3	43826	"ATPase, H+ transporting, lysosomal (vacuolar proton pump) 42kD; Vacuolar proton-ATPase, subunit C; V-ATPase, subunit C"	1.3	0.93	1.07	1.08	0.88	1.54	0.81	1.46	1.62	1.22	0.83	1.29	1.19	0.66	1.27	0.66	1.23	0.81	0.75	1.68	0.7	1.28
UG5C4	43858	"discoidin domain receptor family, member 2"	1.5	2.74	2.69	5.33	4.5	2.1	3.34	6.03	2.66	3.24	2.99	2.05	3.37	3.52	1.57	2.6	2.21	4.24	3.11	1.16	1.78	2.88
UG5C5	43885	isoleucine-tRNA synthetase	1.21	1.98	0.79	1.95	1.27	0.98	0.87	1.14	0.86	0.76	0.85	0.64	1.1	0.79	1.45	0.8	1.85	1.39	0.6	0.61	0.54	0.64
UG5C6	43960	Ras suppressor protein 1	1.92	2.69	2.22	1.66	1.91	2.35	1.51	1.94	1.59	1.56	1.79	1.35	1.43	1.17	1.08	1.68	2.71	1.63	0.93	0.65	1.03	0.88
UG5C7	44014	FK506-binding protein 1A (12kD)	0.5	0.81	1.13	0.54	0.55	0.44	0.45	0.62	0.48	0.39	1.7	0.5	0.73	0.49	0.97	0.54	0.55	0.6	0.48	0.35	0.5	0.45
UG5C8	44050	LIM and SH3 protein 1	0.91	0.57	0.62	0.58	0.66	0.85	0.7	1.72	1.26	0.56	1.33	1.62	0.9	1.09	2.36	1.28	0.5	0.56	0.89	0.98	1.24	1.29
UG5C9	44105	"Sec24p, S. Cerevisiae, homolog of"	0.88	0.74	0.57	0.69	0.87	0.78	0.7	0.85	0.64	0.82	0.93	0.98	1.03	0.89	1.2	0.88	0.67	0.85	0.73	1.06	0.8	0.89
UG5C10	44159	MARCKS-like protein	3.72	8.06	5.15	4.36	6.57	3.69	3.72	5.44	5.22	3.59	5.22	4.23	2.96	3.98	2.48	4.67	5.21	3.59	3.16	3.81	2.31	4.25
UG5C11	44173	retinoblastoma-binding protein 4	2.62	1.46	1.61	1.62	0.94	1.23	0.89	1.61	0.77	0.85	1.62	1.94	1.74	1.68	2	1.07	1.81	1.34	1.8	1.98	1.52	2.23
UG5C12	44180	alpha-2-macroglobulin	0.87	0.74	0.53	0.65	0.87	1.2	0.95	1.27	0.9	1.39	1.19	1.69	1.51	1.58	1.19	1.65	0.94	0.56	0.88	1.44	0.95	1.27
UG5D1	44178	testis enhanced gene transcript	2.55	2.49	13.02	9.72	13.61	6.39	7.09	9.15	6.25	7.03	5.75	5.67	4.37	9.47	3.14	4.84	3.94	9.21	8.39	2.91	4.82	7.65
UG5D2	44193	vinculin	1.06	0.85	2	1.2	1.66	0.89	1.53	2.16	0.99	1.07	1.66	0.93	1.61	1.52	1.13	0.92	0.88	1.03	1.14	0.66	0.87	1.04
UG5D3	44218	glutaminyl-tRNA synthetase	0.64	0.6	0.55	0.5	0.67	0.6	0.99	0.46	0.5	0.7	0.67	0.56	0.96	0.79	0.38	0.61	0.36	0.78	0.55	0.65	0.55	0.78
UG5D4	44255	"ribosomal protein, mitochondrial, L3"	1.45	0.85	1.02	1.09	1.46	1.11	1.34	1.53	1.38	1.03	1.13	1.19	1.55	1.78	1.42	0.84	1.45	1.25	0.82	0.88	0.92	0.53
UG5D5	44266	"proteasome (prosome, macropain) subunit, alpha type, 6"	1.12	1.02	0.95	0.86	0.64	0.8	0.93	1.2	1.12	0.85	0.89	1.34	0.78	0.92	1.09	0.9	0.86	0.75	0.82	1.11	1.03	1.03
UG5D6	44302	heat shock 70kD protein 1	1.39	2.19	1.13	1.24	1.94	1.69	2.26	2.53	2.05	2.77	1.97	1.85	1.65	2.6	1.56	1.42	3.36	2	2.52	1.16	1.15	2.47
UG5D7	44307	"H2B histone family, member Q"	3.01	4.1	6.16	2.52	2.45	1.56	3.08	4.72	8.24	1.55	3.32	1.8	1.85	3.87	0.72	1.76	2.49	2.16	1.75	1.37	1.27	2
UG5D8	44311	melanoma adhesion molecule	2.92	2.18	2.79	2.12	2.71	1.7	1.64	2.74	5	2.72	2.04	2	1.57	1.78	1.9	2.71	1.72	2.43	2.33	1.27	2.04	2.28
UG5D9	44367	lysyl-tRNA synthetase	0.71	0.54	0.54	0.47	0.94	0.68	0.53	0.77	0.53	0.52	0.56	0.67	0.48	0.53	0.8	0.99	0.87	0.85	0.33	0.28	0.34	0.35
UG5D10	44414	iduronate 2-sulfatase (Hunter syndrome)	1.61	1.8	0.93	0.93	1.44	1.19	1.5	1.84	1.42	1.13	1.42	1.6	1.45	1.36	1.47	1.35	1.9	1.19	1.18	1.33	1.38	1.23
UG5D11	44477	vascular cell adhesion molecule 1	2.8	23.62	19.06	10.11	5.07	5.72	6.32	10.32	0.95	4.92	3.5	3.7	2.37	2.06	2.24	3.66	4.2	2.19	4.23	1.85	1.97	3.11
UG5E2	44537	small nuclear ribonucleoprotein polypeptides B and B1	1.1	1.04	1	1.03	1.02	1.11	1.39	0.79	0.85	1.23	2.16	0.8	0.95	1.2	1.1	2.59	0.68	1.3	1.03	1.26	1.21	0.96
UG5E3	44563	growth associated protein 43	1	1.01	1.06	0.96	0.87	0.95	1.13	0.86	0.73	1.06	1.67	0.78	0.86	1.19	0.99	1.46	0.46	1.35	0.97	1.02	1.32	0.87
UG5E4	44584	regulated in glioma	1.33	0.49	2.05	0.72	1.43	1.21	1.56	2.73	1.24	1.34	1.48	0.88	1.82	1.76	0.9	1.33	1.16	1.09	1.35	0.72	1.03	1.15
UG5E5	44605	small membrane protein 1	0.61	0.55	0.98	0.52	0.7	0.75	0.62	1.16	0.67	0.59	0.91	0.49	0.58	0.6	0.47	0.53	0.54	0.45	0.56	0.58	0.86	0.56
UG5E6	44666	thyroid autoantigen 70kD (Ku antigen)	1.01	0.91	1.39	1.25	1.32	1.75	0.81	0.9	0.9	1.01	1.27	1.02	1.12	1.23	1.03	1.31	1.84	1.02	0.67	0.62	0.81	0.98
UG5E7	44689	retinoblastoma-binding protein 7	1.85	1.66	1.9	1.69	1.73	0.83	1.05	1.17	1.01	1.18	1.26	1.22	1.37	1.24	0.91	1.01	1.37	1.27	0.66	0.99	0.62	1.42
UG5E8	44699	"ATPase, H+ transporting, lysosomal (vacuolar proton pump) 21kD"	1.13	2.43	1.86	1.39	2.23	1.67	2.67	2.13	4.27	2.83	1.7	2	1.2	2.37	1.67	2	1.04	2.37	1.91	2.23	1.98	2.36
UG5E10	44721	"proteasome (prosome, macropain) subunit, beta type, 5"	1.2	1.15	1.2	0.73	0.88	0.76	1.09	0.86	1.19	1.14	1.08	1.51	0.84	1.12	1.14	1.52	0.88	1.15	0.74	1.1	1.27	1.27
UG5E11	44722	macrophage maturation-associated	1.89	1.59	3.29	3.04	2.81	3.02	5.35	5.78	4.5	6.79	2.72	2.15	1.73	2.57	1.8	1.29	3.51	2.85	3.94	1.43	2.05	2.8
UG5F1	45222	villin 2 (ezrin)	0.77	0.69	0.84	0.8	0.78	2.38	0.8	1.47	0.77	0.99	1.02	0.82	0.68	0.72	1.18	0.76	0.4	0.87	1.06	1.1	1.17	1.14
UG5F2	45233	"chaperonin containing TCP1, subunit 6A (zeta 1)"	1.7	1.42	1.1	1.69	1.62	1.88	0.92	0.78	0.88	1.62	0.91	1	1.11	1.05	1.5	2.16	1.8	1.13	0.77	0.67	0.68	0.83
UG5F3	45291	dentatorubral-pallidoluysian atrophy (atrophin-1)	1.17	1.42	1.02	1.39	1.48	4.57	0.7	0.65	0.82	1.35	1.72	0.72	0.76	0.95	1.33	0.48	0.87	1.3	0.67	0.8	1.03	0.93
UG5F4	45376	acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase)	1.12	0.46	0.73	0.61	0.7	1.19	0.4	0.49	0.41	0.79	0.6	0.67	0.82	0.75	0.7	0.72	0.72	0.72	0.59	0.37	0.73	0.59
UG5F5	45421	"transforming growth factor, beta-induced, 68kD"	0.23	0.16	0.99	0.2	0.26	0.3	0.3	0.56	0.19	0.28	0.38	0.23	0.24	0.26	0.29	0.17	0.15	0.25	0.43	0.41	0.38	0.21
UG5F6	45564	"zinc finger protein 7 (KOX 4, clone HF.16)"	1.3	0.65	1.05	0.74	1.67	1.23	0.69	1.64	1.37	1.01	1.34	1.67	1.69	2.09	0.81	1.1	1.16	0.66	0.83	1.99	0.84	1.53
UG5F7	45568	catalase	0.95	1.12	1.84	1.02	1.25	1.2	1.33	2.78	1.04	0.96	1.15	1.27	1.72	1.46	1.38	0.79	0.79	1.07	0.96	1.06	1.39	1.11
UG5F8	45604	B-cell CLL/lymphoma 7A	1.04	1.02	0.81	0.74	1.06	2.13	0.85	1.09	0.92	0.94	1.06	1.18	1.63	1.4	1.04	0.62	0.91	1.47	0.49	1.55	0.92	0.7
UG5F9	45643	hexosaminidase B (beta polypeptide)	0.81	0.88	0.89	0.69	1.04	0.99	0.69	0.81	0.54	2.65	0.99	0.85	0.81	0.78	1.15	0.44	1.03	0.68	0.72	0.66	0.9	0.85
UG5F10	45658	KIAA0009 gene product	1.56	1.34	1.03	1.73	1.34	1.75	0.8	1.01	0.65	1.84	1.33	1.33	1.37	1.03	1.75	1.44	2.61	0.97	0.91	1.36	1.07	1.08
UG5F11	45794	uracil-DNA glycosylase	1.21	2.41	0.93	1.75	1.39	1.3	1.05	1.71	1.8	1.46	1.35	0.98	1.2	0.93	0.77	0.93	1.24	2.04	0.98	1.14	0.85	0.96
UG5F12	45851	"collagen, type XVIII, alpha 1"	1.39	2.85	3.53	2.14	3.5	3.1	2.57	3.87	1.58	3.6	2.48	2.64	3.13	4.78	2.18	1.6	0.91	6.12	1.15	0.95	1.42	2.21
UG5G1	45840	"splicing factor, arginine/serine-rich 4"	1.79	1.63	1.63	1.4	1.1	1.77	1.04	1.19	1.02	0.89	1.39	1.34	1.42	1.4	1.09	0.91	1.11	1.35	1.21	0.74	1.05	1.15
UG5G2	45941	DNA (cytosine-5-)-methyltransferase 1	1.58	4.96	1.62	3.03	2.69	2.84	1.61	1.89	2.2	1.61	2.04	0.94	1.45	1.42	1.42	2.46	2.46	1.45	0.95	0.92	0.83	0.93
UG5G3	46019	minichromosome maintenance deficient (S. cerevisiae) 7	1.19	3.35	1.94	2.25	1.66	2.3	1.13	0.81	0.81	1.27	1.03	0.54	1.13	1.4	1.17	0.84	1.16	1.47	0.81	0.79	1	0.76
UG5G4	46042	"protein phosphatase 2, regulatory subunit B (B56), beta isoform"	1.4	2.38	1.6	1.93	2.07	1.69	1.85	1.16	2.06	1.69	2.07	1.52	1.58	1.71	1.37	1.79	1.62	1.92	1.63	1.51	1.51	1.39
UG5G5	46171	"eukaryotic translation initiation factor 4A, isoform 1"	0.68	0.76	1.61	0.78	0.97	0.79	1.15	0.67	0.51	1.05	0.98	0.68	1.09	0.86	0.77	0.73	0.93	0.98	0.87	1.07	0.92	0.76
UG5G6	46213	DEK gene	0.87	0.84	1.15	0.49	1.04	0.6	0.9	0.62	0.63	0.6	0.94	0.69	1.36	0.98	0.67	0.84	0.69	0.86	0.61	0.63	0.61	0.7
UG5G7	46302	"aldolase A, fructose-bisphosphate"	0.35	0.49	1.27	0.29	0.38	0.25	0.46	0.43	0.79	0.38	0.52	0.7	0.86	0.75	0.72	0.37	0.63	0.57	0.37	1.79	0.74	0.48
UG5G8	46303	"tumor protein, translationally-controlled 1"	0.64	0.76	0.91	0.44	0.43	0.59	0.67	0.72	0.82	0.7	0.81	1.02	1.3	0.96	0.75	0.58	0.42	0.64	0.29	1.53	0.84	0.54
UG5G9	46329	"capping protein (actin filament) muscle Z-line, beta"	1.48	1.12	1.15	1.06	0.84	1.7	0.87	1.89	0.88	0.98	2.01	1.54	1.37	1.07	1.41	0.75	0.93	0.94	1.07	1.05	1.2	1.04
UG5G10	46339	v-raf-1 murine leukemia viral oncogene homolog 1	1.56	1.19	1.47	1.01	1.41	0.88	1.02	0.79	0.99	1.05	1.33	1.57	1.21	1.37	1.05	0.92	1	1.06	1.18	0.68	0.9	0.94
UG5G11	46354	N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1	1.5	1.76	2.41	1.57	2.35	2.09	2.3	3.69	1.52	2.39	2.78	1.97	2.64	1.79	0.98	1.04	1.67	1.63	1.23	1.7	1.89	1.26
UG5G12	46419	ribosomal protein L4	0.51	0.85	0.45	0.83	0.53	0.47	0.55	0.43	0.33	0.79	0.45	0.37	0.8	0.63	0.59	0.54	0.69	0.77	0.81	0.5	0.7	0.85
UG5H3	46548	Rho GTPase activating protein 1	1.86	1.45	1.09	0.84	1.76	1.54	1.13	1.62	1.28	1.18	2.11	1.67	1.85	1.29	0.91	2.15	1.47	1.94	1.47	1.67	1.5	1.66
UG5H4	46574	"guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2"	1.09	1.45	1.45	1.17	1.84	1.39	1.76	1.83	1.31	1.75	1.9	1.39	1.38	1.35	1.15	1.35	1.43	1.42	1.69	1.16	1.2	1.3
UG5H5	46711	"splicing factor, arginine/serine-rich 9"	0.76	0.72	0.81	0.63	0.81	0.76	1	0.83	0.43	0.66	0.87	0.79	1.14	0.82	0.79	0.9	0.58	0.91	0.71	0.67	0.44	0.77
UG5H6	46777	"ribosomal protein S4, X-linked"	0.86	0.79	0.3	0.49	1.09	0.91	0.9	0.49	0.45	0.75	0.79	0.45	1.25	0.9	0.4	0.86	0.73	0.82	0.7	0.2	0.39	0.73
UG5H7	46920	"protein phosphatase 1, catalytic subunit, gamma isoform"	0.58	0.83	0.63	1.38	0.61	0.7	0.57	0.94	0.43	0.59	0.68	0.65	0.91	0.6	0.66	0.72	0.91	0.73	0.42	0.72	0.32	0.63
UG5H8	46936	"myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog); translocated to, 3"	1.34	1.19	1.05	1.47	1.24	1.16	1.12	1.1	1.04	1.16	1.11	1.18	1.59	1.25	0.97	1.44	1.01	1.35	0.84	0.67	0.71	1.05
UG5H9	47038	gene predicted from cDNA with a complete coding sequence	0.76	0.69	1.14	1.13	0.89	1.04	0.65	1.09	0.54	0.7	0.99	0.77	1.17	0.48	0.58	0.98	1.1	0.64	0.47	0.36	0.55	0.5
UG5H11	47125	cathepsin D (lysosomal aspartyl protease)	1.2	2	1.14	1.61	1.34	1.33	1.59	1.74	0.87	1.2	1.5	1.18	1.03	1.28	0.89	1.34	0.85	1.21	0.61	0.53	0.65	0.79
UG5H12	47202	ADP-ribosylation factor 1	2.46	1.68	1.05	1.36	1.71	1.44	1.85	1.6	0.78	1.23	1.78	1.68	1.1	1.5	1.48	1.85	1.96	2.16	1.78	3.13	1.72	1.76
UG6A6	47384	"methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase"	1.75	0.91	1.13	1.25	0.92	1.11	0.66	0.46	0.59	0.93	0.82	0.84	1.19	1.65	1.03	1.26	1.5	1.13	0.64	0.82	0.43	1.08
UG6A7	47386	alpha-1-antichymotrypsin	1.33	4.98	0.52	2.57	7.07	0.24	2.26	2.48	2.8	1.13	2.02	2.76	2.14	4.23	0.22	0.38	3.57	3.02	1.55	7.46	1.74	6.43
UG6A8	47463	KIAA0155 gene product	1.02	1.34	0.49	1.38	1.91	1.15	1.19	1.52	0.91	1.05	0.86	0.86	1.24	1.5	0.76	1.53	1.68	1.02	1.07	1.03	0.89	1.29
UG6A12	47631	"phosphofructokinase, muscle"	0.44	1.14	0.95	0.75	0.94	0.34	0.62	0.81	0.73	0.82	1.19	0.86	1.07	0.77	0.57	1.05	1	0.74	0.5	0.55	0.65	0.93
UG6B2	47679	CD14 antigen	1.46	1.77	2.85	1.51	2.65	2.5	1.72	2.47	1.11	3.02	2	1.41	1.96	1.38	1.13	1.66	2.39	0.71	1.72	1.62	1.17	1.87
UG6B3	47727	"phosphorylase, glycogen; brain"	0.33	0.14	0.21	0.23	0.25	0.2	0.21	0.16	0.12	0.16	0.2	0.18	0.4	0.3	0.5	0.25	0.23	0.27	0.25	0.2	0.36	0.19
UG6B4	47838	IMP (inosine monophosphate) dehydrogenase 2	0.41	0.38	0.38	0.55	0.49	1.43	1.06	0.25	0.28	1.91	0.5	0.56	1.73	0.96	0.66	0.38	0.49	1.45	0.35	0.87	0.23	0.82
UG6B5	47833	"Tubulin, alpha, brain-specific"	1.61	1.17	2.03	1.75	1.13	1.58	1.56	1.95	1.14	2.39	1.61	1.53	1.61	1.48	1.68	0.75	1.21	2.49	1.07	1.95	1.4	0.86
UG6B7	47884	macrophage migration inhibitory factor (glycosylation-inhibiting factor)	4.11	4.14	8.88	3.19	7.01	4.62	2.58	3.66	1.76	2.85	3.76	2.46	1.73	2.28	1.65	2.49	2.24	2.3	2.6	1.55	2.21	2.31
UG6B8	48077	"3-hydroxybutyrate dehydrogenase (heart, mitochondrial)"	2.83	3.45	0.81	1.24	2.37	1.81	1.45	0.53	0.95	0.95	1.87	1.82	1.36	2.45	2.12	1.7	0.91	0.64	1.93	3.65	1.58	1.46
UG6B9	48085	butyrate response factor 1 (EGF-response factor 1)	1.25	2.49	0.57	1.51	1.44	1.06	1.1	1.09	2.18	1.61	1.94	0.98	0.35	0.95	1.15	1.7	1.96	3	1.15	1.32	1.73	1.18
UG6B11	48234	"ATPase, Na+/K+ transporting, alpha 1 polypeptide"	0.48	0.27	0.32	0.34	0.4	0.32	0.27	0.35	0.19	0.49	0.31	0.29	0.3	0.34	0.84	0.3	0.3	0.38	0.23	0.2	0.4	0.36
UG6B12	48406	hydroxysteroid (17-beta) dehydrogenase 4	0.71	0.85	0.44	0.62	1.01	0.53	0.72	1.27	1.01	0.72	0.86	0.87	0.9	1.3	0.46	0.8	0.97	0.42	0.88	0.52	0.85	1.16
UG6C1	48452	"sphingomyelin phosphodiesterase 1, acid lysosomal (acid sphingomyelinase)"	0.63	0.77	0.74	0.83	1.15	0.69	0.42	1.84	0.66	0.97	1.65	0.77	0.96	0.93	0.85	0.82	1.25	0.63	1.09	1.18	0.97	0.92
UG6C2	48458	melanoma-associated antigen recognised by T lymphocytes	1.02	1.27	0.57	0.66	1.35	0.96	1.65	0.88	1.08	1.44	1.06	1.21	1.4	1.3	0.85	1.07	0.91	1.36	1.24	1.08	0.89	1.35
UG6C3	48503	"solute carrier family 16 (monocarboxylic acid transporters), member 2 (putative transporter)"	0.7	0.94	0.57	0.81	1.04	0.71	0.96	1.5	1.17	0.83	0.97	0.98	0.95	0.75	1.14	0.82	0.62	0.98	0.71	0.92	1.05	0.93
UG6C4	48629	"polymerase (DNA directed), beta"	0.88	1.8	0.55	1.31	1.71	1.38	1.24	1.97	4.34	1.23	1.97	1.55	1.49	1.67	1.7	2.08	1.24	1.7	1.06	0.87	0.87	1.45
UG6C6	48717	transcriptional repressor	1.7	1.63	1.15	1.44	1.93	1.37	1.35	2.04	1.41	1.84	1.79	1.72	1.77	2.02	1.54	1.75	1.33	1.12	0.85	0.89	0.69	1.21
UG6C7	48713	thyroid hormone receptor interactor 3	0.72	0.71	0.48	0.8	0.76	0.94	0.72	0.99	0.54	1.42	0.96	0.58	0.6	0.58	0.77	0.45	0.83	0.56	0.49	0.48	1.12	0.5
UG6C9	48803	NGFI-A binding protein 2 (ERG1 binding protein 2)	1.57	2.28	2.06	1.56	2.48	1.46	2.38	2.82	1.92	2.33	1.66	1.59	1.36	1.7	1.54	1.4	1.93	2.13	2.97	0.91	1.07	1.85
UG6C11	49243	"neural precursor cell expressed, developmentally down-regulated 5"	0.62	1.41	0.65	0.91	1.28	0.88	0.78	1.61	0.66	0.75	1.29	0.65	1.1	0.9	1.02	0.69	1.16	0.77	0.83	0.56	0.83	1.12
UG6D1	49277	P311 protein	2.98	1.3	7.88	3.41	3.85	1.9	2.97	5.72	1.91	4.25	3.27	1.91	1.43	1.88	1.38	2.06	1.55	0.6	2.12	0.95	2.06	2.57
UG6D3	49322	KIAA0064 gene product	0.84	1.39	0.83	0.86	0.86	0.83	1.09	1.17	0.95	0.78	1.11	1.08	0.87	0.82	1.03	2.48	0.75	0.98	0.63	0.77	0.96	0.83
UG6D4	49383	G protein-coupled receptor kinase 6	1.41	1.3	0.97	1.52	1.48	2.15	1.92	1.13	1.85	1.63	1.36	1.08	1.16	0.49	1.5	1.74	1.38	1.31	2.45	1.85	1.58	2.5
UG6D5	49403	nascent-polypeptide-associated complex alpha polypeptide	0.64	0.61	0.74	0.57	0.6	0.66	0.91	0.53	0.47	0.76	0.56	0.78	1.11	0.94	0.62	0.83	0.82	0.95	0.9	0.79	0.62	0.8
UG6D7	49584	"lipase A, lysosomal acid, cholesterol esterase (Wolman disease)"	0.47	0.65	0.52	1.24	1	1.35	0.78	1.65	0.48	1.16	2.2	0.67	0.68	0.4	0.73	1.05	0.96	0.36	0.81	0.72	1.21	0.77
UG6D8	49608	"ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1"	0.57	0.88	0.45	0.7	0.76	1.12	1.25	0.49	0.45	1.95	0.8	0.44	0.6	0.42	0.67	1.09	0.56	0.43	0.26	0.28	0.32	0.44
UG6D9	49665	endothelin receptor type B	1.77	2.94	2.44	1.97	5.15	1.88	2.21	2.28	5.74	1.61	2.77	2.26	1.7	1.76	1.59	3	1.32	2.59	2.92	0.8	0.73	1.84
UG6D10	49666	tetracycline transporter-like protein	0.67	1.19	0.62	0.71	1.57	0.97	2.11	1.86	1.99	1.31	1.39	1.54	1.88	3.33	0.91	1.89	0.75	1.46	1.02	0.19	0.59	0.98
UG6D11	49691	"prion protein (p27-30) (Creutzfeld-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia)"	0.57	0.85	0.57	0.83	1.03	0.54	0.54	1.03	0.42	0.4	1	0.35	0.77	0.43	0.51	0.29	0.73	0.59	0.63	0.48	0.61	0.78
UG6E2	49777	"Human mRNA for ornithine decarboxylase antizyme, ORF 1 and ORF 2"	1.08	0.91	0.76	0.8	0.9	1.15	1.31	1.32	1.03	1.9	1.49	1.56	0.98	1.2	0.99	1.38	0.97	0.64	0.66	1.5	1.31	1.13
UG6E3	49788	carnitine acetyltransferase	0.71	0.95	0.78	0.86	0.76	0.75	1.78	1.03	0.93	1.4	1.63	1.29	0.99	1.05	0.79	1.05	0.58	0.76	0.94	1.4	1.58	1.01
UG6E5	49888	ADP-ribosylation factor 4-like	0.77	0.56	0.38	0.69	0.63	0.25	0.55	0.69	0.48	0.63	0.59	0.77	0.61	0.57	0.47	0.69	0.2	0.51	0.74	1.22	1.19	1.04
UG6E11	50038	phosphoglycerate kinase 1	0.44	0.34	0.81	0.53	0.47	0.87	0.77	0.43	0.24	1.15	0.8	0.39	0.3	0.26	1.09	0.59	0.7	0.26	0.34	1.04	0.61	1.36
UG6F1	50117	glyceraldehyde-3-phosphate dehydrogenase	0.28	0.53	0.53	0.62	0.42	0.59	0.43	0.36	0.36	0.7	0.45	0.25	0.34	0.31	0.26	0.43	0.62	0.92	0.68	0.84	1.07	0.57
UG6F2	50106	nucleoside phosphorylase	2.84	2.15	0.94	1.47	1.13	3.11	0.84	0.68	0.65	2.63	0.8	0.75	1.15	1.53	1.72	1.56	1.09	1.06	0.93	0.53	1.5	0.88
UG6F5	50232	"protein tyrosine phosphatase type IVA, member 2"	0.98	1.21	1.63	1.29	1.56	1.49	1.27	1.86	0.82	1.45	1.9	1.34	1.32	1.7	1.09	1.15	1.73	1.01	1.22	1.12	0.92	2.36
UG6F7	50271	"branched chain keto acid dehydrogenase E1, alpha polypeptide (maple syrup urine disease)"	1.18	1.12	0.99	1.15	1.98	1.35	1.15	1.58	1.31	3.71	1.47	1.69	0.71	0.75	0.87	1.03	1.08	0.72	1.25	1.92	1.31	1.26
UG6F8	50308	"lectin, galactoside-binding, soluble, 3 binding protein (galectin 6 binding protein)"	1.18	3.18	0.9	1.83	1.47	2.15	1.53	1.31	1.86	1.92	1.62	1.15	0.99	0.96	0.79	1.96	2.61	2.43	0.76	0.51	0.71	0.86
UG6F9	50322	proliferation-associated gene A (natural killer-enhancing factor A)	0.88	0.93	1.07	0.91	1.01	1.26	0.72	0.81	1.68	0.99	1.04	0.98	0.43	0.77	0.93	1.13	1	0.93	0.91	0.6	0.93	1.3
UG6F11	50363	"spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)"	1.38	1.16	0.64	1.27	1.52	1.57	0.86	1.3	1.37	1.15	1.67	0.6	0.77	0.81	0.85	0.85	0.87	0.68	1.33	0.89	1.13	1.3
UG6G1	50555	ribosomal protein L3	0.47	0.79	0.57	0.35	0.64	0.33	0.41	0.42	0.41	0.47	0.58	0.57	1.48	0.82	0.4	0.52	0.73	0.95	1.22	0.79	0.65	0.73
UG6G2	50561	"protein kinase C, beta 1"	0.76	0.73	0.57	0.72	0.68	0.6	0.97	0.72	0.51	0.79	1.41	0.59	0.9	0.91	0.87	0.92	0.61	0.68	0.42	0.51	0.41	0.71
UG6G3	50576	zinc finger protein 162	0.83	1.2	0.8	1.19	1.03	1.38	0.96	1.56	0.68	1.23	1.62	0.92	1.14	0.92	1.28	0.69	0.93	1.21	0.68	0.78	0.51	0.67
UG6G4	50609	nucleolin	1.44	2.34	0.61	1.29	1.88	1.26	1.65	1.06	1.58	1.63	1.27	1.09	1.93	1.8	1.89	1.49	1.87	1.93	1.17	0.78	0.65	1.24
UG6G5	50603	eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein)	0.76	1.01	0.7	0.55	0.99	0.68	1.29	0.56	0.5	1.74	0.67	0.34	0.6	0.56	0.95	0.7	0.5	0.88	0.86	1.05	0.8	2.26
UG6G6	50666	dolichyl-diphosphooligosaccharide-protein glycosyltransferase	0.94	0.63	0.85	0.88	0.94	1.03	1.49	0.86	0.47	0.72	0.93	0.79	0.7	0.61	1.1	0.9	0.98	0.63	0.62	0.75	1.13	0.8
UG6G7	50816	"2',3'-cyclic nucleotide 3' phosphodiesterase"	0.88	4.48	1.5	1.67	1.9	2.05	1.78	1.98	3.07	1.63	2.57	0.97	0.72	1.22	0.92	2.29	1.97	1.39	1.16	1.16	2.04	1.5
UG6G8	50888	antioxidant protein 1	0.79	1.15	0.91	1.59	1.48	1.03	1.23	1.37	0.84	1.4	1.37	1.3	1.9	1.16	0.99	1.64	1.44	1.17	1.27	1.13	0.71	1.35
UG6G9	50941	"cadherin 13, H-cadherin (heart)"	0.45	0.71	0.49	0.33	0.86	0.28	0.37	0.81	0.44	0.9	0.9	0.32	0.42	0.48	0.76	0.55	0.43	0.29	1.05	0.82	0.92	0.96
UG6G11	51018	annexin A2	0.41	0.24	0.44	0.29	0.4	0.51	0.31	0.56	0.23	0.34	0.45	0.39	0.36	0.46	0.54	0.15	0.52	0.39	0.24	0.31	0.55	0.31
UG6G12	51209	"protein phosphatase 1, catalytic subunit, beta isoform"	1.79	2.54	1.29	1.13	2.36	1.48	0.69	0.93	0.73	0.71	1.17	1.12	1.21	0.8	1.23	3.04	1.36	1.25	0.62	0.38	0.81	0.73
UG6H1	51219	sialomucin CD164	0.69	0.82	0.8	1.38	1.56	2.37	1.11	1.65	0.53	1.25	1.28	1.53	1.44	1	1.21	2.09	1.01	0.34	0.75	0.45	1.19	0.97
UG6H2	51241	voltage-dependent anion channel 2	0.55	0.39	0.43	0.64	0.59	0.59	0.84	0.46	0.4	0.58	0.73	0.49	0.72	0.65	0.57	0.56	0.69	0.64	0.37	0.54	0.39	0.58
UG6H3	51302	"ras homolog gene family, member A"	0.71	0.59	0.91	0.84	0.7	1.06	0.86	1.02	0.36	1.02	1.24	0.99	0.99	0.66	1.32	0.65	0.41	0.85	0.67	1.24	0.48	0.57
UG6H4	51293	aminoacylase 1	1.25	2.3	1.1	1.27	3.48	0.91	1.77	1.71	3.74	1.13	1.84	1.88	2.02	1.56	1.46	2.79	1.42	1.53	1.73	0.62	0.52	1.08
UG6H5	51318	hexokinase 1	1.07	0.6	0.43	0.55	0.76	0.52	0.72	0.64	0.63	0.62	0.85	1.11	0.93	0.91	0.9	0.91	0.72	0.95	1.66	0.71	1.11	1.13
UG6H9	51432	RAD23 (S. cerevisiae) homolog A	1.47	1.63	0.7	1.03	0.9	1.3	0.69	0.93	1.15	0.66	0.97	0.79	0.64	0.71	0.74	0.59	1.16	1	1.22	1.19	0.83	1.31
UG6H10	51454	"guanine nucleotide binding protein (G protein), beta polypeptide 1"	1.42	1.76	1.01	1.07	1.01	1.19	1.21	1.32	0.98	1.23	1.28	1	1.26	0.75	1.71	1.95	1.07	0.71	0.55	1.01	0.94	0.74
UG6H11	51461	"H3 histone, family 3B (H3.3B)"	1.41	1.9	0.93	1.33	1.33	1.14	1.49	2.5	1.62	1.85	2.01	0.84	1.31	1.11	0.98	0.87	1.77	1.53	1.3	1.98	1.02	1.51
UG6H12	51504	ribosomal protein L7a	1.37	0.94	0.44	0.7	0.92	0.71	1.2	0.68	0.99	1.15	0.88	0.54	1.1	0.89	0.94	2.71	0.54	0.52	0.65	0.62	0.32	0.55
LO6A3	471715	hemopoietic cell kinase	1.12	3.51	1.67	2.01	5.59	5.13	2.71	3.49	2.52	4.32	5.45	1.36	0.97	0.85	0.72	2.72	0.91	1.1	0.81	0.6	0.74	0.89
LO6A4	472067	"glia maturation factor, beta"	5.04	0.38	1.72	1.19	1.51	1.07	1.61	1.04	0.3	1.11	0.77	3.16	2.62	2.57	2.15	1.85	1.23	3.16	2.39	2.34	1.93	2.58
LO6A5	484993	CD81 antigen (target of antiproliferative antibody 1)	0.89	1.32	1.83	1.3	1.21	0.75	0.62	1.54	1.04	1.24	2.16	0.95	0.97	0.84	1.06	0.7	0.36	2.07	0.94	1.45	1.21	1.29
LO6A6	485690	"myosin, heavy polypeptide 9, non-muscle"	0.96	1.87	1.92	1.26	2.39	1.56	1.99	2.43	1.81	1.38	1.88	0.59	1.22	0.47	1.23	1.99	1.81	0.95	0.53	1.1	0.66	0.93
LO6A7	486012	"ESTs, Highly similar to ras-related GTP-binding protein [H.sapiens]"	0.6	1.2	0.94	1.22	0.96	1.45	0.56	1.35	0.81	0.96	1.1	0.79	0.73	0.77	0.7	0.49	0.9	1	0.86	1.23	0.84	0.85
LO6A8	486335	"actinin, alpha 1"	1.06	3.1	1.99	1.38	2.63	1.71	1.89	1.74	1.91	1.57	1.53	1.39	1.58	1.35	1.37	2.39	2.49	1.33	1.63	1.2	1.53	1.37
LO6A9	486375	"integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)"	1.17	1.01	1.59	0.96	1.14	0.58	0.69	0.55	0.76	0.88	0.78	1.11	1.31	1.01	1.18	0.98	0.42	1.35	2.32	0.88	1.2	1.63
LO6A10	486233	"RAB7, member RAS oncogene family"	0.88	2.54	0.54	0.94	1.58	1.12	1.44	1.23	1.83	1.11	1.7	0.7	0.93	1.16	0.74	1.7	2.18	1.01	0.56	0.79	0.87	0.91
LO6A11	486086	"phosphatidylinositol glycan, class F"	1.89	1.19	1.28	1.15	1.38	1	0.87	1.14	1.69	1.29	1.45	1.37	1.09	1.42	1.41	0.79	0.64	1.94	1.41	0.82	1.84	1.12
LO6A12	486785	"solute carrier family 22 (organic cation transporter), member 3"	0.95	6.13	5.26	4.46	9.07	4.5	2.77	4.42	2.34	2.91	2.44	4.3	2.75	3.64	2.08	1.65	0.91	1.57	5.82	2.6	2.31	3.48
LO6B1	486560	"antigen identified by monoclonal antibodies 12E7, F21 and O13"	0.88	1.19	3.51	0.74	1.96	1.41	1.05	2.56	1.12	1.15	1.94	1.06	1	1.21	1.03	1.76	0.48	1.27	0.86	0.82	0.68	1.07
LO6B2	486844	"gap junction protein, alpha 1, 43kD (connexin 43)"	1.52	3.6	7.11	6.1	3.08	2.7	6.06	8.58	4.79	4.83	3	0.65	0.73	1.28	1.41	1.71	4.3	1.66	0.74	0.93	0.97	0.9
LO6B3	487417	mitogen-activated protein kinase 6	1.14	0.98	0.7	0.63	1.23	1.58	0.69	1.2	0.83	2.48	2.29	0.6	0.62	0.6	1.1	1.11	0.91	0.85	0.6	0.56	0.78	0.74
LO6B4	487264		0.88	1.16	0.98	1.13	1.25	1.78	1.23	1.39	1.24	1.57	1.77	1.22	0.78	0.96	0.95	1.26	0.99	0.64	1.06	1.09	0.8	0.89
LO6B5	487386	microtubule-associated protein 4	0.88	1.35	1.26	0.7	0.95	1.13	0.56	0.68	0.33	0.6	1.38	0.71	0.94	0.75	1.48	0.73	0.75	1.35	0.74	0.63	0.84	1.15
LO6B6	487878	"secreted protein, acidic, cysteine-rich (osteonectin)"	1.31	12.91	17.7	7.31	5.83	4.87	7.44	6.5	6.14	13.08	6.44	2.66	2.88	3.59	1.91	4.81	6.66	2.75	2.04	0.97	1.65	2.02
LO6B7	488103	alpha-2-macroglobulin	1.37	3.45	10.38	5.96	14.57	4.4	4.38	3.33	6.96	3.18	4.43	1.4	1.21	1.5	1.6	3.66	3.06	2.14	3.36	1.03	1	1.94
LO6B8	488596	"kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyte antigen, antigen detected by monoclonal and antibody IA4))"	0.76	1.13	0.86	1.12	3.26	1.99	0.87	1.38	0.58	2.45	2.22	1.53	1.06	1.09	0.56	1.47	1.66	1	0.68	1.19	0.6	1.16
LO6B9	488373	myosin IC	0.75	1.04	0.55	0.8	1	1.43	0.69	1.1	1.25	0.51	1.25	1.66	0.86	0.74	1.34	0.54	0.65	1.03	1.4	0.88	2.33	1.03
LO6B10	488801	"pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1)"	1.2	3.21	4.92	2.13	4.6	5.38	1.99	1.56	1.05	2.04	2.27	2.04	1.49	2.27	1.47	1.48	0.91	1.43	2.69	1.23	1.71	1.78
LO6B11	488989	B-cell CLL/lymphoma 7b	1.31	1.62	0.98	1.46	1.4	2.03	1	1.42	1.16	1.27	1.53	0.85	1.39	1.13	1.5	1.02	0.5	0.88	1.3	0.66	1.79	0.48
LO6B12	489419	forkhead (Drosophila) homolog 1 (rhabdomyosarcoma)	1.09	0.42	0.32	0.56	0.98	0.9	0.45	0.77	0.45	1.16	0.84	5.39	1.95	2.34	1.52	0.55	0.41	0.71	4.94	2.03	3.62	4.08
LO6C2	509710	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"	1.71	3.16	1.05	1.37	1.99	1.93	1.22	1.49	2.65	1.46	1.85	1.77	1.87	3.43	1.28	2.56	1.53	2.3	1.27	0.69	0.91	1.14
LO6C3	509731	transmembrane 4 superfamily member 3	2.13	3.33	0.76	1.49	3.4	2	1.35	1.91	1.81	2.67	1.65	1.32	1.56	1.72	1.49	6.29	1.96	2.03	1.84	0.85	1	1.65
LO6C4	509820	"ets variant gene 4 (E1A enhancer-binding protein, E1AF)"	0.9	1.91	0.61	1.68	1.99	1.85	1.4	1.5	0.8	1.35	1.39	0.9	1.3	0.67	1.24	1.78	2.34	0.65	0.59	1.05	0.79	0.97
LO6C5	510101	lactate dehydrogenase B	0.94	0.95	0.89	0.92	1.01	1.03	0.66	1.19	1.04	1.09	1.09	1.02	1.17	0.91	1.49	0.74	0.71	1.58	1.52	0.81	0.8	1.54
LO6C7	510405	carcinoembryonic antigen	0.69	0.59	0.47	0.55	0.45	0.62	0.53	0.43	0.41	0.56	0.43	1.17	0.82	0.78	1.52	1.66	0.5	0.98	1.4	0.68	0.52	1.26
LO6C8	510595	lactate dehydrogenase A	1.24	0.39	0.63	0.42	0.46	0.3	0.65	0.41	0.28	0.74	0.33	0.82	1.1	0.92	0.88	0.79	0.6	1.23	0.5	0.43	0.36	0.6
LO6C9	510245	"eukaryotic translation initiation factor 3, subunit 9 (eta, 116kD)"	0.92	1.18	0.67	1.71	1.22	1.39	1.35	1.75	1.25	1.38	1.35	0.65	0.79	0.56	0.78	1.49	0.79	0.98	0.51	0.69	0.58	0.61
LO6C10	512458	peripheral myelin protein 22	0.98	1.89	1.3	1.04	1.48	1.04	2.21	1.91	1.61	1.58	2.04	1.32	1.15	1.06	1.19	1.63	1.38	0.7	1.03	0.82	0.97	0.96
LO6C11	512472	"ferritin, light polypeptide"	1.11	1.45	0.96	0.72	2.86	0.72	0.45	1.78	1.15	0.82	0.27	3.49	2.33	2.47	2.02	0.98	1.52	1.22	2.63	1.33	3.54	1.95
LO6D1	512276	vimentin	1	1.62	17.77	13.29	16.8	3.19	9.07	9.45	25.02	12.68	6.57	0.82	0.95	0.74	0.99	3.96	2.84	1.35	0.81	0.87	0.8	0.8
LO6D3	512244	CD151 antigen	1.03	1.02	0.51	0.96	1.02	0.78	1.29	0.63	0.6	0.82	0.85	1.58	1.34	0.69	1.08	0.57	2.26	2.69	1.99	2.31	2	1.84
LO6D4	512429	insulin-like growth factor binding protein 2 (36kD)	1.95	0.51	0.96	0.62	1.03	0.52	0.53	0.27	0.31	0.41	0.49	1.62	1.61	1.21	0.97	0.67	0.87	0.72	2.07	1.98	1.69	2.31
UG7A5	51666	"excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing)"	1.19	1.09	1.04	1.09	1.05	1.01	0.43	1.79	1.04	0.94	1.36	0.95	1.47	1.01	1.1	0.51	0.71	1.69	0.73	0.93	1	0.71
UG7A6	51685	poly(A)-binding protein-like 1	1.41	0.94	1.18	1.15	1.11	1.08	0.73	0.42	0.62	0.98	0.8	1.16	1.81	1.79	1.39	0.85	1.36	2.75	2.04	0.83	1.5	1.76
UG7A7	51687	KRAB-associated protein 1	1.25	0.8	0.66	0.78	0.74	0.44	0.44	0.79	0.5	0.41	0.82	0.84	0.87	0.79	1.09	0.8	0.5	0.86	1.17	0.58	1.5	1.18
UG7A8	51699	v-myc avian myelocytomatosis viral oncogene homolog	2.78	0.91	0.4	1.4	0.68	0.83	0.29	0.3	0.18	0.36	0.28	1.58	1.11	2.11	1.54	0.36	2.03	2.86	1.33	0.82	0.66	1.41
UG7A9	51740	"hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit"	1.31	1.73	1.04	1.01	1.54	0.96	0.74	1.21	1.41	0.75	1.17	0.91	0.89	1.21	0.64	1.11	0.67	1.01	0.66	0.56	0.6	0.92
UG7A10	51785	"proteasome (prosome, macropain) subunit, alpha type, 1"	2.29	0.99	0.56	0.75	1.21	0.67	0.83	0.91	0.54	0.81	1	1.45	1.33	1.58	1.11	1.16	1.15	2.21	1.49	2.72	1.91	1.88
UG7A11	51814	cystatin B (stefin B)	1.14	1.78	1.01	1.34	1.2	1.46	0.91	0.9	1.18	0.91	1.2	1.05	1.19	2.14	1.2	0.93	1.52	1.36	1.29	0.92	1.04	1.31
UG7B1	51961	ubiquinol-cytochrome c reductase core protein I	0.96	0.72	0.52	0.97	1.42	0.98	0.83	0.65	0.38	0.69	0.55	0.83	0.72	1.34	0.9	0.65	0.91	0.78	1.26	0.53	0.99	1.03
UG7B3	52222	Human DNA for insulin-like growth factor II (IGF-2); exon 7 and additional ORF	0.85	0.73	0.56	0.52	1.98	1.37	1.23	2.01	0.97	1.58	1.83	0.43	0.66	1.03	1.3	1.07	0.91	1.22	0.8	0.61	1.02	0.7
UG7B4	52342	lamin B2	0.78	0.96	0.88	1.24	0.87	1.14	1.01	0.9	0.74	1.16	1.07	1.96	1.99	2.76	1.33	1.38	1.1	1.12	2.79	0.79	1.28	2.35
UG7B5	52338	"activin A receptor, type II"	0.54	1.14	0.88	0.9	1.13	0.79	0.43	1.27	1.32	0.34	2.37	0.62	0.59	0.5	1.05	0.6	0.62	1.12	0.47	0.36	0.81	0.67
UG7B6	52415	"complement component 1 inhibitor (angioedema, hereditary)"	4.76	7.33	6.73	4.35	5.13	4.77	5.62	6.31	2.74	4.32	4.97	6.92	6.25	13	3.92	2.66	3.95	19.17	31.1	14.2	5.88	22.94
UG7B9	52587	tryptophanyl-tRNA synthetase	0.8	5.2	1.09	2.96	2.08	6.27	1.36	1.9	0.67	2.54	2.57	0.45	0.7	0.73	1.29	0.91	1.53	1.16	1.09	0.68	2.07	1.44
UG7B11	52650	v-ets avian erythroblastosis virus E26 oncogene homolog 2	1.31	1.67	0.82	1.09	1.25	2.96	0.43	0.75	0.42	0.68	0.9	0.99	1.07	1.55	0.86	0.58	0.98	2.09	1.63	1.52	1.45	1.62
UG7C3	52773	"protein tyrosine phosphatase, receptor type, F"	0.89	3.72	0.8	1.59	3.2	1.85	1.35	2.11	2.53	1.6	1.77	1.41	1.13	1.43	1.22	2.57	2.22	1.4	2.08	0.73	1.54	0.52
UG7C4	52896	"peroxisomal membrane protein 3 (35kD, Zellweger syndrome)"	3.44	1.25	0.6	1.23	0.8	0.66	0.97	0.91	0.77	1.28	1.2	1.09	0.93	0.55	0.91	1.51	0.89	0.73	0.9	0.77	1.42	0.87
UG7C5	52931	general transcription factor IIIA	2.45	0.85	1.24	1.13	1.36	1.38	0.35	1.14	1.21	1.31	1.65	1.23	0.99	0.93	1.36	0.73	0.81	0.95	0.91	0.71	1.25	1.04
UG7C7	53068	ubiquitin-conjugating enzyme E2 variant 1	0.38	0.56	0.75	0.49	0.63	0.83	0.66	0.75	0.95	0.58	0.64	0.48	0.37	0.53	0.9	0.84	0.51	1.1	0.38	0.36	1.37	0.37
UG7C9	53084	amyloid beta (A4) precursor-like protein 2	2.3	0.73	0.66	0.9	0.61	0.99	0.67	0.7	0.28	0.76	0.89	1.59	1.46	1.56	1.39	0.96	0.43	1.3	1.05	0.74	1.05	1.45
UG7C10	53107	"calmodulin 3 (phosphorylase kinase, delta)"	1.06	0.97	0.81	0.67	0.91	0.84	0.74	0.85	0.83	1.02	1.14	1.05	1.94	2.64	1.96	1.04	1.09	1.22	0.85	0.31	0.58	1.24
LO1A2	77577	FOS-like antigen 2	1.07	1.53	2.18	0.85	1.5	1.16	1.32	1.56	0.66	1.26	1.15	0.83	1.23	0.8	0.81	1.03	1.08	0.77	1.21	0.41	0.95	0.31
LO1A6	81221	"Fc fragment of IgG, high affinity Ia, receptor for (CD64)"	1.05	14.29	4.98	3.84	8.37	4.5	1.69	7.87	2.57	9.23	3.8	3.15	2.95	3.45	2.5	3.36	0.98	2.52	6.7	1.78	2.96	2.79
LO1A7	82991	phosphodiesterase I/nucleotide pyrophosphatase 1 (homologous to mouse Ly-41 antigen)	1.16	1.19	1.18	1.36	3.07	1.54	3.34	5.06	6.87	3.5	2.09	6.67	1.97	4.37	1.52	1.47	1.47	1.67	6.04	1.96	4.4	5.07
LO1A9	84730	Untitled	1.69	1.35	0.86	1.31	1.4	1.34	1	0.99	0.73	1.56	0.65	0.96	1.39	0.98	0.76	0.99	1.11	0.81	1.05	0.85	0.77	0.91
LO1A10	85906	platelet/endothelial cell adhesion molecule (CD31 antigen)	1.92	7.32	5.5	5.58	12.66	5.45	5.41	7.18	5.86	8.8	5.93	4.82	8.75	3.51	3.33	2.98	2.72	2.53	4.89	3.57	3.45	6.77
LO1A11	86017	"intercellular adhesion molecule 1 (CD54), human rhinovirus receptor"	2.78	5.38	2.26	1.43	4.13	5	2.65	4.37	1.62	7.38	5.22	7.01	2.55	3.79	3.14	1.64	4.85	2.31	3.94	1.81	2.19	2.15
LO1A12	23464	human immunodeficiency virus type I enhancer-binding protein 2	1.45	1.12	0.37	0.58	2.04	1.85	0.85	0.85	0.96	0.63	0.92	0.87	0.99	0.91	1.22	1.63	1.87	0.78	1.7	0.59	1.55	1.13
LO1B5	110589	"Human signal transducer and activator of transcription Stat5B mRNA, complete cds"	1.1	1.68	1.29	1.01	2.57	3.2	1.36	2.25	1.88	0.95	2.03	1.4	2.14	1.82	1.19	1.46	0.91	1.04	1.18	1.12	1.12	1.33
LO1B7	112035	ESTs	1.6	2.21	1.48	0.94	1.49	1.03	1.14	1.43	1.58	1.75	2.36	1.07	0.82	1.48	1.21	1.95	0.91	1.24	1.69	0.97	2.11	1.85
LO1B8	114116	"syndecan 2 (heparan sulfate proteoglycan 1, cell surface-associated, fibroglycan)"	1.25	1.51	1.9	1.42	2.58	2.09	1.73	2.36	1.91	1.01	1.91	2.23	2.73	1.96	0.84	1.95	1.68	1.58	2.58	1.5	1.44	2.12
LO1B9	114648	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)	1.31	0.96	1.62	0.75	1	1.17	0.89	1.2	0.91	0.76	1.19	1.12	1.39	1.45	0.72	0.77	0.91	1.14	1.13	0.73	0.9	1.1
LO1B12	115336	"sialyltransferase 1 (beta-galactoside alpha-2,6-sialytransferase)"	1.11	1.13	1.05	1.23	1.3	1.9	1	1.09	1.24	1.98	0.82	1.4	1.36	1.26	0.89	0.84	1.42	1.46	1.03	0.63	0.64	0.85
LO1C2	116713	monokine induced by gamma interferon	0.92	1.23	0.72	0.91	1.47	0.99	1.12	0.93	1.7	0.75	1.3	1.36	1.18	1.34	1.07	1.62	0.91	0.95	0.81	0.52	0.39	0.78
LO1C5	121849	T-cell acute lymphocytic leukemia 1	1.44	1.38	1.17	0.94	2.54	1.35	2.46	4.62	2.46	3.02	1.71	1.91	1.81	2.05	2.6	2.8	0.83	2.22	1.06	0.85	0.98	1.19
LO1C6	123586	syndecan 1	2	3.82	0.72	0.84	3.37	2.58	2.82	5.76	3.52	2.28	3.78	1.17	2.14	3.45	2.37	1.88	1.6	2.6	2.56	1.27	0.85	1.96
LO1C7	123953	"Human MHC class II DQ-beta associated with DR2, DQw1 protein, complete cds"	1.38	2.27	1.95	1.12	1.41	1.72	1.69	1.03	1.82	1.86	0.83	1.39	1.46	2.15	0.8	1.38	1.24	1.85	1.23	0.7	0.52	0.95
LO1C8	124554	colony stimulating factor 1 (macrophage)	2.42	8.59	5.74	4.96	7	4.54	5.05	6.16	2.8	8.63	3.95	3.46	5.98	6.37	2	4.22	4.93	0.94	5.23	1.81	2.42	4.07
LO1C9	125187	"H.sapiens ERCC2 gene, exons 1 & 2 (partial)"	1.01	1.56	1.05	1.05	1.84	0.92	0.86	1.85	2.03	1.5	1.32	1.42	1.23	1.12	1.3	1.57	0.92	1.13	1.43	1.03	0.98	1.13
LO1C11	126379	"protein tyrosine phosphatase, receptor type, U"	0.83	0.37	0.66	0.23	1.16	0.96	0.78	0.71	0.91	0.57	0.38	0.41	0.4	0.32	0.54	0.27	0.29	0.4	0.87	1.03	1	1.23
LO1D2	128100	"syndecan 4 (amphiglycan, ryudocan)"	0.78	0.48	0.14	0.21	0.6	0.49	0.42	0.61	0.9	0.38	0.48	1.04	0.66	0.98	0.82	0.64	0.29	0.48	0.81	1.09	0.21	0.56
LO1D5	26503	transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	0.74	2.02	1.16	1.91	1.44	2.05	1.98	1.34	1.43	1.09	1.29	0.86	1.22	0.91	0.88	1.89	1.79	0.97	0.86	0.86	0.72	1.03
LO1D6	26474	v-fos FBJ murine osteosarcoma viral oncogene homolog	0.34	0.15	0.28	0.37	0.61	0.09	0.16	0.68	0.07	0.25	0.23	0.29	2.19	0.48	0.29	0.17	0.06	0.18	0.47	0.16	0.3	0.7
LO1D7	26167	Fas (TNFRSF6)-associated via death domain	1.56	0.96	0.88	1.21	1.23	1.26	1.29	1.71	1.27	1.04	1.55	1.15	1.02	1.33	2	1.04	0.07	0.78	0.6	0.97	0.65	0.77
LO1D9	26811	X-ray repair complementing defective repair in Chinese hamster cells 4	0.65	2.28	1.68	1.54	1.54	1.08	2.14	2.38	0.95	2.76	1.91	0.86	0.79	0.79	0.89	1.76	1.45	0.85	0.88	1.58	0.76	0.76
LO1E5	31116	"mutL (E. coli) homolog 1 (colon cancer, nonpolyposis type 2)"	1.9	1.72	1.36	2.22	2.25	1.3	1.65	1.92	1.49	2.01	1.93	1.14	1.57	2.12	1.11	1.18	0.85	1.58	1.59	0.97	1.08	1.32
LO1E6	32790	"mutS (E. coli) homolog 2 (colon cancer, nonpolyposis type 1)"	2.92	2.62	2.36	4.96	3	3.22	1.5	2.03	1.36	1.56	0.76	1.65	1.6	2.02	1.44	3.45	1.04	3.03	2.18	1.05	0.95	1.34
LO1E7	32983	DKFZP434K2235 protein	1.73	0.86	2.29	2.13	2	1.64	1.44	2.01	1.51	2.6	1.97	1.3	1.49	1.91	1.23	0.95	1.5	1.26	2.68	1.4	1.79	2.37
LO1E9	34005	interferon gamma receptor 2 (interferon gamma transducer 1)	1.17	1.59	1.2	1.78	1.66	1.32	1.29	1.82	1.27	1.8	2.24	1.1	1.35	1.71	1.43	1.62	1.8	1.18	2.08	1.6	2.24	1.71
LO1E11	35516	cyclin G1	0.12	0.28	0.31	0.44	0.34	0.27	0.24	0.24	0.18	0.28	0.22	0.16	0.33	0.27	0.23	0.3	0.29	0.34	0.16	0.22	0.17	0.45
LO1F1	36215	"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon"	1.85	3.02	10.43	4.88	4.91	5.59	4.75	10.17	8.75	3.94	5.2	3.63	3.76	7.75	2.92	0.61	2.52	2.92	5.92	6.36	4.9	7.15
LO1F5	43129	"phospholipase C, gamma 1 (formerly subtype 148)"	0.72	0.86	0.71	0.95	1.02	0.63	0.94	0.89	0.93	1.06	0.76	0.77	0.65	1.15	0.93	1.03	0.62	0.85	0.68	0.58	0.75	0.66
LO1F6	131828	ESTs	1.29	1.6	0.84	1.47	1.58	1.67	1.45	0.94	1.24	1.1	1.41	1.26	1.82	2.24	1.05	1.33	1.28	1.85	1.56	1.4	0.94	2.01
LO1F7	132420	v-ets avian erythroblastosis virus E26 oncogene homolog 2	2.25	6.29	4.44	2.52	8.32	4.79	4.37	6.35	5.86	3.06	5.07	3.25	4.57	5.4	2.67	2.47	1.9	3.28	7.34	2.13	6.3	5.04
LO1F9	135381	growth arrest and DNA-damage-inducible 34	1.37	1.57	0.95	1.74	2.07	1.12	1.19	1.1	0.88	1.14	1.14	0.8	1.19	1.52	1.13	0.89	1.61	1.59	1.04	0.48	0.87	1.02
LO1F12	138460	cyclin G2	1.07	1.18	1.24	0.98	1.67	1.47	1.77	1.47	1.25	2.17	1.27	2.01	1.82	2.6	1.14	1.32	1.9	0.99	1.37	0.9	0.8	2.27
LO1G1	138604	"MAD (mothers against decapentaplegic, Drosophila) homolog 2"	1.33	1.13	1.13	1.31	0.92	1.17	0.9	1.14	0.74	0.46	0.89	0.94	1.11	0.99	1.07	0.62	1.08	0.96	0.81	0.5	0.77	1.02
LO1G6	140827	"MAD (mothers against decapentaplegic, Drosophila) homolog 4"	1.38	1.15	1.48	1.81	1.24	1.09	0.86	1.33	0.66	1.08	1.11	0.98	1.96	1.46	1.28	1.08	1.7	1.62	1.15	0.49	0.61	0.97
LO1G7	143751	lymphocyte-specific protein 1	1.65	2.63	1.35	1.81	2.57	1.71	1.54	2.16	1.64	1.83	2.27	1.27	2.4	2.03	1.12	1.25	1.24	1.47	1.89	0.69	1.61	1.36
LO1G8	144944	"chemokine (C-X-C motif), receptor 4 (fusin)"	3.76	16.68	7.11	8.57	8	8.74	7.23	7.4	5.11	9.08	6.99	7.07	5.32	15.6	3.37	6.35	4.64	17.17	13.08	1.71	2.83	4.94
LO1G9	144693	"transforming growth factor, beta 1"	2.34	7.15	3.86	4.69	7.3	5.8	5.22	8.99	8.61	7.06	5.54	3.05	3.78	4.84	1.62	3.34	0.88	2.52	4.72	1.52	3.34	3.21
LO1H7	154472	"fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome)"	1.38	1.07	2.83	2.26	2.47	0.86	3.51	5.77	13.09	3.02	2.2	3.78	1.55	1.89	1.31	1.74	0.37	5.98	5.53	3.77	1.41	2.17
LO1H9	154536	X-ray repair complementing defective repair in Chinese hamster cells 1	1.34	1.72	1.4	1.2	1.69	1.43	1.38	1.53	2.13	1.69	1.37	1.1	0.94	1.25	0.8	1.22	1.93	0.96	0.88	0.72	1.22	1.14
LO2A3	162772	early growth response 1	1.12	6.11	0.45	4.2	7.73	2.67	3.26	2.8	2.27	7	3.03	0.84	2.95	1.78	2.24	3.37	1.55	1.91	5.19	0.75	1.3	3.97
LO2A4	48398	cell division cycle 25B	0.98	0.54	1.55	1.42	1.15	1.15	0.71	0.46	0.52	0.76	1.35	0.53	0.75	0.63	1.61	1.72	0.63	0.94	1.88	2.4	2.51	1.51
LO2A6	49950	flap structure-specific endonuclease 1	1.79	2.96	1.25	2.27	2.36	2.36	1.44	1.01	1.87	2.46	0.48	1.17	0.87	2.3	1.58	2.47	2.4	4.33	1.02	0.95	1.08	1.32
LO2A7	50576	zinc finger protein 162	1.24	2.2	1.33	1.78	2.04	1.79	1.45	1.42	0.96	1.7	2.03	0.93	1.22	1.12	1.1	1.19	1.58	0.96	4.97	5.35	4.04	1.26
LO2A8	50503	"integrin, beta 2 (antigen CD18 (p95), lymphocyte function-associated antigen 1; macrophage antigen 1 (mac-1) beta subunit)"	0.89	2.06	1.28	1.39	1.7	3.44	1.94	2.15	1.37	4.08	1.32	1.17	1.07	1	1.12	1.64	1.97	0.63	3.09	1.44	1.58	1.91
LO2B1	52489	fibroblast growth factor 9 (glia-activating factor)	1.87	3.23	1.98	1.88	5.45	2	2.16	3.18	4.11	1.93	2.82	3.36	1.5	1.99	1.89	3.18	1.64	2.93	2.8	0.93	0.66	2.34
LO2B2	52162	ESTs	1.49	4.24	0.79	1.76	6.47	3.2	3.14	2.2	2.34	5.38	3.35	1.54	1.89	2.18	1.51	2.28	0.91	1.45	3.59	0.84	1.93	2.73
LO2B3	52681	v-rel avian reticuloendotheliosis viral oncogene homolog B (nuclear factor of kappa light polypeptide gene enhancer in B-cells 3)	1.02	7.27	1.21	2.01	6.18	3.37	2.52	3.98	2.08	4.7	3.2	0.86	1.94	1.46	1.67	2.85	5.17	1.19	3.95	0.72	1.57	2.02
LO2B4	179711	"nuclear factor of activated T-cells, cytoplasmic 4"	2.38	4.41	10.8	1.83	6.9	1.67	2.66	4.42	9.28	9.72	3.33	2.54	3.44	4.94	1.01	2.85	0.91	1.62	3.8	2.74	2.75	6.71
LO2B6	183950	Thy-1 cell surface antigen	4.08	8.51	14.59	7.79	13.45	6.83	7.61	9.6	10.06	13.81	6.16	6.49	4.45	11.56	3.79	7.12	4.1	8.26	11.26	4.75	4.09	9.58
LO2B7	187987	interleukin 4 receptor	1.25	2.15	0.82	1.5	3.98	2.09	2	2.35	1.37	2.27	1.82	1.14	1.38	1.88	1.04	1.09	1.64	1.02	2.98	0.88	1.95	1.35
LO2B8	192694	"POU domain, class 2, transcription factor 1"	1.72	3.12	1.57	1.44	3.09	2.28	2.88	1.92	2.89	2.21	1.62	1.86	1.82	2.63	1.25	3.13	1.51	1.66	2.79	1.08	1.6	3.24
LO2B12	201797	RAS p21 protein activator (GTPase activating protein) 1	0.9	0.92	0.69	0.82	1.79	1.16	0.94	1.07	0.71	0.49	1.18	0.85	1.67	1.48	0.66	0.98	1.11	0.48	1.65	0.79	0.57	0.89
LO2C1	201673	interferon regulatory factor 2	1.67	2.26	1.49	1.87	2.63	2.78	1.91	2.67	1.75	2.21	2.69	1.85	1.53	1.19	1.45	1.91	1.75	0.89	3.24	1.69	2.22	2.49
LO2C2	203132	"tumor necrosis factor (ligand) superfamily, member 10"	5.56	12.3	1.3	5.19	3.57	6.43	7.86	10.02	2.49	12.51	5.36	4.33	4.81	4.14	1.82	5.69	5.36	1.55	4.01	0.76	2.35	3.35
LO2C3	203017	interferon regulatory factor 3	1.02	1.66	0.8	0.85	2.1	0.92	1.59	1.38	1.35	1.16	1.26	1.25	1.15	1.9	1.58	1.32	0.54	1.08	2.05	0.88	1.29	1.08
LO2C5	204681	breakpoint cluster region	0.94	2.94	0.76	1.42	2.33	1.78	1.83	1.78	1.71	2.42	1.83	1	1.17	1.14	1.71	2.93	1.83	3.46	1.42	1.88	1.46	1.55
LO2C7	209310	v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (p65))	0.95	1.05	0.81	1.1	1.42	0.99	1.32	1.36	0.9	1.05	1.22	1.2	1.12	1.24	1.45	1.22	0.74	1.89	1.54	1.19	1.31	1.53
LO2C9	221690	programmed cell death 2	0.78	0.99	0.6	1.16	0.94	1.19	0.94	0.92	0.92	1.81	1.23	0.76	1.13	0.81	1.93	1.09	0.77	1.11	0.97	0.78	0.94	0.94
LO2C10	221619	"major histocompatibility complex, class II, DQ alpha 1"	2.77	17.65	6.2	7.95	7.62	8.52	5.7	9.07	12.01	16.24	4.72	4.11	5.43	10.31	3.15	9.7	8.24	7.85	15.28	7.53	5.37	6.79
LO2C11	223176	ESTs	1.48	2.47	1.11	2.02	2.99	2.19	1.67	2.37	1.18	3.1	2.12	1.52	1.55	1.43	1.47	2.21	1.94	1.09	2.05	1.4	2.1	1.32
LO2C12	230976	menage a trois 1 (CAK assembly factor)	1.5	1.08	1.16	0.89	1.62	0.95	1.07	0.99	0.98	0.85	0.96	1.4	1.57	1.8	1.48	1.55	0.82	1.04	1.57	1.14	0.93	1.3
LO2D1	231302	E2F transcription factor 3	1.22	2.48	2.36	3.18	2.49	1.59	1.43	1.64	0.95	1.01	1.73	0.84	0.94	0.79	1.09	1.86	2.27	1.76	1.16	0.81	1.19	1.51
LO2D2	233194	special AT-rich sequence binding protein 1 (binds to nuclear matrix/scaffold-associating DNA's)	1.34	2.17	1.32	2.03	2.96	2.54	1.47	1.7	0.85	1.14	1.19	0.77	1.06	0.69	0.9	1.76	1.66	1.07	0.81	0.37	0.88	0.75
LO2D5	236338	tumor protein p53 (Li-Fraumeni syndrome)	1.53	3.59	1.24	1.54	1.8	1.15	1.87	1.96	1.04	1.23	2.37	0.73	1.12	0.55	0.85	2.05	5.39	1.29	0.99	0.83	0.89	0.94
LO2D7	238577	"major histocompatibility complex, class II, DP beta 1"	3.27	16.45	16.07	10.44	9.53	7.79	9.31	17.66	75.18	14.51	6.08	6.14	4.2	5.64	2.88	5.61	4.23	4	7.51	1.48	3.08	4.88
LO2D8	243159	occludin	1.74	1.1	1.32	1.42	0.98	1.16	1.8	1.14	1.07	1.64	1.11	0.97	1.2	1.74	2.03	1.49	1.5	1.57	0.45	0.7	0.71	0.74
LO2D9	244355	"interleukin 2 receptor, gamma (severe combined immunodeficiency)"	1.28	2.34	1.34	2.13	2.12	2.22	5.41	2.42	2.09	6.92	2.18	2.11	1.2	2	3.24	3.31	2.52	2.14	1.74	1.07	1.08	2.07
LO2D10	248032	"ESTs, Highly similar to topoisomerase II alpha {C-terminal} [H.sapiens]"	2.31	3.24	3.25	2.62	1.41	2.61	5.73	1.43	2.03	7.38	0.78	1.65	0.78	3.92	1.55	3.91	2.7	3.1	0.3	0.64	0.45	0.69
LO2D11	248613	v-myb avian myeloblastosis viral oncogene homolog	1.54	1.3	1.34	1.36	1.41	1.44	1.71	1.18	1.47	1.58	1.24	1.5	1.24	1.27	1.44	0.78	1.12	0.96	1.05	0.69	1.14	1.22
LO2E3	257766	cyclin H	0.97	1.22	0.49	1.6	1.67	0.79	1.18	0.83	0.88	1.33	0.86	0.59	0.99	1.02	0.7	0.68	0.64	0.65	1.22	0.72	0.94	1
LO2E5	260052	hematopoietic cell-specific Lyn substrate 1	1.77	3.83	3.69	1.76	4.63	2.92	2.2	2.96	2.03	3.05	2.4	1.93	1.8	1.61	1.54	1.51	2.25	1.18	3.49	1.28	1.8	2.38
LO2E7	262575	DKFZP566A0946 protein	1.03	1.13	1.17	1.21	1.58	1.19	1.04	1.39	1.03	1.05	1.6	1.43	0.96	0.94	0.88	1.08	0.84	1.27	1.37	2.21	1.79	1.62
LO2E8	264606	ESTs	1.05	1.47	0.72	0.98	1.32	1.45	0.85	0.98	1.26	0.81	0.55	1.08	0.89	0.94	0.85	1.65	1.36	0.78	0.71	1.03	0.72	0.73
LO2E10	267246	presenilin 2 (Alzheimer disease 4)	1.37	0.96	1.04	1.26	1.69	1.55	1.77	1.66	1.39	1.86	1.52	1.28	1.04	1.68	1.29	1.8	1.66	1.16	1.05	0.99	0.81	1.09
LO2E11	267682	p21 (CDKN1A)-activated kinase 2	2.72	2.35	1.3	1.98	7.82	2.77	1.49	1.61	1.13	2.3	1.73	1.62	1.54	1.08	1.31	1.18	2.45	1.12	1.71	1.91	1.42	1.96
LO2F6	271662	cholinesterase-related cell division controller	0.97	0.92	0.97	1.02	1.26	1.2	1.43	1	1.27	1.43	0.87	1.48	0.97	1.41	0.75	1.21	1.7	1.04	0.89	0.68	0.59	0.94
LO2F7	272110	new Ets-related factor	0.72	0.34	0.67	0.81	1.01	0.51	0.37	0.51	0.53	1.12	0.58	0.3	0.34	0.29	0.55	1.36	0.75	0.47	0.51	1.1	0.51	1.47
LO2F8	278409	mitogen-activated protein kinase kinase 4	1.15	1.01	2.39	0.9	2.29	1.53	1.41	1.16	1.22	1.01	1.64	1.25	1.42	0.99	0.95	1.45	1.67	1.12	1.15	0.69	0.56	0.99
LO2F9	279482	damage-specific DNA binding protein 1 (127kD)	1.9	3.81	1.15	2.26	5.91	2.04	3.39	6.01	4.01	1.93	1.61	1	2.45	4.89	1.5	3.88	1.44	1.22	2.87	1.17	1.53	3.5
LO2F12	281778	"transforming growth factor, beta 2"	1.22	2.29	3.42	1.9	2.18	1.47	2.13	1.64	1.75	1.91	1.11	2.84	1.2	1.69	1.29	1.72	1.51	1.58	1.59	1.05	1.32	1.33
LO2G6	291057	"cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)"	1.89	2.09	2.02	2.13	2.24	1.47	1.44	1.26	1.64	1.54	1.32	1.72	1.65	2.48	1.1	1.77	0.91	2.07	1.01	0.67	0.8	1.11
LO2G8	291736	interferon regulatory factor 4	1.96	2.29	2.26	1.63	1.54	1.33	2.32	2.04	1.92	2.78	1.01	1.55	2.23	2.71	1.26	2.18	1.22	1.21	1.71	1.09	1.08	2.08
LO2G9	293274	cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase)	1.23	2.38	4.4	2.23	4.37	2.49	2.8	4.83	2.44	2.79	2.24	1.31	2.84	2.78	1.1	2.64	2.05	1.28	1.66	0.98	1.12	1.61
LO2G10	293934	chromosome segregation 1 (yeast homolog)-like	1.35	1.44	1.62	1.2	1.41	1.48	1.64	0.81	1.57	1.64	0.73	1.35	0.88	1.21	1.18	1.86	1.63	1.28	0.75	0.75	0.42	0.59
LO2H1	299198	ESTs	2.5	1.47	8.9	8.28	6.98	3.56	4.31	50.6	4.66	5.11	2.9	3.69	3.73	5.17	2.35	2.68	3.18	7.95	5.19	1.43	2.43	5.46
LO2H2	299539	fibroblast growth factor 12	3.04	8.68	11.26	5.63	6.82	4.23	7	8	7.2	7.11	3.58	3.47	4.33	5.23	2.69	3.98	3.47	7	5.47	1.83	3.16	5.73
LO2H3	300973	"CD8 antigen, alpha polypeptide (p32)"	1.52	14.46	4.77	13.52	3.04	7.35	4.62	609.63	2.89	4.57	5.62	6.8	2.42	3.03	1.66	3.43	2.79	3.36	2.18	0.46	1.09	1.22
LO2H4	301723	CDW52 antigen (CAMPATH-1 antigen)	2.35	4.93	1.83	3.63	3.29	4.6	3.12	2.96	2.95	4.57	4.26	3.48	1.82	2.03	1.82	3.51	2.38	1.67	5.09	0.48	3.1	1.9
LO2H5	302394	natural killer cell transcript 4	2.42	14.6	2.55	13.13	7.42	6.61	6.33	9.26	4.61	9.58	3.87	5.19	3.13	2.56	2.09	2.87	5.93	5.95	9.86	2.63	4.01	8.09
LO2H8	305455	"interferon-stimulated transcription factor 3, gamma (48kD)"	3.71	7.03	3.02	4.34	2.87	5.18	5.03	5.3	6.89	6.1	3.43	5.18	2.04	3.48	2.91	4.62	2.08	1.7	2.58	2.81	3.93	0.72
LO2H9	306013	CD20 antigen	1.25	2.55	1.35	1.49	1.96	1.25	1.69	1.79	2.31	1.47	1.5	0.94	1.36	0.73	1.34	1.41	1.21	1.26	1.69	0.77	1.17	1.11
LO2H10	306134	ESTs	1.2	0.77	0.66	0.87	1.46	0.88	0.79	1.25	0.77	0.67	0.73	0.6	0.98	0.49	0.78	1.2	0.56	0.26	0.46	0.26	0.69	0.44
LO2H11	307293	"RAP1A, member of RAS oncogene family"	1.28	1.31	1.46	1.44	1.44	1.27	1.97	1.69	1.12	1.98	1.15	0.96	0.92	0.69	0.94	0.62	1.25	0.72	1.02	0.37	0.57	0.93
LO3A6	310490	RAD23 (S. cerevisiae) homolog B	1.84	2.28	0.9	1.35	1.58	0.85	1.54	1.68	1.8	1.15	1.31	1.01	1.46	2.46	1.49	2.35	1.53	2.57	0.76	1	0.85	1.48
LO3A7	310390	"protein kinase, cAMP-dependent, regulatory, type II, beta"	0.78	0.85	0.72	0.57	0.5	0.48	0.58	0.6	0.52	0.46	0.49	0.64	0.72	1.13	0.68	0.73	0.58	1.1	0.63	0.42	0.48	0.65
LO3A8	310428	cyclin-dependent kinase (CDC2-like) 10	2.64	1.69	1.26	1.45	3.68	0.96	1.88	0.69	1.17	1.06	1.71	1.02	2.26	2.29	0.76	1.84	0.94	1.65	1.71	1.09	1.35	3.49
LO3A10	322604	B-cell CLL/lymphoma 7A	1.57	1.68	0.95	1.29	1.73	1.5	1.82	1.14	1.54	1.32	1.78	1.49	1.75	1.72	1.93	1.79	1.51	2.03	2.34	1.43	1.27	1.96
LO3A11	323162	cyclin-dependent kinase 2	1.12	1.07	1.54	1.19	1.39	0.63	0.71	1.09	0.88	0.98	0.64	0.66	1.38	1.44	1.19	0.55	0.58	1.29	1.05	0.58	0.72	1.11
LO3A12	323001	interferon regulatory factor 1	1.3	0.95	0.39	1.05	0.98	0.7	0.99	0.4	0.46	0.98	0.62	0.62	1.65	0.74	0.54	0.96	0.65	0.96	0.41	0.36	0.51	0.83
LO3B1	323028	"MAD (mothers against decapentaplegic, Drosophila) homolog 3"	1.1	1.35	1.24	1.14	0.95	0.96	0.52	1.06	0.93	0.7	3.81	1.05	1.07	0.86	1.1	0.53	0.78	1.13	1.58	1.38	1.75	1.82
LO3B2	323390	"excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing)"	2.22	1.94	0.91	1.29	2.97	1.94	0.93	1.1	1.23	1.48	1.6	1.41	1.35	1.4	1.07	1.3	1.56	1.47	1	1.17	1.07	1.04
LO3B3	323555	"FYN oncogene related to SRC, FGR, YES"	0.76	1.17	1.94	2.23	2.3	1.61	1.39	1.76	1.3	1.4	1.92	1.08	1.21	0.92	1.09	0.86	0.69	1.04	1.05	0.39	1.16	0.94
LO3B4	323500	"caspase 6, apoptosis-related cysteine protease"	1.7	2.24	1.43	1.46	3.64	2.2	1.29	1.53	1.09	2.73	2.13	1.66	1.75	1.9	0.83	2.89	2.26	1.49	1.53	0.93	0.94	1.91
LO3B6	324698	cyclin-dependent kinase 9 (CDC2-related kinase)	1.89	1.54	0.67	0.88	1.57	1.6	1.11	1.41	1.96	1.25	1.75	1.61	2.09	2.86	1.26	1.27	0.86	1.37	2.54	1.1	1.7	2.19
LO3B7	324655	"interleukin 1, beta"	1.39	1.45	1.28	1.24	1.5	1.72	0.54	1.75	1.08	0.97	0.91	1.31	1.52	1.16	1.46	0.74	1.04	1.09	0.77	1.23	1.1	0.88
LO3B10	327396	cell division cycle 2-like 1 (PITSLRE proteins)	1.65	1.2	0.81	0.82	1.43	1.83	1.33	1.34	1.4	1.95	1.3	1.89	1.78	1.74	0.88	1.64	1.09	1.72	3.02	1.33	1.16	2.68
LO3B12	340644	"integrin, beta 8"	1.8	1.14	0.96	1.1	1.93	2.24	1.08	1.02	0.76	0.96	1.23	1.37	1.44	2.16	1.08	1.35	1.95	1.23	0.79	0.51	0.54	0.53
LO3C1	340734	"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha"	1.41	1.17	1.39	1.18	1.06	1.29	0.48	1.13	1.55	0.5	0.74	1.28	1.32	1.66	1.39	0.48	0.88	2.17	1.14	0.89	1.28	1.25
LO3C2	341130	retinoblastoma-like 2 (p130)	1.31	1.12	0.89	1.07	1.02	1.03	0.88	0.74	0.78	1.22	1	1.02	1.34	1.49	1.8	1.08	1.01	1.24	0.47	0.55	0.61	0.79
LO3C3	340922	"nuclear factor of activated T-cells, cytoplasmic 3"	0.96	1.02	1.08	0.99	0.62	0.84	0.83	0.96	0.63	0.77	0.83	0.69	1.13	0.89	1.33	0.75	0.51	0.98	0.49	0.52	0.64	0.68
LO3C4	340878	"acid phosphatase, prostate"	1.12	1.01	0.7	0.77	0.82	0.74	0.88	0.93	0.65	0.8	0.91	0.8	1.43	1.16	1.65	1.07	0.69	0.96	0.49	0.44	0.55	0.72
LO3C5	343166	E1B-55kDa-associated protein 5	1.17	2.03	1.1	1.23	1.19	0.89	1.14	0.94	1.07	0.87	1.03	1.12	0.9	0.95	1.19	0.98	0.86	1.23	0.7	0.54	0.77	0.78
LO3C6	343871	mitogen-activated protein kinase kinase 5	1.45	1.15	0.58	1.05	1.45	1.31	0.89	1.08	1.62	0.81	1.18	1.03	1.29	1.32	1.07	1.16	1.17	0.86	0.96	0.48	0.64	0.98
LO3C7	344109	proliferating cell nuclear antigen	1.45	0.88	0.85	0.93	0.78	1.3	0.7	0.47	0.69	0.77	1.1	0.76	0.63	1.35	1.72	1.27	0.91	1.05	0.49	0.44	0.41	0.5
LO3C8	345600	serine/threonine kinase 2	1.62	1.39	1.85	1.91	3.4	1.18	1.23	2.23	1.31	1.19	1.61	1.31	1.73	1.31	1.56	1.45	1.71	2.89	1.35	0.78	0.9	1.55
LO3C9	345928	"MAD (mothers against decapentaplegic, Drosophila) homolog 1"	1.28	1.25	0.86	1.02	1.46	1.96	1.05	1.93	2.35	1.15	1.44	1.18	1.48	1.24	1.52	0.69	0.66	1.04	1.38	0.89	1.2	1.09
LO3C10	346534	"cell division cycle 2, G1 to S and G2 to M"	2.74	0.93	1.58	2.52	1.92	1.5	1.48	0.79	0.86	2.02	0.73	0.98	1.75	2.55	1.21	1.65	1.8	1.75	1.62	1.43	0.73	1.5
LO3C11	357309	"xeroderma pigmentosum, complementation group C"	0.98	0.7	1.23	1.02	1.11	1.61	2.05	3.29	2.16	2	1.61	1.09	1.23	1.9	1.42	0.67	0.53	0.92	1.62	0.91	1.6	0.97
LO3C12	357239	replication protein A3 (14kD)	1.92	1.13	0.91	1.29	1.73	1.17	1.31	1.01	0.89	1.34	0.89	1.44	1.08	2.21	1.4	1.89	0.92	1.24	0.7	0.73	0.59	1.03
LO3D1	357435	growth factor receptor-bound protein 2	1.62	0.82	1.67	1.03	1.86	1.62	0.99	1.46	2.58	0.84	1.49	1.88	1.59	1.78	0.97	0.67	0.9	1.39	1.63	1.18	1.31	1.48
LO3D2	357442	"CD47 antigen (Rh-related antigen, integrin-associated signal transducer)"	1.53	1.49	0.87	1.16	1.56	0.5	1.29	1.26	1.03	0.46	0.48	0.76	1.26	1.34	1.16	0.97	1.21	0.96	0.55	0.58	0.53	0.67
LO3D3	357909	"protein tyrosine phosphatase, receptor type, M"	0.78	1.51	0.63	0.51	1.49	0.34	0.81	0.82	1.63	0.54	0.6	0.68	0.8	0.87	0.64	0.61	0.5	1.13	1.79	1.08	0.82	1.51
LO3D4	357807	cyclin E1	0.39	0.8	0.26	0.34	0.56	0.19	0.5	0.63	0.36	0.29	0.42	0.37	0.64	0.62	0.55	0.25	0.53	0.34	0.45	0.25	0.32	0.42
LO3D5	358467	BCL2/adenovirus E1B 19kD-interacting protein 1	0.85	1.1	1.78	1.14	1.47	1.2	2.42	1.01	2.13	0.77	0.69	1.18	1.29	1.42	1.07	0.69	0.53	2.18	1.16	0.74	1.03	1.39
LO3D6	358168	Homo sapiens clone 25056 mRNA sequence	5.75	13.9	21.03	13.19	16.77	8.95	8.08	8.85	14.75	18.04	7.81	7.96	7.05	13.61	3.38	6.38	6.18	21.64	34.05	7.42	13.68	49.54
LO3D7	359171	"transcription elongation factor B (SIII), polypeptide 1-like"	1.42	2.11	1.25	1.22	1.06	1.62	1.83	0.94	1.85	1.08	0.97	1.09	1.51	1.81	1.25	1.29	1.13	1.92	1.83	1.86	0.97	1.15
LO3D8	359051	"cadherin 3, P-cadherin (placental)"	1.09	1.74	0.4	0.68	1.57	0.67	0.75	1.33	0.5	0.53	0.94	0.82	1.11	0.99	0.63	0.43	1.47	1.23	0.39	0.33	0.24	0.31
LO3D9	359412	cyclin D2	0.52	0.23	1.67	0.64	0.91	1.35	1.37	2.08	1.53	1.75	1.72	0.87	1.13	1.26	1.02	0.49	0.7	0.69	2.17	1.36	1.62	0.86
LO3D10	359769	RAB interacting factor	0.67	0.66	0.39	0.49	0.86	0.66	0.62	0.59	0.49	0.69	0.9	0.61	1.24	0.96	0.42	0.79	0.37	0.38	1.87	0.68	0.5	0.52
LO3D11	360531	v-raf murine sarcoma 3611 viral oncogene homolog 1	0.92	1.41	1.13	0.78	1.42	1.05	1.58	0.63	1.8	1.11	1.03	0.85	1.17	1.04	0.58	0.92	0.95	0.97	1.13	0.75	0.85	0.8
LO3E2	362332	cAMP responsive element binding protein 1	1.54	1.68	1.49	1.37	2.37	1.86	1.19	1.3	0.99	1.47	1.59	1.12	1.53	1.36	1.46	2.15	1.88	1.46	1.09	1.32	1.15	1.12
LO3E4	363799	CDC-like kinase 1	0.72	0.37	0.37	0.42	0.81	0.31	0.46	0.6	0.39	0.43	0.43	0.63	2.37	1.07	0.61	0.5	0.21	0.42	0.5	0.31	0.4	0.66
LO3E6	364982	"protein tyrosine phosphatase, receptor type, F"	2.51	2.57	0.69	1.02	2.21	1.41	1.75	1.19	1.5	1.6	1.46	1.62	1.63	2.06	1.51	2.63	1.26	2.7	1.16	1.12	1.29	1.22
LO3E7	364752	"ras homolog gene family, member C"	0.83	0.93	1.1	0.56	0.59	0.37	1.84	1.52	1.39	2.68	1.16	0.6	0.97	0.94	0.8	0.47	0.68	0.91	0.99	0.88	1.1	1.01
LO3E8	364716	mutS (E. coli) homolog 6	2.27	2.27	2.03	1.83	3.66	2.63	1.96	1.67	1.9	1.77	1.21	1.86	1.8	2.62	1.31	3.51	2.03	3.46	1.72	0.88	1.01	1.55
LO3E9	365147	v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	1.22	1.54	0.77	0.89	1.1	1.19	2.75	2.13	1.91	3.19	4.39	1.99	1.24	2.39	3.31	4.67	0.7	1.4	1.47	1.54	1.89	2.15
LO3E10	365647	ESTs	5.75	5.94	2.33	1.91	4.15	3.53	3.98	2.88	3.64	6.66	2.62	7.39	5.78	6.14	3.68	1.98	2.29	17.83	18.35	10.4	3.57	10.22
LO3E12	366576	"ESTs, Highly similar to titin-like protein [H.sapiens]"	1.12	1.01	0.58	0.86	1.84	0.73	1.19	0.94	0.94	1.17	0.89	0.81	1.19	1.44	0.84	1.26	1.01	1.08	1.94	0.49	0.56	1.27
LO3F1	366647	butyrate response factor 1 (EGF-response factor 1)	3.02	2.51	3.64	2.81	1.25	2.5	1.28	1.13	1.03	1.03	1.53	1.08	0.99	2.07	1.91	1.44	1.41	4.08	1	1.31	2.02	1.3
LO3F2	366824	cyclin-dependent kinase 4	2.98	2.84	2.73	2.44	1.73	2.19	1.29	0.93	1.12	2.01	1.64	1.72	1.33	2.51	2	1.74	2.22	4.1	1.06	1.06	1.04	1.2
LO3F3	366904	"non-metastatic cells 2, protein (NM23B) expressed in"	1.38	1.33	0.67	1.3	0.54	0.67	1.77	0.85	0.71	1.31	1.06	0.91	1.25	2.12	1.34	0.63	0.91	1.86	1.94	0.81	1.49	0.71
LO3F4	375724	activating transcription factor 4 (tax-responsive enhancer element B67)	0.59	0.78	0.43	0.53	0.56	0.92	0.58	0.53	0.6	0.62	1.09	0.92	1.01	1.06	1.42	0.86	0.51	1.14	0.47	0.46	0.6	0.88
LO3F5	375922	PCTAIRE protein kinase 1	1.68	1.53	1.42	0.89	1.78	2.68	0.83	0.94	1.19	1.02	1.39	0.77	1	1.03	0.8	0.95	1.87	1.42	0.96	1.27	1.16	1.03
LO3F6	376362	"ribosomal protein S6 kinase, 90kD, polypeptide 1"	1.05	2.08	0.95	1.33	1.87	1.77	1.2	1.91	2.81	1.84	1.65	1.32	1.57	1.77	1.24	1.86	1.79	1.36	1.71	1.65	1.12	1.41
LO3F7	376285	ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase)	2.39	2.87	4.09	3.26	2.54	3.29	1.74	2.22	3.21	1.48	2.04	1.82	1.55	4.39	1.14	1.43	2.53	2.43	1.41	1.32	1.26	1.41
LO3F9	376649		1.22	2.08	1.89	1.19	1.65	1.08	1.5	1.53	1.26	1.18	1.59	1.19	1.85	1.53	1.16	1.13	0.84	1.4	1.03	0.81	1.11	0.94
LO3F10	380403	"ras homolog gene family, member A"	0.99	0.86	1.1	0.88	0.93	1.07	0.93	0.91	0.55	1.08	1.21	1.16	1.4	1.05	1.37	0.81	0.8	1.21	0.53	0.72	0.43	1.11
LO3F11	415102	cell division cycle 25C	1.59	0.91	0.92	1	1.55	1.33	1.43	1.18	1.38	1.33	1.46	2.33	2.07	3.33	1.38	0.98	0.91	1.37	1.54	0.76	2.62	2.98
LO3F12	415731	"ribosomal protein S6 kinase, 70kD, polypeptide 1"	1.63	2.11	1.02	1.62	1.61	2.52	5.2	2.17	4.38	4.4	1.95	1.94	1.49	2.21	0.85	1.49	1.31	2.08	2.9	1.21	1.58	2.62
LO3G1	417226	v-myc avian myelocytomatosis viral oncogene homolog	0.54	0.96	0.42	1.38	0.49	0.76	0.28	0.4	0.39	0.29	0.25	0.34	2.32	0.4	0.83	0.11	1.23	1.25	0.25	0.58	0.24	0.6
LO3G2	417124	APEX nuclease (multifunctional DNA repair enzyme)	1.37	1.01	1.03	1.04	0.89	1.03	0.94	0.95	0.77	1.11	0.9	1.02	1.21	1.23	1.71	1.18	1.64	0.95	0.44	0.66	0.77	0.72
LO3G3	417322	FAT tumor suppressor (Drosophila) homolog	0.84	0.81	1.45	0.77	0.89	0.47	0.59	0.8	0.55	0.48	0.64	0.31	0.93	0.64	1.38	0.67	0.47	0.76	0.45	0.35	0.8	0.51
LO3G4	417357	dual specificity phosphatase 1	0.27	0.13	0.16	0.16	0.41	0.07	0.19	0.66	0.08	0.26	0.29	0.45	1.75	0.34	0.42	0.26	0.09	0.16	0.38	0.07	0.4	0.22
LO3G6	417592	canalicular multispecific organic anion transporter	0.27	0.22	0.09	0.07	0.32	0.08	0.11	0.07	0.12	0.09	0.11	0.16	0.21	0.23	0.22	0.32	0.1	0.25	0.27	0.11	0.19	0.18
LO3G11	428248		1.12	0.77	0.49	0.85	1.56	0.54	0.46	1.56	0.39	0.73	0.5	0.91	2.07	0.48	1.39	0.4	0.36	1.03	0.74	0.25	0.52	0.63
LO3G12	429142	"protein kinase, cAMP-dependent, catalytic, alpha"	2.54	1.98	1.2	1.79	1.81	1.91	1.37	1.42	1.68	1.15	1.9	1.29	1.64	1.81	1.04	1.57	1.1	2.07	1.54	1.09	1.01	1.58
LO3H3	429926	adenomatosis polyposis coli	0.73	0.94	0.9	1.38	1.5	0.8	1.03	1.23	0.95	0.62	0.32	0.68	1.14	1.25	0.78	0.5	0.82	0.64	0.85	0.27	0.5	0.83
LO3H6	469256	BCL2-associated athanogene	1.1	0.58	0.25	0.69	0.79	0.72	0.68	0.94	0.36	0.39	0.56	0.56	0.74	1.03	0.69	0.41	0.44	0.65	0.32	0.34	0.34	0.63
LO3H7	469724	far upstream element (FUSE) binding protein 1	1.24	1.42	1.1	0.79	0.87	1.18	1.24	0.89	1.06	0.98	0.84	0.86	1.14	1.05	1.14	0.94	0.86	1.16	0.51	0.32	0.44	0.77
LO3H8	470185	transforming growth factor beta-activated kinase-binding protein 1	1.4	1.59	1.04	1.19	1.69	2.1	1.59	2.21	2.68	1.22	1.26	1.28	1.74	1.62	1.36	1.05	0.91	2.08	1.16	0.76	1.05	1.79
LO3H9	470196	"excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome))"	1.53	1.62	1.12	1.01	0.95	1.3	1.35	1.26	1.56	1.2	0.86	1.06	0.97	0.98	0.84	0.98	0.94	0.79	0.69	0.47	0.62	0.78
LO3H10	470251	"interleukin 15 receptor, alpha"	2.35	1.69	2.58	1.32	2.45	1.69	1.96	1.84	1.25	0.97	1.01	2.05	2.45	2.65	0.66	1.93	0.82	0.26	1.84	0.09	0.57	1.37
LO3H12	470621	cyclin-dependent kinase 7 (homolog of Xenopus MO15 cdk-activating kinase)	0.76	0.51	0.2	0.34	0.5	0.39	0.75	0.36	0.33	0.36	0.6	0.27	0.51	0.63	0.44	0.39	1.15	0.52	0.35	0.2	0.22	0.27
LO4A3	470730	PTK2 protein tyrosine kinase 2	0.91	3.61	1.97	0.94	2.59	1.12	1.37	0.92	1.65	1.45	1.04	0.56	1.1	1.11	1.09	1.09	1.25	1.89	0.85	1.23	0.64	1.56
LO4A4	470691	RAD23 (S. cerevisiae) homolog A	2.01	2.15	0.98	1.34	1.87	1.83	1.48	1.25	2.25	1.32	1.34	1	1.12	1.62	1.3	1.93	1.32	4.49	0.96	0.94	0.87	1.32
LO4A5	471217	TIA1 cytotoxic granule-associated RNA-binding protein-like 1	0.6	0.98	0.66	1.25	1.11	0.83	0.81	0.53	0.35	0.76	0.69	0.42	0.71	0.6	0.54	0.68	0.88	1.05	0.68	0.3	0.68	0.86
LO4A6	471620	endoglin (Osler-Rendu-Weber syndrome 1)	1.22	0.9	1.02	1.15	2.07	0.9	1.34	1.16	1.07	1.26	1.38	0.96	1.59	1.85	1.72	1.74	0.93	1.35	1.72	0.67	0.73	1.24
LO4A7	471822	junction plakoglobin	0.92	0.85	0.26	0.63	0.6	1	0.52	1.82	1.27	0.32	0.67	0.74	0.47	0.84	0.35	0.8	0.69	1.02	0.54	1.02	0.96	0.93
LO4A8	471918	intercellular adhesion molecule 2	1.17	0.65	1.02	1.31	1.04	0.96	0.64	0.83	0.75	0.7	0.68	0.77	0.7	1	0.76	2.17	1.59	1.01	0.48	0.32	0.6	0.64
LO4A10	486161	lymphocyte-specific protein tyrosine kinase	2.17	13.8	0.82	5.02	3.41	4.53	3.63	2.61	2.25	2.72	1.76	2.66	1.88	1.86	1.28	1.75	1.69	1.17	5.08	0.95	1.69	1.34
LO4A11	486074	mitogen-activated protein kinase kinase 1	0.92	1.17	0.78	1.45	1.98	0.97	2.87	6.89	2.56	2.35	2.77	1.03	1.18	1.36	1.35	0.97	1.32	1.32	2.25	0.53	2.08	1.65
LO4A12	486716	mitogen-activated protein kinase 3	0.72	0.21	0.13	0.24	0.31	0.39	0.32	0.17	0.32	0.5	0.42	0.08	0.2	0.18	0.67	0.82	0.24	0.15	0.21	0.09	0.18	0.12
LO4B1	486510	"cadherin 13, H-cadherin (heart)"	0.52	0.62	0.55	0.45	1.03	1.23	0.49	0.75	0.39	0.86	1.62	0.47	0.52	0.79	1.02	0.42	0.91	0.38	0.74	0.3	0.42	0.46
LO4B3	487097	"protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)"	0.63	0.71	1.17	0.61	0.74	0.46	0.49	0.99	0.63	0.79	0.55	0.67	0.43	0.47	0.64	0.36	0.91	0.54	0.68	0.52	0.35	0.51
LO4B4	487777	retinoblastoma 1 (including osteosarcoma)	0.82	1.2	1.31	0.88	1.42	0.94	1.27	1.09	0.92	1.03	1	0.84	1.56	1.69	1.35	1.15	1.53	1.49	0.89	0.58	0.59	1.25
LO4B5	487965	ubiquitin-conjugating enzyme E2A (RAD6 homolog)	0.78	1.01	2.28	1.14	1.47	0.73	1.23	2.5	0.89	1.02	1.12	0.73	0.91	1.07	0.69	0.76	0.95	0.93	1.35	0.57	0.63	1.14
LO4B6	488891	ubiquitin-conjugating enzyme E2B (RAD6 homolog)	0.99	1.28	0.68	0.87	1.59	1.69	1.29	1.13	1.89	1.07	0.97	2.04	1.52	2.08	1.35	0.92	1.38	1.06	1.62	0.95	0.93	1.28
LO4B8	489327	v-raf-1 murine leukemia viral oncogene homolog 1	1.44	1.38	1.57	1	1.92	1.12	1.35	0.86	1.4	1.46	1.2	1.57	1.18	1.61	0.82	0.92	1.18	1.3	1.46	0.58	0.91	0.98
LO4B9	489217	heterogeneous nuclear ribonucleoprotein K	1.38	1.5	1.13	1.21	1.54	0.97	0.97	1.49	0.93	0.86	0.98	0.65	1.18	1.64	1.04	0.94	1.24	1.05	1.12	0.81	0.62	1.05
LO4B10	489194	"catenin (cadherin-associated protein), alpha 1 (102kD)"	0.64	0.43	0.44	0.75	0.85	0.63	0.9	0.84	0.8	0.88	0.8	1.02	0.77	0.88	1.36	0.69	0.85	0.52	0.57	0.56	0.59	0.67
LO4B11	510130	"cadherin 17, LI cadherin (liver-intestine)"	0.92	0.32	0.29	0.25	0.37	0.34	0.31	0.34	0.17	0.34	0.43	0.25	0.26	0.42	0.47	0.41	0.16	0.33	0.46	0.11	0.36	0.27
LO4B12	510258	KIAA0108 gene product	2.56	1.74	0.86	1.11	1.74	0.9	1.92	1.12	1.52	1.8	1.66	2.08	2.73	3.76	1.27	1.5	1.01	2.24	2.06	1.05	0.95	3.55
LO4C1	510467	"cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)"	1.58	1.05	0.75	1.19	1.01	1.51	0.84	1.28	0.9	0.92	1.28	1.19	1.23	1.56	1.2	0.97	0.71	1.55	1.31	0.93	0.95	1.18
LO4C3	198205	v-myb avian myeloblastosis viral oncogene homolog-like 2	2.73	1.83	1.5	1.88	2.1	3.61	1.61	1.17	1.82	1.85	1.32	1.76	0.98	2.03	1.53	1.55	1.87	4.49	1.66	1.71	0.84	0.73
LO4C4	322029	mitogen-activated protein kinase 9	0.78	0.89	0.55	1.05	1.33	1.28	1.42	1.32	0.68	1.39	0.88	0.94	1.35	1.4	1.44	1.26	1.82	0.82	0.62	1.44	0.57	0.83
LO4C11	124086	"interleukin 11 receptor, alpha"	3	1.68	0.95	2.35	1.32	1.13	0.97	0.77	0.77	0.9	0.71	1.05	0.98	0.76	0.99	1.56	0.88	0.86	0.98	0.47	1.11	0.88
LO4D1	36809	"ESTs, Moderately similar to neural cell adhesion molecule [H.sapiens]"	1.29	1.48	1.29	2.18	1.39	2.45	1.85	2.56	2.12	1.56	1.67	2.17	1.71	1.61	1.71	2.15	0.98	0.72	2.12	1.62	1.44	1.76
LO4D3	151767	"tumor necrosis factor receptor superfamily, member 6"	0.28	1.03	0.29	1.01	0.64	0.4	0.46	0.63	0.41	1.28	0.47	0.27	0.81	0.43	0.44	0.33	0.93	0.29	0.32	0.15	0.35	0.33
LO4D5	154420	platelet-derived growth factor receptor-like	2.03	1.22	0.59	5.1	6.26	3.83	5.97	13.02	0.28	10.67	5.36	4.26	3.86	5.59	2.02	2.21	0.91	3.99	5.12	1.27	4.31	7.83
LO4D7	158970	EphB3	3.06	1.72	3.3	2.41	3.45	0.74	1.57	2.14	2.54	1.11	1.19	1.3	2.01	0.82	1.1	1.2	4.14	4.09	1.71	0.85	1.09	1.42
LO4D8	158970	EphB3	3.78	2.32	3.15	2.75	3.73	0.93	1.73	2.37	2.59	1.23	1.57	1.74	2.48	1.14	1.36	1.81	3.27	4.54	1.69	0.72	1.03	0.38
LO4D9	43504	"thyroid hormone receptor, alpha (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog)"	0.97	0.9	1.47	1.16	1.37	0.8	1.21	1.31	1.09	0.92	1.15	1.33	0.94	0.64	1.02	0.87	1.63	1	0.97	0.92	0.68	0.82
LO4D10	47559	"RAB5A, member RAS oncogene family"	1.2	0.9	1.5	1.26	1.66	0.98	1.4	1.39	1.21	1.1	1.5	1.45	1	0.76	1.03	1.19	1.49	0.87	0.8	0.74	0.65	0.8
LO4D11	49576	ESTs	1.4	1.79	1.56	2.62	2.18	1.97	1.85	3.28	2.52	1.43	2.37	1.55	1.38	0.78	1.2	1.51	1.76	1.41	1.65	1.21	1.18	1.41
LO4E11	199381	ESTs	3.46	1.47	1.73	2.02	2.52	3.65	5.63	7.64	6.22	8.75	3.73	5.82	3.69	4.27	2.54	2.02	1.64	1.17	3.43	2.85	3.61	4.62
LO4F3	213502	CD53 antigen	2.6	6.53	6.21	2.98	8.88	9.9	6.52	10.11	5.09	2.11	5.26	9.02	4.54	5.16	2.7	3.81	4.38	4.08	5.22	1.86	1.32	5.22
LO4F9	236420	"discoidin domain receptor family, member 2"	1.59	2.7	3.18	2.1	11.52	3.41	4.35	9.45	4.72	6.79	3.82	1.38	2.97	4.21	0.82	1.82	1.86	3.73	3.05	1.24	2.09	2.81
LO4F11	241489	"adrenergic, beta-2-, receptor, surface"	1.69	1.96	1.84	1.6	2.36	1.68	1.6	1.49	1.48	1.94	2.42	1.62	1.79	1.35	1.2	2.03	1.2	1.45	4.42	1.15	1.7	1.98
LO4F12	242134	follistatin-like 1	1.22	1.75	0.82	1.06	2.04	1.49	1.3	1.07	2.15	1.12	1.61	1.5	1.33	1.4	0.95	0.96	1.32	0.76	1.4	0.96	1.56	1.08
LO4G3	254428	"integrin, alpha 6"	0.74	0.37	0.26	0.65	0.57	0.15	0.22	0.29	0.15	0.15	0.24	0.21	0.81	0.45	0.81	0.3	0.48	1.1	0.32	0.31	0.37	0.32
LO4G5	258747	"interleukin 10 receptor, alpha"	2.33	2.28	1.81	2.48	2.66	2.05	1.57	2.05	3.13	2.26	2.26	1.33	1.43	1.8	1.51	1.41	0.48	1.6	2.07	0.91	1.82	2.33
LO4G7	259241	"major histocompatibility complex, class II, DM alpha"	2.18	9.28	3.67	4.7	5.74	6.41	4.36	6.15	4.91	7.09	5.62	4.05	3.31	4.46	2.08	2.36	3.18	1.81	7.79	1.43	4.49	3.81
LO4G8	259291	"integrin, beta 5"	1.3	1.39	1.06	0.77	2.87	0.99	2.12	3.64	2.62	1.68	2.48	2.06	1.69	2.62	1.38	1.82	0.65	1.13	4.01	1.56	1.67	2.89
LO4G9	262691	"nuclear receptor subfamily 3, group C, member 1"	0.75	0.85	0.63	0.74	0.99	0.64	0.58	0.87	0.62	0.69	0.76	0.77	1	0.76	0.85	0.49	0.34	0.62	1.06	0.71	0.66	1.11
LO4G10	264576	ESTs	1.49	2.21	3.51	3.72	5	2.29	3.6	4.37	3.85	3.62	2.33	1.89	2.38	1.82	1.49	4.77	2.95	7.03	1.75	1.1	2.04	1.78
LO4G11	264554	Ewing sarcoma breakpoint region 1	0.88	1.1	0.98	1.31	1.08	1.56	1.12	1.49	0.58	1.45	1.65	0.95	1.2	0.93	1.06	1.18	1.42	0.85	0.9	0.95	1.95	0.9
LO4G12	268412	MCF.2 cell line derived transforming sequence	1.3	1.85	0.62	0.85	1.74	0.84	1.93	1.58	3.1	2.04	1.46	1.7	1.48	1.83	1.14	1.64	1.04	1.19	1.51	1.28	1.03	1.72
LO4H1	271198	"nuclear receptor subfamily 3, group C, member 1"	0.55	0.78	0.57	0.63	0.82	0.65	0.4	0.62	0.95	0.39	0.61	0.56	1.07	0.42	0.52	0.35	1.68	0.19	0.51	0.72	0.46	0.68
LO4H2	280376	"Homo sapiens mRNA for protein kinase SID6-1512, complete cds"	0.98	1.52	1.01	1.12	1.32	1.08	1.7	1.72	1.69	1.1	1.7	1.19	1.4	1.25	1.25	1.69	1.32	0.82	1.26	0.95	1.06	1.08
LO4H3	280768	transmembrane 4 superfamily member 1	3.22	1.02	0.73	2.65	2.71	3.92	0.43	2.43	0.08	0.4	0.42	0.49	0.71	0.34	0.75	0.63	2.2	1.92	0.83	0.47	2.01	1.16
LO4H4	284546	glial fibrillary acidic protein	2.56	1.13	1.24	1.77	3.53	3.57	3.68	3	5.11	2.17	1.78	2.05	1.56	2.11	1.88	5.11	2.1	1.51	2.46	1.12	1.91	2.01
LO4H9	290493	ESTs	0.7	1.58	1.39	1.87	2.04	1.17	1.33	1.24	1.16	1.04	0.95	0.66	1.07	0.72	1.25	1.23	0.9	1.93	1.04	0.64	0.81	1
LO4H10	290871	"integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)"	0.25	0.28	0.12	0.11	0.33	0.1	0.61	0.46	0.28	0.3	0.43	0.24	0.43	0.42	0.47	0.34	0.1	0.16	0.27	0.18	0.28	0.26
LO4H11	290724	MHC class I polypeptide-related sequence A	0.47	0.84	0.35	0.62	0.78	0.63	0.83	0.81	0.84	0.63	0.91	0.65	0.68	0.44	0.53	0.77	0.57	0.5	0.93	1.27	0.95	0.97
LO5A3	297589	absent in melanoma 1	0.83	0.73	0.72	1.21	1.17	0.82	0.48	1.1	0.77	0.49	0.64	0.8	0.58	0.58	0.93	0.56	0.7	0.77	1.42	0.74	1.68	0.93
LO5A4	298187	BCL2-like 1	0.88	0.83	0.44	1.08	2.11	1.29	1.45	1.06	0.9	1.52	1.15	1.18	1.17	0.89	0.57	1.44	0.64	0.73	1.57	0.45	0.82	1.18
LO5A7	299626	S-phase response (cyclin-related)	0.63	0.46	0.62	0.63	0.67	0.43	0.69	0.59	0.35	0.78	0.61	0.36	0.57	0.56	0.65	0.47	0.64	0.54	0.35	0.47	0.4	0.34
LO5A8	300051	"myosin, light polypeptide 2, regulatory, cardiac, slow"	2.28	3.01	1.58	2.29	2.64	1.86	3.64	3.15	3.4	1.93	1.9	1.56	1.96	2.57	1.57	2.43	2.09	1.32	2.06	1.2	1.43	1.95
LO5A10	303109	purinergic receptor (family A group 5)	1.29	1.23	3.36	1.22	4.02	1.18	1.98	2.09	1.88	1.41	1.35	1.21	2.74	3.29	1.67	0.58	1.15	1.2	2.5	1.32	1.95	2.61
LO5A11	306170	CD9 antigen (p24)	1.01	0.63	0.41	1.11	0.81	0.9	1.2	1.21	1.23	1.08	1.38	1.33	0.99	0.78	0.69	1.07	0.7	1.72	0.64	1.16	0.77	1.41
LO5B2	320514	EphA1	1.24	1.24	0.39	0.85	2.48	1.45	1.39	1.14	2.63	1.09	1.74	1.21	1.35	1.43	1.25	2.45	0.91	1.27	1.63	0.59	0.85	1.39
LO5B5	321246	DKFZP586H0723 protein	0.65	0.87	1.6	1.46	1.85	1.05	0.99	1.87	0.74	1.21	1.34	1.2	0.86	1.01	1.26	1.27	0.94	0.84	0.88	0.75	0.79	0.99
LO5B6	321308	"tumor protein p53-binding protein, 2"	1.75	3.18	1.28	1.31	2.83	2.27	2	1.62	4.71	2.91	1.63	3.24	1.54	2.8	1.21	1.94	1.76	2.42	2.16	1.14	0.88	1.56
LO5B7	322148	chromogranin B (secretogranin 1)	2.01	1.73	0.46	1.39	1.99	2.43	0.89	1.1	0.66	0.71	1.03	0.88	1.05	0.75	0.87	2.13	1.5	0.55	1.06	0.69	1.2	1.09
LO5B9	323181	"fibroblast activation protein, alpha"	1.31	0.95	1.77	1.42	1.57	1.11	1.33	3.03	1.86	1.15	1.39	1.26	1.19	1.72	1.54	0.78	0.78	1.99	1.63	0.74	1.22	1.69
LO5B10	323648	diptheria toxin resistance protein required for diphthamide biosynthesis (Saccharomyces)-like 1	0.93	0.79	0.73	0.96	1.34	0.72	1.26	0.77	0.91	1.03	1	1	1.35	0.96	0.88	1.13	0.8	0.89	1.09	0.97	0.89	0.88
LO5B12	328330	"cadherin 4, R-cadherin (retinal)"	1.85	1.29	0.59	0.76	2.73	1.25	1.55	1.31	1.47	1.63	2.36	1.31	1.84	2.37	1.04	2.12	0.7	2.06	3.06	1.02	1.23	2.86
LO5C1	328467	ESTs	2.92	2.31	1.26	1.71	3.1	1.63	1.27	2.05	1.29	1.27	1.45	1.29	1.16	1.32	1.19	1.53	1.23	1.76	1.83	0.63	1.14	1.02
LO5C3	341763	"caspase 5, apoptosis-related cysteine protease"	1.08	1.34	1.5	1.04	1.83	1.09	1.6	2.38	1.35	1.55	1.63	1.35	1.34	1.61	1.33	1.37	0.92	1.32	1.77	1.09	1.24	1.98
LO5C4	342256	"T-cell receptor, beta cluster"	1.93	1.82	1.8	1.64	2.44	1.59	2.28	2.27	2.19	1.76	1.43	1.32	1.81	1.04	1.71	2.24	1.48	2.19	1.48	0.76	1.16	1.41
LO5C5	343465	"Homo sapiens connexin 37 (GJA4) mRNA, complete cds"	1.81	1.53	1.24	1.41	2.92	1.76	1.83	2.76	2.06	1.76	1.99	2.42	1.25	1.93	1.43	3.12	2.07	2	1.06	0.83	0.88	1.26
LO5C6	343311	"nerve growth factor receptor (TNFR superfamily, member 16)"	1.7	2.29	2.46	1.85	3.32	1.57	1.98	2.14	1.97	1.69	1.67	2.31	2.26	3.97	1.83	3.1	1.33	1.65	1.22	1.05	0.99	1.48
LO5C7	343646	v-ski avian sarcoma viral oncogene homolog	1.29	1.49	0.95	1.55	1.84	1.79	2.08	1.27	1.58	1.71	1.42	0.97	0.86	0.76	1	1.36	1.48	0.83	1.61	0.76	1.2	1
LO5C8	345645	platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog)	1	1.33	1.53	1.13	2.96	1.95	2.35	4.18	4.67	3.7	2.32	2.47	1.84	1.28	1.02	1.67	1.13	3.65	15.21	9.04	4.64	3.94
LO5C9	345722	"ESTs, Weakly similar to RAS-RELATED PROTEIN RAB-11A [H.sapiens]"	1.28	1.06	1.79	2.88	1.1	1.06	0.51	1.68	1.65	0.61	0.79	1.97	1.34	2.28	1.63	1.15	1.14	2.12	1.67	1.09	1.47	1.54
LO5C10	346587	quiescin Q6	0.86	1.68	0.76	0.82	2.56	0.69	2.07	1.24	1	1.22	1.82	1.17	1.12	1.13	0.82	2.32	1.39	0.72	4.25	1.22	0.85	1.99
LO5C11	346396	related RAS viral (r-ras) oncogene homolog	0.85	0.77	0.44	0.5	0.81	0.81	0.29	0.36	1.95	0.33	0.34	0.65	1.27	0.9	1.1	0.68	0.76	0.88	0.42	0.43	0.46	0.77
LO5C12	346305	"tumor protein 53-binding protein, 1"	1.81	1.29	0.59	1.07	1.68	1.31	1.36	1.39	1.52	1.23	1.24	1.32	1.91	2.32	1.08	1.29	2.29	1.42	0.99	0.67	0.94	1.4
LO5D1	347032	v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein)	0.54	0.81	0.52	0.53	1.14	0.84	0.94	1.77	0.95	0.83	1.23	0.6	0.6	0.55	0.74	0.71	0.83	0.78	0.62	0.57	0.6	0.69
LO5D2	347751	Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog	3.53	3.11	2.1	2.44	3.1	2.19	3.75	3.54	3.77	2.43	1.55	6	4.38	2.29	2.55	3.66	1.6	0.94	1.98	0.78	0.7	0.99
LO5D3	356890	hyaluronoglucosaminidase 1	0.89	0.88	0.83	0.8	1.15	0.63	1.36	0.64	1.09	0.92	0.71	1.32	0.96	0.7	0.3	0.74	1.79	1.98	0.65	0.85	0.63	0.68
LO5D4	356964	v-abl Abelson murine leukemia viral oncogene homolog 1	1.55	3.66	1.81	1.91	2.11	1.88	5.94	1.94	2.97	4.75	1.5	1.61	2.04	2.96	3.02	4.73	1.9	1.91	1.36	1.25	0.86	1.53
LO5D6	358848	"integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)"	1.08	1.11	1.01	0.8	1.14	0.82	1.09	0.92	0.78	0.81	0.7	0.73	0.9	0.78	1.24	1.2	0.79	0.49	0.53	0.32	0.56	0.57
LO5D7	359119	CDC28 protein kinase 2	1.67	3.22	1.52	1.89	1.63	1.18	1.88	0.66	1.45	1.29	0.74	0.63	1.12	1.57	1.06	0.68	2.85	3.8	0.74	0.55	0.45	0.57
LO5D8	359077	"integrin, alpha 5 (fibronectin receptor, alpha polypeptide)"	1.75	1.42	5.78	2.59	1.42	1.31	3.55	2.29	3.82	3.7	1.27	2.27	3.24	3.31	1.8	2.85	1.33	6.39	1.69	0.57	1.33	1.54
LO5D9	359466	von Willebrand factor	2.7	0.78	3.77	1.44	12.02	3.98	1.25	10.1	2.85	3.92	1.73	5.05	2.11	6.68	1.75	1.63	3.83	1.65	6.85	1.08	5.71	9.33
LO5D10	359465	dihydrofolate reductase	2.35	1.18	0.53	1.59	0.66	1.2	1.53	1.45	1.37	1.35	0.91	1.35	2.17	1.52	2.05	0.57	0.91	1.37	0.73	0.58	0.86	0.96
LO5D11	359793	ESTs	0.37	0.53	0.36	0.42	0.6	0.44	0.57	0.52	0.37	0.53	0.74	0.55	0.95	0.69	0.34	0.61	0.34	0.27	0.96	0.61	0.42	0.41
LO5E2	361692	sarcoma amplified sequence	1.31	1.09	1.2	1.03	2.26	1.22	2.27	2.76	2.22	2.18	0.62	2.63	2.18	1.65	1.26	1.84	1.3	1.67	1.92	1.9	1.92	2.2
LO5E4	363539	"enolase 2, (gamma, neuronal)"	2.19	2.99	4.3	3.58	1.99	1.82	9.45	4.15	6.26	3.4	1.8	3.84	2.27	2.13	0.92	1.99	2.25	5.69	2.23	3.41	1.95	2.83
LO5E5	363805	Ewing sarcoma breakpoint region 1	0.95	1.41	1.02	1.07	0.97	1.27	1.06	1.05	0.76	1.73	1.36	0.87	1.03	1.04	1.18	1.13	1.28	1.08	0.94	1.39	1.37	1.41
LO5E7	364975	ESTs	2.81	3.41	0.99	1.52	8.82	2.87	1.98	1.72	4.49	1.42	1.35	1.72	2.29	2.32	1.64	3.44	2.41	1.95	1.42	1.08	2.25	1.89
LO5E9	366509	"actin, alpha 1, skeletal muscle"	1.27	1	1.19	0.92	0.81	0.89	0.97	1.48	0.92	1.15	1.36	0.93	1.18	1.25	1.29	0.74	0.63	2.02	0.7	0.5	1.1	0.89
LO5E10	366942	myogenic factor 6 (herculin)	2	1.4	1.04	1.07	2	0.84	1.73	2.11	1.59	1.19	1.25	1.05	1.39	3.08	1.58	1.98	1.31	1.75	1.14	0.6	1.11	1.9
LO5E11	375620	"dystrophin (muscular dystrophy, Duchenne and Becker types), includes DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272"	0.77	1.01	0.41	0.57	1.04	0.43	0.72	0.58	0.43	0.62	0.64	0.46	1.16	1.87	0.88	0.53	0.27	0.85	0.66	0.18	0.51	0.71
LO5E12	375635	"transcription factor 12 (HTF4, helix-loop-helix transcription factors 4)"	0.97	0.69	0.38	0.41	1.05	0.9	0.6	0.9	0.44	0.53	0.66	0.59	1.37	1	0.44	0.98	0.8	1.47	0.62	0.7	0.53	0.72
LO5F1	376110	alpha-1-microglobulin/bikunin precursor	0.92	1.08	1.81	1.33	2.95	1.03	2.6	3.69	2.18	2.65	2.23	1.47	1.88	4.15	1.64	0.76	1.32	1.47	1.7	0.43	1.47	2.66
LO5F4	376725	tropomyosin 1 (alpha)	1.08	1.24	6.71	0.96	2.32	1.73	1.54	2.59	1.76	0.79	1.48	1.32	2.04	2.39	1.55	0.73	0.91	2.14	1.04	0.64	1.02	1.19
LO5F5	377275	ataxia-telangiectasia group D-associated protein	0.94	0.12	0.11	0.26	0.44	0.16	0.14	0.13	0.07	0.12	0.13	0.13	0.27	0.19	0.14	0.15	0.07	0.43	0.12	0.05	0.15	0.13
LO5F6	377181	Cas-Br-M (murine) ectropic retroviral transforming sequence b	1.1	1.43	0.65	0.73	0.78	1.74	1.58	0.83	1.52	0.77	1.66	1.42	1.2	1.69	1.15	1.21	0.91	1.26	1.69	0.45	0.98	1.28
LO5F8	415206	myoglobin	1.58	1.26	1.6	1.68	1.28	1.55	1.96	1.51	1.41	2.07	1.4	1.49	1.53	1.68	1.51	1.59	1.6	2.29	0.75	1.12	1.01	1.03
LO5F12	416184	cyclin B2	1.87	1.99	1.74	1.27	1.41	1.61	1.3	1.45	0.99	1.75	1.66	0.98	0.92	1.33	1.13	1.13	1.78	1.23	1.1	0.47	0.7	1.34
LO5G1	417136	amplified in osteosarcoma	0.94	1.17	1.61	0.94	1.73	1.05	1.46	2.21	1.65	1.92	1.75	1.54	0.94	1.3	1.09	1.44	0.84	1.05	1.4	0.75	1.2	1.31
LO5G3	418105	"RAB2, member RAS oncogene family"	1.09	1.12	1.55	0.93	1.79	1.04	1.14	2.21	1.36	1.53	1.44	1.23	1.12	1.28	0.97	1.28	0.9	1.02	0.9	0.56	0.95	1.11
LO5G6	427943	EphA2	0.53	0.38	0.29	0.26	0.57	0.39	0.34	0.33	0.27	0.4	0.35	0.25	0.68	0.41	0.61	0.34	0.4	0.38	0.68	0.31	0.39	0.49
LO5G7	427943	EphA2	0.38	0.34	0.28	0.24	0.54	0.39	0.53	0.36	0.2	0.86	0.39	0.22	0.68	0.36	0.86	0.33	0.19	0.36	0.23	0.22	0.37	0.26
LO5G10	428404	pim-1 oncogene	2.12	0.88	0.6	0.86	1.82	1.06	0.78	0.98	0.5	0.8	1.18	0.77	1.85	1.04	0.87	0.9	1.29	1.06	1.48	0.42	0.64	0.81
LO5G11	428231	apoptosis inhibitor 2	1	1.16	0.91	0.83	1.24	1.94	0.6	1.23	1.11	0.85	0.7	0.85	1.56	1.12	1.08	0.5	3.88	1.04	1.06	0.5	0.76	1.05
LO5G12	429135	suppression of tumorigenicity 13 (colon carcinoma) (Hsp70-interacting protein)	1.03	0.97	0.84	0.94	1.27	1.14	0.84	0.98	0.85	0.73	1.02	0.98	1.57	1.39	1.08	0.93	2.06	0.86	0.71	0.3	0.54	0.79
LO5H1	429539	"collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant)"	1.31	1.56	0.92	1.7	2.17	2.49	2.29	1.4	0.95	1.64	1.52	1.57	1.02	1.23	0.59	2.19	2.61	3.38	1.37	0.93	0.82	1.28
LO5H2	429861	alpha-fetoprotein	1.63	2	2.22	1.49	1.39	1.61	2.13	1.86	2.45	1.67	2.1	1.76	1.74	2.67	1.59	2.26	1.77	1.77	0.8	0.47	1.19	1.04
LO5H3	469272	epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b) oncogene homolog)	0.72	0.52	0.57	0.83	1.03	0.84	0.62	1.83	1.66	0.44	0.68	0.46	0.62	0.39	0.18	0.84	1.92	0.67	0.36	0.28	0.39	0.37
LO5H4	469731	ESTs	2.03	1.77	1.33	1.66	2.6	2.15	2.25	1.79	2.72	1.59	1.69	1.04	1.72	2.26	0.83	2.36	0.7	1.39	2.26	1.29	2	1.78
LO5H6	470602	estrogen-related receptor alpha	0.63	0.95	0.87	0.67	0.83	0.52	1.22	1.54	1.43	0.85	1.04	0.99	1.34	1.41	1.59	1.96	0.44	0.52	0.68	0.29	1.14	0.69
LO5H7	470493	"tumor necrosis factor receptor superfamily, member 1B"	1.59	1.04	1.27	1.93	1.88	2.51	2.04	2.93	2.13	2.11	1.7	1.43	0.72	1.43	0.37	1.21	1.61	7.88	1.09	0.39	0.84	0.91
LO5H8	470635	"placental growth factor, vascular endothelial growth factor-related protein"	1.55	1.99	2.02	2.26	1.28	2.06	1.94	2.24	2.48	1.83	0.85	1.74	1.86	1.98	1.36	2.43	1.38	1.9	1.22	0.64	1.07	0.83
LO5H9	470610	Homo sapiens mRNA in the region near the btk gene involved in a-gamma-globulinemia	1.6	0.69	1.19	1.11	1.28	1.06	1.21	1.92	1.37	0.73	1.2	1.49	1.41	1.81	1.26	0.82	0.85	1.48	1.02	1.03	0.82	1.19
LO5H11	471096	glioma pathogenesis-related protein	0.76	0.61	2.43	1.13	1.63	1.05	1.31	2.87	2.39	0.86	1.08	1.07	1.38	1.12	0.59	0.95	0.51	0.99	1.06	0.53	0.74	0.83
TNF1A2	80549	pre-B-cell leukemia transcription factor 2	1.39	1.38	1.31	0.24	2.23	0.96	1.75	1.29	0.89	0.92	1.23	1.56	1.7	2.01	1.36	2.71	1.36	2.22	1.53	1.32	1.38	1.97
TNF1A6	129268	"general transcription factor IIA, 1 (37kD and 19kD subunits)"	0.84	1.13	0.63	0.83	1.37	1.01	1	0.85	1.14	0.88	0.61	0.62	0.88	1.31	0.64	1.49	1.1	1.29	0.75	0.35	1.1	0.87
TNF1A7	26503	transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	0.38	1.47	1.4	1.37	1.36	1.63	0.92	1.04	1.08	1.17	1.23	0.62	0.82	1	0.57	1.27	1.27	1.21	1.48	1.04	0.92	1.36
TNF1A8	26599	"signal transducer and activator of transcription 1, 91kD"	1.34	1.64	0.68	1.48	1.68	1.09	1.53	0.79	0.99	1.2	0.84	1.31	1.64	1.63	1.33	2.25	1.13	1.37	1.64	0.91	1	1.73
TNF1A9	41959	forkhead (Drosophila)-like 1	0.92	1.3	0.79	0.88	1.86	1.03	0.87	1.03	1.71	1.24	1.28	1.5	1.31	1.33	1	0.73	0.91	1.68	2.77	1.83	1.95	3.12
TNF1A10	135118	GATA-binding protein 3	0.76	2.48	0.2	0.46	3.05	2.12	5	5.28	5.01	6.23	4.29	2.72	3.69	4.75	0.7	0.91	1.85	1.11	6.78	3.4	0.85	4.93
TNF1A11	136769	"TATA box binding protein (TBP)-associated factor, RNA polymerase II, A, 250kD"	0.43	0.95	1.06	1.23	1.64	0.88	2.46	3.19	4.13	2.68	1.69	3.33	2.74	3.55	0.89	0.34	1.37	1.22	4.29	3.66	0.93	5
TNF1A12	154763	promyelocytic leukemia	1.55	3.67	0.51	1.6	2.65	1.95	2.46	2.34	1.37	1.72	1.07	1.28	1.12	1.46	0.99	1.39	2.91	1.2	2.06	0.85	1.59	1.43
TNF1B1	162479	E74-like factor 3 (ets domain transcription factor)	0.63	3.6	0.11	1.05	2.61	1.7	1.91	1.49	1.4	2.54	2.47	1.09	2.13	1.05	1.58	1.45	0.61	0.66	1.91	1.04	0.18	1.41
TNF1B2	50576	zinc finger protein 162	1.57	2.34	1.04	1.49	2.4	1.97	1.49	1.61	1.09	1.87	1.92	1.49	1.91	1.37	1.1	1.94	1.36	1.24	1.87	2.14	1.61	2.03
TNF1B3	52681	v-rel avian reticuloendotheliosis viral oncogene homolog B (nuclear factor of kappa light polypeptide gene enhancer in B-cells 3)	2.14	2.2	0.79	0.91	1.81	0.76	1.24	1.47	1.07	1.98	1.87	3.36	2.04	3.4	0.93	1.24	0.93	3.05	3.75	2.44	2.27	2.66
TNF1B4	190107	histone deacetylase 3	1.51	2.51	1.29	0.95	2.66	1.46	1.52	1.58	1.26	0.85	1.19	1.9	1.84	2.36	1.4	1.82	1.8	1.25	1.7	0.85	0.55	1.87
TNF1B5	192694	"POU domain, class 2, transcription factor 1"	1.53	0.92	1.2	1.04	1.21	1.3	1.18	1.68	1.91	0.92	0.6	1.43	1.28	2.33	0.9	0.72	0.98	1.4	2.54	0.96	1.64	1.77
TNF1B6	193901	"TATA box binding protein (TBP)-associated factor, RNA polymerase II, A, 250kD"	1.62	1.96	0.81	1.24	3.58	2.84	1.86	2.21	2.63	2.02	2.37	1.89	2.49	2.37	1.48	2.93	0.91	1.97	1.87	1.11	1.41	2.26
TNF1B7	209310	v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (p65))	0.84	0.81	0.89	1.03	1.15	0.86	1.05	1.01	0.79	0.65	0.86	1.17	1.05	1.04	0.81	0.6	0.57	1.61	1.87	1.11	0.81	1.21
TNF1B8	222502	transcription factor AP-2 beta (activating enhancer-binding protein 2 beta)	1.26	1.57	0.92	0.96	2.26	5.59	1.5	1.15	1.12	2.48	1.22	1.37	1.37	1.65	0.88	1.41	2.21	1.12	1.35	0.96	0.7	1.63
TNF1B10	247869	GATA-binding protein 1 (globin transcription factor 1)	1.94	2.81	0.71	1.39	3.25	1.94	1.96	2.08	3.39	1.27	1.14	3.02	2.12	2.4	1.38	2.96	1.83	2.02	2.47	1.34	1.94	2.82
TNF1B11	252185	"TATA box binding protein (TBP)-associated factor, RNA polymerase I, C, 110kD"	1.3	1.71	1.37	1.08	2.16	0.96	1.34	1.27	2.04	0.96	0.64	1.89	1.13	2.05	0.7	0.8	0.91	1.3	2.05	1.23	0.93	1.24
TNF1B12	256323	signal transducer and activator of transcription 3 (acute-phase response factor)	0.46	0.78	0.33	0.41	0.82	0.85	0.61	0.5	0.42	0.63	0.65	0.41	1.02	0.96	0.58	0.66	0.62	1.02	0.49	0.29	0.44	0.74
TNF1C1	257458	"transcription elongation factor A (SII), 1"	1.26	0.77	1.14	1.07	1.55	0.92	0.86	1.1	1.13	0.87	0.94	1.22	1.85	1.26	1.33	1.17	0.72	1.27	0.57	0.74	0.56	0.8
TNF1C2	260288	"Homo sapiens transcriptional enhancer factor (TEF1) DNA, complete CDS"	3.42	3.64	4.03	3.63	8.49	2.43	7.68	7.36	7.14	11.51	3.91	3.88	3.48	5.52	2.11	4.47	3.57	5.36	2.3	3.3	1.03	1.97
TNF1C3	264200	signal transducer and activator of transcription 5A	0.95	0.83	1.05	0.35	1.57	1.25	0.5	1.54	2.74	1.49	0.81	0.97	1.79	1.39	1.34	0.65	0.91	2.82	2.14	1.28	1.16	1.42
TNF1C4	271416	Sp1 transcription factor	1.4	1.5	0.65	1.26	1.7	1.74	1.2	1.38	1.17	1.06	1.26	1.24	2.06	0.98	1.42	1.33	1.6	0.71	1.19	1.15	1.11	1.29
TNF1C5	272110	new Ets-related factor	0.84	0.57	0.67	0.44	0.68	0.52	0.34	0.52	0.98	0.32	0.27	0.34	0.47	0.35	0.96	0.56	0.33	0.4	0.84	0.31	0.37	0.43
TNF1C7	280465	ESTs	2.97	2.11	1.83	1.68	2.37	1.58	1.03	1.73	2.81	0.74	1.02	1.28	1.92	4.92	1.02	1.05	1.85	1.35	2.2	1.72	1.02	1.21
TNF1C8	280735	TATA box binding protein	1.56	2.32	1.48	1.34	1.72	1.77	1.84	1.1	1.85	1.95	0.95	1.55	1.35	2.14	1.34	2.13	1.85	1.81	1.23	0.89	0.55	1.1
TNF1C9	282065	"amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)"	1.4	1.05	0.91	1.15	2.55	1.62	1.44	2.27	2.89	1.36	1.31	2.81	1.56	2.39	1.13	1.18	0.58	0.97	1.69	0.87	1.13	1.77
TNF1C11	288650	"ESTs, Weakly similar to !!!! ALU SUBFAMILY SQ WARNING ENTRY !!!! [H.sapiens]"	1.32	1.36	1.14	1.54	1.66	2.26	1.4	3.4	2.35	1.65	1.78	3.13	1.5	1.26	1.06	1.01	1.63	1.79	2.1	1.01	1.73	1.88
TNF1C12	290117	"pleckstrin homology, Sec7 and coiled/coil domains, binding protein"	1.67	3.98	1.07	4.49	5.99	6.54	4.48	2.38	1.93	7.39	3.94	4.3	2.85	2.41	0.9	3.9	2.53	2.02	2.79	1.06	2.01	1.48
TNF1D1	291943	"general transcription factor IIF, polypeptide 2 (30kD subunit)"	0.66	0.6	0.8	0.8	1.03	0.54	0.59	0.68	2	0.4	0.38	0.4	0.62	0.67	0.58	0.67	0.61	0.51	0.39	0.23	0.26	0.44
TNF1D2	293032	transcription factor AP-2 alpha (activating enhancer-binding protein 2 alpha)	1.58	1.1	0.58	1.45	2.05	1.49	1.65	2.01	1.54	0.97	1.47	1.14	1.39	1.13	1.29	1.49	1.72	1.45	0.84	0.76	0.68	0.93
TNF1D3	295093	Spi-B transcription factor (Spi-1/PU.1 related)	1.64	1.01	2.17	1.06	0.82	1.47	1.46	1.5	2.38	1.11	1.06	1.7	1.29	1.22	1.82	1.05	0.98	3.82	0.82	1.3	0.91	0.78
TNF1D5	300071	thyroid transcription factor 1	0.78	1.09	1.93	1.58	0.96	0.71	1.28	0.63	2.56	0.43	0.66	0.95	1.2	1.17	0.86	1.07	0.59	0.85	1.94	0.69	0.51	0.98
TNF1D6	300960	ESTs	2.17	1.17	1.81	1.45	1.45	1.73	1.56	1.99	1.49	1.3	1.3	1.44	1.46	1.63	1.62	1.53	1.6	1.63	1.28	0.74	0.8	1.13
TNF1D7	304947	promyelocytic leukemia	1.41	1.5	1.7	1.1	1.61	1.39	1.65	1.93	1.67	1	1.19	1.45	1.41	1.45	1.11	1.09	1.29	0.98	1.14	0.96	0.83	1.15
TNF1D8	305455	"interferon-stimulated transcription factor 3, gamma (48kD)"	3.74	5.96	2.14	3.29	2.37	4.93	3.86	4.57	5.54	4.52	4.67	5.43	2.72	3.36	2.42	3.43	2.22	2.91	4.17	6.51	6.04	7.87
TNF1D9	309924	histone deacetylase 2	0.76	1.47	1.17	1.95	2.07	2.58	1.28	1.06	0.79	0.88	0.77	1.12	0.55	0.5	0.72	2.33	1.35	1.27	0.71	0.33	0.82	0.68
TNF1D10	320538	YY1 transcription factor	1.39	1.85	1.42	1.93	1.98	1.29	2.11	1.28	1.47	1.71	1.78	0.96	1.24	1.51	0.9	1.43	1.59	1.44	1.15	0.76	0.7	1.12
TNF1D11	322000	E74-like factor 1 (ets domain transcription factor)	0.96	0.81	1.13	1.19	0.97	1.15	1.33	1.63	1.02	0.34	0.64	1.21	0.99	0.93	0.24	0.31	1.41	1.14	3.25	1.94	3.14	3.67
TNF1D12	327111	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1"	2.21	2.68	8.73	5.09	2.68	1.89	4.98	6.74	10.53	2.96	1.45	7.15	3.33	3.1	2.44	2.72	0.91	3.52	1.19	3.38	1.22	1.96
TNF1E2	344769	"ESTs, Weakly similar to P300/CBP-associated factor [H.sapiens]"	1.31	2.29	0.89	1.31	1.91	1.32	2.96	1.7	2.71	1.65	1.16	1.57	1.41	1.71	1.07	2.3	1.53	1.92	1.5	1.19	1.08	1.78
TNF1E3	345527	forkhead (Drosophila)-like 8	1.83	1.01	1.59	0.85	0.65	0.9	0.58	1.25	1.4	0.51	0.48	0.8	0.85	0.7	0.86	0.41	0.62	1.03	0.55	0.39	0.61	0.57
TNF1E4	347573	ADP-ribosylation factor related protein 1	1.68	0.9	0.92	0.5	1.65	1.17	1.24	1.68	2.37	0.99	1.03	1.95	1.48	0.62	0.63	1.83	0.68	0.76	1.57	0.69	0.69	1.19
TNF1E5	347685	"core-binding factor, beta subunit"	1.91	1.02	1.08	1.23	1.15	0.98	0.89	1.51	0.96	0.7	0.96	1	0.96	1.64	1.12	0.91	0.96	1.01	0.96	0.38	0.81	0.77
TNF1E6	357357	transcription factor 6-like 1 (mitochondrial transcription factor 1-like)	1.7	2.34	0.65	0.9	2.24	1.39	1.3	1.41	1.59	1.23	0.84	1.89	1.89	2.45	0.91	1.88	0.91	2.06	1.11	0.76	0.66	1.46
TNF1E7	358677	"general transcription factor IIE, polypeptide 2 (beta subunit, 34kD)"	0.92	1.57	1.11	1.17	1.04	0.58	0.67	1.04	1.06	0.89	0.93	0.61	0.96	0.9	0.87	0.8	0.63	1.54	0.71	0.29	0.56	0.7
TNF1E8	358538	immediate early protein	0.97	0.97	0.76	0.55	1.93	0.78	1.16	1.05	0.96	1.19	0.52	0.97	1.5	1.27	0.6	1.33	0.97	0.84	0.56	0.86	0.52	1.29
TNF1E10	361401	"general transcription factor IIH, polypeptide 1 (62kD subunit)"	1.5	1.68	0.48	0.57	2.47	1.52	3.4	2.72	2.95	2.39	2.11	1.29	1.17	1.64	1.13	1.61	1.85	1.56	1.74	0.78	0.66	1.13
TNF1E11	361815	Homo sapiens mRNA; cDNA DKFZp434E033 (from clone DKFZp434E033)	0.6	0.56	0.69	0.81	0.78	0.27	0.54	1.22	0.58	0.6	1.19	0.35	1.35	0.76	0.54	0.58	0.56	0.52	1.52	1.49	0.75	1.26
TNF1E12	366981	transcription factor CP2	1.32	2.25	0.77	1.25	2.58	0.94	1.82	1.65	1.7	0.68	0.66	1.73	1.35	1.98	1.14	1.75	1.98	1.46	2.1	0.54	1.33	1.74
TNF1F1	375635	"transcription factor 12 (HTF4, helix-loop-helix transcription factors 4)"	0.83	0.94	0.55	0.67	0.91	3.49	0.54	0.83	0.55	0.38	0.58	0.53	0.82	0.98	0.55	0.3	0.43	1.04	0.96	0.63	0.64	0.7
TNF1F2	375724	activating transcription factor 4 (tax-responsive enhancer element B67)	0.47	0.78	0.47	0.55	0.7	0.71	0.78	0.63	0.65	0.51	1.15	0.82	1.03	0.9	1.24	1.07	0.56	1.01	0.74	0.35	0.59	0.87
TNF1F3	375843	"Homo sapiens mRNA for HSM-2, complete cds"	1.71	1.01	1.09	1.13	1.47	2.19	0.58	1.12	1.01	0.91	0.98	1.2	1.49	1.4	1.3	0.58	0.76	1.26	1.28	0.61	1.18	1.11
TNF1F4	376294	transcriptional repressor	1.58	2.08	1.13	1.19	2.49	1.53	1.46	1.93	1.82	1.93	1.94	1.79	1.47	3.13	1.04	1.52	1.59	1.47	1.22	0.49	0.52	1.08
TNF1F5	376218	promyelocytic leukemia	0.97	1.97	1.39	1.73	1.78	1.71	1.86	1.7	1.6	1.36	1.7	1.53	1.28	2.35	1.3	0.95	1.9	1.79	3.01	1.13	2.03	1.92
TNF1F7	380738	transcription factor 4	1.07	0.84	1.18	1.91	2.27	2.25	2.67	4.31	1.56	1.93	1.88	1.42	2.92	2.94	1.5	1.32	1.58	1.54	2.57	1.4	1.9	2.68
TNF1F8	381219	"ISL1 transcription factor, LIM/homeodomain, (islet-1)"	0.6	0.96	0.39	0.62	1.22	0.77	0.9	0.66	0.73	1.14	0.81	1.23	1.33	2.03	0.39	0.85	1.57	0.98	0.73	0.4	0.34	1.07
TNF1F9	417127	nuclear factor I/C (CCAAT-binding transcription factor)	2.18	2.75	1.58	1.69	2.12	2.03	1.47	2.26	1.98	1.13	2.02	1.94	2.09	2.89	1.72	1.05	0.91	1.35	1.38	0.96	0.97	1.09
TNF1F10	418320	Homo sapiens mRNA; cDNA DKFZp434E082 (from clone DKFZp434E082)	1.66	1.56	0.48	0.94	1.35	2.24	1.36	1.13	1.07	1.03	1.83	1.68	1.7	2.22	1.31	1.54	1.81	1.06	1.12	0.85	0.83	1.01
TNF1F11	428248		0.85	0.92	0.49	0.81	1.63	0.5	0.43	1.53	0.47	0.75	0.92	0.97	1.67	0.38	0.75	0.47	0.46	0.61	1.15	0.34	0.73	0.67
TNF1F12	470792	general transcription factor IIB	2.1	2.06	1.84	1.48	2.18	1.65	1.77	1.77	1.47	0.93	1.49	1.54	1.93	2.38	0.94	1.9	1.98	2.34	1.41	0.81	1.22	1.59
TNF1G1	471218	transcription factor 8 (represses interleukin 2 expression)	1.32	1.45	0.79	0.79	1.23	1.91	0.79	0.96	1.1	0.74	0.61	1.02	0.95	1.21	1.52	0.45	1.04	0.96	0.68	0.64	0.82	1.28
TNF1G3	471889	"nuclear receptor subfamily 2, group F, member 1"	1	1.04	0.69	0.62	1.11	0.83	0.69	1.04	0.63	0.83	0.79	0.91	1.34	1.26	1.34	0.8	0.6	1.11	1.23	0.62	0.77	1.69
TNF1G4	485192	ESTs	2.3	2.94	1.23	2.29	2.54	1.72	2.27	1.83	1.72	1.68	1.88	1.98	2.01	4	1.57	2.31	1.79	2.9	2.16	0.83	1.17	1.98
TNF1G6	486410	YY1 transcription factor	1.45	1.82	0.66	1.16	1.78	1.23	1.12	1.09	0.76	1.01	1.49	1.21	1.42	1.04	1.21	1.13	2.02	1.81	1.14	0.62	0.8	0.63
TNF1G7	487982	basic transcription factor 3	0.6	0.38	0.39	0.49	0.58	0.48	0.73	0.6	0.5	0.62	0.58	0.5	1.13	1.37	0.71	0.44	0.52	0.92	0.57	0.38	0.52	0.81
TNF1G8	488092	DKFZP434H071 protein	2.06	1.24	1.2	1.73	2.59	1.48	2.61	4.61	2.01	2.02	2.15	3.48	3.15	2.3	2.16	2.23	1.28	1.07	4.86	1	2.67	3.72
TNF1G9	488658	"Homo sapiens mRNA for transcription elongation factor S-II, hS-II-T1, complete cds"	0.67	1.36	1.14	0.63	1.12	0.68	0.93	1.03	1.31	0.65	0.79	1.43	0.74	1.3	0.81	0.57	0.45	1.04	1.64	0.93	0.78	1.02
TNF1G10	488904	suppressor of Ty (S.cerevisiae) 4 homolog 1	1.79	1.84	1.01	1.6	1.45	1.27	5.04	1.9	3.38	3.97	1.53	1.75	1.29	1.67	1.02	1.54	1.4	1.77	2.16	1.47	1.59	2.66
TNF1G11	509710	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"	0.83	2.4	0.95	1.35	1.37	1.75	1.23	1.45	1.99	1.01	1.62	1.26	0.79	1.4	1.3	1.29	1.52	1.69	1.6	0.87	1.12	1.3
TNF1G12	509682	histone deacetylase 3	0.75	0.9	0.95	0.91	1.83	0.72	1.44	1.85	1.58	1.08	1.81	1.53	2.32	3.91	2.23	1.21	0.98	1.11	5.43	1.61	2.7	7.78
TNF1H1	509588	"TATA box binding protein (TBP)-associated factor, RNA polymerase II, J, 20kD"	1.1	0.67	0.91	0.74	0.53	0.9	0.99	0.66	0.53	0.66	0.66	0.73	1	1.12	0.7	0.61	0.9	0.73	0.63	0.42	0.5	0.81
TNF1H3	510381	core promoter element binding protein	0.71	0.73	0.47	0.53	0.54	0.57	0.51	0.84	0.35	0.34	0.4	0.57	1.34	0.63	0.73	0.41	0.7	1.18	0.53	0.22	0.33	0.56
TNF1H5	125555	activating transcription factor 4 (tax-responsive enhancer element B67)	0.82	0.82	0.47	0.53	0.6	0.63	0.59	0.85	0.57	0.29	0.28	0.63	1.21	0.83	0.87	0.27	0.77	1.16	0.51	0.24	0.37	0.58
TNF1H7	194384	basic transcription factor 3	0.98	0.55	0.47	0.6	0.79	0.67	0.43	1.15	1.13	0.18	0.17	0.93	1.55	1.34	0.93	0.3	0.91	1.18	0.74	0.31	0.56	0.7
TNF1H9	203184	ESTs	0.62	0.68	0.67	0.77	0.53	0.82	0.73	1.52	0.67	0.17	0.18	0.75	1.07	0.92	0.6	0.23	0.91	1.02	0.64	0.62	0.55	0.8
TNF1H10	241412	E74-like factor 1 (ets domain transcription factor)	1.06	1.44	0.64	1.02	1.13	1.33	1.31	1.2	1.34	0.9	1.02	1.16	1.45	1.56	1.31	1	0.91	1.44	0.91	0.48	0.74	0.87
TNF1H11	248258	EST	0.81	0.87	0.67	1.09	0.73	0.93	0.93	1.33	0.8	1.72	0.84	1.04	1.17	1.15	0.47	0.27	0.26	1.05	1.65	0.86	1.22	1.69